{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO's financial exposure to the 5.000% notes due April 2030 remained stable at $606 million from fiscal years 2022 through 2024, as shown in the respective 10-K filings. This consistency suggests that AVGO did not refinance or significantly alter its position in these notes during this period. The stable exposure, combined with the notes' effective interest rate of 5.18%, indicates a disciplined debt management strategy, where AVGO has maintained long-term fixed-rate debt obligations without increasing leverage or restructuring existing debt, thereby preserving financial stability and predictable interest costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the evolution of AVGO's exposure. The ground truth states that exposure decreased from $1,086 million in 2022 to $606 million in 2023 and remained at $606 million in 2024. However, the LLM claims exposure was stable at $606 million from 2022 through 2024, which misrepresents the key trend—there was a significant reduction in 2023. This error undermines the entire analysis. (2) Quantitatively, the $606 million figure for 2023 and 2024 is correct, but the $1,086 million value for 2022 is entirely omitted and replaced with an incorrect assertion of stability. The effective interest rate of 5.18% mentioned in the LLM answer is not present in the ground truth and cannot be verified, introducing unconfirmed data. (3) The multi-hop reasoning is flawed because the model failed to detect and report the decrease from 2022 to 2023, which is central to understanding AVGO’s debt management strategy as one of active reduction. Instead, it concludes stability and lack of restructuring, which contradicts the ground truth showing a deliberate paydown. (4) While the answer is relevant to the question and discusses debt management strategy, the incorrect data leads to an invalid conclusion. The contextual relevance is moderate because it addresses the right topic and metric, but with critical factual errors. Correctness and quantitative accuracy are low due to the misstatement of the core financial figures and trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 409,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "From 2022 to 2024, MetLife maintained a consistent use of the modified coinsurance agreement, reinsuring 59.25% of the closed block in 2022 and 59% in both 2023 and 2024. This consistency in the percentage of risk transferred through the agreement highlights the stability of MetLife’s long-term reinsurance strategy, particularly in managing the closed block. By retaining a similar level of risk transfer over the three-year period, MetLife demonstrates a deliberate and strategic approach to balance risk mitigation and capital efficiency, leveraging well-capitalized third-party reinsurers to manage exposure while maintaining financial control through the deposit method of accounting and offsetting mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage of the closed block reinsured each year: 59.25% in 2022 and 59% in both 2023 and 2024, matching the ground truth exactly. It also correctly identifies the use of the deposit method of accounting and the right of offset, which are key qualitative elements. However, it omits the specific growth in total net ceded reinsurance recoverables from $6.3 billion (referenced in 2022 filing) to $17.6 billion in 2024, which provides important context for the scale of reinsurance activity despite stable risk transfer percentages. (2) All numeric values—percentages and years—are accurate and correctly attributed. No calculations are required beyond reporting, and all figures align with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that stable risk transfer percentages indicate a consistent long-term reinsurance strategy focused on capital efficiency and risk management. The conclusion about strategic balance is logically supported. (4) The answer is highly relevant and factually correct, with only a minor omission of the dollar-value trend in recoverables, which slightly reduces completeness but does not affect the core correctness of the response. Hence, a score of 9 is justified—excellent accuracy with near-full completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 382,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This declining trend suggests that the company is effectively managing its derivative exposure by reducing the amount of collateral required, likely due to improved credit terms, lower counterparty risk, or a reduction in the volume of derivative contracts. The consistent linkage across the three years, as shown in the provided 10-K filings, indicates a strategic and controlled approach to collateral management in derivative transactions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. There are no discrepancies in dollar amounts or years. (2) All numbers are accurate and consistent with the original answer; no calculations are required beyond the stated values, and the trend (decreasing over time) is correctly identified. Format variations (e.g., 'million' vs 'M') are acceptable and not present here, but would be permissible. (3) The multi-hop reasoning is sound: the model synthesizes data across three years from ExxonMobil's 10-K filings, correctly identifying the trend and linking it to derivative exposure management. The conclusion about strategic reduction in exposure or improved offsetting mechanisms is logically extended in the LLM answer with plausible explanations (e.g., improved credit terms, lower counterparty risk), which are consistent with and expand upon the ground truth without introducing inaccuracies. (4) The answer fully addresses both parts of the question: the quantitative change over time and the implication for derivative exposure management. Semantic equivalence is maintained and enhanced with contextually appropriate elaboration. All scores are maximized due to complete factual accuracy, correct entity and year identification, logical reasoning, and full relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 394,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO's financial exposure to the 3.625% notes due October 2024 was $622 million in both fiscal years 2022 and 2023, as shown in the respective 10-K filings. However, in fiscal year 2024, the balance for these notes dropped to $0, indicating that AVGO had fully repaid or redeemed this debt instrument by the end of fiscal 2024. This progression suggests a deliberate debt management strategy to retire the 2024 notes ahead of their maturity, likely to reduce near-term debt obligations and potentially take advantage of favorable market conditions for refinancing or to strengthen liquidity. The repayment aligns with AVGO’s broader approach of managing its debt portfolio to optimize interest costs and maintain financial flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the figures of $622 million in 2022 and 2023, and $0 in 2024, are accurately reported with correct fiscal years and consistent with the original answer. The note's interest rate (3.625%) and maturity (October 2024) are correctly identified. (2) The answer is complete, addressing both the evolution of AVGO's exposure across all three fiscal years and the implications for debt management strategy. (3) Entity accuracy is perfect: AVGO is correctly identified, the debt instrument is accurately described, and the timeline (fiscal years 2022–2024) aligns with the filings. (4) The reasoning is sound and adds value: the conclusion that AVGO retired the debt ahead of maturity is logically derived from the drop to $0, and the interpretation about reducing near-term obligations, potential refinancing, and financial flexibility is a reasonable and contextually appropriate extension of the facts. The multi-hop synthesis—connecting the consistent principal in 2022–2023, the drop to zero in 2024, and the strategic implications—is correctly executed. Minor enhancements in interpretation (e.g., mentioning refinancing or market conditions) do not detract from factual accuracy and improve contextual insight. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 374,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics' revenue from surface ships increased from $2,328 million in 2022 to $2,698 million in 2023 and further to $2,819 million in 2024, reflecting a consistent upward trajectory over the three-year period. This growth, combined with the broader increase in Total Marine Systems revenue, indicates that General Dynamics is strengthening its positioning in naval shipbuilding, likely due to increased demand for surface ship production and its strategic focus on defense-related contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 revenue figure. The ground truth states $2,561 million for 2022, but the LLM reports $2,328 million, which is incorrect by over $230 million. The 2023 and 2024 figures ($2,698M and $2,819M) are accurate and match the original answer. This quantitative inaccuracy severely impacts the correctness score. (2) Calculations: While the LLM shows an upward trend, the starting point is wrong, leading to an inflated growth narrative. The actual growth from 2022 to 2023 is $137M, not $370M as implied by the LLM's numbers. This undermines the precision of any implied growth rate or trajectory analysis. (3) Multi-hop reasoning: The LLM correctly identifies the three-year trend and draws a reasonable qualitative conclusion about General Dynamics' positioning in naval shipbuilding, citing strategic focus and demand—this aligns with the intent of the original answer and demonstrates sound reasoning based on the (partially incorrect) data it used. It also appropriately contextualizes the surface ship revenue within the broader Marine Systems division. (4) Despite the major error in the 2022 figure, the answer is otherwise well-structured, addresses both parts of the question (revenue evolution and strategic implication), and uses semantically appropriate language. The conclusion about strengthening positioning is consistent with the trend, even if the magnitude of growth is misrepresented. Hence, qualitative accuracy and contextual relevance are high, but quantitative accuracy and overall correctness are significantly reduced due to the incorrect financial figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 451,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024, the A Class shares of MA consistently retained one vote per share and dividend rights, as disclosed in the 10-K filings for each year. The voting and dividend structure remained unchanged across all three years, with no modifications to the rights associated with A Class shares. This three-year consistency indicates a stable shareholder governance structure, reinforcing the predictability and continuity of voting and dividend entitlements for A Class shareholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that MA's A Class shares had one vote per share and standard dividend rights from 2022 to 2024, with no changes—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the description of voting and dividend rights is factually consistent. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of 10-K filings, confirming consistency over time, and drew the appropriate conclusion about governance stability. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of rights and the implication for shareholder governance stability. All entities—MA, A Class shares, 2022–2024 timeframe—are correctly identified. Wording differs slightly but conveys identical meaning, satisfying semantic equivalence. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 297,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics' revenue from surface ships increased from $2,328 million in 2022 to $2,698 million in 2023 and further to $2,819 million in 2024, reflecting a consistent year-over-year growth of 16.1% (2022 to 2023) and 6.3% (2023 to 2024). This upward trend indicates the company's strengthening positioning in naval defense programs, particularly in the production of surface ships, as highlighted by the interconnected disclosures and production relationships between General Dynamics and the Surface Ships segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 revenue figure. The ground truth states $2,561 million for 2022, but the LLM reports $2,328 million, which is incorrect. The 2023 and 2024 figures ($2,698 million and $2,819 million) are accurate and match the original answer. (2) Due to the incorrect 2022 baseline, the calculated year-over-year growth rates are wrong: the LLM reports 16.1% growth from 2022 to 2023, but the correct growth is (2,698 - 2,561) / 2,561 ≈ 5.35%. The 2023 to 2024 growth is correctly calculated as approximately 6.3%. (3) The qualitative reasoning and multi-hop synthesis are sound—the LLM correctly infers that the upward trend reflects strengthening positioning in naval defense programs, which aligns with the original answer’s interpretation. It appropriately connects revenue growth to increased involvement in defense contracts. (4) While the reasoning and contextual relevance are strong, the quantitative inaccuracy in the 2022 revenue number and the resulting incorrect YoY percentage significantly impact the correctness score. The answer is partially correct but contains a major factual flaw in the initial data point, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 343,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde's reliance on long-term contracts for industrial gas products remained consistent from 2022 to 2024, as highlighted in its 10-K filings for each year, with each document emphasizing that the majority of the company's business is conducted through such contracts. This consistency underscores Linde's strategic focus on cash flow stability, particularly in the face of fluctuating energy markets, by enabling the company to pass through changes in energy and feedstock costs to customers. The sustained use of long-term contracts reflects a deliberate approach to mitigate financial volatility and maintain reliable product supply across its global customer base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde's reliance on long-term contracts is consistently emphasized from 2022 to 2024, and the purpose—cash flow stability and cost pass-through amid fluctuating energy markets—is accurately conveyed. There are no incorrect numbers, dates, or entities; the time frame (2022–2024) is correctly referenced. (2) Quantitative accuracy is perfect: while no specific numerical values (e.g., dollar amounts or percentages) are present in either answer, the temporal span and consistency across three years are correctly noted, matching the original. (3) The multi-hop reasoning is sound—the model synthesizes Linde’s contractual strategy across multiple years and correctly infers its strategic implications for financial stability and risk management. The only minor shortcoming is that the LLM answer does not explicitly mention 'inflationary pressures' or frame the strategy as a signal of 'deliberate and stable approach to risk management' as directly as the original, slightly reducing qualitative depth. However, the core reasoning about mitigating volatility and ensuring reliability is present. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution (consistency over time) and implications for cash flow stability—and remains focused on Linde’s strategic posture in energy-sensitive markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 401,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "From 2022 through 2024, GD consistently excluded non-economic accounting changes from its ROIC calculation, as stated in its 10-K filings for each year. This consistent treatment reveals that GD maintains a focused approach to measuring core performance by filtering out non-operational or non-economic adjustments that do not reflect the company’s underlying operational results. The continuity in this policy across all three years underscores GD’s commitment to a standardized and performance-oriented metric for evaluating returns.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability over the three-year period. (2) There are no numerical values requiring calculation in this question, but the years (2022–2024) and the metric (ROIC) are correctly identified and consistently referenced. (3) The multi-hop reasoning is sound—by synthesizing information across three years of 10-K filings, the model correctly infers a consistent policy, which supports the conclusion about GD’s institutionalized approach to core performance measurement. (4) The LLM adds slight elaboration (e.g., 'performance-oriented metric', 'standardized') that enhances clarity without introducing inaccuracies, and it maintains full factual alignment with the ground truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 291,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's service level guarantee obligations were consistently disclosed as immaterial, with no material amounts accrued, paid, or charged to income in any of the years. This consistent immateriality across all three years suggests that the company has effectively managed the risks associated with these guarantees and has maintained consistent contractual performance, avoiding significant financial exposure or penalties. The pattern reflects strong risk management practices and operational reliability in meeting service level commitments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group's service level guarantee obligations were consistently immaterial from 2022 to 2024, with no material amounts accrued, paid, or charged to income—matching the original answer exactly in factual content. (2) There are no numerical discrepancies; the time frame (2022–2024) and the qualitative financial impact ('immaterial') are correctly reported across all years. No calculations are required, but the synthesis of consistent disclosures over three years is properly conveyed. (3) The multi-hop reasoning is sound: the model correctly infers from the pattern of immaterial impacts that UnitedHealth maintained strong risk management and contractual performance, which is a valid conclusion supported by the data. (4) All entities—UnitedHealth Group, service level guarantees, financial impact disclosures—are accurately identified and contextualized. The answer addresses both parts of the question: the evolution of obligations (consistently immaterial) and the implication for risk management and performance (effective and consistent). Wording differs slightly but preserves full meaning, demonstrating strong qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 357,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics' revenue from surface ships increased from $2,328 million in 2022 to $2,561 million in 2023 and further to $2,819 million in 2024, reflecting a consistent upward trend over the three-year period. This growth, combined with the broader increase in Marine Systems revenue, indicates a strategic positioning by General Dynamics to strengthen its presence in naval defense platforms, particularly in surface ship production, likely driven by sustained demand from defense modernization initiatives and long-term contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue for 2022 ($2,328 million) and 2024 ($2,819 million), matching the ground truth. However, it reports $2,561 million for 2023, which is incorrect—the ground truth is $2,698 million. This is a significant numerical error affecting the quantitative accuracy. (2) The calculation of growth trend is directionally correct (upward), but the magnitude of 2023 growth is misrepresented. The actual increase from 2022 to 2023 is $370 million, while the LLM implies a $233 million increase, underestimating the growth. The 2023 to 2024 increase is accurate in the ground truth ($121 million), and the LLM correctly shows continued growth. (3) The reasoning and synthesis are sound: the LLM correctly infers that increasing surface ship revenue reflects strategic positioning in naval defense platforms, links it to Marine Systems, and attributes the trend to defense modernization and long-term contracts—this aligns with the ground truth's implication of sustained demand and segment expansion. (4) Despite the incorrect 2023 figure, the overall trend and strategic interpretation are valid, warranting a 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the material error in a core data point. Qualitative accuracy is high (8) due to correct reasoning and contextual framing. Contextual relevance is perfect (10) as all parts of the question are addressed with relevant analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 404,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "From 2022 through 2024, GE's relationship with Electric Insurance Company (EIC) evolved from being a classified held-for-sale asset to its eventual divestiture. In the fourth quarter of 2022, GE classified EIC, a captive industrial insurance subsidiary with assets of $541 million and liabilities of $378 million as of December 31, 2023, as held for sale. In the third quarter of 2023, a binding agreement to sell EIC was signed, and a $109 million loss was recorded in 2023 in connection with the expected sale. The transaction was completed in the second quarter of 2024, with EIC sold to Riverstone International Holdings Inc. for cash proceeds of $120 million. This transition reflects GE's strategic move to divest non-core insurance operations, reducing financial exposure and reclassifying EIC from an associated company to a divested entity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events in GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including classification as 'held for sale', the $109 million loss, sale to Riverstone International Holdings Inc. for $120 million, and the strategic rationale. However, there are significant factual inaccuracies in timing and data attribution. (2) Quantitative inaccuracies: The LLM incorrectly states that EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023, in the context of 2022 disclosures — this data belongs to 2023, not 2022. The original answer specifies that the $0.2 billion net claim reserves were as of December 31, 2021, but the LLM omits this entirely and misattributes the 2023 balance sheet figures to 2022. Additionally, the LLM claims classification occurred in Q4 2022, but the original answer does not specify the quarter — only that by 2023 it was classified as held for sale. The $109 million loss is correctly cited, as is the $120 million sale price in 2024. (3) Multi-hop reasoning is generally sound — the LLM traces the evolution from ownership to divestiture, recognizes the financial impact, and identifies the buyer. However, it conflates timelines and misassigns financial data across years, weakening the synthesis. (4) The contextual relevance is perfect — it directly addresses classification, financial exposure, and divestiture. Qualitative accuracy is high due to correct entities and logical flow, but quantitative accuracy is reduced due to incorrect date/figure pairing. Correctness score is 7 because core facts (sale, loss, buyer, amount) are correct, but key financial data is misattributed across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> COMP <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 471,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips initiated the monetization of its CVE common shares in May 2021, completing the sale of its remaining 91 million shares by the first quarter of 2022. The proceeds from this disposition were directly applied to its share repurchase program, which saw an authorization increase from $25 billion to $45 billion in October 2022. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion. In 2024, the share repurchase program continued with further authorization increased to $65 billion, and total repurchases reached 433 million shares at a cost of $34.3 billion. This progression indicates a consistent and strategic capital allocation approach, where proceeds from asset monetizations are being actively reinvested into share repurchases to return value to shareholders and optimize capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately states that ConocoPhillips completed the sale of its remaining 91 million CVE shares by Q1 2022 (consistent with the ground truth that the monetization started in May 2021 and concluded in 2022). The share repurchase program's initial $45 billion authorization is correctly noted, and the $20 billion increase in 2024 (to a total of $65 billion) is accurately described. The cumulative repurchase figures—383 million shares at $29 billion by end of 2023 and 433 million shares at $34.3 billion by end of 2024—are exactly matched in both answers. (2) Quantitative accuracy is high: all dollar amounts ($29B, $34.3B, $45B, $65B), share counts (91M, 383M, 433M), and timeframes (2022 completion, 2024 increase) align with the ground truth. One minor discrepancy: the LLM mentions the repurchase authorization increased from $25B to $45B in October 2022, which is not in the original answer; the ground truth only states the $45B authorization existed without specifying a prior $25B level or the October 2022 timing. This introduces a small factual overprecision not supported by the source, slightly reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links the CVE share monetization proceeds to funding share repurchases and interprets this as part of a broader capital return strategy, showing synthesis across events and years. (4) The answer is semantically equivalent to the original, with slightly enhanced wording but no distortion of meaning. The conclusion about strategic capital allocation and shareholder value return is fully justified and consistent with the ground truth. Thus, the answer is excellent overall, with only a minor unsupported detail affecting quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 493,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "From 2022 to 2024, MetLife consistently reinsured 59% (or 59.25% in 2022) of its closed block through a modified coinsurance agreement and continued to account for this arrangement under the deposit method of accounting. This consistency in both the percentage reinsured and the accounting treatment reflects a stable long-term risk transfer strategy, where MetLife seeks to mitigate risk exposure while maintaining financial reporting clarity and offsetting obligations through the right of offset. The unchanged approach underscores MetLife’s commitment to a structured and predictable method of risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MetLife reinsured approximately 59% of the closed block from 2022 to 2024, with the precise figure of 59.25% in 2022 and 59% in 2023 and 2024, matching the ground truth. The accounting treatment—deposit method and right of offset—is accurately described. (2) All numeric values are correct and consistent with the original answer; minor rounding (59% vs 59.25%) is acceptable and commonly used in reporting. No calculations were required beyond accurate representation of percentages. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that consistency in both reinsurance percentage and accounting treatment reflects a stable long-term risk transfer strategy. The conclusion about structured risk management aligns with the ground truth’s emphasis on longevity risk mitigation through a third-party reinsurer, though the LLM omits the explicit mention of 'longevity risk' and 'unaffiliated third-party reinsurer,' which slightly weakens qualitative completeness. (4) The answer is highly factually accurate, fully relevant, and conveys the same core meaning as the original. The minor omission of specific risk type and reinsurer affiliation prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 366,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The penetration rate of the Target MasterCard Credit Card (as part of RedCards/Target Circle Cards) declined from 20.22% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. This consistent decline suggests a gradual reduction in consumer engagement with Target's financial products over the three-year period, potentially indicating that fewer customers are opting to use these credit cards for purchases at Target, despite the 5% discount incentive. The trend may reflect broader macroeconomic factors, competitive pressures, or shifts in consumer behavior impacting the adoption of branded credit cards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. The LLM incorrectly reports 20.22% in 2022, 18.6% in 2023 (which matches the true 2024 value), and 17.8% in 2024 (which is incorrect). This misalignment suggests a failure in retrieving or synthesizing the correct time-series data. (2) The numbers are not just off by minor rounding—the 2022 figure is wrong, the 2023 figure is erroneously set to the actual 2024 value, and the 2024 projection is both incorrect and inconsistent with the source. These errors affect the validity of the trend interpretation, even though the direction (decline) is correct. (3) The qualitative reasoning is sound in interpreting the decline as a sign of reduced consumer engagement and considering possible causes like macroeconomic factors or competition. The mention of the 5% discount and rebranding context (implied by Target Circle Cards) shows appropriate multi-hop synthesis of product incentives and branding changes. However, the LLM fails to note that the 2024 rebranding did not reverse the trend—a key insight in the original answer. (4) Despite correct identification of entities (Target MasterCard, RedCard/Target Circle Card, time period) and relevance to the question, the severe numerical inaccuracies severely undermine the correctness score. The trend direction is right, but the magnitude and specific values are not, warranting a partial score. Contextual relevance is high as the answer addresses both parts of the question and provides plausible interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 451,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Philip Morris International (PMI) consistently classified Colgate-Palmolive Co. as part of its peer group in 2022, 2023, and 2024, indicating no change in its strategic benchmarking approach for consumer product peers during this period. This consistency reflects PMI's adherence to its established criteria for peer selection, which include global presence, a focus on consumer products, and similar net revenues and market capitalization. The inclusion of Colgate-Palmolive Co. across all three years underscores PMI's ongoing emphasis on benchmarking against well-established, multinational consumer goods companies, reinforcing its strategic alignment with firms operating in comparable global markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, with no change in classification—matching the original answer's claim of consistent inclusion over three years. (2) There are no numerical values requiring calculation (e.g., revenues, market cap figures), but the time frame (2022–2024) is correctly referenced, and no incorrect dates or numbers are present. (3) The multi-hop reasoning is sound: the answer synthesizes the continuity of peer group membership and correctly attributes it to PMI’s established benchmarking criteria—global presence, consumer product focus, and similarity in net revenues and market capitalization—exactly as specified in the ground truth. (4) The conclusion about PMI’s stable strategic benchmarking approach and alignment with multinational consumer goods firms is logically derived and contextually appropriate. All parts of the question are addressed: evolution (consistency), peer classification, and strategic implications. Wording differs slightly but meaning is preserved. No factual, quantitative, or reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Relates_To]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 334,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, as outlined in its 10-K filings. In all three years, AMD evaluated whether the licensing component in combined arrangements was distinct—requiring both capability of being distinct and distinctness in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. This approach remained unchanged across the three years, indicating a consistent accounting treatment for these agreements. Additionally, for standalone IP licensing arrangements, revenue was consistently recognized at a point in time, with no variable consideration estimates involved in either combined or standalone arrangements. This consistency reflects AMD’s adherence to its established accounting principles for these types of agreements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurately represented: AMD's revenue recognition policy remained consistent from 2022 to 2024; the two criteria for distinctness (capable of being distinct and distinct in the context of the arrangement) are correctly stated; the treatment of non-distinct licenses (combined with development services and recognized over time) and distinct licenses (recognized at a point in time) is accurate; standalone IP licenses are correctly described as recognized at a point in time; and the absence of variable consideration estimates across all years is properly noted. (2) There are no numeric values requiring calculation in this question, but all dates (2022–2024) and qualitative financial accounting treatments are correct. (3) The multi-hop reasoning—synthesizing AMD’s policy across three years and differentiating between combined and standalone arrangements—is sound and complete. The answer correctly infers consistency in accounting policy over time, which is the key insight requested. (4) The LLM response matches the original answer in both substance and depth, with only minor rephrasing (e.g., 'combined with development services as a single performance obligation' adds slight clarification but does not alter meaning). All aspects of the question—evolution (or lack thereof), distinction between arrangement types, and implications for consistency—are thoroughly and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 419,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate-Palmolive Co. has consistently been included in PM's (Philip Morris International) peer group for benchmarking purposes from 2022 through 2024, as confirmed by the identical PMI Peer Group listings in the 2022, 2023, and 2024 10-K filings. This consistency reflects PM's strategic framing of its competitive positioning within the global consumer products sector, aligning itself with firms that share similar characteristics such as global presence, focus on consumer goods, and comparable revenue and market capitalization. The sustained inclusion of Colgate-Palmolive Co., a major player in consumer goods, underscores PM's emphasis on benchmarking against diversified, globally operating companies beyond the tobacco industry, reinforcing its broader strategic identity in the consumer sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was consistently included in PM's peer group from 2022 to 2024, which matches the original answer's claim of unchanged inclusion across all three years. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly cited, and the reference to 10-K filings supports the data source appropriately. (3) The multi-hop reasoning is sound: the LLM infers from consistent peer group composition that PM maintains a stable benchmarking methodology and uses it to position itself strategically among global consumer product firms. It correctly identifies the rationale—global presence, consumer focus, revenue, and market cap comparability—even expanding slightly with relevant context about PM's strategic identity beyond tobacco. (4) The only minor gap is that the LLM does not explicitly state that the *entire peer group* remained unchanged, which is a detail emphasized in the original answer and adds weight to the 'stable benchmarking framework' point. However, this omission does not distort the overall meaning. The answer remains semantically equivalent in substance and correctly captures the strategic implication of this consistency. Thus, the response earns high marks across all categories, with a slight deduction in qualitative accuracy for not fully mirroring the completeness of the original reasoning around peer group stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 414,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "From 2022 through 2024, AMD’s revenue recognition policy for combined development and IP licensing agreements remained consistent in its core principles but evolved slightly in the context of performance obligations and timing. In 2022, the Company evaluated whether the licensing component in combined arrangements was distinct based on its capability to be distinct and its distinctness in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. By 2023 and 2024, the policy was reiterated with the same criteria for determining distinctness and timing of revenue recognition, emphasizing that revenue for combined arrangements is recognized over time or at a point in time depending on the nature of the arrangement. Additionally, for standalone IP licensing arrangements, revenue was consistently recognized at a point in time when the customer had the ability to benefit from the license across all three years. There were no variable consideration estimates associated with these arrangements during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes. The two criteria for assessing whether a license is distinct—(i) capable of being distinct and (ii) distinct in the context of the arrangement—are accurately described. The treatment of non-distinct licenses (combined with development services and recognized over time) and distinct licenses (recognized at a point in time) is correctly reported for all three years. The LLM also correctly notes the absence of variable consideration estimates, indicating stable accounting treatment. The only minor deviation is the use of the phrase 'evolved slightly,' which could imply a change in policy, but the subsequent explanation clarifies that the policy was reiterated with the same criteria, making this more a wording nuance than a factual error. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (AMD, years 2022–2024, performance obligations, IP licensing) are correct. The reasoning is sound, demonstrating proper synthesis across years and arrangement types. Contextual relevance is excellent, fully addressing the question about evolution, performance obligations, and timing. Thus, the answer deserves a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 415,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips initiated the monetization of its CVE common shares in May 2021, with proceeds directly applied to share repurchases. By the first quarter of 2022, the company had sold its remaining 91 million CVE common shares, marking the completion of this monetization. From 2022 through 2024, the share repurchase program expanded significantly, with the repurchase authorization increasing from $25 billion in 2022 to $65 billion by 2024, and total repurchases rising from $29 billion (383 million shares) in 2023 to $34.3 billion (433 million shares) in 2024. This multi-year progression underscores a disciplined and aggressive capital allocation strategy focused on returning value to shareholders through share repurchases, leveraging both the proceeds from CVE share sales and sustained authorization increases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: ConocoPhillips began monetizing CVE shares in May 2021, completed the sale of 91 million shares by Q1 2022, applied proceeds to share repurchases, and by end of 2023 had repurchased 383 million shares at a cost of $29 billion. By 2024, repurchases reached 433 million shares at a cost of $34.3 billion, with the authorization increased to $65 billion. These numbers match the original answer exactly, with acceptable format variations. (2) Quantitative accuracy is perfect: all dollar amounts, share counts, and timeframes are correct. The progression from $29B to $34.3B in repurchase costs and the increase in authorization to $65B are accurately reported. (3) Reasoning is sound: the LLM correctly infers that the monetization of CVE shares enabled the repurchase program and that the multi-year expansion reflects a disciplined capital allocation strategy focused on shareholder returns. It synthesizes information across 2022–2024 correctly. (4) The only minor shortcoming is that the LLM implies the $25B repurchase authorization was in place in 2022, which is not explicitly confirmed in the ground truth—though it is consistent with the $29B spent by end of 2023. The original answer does not specify the initial authorization amount, so this is a small assumption but not a factual error. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 413,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s exposure to changes in the competitive landscape has intensified across its business segments from 2022 through 2024, reflecting increasing market pressures and evolving strategic responses. In 2022, the company highlighted that segments like Honeywell Building Technologies and Safety and Productivity Solutions faced risks from new market entrants and technologies that could lead to product commoditization and margin compression. By 2023, this trend continued, with similar concerns noted across all segments, including Aerospace and Performance Materials and Technologies, as competitive pressures grew alongside global economic uncertainties. In 2024, the company restructured its segment reporting, and the competitive landscape risk remained a key concern, particularly in Industrial Automation and Building Automation, where new entrants and technological disruption are increasingly impacting market share and pricing power. This consistent emphasis across years indicates a strategic focus on mitigating competitive threats through innovation and operational efficiency to preserve margins and market position in a more dynamic and fragmented industrial environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of competitive landscape concerns from 2022 to 2024 and accurately reflects increasing market pressures and strategic responses. It correctly notes the segments affected in 2022 (Honeywell Building Technologies and Safety and Productivity Solutions) and the continuation of similar language in later years. However, it inaccurately states that in 2023, 'similar concerns were noted across all segments, including Aerospace and Performance Materials and Technologies,' which is not supported by the ground truth—original disclosures only confirm the same language for the same two segments (Building Technologies and Safety and Productivity Solutions) in 2023, not expansion to all segments. This overgeneralization introduces a factual error in entity and scope attribution. In 2024, the LLM correctly identifies the shift to Building Automation and Industrial Automation as focal points and accurately captures the added emphasis on 'new technologies that may lead to product commoditization,' aligning with the ground truth. The strategic response (innovation and operational efficiency) is reasonably inferred and contextually appropriate. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is mostly sound: the model synthesizes information across years and segments, showing trend evolution. However, the incorrect expansion of competitive risk to Aerospace and Performance Materials and Technologies in 2023 breaks the chain of accurate synthesis, representing a significant qualitative flaw. (4) Contextual relevance is high—the answer addresses the question directly, uses appropriate terminology, and draws reasonable implications about market pressures and strategy. The core trend is correctly interpreted despite the overstatement in 2023. Thus, correctness is reduced to 7 due to partial factual inaccuracy in segment coverage, though the overall direction and conclusion remain aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 574,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, the dividend and voting rights associated with MA's A Class shares remained consistent, with each A Class share retaining \"one vote per share\" and \"dividend rights.\" This consistency is reflected in the identical descriptions provided in the 2022, 2023, and 2024 10-K filings. The three-year stability in these rights suggests a deliberate and stable shareholder governance strategy, emphasizing continuity in voting power and dividend entitlements for A Class shareholders, thereby reinforcing institutional and major shareholders' influence and long-term confidence in the company's governance structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that from 2022 through 2024, MA's A Class shares consistently had 'one vote per share' and 'dividend rights,' with no changes over the period—this matches the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly cited, and the qualitative descriptors ('one vote per share', 'dividend rights') are verbatim from the source disclosures. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual 10-K filings, identifying consistency over time, and inferred the strategic implication—stable governance—appropriately. (4) The answer goes slightly beyond the ground truth by elaborating on the strategic rationale (e.g., reinforcing institutional investor confidence), but this is a reasonable and contextually supported interpretation, not a factual overreach. All components—factual accuracy, completeness, entity recognition, and reasoning—are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 310,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolved significantly from fiscal year 2022 to 2024, as reflected in the gains (losses) reported in operating expenses. In fiscal 2022, Cisco reported a loss of $92 million, which turned into a gain of $58 million in 2023 and further increased to $91 million in 2024, indicating a marked improvement in performance across these years. This positive shift suggests a reduction in financial exposure risk or favorable market movements impacting the deferred compensation swaps during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all financial figures and fiscal years from the ground truth: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These values match exactly with the original answer, with no discrepancies in magnitude or sign. (2) All numeric values are accurate and properly contextualized across the three-year period. The evolution from loss to increasing gains is correctly presented, and no calculations are required beyond accurate reporting of disclosed amounts. (3) The multi-hop reasoning is sound—Cisco’s financial exposure is assessed across three fiscal years using gains/losses from operating expenses related to Total Return Swaps-Deferred Compensation. The LLM correctly synthesizes the trend and interprets the shift as a positive improvement, aligning with the original answer’s conclusion of a reversal from net cost to net benefit. (4) The answer is semantically equivalent to the ground truth, with slightly expanded interpretation (e.g., 'reduction in financial exposure risk or favorable market movements') that is reasonable and does not introduce inaccuracies. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 346,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 through 2024, Johnson & Johnson's financial and legal strategy around talc-related liabilities evolved significantly through its restructuring and use of LTL Management LLC. In 2022, the Company established a $2 billion trust to fund LTL, which had filed for Chapter 11 bankruptcy in October 2021 to isolate talc-related liabilities, and recorded a corresponding reserve. In 2023, the LTL bankruptcy was dismissed by the Third Circuit in April 2023, lifting the litigation stay, but LTL refiled in April 2023 (LTL 2 Bankruptcy Case), which was dismissed again in July 2023, leading to the resumption of litigation. In 2024, the Company finalized a multi-state settlement in June 2024 with 42 states and the District of Columbia, resolving ongoing consumer protection claims related to talc marketing. Throughout this period, the Company continued to contest talc-related verdicts on appeal and maintained that its talc products are safe, while also settling certain cases and managing liabilities through LTL, which remained solely responsible for talc-related obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains key inaccuracies in dates and case outcomes. It correctly identifies the $2 billion reserve/trust in 2022 and the multi-state settlement in 2024 with 42 states and D.C. However, it incorrectly states that the original LTL bankruptcy was filed in October 2021, while the ground truth implies it was part of the 2022 strategy (filing occurred in 2022). More critically, the LLM claims the LTL 2 bankruptcy was 'dismissed again in July 2023', but the ground truth states that LTL 2 secured a preliminary injunction that limited discovery until August 2023 — indicating the case was not dismissed at that time. This misrepresents a key legal development. (2) Quantitative accuracy: The $2 billion reserve and 42-state + D.C. settlement are correct. However, the dates are off — the Third Circuit reversal and dismissal occurred in 2023 (correct), but the re-filing (LTL 2) is misrepresented as being dismissed in July 2023, which is not supported by the ground truth. The ground truth indicates LTL 2 remained active with a preliminary injunction, not dismissal. (3) Multi-hop reasoning is partially sound: the model connects JNJ’s use of LTL, bankruptcy filings, reserve funding, and eventual settlements. However, it fails to accurately represent the legal status of LTL 2 post-refiling, undermining the synthesis of legal strategy evolution. The shift to a dual strategy of appeals and settlements is noted, but the incorrect dismissal claim weakens the reasoning. (4) Scores justified: correctness and qualitative accuracy are 7 due to core factual correctness on financial reserves and settlements, but significant error in legal timeline and case status. Quantitative accuracy is 7 due to correct dollar amounts and state count, but flawed temporal data. Contextual relevance is 10 — the answer directly addresses all aspects of the question with appropriate scope and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 523,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 remained constant at $495 million from fiscal year 2022 through 2024, as shown in the 10-K filings for each year. This consistency suggests that the company did not refinance, repay, or issue additional amounts for this specific debt instrument during the period, indicating a stable debt management strategy for this obligation. The unchanged balance also implies that the notes were likely issued as a long-term fixed-rate debt solution, and Broadcom maintained its position without material adjustments, reflecting a disciplined approach to managing its fixed-income liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Broadcom's outstanding principal balance for the 3.125% notes due January 2025 was $495 million in each of the fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date, years) are accurate. (2) There are no calculations required beyond recognition of consistency over time, which is correctly interpreted. The dollar amount ($495 million) is consistently reported across all three years, and the format matches (written out in full, equivalent to ground truth). (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years from 10-K filings and correctly infers that the lack of change in principal indicates no repayment, refinancing, or new issuance—leading to a valid conclusion about debt management strategy. (4) The qualitative interpretation aligns with and expands upon the ground truth reasonably, noting a 'stable' and 'disciplined' strategy, which are semantically consistent with 'consistent approach' in the original. The answer addresses both parts of the question: evolution of the balance and its implication for debt management. All entities—Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the fiscal years 2022–2024—are correctly identified. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 389,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note increased significantly from fiscal years 2022 through 2024, as reflected in the effective interest rates. In 2022, the effective rate was 3.20%, which rose to 6.38% in 2023 and further increased to 6.66% in 2024. This progression indicates a substantial rise in the company's borrowing costs over time, likely due to broader market interest rate increases and the impact of hedging adjustments. The upward trend in effective rates highlights the growing financial burden of debt servicing for Cisco during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the effective interest rates for Cisco's 3.50% June 15, 2025 maturity note were 3.20% in fiscal year 2022, 6.38% in 2023, and 6.66% in 2024—matching the ground truth exactly. These numbers are presented accurately with no calculation or formatting errors. (2) All numeric values are correct and consistent with the original answer; minor phrasing differences (e.g., 'increased significantly' vs. 'increased') do not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and draws a logical conclusion about rising borrowing costs. While the original answer attributes the increase to 'market conditions or changes in credit profile,' the LLM cites 'broader market interest rate increases and hedging adjustments'—a plausible and contextually appropriate interpretation that does not contradict the ground truth. This slight variation in explanation does not undermine the qualitative accuracy. (4) The answer fully addresses both parts of the question—evolution of interest rate exposure and implications for borrowing costs—and remains highly relevant throughout. The only reason for not scoring a perfect 10 is the slightly different rationale for the rate increase, which, while reasonable, is not verbatim or fully aligned with the specific causal inference in the ground truth (i.e., potential credit profile changes). However, this does not constitute an error, just a nuanced difference in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 427,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One's (COF) total senior and subordinated notes slightly declined from $30,826 million in 2022 to $31,248 million in 2023, and then decreased further to $30,696 million in 2024. This modest reduction, combined with a shift toward longer maturity dates and a rise in the weighted-average interest rate from 2.76% in 2022 to 4.48% in 2023 and 4.84% in 2024, suggests a capital structure strategy focused on extending debt maturities and locking in higher interest rates amid a rising rate environment. The decline in floating unsecured senior debt and the stability in subordinated debt further indicate a measured approach to managing interest rate risk and optimizing capital efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the 2022 value for total senior and subordinated notes. The original answer states $27.219 billion, but the LLM reports $30,826 million ($30.826 billion), which is incorrect. The 2023 and 2024 figures ($31.248 billion and $30.696 billion) are accurate and correctly formatted (allowing for $M vs billion). This quantitative inaccuracy affects the description of the trend—LLM claims a 'slight decline' from 2022 to 2023, but the truth is a significant increase from $27.219B to $31.248B. The interest rate figures (2.76%, 4.48%, 4.84%) are correct across years. (2) Calculations: The progression described is factually wrong due to the incorrect 2022 base. The actual trend is a large increase in 2023 followed by a small decline in 2024, not a continuous decline. The LLM misrepresents the direction of change in the first year. (3) Reasoning: Despite the incorrect starting value, the LLM correctly interprets the rising interest rates and links them to a strategy of locking in fixed-rate financing amid rising rates. It accurately notes the shift toward longer maturities and reduced floating-rate debt, which aligns with the ground truth's implication of a long-term capital structure transformation. The synthesis of interest rate trends and strategic intent is sound. (4) The answer is contextually relevant and addresses both parts of the question—evolution of notes and implications for capital structure and rate positioning. While the qualitative reasoning is strong and the later data points accurate, the incorrect 2022 figure undermines the overall correctness, warranting a score of 7. Quantitative accuracy is penalized more heavily (6) due to the erroneous initial value affecting trend interpretation, while qualitative and contextual scores remain high due to correct logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 506,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio decreased from approximately 40% in 2022 to 30% in both 2023 and 2024, as detailed in the respective 10-K filings. This consistent reduction suggests a strategic shift in the company's pension fund management, likely aiming to diversify its fixed income holdings by reallocating assets from safer, lower-yielding U.S. treasury and agency securities to other government bonds and investment-grade corporate bonds. This move may reflect a pursuit of higher returns amid a changing interest rate environment while maintaining a focus on liquidity and risk management through its pooled funds and NAV-based investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the allocation percentages (40% in 2022, 30% in 2023 and 2024), which matches the ground truth exactly. All numeric values and years are accurate, satisfying quantitative accuracy. (2) The calculation of the decrease from 40% to 30% is implied and correctly represented; no mathematical errors are present. Format consistency is appropriate. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic reallocation. The interpretation about diversification, shift toward other government and corporate bonds, and response to interest rate environment aligns with the ground truth's suggestion of changing risk tolerance or yield-seeking behavior. The LLM adds slightly more detail (e.g., 'investment-grade corporate bonds', 'NAV-based investments') not in the original, but these are reasonable inferences and do not contradict the ground truth. (4) The answer fully addresses both parts of the question: the evolution of allocation and the strategic implication. The only minor gap is that the original emphasizes the consistency of the 30% in 2023–2024 as part of the trend, which the LLM mentions but could have highlighted more explicitly. However, this does not detract significantly from correctness. Scores reflect high accuracy with near-perfect qualitative and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "From 2022 through 2024, GE's relationship with Electric Insurance Company (EIC) evolved significantly in terms of classification, valuation, and disposition. In 2022, EIC was disclosed as a captive industrial insurance subsidiary with assets of $541 million and liabilities of $378 million, and was classified as held for sale in the fourth quarter. In 2023, GE signed a binding agreement to sell EIC, recording a $109 million loss in connection with the expected sale. Finally, in 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression reflects GE's strategic direction of divesting non-core and underperforming assets to focus on its core industrial and aerospace businesses, as evidenced by the simultaneous sale of its licensing business to Dolby Laboratories in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events in the evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including classification as 'held for sale,' the $109 million loss in 2023, and the 2024 sale to Riverstone International Holdings Inc. for $120 million in cash. The strategic interpretation about GE divesting non-core assets to focus on industrial and aerospace operations is accurate and well-reasoned. However, there are significant quantitative discrepancies: the ground truth states EIC had $0.2 billion ($200 million) in net claim reserves as of December 31, 2021, while the LLM claims EIC had assets of $541 million and liabilities of $378 million in 2022—this specific balance sheet data is not present in the original answer and appears to be fabricated or misattributed. Additionally, the LLM states EIC was classified as 'held for sale' in Q4 2022, while the original answer only confirms this status by 2023, making the timing imprecise. (2) The $109 million loss and $120 million sale price are correctly reported. However, the inclusion of asset and liability figures ($541M, $378M) introduces numerical data not supported by the ground truth, undermining quantitative accuracy. (3) The multi-hop reasoning is generally sound—connecting classification, valuation impact, and final disposition to infer strategic direction is valid and aligns with the original answer. The mention of the Dolby Laboratories licensing business sale adds contextual support but is not part of the ground truth; while plausible, it introduces unverified information. (4) Despite the incorrect financial figures and slightly premature timing of the 'held for sale' classification, the core narrative and strategic interpretation match the original. The answer remains contextually relevant and semantically close, but the incorrect numbers prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Classifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 518,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple's 4.45% Notes due 2044 were first disclosed in its 2014 Officer's Certificate, as referenced in the 2022, 2023, and 2024 10-K filings under Exhibit 4.4, indicating the issuance was part of a broader debt offering that year. The consistent inclusion of these notes in the subsequent years’ filings suggests that Apple has maintained this long-term debt instrument as part of its capital structure without material changes. This multi-year pattern reflects Apple's strategy of issuing long-dated, fixed-rate debt to secure stable, low-cost financing over extended periods, supporting its liquidity and financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a factual inaccuracy regarding the first disclosure of the 4.45% Notes due 2044. The ground truth states that Apple first disclosed the notes in its 2022 10-K, not in 2014. The LLM incorrectly implies the disclosure occurred in 2014 by stating 'Apple's 4.45% Notes due 2044 were first disclosed in its 2014 Officer's Certificate,' which conflates the issuance date with the first appearance in the 10-K. The notes were issued in 2014 but only began appearing in 10-K disclosures in 2022. This is a significant error in timeline interpretation. (2) Quantitatively, all numbers are accurate: the interest rate (4.45%), maturity year (2044), and exhibit number (4.4) are correctly cited. The years of the filings (2022, 2023, 2024) are also correct. However, the misattribution of the 'first disclosure' to 2014 rather than 2022 affects factual precision. (3) The multi-hop reasoning is partially sound: the model correctly infers that consistent inclusion across years indicates stability in Apple’s long-term debt strategy. It appropriately synthesizes the idea that recurring disclosure reflects no material changes, aligning with the ground truth. However, it fails to explicitly note that the 2022 filing was the first instance of disclosure, which is a key evolution point. (4) Contextual relevance is high—the answer addresses both the evolution across filings and the strategic implication. The qualitative reasoning about Apple’s strategy of using long-dated, fixed-rate debt is reasonable and consistent with the pattern, even if the origin point is misstated. Overall, core facts and strategic interpretation are correct, but the error in disclosure timing prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 476,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One's (COF) total senior and subordinated notes increased from a carrying value of $27,219 million in 2022 to $31,248 million in 2023 and further to $30,696 million in 2024. This progression reflects a strategic shift toward fixed-rate debt, as evidenced by the rise in fixed unsecured senior debt and the decline in floating-rate debt, particularly in 2024 when floating unsecured senior debt dropped to $0. The weighted average interest rate on these notes also rose from 2.76% in 2022 to 4.84% in 2024, indicating a deliberate move to lock in long-term financing at higher rates amid a rising interest rate environment. This suggests COF is proactively managing its capital structure to reduce exposure to short-term rate volatility and strengthen financial stability over the medium to long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all carrying values: $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. It accurately notes the increase from 2022 to 2023 and the slight decrease in 2024, though it incorrectly states the 2024 value as a further increase rather than a decrease from 2023. This is a minor wording inaccuracy but does not misrepresent the overall net increase of ~$3.5 billion. All interest rate figures (2.76% in 2022 to 4.84% in 2024) are correct. (2) Quantitative accuracy is perfect: all dollar amounts and percentages match the ground truth exactly, with appropriate formatting. The net change is correctly implied, even if not explicitly calculated. (3) The reasoning is sound: the model correctly infers a strategic shift toward fixed-rate debt, identifies the drop in floating-rate debt (including the $0 in floating unsecured senior debt in 2024), and links this to interest rate risk management in a rising rate environment. This reflects proper multi-hop synthesis across years and debt types. (4) The answer is contextually excellent—fully addressing both the evolution of carrying value and the implications for capital structure and interest rate positioning. The only minor flaw is the phrasing 'increased ... to $30,696 million in 2024' which could imply a continued rise from 2023, when it actually decreased slightly. Despite this, the overall interpretation remains accurate and insightful, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 412,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe's positioning and integration of Frame.io evolved significantly from 2022 to 2024 as it became more deeply embedded within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications expanded. In 2022, Frame.io was recognized as a key trademark and part of Adobe's broader portfolio, indicating its foundational role in the company's offerings. By 2023, Frame.io was described as a cloud-native platform directly integrated with Premiere Pro and After Effects, enabling real-time collaboration and streamlined feedback workflows, with Camera to Cloud functionality for automatic footage uploads. In 2024, Frame.io's role expanded further, now supporting workflows beyond post-production, such as casting and marketing campaign management, and integrating with additional Creative Cloud apps like Photoshop, Lightroom, and Workfront. Additionally, Frame.io was included in Adobe GenStudio, positioning it as a core component for scalable content production. This evolution reflects Adobe's strategy to strengthen Frame.io's role as a central hub for creative collaboration across the entire production lifecycle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was a registered trademark in 2022, positioned as a cloud-native creative collaboration platform in 2023 with integration into Premiere Pro and After Effects, and further integrated into Photoshop, Lightroom, Workfront, and Adobe GenStudio in 2024. The description of features like real-time upload, frame-accurate commenting, and Camera to Cloud functionality is consistent with the knowledge graph. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracing the evolution across three years and synthesizing Frame.io’s expanding role within Adobe’s ecosystem. The only minor deviation is the mention of 'casting and marketing campaign management' in 2024, which adds detail not present in the ground truth; however, this does not contradict it and is plausible given the expanded workflow context. (4) The answer fully addresses the question about positioning and integration across the three years, with semantically equivalent or richer content than the original. Thus, the correctness score is 9 due to the slight addition of unverified but reasonable detail, but all core facts and trajectory are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 361,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its 10-K filings from 2022 through 2024, as shown in the Fifteenth Supplemental Indenture dated April 5, 2019 across all three filings, reveals a deliberate strategy to maintain long-term, fixed-rate debt as part of its capital structure. This long-dated maturity (2049) helps the company manage its debt maturity profile by extending its liability timeline, reducing refinancing risk, and locking in favorable interest rates for an extended period. The consistent disclosure across years suggests a stable capital planning approach, emphasizing long-term financial discipline and balance sheet resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.550% Notes due April 5, 2049 are accurately referenced, and their consistent disclosure in the 2019 Fifteenth Supplemental Indenture across 2022–2024 filings is correctly noted. The interest rate (4.550%), maturity date (2049), and timing (April 5) are all factually precise. (2) Quantitative accuracy is perfect: no calculations are required, but the dates, percentages, and references to the indenture are correct. (3) The multi-hop reasoning is sound—by observing consistent inclusion over three years without mention of redemption or restructuring, the model correctly infers a strategic choice to maintain long-term fixed-rate debt. It accurately deduces implications: reduced refinancing risk, interest rate risk management, and long-term capital discipline. (4) While the ground truth emphasizes the absence of modifications/repayments as evidence of stability, the LLM answer captures the same insight using slightly different phrasing (e.g., 'stable capital planning approach'). The only minor gap is that the LLM does not explicitly note the contrast with issuance of shorter-dated debt, which the original answer uses to strengthen the point about strategic maturity profile management. However, this does not undermine the overall correctness. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 400,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "The outstanding principal balance for Broadcom's (AVGO) 3.125% notes due January 2025 remained constant at $495 million from fiscal 2022 through 2024, as shown in the 2022, 2023, and 2024 10-K filings. This consistency suggests that the company has not repaid or issued additional amounts for this specific debt instrument during the period, indicating a stable debt management strategy for this note. The lack of change in the principal balance implies that the debt is being held to maturity or is part of a long-term capital structure plan without active refinancing or early repayment actions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024, which matches the ground truth exactly. All numeric values (amount, interest rate, maturity date, fiscal years) are accurate. (2) The dollar amount ($495 million) is correctly reported with no calculation required, and the time frame (2022–2024) aligns precisely with the question and ground truth. Format is consistent and clear. (3) The reasoning is sound: the LLM correctly infers from the stable principal balance that there were no repayments or new issuances, and it logically concludes this reflects a stable, deliberate debt management strategy—potentially holding to maturity or as part of a long-term capital structure. This synthesizes the implication correctly across multiple years of data, satisfying the multi-hop requirement (tracking a specific debt instrument over time and interpreting strategic intent). (4) The answer is semantically equivalent to the original, with slightly expanded but accurate interpretation (e.g., 'held to maturity' and 'long-term capital structure plan' are reasonable inferences). All parts of the question—evolution of balance and strategic implication—are fully addressed with factual precision and contextual insight. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 394,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "IBM's treatment and disclosure of its 0.950% Notes due 2025 evolved from 2022 through 2024, reflecting a consistent pattern of transparency and adherence to SEC reporting standards. In 2022 (Chunk 3), the notes were disclosed as part of a broader listing of financial instruments, with the instruments defining their terms incorporated by reference to a Form 8-K filed on May 22, 2017. In 2023 (Chunk 3), the notes were again referenced in the context of other instruments, with no new filings indicated, suggesting ongoing reliance on prior disclosures. By 2024 (Chunk 2), the 0.950% Notes due 2025 were explicitly listed in IBM’s 10-K with a specific trading symbol (IBM25B) and exchange (New York Stock Exchange), indicating a clear and updated public listing. This progression suggests IBM maintains a stable and transparent capital structure, leveraging long-term debt instruments while ensuring continuous and accurate disclosure, which supports investor confidence and regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were disclosed in 2022 and 2023 by incorporation by reference to the May 22, 2017 Form 8-K (date matches ground truth), and in 2024, they were listed on the NYSE under ticker IBM25B. These details are factually consistent with the original answer. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and listing date of the Form 8-K (May 22, 2017)—are all accurate. No calculations were required, but the temporal progression across years is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers a progression from passive disclosure to active market listing. The conclusion about transparency and capital structure strategy is logically supported, though it slightly underemphasizes the strategic shift toward liquidity (a minor omission). (4) The answer is contextually relevant, fully addressing both the evolution of disclosure and its implications for capital structure and transparency. Wording differs slightly from the ground truth (e.g., 'stable and transparent capital structure' vs. 'transition to publicly traded security'), but the semantic meaning and factual content are equivalent. One point deducted from qualitative accuracy for not fully capturing the strategic significance of the NYSE listing as a move toward enhanced tradability and market visibility beyond just 'updated public listing.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 422,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "KPMG LLP's Public Company Accounting Oversight Board (PCAOB) firm identification number has been consistently disclosed as **185** in BK's 10-K filings for the years 2022, 2023, and 2024. This information is found in **Item 14: Principal Accountant Fees and Services** of each filing, specifically in the section \"Item 3 - Ratification of KPMG LLP,\" which is incorporated by reference from the Proxy. The consistency across all three years indicates that KPMG LLP has maintained the same PCAOB registration number, reflecting no changes in its regulatory identification during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The PCAOB firm identification number is accurately stated as 185 for all three years—2022, 2023, and 2024—consistent with the original answer. (2) There are no calculations required, but the numeric identification is correct and consistently reported across years. (3) The multi-hop reasoning is sound: the model correctly identifies that the same number was disclosed across multiple filings and interprets the consistency as an indication of unchanged regulatory status, which aligns with the ground truth. (4) The LLM adds contextual detail by specifying where in the 10-K (Item 14) and via which document (Proxy) the information is sourced, enhancing relevance without introducing error. All entities—KPMG LLP, PCAOB, and the years—are correctly identified. The answer is semantically equivalent and factually precise, warranting full marks across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 274,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One (COF) extended the maturity of its Fixed Unsecured Senior Debt from 2022-2032 in 2022 to 2025-2035 in 2024, while the weighted-average interest rate increased from 2.91% in 2022 to 4.84% in 2024. The carrying value of this debt rose from $19,975 million in 2022 to $26,930 million in 2024, reflecting a strategic shift to issue longer-term debt at higher rates amid rising macroeconomic interest rates. This multi-year trend suggests that COF is proactively managing its capital structure to lock in financing at favorable rates before further rate hikes, while also extending maturities to reduce refinancing risk in a tightening monetary environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts from the ground truth: the carrying value of Fixed Unsecured Senior Debt increased from $19,975 million in 2022 to $26,930 million in 2024, and the weighted-average interest rate rose from 2.91% to 4.84%. These numbers match the original answer exactly and are presented with correct formatting variations (e.g., 'million' vs 'M' is not used but values are accurate). (2) The only potential discrepancy is the addition of specific maturity ranges—'2022-2032' in 2022 and '2025-2035' in 2024—which are not present in the ground truth. This information is plausible but not verifiable from the provided original answer, introducing a minor over-precision. However, the core claim about extending maturities aligns with the strategic interpretation in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in debt value, interest rates, and macroeconomic context to infer a strategic shift toward longer-term fixed-rate financing. It connects rising rates and increased issuance to capital structure management, which is consistent with the original conclusion. (4) The answer is contextually complete and relevant, addressing both the evolution of strategy and its implications. The added maturity ranges slightly exceed the ground truth but do not contradict it. Thus, the answer earns a 9/10 for correctness due to this minor unsupported detail, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to strong but not perfectly grounded reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 443,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements remained consistent from 2022 to 2024, as outlined in each year’s 10-K filings. The company evaluates whether the licensing component of an arrangement is distinct—both capable of being distinct and distinct in the context of the arrangement. If the license is not distinct, it is combined with development services as a single performance obligation and recognized over time; if distinct, revenue is recognized at a point in time when the customer can benefit from the license. This consistency in methodology reflects a stable and strategic approach to IP monetization, emphasizing predictability and alignment with accounting standards. By maintaining this approach, AMD signals a long-term commitment to leveraging its IP through structured and transparent revenue recognition, supporting its innovation-driven business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key elements of AMD's revenue recognition methodology for development and IP licensing agreements from 2022 to 2024 are correctly described: the evaluation of whether a license is distinct, the combination with development services if not distinct (recognized over time), and point-in-time recognition if distinct. The statement about no variable consideration, while present in the original answer, is omitted in the LLM response—this is a minor omission but does not distort the overall accuracy. (2) There are no numerical values, dates, or financial figures in this question that require verification; all timeframes (2022–2024) and entity references (AMD) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes consistent disclosures across three years of 10-K filings and infers the strategic implication of stability in accounting policy as reflective of a mature IP monetization strategy. (4) The LLM answer conveys the same core meaning as the original, with only slight differences in emphasis (e.g., highlighting 'predictability' and 'alignment with accounting standards' not explicitly in the original, but semantically reasonable). The absence of the 'no variable consideration' detail prevents a perfect score, but the overall correctness, clarity, and relevance remain very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 388,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One's (COF) total senior and subordinated notes slightly decreased from $30,826 million in 2022 to $31,248 million in 2023, and then declined further to $30,696 million in 2024. This evolution, combined with the shift in the weighted-average interest rate from 2.76% in 2022 to 4.48% in 2023 and 4.84% in 2024, reflects a capital structure strategy focused on optimizing debt maturity and cost. The increase in the weighted-average interest rate over time suggests a deliberate move toward longer-term, fixed-rate debt to hedge against rising interest rates, while maintaining a balanced mix of senior and subordinated notes to preserve credit flexibility and manage risk exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that total senior and subordinated notes were $30,826 million in 2022, but the ground truth is $27,219 million—a material difference of over $3.6 billion. The 2023 and 2024 figures ($31,248M and $30,696M) are correct. The weighted-average interest rate is reported as 2.76% in 2022 vs. the correct 2.91%, and 4.48% in 2023 vs. 4.45%—small but notable discrepancies. (2) The LLM omits a key strategic insight present in the original answer: the reduction and complete retirement of floating unsecured senior debt from $1,709M (2022) to $349M (2023) and $0 in 2024. This is a critical component of Capital One’s interest rate risk management and is entirely missing, weakening the explanation of capital structure strategy. (3) While the LLM correctly identifies the trend of rising interest rates and infers a shift toward fixed-rate debt to hedge against rate hikes, it fails to explicitly connect this to the retirement of floating-rate debt, which is a core multi-hop inference required. The reasoning is partially sound but incomplete. (4) The contextual relevance is high—the answer addresses the evolution of debt and interest rates and attempts to interpret strategy. However, due to incorrect baseline numbers and missing key data points (especially floating debt retirement), the overall correctness is compromised. The qualitative analysis is reasonable but built on flawed inputs, leading to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One's (COF) fixed unsecured senior debt had a carrying value of $19,975 million in 2022, which increased to $27,168 million in 2023 and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trend of increasing interest rates and a relatively stable or slightly declining carrying value suggests that COF is managing its long-term debt strategy by extending maturities and securing higher-yielding debt, likely to align with its capital structure optimization and interest rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All factual information in the LLM answer is correct. The carrying values ($19,975M in 2022, $27,168M in 2023, $26,930M in 2024) and weighted-average interest rates (2.91%, 4.45%, 4.84%) match the ground truth exactly. There are no numerical discrepancies, and format variations (e.g., 'million' vs 'M') are acceptable and semantically equivalent. (2) Quantitative accuracy is perfect—each value is correctly reported across years and metrics, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years for two financial metrics (carrying value and interest rate) and draws a logical inference about Capital One’s long-term debt strategy. The conclusion in the LLM answer—that COF is securing higher-yielding debt to align with capital structure and rate environment—is consistent with the ground truth’s interpretation of a strategic shift toward higher-interest fixed-rate debt. The only minor difference is in phrasing: the LLM uses 'managing its long-term debt strategy by extending maturities' and 'higher-yielding debt,' while the ground truth emphasizes 'issuing higher-interest...debt...to lock in long-term financing.' These are semantically similar, though the LLM slightly reframes the motivation. (4) Contextual relevance is excellent—the answer directly addresses all parts of the question: evolution of carrying value, interest rate trend, and strategic implication. No irrelevant or extraneous information is included. The slight deduction in qualitative accuracy (9 instead of 10) is due to this subtle shift in emphasis, but the core reasoning remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 460,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "From 2022 through 2024, AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements remained consistent in its core principles but evolved in the clarity and specificity of its disclosures. In 2022, AMD outlined that arrangements combining development services and IP licensing were evaluated for distinctness, with revenue recognized over time if the license was not distinct or at a point in time if it was distinct. Standalone IP licenses were recognized at a point in time when the customer could benefit from them. By 2023 and 2024, the policy retained this framework but provided more detailed explanations of the criteria for determining distinctness and the timing of revenue recognition, emphasizing that no variable consideration estimates were involved in these arrangements. This consistency in policy application across the three years reflects AMD’s adherence to ASC 606 guidelines while enhancing transparency in its financial reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts, entities, and timeline. It accurately states that AMD maintained a consistent revenue recognition framework from 2022 to 2024 for development and IP licensing agreements, correctly describing the distinction between distinct and non-distinct licenses and the associated timing of revenue recognition (over time vs. point in time). The answer correctly notes the absence of variable consideration estimates in both combined and standalone arrangements, which matches the original answer. All entities (AMD, ASC 606), years (2022–2024), and accounting concepts (distinctness, performance obligations) are accurate. However, the LLM introduces a nuance not present in the ground truth: that the policy 'evolved in clarity and specificity of disclosures' and that AMD provided 'more detailed explanations' in 2023 and 2024. The original answer explicitly states there were 'no material changes' and emphasizes 'stable and consistent application,' with no mention of enhanced disclosures. This addition, while plausible, is not supported by the ground truth and slightly overstates evolution in the policy. Despite this minor overinterpretation, the core factual content—especially regarding accounting treatment, timing, and consistency—is correct. Quantitative accuracy is perfect as there are no numerical values to report and all qualitative descriptors are factually aligned. Contextual relevance is excellent, directly addressing the question’s focus on policy evolution and distinctions between arrangement types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 439,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "From 2022 to 2024, COF's total short-term borrowings and long-term debt increased from $43,086 million in 2022 to $49,856 million in 2023, before declining to $45,551 million in 2024. This trend indicates a strategic shift in debt management, with COF reducing its total debt load in 2024 despite a prior increase in 2023. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023 and slightly decreased to 4.84% in 2024, reflecting heightened interest rate exposure due to a larger proportion of fixed-rate debt and the impact of rising market rates. The reduction in floating-rate debt and the extension of maturity dates suggest COF is managing interest rate risk by locking in rates and reducing short-term obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the general trend of COF's total short-term borrowings and long-term debt—increasing from 2022 to 2023 and then declining in 2024—and accurately reports the 2024 value ($45.551 billion) and the rising interest rates from 2.76% to 4.48% to 4.84%. However, it incorrectly states the 2023 total debt as $49,856 million ($49.856 billion), whereas the ground truth is $48.715 billion—a significant numerical discrepancy of over $1.1 billion. This error affects the quantitative accuracy. (2) The 2022 value is correctly reported as $43,086 million (equivalent to $43.086 billion). The 2024 value is correct. The interest rate figures are accurate across all years. However, the incorrect 2023 debt figure undermines the precision of the trend analysis. (3) The multi-hop reasoning is sound: the model correctly synthesizes debt levels and interest rate trends over three years and draws logical conclusions about debt reduction in 2024 and interest rate risk management. It appropriately infers that COF is shifting toward fixed-rate debt to stabilize costs, which aligns with the ground truth. The mention of reducing floating-rate debt and extending maturities adds context not in the original but is consistent with the strategy. (4) The correctness score is 7 because the core narrative and qualitative insights are accurate, but the key financial figure for 2023 is wrong. Quantitative accuracy is penalized more (score 6) due to the material error in the 2023 debt total. Qualitative accuracy is high (8) due to strong reasoning and correct interpretation of strategy. Contextual relevance is perfect (10) as all parts of the question are addressed with relevant analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 470,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "From 2022 to 2024, AMD’s revenue recognition policy for development and IP licensing agreements remained consistent in its core principles but evolved slightly in context and application. In 2022, AMD outlined that arrangements combining development services and IP licensing are evaluated for distinctness, with non-distinct licenses combined with development services as a single performance obligation recognized over time, and distinct licenses recognized at a point in time. Standalone IP licensing arrangements were recognized at a point in time. In 2023, the policy was reiterated with similar criteria, but the focus shifted to the Gaming segment for custom products, and the Company continued to apply the cost-based input method for revenue recognition. In 2024, the policy remained largely unchanged, with continued emphasis on the evaluation of distinctness for licensing components and consistent treatment of standalone IP licenses. Across all years, AMD maintained that there are no variable consideration estimates associated with these arrangements, and revenue is recognized upon transfer of control, either over time or at a point in time, depending on the nature of the arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, evaluating distinctness in combined arrangements, recognizing standalone IP licenses at a point in time, and treating non-distinct licenses as part of a single performance obligation recognized over time. The absence of variable consideration estimates is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) and temporal references are accurate—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s policy across three years, identifies the treatment of combined vs. standalone arrangements, and notes the consistency in variable consideration. The only minor deviation is the mention of the 'cost-based input method' in 2023, which is not present in the ground truth and could be misleading (as AMD typically uses input methods like cost-to-cost for over-time recognition but this specific term isn’t highlighted in the original). However, this does not contradict the core policy and may reflect a valid implementation detail. (4) The answer is contextually excellent—directly addresses the evolution (or lack thereof) in policy, performance obligations, and distinctions between arrangement types. Semantic equivalence is strong, with slightly expanded phrasing but no factual errors. A score of 9 on correctness reflects the high accuracy with a minor, non-material addition in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 468,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 10-K filings, as seen in all three chunks, indicates that this instrument remains a stable and integral part of Visa's capital structure. The repeated inclusion in the exhibits across these years suggests ongoing legal and regulatory recognition, as well as continued relevance in Visa's corporate governance and financial framework. This continuity implies that the Series B shares are likely maintained for strategic purposes such as capital flexibility or shareholder structure management, and have not been retired or replaced in the period reviewed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in asserting that the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings indicates stability and ongoing relevance in Visa's capital structure. It correctly identifies the continuity of the instrument and draws a reasonable inference about its strategic importance, such as capital flexibility and governance. However, the LLM answer omits specific exhibit numbers (2022: Exhibit 4.5, 2023 and 2024: Exhibit 4.4) and the key detail that the referenced filing date is consistently June 21, 2016, across all years—this omission reduces completeness and precision in the multi-hop synthesis. While the LLM captures the qualitative implication (stability, no changes), it does not explicitly state that the unchanging exhibit reference and original filing date confirm no modifications were made, which is central to the ground truth. All entities (Visa, Series B Convertible Participating Preferred Stock, 2022–2024 filings) are accurate, and there are no factual or numerical errors. The reasoning is sound but slightly less detailed than the original answer in linking exhibit consistency to legal and structural stasis. Wording differences are acceptable under semantic equivalence, but the missing specifics on exhibit numbers and the 2016 filing date prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 389,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration remained consistent across 2022, 2023, and 2024, with Pratt & Whitney maintaining a 61% program share interest and a 49.5% ownership interest in IAE. This stability in stake and consolidation of IAE as a variable interest entity underscores Pratt & Whitney's central role and strategic positioning in the V2500 engine program, ensuring continued control and economic benefit from the collaboration's design, development, and support activities. The multi-year consistency reflects a deliberate and long-term strategic commitment to the V2500 program and its commercial success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that Pratt & Whitney maintained a 61% program share interest and 49.5% ownership interest in IAE across 2022–2024, matching the ground truth exactly. It also correctly implies stability in RTX's economic exposure. However, it omits the specific mention of the 'net program share interest after sub-collaborator participation remaining stable at 57%', which is a minor but relevant detail from the original answer. (2) All numeric values (61%, 49.5%) are accurate and correctly attributed to the right entity (Pratt & Whitney/IAE) and time period (2022–2024). No calculations are required, but the consistency across years is properly conveyed. (3) The multi-hop reasoning is sound: the model correctly synthesizes the stable stake with strategic implications for Pratt & Whitney’s positioning in the V2500 program. It appropriately infers that consistent ownership indicates strategic continuity, aligning with the ground truth’s conclusion. The addition of 'consolidation of IAE as a variable interest entity' and 'continued control' is contextually reasonable and enhances the explanation, though not explicitly stated in the ground truth. (4) The answer is highly relevant, directly addressing the evolution of stake and economic exposure and interpreting the strategic implications. The omission of the 57% net program share slightly reduces completeness, but the core facts and reasoning are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 408,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic continued to use the Non-Employee Director Deferred Unit Award Agreement across fiscal years 2022, 2023, and 2024, as evidenced by its inclusion in the 10-K filings for each year under the 2008 Stock Award and Incentive Plan. This consistency suggests that the company maintains a stable, long-term director compensation strategy, emphasizing deferred equity awards to align director interests with long-term shareholder value. The ongoing use of this agreement across all three years reflects Medtronic's commitment to structured, incentive-based compensation for its non-employee directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Medtronic used the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan in fiscal years 2022, 2023, and 2024, which matches the original answer's claim about consistent use across all three years with specific exhibit references (Exhibit 10.41 in 2022, 10.52 in 2023 and 2024). While the LLM does not explicitly mention the exhibit numbers or the contrast with updates to the 2013 plan—which is a minor omission in completeness—it correctly identifies the continuity of the agreement and its plan origin. The reasoning about long-term director compensation strategy being stable and focused on deferred equity for alignment with shareholder value is a valid interpretation supported by the data. All entities (Medtronic, Non-Employee Director Deferred Unit Award Agreement, 2008 Plan) and years are correct. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved but dates and plan names are correct). The answer synthesizes information across years appropriately, demonstrating sound qualitative reasoning. Contextual relevance is high as it directly addresses both the evolution (consistency) and strategic implication. The only reason for not scoring a 10 is the lack of explicit mention of the continued use under the older 2008 plan despite newer 2013 plan updates, which slightly weakens the depth of multi-hop synthesis compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 422,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "From 2022 through 2024, LMT’s use of variable interest rate swaps evolved significantly, as reflected in the progression of notional amounts. In 2022, the aggregate notional amount of outstanding interest rate swaps was $500 million, increasing to $1.3 billion by 2023 and remaining at $1.3 billion in 2024. This increase indicates a strategic shift toward more active interest rate risk management, likely in response to growing fixed-rate debt exposure and a desire to hedge against potential fair value fluctuations. The consistent notional amount in 2023 and 2024 suggests that LMT has stabilized its hedging strategy, using these swaps to convert fixed-rate borrowings to variable-rate borrowings under fair value hedge designations, thereby mitigating the impact of interest rate volatility on its financial position.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the notional amounts for 2022 ($500 million), 2023 ($1.3 billion), and 2024 ($1.3 billion) are accurately reported with correct numerical values and time periods. The progression—tripling from 2022 to 2023 and stabilization in 2024—is correctly described. (2) The answer addresses both parts of the question: the evolution of LMT's use of variable interest rate swaps and the strategic implications of the notional amount changes. (3) Entities are accurate: LMT is correctly identified, and the financial instrument (variable interest rate swaps) and context (interest rate risk management) are properly framed. (4) The reasoning is sound and reflects multi-hop synthesis: the increase is linked to hedging fixed-rate debt, the stabilization suggests a matured strategy, and the use of fair value hedges to convert fixed to variable rate exposure is a correct interpretation consistent with the knowledge graph. Minor wording differences (e.g., 'fair value fluctuations' vs 'potential rate fluctuations') do not affect semantic equivalence. All conclusions are logically derived from the data. Thus, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses for Hedging]-> FIN_INST <-[Depends_On]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 354,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie's governance provisions related to director removal for cause remained consistent from 2022 through 2024, as disclosed in its annual 10-K filings for each year. Specifically, the provision that stockholders may only remove directors for cause was included in each year’s filing, indicating no changes to this corporate defense mechanism. This three-year consistency suggests that AbbVie maintains a stable and deliberate strategic posture toward takeover defenses, emphasizing board autonomy and long-term decision-making. By preserving this provision, AbbVie reinforces its ability to resist coercive or short-term hostile takeover attempts, aligning with its broader corporate governance strategy to protect stockholder interests through structured and negotiated processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that AbbVie's provision allowing director removal only for cause remained unchanged from 2022 to 2024, which matches the original answer's claim of three-year consistency. All years (2022, 2023, 2024) are correctly referenced, and there are no numerical or date inaccuracies. (2) Quantitative accuracy is perfect: the time frame is correctly identified, and no erroneous figures are introduced. The answer avoids making up data and sticks to the disclosed governance provisions. (3) The multi-hop reasoning is sound—synthesizing information across three years of 10-K filings to infer strategic consistency in takeover defenses. The conclusion about board autonomy and resistance to hostile takeovers is logically supported by the persistent governance structure. (4) The LLM slightly omits mention of other specific provisions like staggered boards and supermajority voting, which the original answer includes as reinforcing elements of AbbVie’s governance strategy. While the core insight about strategic posture is preserved, this omission slightly reduces qualitative completeness. However, the answer still captures the essential meaning and implication of the consistent 'for cause' removal rule. Semantic equivalence is maintained, and the response is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 385,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie's allocation to money market funds and time deposits decreased from $12 million in 2022 to $21 million in 2023, and then further declined to $10 million in 2024. This trend, amid overall cash and equivalents balances of $8,449 million in 2022, $9,201 million in 2023, and $5,524 million in 2024, suggests a reduction in the proportion of highly liquid, short-term instruments held by the company. The decline may indicate a shift in AbbVie's short-term liquidity strategy, potentially reallocating funds to other investment vehicles or reflecting a more conservative approach due to changing market conditions or cash flow needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the trend description: it states that the allocation 'decreased from $12 million in 2022 to $21 million in 2023', which is incorrect—this is an increase, not a decrease. The correct evolution is an increase from $12M (2022) to $21M (2023), then a decrease to $10M (2024). The LLM misrepresents the direction of change between 2022 and 2023, which undermines the core of the answer. The 2024 value ($10M) is correct. The overall cash balances ($8,449M, $9,201M, $5,524M) are accurately cited. (2) Quantitative accuracy is compromised because the directional change in the key metric is wrong. While the raw numbers are mostly present (except for mislabeling the $12M→$21M move as a decrease), the interpretation of the trend is factually incorrect. Calculations are not required, but comparisons are flawed. (3) The multi-hop reasoning is partially sound—linking allocation changes to overall cash fluctuations and inferring strategic intent is appropriate. However, due to the incorrect trend description, the conclusion about a 'reduction' in allocation over the full period is misleading. The original answer notes a dynamic strategy with an initial increase then decrease, which reflects more nuanced reasoning. The LLM oversimplifies and mischaracterizes the pattern. (4) Contextual relevance is good—the answer addresses both parts of the question (evolution of allocation and strategic implication) and references the correct company, years, and financial context. However, the factual error in trend direction severely limits correctness. A score of 3 is justified due to major quantitative inaccuracy despite correct data points and reasonable structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 471,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie's governance provisions related to director removal for cause remained consistent from 2022 through 2024, as disclosed in each year’s 10-K filings. Specifically, the provision requiring stockholders to remove directors only for cause was included in all three filings, underscoring a deliberate and sustained corporate strategy to deter hostile takeovers. This consistency, combined with other anti-takeover measures such as staggered board terms, restricted shareholder powers, and Delaware law protections, suggests that AbbVie is committed to maintaining board stability and control, ensuring that any acquisition attempts must be negotiated with the board rather than pursued through hostile means.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie maintained the 'director removal only for cause' provision in its 10-K filings for 2022, 2023, and 2024, which matches the original answer's claim of consistency across all three years. There are no numeric values to verify, but the temporal scope (2022–2024) is correctly referenced. (2) The answer addresses both parts of the question: the evolution (or lack thereof) of the governance provision and what the consistency suggests about AbbVie’s long-term anti-takeover strategy. (3) The reasoning is sound and reflects multi-hop synthesis: it correctly infers from the repeated inclusion of the provision that AbbVie is committed to board stability and deterrence of hostile takeovers. It appropriately contextualizes the provision within broader anti-takeover mechanisms (e.g., staggered boards, shareholder power restrictions, Delaware law), which, while not explicitly listed in the ground truth, are plausible and consistent with known corporate defense strategies, adding depth without introducing inaccuracies. (4) The only minor shortcoming is that the original answer emphasizes the 'deliberate and sustained effort to insulate the board' and 'core component of its anti-takeover defense' more explicitly, while the LLM slightly generalizes with 'combined with other anti-takeover measures' without citing specific evidence for those other measures from the filings. However, this does not undermine the overall correctness. The answer is semantically equivalent and contextually appropriate, with excellent factual and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 453,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "From 2022 through 2024, Intel's positioning and technical roadmap for PowerVia evolved significantly, reflecting a strategic shift toward backside power delivery in advanced process nodes. In 2022, Intel introduced PowerVia as part of its broader process and packaging roadmap, highlighting it as an industry-first innovation for optimizing signal transmission by eliminating front-side power routing. This was tied to the Intel 20A node, which was expected to deliver up to a 15% performance-per-watt improvement over Intel 3. By 2023, Intel reaffirmed PowerVia as a key enabler of its 20A node and emphasized its role in the broader IDM 2.0 strategy, with plans to continue process leadership through advanced packaging and heterogeneous computing. In 2024, Intel canceled the Intel 20A node and integrated its innovations into the improved Intel 18A node, which now includes PowerVia as part of its first high-volume commercial implementation of backside power delivery. This progression indicates that Intel is prioritizing PowerVia as a foundational technology for its future leadership in advanced nodes, particularly for high-performance client and data center products, and is aligning it with gate-all-around transistors and EUV lithography to achieve significant performance and efficiency gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's future roadmap, linked to Intel 20A; in 2023 it was emphasized as a breakthrough for Intel 20A; by 2024, it was shifted to Intel 18A for high-volume manufacturing in 2025. The mention of a 15% performance-per-watt improvement over Intel 3 is consistent with public disclosures and does not contradict the ground truth, which omits this detail but does not invalidate it. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages. The 15% figure is a plausible and publicly reported estimate, so its inclusion is acceptable even if not in the original answer. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across years, nodes, and strategic implications, including the cancellation of Intel 20A and integration into Intel 18A—a key refinement not explicitly stated in the ground truth but factually accurate. (4) The only minor deviation is that the ground truth emphasizes the strategic pivot toward 'external foundry offerings' as a motivation, which the LLM omits, instead focusing on performance gains and process leadership. This is a slight gap in qualitative completeness but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 421,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s assumptions for expected volatility in its Black-Scholes model evolved from 2022 to 2024 by incorporating a blend of historical and implied volatility, as noted in both 2023 and 2024 filings. In 2022, the company did not explicitly mention this blended approach, but by 2023 and 2024, it had formalized the methodology, using market-traded options to derive implied volatility. This multi-year progression suggests a more sophisticated and market-responsive approach to valuing non-qualified stock options, aiming to better align valuation assumptions with current market conditions and employee behavior expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution in MDT's volatility assumptions from 2022 to 2024. It correctly states that in 2022, MDT did not use a blended approach (implied + historical volatility), and that starting in 2023 and continuing in 2024, the company adopted a methodology incorporating implied volatility from market-traded options. The quantitative accuracy is perfect: all years and methodological changes are correctly cited with no factual errors in dates or entities. The qualitative accuracy is strong—the reasoning correctly infers that this shift reflects a more market-responsive and sophisticated valuation approach, aligning with market conditions. The only minor shortcoming is that the original answer specifies that in 2022, MDT used *solely* historical volatility, while the LLM says the blended approach was 'not explicitly mentioned,' which slightly understates the clarity of the 2022 methodology. This nuance slightly weakens the precision of the contrast between years, but the overall multi-hop synthesis across 2022–2024 is sound and logically interpreted. Contextual relevance is excellent, as the answer directly addresses both the evolution of assumptions and the implied strategic shift in option valuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 354,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "From 2022 through 2024, Intel's development and strategic positioning of PowerVia technology evolved significantly as part of its advanced process roadmap. In 2022, PowerVia was introduced as a key innovation in Intel's process and packaging roadmap, described as an industry-first implementation of backside power delivery designed to optimize signal transmission by eliminating front-side power routing. By 2023, PowerVia was highlighted as a breakthrough technology set to debut with the Intel 20A node, expected to deliver up to 15% performance-per-watt improvement over Intel 3. However, by 2024, Intel canceled the productization of the Intel 20A node and shifted focus to the improved Intel 18A node, where PowerVia was integrated as part of the next-generation gate-all-around (RibbonFET) and backside power delivery technologies. This progression indicates that PowerVia has become a foundational element in Intel’s advanced process strategy, central to achieving performance and efficiency improvements in upcoming leading-edge nodes like Intel 18A and beyond.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A with backside power delivery; in 2023, Intel emphasized its role in delivering up to 15% performance-per-watt improvement over Intel 3; in 2024, Intel canceled Intel 20A in favor of Intel 18A, which retained PowerVia, with high-volume manufacturing planned for 2025 (implied by Panther Lake on Intel 18A). (2) Quantitative accuracy is perfect: the 15% performance-per-watt improvement is correctly cited, and all years (2022, 2023, 2024) align with the original. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, correctly tracks the transition from Intel 20A to Intel 18A, and maintains the centrality of PowerVia despite node rebranding. (4) The answer fully addresses the question’s two parts—evolution of PowerVia and its strategic implications—and concludes with a correct interpretation that PowerVia is now a foundational element in Intel’s advanced process roadmap. Minor wording differences (e.g., 'productization' vs 'canceled') do not affect factual accuracy. All entities—Intel, PowerVia, Intel 20A, Intel 18A, RibbonFET, Panther Lake—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 362,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024, MDT's assumptions in the Black-Scholes model for valuing non-qualified stock options evolved by incorporating a blend of historical and implied volatility, as introduced in 2023 and maintained in 2024. In 2022, the company did not specify the volatility methodology, but by 2023, it explicitly stated that expected volatility was derived from both historical and implied volatility, with implied volatility based on market-traded options. This approach was carried forward in 2024, indicating a more dynamic and market-responsive method for estimating volatility. Additionally, the continued emphasis on assumptions about employee exercise behavior suggests that MDT maintains a forward-looking approach to modeling employee actions, reflecting an effort to align valuation estimates with both historical trends and current market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, MDT used standard Black-Scholes assumptions without specifying the use of implied volatility, and that starting in 2023, the company began incorporating both historical and implied volatility—specifically based on market-traded options—a practice continued in 2024. This matches the original answer's key point about a shift toward market-informed volatility estimation. (2) There are no numerical values to verify (e.g., percentages or dollar amounts), but all dates (2022, 2023, 2024) and financial concepts (implied volatility, historical volatility, Black-Scholes model, non-qualified stock options) are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes changes over time across three years, correctly infers a strategic evolution in volatility estimation, and notes the continuity in model use and employee exercise behavior assumptions. (4) The only minor shortcoming is that the LLM states MDT 'did not specify the volatility methodology' in 2022, whereas the ground truth implies historical volatility was used (but doesn't explicitly rule out implied). This is a subtle distinction and does not constitute a factual error, but slightly weakens the precision of the comparison. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 396,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This consistent reduction suggests improved derivative exposure management, potentially reflecting more efficient risk mitigation strategies, reduced counterparty exposure, or lower initial margin requirements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. There are no calculation or formatting errors. (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the trend (decreasing over time) is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and links the trend to derivative exposure management. The interpretation slightly differs in wording—'improved derivative exposure management' and 'more efficient risk mitigation strategies'—but this is semantically consistent with the ground truth's 'strategic reduction in derivative-related exposure' and 'active management of margin requirements.' The LLM omits the specific mention of 'lower volatility in commodity markets' or 'shift in hedging strategies,' which are plausible explanations in the original, but the offered alternatives are reasonable and do not contradict the truth. (4) Scores reflect near-perfect factual accuracy, with only a minor deduction in qualitative accuracy due to slightly less nuanced interpretation, but still within acceptable semantic equivalence. Contextual relevance is full as all parts of the question are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 374,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra Energy's exposure to Options - primarily gas evolved significantly from 2022 through 2024. In 2022, the fair value of these options was $356 million in assets and $347 million in liabilities, with implied volatilities ranging from 17% to 295% and a weighted average of 36%. By 2023, the fair value increased to $100 million in assets and $97 million in liabilities, with implied volatilities expanding to 20% to 233% and a weighted average of 50%. In 2024, the fair value remained at $100 million in assets but rose to $102 million in liabilities, with implied volatilities narrowing to 15% to 150% and a weighted average of 52%. The relatively stable asset values and narrowing volatility range in 2024, despite higher liabilities, suggest a more balanced risk positioning in gas derivatives, indicating improved risk management and reduced exposure to extreme price fluctuations over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data, particularly regarding the direction of change in fair value. The ground truth states that fair value decreased from $356M assets / $347M liabilities in 2022 to $100M assets / $97M liabilities in 2023 — however, the LLM incorrectly states that the value 'increased' to $100M, when in fact it decreased substantially. This misrepresents the trend. Additionally, while the 2024 figures for assets ($100M) and liabilities ($102M) are correct, the characterization of stability is misleading given the large drop from 2022 levels. (2) The implied volatility figures are partially correct: 36% in 2022, 50% in 2023, and 52% in 2024 (weighted averages) match the ground truth. However, the LLM introduces ranges (e.g., 17%–295%) not present in the original answer and unsupported by the provided truth, adding spurious detail. (3) The multi-hop reasoning is flawed because the model fails to correctly interpret the reduction in notional exposure and mischaracterizes the increase in liabilities as part of a 'more balanced risk positioning' — whereas the ground truth emphasizes reduced perceived risk due to lower volatility assumptions, not balance from higher liabilities. The conclusion about improved risk management is speculative and not directly supported by the data in the original answer. (4) Despite these issues, the answer addresses all parts of the question (evolution over time, fair value, volatility, risk positioning), showing good structural completeness and contextual relevance. The qualitative reasoning attempts synthesis but draws questionable inferences from inaccurate numerical interpretation, leading to a moderate score on qualitative accuracy. Quantitative accuracy is low due to incorrect directional trends and fabricated volatility ranges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 503,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "SPG's Unsecured Notes - 35A had a face amount of $750,000 in 2022, with an annual debt service of $19,875 and a maturity date of July 15, 2030. In 2023, the face amount and annual debt service remained unchanged, indicating no new issuance or refinancing activity. Similarly, in 2024, the face amount and annual debt service stayed the same, showing continuity in the obligation. This consistency suggests that SPG has maintained a stable long-term debt strategy for this particular note, avoiding refinancing or restructuring in the period from 2022 through 2024, likely to preserve capital for other priorities or to benefit from favorable interest rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the face amount ($750,000) and annual debt service ($19,875) for Unsecured Notes - 35A across 2022, 2023, and 2024, matching the ground truth exactly. These values are consistent year-over-year, which the model accurately reflects. The addition of a maturity date (July 15, 2030) is not present in the original answer but does not contradict it and adds plausible context without affecting correctness. (2) All numeric values are accurate and correctly formatted; no calculation errors exist. The model correctly infers no changes imply no new issuances or repayments, aligning with the ground truth's interpretation. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly concludes stability in SPG's debt structure. The qualitative interpretation about maintaining a stable long-term debt strategy, avoiding refinancing, and preserving capital or benefiting from favorable rates is a reasonable extension of the ground truth's conclusion about predictability. While slightly more speculative, it remains logically consistent with the data. (4) The answer is fully contextually relevant, addressing all parts of the question: evolution over time, face amount, annual debt service, and implications for long-term debt strategy. The only minor deviation is the added maturity date, which is not in the original but does not harm accuracy. Thus, the answer is factually excellent with only slight interpretive expansion, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 431,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments (TXN) maintained a consistent strategic emphasis on embedded processing products from 2022 to 2024, as highlighted in its annual 10-K filings, with a focus on leveraging these products as a core component of its business model centered on analog and embedded processing. In 2022, TXN outlined its strategy around four competitive advantages, including a broad portfolio of embedded processing products to enhance customer value and investment returns. This emphasis continued in 2023 and 2024, with no significant changes in the strategic narrative, underscoring the long-term positioning of embedded processing as a key pillar of TI's operations. The three-year consistency in strategic focus suggests that TI is reinforcing its market position in the semiconductor industry by capitalizing on embedded processing to drive sustainable growth, diversify customer engagement, and strengthen its competitive advantages for long-term free cash flow generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments (TXN) consistently emphasized embedded processing from 2022 to 2024 as part of its four competitive advantages, with no changes in strategic language across the 10-K filings. The core themes—customer value, investment returns, customer diversity, and long-term free cash flow—are accurately reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers long-term strategic intent from consistent messaging. (4) The LLM slightly condenses some details—e.g., it does not explicitly mention 'channel reach' or 'greater opportunity per customer' as in the original—but captures the semantic essence and strategic implications. Wording differs but meaning is preserved. Minor omission prevents a perfect 10, but overall correctness, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 320,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 to 2024, CMCSA evolved its strategy around shared data plans by increasingly positioning them within bundled service offerings and expanding the range of payment options available to customers. In 2022, wireless services were offered exclusively as part of bundled offerings with broadband, with shared data plans among the payment options, alongside unlimited or per-gigabyte plans. By 2023, shared data plans remained a key component of wireless service options, with international customers having access to various gigabyte plans. In 2024, CMCSA expanded its wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to provide shared data plans and per-gigabyte options for domestic customers. This evolution reflects a broader strategy to enhance flexibility and customer choice within bundled services, leveraging both traditional and emerging payment models.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic evolution. Quantitatively, all years (2022, 2023, 2024) and plan types (shared data, unlimited, per-gigabyte, prepaid) are accurately referenced, with no numerical or date inaccuracies. The introduction of prepaid unlimited plans under the NOW brand in 2024 is correctly noted. The core strategy of maintaining shared data plans within bundled offerings across all three years is accurately conveyed. However, there is a minor factual inaccuracy regarding 'international customers having access to various gigabyte plans' in 2023—the ground truth specifies residential (domestic) customers and does not mention international offerings, which introduces a slight misrepresentation. Additionally, the LLM incorrectly states that wireless services in 2022 were offered 'exclusively as part of bundled offerings,' while the original answer does not use the word 'exclusively,' implying possible overstatement. Despite these nuances, the overall reasoning is sound, the multi-hop synthesis across years is effective, and the answer addresses both parts of the question: positioning within bundles and evolution of payment/plan options. The semantic meaning is largely equivalent to the original answer, warranting a high correctness score with a small deduction for the noted inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 388,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard's investment in Class A Treasury Stock increased from $(51,354) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024, indicating a consistent and substantial increase in treasury stock purchases over the three-year period. This trend suggests that Mastercard has been actively repurchasing its own shares, reflecting a capital allocation strategy focused on returning value to shareholders through share buybacks, likely driven by confidence in its financial position and a desire to optimize capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) figures. However, it incorrectly states the 2022 value as $(51,354) million, whereas the ground truth reports $(36,658) million—a significant discrepancy of nearly $14.7 billion. This error affects the quantitative accuracy. (2) The numbers for 2023 and 2024 are correct and match the ground truth exactly. The 2022 figure in the LLM answer is wrong, and no calculation (e.g., year-over-year change) is performed, so no derived metrics need validation. (3) The multi-hop reasoning is sound: the model correctly interprets increasing negative values in treasury stock as increased buyback activity and links this to capital allocation strategy, shareholder value return, and confidence in financial position—aligning with the ground truth's interpretation. (4) Despite the incorrect 2022 number, the overall trend and strategic implication are correctly conveyed, warranting a 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the large error in the initial year. Qualitative reasoning and contextual relevance remain strong (9 and 10) because the explanation is logically sound and fully addresses the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 380,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics' revenue from Repair and other services increased from $1,081 million in 2022 to $1,132 million in 2023 but slightly declined to $1,132 million in 2024, showing a modest and relatively stable trajectory in its service business during this period. This pattern suggests that while the service segment experienced growth in 2023 compared to 2022, it plateaued in 2024, indicating a potential stabilization or slower growth phase in the company's Repair and other services business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Repair and other services revenue was $1,169 million in 2022, not $1,081 million as stated by the LLM. The 2023 and 2024 figures ($1,132 million) are correct. This error in the 2022 value leads to an incorrect interpretation of growth from 2022 to 2023—LLM claims an increase, while in reality there was a decline. The 2024 figure is correctly reported as flat compared to 2023, but the overall trajectory is misrepresented. (2) Calculations: The ground truth shows a 3.2% decline from 2022 to 2024 [(1,169 - 1,132)/1,169 ≈ 3.2%], whereas the LLM implies a net increase due to wrong starting value. The LLM’s claim of 'increased from $1,081M to $1,132M' suggests a ~4.7% rise, which is factually incorrect. (3) Multi-hop reasoning: The model attempts to synthesize trends across three years, which is appropriate, but due to the incorrect 2022 figure, the reasoning is flawed. It concludes 'modest and relatively stable trajectory' and 'potential stabilization', which downplays the actual slight decline and stagnation revealed in the ground truth. (4) Contextual relevance is high—the answer addresses the question structure, discusses year-over-year changes, and interprets the business trajectory. However, due to the critical error in the 2022 revenue number, the qualitative and quantitative accuracy scores are low. The conclusion is not supported by the actual data, leading to a correctness score of 4—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 435,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) evolved significantly from 2022 to 2024. In 2022, the fair value of RMBS was $629 million with $10 million in unrealized losses, while in 2023, the fair value decreased to $721 million with $89 million in unrealized losses, reflecting a notable increase in risk exposure. By 2024, the fair value further declined to $71 million, but unrealized losses were reduced to $1 million. This trajectory suggests that CVS significantly reduced its RMBS holdings by 2024, likely to mitigate risk, as the asset class experienced substantial unrealized losses in 2023. The multi-year trend indicates a strategic de-risking in this asset class, aligning with broader market volatility and potential credit concerns in residential mortgage-backed securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, in 2023, the fair value of RMBS was $614 million with $60 million in unrealized losses. However, the LLM states a fair value of $721 million and $89 million in unrealized losses—both figures are incorrect. The 2024 fair value of $71 million and $1 million in unrealized losses is partially correct (fair value matches), but the ground truth does not specify unrealized losses for 2024, so asserting $1 million is unsupported. Only the 2022 figures ($629 million fair value, $10 million unrealized losses) are accurate. (2) Calculations and comparisons are therefore flawed: the LLM suggests increasing risk in 2023 due to higher unrealized losses, which aligns directionally with the truth (losses increased), but the magnitude is wrong, and the fair value decrease from $629M to $721M is mathematically impossible (it should be a decrease, not increase). This undermines quantitative reliability. (3) The multi-hop reasoning is partially sound—the conclusion that CVS is de-risking by reducing RMBS exposure is correctly inferred from the declining fair values, especially the sharp drop to $71 million in 2024. The interpretation of strategic de-risking aligns with the ground truth’s implication. However, the reasoning is based on incorrect data for 2023, weakening the validity of the trajectory analysis. (4) Contextual relevance is high—the answer addresses all parts of the question: evolution over time, fair value, unrealized losses, and risk positioning. The narrative structure and intent to synthesize across years are appropriate. However, due to major quantitative errors, especially in the critical 2023 data point, the correctness score is limited to 4. The qualitative score is moderate because the logic and entity identification (CVS, RMBS, years) are correct, but reasoning is based on faulty inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 525,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 to 2024, Linde’s contractual structure and pricing mechanisms for atmospheric gases, particularly in on-site customer agreements, remained largely consistent, with on-site contracts typically being long-term (10–20 years) total requirement agreements that include minimum purchase requirements and price escalation provisions. These contracts are characterized by pricing that fluctuates with various price indices, reflecting variable pricing components. In 2023 and 2024, Linde clarified that while variable components of consideration exist within on-site contracts, they are considered constrained, indicating a cautious approach to revenue recognition in line with ASC 606 guidelines. This structure supports Linde’s industrial gases business, where atmospheric gases are produced and supplied primarily through on-site, merchant, and packaged gas distribution methods, with on-site arrangements being central to large-volume, stable-demand customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Linde maintained long-term on-site contracts (10–20 years) with minimum purchase requirements and price escalation provisions from 2022 to 2024. The 2023 clarification that variable pricing components are present but constrained is correctly noted, as is the alignment with ASC 606. (2) Quantitative elements—contract duration (10–20 years), timing (2022–2024), and the nature of variable consideration—are factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information across years, correctly identifying the evolution in disclosure around variable pricing and revenue recognition. The only minor omission is that the 2024 reinforcement of the practical expedient for measuring progress toward performance obligations (aligning revenue recognition with invoicing) is not explicitly mentioned, which slightly reduces completeness. (4) Despite this, the answer captures the core progression—increased transparency in pricing mechanisms and constrained variable consideration—and remains contextually precise, directly addressing the evolution in contractual structure and pricing mechanisms for atmospheric gases. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 405,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy's net exposure to forward gas contracts evolved as follows: in 2022, the net exposure was $160 million (assets of $191 million minus liabilities of $31 million); in 2023, it increased to $300 million (assets of $377 million minus liabilities of $77 million); and in 2024, it further rose to $250 million (assets of $296 million minus liabilities of $46 million). This three-year trend suggests a growing risk positioning in natural gas markets, as the company has increased its net long exposure, likely to hedge against rising gas prices or to capitalize on market opportunities, reflecting a more active stance in managing gas-related price volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the net exposure values for 2022 ($160M), 2023 ($300M), and 2024 ($250M), with accurate underlying asset and liability figures for each year. All numbers match the ground truth, and calculations (e.g., $191M - $31M = $160M) are correct. However, the LLM states that net exposure 'further rose to $250 million in 2024', which is incorrect — it actually declined from $300M in 2023 to $250M in 2024. This mischaracterization affects the reasoning but not the numerical accuracy. (2) Quantitative accuracy is high: all dollar amounts and years are correct, and arithmetic checks out. Only minor error is the directional misstatement in 2024 change. (3) The multi-hop reasoning is mostly sound — the model identifies the trend across three years and attempts to interpret strategic implications. However, the conclusion that risk positioning is 'growing' contradicts the slight decline in 2024, leading to a flawed overall interpretation. The ground truth notes a 'strategic shift toward greater exposure before reducing positions', which reflects the peak-and-retract pattern better than the LLM's 'growing' narrative. (4) Scores reflect high factual accuracy with a moderate deduction in correctness and qualitative reasoning due to the misinterpretation of the trend direction in the final year. Contextual relevance is perfect — the answer directly addresses both parts of the question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 401,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "AVGO's positioning of Industrial Fiber Optics within its product portfolio remained consistently integrated within its broader industrial offerings across 2022, 2023, and 2024. In 2022, Industrial Fiber Optics was explicitly listed as part of AVGO's general industrial and automotive product suite, supporting applications such as industrial automation, power generation, medical systems, and vehicle subsystems. By 2023 and 2024, the product was similarly highlighted under the \"Industrial\" end market in AVGO’s key offerings, aligned with applications like factory automation, renewable energy, and automotive electronics. This continuity reflects AVGO's strategic emphasis on leveraging Industrial Fiber Optics to support diverse industrial and automotive markets, reinforcing its role as a foundational component within the company’s broader industrial product ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Industrial Fiber Optics is consistently positioned within AVGO's industrial portfolio across 2022–2024, with correct application markets cited each year (industrial automation, power generation, medical, automotive, etc.). The evolution—or lack thereof—is correctly interpreted as stable, with no significant expansion or contraction. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are all accurate. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers continuity in strategic positioning. The only minor omission is that the LLM does not explicitly name all co-located product lines in each year (e.g., optocouplers, sensors, motion encoders in 2023; Ethernet ICs in 2024), which are present in the original answer and add granularity to the product grouping. This slightly reduces completeness but does not distort meaning. (4) The answer is contextually relevant, directly addressing the evolution of positioning over time and its relation to broader industrial offerings and markets. Wording differs but semantic equivalence is preserved. Overall, this is a strong response with only minor detail omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 397,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "SPG's Unsecured Notes - 31B had a face amount of $750,000 in 2022, with an interest rate of 3.25% and a maturity date of November 30, 2026. By 2023, the face amount and interest rate remained unchanged, and in 2024, the same $750,000 face amount and 3.25% interest rate were still in place, with the maturity date also unchanged. This consistency in the face amount and interest rate across all three years suggests that SPG did not refinance or retire this particular note during the period. Given the long maturity date of 2026, the company appears to be employing a long-term debt strategy that includes maintaining fixed-rate obligations to manage interest costs and ensure stable cash flow planning over an extended horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the face amount of the Unsecured Notes - 31B. The original answer states the face amount is $750,000,000 (750 million dollars), but the LLM incorrectly reports it as $750,000 (750 thousand dollars), which is off by a factor of 1,000. This is a severe quantitative inaccuracy. All other numerical values—interest rate (3.25%), maturity date (November 30, 2026)—are correctly stated. However, the annual debt service of $24,375,000, which is a key financial obligation derived from the face amount and interest rate, is entirely omitted from the LLM answer, weakening completeness and quantitative accuracy. (2) The calculation of annual interest ($750,000,000 × 3.25% = $24,375,000) is implied in the ground truth but not recognized or reproduced in the LLM response, suggesting a failure to fully synthesize or validate the financial obligation. The LLM’s omission of this figure undermines its ability to fully address the question about 'interest obligations.' (3) The reasoning about SPG’s long-term debt strategy—stable fixed-rate debt, no refinancing, long maturity—is logically sound and consistent with the data, demonstrating correct qualitative interpretation and multi-hop synthesis across years. The entity (SPG), instrument (Unsecured Notes - 31B), and time period (2022–2024) are all accurately identified. (4) While the LLM captures the strategic implication correctly and maintains contextual relevance, the massive error in the face amount severely compromises factual correctness. A face amount of $750,000 would imply an annual interest of ~$24,375, not $24,375,000, making the LLM’s failure to report the correct obligation a direct consequence of the initial number error. Thus, despite strong qualitative reasoning and relevance, the quantitative inaccuracy results in a moderate overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 510,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $63 million in 2021, to $70 million in 2022, $75 million in 2023, and $76 million in 2024. This three-year upward trend indicates a growing investment by the company in employee retirement benefits, particularly through its defined contribution plans, which include employer-matching and fixed contributions based on employee eligibility and hiring dates. The steady rise in expenses reflects TI's continued commitment to supporting employee retirement savings, despite the defined benefit plans being closed to new participants since 1997.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $70M (2022), $75M (2023), and $76M (2024) expenses, which match the ground truth for the requested 2022–2024 period. However, it incorrectly includes $63M for 2021, which is outside the question's scope and not part of the ground truth answer. This extra data is factually irrelevant to the question and introduces a potential confusion, though it does not contradict the core trend. (2) The quantitative values for 2022–2024 are accurate, and the implied increase from $70M to $76M (approximately 8.6%) aligns with the ground truth. However, the inclusion of 2021 data and the phrasing 'three-year upward trend' could mislead, as the question specifically asks about 2022 through 2024 (a three-year span), not 2021–2024. The calculation of the percentage increase is not explicitly stated but would be correct if based on $70M to $76M. (3) The reasoning is sound in interpreting the trend as indicating growing investment in retirement benefits, and the additional context about plan structure and historical background (e.g., defined benefit plans closed since 1997) shows strong qualitative synthesis, even if not required. This enhances understanding but does not detract from accuracy. (4) The answer is highly contextually relevant, fully addressing the evolution and implications of the expense trend. The main deduction is in quantitative accuracy due to the inclusion of an incorrect, out-of-scope year (2021) with a number ($63M) not present in the ground truth, though the core requested data is correct. Thus, correctness is reduced to 7 due to partial factual overreach, despite strong performance on the main task.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 459,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "From 2022 through 2024, GD consistently excluded non-economic accounting changes from its ROIC calculations, as stated in each year's 10-K filings (pages 47, 49, and 50 for 2022, 2023, and 2024, respectively). This consistent treatment reflects GD's performance evaluation methodology, which aims to isolate operational performance by excluding items that are not indicative of core business performance, such as non-economic accounting changes and goodwill impairments. The continuity in this approach suggests a stable and deliberate strategy to provide a clearer view of the company’s operational returns to stakeholders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the cited document pages (47, 49, 50) are consistent with expected sourcing and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound—by synthesizing data across three years of 10-K filings, the model correctly infers that the consistent exclusion reflects a stable performance evaluation methodology focused on core operational results. (4) The LLM adds slight elaboration (e.g., mentioning goodwill impairments as an example) that is contextually appropriate and commonly associated with non-economic items, without introducing inaccuracies. The semantic meaning, factual content, and reasoning depth are equivalent to or exceed the ground truth, warranting top scores in all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 310,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS's Separate Accounts Assets were $5,087 million in 2022, decreased to $3,250 million in 2023, and further declined to $3,311 million in 2024. This three-year trend indicates a reduction in the company's investment positioning in long-term insurance products, as Separate Accounts Assets, which represent funds managed on behalf of policyholders, have shown a consistent decline. The downward trajectory suggests a potential shift in investment strategy or a reduction in the scale of long-term insurance-related obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 ($5,087M) and 2023 ($3,250M) values for CVS's Separate Accounts Assets, which match the ground truth. However, it incorrectly states that assets 'further declined' to $3,311M in 2024, when in fact this represents a slight increase from 2023. This mischaracterization of the trend in 2024 undermines the accuracy. (2) The numbers themselves are quantitatively accurate (allowing for format variations), but the directional description of the 2024 change is wrong—$3,311M is higher than $3,250M, so it is a marginal recovery, not a continued decline. (3) The reasoning is partially sound in linking Separate Accounts Assets to long-term insurance products, but the conclusion of a 'consistent decline' and 'downward trajectory' is factually incorrect due to the 2024 increase. The model fails in multi-hop synthesis by not recognizing that a rise from 2023 to 2024 breaks the pattern of decline, thus misinterpreting the trend. (4) The contextual relevance is high as the answer addresses both parts of the question—trend evolution and strategic implication—but the qualitative inaccuracy in trend interpretation reduces correctness. Due to correct numbers but flawed trend analysis and reasoning, the correctness score is 5—partially correct with significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 370,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. was initially established on October 22, 2012 (Chunk 3), and was amended for the first time on February 24, 2015 (Chunk 3). A second amendment was filed on November 19, 2019 (Chunk 3), indicating a significant contractual update. By 2022, the agreement remained unchanged, as no new amendments were noted in that year’s filings (Chunk 1). However, in 2024, the agreement was still referenced under the same original and amended terms, with no indication of a new amendment in that year (Chunk 2). Thus, the agreement evolved through two key amendments in 2015 and 2019, with no further changes reported in 2022 or 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the original agreement date (October 22, 2012), first amendment (February 24, 2015), and second amendment (November 19, 2019) are correctly cited, matching the ground truth. There are no calculation errors, and the timeline of amendments is accurately presented. The answer correctly notes that no new amendments were reported in 2022 or 2024, which aligns with the original answer's implication that the 2019 amendment was the latest formally listed by 2024. The reasoning is sound and reflects proper multi-hop synthesis across time points (2022, 2023, 2024) and contractual milestones. The only minor shortcoming is that the original answer emphasizes the continued strategic evolution and explicit listing of the 2019 amendment in 2024 filings as a sign of formal evolution, while the LLM answer interprets the lack of new amendments as 'no further changes,' which is accurate but slightly less nuanced in conveying the ongoing contractual recognition. However, this does not constitute a factual error. All entities (Target Corporation, TD Bank USA, N.A., dates, amendment structure) are correct. The response is fully relevant and addresses all parts of the question, including amendments and contractual milestones across the specified period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 365,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024, Linde enhanced its production and strategic positioning around rare gases by leveraging advanced air separation technologies and integrating rare gas production with other product lines. In 2022, Linde produced rare gases as part of its atmospheric gases portfolio, primarily through cryogenic air separation processes. By 2023, Linde expanded its technological differentiation by utilizing non-cryogenic methods such as vacuum pressure swing adsorption (VPSA) and membrane separation, which enabled on-site delivery for a broader range of customers. In 2024, Linde further solidified its leadership by producing rare gases like krypton, neon, and xenon as by-products of air separation and integrating them into its broader industrial gas offerings, including hydrogen and process gases, through shared production and distribution infrastructure. This integration allowed Linde to optimize costs and enhance customer solutions across its industrial gas segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde produced rare gases as part of its atmospheric gas portfolio in 2022 via air separation; by 2023, it emphasized non-cryogenic technologies like VPSA and membrane separation for on-site delivery; and in 2024, it highlighted leadership in these technologies and integration of rare gases (krypton, neon, xenon) as byproducts. The strategic evolution from product-centric to technology- and integration-driven is correctly conveyed. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the answer synthesizes Linde’s technological shift, production methods, and integration with other gas lines (e.g., hydrogen and process gases) across years, reflecting proper cross-year and cross-product synthesis. (4) Minor difference: the original answer emphasizes 'price escalation clauses' and 'long-term contracts' in 2023, which the LLM omits, and the original explicitly frames the shift as from 'product-centric to technology-driven,' which the LLM implies but does not state directly. However, these are nuances rather than factual errors. The LLM compensates by correctly identifying integration through shared infrastructure and cost optimization, which is consistent with the strategic trajectory. Overall, the answer is semantically equivalent and factually robust, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 427,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to advances to equity companies decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This consistent reduction suggests a decreasing exposure to derivative liabilities tied to equity company relationships, potentially indicating improved risk management, reduced derivative activity with equity companies, or more favorable terms in collateral requirements. The trend reflects a narrowing financial risk profile in these intercompany arrangements over the three-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. There are no discrepancies in dollar amounts or years. (2) All numbers are accurate and consistent with the original answer; no calculations are required beyond the stated values, and the trend of decline is correctly described. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the three-year trend across filings and synthesizes the implication regarding derivative liability exposure. The conclusion about decreasing risk exposure is logically derived from the declining collateral amounts. (4) The LLM answer not only matches the ground truth factually but also enriches the interpretation slightly with additional plausible explanations (e.g., improved risk management, favorable terms), which are semantically consistent and do not introduce inaccuracies. All parts of the question—evolution over time and implications for exposure—are fully addressed. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 332,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity increased from 92% in 2022 to 94% in both 2023 and 2024, indicating a stable and slightly growing commitment to long-term contracting. This trend suggests a deliberate risk mitigation strategy in competitive markets, as NEER aims to hedge against price volatility by securing long-term revenue streams and diversifying its portfolio by fuel type and location. The consistent use of such contracts, along with shorter-term hedges for spot market exposure, reflects a proactive approach to managing market and regulatory uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that NEER's reliance on long-term bilateral contracts increased from 92% in 2022 to 94% in both 2023 and 2024, matching the ground truth exactly. All percentages and years are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers align precisely with the original answer. Format is consistent and clear. (3) The multi-hop reasoning is sound: the model correctly infers that increasing long-term contract coverage reflects a risk mitigation strategy, particularly against price volatility in competitive markets. It appropriately references the use of shorter-term contracts as a hedge, which is mentioned in the ground truth. The addition of 'diversifying its portfolio by fuel type and location' and 'regulatory uncertainties' extends slightly beyond the original answer but does not contradict it and adds reasonable context consistent with industry practices. (4) The answer is fully relevant to the question, addressing both the evolution of contract reliance and its implications for risk management. The only minor deviation is the inclusion of slight interpretive expansion, which does not detract from factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect alignment with the ground truth, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into_Contract]-> FIN_INST <-[Contracts]- ORG <-[Enters_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 387,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million from fiscal 2022 through fiscal 2024, as reported in the 2022, 2023, and 2024 10-K filings. This consistency suggests that AVGO did not refinance, repay, or issue additional amounts under this specific debt instrument during the period, indicating a stable debt management strategy for this maturing obligation. The lack of change in the principal balance implies that the company likely plans to address the repayment of this debt as it comes due in January 2025, either through cash reserves or by issuing new debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million from fiscal 2022 through fiscal 2024, which matches the ground truth. All numeric values—$495 million, 3.125%, January 2025 maturity—are accurate and consistently reported across the three years. (2) Quantitative accuracy is perfect: the dollar amount, interest rate, and time period are all factually correct, with no calculation errors. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years (2022–2024) from 10-K filings, and the conclusion about debt management strategy is logically derived. The LLM correctly infers that the lack of principal reduction suggests repayment will likely come from cash reserves or new debt. (4) The only minor difference from the ground truth is in emphasis: the original answer explicitly notes that the balance remained unchanged 'despite approaching maturity' and suggests 'refinance or use cash reserves,' while the LLM uses slightly more general phrasing ('address the repayment... through cash reserves or issuing new debt'). However, the semantic meaning and factual content are equivalent. No critical information is missing, and the reasoning is strong. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall due to slight difference in strategic interpretation nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 409,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Simon Property Group's Unsecured Notes - 37B had a face amount of $700,000, an interest rate of 2.25%, and a maturity date of 01/15/32 in 2022 (Chunk 1). In 2023, the note retained the same face amount and interest rate, with no changes in maturity date (Chunk 3). Similarly, in 2024, the note's face amount, interest rate, and maturity date remained unchanged at $700,000, 2.25%, and 01/15/32 (Chunk 2). This three-year consistency in interest rate, face amount, and maturity date suggests that SPG has maintained a stable long-term debt strategy, avoiding refinancing or restructuring of this particular note, likely to preserve financial predictability and manage interest costs over an extended period.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the interest rate (2.25%) and maturity date (01/15/32) as consistent across 2022–2024, and correctly notes the stability in terms, which aligns with the ground truth. However, there is a critical error in the face amount: the LLM states $700,000, whereas the ground truth specifies $700,000,000. This is off by a factor of 1,000 and represents a major quantitative inaccuracy. (2) The face amount appears incorrectly in all three years (2022, 2023, 2024) in the LLM answer as $700,000 instead of $700 million. All other numbers (interest rate, maturity date) are correct in value and format. (3) The multi-hop reasoning is sound—the model synthesizes data across the three years and correctly infers that the lack of change indicates a stable long-term debt strategy focused on predictability and cost management. This matches the qualitative conclusion in the ground truth. (4) Despite the severe numerical error in face amount, the reasoning and contextual interpretation are strong, and all other entities (company, note identifier, years) are accurate. The answer remains contextually relevant and logically coherent. Due to the magnitude of the dollar amount error, quantitative accuracy is severely penalized, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 368,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 to 2024, Texas Instruments (TXN) maintained a consistent operational footprint in Melaka, Malaysia, focusing exclusively on analog products, as indicated by the \"X\" under the Analog column and the absence of an \"X\" under Embedded Processing in all three years. This three-year progression highlights TXN's sustained emphasis on analog operations in Melaka, with no evidence of diversification into embedded processing during this period. The consistency in the data across the 10-K filings underscores the site's specialized role in supporting TXN's analog business strategy in the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments maintained an analog-only operational footprint in Melaka, Malaysia from 2022 to 2024, with an 'X' under Analog and no mark under Embedded Processing each year—this matches the original data exactly. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the consistent presence/absence of markers is accurately described across all three years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to identify a pattern of sustained focus on analog products without expansion into embedded processing. (4) The conclusion about TXN’s strategic emphasis on analog capabilities in Melaka is logically derived and contextually appropriate. All aspects of the question—evolution over time and implications for product focus—are addressed with factual precision and coherent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 295,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard's multi-layered security approach evolved from 2022 through 2024 in response to the expansion of real-time payment infrastructure across global markets. In 2022, Mastercard already had a multi-layered security program in place, incorporating multiple layers of protection, third-party assessments, and collaboration with industry stakeholders to establish technical standards like EMV. By 2023, the company had implemented real-time payments infrastructure in 13 markets, enhancing its capabilities to support instant, secure account-to-account transactions while maintaining a robust security framework that included fraud scoring, tokenization, and enterprise resilience programs. In 2024, Mastercard expanded further, beginning to process domestic transactions in China through a joint venture, and continued to strengthen its security approach by integrating real-time services with enhanced monitoring and response mechanisms, ensuring the integrity of its growing real-time payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, Mastercard had a robust multi-layered security approach with EMV standards and stakeholder collaboration; by 2023, real-time payments were in 13 markets (up from 12 in 2022), with fraud scoring and tokenization applied in real time; in 2024, domestic processing in China via a joint venture marked a significant expansion. (2) Quantitative accuracy is perfect: the progression from 12 to 13 markets is correctly implied (though 12 is not explicitly mentioned in the LLM answer, the increase to 13 is accurate), and no incorrect numbers are presented. (3) Multi-hop reasoning is sound—the answer synthesizes evolution across years, markets, and security enhancements in response to real-time payment growth. (4) The only minor omission is the lack of explicit mention that real-time infrastructure was in 12 of the top 50 GDP markets in 2022, which provides context for the scale of expansion. Additionally, the LLM mentions 'third-party assessments' not emphasized in the original, and omits specific mention of integrating third-party service risks and public-private partnerships in 2024, which are part of the security evolution. However, the core factual trajectory, entities, years, and technological responses are accurately conveyed with strong contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 389,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 360 units in 2022 (as reported in Chunk 1) to 399 units in 2023 (Chunk 3), and further to 449 units in 2024 (Chunk 2), indicating a steady rise in output over the three-year period. This upward trend, combined with the company's ongoing fleet upgrades and expansion into advanced variants such as the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS), reflects a strategic focus on deepening its involvement in LAV programs. The progression underscores General Dynamics' commitment to strengthening its market leadership in armored vehicle production and enhancing its technological capabilities, particularly in meeting the evolving defense needs of international allies like Canada.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all production volumes—360 units in 2022, 399 in 2023, and 449 in 2024—matching the ground truth exactly. These numbers are cited with reference to document chunks, confirming accurate sourcing. (2) All quantitative data are accurate, with no calculation errors. The progression (360 → 399 → 449) is correctly described as an upward trend, and the values align precisely with the original answer. (3) The multi-hop reasoning is sound: the model synthesizes data across three time points and correctly infers a growing strategic focus on LAV programs. It adds contextual depth by referencing the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) and fleet upgrades, which, while not in the ground truth, are plausible extensions consistent with the company’s known activities and do not contradict the core facts. (4) The answer fully addresses both parts of the question: the evolution of production volume and its strategic implications. The interpretation ('steady rise', 'strategic focus', 'commitment to market leadership') is logically derived and semantically aligned with the ground truth’s conclusion about 'growing strategic emphasis' and 'expanding defense contracts'. The only minor deduction is in qualitative accuracy due to the addition of LRSS, which, while reasonable, is not verifiable from the provided ground truth and slightly extends beyond it. However, this does not undermine factual correctness. Overall, the answer is factually precise, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 431,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS's allocation to hedge fund limited partnership (HF LP) investments through pension plan assets increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This three-year upward trajectory suggests a gradual expansion in the company's exposure to alternative investments, specifically hedge fund partnerships, indicating a potential strategic shift toward diversifying pension fund assets to enhance returns or manage risk over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts: $214 million in 2022, $225 million in 2023, and $252 million in 2024, matching the ground truth exactly. The upward trajectory is accurately described. (2) While the ground truth includes a calculated total increase of 17.8% over the period, the LLM omits this specific percentage but still correctly characterizes the trend as an 'upward trajectory' and 'gradual expansion.' This is a minor omission but does not detract from the overall accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers a strategic trend in pension fund allocation. The conclusion about diversification to enhance returns or manage risk is a reasonable interpretation consistent with the ground truth's suggestion of a 'consistent, and potentially more confident, strategic approach.' (4) All entities—CVS, hedge fund limited partnership investments, pension plan assets, and the time frame—are correctly identified and contextualized. The answer is fully relevant and semantically equivalent to the original, with only slight variation in emphasis. Quantitative accuracy is perfect; qualitative and contextual accuracy are excellent, warranting a 9/10 overall due to the missing percentage change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 364,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the broader RedCard or Target Circle Card program) declined from 20.20% in 2022 to 19.8% in 2023 and further to 18.6% in 2024. This downward trend suggests that while consumer adoption of the card may still be growing (as noted in the 2022 report that RedCard sales increased), the overall rate at which customers are using these financial products to make purchases at Target has slowed. This could indicate either a shift in consumer payment preferences or a relative increase in total sales that outpaced the growth in card usage, as noted in the 2022 report.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. However, the LLM reports 20.20% in 2022 (incorrect) and 18.6% in 2024 (too high), which misrepresents the magnitude of the decline, especially in 2024. The 2023 figure (19.8%) is correct. (2) The calculation of the trend is partially accurate—there is a correct identification of a downward trajectory—but the specific values are not fully aligned with the ground truth. The 2022 and 2024 numbers are off by 0.3 and 0.8 percentage points respectively, which affects the interpretation of the trend's severity. (3) The qualitative reasoning is sound: the LLM correctly infers that the decline may reflect shifting consumer preferences or total sales outpacing card usage, and it appropriately references RedCard sales growth relative to total sales. It also correctly identifies the 5% incentive contextually. The synthesis across years and concepts (penetration vs. dollar sales) shows adequate multi-hop reasoning. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of penetration rate and implications for adoption/engagement) and stays focused on Target's financial products. However, due to the incorrect numerical values, especially the underreporting of the 2024 drop (18.6% vs. actual 17.8%), the correctness score is limited to 6, as the core trend is right but the factual precision is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 425,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolved from 2022 through 2024 as follows: In 2022, the total fair value contribution was $1 million, with $5 million from significant other observable inputs and $6 million from significant unobservable inputs. By 2023, the total fair value contribution increased to $12 million, with $12 million from significant other observable inputs and $24 million from significant unobservable inputs. In 2024, the total fair value contribution further rose to $38 million, with $4 million from significant other observable inputs and $34 million from significant unobservable inputs, indicating a growing reliance on unobservable inputs over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors in the treatment of contributions from significant other observable inputs. According to the ground truth, these inputs were negative in 2022 (-$5 million) and 2023 (-$12 million), indicating a liability or reduction in fair value, but the LLM incorrectly reports them as positive values ($5 million and $12 million). This misrepresents the nature of the inputs and fails to reflect the actual financial dynamics. Only in 2024 does the LLM correctly report a positive $4 million contribution, which aligns with the ground truth. The unobservable inputs are correctly reported as $6M, $24M, and $34M, and total fair values of $1M, $12M, and $38M are accurate. (2) Calculations: The totals only make sense if negative inputs are considered. For example, in 2022: -$5M + $6M = $1M (correct total), but LLM implies $5M + $6M = $11M, which contradicts the $1M total it states—this is a critical inconsistency. Similarly, in 2023: -$12M + $24M = $12M, but LLM implies $12M + $24M = $36M, not $12M. These calculation inconsistencies reveal flawed reasoning. (3) Multi-hop reasoning: While the LLM identifies the correct years, company (NextEra Energy), and metric (fair value exposure related to FPL Cost Recovery Clauses), it fails to correctly interpret the directional impact (positive/negative) of input categories, undermining the synthesis. The conclusion about growing reliance on unobservable inputs is partially valid, as those inputs do increase, but the reasoning is based on incorrect data. (4) Correctness score is 5 due to major quantitative inaccuracies that affect interpretation, despite correct totals and trend direction. Quantitative accuracy is 4 due to repeated sign errors in key financial inputs. Qualitative accuracy is 6 because the structure and intent are sound, and some data is correct. Contextual relevance is 9—response directly addresses the question’s scope and evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 533,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "From 2022 through 2024, NKE (Nike) and Anta have maintained a competitive relationship in the global athletic footwear, apparel, and equipment industry, with both companies emphasizing product innovation and brand engagement as key competitive differentiators. In 2022, NKE highlighted its focus on product innovation, including quality, performance, and design, as well as brand engagement through marketing, digital experiences, and partnerships with athletes and influencers. By 2023 and 2024, NKE continued to reinforce these strategies, emphasizing its leadership in innovation and brand connection, while also acknowledging Anta as a key competitor in its global competitive landscape. Anta, as a rising global player, has increasingly challenged NKE through its own innovation and brand-building efforts, particularly in emerging markets. This evolving dynamic reflects the intensifying competition in the industry, with both companies leveraging intellectual property, digital engagement, and strategic partnerships to maintain and expand their market positions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the competitive relationship between NKE and Anta from 2022 to 2024 and acknowledges NKE's emphasis on product innovation and brand engagement. It accurately notes NKE’s focus on quality, performance, design, digital experiences, and athlete partnerships. However, it misses a key strategic shift highlighted in the ground truth: in 2023, NKE elevated 'innovation and development' ahead of 'performance and reliability,' signaling a prioritization of technological leadership. This nuanced but important evolution in competitive positioning is absent in the LLM response. Additionally, while the LLM mentions Anta as a competitor and rising player, it does not confirm that NKE explicitly named Anta as a competitor across all three years, which is a factual detail present in the ground truth. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is partially sound: the LLM synthesizes NKE’s innovation and engagement strategies over time and positions Anta as a growing competitor. However, it fails to fully capture the strategic re-prioritization within NKE’s own competitive differentiators (i.e., innovation moving ahead of reliability), which is central to the question about evolving competitive positioning. This weakens the qualitative accuracy. (4) The answer remains contextually relevant and well-structured, addressing both product innovation and brand engagement across the three-year horizon. It correctly frames the intensifying competition and use of digital and partnership strategies. While it conveys a similar overall narrative, the omission of the specific shift in NKE’s stated competitive priorities reduces factual completeness and precision, justifying a 7 on correctness and qualitative accuracy. Wording differences are acceptable under semantic equivalence, but missing key strategic shifts lowers the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 553,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan declined from 2022 to 2024, as no specific remaining shares for future issuance under this plan are mentioned in any of the provided chunks, while newer plans like the 2018 Director Plan and 2024 LTIP are highlighted. In 2022, the 2018 Director Plan had 1,843,134 shares available, which decreased to 1,786,785 in 2023 and further to 1,745,284 in 2024. This trend suggests that TI is increasingly relying on newer compensation plans, such as the 2024 LTIP, for director compensation, while the 2003 plan is likely being phased out or used minimally.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the declining availability and phase-out trend of the 2003 Director Compensation Plan from 2022 to 2024, aligning with the ground truth. It accurately notes that newer plans like the 2018 Director Plan and 2024 LTIP are now the focus. However, the LLM introduces specific share numbers (e.g., 1,843,134 in 2022) for the 2018 Director Plan, which are not relevant to the 2003 plan and were not part of the original answer. These numbers, while possibly accurate for the 2018 plan, distract from the core question about the 2003 plan and introduce quantitative details not supported by the ground truth in this context. (2) The original answer does not include any share counts for the 2003 plan or related plans, so the inclusion of precise figures for the 2018 plan is extraneous and potentially misleading. There is no verification that these numbers are correct in the context of the provided knowledge graph, and they shift focus from the 2003 plan's status. (3) The multi-hop reasoning is sound in that the model infers the phase-out of the 2003 plan based on its decreasing mention and the rise of newer plans. It correctly synthesizes across years and plans to conclude a strategic shift, which matches the ground truth's interpretation. (4) The correctness score is 7 because the core conclusion about the plan being phased out is accurate and well-supported. However, the quantitative accuracy is reduced due to the introduction of irrelevant numerical data not present in the ground truth. Qualitative accuracy remains high due to correct reasoning and entity identification, and contextual relevance is strong as the answer directly addresses the trend and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 470,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, CMCSA expanded its data-driven services within its advertising offerings by enhancing its technology, tools, and marketplace solutions to better enable advertisers to engage with target audiences. In 2022, CMCSA already provided data-driven services and tools to the media industry as part of its advertising business, which also represented third-party advertising sales and offered solutions to improve ad effectiveness. By 2023, the company had launched its DTC streaming service under the NOW brand in the U.S., which integrated ad-supported tiers and expanded digital access to content, further supporting data-driven ad delivery. In 2024, CMCSA continued to offer and expand these technology and data-driven solutions, emphasizing their role in facilitating effective engagement for advertisers across its platforms, including Sky-branded networks and digital services. These enhancements reflect a strategic evolution toward more integrated, data-centric advertising solutions across CMCSA's expanding digital and streaming ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies CMCSA's progression in enhancing data-driven advertising services from 2022 to 2024 and acknowledges the strategic shift toward integrated, technology-enabled solutions. However, it introduces a factual inaccuracy by claiming that CMCSA launched a DTC streaming service under the 'NOW' brand in the U.S. in 2023, which is not supported by the ground truth and appears to be hallucinated. The original answer makes no mention of a NOW brand or DTC launch as part of the advertising evolution. Instead, the ground truth emphasizes cloud-based platforms, integrated search functionality, and strengthened third-party representation agreements—none of which are accurately reflected in the LLM response. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; all years (2022, 2023, 2024) are used appropriately in context. (3) The multi-hop reasoning is partially sound—the LLM correctly tracks the evolution across years and links data-driven services to advertising effectiveness. However, it fails to synthesize the correct enhancements: it omits cloud-based platforms and integrated search (2023), and misrepresents the 2024 developments by focusing on streaming expansion rather than refinement of digital tools and third-party representation agreements. (4) The contextual relevance is high because the answer addresses the evolution of advertising offerings and ties in technology and data tools. But due to the inclusion of unsupported details (NOW brand) and omission of key factual enhancements from the ground truth, the qualitative and overall correctness scores are reduced to 6, reflecting partial accuracy with significant factual gaps and one major hallucination.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 486,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 through 2024, both in terms of fair value and number of securities. In 2022, CMBS had a total fair value of $574 million with $12 million in unrealized losses, and by 2023, this dropped to $675 million in fair value with $100 million in unrealized losses. In 2024, the exposure further reduced to $3 million in fair value with negligible losses. This trend suggests a strategic reduction in risk positioning in the CMBS asset class, likely due to market volatility and potential credit concerns, as evidenced by the rising unrealized losses in 2023 compared to 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2023 fair value of CMBS: it states $675 million, while the ground truth reports $675 million as a *decrease* from 2022's $574 million, which is logically inconsistent—$675M is higher than $574M. This suggests a likely typo or data inversion. The correct trend is a drop from $574M (2022) to $675M (2023) is factually incorrect—it should be a decrease, not an increase. However, the 2024 value is nearly correct ($3M vs. $6M in truth), and the unrealized losses are accurately reported as increasing to $100M in 2023 and becoming negligible in 2024. (2) The quantitative inaccuracy in 2023 fair value undermines confidence in the data synthesis. The increase from $574M to $675M contradicts the stated 'decline' in exposure, creating a logical inconsistency. The correct sequence should show a decline: $574M (2022) → lower in 2023 → $6M (2024). The $675M figure is likely a reversal of the correct number (possibly meant to be $76.5M or similar, but not verifiable). (3) The multi-hop reasoning is otherwise sound: the model correctly infers a strategic de-risking from rising unrealized losses and declining holdings. It connects 2022–2024 trends and draws a reasonable conclusion about risk positioning. (4) Despite the major quantitative error in 2023 fair value, the answer captures the overall narrative of reduction and risk mitigation, and all other years and qualitative insights are aligned. Hence, correctness is reduced to 7 due to the significant numerical inaccuracy, but not lower because the directionality and conclusion are still partially supported by correct data points in 2022 and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 456,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target's 2022, 2023, and 2024 disclosures consistently highlight merchandise discounts as part of its employee benefits, though no specific dollar values or scope changes are quantified across the years. The 2022 disclosure notes a starting wage of at least $15 per hour and mentions merchandise discounts among other benefits, while 2023 and 2024 expand on the wage range ($15 to $24 per hour) and reiterate merchandise discounts as part of a broader, more comprehensive benefits package. The multi-year progression reflects a strategic emphasis on maintaining and enhancing employee benefits to support financial well-being and reinforce Target’s commitment to being an employer of choice, particularly in a competitive retail environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of Target's disclosures across 2022, 2023, and 2024, with no incorrect numbers or misstated entities. It correctly identifies that merchandise discounts remained a consistent benefit without quantified scope changes, and accurately reports the wage floor of $15/hour in 2022 and the expanded range of $15–$24/hour in 2023 and 2024. These quantitative details match the ground truth exactly. The answer also correctly observes that the framing of benefits evolved toward a more comprehensive package, which aligns with the ground truth's emphasis on broader financial wellness and employee well-being. However, the LLM answer omits specific qualitative enhancements noted in the original answer—particularly the introduction of 401(k) matching, tuition reimbursement, mental health services, and virtual healthcare in 2024. While it generalizes these as a 'broader, more comprehensive benefits package,' it fails to name the specific new components that support the strategic shift toward holistic well-being. This missing detail reduces completeness and weakens the depth of multi-hop synthesis, particularly in connecting the evolution of non-discount benefits to the overall strategy. Nevertheless, the reasoning is sound, the entities and years are correct, and the conclusion about Target’s employer-of-choice strategy is contextually appropriate and relevant. The answer captures the core progression but lacks the granular support that would fully substantiate the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 425,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "Linde's emphasis on cultural challenges during acquisition integration remained a consistent concern from 2022 to 2024, as highlighted in each year’s 10-K filings. In 2022, Linde identified cultural challenges as a key integration risk, particularly in cross-border acquisitions, noting the difficulty of assimilating employees from different organizational and national cultures. By 2023, the company continued to stress the importance of cultural integration, reiterating the risk of operational and cultural misalignment in foreign acquisitions and the potential for these challenges to hinder synergy realization and employee retention. In 2024, while the broader section on integration risks was slightly condensed, cultural challenges were still explicitly mentioned, indicating that Linde maintains a strategic focus on managing these risks to ensure successful post-acquisition performance. This consistent emphasis reveals that Linde views cultural integration as a critical component of its cross-border acquisition strategy, reflecting a proactive approach to mitigating integration risks and enhancing long-term value creation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and overall trajectory of Linde's evolving emphasis on cultural challenges from 2022 to 2024. It correctly identifies that cultural challenges were consistently mentioned across all three years and were tied to cross-border integration risks. The answer accurately reflects Linde’s ongoing concern with cultural integration affecting synergy realization and employee retention, particularly in foreign acquisitions. However, it misses a key nuance present in the original answer: the progressive strategic reframing of cultural risks in terms of financial outcomes and regulatory complexity. Specifically, the 2023 shift toward linking cultural differences with global regulatory and compliance risks is not mentioned, and the 2024 sharpened focus on financial impact (e.g., negative effect on financial results if integration fails) is underemphasized. Instead, the LLM notes only that the 2024 discussion was 'slightly condensed,' which does not fully capture the strategic pivot toward financial risk framing. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are involved), and all entities (Linde, 2022–2024, cross-border integration) are correct. The reasoning is sound but lacks full depth in tracing the evolution of risk framing. Contextual relevance is excellent—the response directly addresses the question and maintains focus on strategic implications. Minor omission of strategic evolution details prevents a 9–10 score, but core facts and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 439,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net changed from $1,494 million in 2022 to $800 million in 2023 and further decreased to $491 million in 2024. This declining trend suggests that the company has been effectively managing its derivative exposure by reducing the amount of collateral required, likely through improved risk mitigation strategies, more favorable credit terms, or a reduction in the volume or risk profile of its derivative positions. The reduction in collateral aligns with the company's broader efforts to optimize its balance sheet and manage liquidity efficiently.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, with correct directional change (decreasing) across the years. There are no calculation errors, and the values align exactly with the original answer, allowing for standard format variation. (2) The answer is complete, addressing both parts of the question: the net change in collateral from 2022 to 2024 and the implication regarding derivative exposure management. (3) Entity accuracy is correct—ExxonMobil is properly identified, and the financial metric 'collateral under master netting arrangements related to Notes and accounts receivable - net' is accurately referenced with correct fiscal years (2022, 2023, 2024). (4) The reasoning is sound and adds value: the declining collateral trend is correctly interpreted as indicative of reduced derivative exposure or improved risk mitigation, with plausible explanations such as better credit terms or risk management strategies. The LLM extends the insight logically by linking it to balance sheet optimization and liquidity management, which is contextually appropriate and does not contradict the ground truth. Overall, the answer demonstrates accurate multi-hop synthesis across time points and correct qualitative interpretation, meeting all evaluation criteria at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 396,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "From 2022 to 2024, AVGO's Security Insights Platform evolved significantly in integration, remediation, and alignment with broader cybersecurity strategies. In 2022, the platform focused on interpreting and assessing mainframe security posture, identifying risks, and developing remediation steps, with data available for use with in-house security information and event management (SIEM) tools. By 2023, the platform remained central to ensuring a trusted environment but was increasingly positioned within a broader cybersecurity ecosystem, as evidenced by the introduction of complementary solutions like Lateral Security Firewall and Advanced Threat Prevention, which enhanced threat detection and access control. In 2024, the platform continued to support risk identification and remediation while aligning with AVGO's expanded cybersecurity portfolio, including advanced threat prevention and lateral movement protection, reinforcing its role in a holistic, integrated security strategy across mainframe and distributed environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the platform's evolution from 2022 to 2024. It accurately captures the core functionality in 2022: interpreting mainframe security posture, identifying risks, and generating remediation steps, with integration into in-house SIEM tools. The 2023 description correctly notes continuity in function but increased positioning within a broader cybersecurity ecosystem. The mention of 'Lateral Security Firewall' and 'Advanced Threat Prevention' is consistent with the ground truth’s emphasis on alignment with modern security practices and expanded portfolio integration. In 2024, the LLM correctly identifies continued support for risk and remediation, and alignment with an expanded portfolio, including threat prevention and lateral movement protection. However, the ground truth specifically highlights integration within a broader software suite including Cybersecurity, AIOps, and DevOps, emphasizing regulatory compliance and enterprise-wide planning—nuances not fully reflected in the LLM response. While the LLM captures the strategic integration theme, it substitutes specific suite components (AIOps, DevOps) with product names not mentioned in the original (e.g., Lateral Security Firewall), which may be accurate but are not verifiable from the provided ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates are correct. The reasoning is sound and multi-hop synthesis across years is appropriate. The answer is contextually relevant and addresses all parts of the question, though with slightly less precision on the nature of the 2024 integration. Hence, a score of 8 is justified for minor omissions in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 475,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "SPG’s Unsecured Notes - 32B had a consistent face value of $750,000 in 2022, 2023, and 2024, with an interest rate of 3.38% in all three years and a maturity date of June 15, 2027. This consistency in face value and interest rate indicates that SPG did not refinance or issue new debt related to this instrument during the period. The stable exposure suggests a disciplined long-term debt management strategy, maintaining fixed-rate obligations to manage interest costs and maturity profiles, likely to avoid refinancing risks and ensure predictable debt service obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the face value amount: it states $750,000 instead of $750,000,000 as per the ground truth. This is a significant quantitative inaccuracy—off by three orders of magnitude. All other numeric values (interest rate of 3.38%, maturity date of June 15, 2027) are correct and consistently reported across 2022–2024. (2) The calculation and comparison across years are not applicable here since the values are static, but the model failed to accurately report the face amount, which is central to the question. Format variation is acceptable (e.g., $750M vs $750,000,000), but $750,000 is not equivalent and represents a factual error. (3) The multi-hop reasoning is sound—the model correctly identifies that the terms remained unchanged over the three years and infers a stable debt management strategy, which aligns with the ground truth. It synthesizes information across years appropriately and draws a logical conclusion about SPG’s long-term strategy. (4) Despite the major numerical error, the reasoning and contextual interpretation are strong, and the answer addresses all parts of the question (evolution over time and strategic implication). The correctness score is reduced primarily due to the severe quantitative inaccuracy, which undermines trust in the financial analysis, even though the qualitative and strategic assessments are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 393,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, the competitive threat posed by Lumen to CMCSA's broadband services has intensified, particularly in the areas of fiber network expansion and service bundling. In 2022, Lumen was already noted as a key competitor building fiber-based networks that enabled higher-speed data transmission, directly challenging CMCSA’s traditional HFC infrastructure. By 2023 and 2024, Lumen continued to expand its fiber network further into its service areas, offering faster speeds and bundled services—such as combining broadband with wireless phone services—to attract residential and business customers. This evolution in Lumen’s strategy, supported by broader industry trends of fiber deployment and bundling, has increasingly pressured CMCSA to maintain its competitive edge in broadband performance and service offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumen remained a consistent and intensifying competitor to CMCSA from 2022 to 2024, with a focus on fiber expansion and service bundling. The evolution across the three years is accurately portrayed—starting with fiber deployment in 2022, continuing in 2023, and persisting in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes Lumen’s competitive actions across years and connects fiber expansion with bundling strategies, correctly identifying the strategic shift as a growing threat. It appropriately infers intensification, which is supported by the original’s 'consistent and possibly intensifying' language. (4) The only minor gap is that the LLM slightly strengthens the claim by stating the threat 'has intensified' with confidence, whereas the original allows for 'possibly intensifying'—a nuance in certainty. However, this does not constitute a factual error, as 'intensified' is a reasonable interpretation. The mention of bundling with wireless services is a plausible detail consistent with industry trends and does not contradict the ground truth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 414,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target's RedCard (later rebranded as Target Circle Card) penetration rate declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This downward trend suggests that the effectiveness of Target's loyalty-driven payment strategy may have diminished over time, as fewer purchases were made using the branded payment cards despite the 5% discount incentive. The decline in penetration could indicate shifting consumer behavior, increased competition, or a potential need for strategic adjustments to reinvigorate the loyalty-driven payment program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for Target's branded payment cards as 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024, matching the ground truth exactly. These numbers are presented accurately with no calculation or formatting errors. (2) All numeric values are correct and consistent with the original answer; the downward trend is properly quantified. (3) The LLM correctly identifies the multi-hop nature of the question by tracking the metric over three years and synthesizing the trend into a meaningful interpretation about the effectiveness of Target's loyalty-driven payment strategy. It appropriately infers that declining penetration may signal reduced effectiveness, aligning with the ground truth's implication. The addition of possible reasons (e.g., shifting consumer behavior, competition, need for strategic adjustments) extends the reasoning slightly beyond the original but remains logically sound and contextually appropriate. (4) The only minor deviation from the original answer is the inclusion of 'RedCard' and 'Target Circle Card' branding details and the mention of the 5% discount, which are not present in the ground truth. However, these are factually plausible and do not contradict known information, so they don't detract significantly from accuracy. Overall, the answer is semantically equivalent, quantitatively precise, and contextually rich, warranting a high correctness score with a small deduction for slight over-elaboration on brand details not in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 423,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron's financial and operational engagement with the Republic of Congo evolved significantly from 2022 through 2024. In 2022, the Republic of Congo was listed as one of Chevron's key operating regions, reflecting ongoing upstream activities and asset ownership. By 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects in the Republic of Congo, indicating continued operational and financial commitment. However, by early 2025, Chevron exited its 31.5 percent nonoperated working interest in the offshore Haute Mer permit area and its 15.75 percent interest in the Republic of Congo portion of Lianzi, signaling a strategic divestment from the region. This shift aligns with Chevron's broader strategy to optimize its portfolio and focus on higher-return opportunities, as outlined in its 2024 developments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Chevron's engagement with the Republic of Congo from 2022 to 2024, including its status as a key operating region in 2022, the $0.7 billion investment in African offshore and gas projects (including Congo) in 2023, and the divestment of its 31.5% interest in Haute Mer and 15.75% in Lianzi. However, there is a minor but notable error in timing: the original answer states the divestiture occurred 'by 2024', while the LLM claims it happened 'by early 2025', which misaligns with the ground truth timeline. This affects quantitative accuracy. (2) The financial figure of $0.7 billion is correctly cited, and the percentages (31.5% and 15.75%) are accurate. The error lies solely in the year of divestiture. (3) The multi-hop reasoning is sound—linking operational status, investment, and strategic exit—demonstrating proper synthesis across years and strategic intent. The conclusion about portfolio optimization aligns with the original answer’s interpretation. (4) Scores reflect high factual and qualitative accuracy, with a slight deduction in correctness and quantitative accuracy due to the incorrect timing of the divestiture. Contextual relevance is perfect as all aspects of the question (asset ownership, investment, strategy) are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Invests_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 374,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra Energy's exposure to gas-related options, as shown in the 2022 through 2024 10-K filings, remained relatively stable in fair value, with a slight decline from $356 million in 2022 to $100 million in both 2023 and 2024. However, the implied volatility associated with these options decreased significantly over the period, dropping from a weighted average of 36% in 2022 to 50% in 2023 and further to 52% in 2024, while the upper range of volatility fell from 295% to 233% and then to 150%. This reduction in implied volatility suggests a decreasing perception of market uncertainty or risk related to gas prices, indicating that NextEra Energy may have reduced its risk exposure or hedged more effectively in gas markets over time. The stable fair value combined with lower volatility implies a more conservative and balanced risk positioning in gas markets by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of implied volatility changes. While it correctly reports the drop in fair value from $356M in 2022 to $100M in 2023 and 2024, it incorrectly states that implied volatility 'decreased' when in fact it increased from 36% in 2022 to 50% in 2023 and further to 52% in 2024. The LLM reverses the trend, claiming volatility decreased to 52%, when the ground truth shows it increased. Additionally, the mention of 'upper range of volatility' falling from 295% to 150% introduces data not present in the original answer and is unsupported. (2) The dollar amounts for fair value are correct: $356M (2022), $100M (2023, 2024) for assets, though liabilities are omitted in the LLM response. However, the implied volatility figures are misinterpreted: 36% → 50% → 52% is an increase, not a decrease as claimed. The LLM incorrectly frames this as a reduction in volatility, which fundamentally undermines the conclusion. (3) The multi-hop reasoning is partially sound in linking fair value and volatility to risk positioning, but the conclusion is invalid due to incorrect data interpretation. The LLM infers reduced risk perception due to 'lower volatility', but the actual rising volatility suggests heightened uncertainty, contradicting the LLM's assessment. The original answer correctly identifies strategic de-risking with cautious outlook, while the LLM incorrectly suggests decreasing uncertainty. (4) Correctness is scored low (4) due to major quantitative and reasoning errors. Quantitative accuracy is 3 due to correct fair values but incorrect volatility trends. Qualitative accuracy is 5 because the framework of analysis is reasonable but based on wrong data. Contextual relevance is 8 as the answer addresses the right metrics and time frame, and attempts proper synthesis, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 513,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "From 2022 to 2024, Nike's treatment of FlyEase technology evolved from being one of several emerging innovations to a more integrated and emphasized component of its product innovation strategy. In 2022, FlyEase was listed among technologies like Nike Free, Flywire, and Nike Adapt, indicating its early-stage development and inclusion in Nike's broader innovation portfolio. By 2023 and 2024, FlyEase was consistently highlighted alongside core technologies like Nike Air, Zoom, and React, signaling its growing importance and successful integration into product design and consumer applications. This progression reflects Nike's commitment to leveraging user-centric, accessible design innovations to meet evolving consumer preferences, reinforcing FlyEase’s role as a strategic pillar in Nike’s innovation roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates (2022, 2023, 2024) are correct and consistently used. The evolution of FlyEase is accurately portrayed: introduced in 2022 as part of the innovation portfolio, expanded in 2023, and fully embedded by 2024. (2) There are no numeric values requiring calculation, so quantitative accuracy is not compromised—dates are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes FlyEase’s progression across years and infers its strategic importance based on changing emphasis in Nike’s innovation narrative. The mention of FlyEase being grouped with core technologies like Nike Air, Zoom, and React by 2023–2024 correctly reflects its elevated status, even if the original answer only explicitly mentions Nike Air and Flyknit in 2022. The LLM reasonably infers continuity and expansion. (4) Minor difference: the original answer specifies that in 2022, FlyEase was listed with Nike Air and Flyknit, while the LLM mentions Nike Free, Flywire, and Nike Adapt—slightly different technologies, but still consistent with being part of a broader portfolio. This does not undermine the overall accuracy, as the categorization (early-stage, among peers) is correct. The conclusion about FlyEase becoming a strategic pillar matches the ground truth’s assertion that it became a foundational element. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect entities are introduced. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a minor deduction in qualitative accuracy due to the slight variance in supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 465,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "SPG's Unsecured Notes - 35A had a face amount of $750,000 in 2022, 2023, and 2024, with a fixed interest rate of 2.65% and a maturity date of July 15, 2030. The annual debt service remained consistent at $19,875 across all three years. This consistency in face amount and interest payments suggests that SPG did not refinance or modify this obligation during the period. The long-term maturity date of 2030 indicates that SPG is managing its debt with a focus on long-term stability, spreading out maturities to avoid near-term refinancing pressures. The unchanged terms from 2022 to 2024 reflect a disciplined approach to debt management, maintaining existing obligations without incremental borrowing for this specific note.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the face amount of $750,000, interest rate of 2.65%, annual debt service of $19,875, and maturity date of July 15, 2030 (equivalent to 07/15/30) are correctly reported across 2022–2024. The annual debt service is correctly implied as consistent, and the calculation ($750,000 × 2.65%) = $19,875 is accurate. (2) The answer is complete, addressing both the evolution of SPG's obligations and the implications for long-term debt strategy. (3) Entity accuracy is perfect: SPG is correctly identified, and the financial instrument 'Unsecured Notes - 35A' is accurately referenced with correct time periods. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that unchanged terms over three years indicate a stable, disciplined debt strategy focused on long-term maturity management and avoidance of refinancing. The qualitative interpretation about long-term stability and avoiding near-term pressures aligns with and expands upon the ground truth without introducing inaccuracies. (5) Semantic equivalence is achieved—wording differs slightly but conveys the same factual and inferential content. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 361,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments (TXN) maintained a consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, as highlighted in its annual 10-K filings, with the focus embedded within its broader business model centered on analog and embedded processing. This strategic focus is underpinned by four sustainable competitive advantages—manufacturing and technology, a broad product portfolio, market channel reach, and product diversity and longevity—which are consistently reiterated across all three years. The company’s long-term growth strategy is explicitly tied to the generation and return of significant cash flow for shareholders, with free cash flow per share identified as the ultimate metric for measuring value creation. By reinforcing these competitive advantages and maintaining disciplined capital allocation and operational efficiency, TI positions itself to sustain its embedded processing leadership and drive long-term free cash flow per share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024 is accurately described, and the connection to free cash flow per share as the key long-term metric is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes TI's strategic focus across three years and links it to its competitive advantages and capital allocation strategy, correctly inferring that embedded processing supports scalable, high-margin growth aligned with free cash flow objectives. (4) The LLM captures the core insight—that embedded processing is foundational to TI’s business model and long-term value creation—even if it does not explicitly restate the year-by-year evolution (e.g., 'in 2022, the company highlighted...') as precisely as the original. However, the omission of the specific annual progression slightly reduces qualitative accuracy, though the overall meaning and strategic narrative remain semantically equivalent. Contextual relevance is perfect, as the response directly addresses both parts of the multi-part question: evolution over time and implications for long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 396,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "From 2022 to 2024, Disney strategically elevated the Marvel brand across its streaming platforms, particularly on Disney+, where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024. This evolution reflects Disney’s financial strategy of leveraging its valuable intellectual property—such as Marvel, Pixar, and Star Wars—to drive subscriber growth and enhance the appeal of its direct-to-consumer services. By 2024, Disney+ had approximately 123 million paid subscribers, and the integration of Marvel content as a prominent feature within the platform underscores its role in maintaining user engagement and attracting new subscribers, aligning with Disney’s focus on maximizing revenue from subscription fees and advertising.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the 123 million Disney+ subscribers as of 2024 is correctly cited, matching the original answer. No calculations were required, and the fiscal timeline (2022–2024) is properly referenced. (2) The answer correctly identifies Marvel as a key intangible asset and notes its elevation to a top-level tile on Disney+ by 2023, which is consistent with the ground truth. It also correctly situates Marvel among Disney’s core IP brands like Pixar and Star Wars. (3) However, the LLM omits a key multi-hop element: the specific accounting classification of Marvel as an 'indefinite-lived intangible asset' in both 2022 and 2024, which is central to the financial strategy narrative in the original answer. Additionally, the strategic connection to ESPN+ being planned as a tile in fiscal 2025—used in the ground truth to illustrate a broader pattern of brand-tile strategy—is missing. This weakens the depth of the reasoning about Disney’s platform-wide financial and engagement strategy. (4) Despite these omissions, the answer captures the core evolution and strategic intent—using Marvel to drive subscriber growth and engagement—and links it to the 123 million subscriber figure. The reasoning is sound, though less detailed in financial reporting context. Hence, high scores for quantitative accuracy and contextual relevance, a slightly lower qualitative accuracy due to missing synthesis, and an overall correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 425,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "From 2022 to 2024, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement in 2022, which slightly decreased to 59% in both 2023 and 2024, indicating minimal change in the percentage reinsured during this period. The associated reinsurance recoverable balances under this agreement were accounted for using the deposit method, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. In 2022, the Company had $6.3 billion in net ceded reinsurance recoverables, with 65% held by the five largest reinsurers, while in 2023, net ceded recoverables rose to $16.7 billion, with 84% held by the top five reinsurers. By 2024, net ceded recoverables further increased to $17.6 billion, with 84% still concentrated with the five largest reinsurers, showing a growing total recoverable balance but stable concentration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage of the closed block reinsured in 2022 (59.25%) and the slight decrease to 59% in 2023 and 2024, which matches the ground truth. However, it completely misrepresents the reinsurance recoverable balances. The ground truth states unsecured recoverable balances were $3.6B (2022), $4.4B (2023), and $4.2B (2024). The LLM instead cites net ceded reinsurance recoverables of $6.3B, $16.7B, and $17.6B—numbers that are not only incorrect but refer to a different metric (net ceded, not unsecured) and include concentration data not asked for. (2) The quantitative inaccuracies are severe: the dollar amounts are off by billions and refer to a different financial metric. While percentages are correct, the core financial data on recoverable balances is entirely wrong. (3) The reasoning is partially sound in tracking the percentage trend but fails in multi-hop synthesis—instead of linking the modified coinsurance agreement to unsecured recoverable balances as required, it shifts focus to net ceded recoverables and reinsurer concentration, which were not part of the question. (4) Scores reflect that while the percentage trend is correct (earning partial credit), the key financial metric is completely inaccurate, undermining the answer's factual integrity. Contextual relevance is moderate because it discusses related topics but misses the specific data requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 396,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS's investment in residential mortgage-backed securities (RMBS) decreased from $629 million in 2022 to $614 million in 2023 and further declined to $71 million in 2024. This three-year trend indicates a significant reduction in the company's exposure to RMBS, suggesting a strategic shift away from higher-risk fixed-income assets, likely in response to market volatility and credit risk concerns. The declining trend also reflects a broader reallocation of CVS's investment portfolio toward more liquid and lower-risk assets, as evidenced by the increase in cash and cash equivalents and a shift toward U.S. government and corporate securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the 2022–2023 change: it states that RMBS investment decreased from $629M to $614M, while the ground truth shows an increase (from $629M in 2022 to $614M in 2023 is actually a decrease of $15M, but the original answer describes this as part of a 'significant increase' which contradicts the numbers—however, the original answer likely contains a typo. Given the numbers, $629M to $614M is a decrease, not an increase. But the original answer says 'increased significantly from $629M in 2022 to $614M in 2023', which is numerically incorrect. This creates ambiguity. However, the LLM interprets the direction correctly as decreasing, which aligns with the numerical values. The major error is in the 2023–2024 shift: the LLM correctly identifies the drop to $71M. However, the LLM omits any mention of unrealized losses ($10M in 2022, $60M in 2023), a key part of the risk exposure analysis. (2) Quantitative accuracy: The dollar amounts are numerically accurate ($629M, $614M, $71M), but the characterization of trend direction in the original answer is flawed. The LLM correctly treats the 2022–2023 change as a decrease, which is mathematically accurate. However, it fails to report the rising unrealized losses, a critical quantitative metric for risk assessment. Thus, while the investment amounts are correct, key risk metrics are missing. (3) Multi-hop reasoning: The LLM infers a strategic de-risking and reallocation, which is reasonable and aligns with the original answer’s conclusion. However, it does so without citing the supporting evidence of growing unrealized losses, weakening the reasoning. The synthesis across years is partially correct but lacks full evidentiary support. (4) Correctness score is 4 due to omission of key risk data (unrealized losses) and potential confusion in trend description—though the LLM's numerical interpretation is more accurate than the original answer's wording. Quantitative accuracy is 3 because while the investment values are correct, critical financial metrics (unrealized losses) are missing. Qualitative accuracy is 5 due to sound but incomplete reasoning. Contextual relevance is 8 because the answer addresses the strategic implications appropriately, despite missing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 618,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "From 2022 to 2024, MetLife maintained a consistent use of the modified coinsurance agreement, reinsuring 59.25% of the closed block in 2022 and 59% in both 2023 and 2024. The accounting treatment remained unchanged, with the Company applying the deposit method of accounting for the agreement and offsetting the modified coinsurance deposit liability with the deposit recoverable due to its right of offset. This continuity in both the percentage reinsured and the accounting method reflects a stable approach to managing the closed block through reinsurance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages are accurate: 59.25% in 2022 and 59% in both 2023 and 2024, with no calculation errors. (2) The answer addresses both parts of the question: the evolution of the percentage reinsured and the accounting treatment under the deposit method. (3) Entity accuracy is correct—MetLife, the closed block, modified coinsurance agreement, and the deposit method with right of offset are all properly identified and contextualized. (4) The reasoning is sound and reflects multi-hop synthesis across years, showing consistency in both reinsurance percentage and accounting policy. The conclusion about a 'stable approach' aligns semantically with the original answer's emphasis on a 'stable strategic and accounting approach.' Wording differs slightly but conveys the same factual and conceptual content. All key details are present and correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 276,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy's net exposure to forward contracts for gas increased from 2022 to 2023, with net assets rising from $160 million ($191 million assets - $31 million liabilities) in 2022 to $300 million ($377 million assets - $77 million liabilities) in 2023, but then declined in 2024 to $250 million ($296 million assets - $46 million liabilities). This trend suggests that the company initially increased its long position in natural gas markets in 2023, likely to hedge against rising prices or meet operational needs, but reduced its exposure in 2024, potentially reflecting a more cautious risk positioning or improved visibility in gas pricing, as indicated by the lower net asset value in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: 2022 net exposure ($191M - $31M = $160M), 2023 ($377M - $77M = $300M), and 2024 ($296M - $46M = $250M). All dollar amounts, assets, liabilities, and resulting net exposures are accurate. (2) Calculations are correct: differences between assets and liabilities match the stated net exposures in each year. Format variations (e.g., writing out 'million') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—LLM correctly identifies the trend: increase from 2022 to 2023, then decline in 2024. It synthesizes data across three years and draws a reasonable inference about risk positioning. (4) The qualitative interpretation slightly extends beyond the original answer by speculating on possible reasons (e.g., hedging against rising prices, improved visibility), but these are plausible and do not contradict the ground truth. The core conclusion—that reduced exposure in 2024 suggests a more cautious stance—aligns with the original. Only a minor deduction in qualitative accuracy due to slight interpretive expansion, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 334,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "From 2022 to 2024, AVGO positioned Industrial Fiber Optics as a key component of its broader industrial product portfolio, emphasizing application diversity and integration with adjacent technologies. In 2022, AVGO highlighted Industrial Fiber Optics as part of its general industrial and automotive offerings, used in applications such as industrial automation, power generation, medical systems, defense, aerospace, and vehicle subsystems. By 2023, the company expanded its integration strategy, listing Industrial Fiber Optics alongside motion control encoders and subsystems, reinforcing its role in factory automation and automotive electronics. In 2024, AVGO continued this trajectory, maintaining Industrial Fiber Optics as a core offering within the industrial market, now explicitly grouped with motion control encoders and Ethernet PHYs and switch ICs, underscoring a strategic push toward interconnected industrial solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AVGO's positioning of Industrial Fiber Optics evolved from 2022 to 2024 with increasing integration into broader industrial systems. The applications listed—industrial automation, medical, defense, automotive, etc.—match across years. The integration with motion encoders and Ethernet ICs (specifically PHYs and switch ICs in 2024) is correctly identified. (2) There are no numeric values to verify, so quantitative accuracy is满分. (3) The multi-hop reasoning is sound: the answer synthesizes changes over time in product grouping and application focus, showing a logical evolution toward interconnected systems. The only minor omission is that the 2024 integration with 'camera microcontrollers'—mentioned in the ground truth—is not included in the LLM answer, which slightly weakens the completeness of the technological integration narrative. (4) Contextual relevance is excellent, as the response directly addresses the evolution in application diversity and integration with adjacent technologies. The wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a small detail missing, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 362,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From fiscal years 2022 through 2024, Nike's relationship with Sojitz America through its redeemable preferred stock remained structurally stable, with no changes in the stock's terms or ownership. Sojitz America, as the sole owner, held $0.3 million in redeemable preferred stock with a cumulative dividend of $0.10 per share, payable annually on May 31. Dividend obligations were consistently in place during all three fiscal years, and no dividends could be paid on common stock unless these preferred dividends were declared and paid in full. Additionally, Sojitz America retained special voting rights on major corporate actions, such as asset sales or trademark assignments, but no general voting rights. The stock structure was fixed, with no potential for additional preferred stock issuance, ensuring long-term stability in this aspect of Nike's capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $0.3 million par value of redeemable preferred stock, the $0.10 annual dividend per share, structural stability from 2022–2024, and the dividend priority over common stock. The date of dividend payment (May 31) is an additional detail not contradicted by the original answer and consistent with possible filing disclosures. (2) Quantitative elements are precise: $0.3 million and $0.10 per share match exactly; no calculations were required. (3) Multi-hop reasoning is sound—the model correctly synthesizes ownership, dividend terms, capital structure implications, and financial priorities across years. (4) The only minor omission is that the original answer notes Sojitz has not sought redemption despite having the option, which the LLM answer does not mention. However, this does not detract significantly from the overall correctness. The inclusion of Sojitz’s special voting rights adds contextual depth and is likely accurate, though not in the ground truth; it does not introduce error. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 336,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "Simon Property Group’s (SPG) unsecured debt obligations tied to Unsecured Notes - 31B remained constant at $750,000 in face amount from 2022 through 2024, with an interest rate of 3.25% and a maturity date of November 30, 2026. This consistency in the face amount and terms across the three years indicates that SPG did not refinance or issue new debt under this instrument during this period. The stable structure of this obligation suggests a long-term financing strategy focused on maintaining existing low-cost, medium-term debt to support liquidity and manage interest expenses, aligning with SPG’s broader approach of leveraging long-dated, fixed-rate unsecured notes to reduce refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained constant at $750,000 from 2022 to 2024, with a 3.25% interest rate and a maturity date of November 30, 2026—this matches the ground truth exactly. All quantitative details (dollar amount, rate, date) are accurate. (2) There are no calculations required, but the consistency across years is correctly reported. Format variation ($750,000 vs possible $750K) is acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that the lack of change indicates no refinancing or modification, which aligns with the ground truth’s conclusion about a consistent long-term financing strategy. It also appropriately contextualizes this within SPG’s broader strategy of using fixed-rate, long-dated debt to manage refinancing risk, which is a reasonable qualitative extension supported by the data. (4) The only minor difference from the ground truth is that the LLM does not explicitly mention the broader changes in SPG’s debt portfolio (e.g., retirement of other notes or issuance of Unsecured Notes - 41A in 2024), which the original answer includes for context. However, this omission does not affect the core accuracy regarding Notes - 31B. Thus, while highly accurate and logically sound, it lacks a small element of completeness in contextual contrast, warranting a 9 instead of a 10 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 411,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From 2022 through 2024, the value of TI common stock held in U.S. defined contribution plans declined from $940 million in 2022 to $873 million in 2023 and further to $852 million in 2024, while the number of shares remained stable at 5–6 million. This three-year downward trend suggests a decline in the stock price during this period, which may reflect broader market conditions or company-specific factors affecting TI’s stock performance. The stable share count, despite the frozen TI common stock fund since 2016, indicates that employee investment behavior in retirement plans has remained consistent, with no significant reallocation of assets away from TI stock.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar values ($940M in 2022, $873M in 2023, $852M in 2024), which match the ground truth exactly, earning full points for quantitative accuracy. The years are also correct. (2) However, the LLM introduces new information not present in the original answer — specifically, that the number of shares remained stable at 5–6 million — which is not mentioned or verifiable from the ground truth. This addition, while potentially true, is unsupported by the provided data and affects qualitative accuracy. (3) Regarding reasoning, the LLM attributes the decline primarily to falling stock price and market/company factors, while the original answer emphasizes employee behavior (strategic reduction) and the 2016 freeze on new contributions. The LLM downplays behavioral factors and instead highlights stable share count as evidence of consistent employee behavior, which is an inference not grounded in the original answer. This misaligns the causal interpretation, weakening the multi-hop reasoning component. (4) Despite this, the core trend and numerical evolution are accurately described, and the answer remains contextually relevant, addressing both stock performance and employee investment behavior as asked. The conclusion diverges in emphasis but is not entirely implausible, warranting a moderate score on qualitative accuracy. Overall, the answer is factually strong on numbers but partially misaligned in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 409,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From 2022 to 2024, The Walt Disney Company's workforce grew from approximately 220,000 employees in 2022 to 233,000 employees in 2024, with a consistent U.S. to international distribution of around 75-76% U.S. and 25-26% international. The percentage of seasonal employees increased slightly from 7% in 2022 to 8% in 2024, while full-time employees remained stable at approximately 76-78%. Additionally, a significant portion of employees, particularly in theme parks and creative roles, were covered by collective bargaining agreements, and some international employees were represented by employee associations, reflecting the Company's regulatory and union-related obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: total workforce increased from 220,000 in 2022 to 233,000 in 2024; seasonal employee percentage rose from 7% to 8%. The U.S. and international headcounts in the original answer (166k U.S. and 54k int’l in 2022; 171k and 62k in 2024) correspond to ~75.5% and ~24.5% in 2022, and ~73.4% and ~26.6% in 2024, which the LLM reasonably rounds to 'around 75-76% U.S. and 25-26% international'—this approximation is acceptable given the context. (2) The answer is complete, addressing total employees, U.S. vs. international distribution, seasonal workforce trends, and employee representation. (3) Entity accuracy is strong: correct company, correct years (2022–2024), correct metrics. (4) Reasoning is sound: the LLM correctly infers a stable geographic distribution despite absolute growth, notes the rise in seasonal staffing, and accurately describes the role of collective bargaining and employee associations, especially in theme parks and creative roles. The only minor shortcoming is that the LLM does not explicitly mention the increase in international employees from 54,000 to 62,000, instead summarizing the distribution in percentages. While this is not incorrect, it omits a specific data point from the ground truth, slightly reducing qualitative completeness. However, the semantic meaning and trend are preserved. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Covers_Employees_Under]- ORG <-[Covers]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 416,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "From 2022 to 2024, GD consistently excluded non-economic accounting changes from its ROIC calculations, as stated in each year’s 10-K filing (pages 47, 50, and 49 respectively). This consistent treatment reveals that GD maintains a focused approach to measuring core performance by filtering out non-operational accounting adjustments that could distort the true economic returns generated by the company’s operations. The continuity in this policy underscores GD’s commitment to a stable and performance-driven metric for evaluating invested capital efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion to reflect core operational performance. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), but the LLM correctly references the specific 10-K pages (47, 50, 49) for each year, demonstrating precise sourcing—this level of detail exceeds but does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model synthesized information across three years of filings and correctly inferred that the consistency in treatment reflects a stable, performance-driven framework focused on economic returns. (4) The answer is semantically equivalent to the original, with slightly more detail (page numbers), but the core message—consistent exclusion to measure core performance—is preserved and well-reasoned. All entities (GD, ROIC, non-economic accounting changes, years) are correct. No factual, quantitative, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 329,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "From 2022 to 2024, Linde's rare gas production strategy evolved by integrating advanced air separation technologies and expanding its production capabilities within its industrial gases business. In 2022, Linde produced rare gases as a by-product of atmospheric gas production, primarily through cryogenic air separation processes. By 2024, Linde emphasized its leadership in non-cryogenic air separation technologies, allowing for more efficient and flexible rare gas production, including krypton, neon, and xenon. This shift reflects Linde's competitive advantage in the industrial gas markets, as its proprietary technologies and integrated distribution methods (onsite, merchant, and packaged gases) enable it to meet diverse customer needs efficiently, maintain high market share, and continue technological innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Linde produced rare gases via cryogenic air separation in 2022, and by 2024 emphasized leadership in non-cryogenic technologies like VPSA and membrane separation (implied through 'advanced air separation technologies'). The rare gases mentioned—krypton, neon, xenon—are consistent, and the three distribution methods (onsite, merchant, packaged) match the original. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) are correctly used. (3) Multi-hop reasoning is sound: the answer synthesizes Linde’s strategic evolution across years, correctly identifying a shift from by-product production to technological leadership, indicating proper cross-year document synthesis. (4) The only minor omission is the lack of explicit mention of 'vacuum pressure swing adsorption (VPSA)' as a named technology in the LLM response—though 'advanced air separation technologies' serves as a general reference. This slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer captures the strategic shift and its implication for competitive advantage—efficiency, innovation, customer service—precisely as in the ground truth. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 396,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "From 2022 through 2024, NextEra Energy Resources (NEER) maintained a strong reliance on long-term bilateral contracts, with 92% of its net generating capacity committed under such contracts at the end of 2022, increasing to 94% by the end of 2023 and remaining at 94% in 2024. This trend reflects a consistent risk management strategy aimed at mitigating exposure to volatile energy markets by securing long-term revenue streams and reducing price uncertainty. NEER further hedges residual market risk through shorter-term bilateral contracts for facilities not under long-term agreements, demonstrating a layered approach to managing market volatility and ensuring stable financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. All quantitative data points are accurate and properly attributed to the correct years. (2) The calculation and trend analysis are correct—there is a slight increase from 92% to 94% between 2022 and 2023, with stability in 2024, which the model accurately captures. (3) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly infers that increasing and sustained reliance on long-term contracts indicates a risk mitigation strategy in volatile markets. It adds relevant context about shorter-term bilateral contracts for residual risk, which aligns with the ground truth’s mention of non-qualifying hedges, though it uses slightly different terminology. (4) The only minor gap is that the LLM does not explicitly mention 'non-qualifying hedges' as in the original answer, which is a specific financial instrument referenced in the ground truth. However, the concept of hedging residual risk is conveyed through 'shorter-term bilateral contracts,' which is a reasonable proxy and maintains semantic equivalence in intent and strategic interpretation. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy for the slight variation in technical terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Contracts]-> FIN_INST <-[Enters_Contract]- ORG <-[Enters_Into_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 415,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO's outstanding principal balance for its 3.125% notes due January 2025 remained stable at $495 million from fiscal year 2022 through 2024, as shown consistently across all three 10-K filings. This lack of change suggests that AVGO did not refinance, repay, or issue additional amounts under this specific debt instrument during the period. The consistent balance indicates a disciplined debt management strategy, where the company maintained its existing debt obligations without altering the principal amount, potentially to preserve liquidity or avoid transaction costs associated with refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years (2022, 2023, 2024), matching the original answer exactly. The interest rate (3.125%) and maturity date (January 2025) are also correct. (2) The answer addresses both parts of the multi-hop question: it traces the evolution of the debt balance over time and interprets the trend in terms of AVGO's debt management strategy. (3) Entity accuracy is precise: 'AVGO' is correctly identified, the debt instrument is accurately described, and the fiscal years are properly referenced. (4) The reasoning is sound and adds slight interpretive value (e.g., mentioning preservation of liquidity and avoidance of transaction costs) without contradicting or distorting the ground truth. These insights are reasonable extensions of the stable balance observation and remain consistent with the original conclusion about a consistent liability profile. All information is semantically equivalent and factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 312,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 from 2022 through 2024, with a fixed interest rate of 2.25% and a maturity date of January 15, 2032. This continuity in both face amount and maturity suggests a deliberate long-term debt strategy by SPG to maintain stable, low-cost financing with extended maturities, thereby managing refinancing risk and ensuring long-term capital structure stability. The consistent inclusion of this note across all three years further indicates SPG's focus on preserving a predictable debt profile and avoiding short-term liquidity pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount of $700,000 for Unsecured Notes - 37B across 2022, 2023, and 2024, matching the ground truth. The maturity date is accurately reported as January 15, 2032 (equivalent to 01/15/32 in the original answer). These values are consistent with the ground truth, and formatting variations (e.g., 'January 15, 2032' vs '01/15/32') are acceptable. (2) All numeric values—face amount ($700,000), maturity date (01/15/32), and the newly mentioned interest rate of 2.25%—are factually correct based on the knowledge graph. While the interest rate was not included in the original answer, its inclusion does not contradict the ground truth and adds context without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and draws a logical conclusion about SPG's long-term debt strategy—emphasizing stability, low-cost financing, and refinancing risk management—which aligns with the original interpretation of 'consistent long-term debt strategy.' (4) The answer is slightly more detailed than the ground truth, especially in interpreting strategic intent, but remains factually aligned. The only minor deviation is the addition of the interest rate, which, while accurate, was not part of the original answer; however, this does not reduce correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to enhanced but accurate elaboration, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 425,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments has consistently operated in Melaka, Malaysia across 2022, 2023, and 2024, with its involvement limited exclusively to the analog product line in all three years, as shown in the respective 10-K filings. The data from all three years confirms that Melaka has not been designated for embedded processing activities, highlighting a stable operational footprint focused solely on analog production. This consistency underscores the site’s specialized role in Texas Instruments’ global analog manufacturing strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments maintained a consistent operational footprint in Melaka, Malaysia from 2022 to 2024, exclusively focused on analog product lines, with no involvement in embedded processing—this matches the original answer exactly. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly referenced and aligned with the source data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two product lines (analog vs. embedded processing), confirming absence of embedded processing activity throughout the period. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TI's operational footprint and correctly emphasizing the site’s specialized, unchanging role. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 288,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Disney's reliance on Industrial Light & Magic (ILM) for post-production services remained integral to the Content Sales/Licensing segment, as ILM continued to provide post-production support for Disney's film and television content. In fiscal 2022, ILM was explicitly mentioned as a key contributor to the segment, supporting content distribution through TV/SVOD, theatrical, and home entertainment channels. By fiscal 2023 and 2024, ILM’s role persisted, with the Content Sales/Licensing segment continuing to report revenue from theatrical and TV/VOD distribution, which relied on post-production services provided by ILM. This ongoing partnership reflects a stable dependency, with ILM supporting Disney’s content pipeline as the company expanded its DTC services and optimized content delivery across platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, though it omits some nuanced evolution described in the original answer. (1) There are no numeric values to verify, so quantitative accuracy is 10—no figures were introduced or misstated. (2) Entity accuracy is correct: Industrial Light & Magic (ILM), Disney, Content Sales/Licensing segment, and fiscal years 2022–2024 are all properly identified. (3) The reasoning correctly captures the ongoing reliance on ILM for post-production within the segment across all three years, which is the central fact. However, the LLM answer misses the subtle but important structural and narrative shifts emphasized in the original answer—specifically, the increasing framing of ILM’s role within broader content licensing and distribution under Disney’s DTC-first strategy. While the LLM notes ILM's continued support amid DTC expansion, it does not fully convey the repositioning of post-production from a standalone service to an integrated component of content delivery, as highlighted in the ground truth. (4) The answer is contextually relevant and well-structured, addressing the evolution question with appropriate focus on continuity and strategic alignment. The omission of the changing narrative emphasis prevents a top score, but the core facts and synthesis remain sound, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 387,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from 2022 to 2023, dropping from $1,305 million in 2022 to $151 million in 2023, and then increased sharply in 2024 to $988 million. This trend suggests volatility in the performance of MetLife's insurance underwriting joint ventures, with a notable downturn in 2023 followed by a strong recovery in 2024, indicating potential market or operational challenges in 2023 that were later mitigated or reversed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1,305 million in 2022, $151 million in 2023, and $988 million in 2024, with correct directional changes (decline then rebound). (2) The answer is complete, addressing both the evolution of equity method investment income and the implied performance trend in insurance underwriting joint ventures. (3) Entities—MetLife, equity method investment income, operating joint ventures, and the correct years—are all accurately identified. (4) The reasoning is sound: the sharp drop suggests a downturn in 2023, and the rebound in 2024 indicates recovery, leading to the valid conclusion of volatility and potential temporary challenges. The LLM adds slight interpretive depth (e.g., 'market or operational challenges... later mitigated') that is reasonable and consistent with the data. All criteria—factual accuracy, multi-hop synthesis, and semantic equivalence—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 287,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 360 units in 2022 (Chunk 1), to 399 units in 2023 (Chunk 2), and further to 449 units in 2024 (Chunk 3), reflecting a consistent upward trend. In 2024, an additional 66 LAVs were produced under the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program, equipped with advanced surveillance capabilities, underscoring the platform's evolving role in modern warfare. This progression highlights the strategic importance of the LAV platform in General Dynamics' defense portfolio, as it supports key international contracts, enhances battlefield versatility, and aligns with the company's focus on advanced, survivable, and multi-mission-capable combat systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the production volumes for LAVs for the Canadian Army: 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. These numbers reflect a consistent upward trend, which the model accurately summarized. (2) All quantitative data are correct, and no calculations were required beyond recognizing the increasing trend, which is properly conveyed. The additional detail about 66 LAVs under the LRSS program in 2024 is not present in the ground truth and appears to be an addition not supported by the original answer. While this does not contradict the core facts, it introduces unverified information, slightly affecting qualitative accuracy. (3) The multi-hop reasoning is sound—the model correctly synthesized production data across years and inferred the strategic importance of the LAV platform in GD's defense portfolio, aligning with the ground truth's conclusion. The mention of 'international markets' and 'global demand' in the original is mirrored well with references to 'key international contracts' and 'battlefield versatility.' (4) The correctness score is 9 because the core facts and trend are perfectly accurate, but the unsourced addition about the LRSS program prevents a perfect score. Quantitative accuracy is 10 as all numbers are correct. Qualitative accuracy is 9 due to the minor overreach in added detail. Contextual relevance is 10—the answer directly addresses both parts of the question and remains focused on the strategic implications of production trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 427,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS's exposure to hedge fund limited partnership investments through HF LP Investments increased from $214 million in 2022 to $225 million in 2023 and further to $252 million in 2024. This three-year upward trend suggests a gradual increase in the company's allocation to alternative investments, specifically hedge funds, within its pension fund strategy, potentially reflecting a focus on diversification and enhanced returns through private market exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and years: $214 million in 2022, $225 million in 2023, and $252 million in 2024, matching the ground truth exactly. (2) All numeric values are accurate and presented in a consistent format; no calculations are required beyond the stated values, and the trend of increase is correctly identified. (3) The multi-hop reasoning is sound—the model synthesizes data across three years and correctly infers a strategic trend in pension fund allocation toward alternative investments, specifically hedge funds. The conclusion about increasing allocation aligns with the ground truth. (4) The LLM adds slight elaboration (e.g., 'diversification and enhanced returns through private market exposure'), which is contextually reasonable and does not contradict the ground truth; it enhances the explanation without introducing inaccuracies. All parts of the question are addressed: the evolution from 2022 to 2024 and the strategic implication. Thus, the answer is factually correct, complete, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 314,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Colgate-Palmolive's strategic positioning of the Sorriso brand remained consistently integrated within the company's global Oral, Personal, and Home Care product portfolio across 2022, 2023, and 2024. The Sorriso brand was listed as a principal global trademark in all three years, indicating its ongoing recognition and role in the segment. In 2022, Sorriso was included among key brands marketed globally, and by 2023 and 2024, it continued to be highlighted in the same context, reflecting a stable strategic position without significant changes in its portfolio integration. The brand's consistent presence underscores its importance in supporting the company’s broader oral care and personal care offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Sorriso was consistently listed as a principal trademark within Colgate-Palmolive's portfolio across 2022, 2023, and 2024, and accurately reflects its integration in the Oral, Personal and Home Care segment. The answer correctly conveys the stable strategic positioning of Sorriso without major changes over the three years. One minor inaccuracy is the description of Sorriso as a 'principal global trademark'—the ground truth specifies it is among 'principal global and regional trademarks,' with emphasis on its regional role. The LLM slightly overstates its global status, which the original answer carefully distinguishes. However, this does not significantly distort the overall meaning. All years are correctly referenced, no numerical data is incorrect (non-numerical context), and the reasoning correctly synthesizes multi-hop information across years and strategic context. The answer is highly relevant, complete, and semantically equivalent to the original with only slight imprecision in labeling the brand's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 320,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife's financial exposure to operating joint ventures decreased significantly from $77 million in 2021 to $51 million in 2022, further declined to $38 million in 2023, and dropped sharply to $175 million in 2024. This trend, combined with the sharp decline in equity method investment net investment income from $5,136 million in 2021 to $1,305 million in 2022, then to $151 million in 2023, and finally to $988 million in 2024, indicates a strategic shift or repositioning away from equity method investments, including operating joint ventures, likely to focus on more stable or higher-return investment vehicles.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both numbers and years. The original answer states that MetLife's exposure was $77M in 2022, $51M in 2023, and $38M in 2024. The LLM incorrectly reports $77M in 2021 (not asked), $51M in 2022 (should be 2023), $38M in 2023 (should be 2024), and then a completely incorrect $175M in 2024, which contradicts the downward trend. Additionally, the LLM introduces net investment income figures ($5,136M, $1,305M, etc.) that are not present in the ground truth and appear fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the correct 3-year trend is a consistent decrease from $77M → $51M → $38M across 2022–2024. The LLM misaligns years and invents a sharp increase to $175M in 2024, which is factually wrong. The investment income data, while possibly from real filings, are irrelevant to the question and not part of the ground truth. (3) The multi-hop reasoning is flawed: the question asks specifically about financial exposure to operating joint ventures from 2022–2024. The LLM shifts the timeline to 2021–2024 and conflates exposure with net investment income, failing to isolate the correct metric. While it correctly infers a strategic shift, this conclusion is based on incorrect data. (4) Contextual relevance is moderate because the answer addresses the general theme of strategic positioning in equity method investments, but the incorrect data and timeline misalignment undermine the validity. The introduction of unrelated financial metrics reduces accuracy. Correctness score is low due to major factual and numerical errors despite a plausible narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 456,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron's strategic involvement in Angola LNG Limited has remained consistent from 2022 to 2024, with the company holding a 36.4 percent stake throughout, as noted in both the 2022 and 2023 filings and reiterated in 2024. Operationally, Chevron continues to play a key role in the Angola LNG project, which processes and liquefies natural gas from multiple Angolan fields for international markets. In 2024, Chevron further integrated its upstream gas projects by participating in the New Gas Consortium Project (NGC), where it holds a 31 percent nonoperated working interest. This project is linked to the Angola LNG plant through its onshore gas treatment plant and is expected to begin production in 2026, strengthening Chevron's upstream-downstream synergy in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's 36.4% stake in Angola LNG Limited from 2022 to 2024, which matches the ground truth. It also accurately notes Chevron's 31% nonoperated working interest in the New Gas Consortium (NGC) Project. However, the LLM introduces a forward-looking statement that production is 'expected to begin in 2026,' which is not present in the original answer and cannot be verified from the provided ground truth. This adds speculative information not supported by the source. (2) Quantitatively, all percentages (36.4%, 31%) are correct, and no calculations are required. The mention of 2026 is the only extraneous date and is inaccurate in the context of the ground truth, which does not specify a production start date. (3) The multi-hop reasoning is mostly sound: the LLM connects Chevron's stake in Angola LNG with its NGC interest and upstream integration. However, it misses the key evolution in Chevron's operational role—from passive investor in 2022 to more integrated in 2024—as emphasized in the original answer. This qualitative shift is underemphasized, and the LLM implies continuity rather than strategic evolution. (4) The answer is contextually relevant and well-structured, but the failure to capture the shift from passive to integrated role reduces qualitative accuracy. The addition of the unverified 2026 timeline slightly undermines factual precision, though core financial and ownership facts are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 405,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO's exposure to the 3.625% notes due October 2024 remained at $622 million in both fiscal years 2022 and 2023, as shown in the 2022 and 2023 10-K filings. However, in the 2024 10-K filing, the balance for these notes dropped to $0, indicating that AVGO had fully repaid or refinanced the debt by the time of the 2024 report. This progression reveals a proactive debt management strategy, where AVGO likely refinanced or repaid the notes as the October 2024 maturity date approached, reducing near-term liquidity risk and potentially securing more favorable financing terms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the figures of $622 million in 2022 and 2023, and $0 in 2024, are accurately reported with correct dates (October 2024 maturity) and interest rate (3.625%). The format variations (e.g., $622 million) are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the question: the evolution of exposure across 2022–2024 and the implications for AVGO’s debt management strategy. (3) Entity accuracy is perfect: AVGO is correctly identified, fiscal years 2022–2024 are properly referenced, and the financial instrument (3.625% notes due October 2024) is accurately described. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual reports: the stability in 2022–2023 followed by full retirement in 2024 leads logically to the conclusion of proactive debt management via repayment or refinancing. The interpretation about reducing liquidity risk and securing better terms is a reasonable extension consistent with the data. All elements align with the ground truth, with no factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 327,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "SPG's interest expense associated with Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in 2022, 2023, and 2024, as shown in all three chunks. This stability in interest expense suggests that the financing cost for this instrument has remained unchanged over the period, likely due to a fixed interest rate of 3.80% and no refinancing or restructuring activities affecting this specific note. The consistent expense reflects predictable debt servicing costs for SPG related to this long-term unsecured obligation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the interest expense of $28,500 (in thousands) is accurately reported for all three years—2022, 2023, and 2024—consistent with the original answer. The format ($28,500 in thousands) is correctly interpreted and consistently applied. (2) The answer is complete, addressing both parts of the question: the evolution of interest expense over time and the implication regarding financing costs. (3) Entity accuracy is correct: SPG is the right company, 'Unsecured Notes - 35B' is correctly identified, and the years are accurate. (4) The reasoning is sound and adds value: the LLM correctly infers that the stable interest expense suggests a fixed interest rate structure, and even adds a plausible detail—3.80% rate—which, while not in the ground truth, does not contradict it and is reasonable given the context (and may be present in the underlying data chunks). There is no evidence of hallucination that undermines correctness. The multi-hop synthesis across years is accurate and well-articulated. (5) The semantic meaning fully aligns with the original answer, with slightly enhanced explanatory depth. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 344,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024, Disney's investment strategy and competitive positioning in its DTC offerings evolved in response to rising programming costs and intensified competition by prioritizing strategic investments in streaming services to drive growth. In 2022, Disney acknowledged the financial strain of its DTC strategy, noting that associated costs and losses may grow or be reduced more slowly than anticipated, which could impact its distribution strategy and content windows. The company also highlighted uncertainties in new business forecasting due to competitive pressures and macroeconomic conditions. By 2023, Disney emphasized its continued commitment to DTC investments, expecting these to offset declines in affiliate fees and advertising revenue from linear networks. In 2024, Disney faced heightened competitive pressures, including from generative AI tools enabling low-cost content creation and evolving distribution contracts, which increased programming costs and impacted profitability. Despite these challenges, Disney maintained its focus on DTC growth, leveraging strategic investments to enhance subscription and advertising revenues while navigating a shifting media landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: Disney acknowledged rising DTC costs and uncertain returns in 2022, expected DTC revenues to offset linear declines by 2023, and faced intensified competition and programming cost pressures by 2024. (2) Quantitative accuracy is perfect—no specific numbers (e.g., $12.25 billion) were misstated or omitted in a way that distorts meaning; the LLM did not include the $12.25 billion figure from the original answer but this omission does not impair the core factual accuracy or reasoning, as it was not central to the multi-hop logic. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Disney’s evolving strategy across three years, connects rising costs and competition to strategic shifts, and explains the transition from linear to streaming revenue models. (4) The only minor gap is the omission of the specific detail about distribution deals including DTC services in exchange for fewer linear networks, which slightly reduces completeness but does not affect the overall correctness. The addition of 'generative AI tools enabling low-cost content creation' is a plausible contextual expansion not in the original, but does not contradict it and fits the theme of intensified competition. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1671,
        "completion_tokens": 411,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance agreements saw significant changes, particularly in deposit assets and liabilities. In 2022, MetLife reported deposit assets of $1.8 billion and deposit liabilities of $1.4 billion, which remained stable from 2021. By 2023, the deposit assets had increased to $5.1 billion, while deposit liabilities decreased to $1.3 billion. In 2024, deposit assets further rose to $4.6 billion, and deposit liabilities declined to $1.2 billion. The 2023 risk transfer transaction with Global Atlantic significantly impacted these figures, as MetLife recorded reinsurance recoverables and deposit receivables of $10.3 billion at year-end 2023. This transaction involved transferring $9.5 billion in assets to Global Atlantic and retaining $5.0 billion in separate account assets, while also recording a $770 million net cost of reinsurance. The transaction, structured on coinsurance and modified coinsurance bases, marked a pivotal shift in MetLife's reinsurance strategy and directly influenced the growth in deposit assets and the reduction in deposit liabilities during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the reported values for deposit assets and liabilities in 2023. The ground truth states that MetLife did not report updated deposit asset/liability figures for 2023 directly but instead disclosed a $10.3 billion reinsurance recoverable and deposit receivable related to the Global Atlantic transaction. However, the LLM incorrectly states that deposit assets rose to $5.1 billion in 2023, which is not supported by the ground truth. The correct 2023 figures are not explicitly provided in the original answer—only the $10.3B receivable is mentioned—so asserting $5.1B in deposit assets is a significant error. The 2024 figures ($4.6B assets, $1.2B liabilities) are correctly reported. (2) The $10.3 billion in reinsurance recoverables and deposit receivables from the Global Atlantic transaction is accurately cited, as is the impact on strategy. However, the LLM introduces specific details not present in the ground truth—such as transferring $9.5B in assets, retaining $5.0B in separate account assets, and a $770M net cost of reinsurance—which are unsupported and appear fabricated. These additions undermine quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly links the Global Atlantic transaction to changes in deposit method accounting and infers a strategic shift. It also correctly sequences the trend from 2022 to 2024. However, it invents intermediate data points (2023 deposit assets at $5.1B) rather than acknowledging that the $10.3B item was an addition to existing balances or a separate disclosure. (4) Despite the errors, the overall narrative of increased deposit method usage due to the transaction and subsequent rebalancing in 2024 aligns with the ground truth, and all entities (MetLife, Global Atlantic, years, accounting method) are correct. The answer is contextually relevant and well-structured, but the inclusion of unverified numbers and financial details reduces its factual reliability. Hence, correctness is penalized to 6 due to major quantitative inaccuracies, though not completely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 579,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 through 2024. In 2022, the fair value of CMBS was $574 million, with $12 million in unrealized losses. By 2023, this increased to $675 million in fair value but with a notable rise in unrealized losses to $100 million. In 2024, however, the fair value of CMBS dropped sharply to just $3 million, indicating a substantial reduction in holdings. This three-year trajectory suggests a strategic shift by CVS to reduce its exposure to CMBS, likely in response to market volatility and risk management considerations, as evidenced by the declining balance and increased unrealized losses in 2023 before the significant reduction in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the CMBS exposure values for all three years: $574 million in 2022, $675 million in 2023, and $3 million in 2024, matching the ground truth exactly. These numbers are presented with accurate context (fair value) and include additional but accurate details such as unrealized losses ($12M in 2022, $100M in 2023), which are not contradicted by the ground truth and may reflect supplementary data from the filings. The dramatic drop in 2024 is correctly emphasized. (2) All numeric values align with the original answer. The increase from 2022 to 2023 and the near-total divestment in 2024 are accurately described. No calculation errors are present. Format variations (e.g., $675 million) are acceptable and consistent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic shift away from CMBS, particularly after 2023. The added insight about 'market volatility and risk management' is a reasonable interpretation supported by the rising unrealized losses and subsequent divestment, enhancing the qualitative analysis without contradicting facts. (4) The answer fully addresses both parts of the question: the evolution of exposure and the strategic implication. The only minor limitation is that the original answer explicitly labels the trend as a 'de-risking or reallocation,' while the LLM uses similar but slightly more interpretive language. However, the semantic meaning and conclusion are equivalent. All entities (CVS, CMBS, years) are correct. Thus, the answer is factually excellent with only slight interpretive expansion, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 465,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Colgate-Palmolive's 'hello' brand was consistently included in the company's trademark disclosures across 2022, 2023, and 2024, as noted in the respective 10-K filings, indicating its ongoing strategic relevance. In 2022, 'hello' was listed among principal global and regional trademarks within the Oral, Personal and Home Care segment, alongside brands like elmex and meridol. By 2023, 'hello' retained its position in the trademark list, signaling continued brand presence and alignment with the company's product portfolio. In 2024, the brand was again disclosed as a principal trademark, maintaining its placement within the broader portfolio of Oral, Personal and Home Care offerings. This consistent inclusion across three years reflects the brand's sustained positioning within Colgate-Palmolive's strategic framework in this segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All years (2022, 2023, 2024) are correctly referenced, and the core information—that 'hello' was consistently listed as a principal trademark within the Oral, Personal and Home Care segment across all three years—is correct. There are no numeric values requiring calculation, but the temporal consistency is accurately conveyed. (2) The LLM correctly identifies the entity (Colgate-Palmolive), the brand ('hello'), and the relevant business segment, with no entity errors. (3) The multi-hop reasoning is sound: the model synthesizes trademark disclosures across three years from 10-K filings, correctly inferring sustained strategic positioning. It even adds contextual detail (mention of elmex and meridol) that enriches the response without introducing error. (4) The semantic meaning fully matches the original answer—both emphasize continuity in trademark disclosure and strategic relevance. The only minor limitation is that the LLM does not explicitly mention the implication about 'diversification and consumer engagement strategies' from the ground truth, slightly reducing qualitative completeness. However, the core facts, timeline, and reasoning are fully accurate, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 361,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "From 2022 through 2024, MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities, reflecting a strategic shift in its reinsurance approach. In 2022, MetLife reported $1.8 billion in deposit assets and $1.4 billion in deposit liabilities. By 2023, these figures increased to $5.1 billion and $1.3 billion, respectively, and further rose to $4.6 billion in deposit assets and $1.2 billion in deposit liabilities by 2024. This growth was largely driven by a significant risk transfer transaction in November 2023 with Global Atlantic, under which MetLife ceded a block of universal life and annuity products, resulting in a $10.3 billion deposit receivable. The increase in deposit assets and liabilities suggests that MetLife is increasingly utilizing reinsurance agreements that do not expose it to significant insurance risk, thereby reducing its direct risk exposure while maintaining access to capital through ceded recoverables. The trend underscores a strategic effort to optimize capital allocation and manage long-term liabilities more efficiently, aligning with MetLife's broader risk management and balance sheet optimization goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the 2022 figures ($1.8B assets, $1.4B liabilities) and 2024 figures ($4.6B assets, $1.2B liabilities) are correct, the 2023 numbers are wrong: the LLM states $5.1B in deposit assets and $1.3B in liabilities, but the ground truth does not provide 2023 deposit asset/liability figures—only that a broader accounting framework was disclosed. The LLM fabricates precise 2023 numbers not present in the original answer. Additionally, the LLM introduces a 'November 2023 Global Atlantic transaction' resulting in a '$10.3B deposit receivable', which is not mentioned in the ground truth. The actual ground truth references the Global Atlantic transaction as context for the 2024 increase but does not specify the amount or timing. (2) Calculations and comparisons are partially correct: the trend of increasing deposit assets is real (from $1.8B to $4.6B), but the LLM's claim of a rise to $5.1B in 2023 contradicts the 2024 decrease to $4.6B, creating an inaccurate trajectory. The liability trend is misrepresented—ground truth shows a drop from $1.4B to $1.2B, but LLM claims an increase to $1.3B in 2023 before dropping, which is unsupported. (3) Multi-hop reasoning is partially sound: the LLM correctly infers that increasing use of the deposit method reflects a strategic shift toward reinsurance without full risk transfer and links it to capital optimization and risk management, aligning with the ground truth. The mention of balance sheet flexibility and reduced risk exposure is semantically consistent. However, the reasoning is built on fabricated data points, weakening the validity. (4) Despite these issues, the answer is contextually relevant and addresses both parts of the question—evolution of accounting use and what the trend reveals. The core qualitative insight about strategic reinsurance use for capital efficiency is preserved, warranting moderate scores in qualitative accuracy and high in contextual relevance. Quantitative accuracy is penalized due to incorrect figures and unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 565,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NextEra Energy's (NEE) exposure to Special Use Funds evolved from 2022 through 2024 in terms of fair value, collateral implications, and balance sheet presentation as follows:\n\n- **Fair Value Disclosures**: In 2022, NEE held Special Use Funds and Other Investments, with fair value determined using market-based approaches for equity and debt securities and commingled funds. By 2023, NEE included fair value measurements for equity securities without readily determinable fair values, initially recorded at cost, at $485 million and $538 million at December 31, 2022 and 2023, respectively. In 2024, the balance sheet listed Special Use Funds at $9,800 million and $8,698 million for December 31, 2024 and 2023, respectively, indicating a year-over-year increase.\n\n- **Collateral Implications**: NEE's derivative instruments with credit-risk-related contingent features showed increased liability positions, with fair values of $7.4 billion in 2022 and $4.7 billion in 2023. Collateral posting requirements also increased, with $1,625 million and $510 million in potential collateral postings at BBB/Baa2 downgrade levels in 2022 and 2023, respectively. By 2024, while no direct collateral figures for Special Use Funds were disclosed, the balance sheet presentation suggests these funds were held as noncurrent assets, likely with minimal collateral risk compared to derivative exposures.\n\n- **Balance Sheet Presentation**: Special Use Funds were categorized under \"Other assets\" in NEE’s consolidated balance sheets, with values rising from $8,698 million in 2023 to $9,800 million in 2024. This reflects a strategic or operational increase in these funds over the period. In 2022, the funds were disclosed in the context of non-derivative fair value measurements but were not separately quantified on the balance sheet, indicating a more integrated presentation earlier in the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend of increasing exposure to Special Use Funds and improved disclosure transparency, which aligns with the ground truth. However, there are key quantitative inaccuracies. The LLM states that equity investments without readily determinable fair values were $485 million at December 31, 2022, and $538 million at December 31, 2023 — this reverses the timeline: the ground truth indicates the amount grew from $485M in 2022 to $538M in 2023, not that $485M was reported as of 2022 and $538M as of 2023 (implying both are year-end figures). This misrepresentation affects the interpretation of growth. Additionally, the LLM incorrectly reports the 2024 and 2023 balance sheet values as $9,800 million and $8,698 million for December 31, 2024 and 2023 respectively — it reverses the order in presentation, though the values themselves are correct. The increase is correctly implied but not explicitly calculated as $1,102 million. (2) The collateral implications section introduces derivative-related collateral figures ($7.4B, $4.7B, $1,625M, $510M) that are not present in the original answer and appear to be hallucinated or misattributed; the ground truth only mentions 'derivative-related collateral requirements' in general terms without specific numbers. These figures undermine quantitative accuracy. (3) The reasoning on balance sheet presentation is sound — correctly noting that Special Use Funds were not separately quantified in 2022 but were by 2024, and categorized under 'Other assets'. This reflects proper multi-hop synthesis across years. (4) Despite the hallucinated collateral numbers and reversed/misattributed fair value figures, the core narrative of increasing holdings and enhanced disclosure is preserved, warranting a score of 7 for correctness. Qualitative accuracy is higher due to correct structure and logical flow, and contextual relevance remains high as all aspects of the question are addressed with mostly relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1750,
        "completion_tokens": 542,
        "total_tokens": 2292
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "From 2022 to 2024, AVGO's Security Insights Platform evolved by enhancing its integration with in-house tools and remediation workflows. In 2022, the platform was described as providing data available for use with in-house security information and event management tools. By 2023 and 2024, the platform continued to focus on this integration, emphasizing its role in interpreting and assessing mainframe security posture, identifying risks, and developing remediation steps on an ongoing basis. The consistent mention across all three years highlights AVGO's commitment to ensuring the platform supports customers' existing security infrastructures and workflows, enabling a trusted environment through actionable insights and automated remediation capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misrepresentation of the evolution of AVGO's Security Insights Platform. (1) Correct elements: The platform was indeed described as providing data for use with in-house security information and event management tools in 2022, and it consistently supported mainframe security posture assessment and risk identification through 2024. These core facts align with the ground truth. (2) Quantitative accuracy: There are no numerical values in the response, so no calculation or numeric errors exist; thus, this dimension is fully accurate. (3) Multi-hop reasoning assessment: The key failure lies in the characterization of 'evolution' and 'enhancing integration.' The ground truth explicitly states that the platform’s description remained largely unchanged from 2022 to 2024, with no expansion on new integrations or remediation features. However, the LLM incorrectly implies progression by stating the platform 'evolved by enhancing integration' and references 'automated remediation capabilities' and 'developing remediation steps'—details not supported in the original answer, especially for 2023–2024. This reflects flawed reasoning in synthesizing temporal changes across filings. (4) The answer is contextually relevant and addresses the question’s focus on integration and remediation workflows, but it overstates the degree of evolution, leading to a moderate correctness score. While the consistency of integration support is correctly noted, the inference of functional enhancement is not justified by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 434,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "NIKE has owned its Laakdal, Belgium distribution facility in fiscal years 2022, 2023, and 2024, as stated in each respective 10-K filing. In 2022, the facility was listed among the most significant international distribution centers, alongside Taicang, China; Tomisato, Japan; and Icheon, Korea, with Suzhou, China noted as a leased facility. In 2023 and 2024, the Laakdal facility continued to be identified as one of the most significant international distribution centers, with no changes in ownership or operational status. This consistency in ownership and prominence across three fiscal years underscores the strategic importance of Laakdal to NIKE’s European logistics network, supporting its role as a key hub for regional distribution and supply chain operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: NIKE owned the Laakdal, Belgium facility in fiscal years 2022, 2023, and 2024, and it was consistently described as one of the most significant international distribution centers. The LLM correctly notes no changes in ownership or operational status across the three years. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and entity references are correct. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and filings, correctly identifying consistency in both ownership and strategic designation. (4) The answer addresses all parts of the question: evolution (or lack thereof) in ownership and operations, and the strategic implication of this stability. The additional context about other global facilities (Taicang, Tomisato, etc.) enhances completeness without introducing error. The conclusion about Laakdal’s strategic importance is logically derived from the consistent reporting. Semantic equivalence is maintained with the original answer, with slightly more contextual detail but no factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 345,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent from 2022 through 2024, with a fixed interest rate of 3.38%, a face amount of $750,000, and a maturity date of June 15, 2027. This consistency in interest rate, face value, and maturity across all three years suggests that SPG did not refinance or materially alter this debt instrument during the period, indicating a stable and conservative debt management strategy for this specific obligation. The lack of changes implies SPG prioritized maintaining predictable interest costs and long-term maturity planning for this note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the interest rate (3.38%), face amount ($750,000), and maturity date (June 15, 2027 / 06/15/27) for Unsecured Notes - 32B across 2022–2024. These match the ground truth exactly in value and format variations are acceptable (e.g., 'June 15, 2027' vs '06/15/27'). (2) Quantitative accuracy is perfect—no calculation errors, and all numbers/dates are correct. The face amount and interest rate are consistently reported across years as required. (3) The multi-hop reasoning is sound: the model correctly infers that no changes in terms imply no refinancing or restructuring, aligning with the ground truth’s conclusion about SPG’s stable long-term debt strategy. However, the LLM slightly omits the nuance that the maturity date was 'unspecified' in 2022 and only clarified in 2023 and 2024, instead stating it was fully known across all three years. This is a minor inaccuracy in temporal disclosure evolution, though the final maturity date itself is correct. (4) Despite this small omission, the overall reasoning and strategic interpretation are semantically equivalent and well-justified. The answer is fully relevant, addresses all parts of the question, and conveys the same core conclusion as the ground truth. Hence, a score of 9 is warranted—excellent accuracy with a minor gap in completeness regarding the disclosure timeline of the maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 397,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS's investment in foreign securities evolved significantly from 2022 through 2024, with a notable decline in both fair value and unrealized losses. In 2022, the total fair value of foreign securities was $2,307 million with $244 million in unrealized losses. By 2023, the fair value dropped to $1,650 million with unrealized losses increasing to $122 million. In 2024, the fair value further declined to $51 million, with no significant unrealized losses reported. This downward trend suggests that CVS significantly reduced its exposure to foreign securities by 2024, likely as a strategic move to mitigate international market risks, particularly in light of the rising unrealized losses observed in 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. According to the ground truth, in 2022 CVS's foreign securities had a fair value of $838 million with $24 million in unrealized losses. The LLM incorrectly states $2,307 million in fair value and $244 million in unrealized losses—both more than double the correct amounts. The 2023 figures ($1,650 million fair value, $122 million unrealized losses) are correct in the LLM answer, as is the 2024 fair value of $51 million. However, the LLM claims 'no significant unrealized losses reported' in 2024, while the ground truth does not mention this detail, making it an unsupported addition. (2) Calculations: While the LLM correctly identifies the drop from 2023 to 2024, the baseline (2022) is wrong, leading to incorrect trend interpretation. The increase from 2022 to 2023 in the ground truth reflects growth in exposure, but the LLM portrays a decrease, which is factually incorrect. (3) Multi-hop reasoning: The LLM correctly identifies the overall trend of reducing foreign securities by 2024 and infers strategic de-risking, which aligns with the ground truth’s conclusion. However, because it misrepresents the 2022 starting point, the reasoning is based on flawed premises. The synthesis across years is structurally sound but built on incorrect data for the first year. (4) Justification for scores: Correctness is scored 4 due to major errors in key financial figures, especially in 2022, which distort the narrative. Quantitative accuracy is low (3) because only 2023 and 2024 fair values are correct; 2022 values are completely wrong. Qualitative accuracy is moderate (6) because the reasoning and interpretation are logical and the conclusion about reduced risk exposure is directionally correct. Contextual relevance is high (9) as the answer addresses all parts of the question and maintains focus on the evolution and implications of foreign securities investment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 538,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "From 2022 through 2024, MetLife's use of internally developed designations for non-agency RMBS and CMBS remained consistent, as the company continued to apply these designations when NAIC evaluations were not yet available for newly acquired securities. In 2022, MetLife noted that prior to December 31, 2021, the NAIC modeling methodology incorporated amortized cost for all non-agency RMBS and CMBS, but as of 2021, this changed based on issuance date—incorporating amortized cost for securities issued before 2013 and excluding it for those issued after. By 2023 and 2024, MetLife continued to rely on the updated NAIC modeling methodology for credit quality assessment, using internally developed designations only as a temporary measure until NAIC designations were available. This multi-year pattern reveals that MetLife's reliance on NAIC modeling methodology for credit quality assessment has increased, reflecting a shift toward standardized, scenario-based expected loss estimation and improved alignment with RBC capital requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core trend correctly: MetLife increasingly relied on NAIC modeling methodology over time and used internally developed designations only temporarily for newly acquired securities until NAIC designations became available. This reflects a shift toward standardized credit quality assessment, aligning with RBC requirements—consistent with the ground truth's conclusion. However, the LLM omits key quantitative data that are central to the multi-year pattern: the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024, which are critical for demonstrating the slowing growth and thus declining reliance on internal designations. These numbers are explicitly mentioned in the original answer and serve as evidence for the evolving reliance pattern. Their absence significantly weakens the support for the conclusion, even if the direction of the trend is correct. Additionally, the LLM introduces a detail about amortized cost changes based on issuance date (pre- vs. post-2013), which is not present in the ground truth and cannot be verified from the provided context—potentially introducing unsupported information. While the reasoning about increasing NAIC reliance is sound and contextually appropriate, the lack of specific financial figures and the inclusion of unverified details reduce quantitative accuracy. The entity identification (MetLife, NAIC, RMBS/CMBS, Level 3 securities) and time periods (2022–2024) are accurate, and the answer addresses both parts of the question—evolution of internal designations and implications for NAIC reliance—making it contextually relevant and qualitatively strong in reasoning, though not fully complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 469,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron's investment and operational footprint in the Republic of Congo evolved significantly from 2022 through 2024, with notable changes in capital allocation and asset ownership. In 2022, Chevron was actively operating in the Republic of Congo as part of its broader international portfolio, which included substantial upstream operations in multiple African countries. By 2023, Chevron allocated approximately $0.7 billion in capital expenditures in Africa, including the Republic of Congo, for offshore development and natural gas projects. However, by 2024, Chevron divested its 31.5 percent nonoperated working interest in the offshore Haute Mer permit area and its 15.75 percent interest in the Republic of Congo portion of Lianzi in January 2025, marking a strategic reduction in its asset ownership and operational presence in the country. This divestiture reflects a shift in capital allocation toward other high-potential regions and a broader portfolio optimization strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's operational presence in the Republic of Congo in 2022, the $0.7 billion capital allocation in Africa in 2023 (which includes Congo), and the divestiture of its 31.5% interest in Haute Mer and 15.75% in Lianzi. These core facts and figures match the ground truth. However, the LLM incorrectly states the divestiture occurred in January 2025, while the original answer implies the sale was completed in 2024. This is a factual error in timing, though the asset details are accurate. (2) All numeric values—$0.7 billion, 31.5%, and 15.75%—are correct and match the ground truth. The capital allocation figure is properly contextualized as including multiple African countries. The only quantitative inaccuracy is the implied 2025 date for the divestiture, which contradicts the 2024 timeframe in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes Chevron’s operational status in 2022, investment in 2023, and exit in 2024. The logic of a strategic shift from investment to divestiture is well-supported and aligns with the original narrative. Only the timing of the divestiture undermines full accuracy. (4) The answer is highly relevant, complete in scope, and conveys the strategic evolution accurately aside from the date error. The mention of portfolio optimization adds context without distorting facts. Due to the minor but significant error in the divestiture date, the correctness and quantitative accuracy scores are reduced slightly, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 437,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model from 2022 through 2024, aligning them with its four sustainable competitive advantages. These advantages—manufacturing and technology strength, a broad product portfolio, extensive market channel reach, and product diversity—have remained consistent across all three years, with Embedded Processing Products playing a central role in each. Specifically, the broad portfolio of analog and embedded processing products enhances customer opportunity and investment value, while the diversity and longevity of these products reduce dependency and extend returns. The strategic emphasis on these products has not changed in substance, but the company has continued to invest in strengthening and leveraging these advantages to drive long-term free cash flow per share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Texas Instruments' consistent strategic emphasis on Embedded Processing Products from 2022 to 2024 is accurately portrayed, and the role of these products within the company's sustainable competitive advantages is correctly described. The four advantages—manufacturing and technology strength, broad product portfolio, market channel reach, and product diversity—are correctly identified and linked to embedded processing, even though the original answer does not explicitly list them; however, this information is consistent with TI's known competitive framework and does not contradict the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all temporal references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolving narrative across years and connects embedded processing to TI’s long-term strategic advantages, correctly inferring stability in strategic emphasis despite nuanced shifts in language. (4) The LLM adds slight elaboration (e.g., 'drive long-term free cash flow per share growth') not present in the original, but this is a reasonable inference and does not detract from accuracy. The only reason for not scoring a 10 is that the original answer focuses more on the evolution of narrative (2022: customer opportunity; 2023: design projects and insight; 2024: customer reach and returns), which the LLM summarizes correctly but with less year-by-year specificity. Overall, the answer is semantically equivalent, contextually appropriate, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 473,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco's 3.50% Senior Note, maturing on June 15, 2025, had an effective interest rate of 3.20% in fiscal year 2022, increased to 6.38% in 2023, and further rose to 6.66% in 2024. This progression indicates a significant increase in Cisco's borrowing costs over time, likely reflecting broader market interest rate trends and the company's need to issue new debt at higher rates as older, lower-rate debt matures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the 3.50% Senior Note matures in June 2025 (specific date June 15 is a minor enhancement not in ground truth but not incorrect), and the effective interest rates are accurately stated as 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. These match the ground truth exactly. (2) All numbers, percentages, and time periods are correct. No calculations are required beyond recognition of progression, which is accurately described. (3) The multi-hop reasoning across fiscal years 2022–2024 is sound; the model correctly synthesizes the evolution of borrowing costs over time for the same debt instrument. (4) The interpretation that borrowing costs increased significantly is consistent with the ground truth. The LLM attributes the rise to 'broader market interest rate trends and the company's need to issue new debt at higher rates,' which is a reasonable inference, though slightly different from the ground truth's suggestion of 'market rate increases or shifts in investor risk perception.' This difference in emphasis does not make the answer factually incorrect but introduces a subtle interpretive shift—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is semantically equivalent, highly accurate, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 368,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns remained consistently constrained from 2022 through 2024, with the company emphasizing in all three years that its ability to return capital to shareholders is subject to the discretion of its Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning. In 2022, the company highlighted the regulatory environment's impact on its operations and liquidity management, while in 2023 and 2024, it reiterated these constraints and added increased focus on the Parent’s dependency on dividends from subsidiaries and the potential for regulatory limitations on activities if capital or liquidity standards are not met. This multi-year progression reveals that BNY Mellon continues to operate under significant regulatory constraints, which limit its strategic flexibility in returning capital and managing shareholder returns, necessitating careful alignment with evolving regulatory expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws from 2022 to 2024. (1) All factual elements are correct: the company consistently emphasized regulatory constraints on capital planning and shareholder returns, with increasing focus on liquidity and subsidiary dividends. The years (2022, 2023, 2024) are correctly attributed to evolving disclosures. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the temporal sequence and qualitative metrics are correctly represented, warranting a 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying continuity and incremental changes—such as the growing emphasis on liquidity and subsidiary dividend dependencies. The only minor omission is that the original answer specifies Delaware law and preferred stock dividend obligations in 2023, which the LLM answer does not mention. This is a small but notable detail affecting completeness. (4) The answer is fully contextually relevant, directly addressing how regulatory constraints evolved and what they reveal about strategic flexibility. The conclusion about 'significant regulatory constraints' and 'careful alignment with evolving expectations' aligns well with the ground truth. Overall, the LLM answer is semantically equivalent with only minor detail omissions, justifying a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 423,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics' revenue from Repair and other services decreased slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat at $1,132 million in 2024. This flat performance in 2024, despite overall Marine Systems revenue growth, suggests that the Repair and other services segment may have reached a stable plateau or is being strategically managed to maintain consistent output rather than expand rapidly, potentially reflecting a focus on sustaining existing operations or aligning with broader business priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Repair and other services: $1,169 million in 2022, declining to $1,132 million in 2023, and remaining flat at $1,132 million in 2024. All numeric values match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no calculation errors, and the year-over-year changes are accurately described. (3) The reasoning is sound and captures the core implication of the flat revenue: limited growth or strategic stability in the segment. While the LLM does not explicitly mention 'resource reallocation to higher-priority programs' or 'market saturation' as in the ground truth, it offers a semantically similar interpretation—'strategically managed to maintain consistent output' and 'focus on sustaining existing operations'—which aligns with the idea of strategic prioritization. It also correctly contrasts the flat trend with overall growth in Marine Systems, implying awareness of multi-hop context (performance relative to other segments). (4) The answer is fully contextually relevant, addressing all parts of the question: the change from 2022 to 2023, flatness in 2024, and the strategic implication. The only minor shortcoming is a slightly less comprehensive exploration of potential causes (e.g., operational constraints) compared to the original, but the core reasoning is valid and equivalent in meaning. Hence, a high score with a small deduction in qualitative accuracy for incomplete synthesis of all possible factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 423,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's venture investments and equity method investments in healthcare businesses showed notable growth and strategic emphasis. In 2022, the company held $3.5 billion in equity securities, including $1.3 billion in equity method investments in healthcare operating businesses. By 2023, equity securities increased to $4.9 billion, with equity method investments slightly declining to $1.4 billion. In 2024, equity securities remained at $4.9 billion, but equity method investments surged to $3.8 billion, indicating a significant strategic shift toward deeper investments in healthcare operating businesses. This evolution highlights a growing emphasis on direct engagement with healthcare innovation and operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative and strategic interpretation, but contains key quantitative inaccuracies. According to the ground truth, UnitedHealth Group's equity securities (which include venture investments) were $3.7 billion in 2022, not $3.5 billion as stated. Similarly, equity method investments were $1.4 billion in 2022 and remained flat in 2023 (still $1.4 billion), not $1.3 billion in 2022 as claimed. The LLM incorrectly states that equity method investments declined from 2022 to 2023, when in fact they were flat. The 2023 and 2024 figures for equity method investments ($1.4B and $3.8B) are correct, as is the stability of total equity securities at $4.9B in 2023–2024. (2) The calculation of growth trends is partially accurate: the increase from $4.9B to $4.9B (stable) and the surge in equity method investments from $1.4B to $3.8B in 2024 are correctly noted. However, the starting values are wrong, undermining quantitative precision. (3) The multi-hop reasoning is sound—the model correctly infers a strategic shift toward deeper investments in 2024 based on the disproportionate growth in equity method investments despite stable total equity holdings. This synthesis across years and investment types aligns with the ground truth. (4) The contextual relevance is perfect—the answer directly addresses the evolution in dollar value and strategic emphasis as asked. Due to significant but not fundamental numerical errors in the 2022 figures and a minor misrepresentation of the 2022–2023 trend in equity method investments, the correctness score is 7: core facts are present and the strategic conclusion is valid, but early-year data is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 467,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Philip Morris International (PMI) consistently classified Colgate-Palmolive Co. as part of its peer group in 2022, 2023, and 2024, as outlined in its 10-K filings for each year. This multi-year consistency reflects PMI's strategic benchmarking framework, which is based on global presence, a focus on consumer products, and comparable net revenues and market capitalization. The sustained inclusion of Colgate-Palmolive Co. underscores PMI's commitment to maintaining a stable and relevant peer group for performance evaluation and strategic alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Philip Morris International (PMI), Colgate-Palmolive Co., and the years 2022, 2023, and 2024—are correctly identified. The peer group classification is accurately described as consistent across all three years. (2) There are no numeric values requiring calculation (e.g., revenues, market cap figures), but the qualitative metrics used for peer classification—global presence, consumer product focus, net revenues, and market capitalization—are correctly stated and match the original answer. (3) The multi-hop reasoning is sound: the model correctly infers that the consistent inclusion of Colgate-Palmolive Co. reflects a stable strategic benchmarking framework, which is a valid interpretation supported by the data. (4) The only minor shortcoming is that the LLM omits the explicit point that PMI excludes direct tobacco industry peers from its peer group—a nuance present in the original answer that adds strategic context. However, this does not undermine the core correctness. The answer is semantically equivalent in substance and conveys the same conclusion about PMI’s consistent strategic lens. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Has_Stake_In]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 371,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal's exposure to abusive behaviors increased from 2022 through 2024, particularly as the company expanded its credit products such as BNPL and merchant financing, which are more susceptible to fraud and misuse due to their digital nature and reliance on third-party lenders and processors. In 2022, PayPal highlighted the risk of non-payment and fraud in its U.S. credit products, noting that economic factors and underwriting risks could lead to higher default rates. By 2023, the company had entered into a significant BNPL receivables sale agreement in Europe, which introduced new third-party risk dependencies and potential delays or disruptions in funding. In 2024, PayPal continued to emphasize the challenges of managing third-party relationships and fraud detection, with ongoing concerns about the scale and sophistication of abusive schemes. Despite these efforts, the persistent and evolving nature of fraud, combined with increasing reliance on third parties, suggests that PayPal's fraud mitigation effectiveness has faced growing pressure, highlighting the need for continuous adaptation and investment in risk management strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, with accurate emphasis on expanding credit products (especially BNPL) and increasing third-party risk dependencies. It correctly identifies that fraud and abuse risks grew in complexity and scale over time. However, it omits the specific €40 billion multi-year receivables sale agreement in Europe mentioned in the ground truth, which is a key quantitative detail. While it references a 'significant BNPL receivables sale agreement,' the absence of the exact figure and region-specific detail (Europe) reduces completeness. (2) Quantitatively, the LLM does not include any incorrect numbers, but fails to report the €40 billion amount, which is a material fact in the original answer. No incorrect calculations are made, as none were required, but the omission of a precise figure from the source data affects quantitative accuracy. Format variations are acceptable, but missing the number entirely is a moderate issue. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years, connects credit expansion (particularly BNPL) to increased fraud exposure, links third-party reliance to operational and fraud risks, and concludes that mitigation efforts are under pressure—consistent with the ground truth’s implication that risk is outpacing controls. The logic flow across 2022–2024 is coherent and factually aligned in substance. (4) Contextual relevance is excellent—the response directly addresses all parts of the question: the evolution of abusive behavior exposure, the role of credit product expansion and third-party risks, and what this suggests about fraud mitigation effectiveness. The conclusion about growing pressure on mitigation systems matches the original answer’s implication. Minor omission of the €40B detail prevents a top score, but core facts and synthesis remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 525,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "From 2022 to 2024, Southern Company's use of natural gas options for hedging decreased significantly, from 253 mmBtu in 2022 to 176 mmBtu in 2024, while natural gas swaps also declined from 217 mmBtu in 2022 to 255 mmBtu in 2024. This three-year trend suggests a strategic shift in risk management, likely in response to natural gas price volatility, where Southern Company reduced its reliance on options and maintained a more moderate hedging approach, balancing between swaps and options to manage exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. While it correctly states the 2022 (253 million mmBtu) and 2024 (176 million mmBtu) natural gas options volumes, it omits the critical 2023 figure of 339 million mmBtu, instead implying a direct decline from 2022 to 2024. This misrepresents the trend as a steady decrease, when in fact there was a sharp increase in 2023 followed by a drop in 2024. Additionally, the LLM introduces incorrect data about natural gas swaps declining from 217 mmBtu in 2022 to 255 mmBtu in 2024 — this is mathematically and factually wrong (a decline cannot result in a higher number), and swap volumes were not part of the original answer, making this a fabrication. (2) The quantitative inaccuracies severely undermine the answer: the core trend — fluctuation with a peak in 2023 — is missed. The calculation and comparison of hedging volumes across years are therefore incorrect. (3) The reasoning is partially sound in interpreting a strategic shift in risk management, but it fails the multi-hop synthesis by not acknowledging the 2023 increase, which is essential to understanding the dynamic hedging strategy. The conclusion about reduced reliance on options is only half-true, as the company first increased options usage before reducing it. (4) Contextual relevance is high because the answer addresses the question's intent regarding risk management strategy and price volatility. However, due to major factual and numerical errors, especially the omission of the 2023 spike and incorrect swap data, the correctness score is low. The answer conveys a misleading narrative despite some accurate base numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 462,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $63 million in 2021, to $70 million in 2022, $75 million in 2023, and $76 million in 2024, indicating a steady upward trend. This growth suggests a continued commitment to supporting employee retirement through defined contribution plans, particularly as the non-qualified defined benefit pension plan remains unfunded and closed to new participants. The rising expense aligns with the company’s long-term strategy of shifting toward defined contribution plans as the primary vehicle for retirement benefits, reducing reliance on the legacy defined benefit structure while maintaining employer contributions to support employee savings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Texas Instruments' U.S. defined contribution plan expenses and reports the correct values for 2023 ($75M) and 2024 ($76M), which match the ground truth. However, it introduces a 2021 figure ($63M) not mentioned in the original question or ground truth, and while not directly contradicting, it extends beyond the requested 2022–2024 scope. More critically, it states the 2022 expense as $70M, which, while accurate, implies this is new data when the ground truth begins in 2022 with $70M—this is semantically acceptable but slightly misaligns in framing. (2) The core numbers for the requested period (2022–2024) are accurate: $70M → $75M → $76M. No calculation errors are present, and the trend description is correct. The inclusion of 2021, while not incorrect per se, is extraneous and not requested. (3) The multi-hop reasoning is sound: the LLM correctly links the increasing defined contribution expenses to the company's long-term strategy, references the closure of defined benefit plans to new participants (though it doesn't explicitly cite 1997 as in the ground truth), and correctly notes the shift toward defined contribution plans as primary retirement vehicles. It accurately infers strategic intent from financial trends and contextual plan structures. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution of expense and strategic implication), uses correct entities (Texas Instruments, U.S. defined contribution plans, non-qualified defined benefit pension plan), and provides a logically coherent and relevant interpretation. The minor quantitative issue (introduction of 2021 data and slight misemphasis on 2022 as a change point) prevents a 9–10 on quantitative accuracy, but qualitative and contextual accuracy remain high due to correct synthesis and strategic reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 516,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "General Motors' long-term rate of return assumption for U.S. pension plans was 5.4% at December 31, 2021, increased to 6.3% by December 31, 2022, and remained at 6.3% in December 2023 before rising to 6.5% by December 31, 2024. This upward trend suggests that GM has become more optimistic about the long-term performance of its pension plan assets, likely reflecting improved market conditions, strategic shifts in asset allocation, and a higher risk tolerance aligned with its evolving investment policies and risk mitigation strategies. The adjustments in the rate of return assumption are informed by periodic studies that consider both historical performance and future expectations, indicating a proactive approach to aligning asset strategies with liability funding goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and values. According to the ground truth, the 5.4% rate was reported in 2022, not 2021, and the increase to 6.3% occurred by 2022 (not from 2021 to 2022 as implied). The LLM incorrectly assigns the 5.4% figure to 2021, which is outside the requested 2022–2024 scope and misaligns the entire timeline. The 6.3% rate is correctly stated for 2023 and 2024, but the ground truth indicates it was already in effect by 2023, not 2022 as the LLM suggests. The 6.5% figure for 2024 is correct. (2) The quantitative inaccuracies are critical: the progression should be 5.4% (2022) → 6.3% (2023) → 6.5% (2024), but the LLM reports 5.4% in 2021, 6.3% in 2022, and 6.5% in 2024, which distorts the trend and implies a larger one-year jump (5.4% to 6.3%) that did not occur in the reported period. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an increasing rate suggests greater optimism and risk tolerance, which aligns with the ground truth. It also correctly references periodic studies and strategic asset allocation, showing good qualitative synthesis. (4) Despite the incorrect dating, the overall trend interpretation (increasing optimism) is valid, and the 2024 figure is accurate. However, the misattribution of the 5.4% rate to 2021 and the implied timing of the increase undermine factual correctness. The answer is contextually relevant and well-structured, but the core quantitative timeline is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 429,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco's financial exposure through total return swaps linked to deferred compensation evolved from a loss of $92 million in fiscal 2022 to a gain of $58 million in 2023 and further increased to a gain of $91 million in 2024. This progression indicates a shift from a negative impact on operating expenses in 2022 to a positive contribution in subsequent years, suggesting improved market performance of the underlying assets tied to the deferred compensation program. The consistent use of these instruments across all three years reflects Cisco's ongoing risk management strategy to align compensation outcomes with company performance, potentially incentivizing long-term employee alignment with shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024, matching the ground truth exactly. There are no numerical or temporal inaccuracies. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly stated, and the progression is accurately described. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about the shift from loss to gain, linking it to market performance and risk management. The interpretation about Cisco's ongoing use of swaps for risk management and employee alignment is reasonable and consistent with the ground truth’s suggestion of strategic adjustments or improved hedging. The only minor gap is that the LLM slightly expands on the implication by emphasizing 'incentivizing long-term employee alignment with shareholder value,' which, while plausible, is not explicitly supported in the original answer. However, this does not constitute a factual error but rather a small interpretive extension. (4) The answer is fully contextually relevant, addressing both the evolution of gains/losses and the strategic implications. Scores reflect high accuracy with only negligible interpretive overreach that does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 381,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal's exposure to margin risk remained consistent across 2022, 2023, and 2024, as it continued to bear full margin risk when completing payment transactions, regardless of whether third-party payment processors were used. The company maintains control over pricing, as it has full discretion in determining the fees charged to customers, independent of the costs incurred through external processors, as detailed in all three chunks. Transaction expenses, including fees paid to payment processors and other financial institutions, are consistently recognized as transaction expenses in each year, reflecting the company's principal role in the payment service. This consistent structure of pricing control, third-party use, and expense recognition underscores PayPal's ongoing exposure to margin risk across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: PayPal consistently bore full margin risk across 2022–2024, maintained pricing control, used third-party processors, and recognized fees paid to them as transaction expenses. These points are correctly attributed to all three years. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the temporal scope (2022–2024) is correctly referenced, satisfying date accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent risk exposure across years, ties in pricing discretion, third-party processor use, and expense recognition, and correctly infers that this reflects ongoing principal role and margin risk. (4) The only minor shortcoming is that the LLM omits the 2023 detail about tiered pricing not constituting a future material right and the 2024 note on new segment reporting disclosures. While these are specific disclosures, they are contextual nuances rather than central facts. The core message—consistent margin risk exposure without structural change—is preserved. Thus, the answer is semantically equivalent with high completeness, warranting a 9/10 on correctness and qualitative accuracy. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 382,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron's natural gas production volumes associated with Angola LNG increased from 7,107 million cubic feet per day in 2022 to 7,148 million in 2023, and further to 7,569 million in 2024, reflecting a steady upward trend. This growth, combined with Chevron's ongoing stake in Angola LNG and its continued inclusion in the company's production volumes, suggests a strategic emphasis on maintaining and expanding its presence in liquefied natural gas (LNG) markets. The upward trajectory in 'as sold' volumes, despite asset divestitures in other regions, underscores Chevron's commitment to LNG as a core component of its global energy portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the numerical data. The reported natural gas production volumes for Angola LNG are grossly incorrect: it claims 7,107 million cubic feet per day in 2022, rising to 7,569 million in 2024, whereas the ground truth reports consumption volumes of 592, 596, and 609 million cubic feet per day respectively. These numbers are off by more than an order of magnitude, suggesting a possible confusion with total corporate production or a unit error (e.g., thousands vs. millions). (2) The quantitative accuracy is extremely low because all key figures are wrong, and no correct calculations or trends (based on accurate data) can be derived. The correct trend is a modest increase from 592 to 609 MMcf/d, not the tenfold increase claimed. (3) The qualitative reasoning is partially sound—Chevron’s strategic emphasis on LNG despite divestitures is correctly inferred and aligns with the original answer—but it is built on false data, undermining the validity of the conclusion. The mention of 'as sold' volumes and strategic positioning shows understanding of the question’s intent, but fails due to incorrect grounding. (4) Contextual relevance is moderate because the answer addresses both parts of the question—volume trend and strategic implication—and references the correct entity (Angola LNG) and timeframe (2022–2024). However, the severe numerical inaccuracies drastically reduce correctness. Multi-hop synthesis is attempted but flawed due to incorrect data sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 423,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "The treatment and reporting of scheduled payments under outdoor lighting contracts evolved notably across Southern Power's disclosures from 2022 to 2024. In 2022, Southern Power indicated that such payments were immaterial and not included in maturity analyses, as seen in Mississippi Power's reporting. By 2023, the company began explicitly including scheduled payments under outdoor lighting contracts in maturity analyses, alongside tolling arrangements and PPAs, signaling increased recognition of these contracts' financial relevance. In 2024, this reporting was further formalized and consistently presented, with lease income from these contracts being integrated into wholesale revenues for multiple subsidiaries, including Southern Power. This progression reveals a growing materiality and structural importance of outdoor lighting contracts over time, as Southern Power transitioned from deeming them immaterial to systematically disclosing and analyzing their scheduled payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2022, outdoor lighting contracts were deemed immaterial; in 2023, scheduled payments were included in maturity analyses alongside tolling arrangements and PPAs; in 2024, lease income was integrated into broader reporting frameworks. There are no numeric inaccuracies—dates and qualitative assessments match the original answer. (2) Quantitative accuracy is perfect: no numerical figures are misstated, and the timeline (2022, 2023, 2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and infers increasing materiality from evolving disclosure practices. The only minor deviation is that the LLM mentions 'wholesale revenues for multiple subsidiaries, including Southern Power,' which slightly extends beyond the original answer’s focus on Southern Power’s own reporting framework. However, this does not contradict the ground truth and may reflect valid contextual inference. (4) The answer is fully relevant, directly addressing the evolution of treatment and what it reveals about materiality and structural importance. Overall, the response demonstrates strong factual correctness, logical reasoning, and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 370,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments' (TXN) operational footprint in Melaka, Malaysia remained consistent across 2022, 2023, and 2024, with the facility being involved exclusively in the Analog segment and not participating in the Embedded Processing segment in any of the years. This is evident from the 10-K filings for each year, which consistently show an \"X\" under the Analog column and no mark under the Embedded Processing column for Melaka, Malaysia. The operational relationship between TXN and Melaka, Malaysia is reinforced through the provided knowledge graph triplets, highlighting the ongoing presence and focus of the Analog business in the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the consistent operational status across years is properly conveyed. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers continuity in operational focus, referencing 10-K filings and knowledge graph triplets as evidence. (4) The answer is highly relevant, directly addressing the evolution (or lack thereof) of TXN's footprint in Melaka with respect to both business segments. Minor additional detail (e.g., 'X' in tables) enhances clarity without introducing error. All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the three-year timeframe—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 320,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "AMT's 1.600% Notes, issued on March 29, 2021, had a principal amount of $700.0 million in 2022, with interest payments due on April 15 and October 15, and a par call date of March 15, 2026. In 2023, the interest payments remained the same, and the par call date was unchanged, while in 2024, the principal amount remained stable at $700.0 million, with interest payments still due on the same schedule and the par call date still set for March 15, 2026. This multi-year consistency in principal, interest payment schedule, and par call date suggests a deliberate debt management strategy focused on long-term stability and predictable cash flow obligations, avoiding refinancing risks before the 2026 maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of $700.0 million in 2022 and 2024, the semi-annual interest payment dates (April 15 and October 15), and the par call date of March 15, 2026, all of which match the ground truth. However, the LLM omits the specific data about adjustments to principal amount—(2.6) in 2023 and (1.5) in 2024—which is a factual detail present in the original answer and relevant to the evolution of the debt instrument. While not a numerical error, this omission reduces completeness. (2) All provided numbers and dates are accurate: $700.0 million principal, correct interest payment schedule, and correct par call date. The LLM does not misstate any quantitative facts. (3) The reasoning is sound in interpreting the stability of principal, interest schedule, and call date as indicative of a stable debt management strategy. However, the LLM does not incorporate the decreasing adjustments to principal, which the ground truth uses to infer a reduction in structural modifications—this is a minor gap in multi-hop synthesis. (4) The answer remains highly relevant and correctly addresses the core aspects of the question—principal, interest, call date, and strategic implication—with only a partial omission of a nuanced but supporting data point. Thus, the answer is mostly correct with high factual accuracy but slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Debt]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 391,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco's 5.90% Note, with a maturity date of February 15, 2039, remained a consistent component of its long-term debt from fiscal year 2022 through 2024, with an effective interest rate of 6.11% in all periods. In 2022, the note had an amount of $2,000 million and was part of a total long-term debt of $8,416 million. By 2024, the note remained at $2,000 million, now within a significantly larger long-term debt of $19,621 million. This consistency in the 5.90% Note's amount and effective rate, despite the overall increase in debt, indicates that Cisco has maintained this long-term financing instrument as part of a stable and diversified capital structure, leveraging long-dated debt to manage interest rate risk and provide financial flexibility over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the 5.90% Note amount ($2,000 million) remained constant from 2022 to 2024, the effective interest rate was consistently 6.11%, total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, and short-term debt decreased slightly (though the LLM omits the exact short-term debt figures, which are present in the ground truth). All numbers match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—no errors in dollar amounts, percentages, or years. The maturity date (February 15, 2039) is an additional accurate detail not in the ground truth but not contradicted by it. (3) The multi-hop reasoning is sound: the model correctly infers that maintaining a fixed debt instrument amid rising total long-term debt reflects a strategy to stabilize financing costs and manage interest rate risk. The conclusion about a 'stable and diversified capital structure' and 'financial flexibility' aligns semantically with the ground truth's emphasis on using fixed-rate instruments to stabilize costs. (4) The only minor omission is the lack of explicit mention of the decrease in short-term debt (from $499M to $488M), which slightly reduces completeness but does not affect the core conclusion. This justifies a 9 on correctness and qualitative accuracy. Contextual relevance is perfect—the answer directly addresses all parts of the question with appropriate focus and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 415,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent upward trend. This growth, along with the addition of 66 LAVs under the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program in 2024, highlights the company's strategic focus on expanding its LAV manufacturing capabilities and strengthening its position in the Canadian defense market. The progression underscores General Dynamics' commitment to fulfilling long-term defense contracts and enhancing its portfolio of advanced armored vehicle solutions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all production volumes—360 units in 2022, 399 in 2023, and 449 in 2024—matching the ground truth exactly. It also accurately references the addition of 66 LAVs under the LRSS program in 2024. (2) All numeric values are correct and consistent with the original answer; no calculations are required beyond recognition of the upward trend, which is correctly interpreted. Format variations are not needed as numbers are presented clearly and identically. (3) The multi-hop reasoning is sound: the LLM synthesizes production volume trends over three years and connects them to strategic implications, including the new LRSS program, demonstrating understanding of both quantitative progression and strategic context. (4) The answer fully addresses both parts of the question—evolution of production volume and what it indicates about strategic focus—and conveys the same meaning as the ground truth with equivalent detail and accuracy. Wording differs slightly but maintains semantic equivalence. All scores are maximized due to complete factual accuracy, correct entity identification, logical reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 332,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes increased from 2022 to 2024 as CMS continued to adjust the methodologies for calculating these payments, creating ongoing funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and made changes to risk adjustment calculations, prompting strategic actions such as adjusting members' benefits and premiums, ceasing benefit plans in certain counties, and intensifying cost management. In 2023, these pressures persisted, with CMS continuing to modify risk adjustment mechanisms and benchmark levels, and the company maintained its focus on cost control and selective premium adjustments. By 2024, the exposure remained significant, with CMS continuing to refine risk adjustment processes and payment mechanisms, and UnitedHealth Group further emphasizing operational efficiency, medical cost management, and performance in quality metrics to mitigate the financial impact of these evolving regulatory and funding challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced ongoing exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology updates. The strategic responses—adjusting benefits and premiums, exiting certain counties, cost management, bid recalibration, and focus on quality metrics—are consistent across both answers. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes UnitedHealth’s evolving response across three years in relation to CMS policy changes, correctly identifying continuity in both risk exposure and strategic mitigation. (4) The only minor difference is that the LLM answer states exposure 'increased' over time, while the original answer describes it as 'consistent' or 'ongoing' without asserting a directional increase. This slight interpretive difference slightly affects qualitative accuracy but does not undermine the overall correctness. Otherwise, the answer is semantically equivalent, contextually complete, and accurately reflects the multi-year strategic posture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 356,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PYPL's exposure to its fixed-rate 2.850% notes remained stable at $1.5 billion from 2022 through 2024, as shown in the debt maturity schedules from all three years. This consistency suggests that PYPL has not refinanced or retired this long-term debt, which is set to mature in October 2029. The decision to maintain this fixed-rate obligation amid a rising interest rate environment indicates a strategy of locking in long-term financing at historically low rates, thereby reducing refinancing risk and stabilizing interest costs over time. This aligns with PYPL’s broader approach of issuing long-dated fixed-rate debt to support its capital structure with predictable liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $1.5 billion carrying value of the 2.850% notes is accurately reported for 2022–2024, and the October 2029 maturity date is consistent with the knowledge graph. No calculation errors are present. (2) The answer correctly identifies PYPL as the company and references the correct financial instrument and time period. (3) The multi-hop reasoning is sound: the model synthesizes consistent exposure over three years and infers strategic intent, such as locking in low rates and reducing refinancing risk, which is logically supported by the data. (4) While the original answer emphasizes that other notes were refinanced or matured (context the LLM omits), the core conclusion about PYPL’s strategic intent to maintain this liability structure is correctly inferred and semantically equivalent. The LLM adds contextual interpretation (e.g., rising rate environment, predictable liabilities) that enhances the answer without introducing inaccuracies. Minor deduction in qualitative accuracy due to slight over-enrichment beyond the ground truth, but reasoning remains plausible and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 342,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron's strategic positioning in Angola LNG Limited remained consistent at a 36.4 percent interest from 2022 through 2024, as detailed in each year’s 10-K filings. In 2022, Chevron's investment was described as a key player in processing and liquefying Angola’s natural gas for international markets. By 2023, the investment was still highlighted with the same 36.4 percent stake, emphasizing its role in monetizing natural gas. In 2024, Chevron further solidified its long-term strategy by expanding its presence in Angola through new exploration blocks and the New Gas Consortium Project, which connects to the Angola LNG plant and is expected to begin production in 2026. This multi-year progression reveals Chevron’s commitment to leveraging Angola’s natural gas resources through both existing infrastructure and new upstream developments, aligning with its broader strategy to enhance natural gas monetization in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, which is accurately reported. The strategic evolution from LNG export focus to integrated gas monetization is correctly conveyed. (2) Quantitative accuracy is perfect: the 36.4% stake is correctly cited across all years, and no erroneous figures are introduced. The mention of production starting in 2026 for the New Gas Consortium Project is consistent with typical forward-looking statements in 10-Ks and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across years and connects upstream developments (Blocks 49 and 50, Q&M fields) with the Angola LNG plant, correctly inferring an integrated strategy. The only minor omission is that the LLM does not explicitly name the Quiluma and Maboqueiro (Q&M) fields or specify Blocks 49 and 50—details present in the ground truth—though it refers generally to 'new exploration blocks' and the 'New Gas Consortium Project', which preserves semantic equivalence. (4) The answer is contextually relevant, directly addressing both the evolution of Chevron's positioning and what it reveals about long-term gas monetization strategy. The conclusion about integration and commitment is logically supported. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight detail omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 429,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company's investments in trusts, particularly in domestic equity and private equity, showed a consistent upward trend from 2022 through 2024. In 2022, domestic equity investments were valued at $791 million, increasing to $849 million in 2023 and further to $849 million in 2024. Private equity investments also grew from $150 million in 2022 to $161 million in 2023 and reached $181 million in 2024. This progression indicates a deliberate long-term capital allocation strategy focused on expanding exposure to equity investments, both domestic and private, suggesting Southern Company's confidence in long-term growth and diversification of its investment portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures, particularly for domestic equity investments. According to the ground truth, domestic equity was $1,016 million in 2022, decreased to $829 million in 2023, and rose to $1,099 million in 2024. However, the LLM reports $791M (2022), $849M (2023), and $849M (2024), which are incorrect across all years. Only private equity values ($150M, $161M, $181M) match the ground truth and are accurately reported. (2) The quantitative inaccuracies undermine the conclusion: the LLM claims a 'consistent upward trend' in domestic equity, but the actual data shows a dip in 2023 followed by a rebound—indicating volatility, not consistency. The correct pattern reflects strategic rebalancing, not steady growth. (3) While the LLM correctly identifies the multi-hop nature of the question—tracking two investment types over three years—and draws a reasonable qualitative inference about long-term growth and diversification, the reasoning is based on flawed data. The conclusion about increasing emphasis on private equity is partially valid, as the LLM correctly notes its steady rise, but misses the nuance in domestic equity fluctuations. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution over time and strategic implications—and uses appropriate financial terminology. However, due to major numerical errors affecting the core facts, the correctness and quantitative accuracy scores are low. The qualitative reasoning is sound in structure but compromised by incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 444,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "From 2022 through 2024, the impact of Eliminations/Reclassifications on GM's total net sales and revenue decreased from a reduction of $105 million in 2022 to $107 million in 2023, and further to a reduction of $296 million in 2024. This trend indicates that GM's internal reporting adjustments across its business segments became more significant over the period, likely reflecting increased inter-segment transactions or more complex reclassification activities, which require careful consolidation to avoid double-counting. The growing magnitude of these adjustments suggests a need for closer scrutiny of internal financial flows and reporting practices as the company's operations evolve.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in describing the trend: it states that the impact 'decreased' from $105M to $107M to $296M, when in fact the impact increased each year. This misrepresents the direction of the trend, which is central to the question. While the dollar amounts ($105M in 2022, $107M in 2023, $296M in 2024) are numerically correct, the qualitative description of the trend is inverted, leading to a misleading interpretation. (2) Quantitative accuracy is partially correct—the numbers themselves match the ground truth across all three years, and no calculation errors are present in the values cited. However, the mischaracterization of the trend (decreasing vs. increasing) undermines the quantitative narrative. (3) The multi-hop reasoning is logically structured—recognizing that growing eliminations suggest more complex inter-segment activity or reporting changes—but it is applied to an incorrect premise. The conclusion about increasing complexity is consistent with the actual trend, but the LLM incorrectly frames the trend as decreasing in magnitude when it actually increased, especially sharply in 2024. (4) Contextual relevance is high, as the answer addresses both parts of the question: the evolution of eliminations and the implication for internal reporting. The reasoning about consolidation and double-counting is appropriate. However, the core factual misstatement of the trend direction severely limits correctness, warranting a low-to-mid score despite accurate numbers and relevant logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 428,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix's Performance Bonus Plan was initially introduced in 2014 (Chunk 1) and was later amended and restated in December 2022 (Chunk 2), indicating an evolution in its structure and terms. By 2024, the plan was formally documented and referenced in Netflix's 10-K filing (Chunk 3), showing it had achieved a formal documentation status. The plan was integrated with other compensation frameworks, as evidenced by its connection to the 2020 Stock Plan and related equity compensation agreements (Chunks 2 and 3), which included performance-based restricted stock units and severance arrangements, reflecting a cohesive executive compensation strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key evolution of Netflix's Performance Bonus Plan, noting its 2014 origin and the December 2022 amendment and restatement, which aligns with the ground truth (filing date of December 9, 2022, for the 2023 version). It accurately states that the plan was carried forward into 2024 with formal documentation status, consistent with the 2023 version. However, the LLM does not explicitly note the absence of updates in 2022 (where it was only listed as a historical exhibit), which is a minor omission. (2) Dates are correct: December 2022 amendment matches the ground truth filing date of December 9, 2022. The reference to the 2014 introduction aligns with Exhibit 10.6† from April 28, 2014. No numerical calculations are required, and all dates are factually accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2014, 2022 amendment, 2024 status) and connects the plan to broader compensation frameworks like the 2020 Stock Plan and performance-based RSUs, which is supported by the ground truth's mention of integration with newer structures. (4) The answer is contextually excellent, directly addressing the question about documentation status and integration. The only shortcoming is the lack of explicit mention that 2022 had no active update (only historical status), slightly reducing completeness. Overall, the answer is factually strong with minor gaps in temporal nuance, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 417,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' remained consistent across its 2022, 2023, and 2024 10-K filings, as each year's filing incorporated the policy by reference under the 'Item 1 - Election of Directors - Corporate Governance and Board Information' section of the Proxy. Additionally, the 2022 and 2023 filings explicitly linked the policy to the 'Director Independence' section, while the 2024 filing maintained this linkage, indicating a consistent approach to disclosing corporate governance practices. This consistency suggests a stable and transparent corporate governance framework, with clear and recurring references to director independence and committee structures, reinforcing the company’s commitment to regulatory compliance and board accountability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and overall interpretation. (1) It correctly identifies that BK disclosed its 'Business Relationships and Related Party Transactions Policy' consistently across 2022, 2023, and 2024, and links this to corporate governance disclosures. The placement under 'Corporate Governance and Board Information' is accurately noted, though the LLM slightly mischaracterizes the location by referencing 'Item 1 - Election of Directors - Corporate Governance and Board Information' of the Proxy, whereas the ground truth specifies 'Item 13' of the 10-K. This is a minor structural inaccuracy but does not undermine the core correctness. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of disclosure across years and ties it to director independence and committee structures. However, it omits specific mention of the three named committees (- Audit Committee, - Corporate Governance, Nominating and Social Responsibility Committee, and - Human Resources and Compensation Committee), which are key details in the ground truth and relevant to completeness. (4) Despite this omission, the answer captures the essential conclusion about stable and uniform corporate governance practices, making it contextually relevant and semantically close to the original. The slight lack of specificity on committee names prevents a top score in qualitative accuracy, but the overall reasoning and intent are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 436,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $679 million (2022) to $596 million (2023) and further to $508 million (2024), while the carrying value declined from $696 million (2022) to $603 million (2023) and then to $512 million (2024). This consistent decline in both fair and carrying values suggests a reduction in the company's investment in held-to-maturity debt securities over the three-year period, potentially reflecting a shift in investment strategy or a response to changing market conditions. The narrowing gap between fair and carrying values also indicates that the valuation assumptions, particularly for Level 2 inputs, have become more aligned with the amortized cost basis, suggesting stable or improving credit quality and market stability for these investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the 2022 fair value was $643 million, but the LLM states $679 million. Similarly, the 2022 carrying value was $641 million, not $696 million as claimed. The 2023 and 2024 values for both fair and carrying amounts are correct ($596M/$508M fair value; $603M/$512M carrying value). These discrepancies in the 2022 figures undermine the accuracy of the trend analysis. (2) Calculations and comparisons based on incorrect 2022 numbers will be flawed. For example, the implied decline from 2022 to 2023 in fair value is $83 million in the LLM answer vs. the correct $47 million drop per ground truth. This affects the interpretation of the trend's magnitude. (3) The qualitative reasoning is sound: the LLM correctly infers a reduction in investment in held-to-maturity securities and notes the narrowing gap between fair and carrying values, linking it to improved market transparency or credit quality. It also appropriately discusses valuation assumptions, though it does not mention the key point in the original answer about the shift away from Level 3 inputs, which is a notable omission in the multi-hop synthesis. (4) Contextual relevance is high—the answer addresses all parts of the question, uses correct entities (UnitedHealth Group, correct years, correct metric), and provides a logical interpretation. However, the major numerical errors in the base year data reduce confidence in the factual foundation, warranting a moderate correctness score of 6 despite otherwise coherent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 440,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "PayPal's exposure to bad transactions through its BNPL loan receivables increased concerns from 2022 through 2024, particularly as the company faced risks related to fraud, abusive behaviors, and rising non-payment rates. In 2022, PayPal highlighted the risk of account defaults and the potential for charge-offs, especially with its U.S. consumer credit products and merchant financing, as underwriting models and economic conditions could lead to higher delinquencies. By 2023, these risks were compounded by the company's decision to offload a significant portion of its BNPL exposure through a €40 billion agreement to sell U.K. and European BNPL receivables, which marked a strategic shift toward risk mitigation by reducing its balance sheet exposure to potentially delinquent loans. The forward-flow arrangement also aimed to offload future receivables, signaling a long-term strategy to limit bad transaction risk. In 2024, PayPal continued to emphasize its reliance on third-party funding and the regulatory uncertainties surrounding loan receivables, reinforcing that its risk mitigation strategy involved diversifying funding sources and limiting direct exposure to credit risk through asset sales and partnerships. Overall, the evolution from 2022 to 2024 reflects PayPal's proactive approach to managing BNPL-related risks by offloading portfolios, enhancing third-party collaboration, and adapting to regulatory and economic uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal highlighted risks of defaults, fraud, and abusive behaviors in 2022; in June 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL receivables; by 2024, it continued to emphasize risks, noting conditions on the sale. The €40 billion figure is correctly cited, and the timing (2023 agreement) is accurate. (2) Quantitative accuracy is perfect: the €40 billion amount is correctly reported, with no miscalculations. (3) The multi-hop reasoning is sound—LLM synthesizes risk disclosures from 2022, the strategic 2023 asset sale, and ongoing 2024 risk management, correctly interpreting the forward-flow structure and its risk mitigation intent. (4) The LLM adds slight elaboration (e.g., 'third-party funding', 'regulatory uncertainties') not in the original answer, but these are contextually reasonable and do not contradict the ground truth. The only minor gap is that the original emphasizes the *conditional nature* of the 2024 benefits more explicitly, which the LLM mentions indirectly via 'regulatory uncertainties' but could have stated more precisely. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 374,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron's upstream production volumes in Myanmar declined from 17,000 barrels per day (17 MBD) in 2022 to 15,000 barrels per day (15 MBD) in 2023, as shown in Chunk 1. By 2024, production in Myanmar ceased entirely, as explicitly stated in Chunk 2, which notes that Chevron withdrew from Myanmar in April 2024. This operational exit reflects a strategic shift to divest from politically and economically sensitive regions, aligning with Chevron's broader focus on more stable and profitable operations. The decline and eventual cessation of production in Myanmar are consistent with the company's asset rationalization efforts, as seen in the sale of other non-core assets in recent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Chevron's upstream production volumes in Myanmar as 17 MBD in 2022 and 15 MBD in 2023, and accurately states that production ceased in April 2024 due to Chevron's withdrawal. These figures and dates match the ground truth exactly. (2) All numeric values and dates are correct—17,000 barrels/day = 17 MBD, 15,000 barrels/day = 15 MBD—and the timeline (decline from 2022 to 2023, full exit in April 2024) is accurately represented. There are no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes production data from 2022–2023 with the 2024 exit event and infers a strategic shift. The original answer cites 'portfolio optimization and risk management' as the strategic rationale; the LLM answer describes it as 'divest[ing] from politically and economically sensitive regions' and 'asset rationalization,' which is semantically equivalent and well-reasoned given the context. (4) The only reason for not awarding a perfect 10 is minor wording difference in framing the strategic shift—'portfolio optimization and risk management' is slightly more precise than the LLM's broader phrasing—but the interpretation is logically supported and contextually appropriate. All other aspects—factual accuracy, completeness, entity recognition (Chevron/CVX, Myanmar, upstream production), and relevance—are fully correct and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 390,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "From 2022 to 2024, the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment declined from 24% of TI revenue in 2022 to 15% in 2023 and further to 20% in 2024. This fluctuation, particularly the drop in 2023, suggests a potential shift in TI's strategic focus away from traditional consumer computing markets, possibly in response to changing demand or a reallocation of resources toward higher-growth areas like automotive and industrial sectors. However, the partial recovery in 2024 indicates a continued, though diminished, role in the consumer computing market, reflecting a balanced but evolving strategic positioning.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2024 percentage. According to the ground truth, the Personal Electronics segment was 20% of TI's revenue in 2024, up from 15% in 2023. However, the LLM incorrectly states that the contribution 'declined... to 15% in 2023 and further to 20% in 2024', which implies a continued decline when 20% is actually an increase from 15%. This misrepresents the trend as a fluctuation with a partial recovery, whereas the ground truth shows a decline from 24% (2022) to 15% (2023), then a rebound to 20% (2024). The 2022 and 2023 figures are correct, but the interpretation of the 2024 number is flawed. (2) The numbers for 2022 (24%) and 2023 (15%) are accurate, but the use of 'further to 20%' incorrectly suggests a continuation of the downward trend when it is actually a rebound. The calculation of directionality is wrong. (3) The multi-hop reasoning is partially sound—TI is indeed shifting focus toward automotive and industrial markets—but the LLM fails to note that PC & Notebooks became a lower priority within the segment in 2024 despite the segment's revenue share rebounding. The strategic inference is plausible but not fully aligned with the ground truth, which emphasizes a continued de-emphasis on PC & Notebooks even as the segment recovers slightly. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of revenue contribution and strategic implications—and attempts synthesis across years. However, due to the misstatement of the trend in 2024, the correctness score is reduced to 5, as the core quantitative narrative is partially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 456,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall matters remained largely consistent from 2022 through 2024, with no material accruals or known liabilities reported in any of the periods. As of December 31, 2022, and reiterated in 2023 and 2024, GM stated it was unable to estimate any reasonably possible material loss or range of loss from these indemnification obligations, either directly or through claims by Stellantis. GM indemnified Stellantis for an immaterial amount for certain recalls, including Takata inflator-related recalls in legacy Opel vehicles, and while future indemnification for additional Takata recalls was possible, GM considered it remote. These obligations were subject to time limitations, thresholds, and/or caps, and no material accruals were recorded in 2022, 2023, or 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and conveys that GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall matters remained immaterial throughout 2022–2024, with no material accruals recorded. It correctly notes the immaterial payment for Takata-related recalls and that future indemnification was considered remote. However, it misses a key evolution highlighted in the ground truth: the increasing specificity of obligations over time, particularly the 2024 disclosure of accruals related to the European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era. While the LLM states 'no material accruals were recorded' (which is consistent, as the amount was immaterial), it fails to mention this new regulatory exposure that emerged in 2024, which represents a qualitative shift in risk disclosure. Additionally, the ground truth notes that in 2023, GM disclosed indemnification for emissions claims, product liabilities, and recalls—specific categories not mentioned in the LLM answer. The LLM simplifies this into a general reference to recalls, missing nuance. Quantitatively, there are no errors: all references to immaterial amounts, inability to estimate losses, and remote likelihood are factually aligned. The reasoning is sound but lacks depth in capturing the evolving nature of disclosures across years, which is central to the question about 'how obligations evolved.' Contextually, the answer is highly relevant and addresses the main thrust of indemnification trends, but omits key developments that show increasing regulatory scrutiny over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Depends_On]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 445,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower Corporation issued the 1.450% Senior Notes due 2026 on September 27, 2021, as documented in the Supplemental Indenture No. 10 in all three years' 10-K filings (2022, 2023, and 2024). The consistent inclusion of these notes in the exhibits across these years indicates that the issuance was a one-time event in 2021, and the notes remained outstanding through 2022, 2023, and 2024. This multi-year pattern reflects a stable debt management strategy, where American Tower Corporation maintained the issuance in its financial disclosures, suggesting a focus on long-term capital structure planning and transparency in its debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (September 27, 2021), the interest rate (1.450%), maturity year (2026), and the consistent reference to Supplemental Indenture No. 10 across 2022, 2023, and 2024 filings. These details align with the ground truth. The core conclusion about a stable debt management strategy is also accurate and supported. (2) All quantitative elements—dates, percentages, and exhibit references (implied via context)—are correct. The issuance date and interest rate match the ground truth exactly. While the LLM does not list the specific exhibit numbers (4.25, 4.22, 4.21) for each year, it correctly emphasizes continuity in documentation, which is semantically aligned. The omission of exact exhibit numbers is a minor detail that does not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer that the notes remained unchanged, indicating no refinancing or modification. This supports the conclusion of a stable debt strategy. The logic is coherent and consistent with the evidence. (4) The answer is contextually relevant, fully addressing both parts of the question: the evolution (or lack thereof) of the notes and the strategic implication. The only minor shortcoming is the lack of explicit mention of the changing exhibit numbers year-over-year, which slightly reduces completeness but does not undermine the overall accuracy. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 437,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolved from 2022 through 2024 with the introduction of updated deferred stock unit agreements and performance share unit agreements each year. In 2022, the company introduced the **2022 Form of Performance Share Unit Agreement**, as noted in the 2022 10-K. By 2023, the deferred stock unit agreements for directors under the 2019 Long-Term Incentive Plan remained referenced from prior filings, while no new performance share unit agreements were introduced in 2023. In 2024, the company introduced the **2021 Form of Performance Share Unit Agreement**, which had been previously filed in 2021, indicating a continuation of the 2021 structure into 2024 without introducing a new 2024-specific form. Thus, the evolution involved incremental updates to performance-based compensation structures under the 2019 plan, with new forms introduced in 2022 and 2021, but no new forms in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the '2022 Form of Performance Share Unit Agreement' was introduced in 2022, whereas the ground truth indicates that the 2019 forms were used in 2022, and the 2022 form was introduced in 2024. (2) It falsely claims that the '2021 Form of Performance Share Unit Agreement' was introduced in 2024, when the ground truth states the 2022 form was used in 2024—there is no mention of a 2021 form in the original answer. (3) It incorrectly asserts that no new performance share unit agreements were introduced in 2023, while the ground truth highlights the introduction of a new deferred stock unit agreement for directors in 2023, which the LLM fails to emphasize. (4) The LLM misrepresents the timeline and evolution: the original answer shows a progressive expansion of the 2019 plan with new forms in each year (2019 forms in 2022, director-specific 2023 form, 2022 PSU form in 2024), but the LLM incorrectly backdates forms and misattributes years. (5) The reasoning is flawed in that it suggests the 2021 form was 'continued into 2024,' which is unsupported by the ground truth and contradicts the stated progression. While the LLM correctly identifies the general theme of evolving use of the 2019 plan, the specific entity-date-agreement mappings are largely incorrect, leading to a low correctness score. Quantitative accuracy is poor due to repeated incorrect dates (2021, 2022, 2023, 2024) being misaligned with actual form introductions. Qualitative accuracy suffers from incorrect synthesis across years and forms. Contextual relevance is moderate because the answer addresses the right topic and structure but with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 475,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 through 2024, General Dynamics' Combat Systems segment consistently focused on aerostructures for next-generation missile subsystems, as highlighted in all three annual reports. In 2022, the segment emphasized its role in supplying critical components such as aerostructures, control actuators, and hypersonic rocket cases for both legacy and next-generation missiles. By 2023 and 2024, this focus remained central, with the Combat Systems segment maintaining a stable revenue contribution of 18% to 20% of consolidated revenue over the three-year period. This continuity underscores General Dynamics' strategic positioning as a key supplier in the modernization of U.S. missile systems, particularly in high-performance and advanced technologies like hypersonic capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent strategic focus on aerostructures within General Dynamics' Combat Systems segment from 2022 to 2024 and links it to next-generation missile subsystems, which aligns with the ground truth. However, there is a quantitative inaccuracy in the revenue percentage: the LLM states that the Combat Systems segment contributed '18% to 20%' over the period, claiming stability, while the ground truth specifies 20% in 2023 and a decline to 19% in 2024. The LLM incorrectly implies a stable 18–20% range, missing the specific 20% (2023) and 19% (2024) figures and introducing an unsupported 18% floor. This affects the precision of the financial trend. (2) The ground truth does not mention 'control actuators' or 'hypersonic rocket cases' in 2022, nor does it specify 'hypersonic capabilities' as a focus—these are plausible but unverified additions not present in the original data, reducing quantitative and qualitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly inferring a sustained strategic emphasis despite minor revenue shifts. It addresses both parts of the question—evolution over time and strategic positioning—demonstrating good qualitative synthesis. (4) Contextual relevance is high, as the answer directly addresses the evolution and strategic implications. The core conclusion about sustained positioning is supported, but the minor factual deviations in percentages and unverified technical details prevent a higher score. Overall, the answer is factually close and well-reasoned but contains measurable inaccuracies in reported figures and added specifics not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 470,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "From 2022 to 2024, Philip Morris International (PMI) maintained Jackpot as a key local cigarette brand in the Philippines, as highlighted in each year's 10-K filings. In 2022, Jackpot was listed among PMI’s important local brands in the Philippines, alongside Fortune, indicating its role in supporting market share in the region. By 2023, Jackpot remained a core local brand, with PMI continuing to emphasize its portfolio of both international and local cigarette brands to maintain strong market positions in key markets. In 2024, Jackpot was still cited as a significant local brand in the Philippines, showing its sustained strategic importance in PMI’s regional cigarette portfolio. This multi-year consistency suggests that Jackpot plays a stable, complementary role in PMI’s broader strategy, supporting market presence and volume in the Philippines, particularly as PMI continues to transition toward smoke-free products while maintaining cigarette operations in regulated markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Jackpot is correctly identified as a key local brand in the Philippines alongside Fortune in 2022, maintained in 2023 amid global restructuring, and still emphasized in 2024 despite PMI's smoke-free transition. There are no incorrect numbers, dates, or entities—this is a purely qualitative multi-year trend analysis, and no numerical data is missing or misrepresented. (2) Quantitative accuracy is perfect: although no specific figures (e.g., sales, market share) are provided in either answer, the temporal references (2022–2024) and contextual facts are consistent with the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of strategic positioning, infers continuity, and connects Jackpot’s sustained role to PMI’s broader dual strategy of maintaining cigarette brands in key markets while transitioning to smoke-free products. (4) The only minor shortcoming is that the LLM does not explicitly mention the expansion to 95 smoke-free markets or the emphasis on IQOS and ZYN by name in 2024, which slightly reduces qualitative completeness. However, it captures the essence—that Jackpot remains important even as PMI pushes smoke-free alternatives. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 391,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "Chevron's investment and operational focus in the Republic of Congo evolved significantly from 2022 through 2024, marked by a strategic shift from capital deployment to asset disposition. In 2022, the Republic of Congo was listed among Chevron's key operating areas, indicating active upstream operations. By 2023, Chevron continued to allocate capital in Africa, with approximately $0.7 billion spent on development activities in the region, including projects in Nigeria, Angola, and the Republic of Congo. However, in 2024, Chevron took a decisive step by selling its 31.5 percent nonoperated working interest in the offshore Haute Mer permit area and its 15.75 percent interest in the Republic of Congo portion of Lianzi in January 2025, signaling a withdrawal from direct operations in the country. This disposition reflects a broader strategic realignment, shifting focus from capital-intensive upstream projects in the region to divesting non-core assets and reallocating resources to higher-return opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Chevron's focus in the Republic of Congo from 2022 to 2024. It accurately notes the company's operational presence in 2022, capital deployment in 2023 via a $0.7 billion investment in African offshore and gas projects (including Congo), and the 2024 decision to sell its upstream assets—specifically the 31.5% nonoperated working interest in Haute Mer and 15.75% in Lianzi—with the transaction closing in January 2025. These facts align with the ground truth. (2) Quantitative accuracy is perfect: the $0.7 billion figure, 31.5%, 15.75%, and January 2025 transaction date are all correct. The mention of Nigeria and Angola as part of the broader African investment is additional context not contradicted by the ground truth. (3) The multi-hop reasoning is sound—synthesizing operational status, capital deployment, and eventual divestiture across three years. The only minor shortcoming is the phrasing 'in 2024, Chevron took a decisive step by selling...' when the sale was announced or executed in January 2025, which may imply the transaction occurred in 2024. However, the answer correctly states the sale happened in January 2025, so the timeline remains factually accurate. (4) The answer is contextually excellent, directly addressing capital deployment and asset disposition as asked. The qualitative score is 9 due to slightly stronger emphasis on strategic realignment beyond the scope of the original answer, but this does not detract from factual correctness. Overall, the response is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 441,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment of outdoor lighting contracts as operating leases evolved in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries. In 2022, Mississippi Power reported that the undiscounted cash flows from these contracts were immaterial, and Southern Power treated payments under PPAs as contingent rents not reflected in maturity tables. By 2023, scheduled payments from outdoor lighting contracts were included in maturity analyses for Alabama Power and Southern Power, with lease income allocated to wholesale revenues. In 2024, the treatment expanded to include Georgia Power, with lease income from PPAs also reported in wholesale revenues and scheduled payments under initial terms of outdoor lighting contracts included in maturity analyses across all three subsidiaries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Mississippi Power considered outdoor lighting contracts immaterial (though LLM adds 'undiscounted cash flows'—a plausible detail not contradicted by ground truth); by 2023, scheduled lease payments were included in maturity analyses (LLM correctly identifies Alabama Power and Southern Power, though ground truth emphasizes Mississippi Power in 2022 and broader rollout by 2023); by 2024, Georgia Power was included and lease income from PPAs was allocated to wholesale revenues across subsidiaries. (2) There are no numeric inaccuracies—no specific dollar amounts are cited in either answer, so scoring is based on qualitative descriptors like 'immaterial', which are used appropriately. (3) Multi-hop reasoning is sound: the LLM synthesizes changes over time and across subsidiaries (Mississippi Power, Alabama Power, Georgia Power, Southern Power) and connects lease treatment to revenue allocation and disclosure practices. One minor discrepancy: the original answer highlights Mississippi Power in 2022 and the 2023 shift toward structured disclosures via maturity analyses, while the LLM attributes 2023 maturity disclosures to Alabama Power and Southern Power—this is not incorrect, but slightly shifts emphasis. (4) The LLM answer captures the evolution in materiality (from immaterial to structured disclosure), revenue allocation (lease income in wholesale revenues), and lease payment structure (inclusion in maturity tables across subsidiaries), fully addressing the question. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent alignment with ground truth, with only a slight nuance difference in subsidiary emphasis in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 494,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco's 3.50% Note, maturing on June 15, 2025, had a consistent carrying amount of $500 million across fiscal years 2022, 2023, and 2024. The effective interest rate increased from 3.20% in 2022 to 6.38% in 2023 and further to 6.66% in 2024. This progression indicates a rising cost of debt for Cisco, reflecting higher market interest rates over time and the impact of interest rate hedging adjustments. The stable carrying amount suggests no refinancing or principal changes, while the increasing effective rate highlights the impact of market conditions on debt valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the carrying amount of $500 million for the 3.50% Note is consistent across fiscal years 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. These match the ground truth exactly. (2) All numeric values are correct and properly formatted; no calculation errors are present. The progression of rates and stable carrying amount are accurately reflected. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years for the same debt instrument and draws a logical conclusion about market conditions and debt valuation. The mention of 'interest rate hedging adjustments' adds contextual insight not in the original answer but is plausible and does not contradict the ground truth. (4) The answer is semantically equivalent to the original, with slightly enhanced interpretation (e.g., 'rising cost of debt', 'impact of hedging'), which improves clarity without introducing inaccuracies. The only minor deduction is for adding a maturity date (June 15, 2025) not present in the ground truth, which, while potentially correct, is unverified and not part of the original data. Otherwise, the response is factually complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 376,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group's exposure to Unsecured Notes - 35A remained consistent at $750,000 (in thousands) from 2022 through 2024, with a fixed interest rate of 2.65% and a maturity date of July 15, 2030. This three-year stability in the face amount and terms of the note suggests a deliberate long-term debt management strategy focused on maintaining a predictable and extended debt maturity profile. By retaining this note and not refinancing or retiring it, SPG appears to be prioritizing financial stability and minimizing refinancing risk in the near term, aligning with a conservative approach to long-term capital structure management.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent exposure to Unsecured Notes - 35A at $750 million across 2022–2024, the 2.65% interest rate, and the July 15, 2030 maturity date. However, it incorrectly states the amount as '$750,000 (in thousands)', which implies $750 million only if interpreted correctly (i.e., $750,000 thousand = $750 million). While this notation is standard in financial filings, the phrasing is ambiguous and could mislead readers unfamiliar with the convention, constituting a minor quantitative inaccuracy. (2) All other numbers—interest rate and maturity date—are correct. No calculations were required, but the synthesis of consistent terms over three years is accurate. (3) The reasoning is sound: the LLM correctly infers that maintaining this note reflects a strategy of stability and reduced refinancing risk. It aligns with the ground truth’s conclusion about deliberate long-term financing, though it omits mention of contrasting portfolio changes (e.g., new 2024 $1B issuance or credit facility refinancing), which weakens the multi-hop synthesis slightly. (4) Despite the minor formatting issue with the dollar amount and the omission of broader portfolio context, the core facts are correct, the logic is strong, and the answer is highly relevant. Thus, correctness is high but not perfect due to the potential ambiguity in numerical presentation and incomplete contextual contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 396,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model from 2022 through 2024, aligning them with its four sustainable competitive advantages. These advantages—manufacturing and technology strength, a broad product portfolio, extensive market channels, and product diversity—have been consistently highlighted across all three years, underscoring Embedded Processing Products as a key driver of opportunity per customer and value for investments. The strategic emphasis has remained stable, with TI leveraging these products to enhance supply chain control, customer access, and long-term returns, reinforcing their role in sustaining free cash flow per share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, positioning them as part of its sustainable competitive advantages. The phrasing about 'opportunity per customer and value for our investments' is correctly attributed, though the LLM paraphrased it rather than quoting verbatim. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect—dates (2022–2024) are accurate and consistently used. (3) The multi-hop reasoning is sound: the answer synthesizes TI’s strategic framing across three years and correctly links Embedded Processing Products to the broader competitive advantages. It accurately identifies the four advantages (manufacturing strength, broad portfolio, market channels, product diversity), though the original answer only explicitly highlights the 'broad portfolio' as the context for the quoted phrase. This expansion is reasonable but slightly overgeneralizes the linkage of embedded processing to all four advantages, whereas the ground truth focuses on its role within the broad portfolio advantage. (4) Despite this minor overextension, the core message—that TI consistently emphasized embedded processing as a key strategic element tied to long-term value creation—is preserved. The answer is contextually relevant, complete, and semantically equivalent to the original, warranting a high correctness score with only a slight deduction for imprecision in mapping the product line to all four advantages rather than the specific portfolio advantage emphasized in the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 464,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2024, CMCSA expanded its wireless shared data plan offerings by enhancing plan flexibility and extending its international reach. In 2022, CMCSA provided shared data plans as part of bundled residential broadband services, allowing customers to choose between unlimited, shared, or per-gigabyte plans. By 2023, the company expanded its wireless services to the United Kingdom under MVNO rights and continued offering shared data plans to both domestic and international customers, with international users having access to various gigabyte plans. In 2024, CMCSA introduced prepaid unlimited data plans under the NOW brand for domestic customers and further refined its international offerings, maintaining flexibility in payment options and device financing terms. These developments reflect a strategic focus on both domestic and international market expansion while enhancing customer choice in data plan structures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that deviate from the ground truth. While it correctly identifies the presence of shared data plans in 2022 as part of bundled residential broadband services, it incorrectly states that in 2022 customers could already choose between unlimited, shared, or per-gigabyte plans. According to the original answer, this emphasis on flexibility (explicitly highlighting customer choice among plan types) was introduced in 2023, not 2022. Additionally, the LLM claims that in 2023, CMCSA expanded to the United Kingdom under MVNO rights and offered shared data plans internationally—this is incorrect. The ground truth states that international expansion occurred in 2024, not 2023. Furthermore, the LLM incorrectly attributes prepaid unlimited data plans under the NOW brand to domestic customers in 2024, while the original answer specifies these were introduced for international markets. (2) There are no explicit numerical values (e.g., dollar amounts, data caps, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the misplacement of key events across years (2022 vs 2023 vs 2024) affects temporal accuracy, which is critical in trend-based questions. (3) The multi-hop reasoning is partially sound—the model attempts to trace evolution over time and considers both flexibility and international dimensions—but it fails in synthesizing the correct sequence and geographic scope of offerings. The conflation of domestic and international rollouts undermines the validity of the synthesis. (4) Despite these errors, the answer remains contextually relevant, addressing the core themes of plan flexibility and international expansion. However, due to significant factual and chronological inaccuracies affecting key claims, the correctness and qualitative accuracy scores are reduced to 5 and 5 respectively. Quantitative accuracy is scored a 6 because while no numbers are wrong, the temporal misalignment of events impacts the precision of the timeline. Contextual relevance is high (8) as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 574,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal's exposure to abusive behaviors increased in complexity from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes. In 2022, the company highlighted the risk of non-payment among credit product users and the potential for fraud through fictitious accounts, stolen identities, and synthetic personal information. By 2023, PayPal expanded on these risks, noting the challenges of managing third-party relationships and the deployment of large-scale fraud attacks that are difficult to detect. In 2024, the company emphasized the evolving nature of fraud, including account takeovers and fraudulent transactions, as well as the growing reliance on third-party lenders and processors, which introduces additional operational and compliance risks. This progression indicates a rising complexity in risk management within PayPal’s digital payments ecosystem, driven by the sophistication of fraud schemes and the expanded use of third-party partnerships in its credit and payment operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, with accurate qualitative progression and strong contextual relevance. (1) Factual correctness: The answer correctly identifies increasing complexity in fraud risks over time, including fictitious accounts, synthetic identities, account takeovers, and third-party fraud. It accurately reflects the growing challenges tied to credit products and third-party relationships. However, it omits the specific €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, a key quantitative and strategic detail present in the ground truth. This omission affects completeness but does not distort the overall narrative. (2) Quantitative accuracy: There are no incorrect numbers or dates stated—only a missing figure (€40 billion). Since no false quantitative claims are made, the quantitative accuracy remains high. (3) Multi-hop reasoning: The LLM synthesizes risk trends across years correctly, showing an understanding of how threats evolved and how third-party dependencies increased risk complexity. It links credit products, fraud tactics, and operational risks logically, though without referencing the specific BNPL transaction that introduced new third-party exposure. (4) Semantic equivalence: The wording differs but the meaning aligns closely with the original, especially in describing synthetic identity fraud, account takeovers, and reliance on third parties. The conclusion about growing risk management complexity is valid and well-supported. The omission of the €40 billion BNPL sale is a notable gap in completeness but does not undermine the overall correctness of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 474,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "GILD's utilization of its El Segundo, California facility has remained focused on cell therapy manufacturing from 2022 through 2024, with consistent emphasis on both clinical and commercial processing activities. In 2022, the facility was identified as one of GILD’s principal manufacturing sites, supporting its broader cell therapy operations. By 2023, the facility was explicitly noted as being used for clinical and commercial manufacturing and processing of cell therapy products, reflecting ongoing strategic investment in this area. In 2024, the El Segundo facility retained the same role, indicating continuity in its function despite the company’s broader manufacturing and supply chain developments. This sustained focus underscores GILD's commitment to strengthening its cell therapy manufacturing capabilities as part of its long-term strategic and operational plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: El Segundo is consistently described as a key facility for clinical and commercial cell therapy manufacturing from 2022 to 2024. The evolution correctly reflects continuity in function and strategic importance. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning across years and strategic context is sound: the LLM synthesizes information across 2022, 2023, and 2024 to show sustained focus, correctly identifying the facility’s role without introducing inaccuracies. The only minor gap is that the original answer includes additional context in 2024 about third-party manufacturers and supply chain risk management, which the LLM omits. This does not distort the answer but slightly reduces completeness. (4) The LLM answer is semantically equivalent in its core claims and fully addresses the question about evolution and strategic investment. Wording differs but meaning matches. Contextual relevance is perfect—directly focused on GILD, El Segundo, cell therapy, and strategic facility use over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 363,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Costco's 2.750% Senior Notes, issued on May 18, 2017, matured on May 18, 2024, as noted in the 2022, 2023, and 2024 10-K filings. The consistent mention of these notes across all three filings indicates that the maturity date remained unchanged, and the company maintained this debt obligation throughout the period. The fact that the notes were due in 2024, and no refinancing or restructuring was indicated in the filings, suggests that Costco likely planned for the debt to mature as scheduled, reflecting a disciplined and stable debt management strategy focused on long-term obligations and timely repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Notes mature on May 18, 2024, and this date is consistently reported in the 2022, 2023, and 2024 filings. The issuance date (May 18, 2017) is an additional but plausible detail not contradicted by the ground truth. (2) The answer correctly observes no refinancing or extension occurred, which matches the ground truth's assertion of a static maturity structure. (3) The reasoning is sound: the lack of change across filings supports the conclusion of a deliberate, disciplined debt strategy focused on predictable repayment. The LLM infers a 'stable debt management strategy' and 'timely repayment,' which is semantically equivalent to the ground truth's 'deliberate capital structure decision' and 'predictable debt repayment.' (4) The only minor gap is that the ground truth emphasizes the *implication* of maintaining the same maturity without modification across years as a strategic choice, which the LLM captures well but slightly less explicitly. However, the core multi-hop synthesis—linking consistent disclosure over time to strategic debt management—is correctly executed. No factual errors; wording differences are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 363,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron's natural gas production volumes associated with Angola LNG increased from 7,107 million cubic feet per day in 2022 to 7,148 million in 2023 and further to 7,569 million in 2024. This upward trajectory, despite asset divestitures in other regions such as Indonesia and Canada, indicates that Chevron is prioritizing and maintaining or expanding its gas production strategy in Africa, particularly through its stake in Angola LNG. The consistent inclusion of Angola LNG in Chevron's affiliate production volumes across the three years also highlights its strategic importance in Chevron's global gas portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all production volumes are accurate: 7,107 million cubic feet per day in 2022, 7,148 in 2023, and 7,569 in 2024—correctly reported with no calculation or transcription errors. Minor formatting variation (omitting 'per day' in 2023 and 2024) does not affect meaning, as the unit is established in the first mention. (2) The answer completely addresses both parts of the question: it traces the evolution of production volumes from 2022 to 2024 and interprets the trend in the context of Chevron's African gas strategy. (3) Entity accuracy is perfect: Chevron, Angola LNG, and correct years are identified; references to divestitures in Indonesia and Canada align with known strategic moves and support the contrast in regional focus. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that increasing volumes in Angola, despite global divestitures, signal a strategic prioritization of gas in Africa. The mention of Angola LNG's consistent inclusion in affiliate production volumes adds contextual depth. (5) Semantic equivalence is achieved—the LLM conveys the same core facts and implications as the original answer, with slightly enhanced detail that remains factually grounded. All scores are 10 due to full factual accuracy, completeness, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 386,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolved significantly from fiscal year 2022 to 2024, as reflected in the gains (losses) reported in the Statements of Operations. In 2022, Cisco recorded a loss of $92 million, which turned into a gain of $58 million in 2023 and further increased to $91 million in 2024. This progression indicates a shift from a negative impact on operating expenses to a positive contribution, suggesting that the company's deferred compensation strategy became more aligned with favorable market performance over time. The increasing gains also highlight the sensitivity of the program to market-linked volatility, as the value of the swaps fluctuated with underlying market conditions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for the three fiscal years—$92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—matching the ground truth exactly. Minor phrasing differences (e.g., 'gains (losses)' vs. explicit negative/positive values) do not affect factual accuracy. (2) All numbers are accurate and consistent with the original answer; no calculations are required beyond correct reporting of values, which the model performs precisely. Format variations (e.g., '$92 million' vs. '$92M') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers the strategic implication—that the shift from loss to increasing gains reflects improved market alignment and sensitivity to market-linked volatility. It accurately captures the transformation from net liability to net benefit, even using different but equivalent phrasing ('negative impact on operating expenses to positive contribution'). (4) The answer fully addresses both parts of the question: the evolution of financial exposure and its implications for strategy and volatility. The reasoning is logical, contextually grounded, and semantically equivalent to the ground truth. All scores are maximized due to complete factual correctness, precise numerical reporting, strong qualitative reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 399,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From 2022 to 2024, Lowe's significantly evolved its approach to supplier practices related to environmental and human rights standards. In 2022, the company updated its human rights policy to address modern slavery and reinforced its Vendor Code of Conduct with enhanced environmental standards, while also committing to a science-based net-zero target and expanding monitoring of supplier practices. By 2023, Lowe's introduced a more robust wood sourcing policy with risk-based country classifications and a new forestry grievance process, demonstrating enhanced monitoring and policy rigor. In 2024, the company further strengthened its supplier monitoring through a more comprehensive risk-based approach and continued to expand its portfolio of independently certified sustainable products. These developments reflect a clear progression in policy updates, monitoring enhancements, and third-party certifications across the supply chain to uphold environmental and human rights standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's evolved its supplier practices from 2022 to 2024 with policy updates (Vendor Code of Conduct, human rights policy, wood sourcing), monitoring enhancements (risk-based frameworks, grievance process), and expansion of third-party certified products. The years 2022, 2023, and 2024 are correctly attributed to specific developments. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound—information is synthesized across years and policy domains (environmental standards, human rights, wood sourcing, certifications). The only minor discrepancy is that the LLM mentions a 'science-based net-zero target' and 'modern slavery' updates in 2022, which are not present in the original answer; however, these are plausible extensions of the human rights and environmental policies and do not contradict the ground truth. (4) The answer fully addresses the question’s three dimensions: policy updates, monitoring enhancements, and third-party certifications. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-attribution of 2022 details, but remains excellent in contextual relevance and fully accurate in timing and progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 394,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services intensified, particularly with the advancement of 4G and 5G technologies, including fixed wireless access (FWA). In 2022, CMCSA noted that wireless telecom companies were offering 4G and 5G broadband services, competing with its traditional broadband offerings. By 2023, the filings highlighted that wireless companies were deploying 5G fixed wireless networks and 4G/5G wireless broadband services, enabling them to offer high-speed internet via devices like smartphones, tablets, and fixed wireless routers. In 2024, the competitive landscape further evolved as wireless telecom providers, such as AT&T, T-Mobile, and Verizon, continued to leverage 5G FWA to offer both stand-alone and bundled services, directly challenging CMCSA’s broadband and wireless offerings. Additionally, these competitors engaged in bundling strategies, offering unlimited data-usage plans and integrating DTC streaming services, which CMCSA acknowledged as a growing competitive pressure. The filings also identified specific competitors, including AT&T, T-Mobile, and Verizon in the U.S., and Virgin Media and BT in the U.K., as key players in this evolving technological and strategic landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the evolution of competitive threat from 2022 to 2024 is accurately described with respect to 4G/5G technology, fixed wireless access (FWA), and bundling strategies. The named competitors—AT&T, T-Mobile, Verizon in the U.S., and Virgin Media and BT in the U.K.—are correctly identified, though the original answer only explicitly mentioned U.S. competitors (AT&T, T-Mobile, Verizon); the addition of U.K. firms is plausible but not confirmed in the ground truth, representing a minor overextension. (2) There are no numeric inaccuracies—no specific numbers (e.g., dollar amounts, percentages) are present in either answer, so the absence or presence of such is not an issue. Dates (2022, 2023, 2024) are used correctly and consistently. (3) Multi-hop reasoning is sound: the LLM synthesizes technological evolution (4G to 5G FWA), competitive deployment, and strategic bundling (including DTC streaming) across years and companies, correctly inferring increasing pressure on CMCSA. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., devices like tablets and routers, unlimited data plans), which enhances clarity without introducing error. The only minor deviation is the inclusion of Virgin Media and BT, which, while reasonable competitors, were not specified in the ground truth response. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction for unverified entity inclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 439,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal's exposure to margin risk remained consistent from 2022 through 2024, as it continued to bear full margin risk for payment transactions due to its role as principal in these arrangements, as outlined in all three annual reports. The company maintains control over pricing, setting fees independently of the costs incurred through third-party payment processors, which are recognized as transaction expenses. Additionally, PayPal's use of tiered pricing based on transaction volume and the provision of revenue incentives to customers, as detailed in 2022 and 2023 filings, introduced variability in its revenue streams, impacting margin stability. The 2024 filing reaffirmed these practices, showing no material changes in how PayPal manages pricing and cost structures. This multi-year trend highlights PayPal's strategic autonomy in pricing decisions and its deliberate assumption of margin risk, reflecting a calculated approach to balancing customer incentives, transaction volume growth, and cost management through its extensive use of payment processors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal bore full margin risk from 2022–2024, acted as principal, set fees independently, and recognized payment processor costs as transaction expenses. The discussion of revenue incentives (discounts, rebates) in 2022 and 2023 is accurately reflected, and the 2024 continuity is correctly noted. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all references to years and financial structures are correct—thus scored as 10. (3) The multi-hop reasoning across years and strategic elements (pricing, incentives, cost management) is sound. The LLM correctly synthesizes PayPal’s consistent risk-bearing role and control over pricing, though it omits the specific 2024 detail about contractual compensation from sellers for fraud or counterfeiting, which slightly reduces completeness. This is a minor omission affecting qualitative depth but not core correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of margin risk, pricing strategy, processor use, and incentives. The conclusion about strategic autonomy and disciplined cost management is well-supported. Overall, the answer demonstrates strong understanding and synthesis, meriting a 9/10 for correctness due to the missing 2024 revenue stream nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 402,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco's accounting treatment and disclosure around free-rent periods in lease agreements remained consistent from fiscal year 2022 through 2024, with no material changes in policy. In all three years, the Company recognized free-rent periods and step-rent provisions on a straight-line basis over the original lease term and any extension options that Costco was reasonably certain to exercise from the date it obtained control of the property. The lease term assumptions included the non-cancelable period plus any renewal options that the Company was reasonably certain to exercise, directly impacting the calculation of the right-of-use (ROU) asset valuation. The ROU assets and lease obligations were initially measured using the present value of future lease payments, discounted at the Company’s incremental borrowing rate, as the implicit rate in the leases was not readily determinable. This consistent approach ensured that the ROU asset valuation reflected the full expected lease term, including probable extensions, thereby providing a more accurate representation of the Company’s lease liabilities and assets across all three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Costco consistently applied the same accounting treatment from fiscal years 2022 to 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term, including reasonably certain extension options. The use of the incremental borrowing rate for discounting lease payments is correctly noted. (2) There are no numeric inaccuracies—though no specific dollar amounts or percentages are involved, all qualitative financial accounting metrics (e.g., ROU asset valuation, lease term assumptions) are accurately described. (3) The multi-hop reasoning across fiscal years is sound: the LLM correctly synthesizes that the policy remained stable over time, which is the core of the question. (4) The only minor shortcoming is that the LLM omits the specific 2023 and 2024 disclosure nuances mentioned in the ground truth—namely, the clarification in 2023 about variable lease payments tied to price indices or sales volume, and the 2024 note on absence of material residual value guarantees. While these are not central to the main evolution (which was stability), their omission slightly reduces completeness. However, the answer still captures the essential conclusion: no material change in policy or impact on ROU asset valuation. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses lease term assumptions and ROU asset impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Includes]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 421,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal's exposure to margin risk remained consistent from 2022 to 2024, as it continued to bear full margin risk in its transaction pricing model, where it acts as the principal in payment transactions. Across all three years, PayPal retained control over pricing decisions, independent of the costs incurred through payment processors or financial institutions, and recognized these fees as transaction expenses. The contract structure, characterized by open-ended, transaction-level agreements with automatic renewal and tiered pricing based on volume, did not change materially across the years, maintaining the same risk exposure. Additionally, in 2024, PayPal continued to recognize fees on a gross basis and retained primary responsibility for fulfillment, consistent with its 2022 and 2023 disclosures, reinforcing its ongoing margin risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core continuity in PayPal's margin risk exposure from 2022 to 2024, accurately stating that PayPal continued to bear full margin risk, act as principal, recognize fees on a gross basis, and treat processor costs as transaction expenses. It also correctly notes the stability of the contract structure with tiered, volume-based pricing and open-ended agreements. These elements align with the ground truth and reflect accurate entity and temporal understanding (PayPal, 2022–2024, transaction pricing model, payment processors, contract structure). However, the LLM omits two key qualitative developments mentioned in the original answer: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized, which introduced variability into margins, and (2) the 2024 adoption of ASU 2023-07 for segment reporting, which increased transparency and could affect margin risk analysis at the segment level. While the fundamental stability of the pricing model is correctly emphasized, the absence of these nuances reduces completeness and weakens the multi-hop synthesis across all three years. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), and the reasoning is logically sound where present, but the omission of evolving operational nuances limits qualitative accuracy. The response remains highly relevant to the question, addressing the main structural aspects of margin risk, hence high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 413,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco's 5.90% Note, with a maturity date of February 15, 2039, has consistently maintained an effective interest rate of 6.11% from fiscal years 2022 through 2024, as shown in all three 10-K filings. The utilization of the note remained unchanged at $2,000 million across all periods. This consistency in both the effective interest rate and the outstanding amount indicates that Cisco has not refinanced or modified this long-term debt instrument during the period, suggesting a stable and long-term financing strategy. The unchanged effective rate, despite broader market fluctuations reflected in other notes, implies that Cisco has locked in favorable long-term financing costs for this debt, contributing to predictable interest expenses and supporting its capital structure management.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: the 5.90% Note has a $2,000 million outstanding balance and a constant effective interest rate of 6.11% across fiscal years 2022–2024. The maturity date (February 15, 2039) is correctly specified, adding precision not strictly required but factually consistent. (2) Quantitative elements—dollar amount ($2,000 million), interest rate (6.11%), and time period (2022–2024)—are all accurate and match the original answer exactly. No calculations were needed, but the consistency across years is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that the lack of change in principal or effective rate indicates no refinancing or modification, reflecting a stable long-term debt strategy. (4) The qualitative interpretation—that Cisco has locked in predictable financing costs despite market fluctuations—is a reasonable and contextually appropriate extension of the data, enhancing the answer without introducing inaccuracies. The response addresses all parts of the question: evolution over time (no change), utilization (stable $2B), effective rate (steady at 6.11%), and implications for debt strategy and financing costs. Semantic equivalence is strong, with slightly more detailed phrasing but no deviation in meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 392,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Lowe's private brand 'Kobalt' has consistently been highlighted in its intellectual property disclosures, reflecting its strategic importance as a key private label offering. In fiscal 2022, 'Kobalt' was listed among other private brand product names, such as 'STAINMASTER' and 'allen+roth,' under Lowe's trademark portfolio, indicating its foundational role in the company’s branding strategy. In fiscal 2023, the mention of 'Kobalt' remained consistent within the intellectual property section, emphasizing its continued recognition as a valuable asset under Lowe's subsidiaries. By fiscal 2024, the disclosure structure and language remained largely unchanged, with 'Kobalt' again listed as a key private brand, suggesting a sustained strategic emphasis on the brand’s intellectual property and market presence. While no direct changes in positioning are explicitly stated, the consistent inclusion of 'Kobalt' in these disclosures across three years underscores its enduring significance in Lowe's private brand strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Kobalt is consistently mentioned in Lowe's intellectual property disclosures from fiscal 2022 to 2024 as a key private brand, listed alongside 'STAINMASTER' and 'allen+roth' in 2022, and retains its position in 2023 and 2024. There is no indication of increased or decreased emphasis, which the LLM correctly interprets as sustained strategic importance. (2) No numeric data is involved, so quantitative accuracy is not applicable beyond correct use of fiscal years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—synthesizing disclosures across three years to infer consistency in strategic positioning. The LLM correctly infers that unchanged disclosure language implies stable strategic role, which matches the ground truth's conclusion. (4) The only minor gap is that the LLM slightly overemphasizes 'subsidiaries' in 2023 ('valuable asset under Lowe's subsidiaries'), which is not mentioned in the ground truth; however, this does not contradict it and is a minor interpretive addition. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong qualitative reasoning with full contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 354,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon Property Group's Unsecured Notes - 37B had a face amount of $700,000 in 2022 with an interest rate of 2.25% and a maturity date of 01/15/32. This remained consistent in 2023 and 2024, with no changes to the interest rate, face amount, or maturity date. The stability of these terms suggests a deliberate long-term financing strategy, leveraging fixed-rate debt with a long maturity horizon to manage interest rate risk and ensure long-term capital availability. This approach reflects SPG's focus on maintaining a balanced debt portfolio with extended maturities to support its real estate investments and operations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all values are accurate: face amount of $700,000, interest rate of 2.25%, and maturity date of 01/15/32 are correctly reported for the 2022–2024 period. There are no calculation errors, and the consistency across years is properly noted. (2) The answer is complete, addressing each component of the question—interest rate, face amount, maturity date, and their evolution (or lack thereof)—over the specified time frame. (3) Entity accuracy is correct: Simon Property Group (SPG) and the specific debt instrument 'Unsecured Notes - 37B' are accurately identified. (4) The reasoning is sound and adds appropriate qualitative insight: the stability in terms indicates a strategic use of fixed-rate, long-term debt to manage interest rate risk and support long-term operations, which aligns with and expands upon the ground truth's interpretation without introducing inaccuracies. The multi-hop synthesis—confirming no changes across years and deriving strategic implications—is logically and factually valid. All elements are semantically equivalent to the original answer, with slightly enhanced contextual explanation that remains faithful to the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 349,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments' (TXN) operational footprint in Melaka, Malaysia remained consistent across 2022, 2023, and 2024, with the site being involved exclusively in the Analog business segment and not in the Embedded Processing segment in all three years, as shown in the respective 10-K filings. The location is directly operated by TXN and is linked through the knowledge graph to both the company and the Melaka, Malaysia region, reflecting a stable and focused operational role in the Analog segment over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog business segment and not in Embedded Processing across all three years—2022, 2023, and 2024—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced, and no incorrect dates or metrics are introduced. (3) The multi-hop reasoning is sound: the answer synthesizes location-specific operational roles with business segment involvement over time, correctly identifying that there was no change or expansion into Embedded Processing. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN’s footprint in Melaka with respect to the two business segments. Minor wording differences (e.g., 'remained consistent' vs 'this remained unchanged') do not affect meaning and are within acceptable variation. All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the three-year timeframe—are correctly identified and linked. No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 349,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PYPL's exposure to its fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, as shown in the debt maturity schedules across all three years. This consistency suggests that PYPL has not refinanced or retired this specific tranche of long-term debt, which matures in 2029, and instead is maintaining its capital structure with this long-dated, fixed-rate obligation. The progression indicates a strategy of preserving long-term debt stability and potentially locking in low interest rates for an extended period, which aligns with managing interest rate risk and ensuring predictable cash flow obligations over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth exactly. All numeric values—interest rate (2.850%), dollar amount ($1.5 billion), and time period (2022–2024)—are accurate. (2) Quantitative accuracy is perfect: no calculations were required beyond recognizing the consistent principal amount across years, which the model reports correctly. Format is consistent and clear. (3) The reasoning is sound and captures the core implication: PYPL maintained this tranche of debt without retirement or refinancing, indicating a strategy of stability and interest rate risk management. The LLM correctly infers that this reflects a deliberate choice to preserve a low-cost, long-term liability (maturing in 2029). However, it omits a key contrast mentioned in the ground truth: PYPL actively retired its 1.350% notes by 2023 and issued new high-interest notes in 2024. This context strengthens the interpretation that the stability of the 2.850% notes is part of a broader, selective debt management strategy, not passive inaction. The absence of this comparative insight slightly weakens the qualitative depth. (4) Despite this omission, the answer is factually correct, contextually relevant, and logically reasoned. The core multi-hop synthesis—linking consistent liability amounts over time to strategic debt management—is well executed. Hence, a score of 9 is justified: excellent but not fully comprehensive in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 430,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Gilead has increasingly integrated its Hoofddorp, Netherlands facility into its global manufacturing strategy for cell therapy products across 2022, 2023, and 2024. As of 2022, the facility was listed among Gilead's principal manufacturing sites, indicating its foundational role in supporting the company's cell therapy operations. By 2023, the facility was explicitly noted as being utilized for commercial manufacturing and processing of cell therapy products, reflecting its expanded role beyond just a listed site to an active contributor in the commercial supply chain. In 2024, the Hoofddorp facility retained its designation for commercial manufacturing and processing of cell therapy products, consistent with 2023, suggesting a stable and strategic placement within Gilead’s global footprint. This evolution highlights the facility’s importance in supporting Gilead’s cell therapy commercialization efforts across Europe and beyond.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth in terms of the evolution of Gilead's Hoofddorp facility from 2022 to 2024. (1) All key facts are correct: in 2022, Hoofddorp was identified as a principal manufacturing site; in 2023 and 2024, it was explicitly used for commercial manufacturing and processing of cell therapy products. There are no errors in entities, years, or functional descriptions. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct use of years, which are all accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the progression across three years, showing an evolution from strategic designation to active commercial role and then continuity. The only minor shortcoming is that the LLM slightly overemphasizes 'increasing integration' and 'expanded role' without explicit evidence of functional expansion beyond the shift in 2023; however, the core facts support growing strategic importance. (4) The answer is contextually excellent, directly addressing the question about the facility’s evolving role in global cell therapy manufacturing. Semantic equivalence is strong, with only slight interpretive wording differences (e.g., 'active contributor in the commercial supply chain') that do not distort meaning. Overall, this is a highly accurate, well-reasoned response deserving a 9 due to minor interpretive overreach on 'increasingly integrated' without explicit 2024 enhancement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 420,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco's treatment of its 1.375% Senior Notes due June 2027 remained consistent in terms of face value at $1,250 million across 2022, 2023, and 2024, as shown in the long-term debt composition in all three years. However, the classification of the current portion of long-term debt changed significantly: in 2022, the current portion was $73 million, in 2023 it increased to $103 million, and in 2024 it remained at $103 million. This suggests that while the note itself was not due until 2027, the amount classified as current likely reflected the portion of debt expected to be refinanced or due within the next 12 months, indicating a shift in liquidity expectations or accounting treatment over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across 2022–2024, which matches the ground truth. However, there is a critical error in the reported current portion of long-term debt: the LLM states that the current portion was $73 million in 2022 (correct), but then claims it increased to $103 million in 2023 and remained at $103 million in 2024. This is incorrect. According to the ground truth, the current portion spiked to $1,081 million in 2023 — a major discrepancy that significantly affects the interpretation of debt classification and liquidity risk. The 2024 value of $103 million is correct. (2) The quantitative inaccuracies are severe: the 2023 current portion is off by over $978 million, which is not a minor rounding or formatting issue but a fundamental factual error. This undermines the reliability of the financial analysis. (3) The reasoning and multi-hop synthesis are otherwise sound — the model correctly interprets the concept of current portion classification and links it to refinancing expectations or accounting treatment within the 12-month window. It also correctly notes the stability of the long-term debt composition. However, due to the incorrect 2023 figure, the conclusion about a 'gradual increase' rather than a sharp spike in 2023 misrepresents the actual debt maturity profile shift. (4) The contextual relevance is high as the answer addresses both parts of the question — long-term debt composition and current portion classification — and attempts to explain the evolution over time. Due to the major numerical error in a key data point, the correctness score is reduced to 6 (partially correct with significant errors), quantitative accuracy to 5 (half the numbers wrong), qualitative accuracy to 7 (reasoning is logical but based on flawed data), and contextual relevance remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 522,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal's Fixed-rate 2.850% notes, issued in September 2019, had a face value of $1.5 billion and an effective interest rate of 2.96%. From 2022 to 2024, the carrying value of these notes remained unchanged at $1.5 billion, as reflected in the 2022, 2023, and 2024 disclosures. However, the current portion of long-term debt in 2024 decreased slightly to $1,191 million from $1,249 million in 2023, indicating a shift in the classification of debt maturities. This stability in the long-term debt balance, combined with the issuance of higher-yield notes in 2022 and 2024, suggests that PayPal is managing its debt maturity profile and accessing capital markets to refinance or extend maturities, potentially to optimize interest costs and maintain liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.5 billion carrying value of the 2.850% notes and the 2.96% effective interest rate, both of which match the ground truth. The issuance date (September 2019) is also correct. However, the LLM introduces a detail not present in the ground truth — a decrease in the current portion of long-term debt from $1,249 million in 2023 to $1,191 million in 2024 — which, while possibly accurate in PayPal’s overall debt structure, is not tied to the 2.850% notes specifically and risks conflating unrelated debt classifications. This distracts from the core point about the stability of this particular note tranche. (2) Quantitatively, the $1.5 billion amount is consistently reported across years, and the interest rate is accurate. The additional current portion figures are plausible but not relevant to the specific obligation in question, introducing minor inaccuracy by implication. (3) The reasoning partially aligns with the ground truth: the LLM correctly infers that stable carrying value suggests no refinancing of this tranche, and it appropriately links this to broader debt management activity. However, it misses the key strategic insight from the original answer — that PayPal maintained this specific liability while actively refinancing *other* tranches, indicating a deliberate choice to preserve stability in this part of the capital structure. Instead, it generalizes about 'issuing higher-yield notes' without specifying that those were separate tranches, weakening the multi-hop synthesis. (4) The answer is contextually relevant and well-structured, but the inclusion of unrelated current debt figures and the lack of precise strategic interpretation reduce the qualitative and quantitative accuracy slightly. The core facts are correct, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 499,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra Energy's exposure to gas-related options declined significantly from 2022 to 2024, with fair value for \"Options - primarily gas\" dropping from $356 million in 2022 to $100 million in 2024. The fair value of these options remained relatively stable in 2023 at $100 million. The multi-year trend in volatility assumptions also reveals a notable shift: implied volatilities for gas options decreased from a weighted average of 36% in 2022 to 52% in 2023, and further to 52% in 2024, while the range of volatility estimates narrowed over time. This suggests a reduction in perceived risk and uncertainty in gas markets, aligning with NextEra Energy's strategic positioning to manage and potentially reduce its exposure to volatile gas price fluctuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the $356 million fair value for assets in 2022 and $100 million in 2023 and 2024, it fails to distinguish between assets and liabilities as in the ground truth. More critically, the implied volatility values are incorrectly reported: the LLM states volatility decreased from 36% in 2022 to 52% in 2023 and 52% in 2024, but this is factually wrong — volatility increased from 36% to 50% in 2023 and 52% in 2024, not decreased. The LLM incorrectly frames rising volatility as a decrease, which misrepresents the risk trend. (2) The dollar amounts for asset fair values are mostly correct (2022: $356M, 2023–2024: $100M), but the liability values ($347M in 2022, $97M in 2023, $102M in 2024) are omitted entirely, reducing completeness and accuracy. The volatility figures are misrepresented: 36% → 50% → 52% (increasing), not decreasing as claimed. (3) The multi-hop reasoning is partially sound — the model correctly infers that declining fair value may indicate de-risking, and connects volatility assumptions to risk perception. However, the conclusion that volatility 'decreased' contradicts the data, undermining the reasoning. The narrowing range of volatility estimates is not in the ground truth and appears to be fabricated. (4) The contextual relevance is high — the answer addresses both parts of the question (evolution of exposure and risk positioning) and uses appropriate financial terminology. However, due to major errors in volatility direction and omission of liability values, the correctness score is limited to 6. The qualitative reasoning is reasonable but based on incorrect data, warranting a 7. Quantitative accuracy is low (5) due to incorrect volatility trends and missing liability figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 494,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco's available-for-sale (AFS) debt investments negatively impacted other income (loss), net across fiscal years 2022 through 2024, as highlighted in the 2022, 2023, and 2024 10-K filings. In fiscal 2022, AFS debt investments contributed to losses, and this trend continued in fiscal 2023 and 2024, where higher losses in AFS debt investments were a primary driver of the decline in other income (loss), net, as noted in both the 2023 and 2024 filings. This consistent negative impact reveals significant volatility in Cisco's investment portfolio during this period, particularly in the debt segment, which offset gains from other investment categories like marketable equity investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Cisco's AFS debt investments negatively impacted other income (loss), net in fiscal years 2022, 2023, and 2024, which matches the original answer's timeline and direction of impact. (2) There are no explicit numerical values (e.g., dollar amounts or percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—any lack of specific numbers is consistent with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers that recurring losses from AFS debt investments indicate portfolio volatility, particularly in the debt segment. It also appropriately notes that these losses occurred despite gains in equity and private investments, which is consistent with the original answer’s mention of offsetting gains. (4) The only minor shortcoming is a slight omission of the phrase 'active portfolio management' in 2022, which adds context about Cisco’s strategy but does not alter the core conclusion about volatility. Otherwise, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 344,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe's Companies, Inc. issued its 4.550% Notes in 2019 as part of the Fifteenth Supplemental Indenture, with a maturity date of April 5, 2049. This issuance was documented in the 2019, 2023, and 2024 10-K filings, indicating the notes remained part of the company's long-term debt structure through 2024. The multi-year pattern of maintaining these long-term notes, alongside other debt instruments with staggered maturities, suggests a strategy to manage interest costs and liquidity by extending debt maturities and securing fixed-rate financing over extended periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. These details match the ground truth. The LLM also correctly states that the notes were referenced in 2019, 2023, and 2024 filings, confirming their ongoing presence in the capital structure. However, the original answer specifies that the documentation was consistently disclosed in filings for 2022, 2023, and 2024 — the LLM omits 2022 and incorrectly includes 2019 (which is the issuance year, not part of the 2022–2024 evolution analysis period). This is a minor but notable omission in completeness. (2) All numeric values — interest rate (4.550%), maturity date (April 5, 2049), and indenture name — are accurate. No calculations are required, but the temporal references are mostly correct except for the misalignment in reporting years. (3) The multi-hop reasoning is sound: the model infers from repeated disclosure that the debt instrument remained unchanged, and correctly interprets this as part of a broader long-term debt strategy involving fixed-rate financing and maturity extension. This aligns with the ground truth’s conclusion about a stable financing approach. (4) The answer is contextually relevant and well-articulated, offering strategic insight beyond mere documentation. The omission of 2022 and inclusion of 2019 slightly weakens the qualitative accuracy, but the core reasoning and factual base remain strong. Hence, a score of 8 is justified for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 433,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "Simon Property Group's (SPG) Unsecured Notes - 35B had a consistent face value of $750,000 (in thousands) across 2022, 2023, and 2024, with an interest rate of 3.80% and a maturity date of 07/15/50. This consistency in face value and interest rate suggests that SPG did not refinance or issue new debt related to this instrument during the period. The long maturity date of over 25 years indicates that SPG is employing a long-term debt strategy to extend its debt maturities and manage refinancing risk, ensuring stable interest costs over an extended period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value, interest rate, and maturity date as consistent across 2022–2024, which aligns with the ground truth. However, there is a critical error in the face value: the LLM states '$750,000 (in thousands)', which implies $750,000,000 × 1,000 = $750 billion — a massive overstatement. The correct face value is $750,000,000, and 'in thousands' formatting would be $750,000 thousand, but the way it's phrased introduces ambiguity and potential misinterpretation. This is a significant quantitative inaccuracy. (2) The interest rate (3.80%) and maturity date (07/15/50) are correctly reported and consistent across years, matching the ground truth. The statement that there was no refinancing is logically sound given the unchanged terms. (3) The multi-hop reasoning is generally sound — the model synthesizes data across years and correctly infers that stable terms suggest a long-term debt strategy focused on maturity extension and refinancing risk mitigation. The conclusion about SPG’s strategy is semantically equivalent to the ground truth, though it adds slight interpretation (e.g., 'managing refinancing risk') not explicitly in the original. (4) Despite the face value formatting error, the core facts are mostly correct, and the strategic interpretation is reasonable. Hence, correctness is reduced to 7 due to the numerical ambiguity, quantitative accuracy to 6 due to the misleading 'in thousands' phrasing, while qualitative and contextual scores remain high due to sound logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 429,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal's exposure to bad transactions risk from 2022 to 2024 evolved with increasing complexity, particularly in relation to its credit products, cross-border trade, and third-party dependencies. In 2022, PayPal highlighted the risk of non-payment among credit product users due to economic factors like recessions and interest rate changes, as well as operational risks from third-party lenders and payment processors. By 2023, the company took proactive steps to mitigate credit risk by entering a multi-year agreement to sell up to €40 billion in BNPL loan receivables from its European operations, signaling a strategic move to reduce balance sheet exposure and improve liquidity. In 2024, PayPal continued to emphasize its reliance on third parties, acknowledging the inherent operational and regulatory risks, while also maintaining that cross-border trade remains a key revenue driver despite ongoing challenges like foreign exchange fluctuations and trade barriers. This multi-year trend reveals a risk management strategy focused on diversification, asset monetization, and strengthening operational resilience through third-party relationship management and regulatory compliance, indicating a more proactive and adaptive approach to mitigating bad transaction risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the €40 billion multi-year agreement to sell BNPL loan receivables in 2023 is accurately reported, including the correct currency and amount. The focus on credit risk, third-party dependencies, and cross-border trade is consistent with the original. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no incorrect numbers are introduced. Format is appropriate and matches ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes PayPal’s evolving risk strategy across 2022–2024, correctly identifying the shift from internal risk absorption (2022 credit defaults and third-party risks) to external mitigation via asset sales (2023) and ongoing regulatory and operational concerns (2024). It captures the strategic trend of proactive risk reduction. (4) Minor omission: the LLM does not mention the 'valid-when-made' doctrine or synthetic identity fraud—specific legal and fraud risks highlighted in the original 2024 discussion—though it broadly covers regulatory and third-party risks. This slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is contextually rich, factually precise, and demonstrates strong synthesis across years and risk domains, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 383,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "From 2022 through 2024, Costco (COST) maintained a strong competitive positioning relative to BJ's Wholesale Club by emphasizing its Kirkland Signature private-label brand as a key differentiator. All three chunks highlight Costco's strategic focus on expanding the sales penetration of Kirkland Signature products, which are positioned as high-quality, cost-effective alternatives to national brands, helping Costco achieve higher margins and distinguish its merchandise offerings. The consistent language across the 2022, 2023, and 2024 10-K filings indicates that Costco has reinforced this strategy over the period, leveraging its intellectual property and brand recognition to sustain a competitive edge in the warehouse club sector, including against BJ's Wholesale Club.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco emphasized Kirkland Signature as a differentiator against BJ's Wholesale Club from 2022 to 2024, positioning it as a high-quality, cost-effective alternative to national brands, contributing to higher margins and merchandise differentiation. The LLM correctly notes the consistency of this messaging across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly identifies the stable strategic emphasis on Kirkland Signature as a competitive lever against BJ's. The only minor gap is that the LLM mentions 'expanding the sales penetration' and 'leveraging intellectual property,' which are plausible inferences but not explicitly stated in the ground truth; the original answer emphasizes consistency rather than expansion or IP strategy. This slight overstatement prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of competitive positioning and the role of private-label branding. Overall, the LLM captures the core truth with high fidelity and only minor interpretive additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 389,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra Energy's exposure to gas forward contracts evolved significantly from 2022 through 2024, with the fair value of assets increasing from $191 million in 2022 to $296 million in 2024, while liabilities rose only modestly from $31 million to $46 million. This widening net asset position suggests a growing strategic advantage in natural gas markets, as the company likely locked in favorable forward prices amid market volatility. The consistent use of discounted cash flow valuation and forward price inputs across all three years indicates a disciplined approach to managing natural gas price risk, reflecting a strengthening risk positioning and potentially enhanced financial resilience in this sector over the three-year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 and 2024 values for both assets ($191M to $296M) and liabilities ($31M to $46M), which matches the ground truth. However, it omits the critical 2023 data point where asset fair value spiked to $377 million — a key detail in the original answer that indicates volatility and a peak in exposure. This omission affects completeness and quantitative accuracy. (2) All provided numbers are accurate in format and value, but the failure to mention the $377M 2023 asset value — a notable spike — means the quantitative progression is incomplete. The liabilities' rise is correctly characterized as modest. (3) The reasoning about a growing strategic advantage and disciplined risk management is plausible but diverges from the original conclusion of 'increasingly balanced exposure' and 'rising market risk.' The LLM interprets the widening net asset position positively, while the ground truth emphasizes increased overall risk due to larger positions, especially during the 2023 spike. This reflects a difference in qualitative interpretation, though the logic is internally sound. (4) The answer is highly contextually relevant, addressing both fair value changes and risk positioning. It synthesizes financial trends and draws a reasoned conclusion about risk, even if it misses the nuance of escalating risk due to the unmentioned 2023 peak. The multi-hop synthesis is partially correct but incomplete without the full 3-year data. Overall, core facts are correct but missing a pivotal intermediate year, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 439,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "From 2022 to 2024, Lowe’s use of forward interest rate swaps evolved from being a disclosed hedging tool in 2022 to a more prominent position in 2023, with a fair value of $251 million, and then was not reported as an active position in 2024. This progression suggests that Lowe’s actively managed its interest rate risk by entering into forward rate agreements in 2023 to hedge against potential increases in benchmark interest rates on forecasted debt issuances, likely in response to rising market rates. The absence of forward swaps in 2024 may indicate that the hedges matured or were replaced by fixed-to-floating interest rate swaps as fair value hedges, which were held in both 2024 and 2023, signaling a shift toward managing existing debt exposure rather than future issuances. This evolution reflects a proactive and adaptive interest rate risk management strategy aligned with changing market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's use of forward interest rate swaps from 2022 to 2024. In 2022, it notes the disclosure of forward swaps in the context of cash flow hedges, consistent with the ground truth. In 2023, it accurately reports the $251 million fair value as of February 3, 2023, and in 2024, correctly states that forward interest rate swaps were no longer reported, aligning with the absence in the January 31, 2025 filing. (2) All numeric values—$251 million and the implied timeline (2022–2024)—are factually correct and match the ground truth. Date references (February 3, 2023, and January 31, 2025) are accurate and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across three fiscal years, correctly infers the strategic shift from hedging forecasted debt (cash flow hedges via forward swaps) to managing existing debt (via fixed-to-floating swaps), and links this to market conditions like rising rates. The suggestion that forward swaps were replaced by fair value hedges is a reasonable inference supported by the presence of such instruments in both years. (4) The only minor limitation is that the ground truth explicitly mentions the classification of the 2023 swaps under 'other current assets,' which the LLM omits. However, this detail is secondary to the overall strategic narrative and does not affect the core correctness. The LLM provides a slightly more interpretive but still accurate explanation of the strategic shift. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 453,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 through 2024, CMCSA faced increasing competitive pressure from Lumen, particularly in overlapping markets where both companies expanded fiber-based broadband infrastructure. In 2022, CMCSA noted that Lumen and other wireline providers were building fiber networks deeper into their systems, enabling higher-speed data transmission and challenging CMCSA’s traditional broadband offerings. By 2023, this trend continued, with Lumen and others like AT&T and Verizon further advancing fiber deployment, which intensified competition in residential and business broadband services. In 2024, CMCSA reiterated the same competitive dynamics, emphasizing that Lumen and other providers were not only expanding fiber infrastructure but also leveraging it to offer bundled services, impacting CMCSA’s ability to retain market share. This evolution in fiber-based infrastructure by Lumen and others has forced CMCSA to adapt its service offerings and maintain its competitive edge in overlapping markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumen is consistently identified as a key competitor to CMCSA from 2022 to 2024, with ongoing fiber infrastructure expansion in overlapping markets. The implications on service offerings—particularly through higher-speed data and bundled services—are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics across years and correctly infers that fiber expansion by Lumen impacts CMCSA’s market positioning and service strategies. The mention of AT&T and Verizon as additional competitors is contextually accurate and does not contradict the original answer, though the original focuses specifically on Lumen. This addition provides broader context without detracting from the core comparison. (4) Semantic equivalence is strong: the LLM captures the evolution of competitive positioning, the role of fiber expansion, and its impact on service bundling and market share. The only minor difference is the inclusion of other competitors, which slightly broadens the scope but does not reduce accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 393,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "From 2022 to 2024, PayPal significantly evolved its focus on seamless checkout experiences by integrating consumer credit offerings, expanding global currency support, and enhancing omnichannel merchant solutions. In 2022, PayPal emphasized creating seamless checkout experiences as part of its core growth strategy, aiming to address customer needs for managing and moving money while expanding adoption by merchants and consumers. By 2023, PayPal had broadened its checkout capabilities to support approximately 150 currencies for transactions and maintained 56 currencies for withdrawals, reinforcing its global reach. In 2024, PayPal further integrated consumer credit offerings such as buy now, pay later (BNPL) products in multiple markets, including the U.S., U.K., France, Germany, and Japan through Paidy, and introduced interest-bearing installment products and credit cards to enhance checkout flexibility. Additionally, PayPal expanded its omnichannel solutions, enabling merchants to manage in-person and online sales through tools like Zettle by PayPal and Braintree, while embedding BNPL options into branded checkout experiences to boost consumer spending and merchant sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies PayPal's evolving focus from 2022 to 2024 on seamless checkout experiences, with accurate emphasis on consumer credit integration, global currency support, and omnichannel solutions. (2) Quantitatively, the LLM states that PayPal supported approximately 150 currencies by 2023, matching the ground truth (up from over 100 in 2022). It adds a specific detail—56 currencies for withdrawals—not in the original answer, but this is factually consistent with PayPal’s operations and does not contradict the ground truth; it enhances precision without error. No calculation errors present. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and domains—credit offerings (BNPL, credit cards), global expansion (currencies), and merchant solutions (Zettle, Braintree)—correctly showing evolution over time. The mention of Paidy in Japan and specific markets for BNPL rollout (U.S., U.K., France, Germany, Japan) adds granularity beyond the original but remains factually accurate. (4) The LLM omits the explicit mention of Venmo-branded credit/debit cards, which is a minor omission from the 2024 developments in the original answer, justifying a score of 9 instead of 10. However, the core strategic shift—deepening financial integration and merchant enablement—is clearly conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is perfect: all parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> PRODUCT <-[Produces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 424,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The penetration rate of the Target Debit Card (as part of the RedCard or later rebranded as Target Circle Card) decreased from 20.2% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. This declining trend suggests that, while the Target Debit Card continues to drive a meaningful portion of incremental purchases, its role in contributing to incremental sales for Target has diminished over time. The reduction in penetration may indicate either a shift in customer payment preferences or a saturation effect, despite the ongoing 5% discount incentive offered to users.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2022 penetration rate as 20.2% instead of the ground truth 20.5%. The 2023 (18.6%) and 2024 (17.8%) figures are accurate. This small error in the initial percentage affects precision but does not alter the overall trend interpretation.\n\n2) Quantitatively, the numbers are nearly correct except for the 2022 figure. The trend of decline is accurately captured—down from ~20% to 17.8% over three years—and the direction and magnitude of change are consistent with the ground truth. The calculation of a declining trend is valid, though the exact drop from 20.2% to 17.8% (2.4 percentage points) slightly understates the actual 2.7-point drop from 20.5%.\n\n3) Qualitatively, the reasoning is sound. The LLM correctly identifies the declining penetration trend and links it to a diminishing role in driving incremental sales, which aligns with the ground truth. It appropriately references the 5% discount incentive and offers plausible explanations (payment preference shifts, saturation), which, while not explicitly in the original, are reasonable inferences that do not contradict the source.\n\n4) Contextually, the response fully addresses both parts of the question: the evolution of penetration from 2022–2024 and the implication for incremental sales. It synthesizes the multi-hop elements (trend over time + business impact) correctly. The rebranding mention (RedCard to Target Circle Card) adds context without introducing error.\n\nOverall, the answer is factually strong with only a minor numerical discrepancy, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 454,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "From 2022 to 2024, AMD's revenue recognition approach for development and IP licensing agreements remained consistent in evaluating whether licensing components are distinct within combined arrangements. In both 2022 and 2024, AMD assessed if a licensing component is distinct by determining if it is both (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license is not distinct, it is combined with development services as a single performance obligation and recognized over time. If the license is distinct, revenue is recognized at a point in time when the customer can benefit from it. This approach was also reiterated in 2023, showing continuity in AMD's accounting policy. Additionally, for standalone licensing deals—where arrangements solely involve the sale or licensing of patents or IP—revenue is recognized at a point in time when the customer has the ability to benefit from the license, with no variable consideration estimates involved in either combined or standalone arrangements across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements of AMD's revenue recognition policy are correctly described: the distinction between distinct and non-distinct licenses, treatment of combined arrangements (recognized over time when not distinct), and standalone licenses (recognized at a point in time). The policy consistency across 2022–2024 is accurately noted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the temporal references (2022, 2023, 2024) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across years and arrangement types (combined vs. standalone), correctly identifying the continuity in accounting policy. (4) The LLM adds slightly more detail (e.g., the two criteria for distinctness: 'capable of being distinct' and 'distinct in the context of the arrangement'), which is consistent with ASC 606 and plausibly derived from the filings, enhancing clarity without introducing error. No irrelevant or incorrect information is present. All aspects of the question—evolution over time, combined vs. standalone deals—are fully addressed with precise, correct reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 354,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Nike's FlyEase technology evolved as part of its broader innovation portfolio, reflecting a consistent focus on integrating user-centric design and accessibility into its product development. In fiscal 2022, FlyEase was listed among Nike's key technologies being leveraged across product categories to meet consumer preferences, emphasizing innovation in design and performance. By fiscal 2023, FlyEase remained a core component of Nike's innovation strategy, with continued emphasis on using market intelligence to incorporate the technology into diverse product lines. In fiscal 2024, FlyEase was again highlighted as part of Nike’s portfolio of technologies, underscoring its ongoing strategic importance in delivering accessible, innovative athletic experiences. The FlyEase technology is managed by a dedicated FlyEase organization, which is connected to and supported by Nike, reflecting a structured approach to scaling and refining the innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but it does not fully align with the ground truth in terms of the strategic evolution of FlyEase. (1) Correct elements: The answer correctly identifies FlyEase as part of Nike’s innovation portfolio across fiscal 2022–2024 and emphasizes its role in accessibility and user-centric design, which is consistent with Nike’s messaging. It also appropriately notes ongoing strategic importance, which matches the general trajectory. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is not applicable; the fiscal years (2022, 2023, 2024) are correctly referenced. (3) Multi-hop reasoning: The ground truth describes a clear progression—FlyEase moving from 'emerging' (2022), to 'established alongside Air/Zoom' (2023), to 'mature, grouped with React/Air Max' (2024)—indicating a maturation in strategic positioning. The LLM answer fails to capture this specific evolution: it treats FlyEase as consistently 'core' or 'key' from the start, missing the nuanced shift from emerging to mature status. It also introduces unverified details, such as a 'dedicated FlyEase organization,' which is not present in the original answer and cannot be confirmed from the knowledge graph. (4) The answer is well-structured and relevant but lacks the precise qualitative trajectory described in the ground truth, leading to a moderate correctness score. While the overall strategic importance is acknowledged, the failure to reflect the stage-based evolution across the three years limits its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Expands]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 433,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The trend in the principal amount of AMT's 1.250% Notes suggests a consistent approach to long-term debt management, with the company issuing $609.1 million in 2021 (Chunk 3), followed by a reduction to $551.9 million in 2022 (Chunk 1) and further to $517.7 million in 2023 and 2024 (Chunks 1 and 2). This gradual reduction in principal amounts, alongside the long maturity dates (extending to 2033), indicates AMT is strategically managing its debt profile by extending maturities and potentially refinancing at lower rates, aiming to reduce future refinancing risk and stabilize interest costs over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and amounts. It incorrectly states that $609.1 million was issued in 2021, which is not supported by the ground truth and misaligns the entire timeline. The ground truth shows the principal was $609.1 million in 2022, not 2021 or as an issuance year. It then states the amount reduced to $551.9 million in 2022, which contradicts the original answer where that value corresponds to 2023. The LLM also incorrectly claims the principal was $517.7 million in both 2023 and 2024, while the ground truth shows $517.7 million only in 2024, with $551.9 million in 2023. These errors severely impact quantitative accuracy. (2) The correct trend is a decrease from $609.1M (2022) → $551.9M (2023) → $517.7M (2024). The LLM reverses and compresses this timeline, misattributing values to wrong years. While the final $517.7M figure is correct for 2024, the path to it is wrong. (3) The reasoning about debt management strategy—such as managed amortization, reducing long-term obligations, and stable interest payments—is partially sound and contextually relevant. The mention of long maturity (2033) and consistent payment terms aligns with the original answer, though the LLM frames it as refinancing at lower rates, which is speculative and not in the ground truth. The synthesis across years is attempted but flawed due to incorrect year mappings. (4) The correctness score is 5 due to partially correct numbers and a reasonable strategic interpretation, but major errors in temporal alignment and principal amounts reduce accuracy. Quantitative accuracy is low (4) due to incorrect year-amount pairings. Qualitative accuracy is moderate (6) as the logic is coherent but based on wrong data. Contextual relevance is high (8) because the answer addresses debt strategy and maturity, staying on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 508,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA's 3.50% Notes Due 2040 had a fair value of $1,066 million in 2022 (Chunk 1), decreased to $851 million in 2023 (Chunk 2), and were reported at a net carrying amount of $1,000 million in 2024 (Chunk 3). This multi-year trajectory reflects a consistent long-term debt strategy, as evidenced by the notes' 15.2-year expected remaining term and 3.54% effective interest rate in 2024 (Chunk 3), indicating NVIDIA's focus on securing stable, long-term financing at favorable rates to support its growth and financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $1,066 million in 2022, $851 million in 2023, and $1,000 million carrying amount in 2024, matching the ground truth exactly. The effective interest rate of 3.54% in 2024 is also accurately cited. These values are presented with correct fiscal years and metric labels (fair value vs. carrying amount), and number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of values. The trajectory of valuation change (down then stabilizing) is correctly implied through accurate reporting of numbers. (3) The reasoning is sound and adds value: the LLM correctly infers that the stable 2024 carrying amount and low effective rate reflect a strategy of securing long-term financing at favorable terms. It introduces the '15.2-year expected remaining term'—a detail not in the original answer but consistent with a long-term debt strategy and plausibly from the source 'Chunk 3'. While this specific detail isn't in the ground truth, it doesn't contradict it and supports the same conclusion. (4) The answer is fully contextually relevant, addressing both the valuation evolution and strategic implications. The only minor gap is that the original answer explicitly notes the 2023-to-2024 'stabilization' and links it to liability management during market fluctuations—a nuance slightly underdeveloped in the LLM response. However, the core multi-hop synthesis across three fiscal years and correct interpretation of strategic intent earns high marks. Overall, the LLM answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with slight enrichment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 467,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "From 2022 to 2024, Netflix expanded its membership plans by introducing new service features such as games in 2022, an ad-supported subscription tier in 2023, and live programming in 2024. These expansions were part of a broader strategy to enhance member value and drive growth, particularly in highly penetrated markets where growth had slowed. Pricing adjustments, including the introduction of lower-priced plans, were also made to attract price-sensitive consumers. However, each year, Netflix highlighted risks tied to these changes: in 2022, the risk was that games might not be valued by members; in 2023, the risk centered on the ad-supported tier and potential backlash from pricing or usage restrictions; and in 2024, the risk included the challenges of sustaining improvements in TV/film offerings and the expansion into live programming and consumer products. Across all years, Netflix emphasized that missteps in these areas could negatively impact member acquisition, retention, and financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix introduced games in 2022, an ad-supported tier in 2023, and live programming in 2024. The stated risks for each year are accurately reflected—2022 focused on whether games would be valued, 2023 on potential consumer backlash to ads and pricing, and 2024 on challenges with live programming and content offerings. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes service expansions and associated risks across three years, correctly linking each initiative to its corresponding risk as disclosed by Netflix. (4) The only minor deviation from the original answer is that the LLM slightly broadens the 2024 risk by mentioning 'sustaining improvements in TV/film offerings' and 'consumer products,' which are not explicitly highlighted in the ground truth. However, this does not contradict the original and remains contextually plausible. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for minor over-extension of risks in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 377,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group's venture investment exposure, as reflected in its total equity securities holdings and equity method investments in healthcare businesses, showed a notable increase. In 2022, the Company held $3.5 billion in equity securities and $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities rose to $4.9 billion, with equity method investments remaining stable at $1.4 billion. In 2024, equity securities were maintained at $4.9 billion, while equity method investments in healthcare businesses surged to $3.8 billion. This progression indicates a strategic deepening of UnitedHealth Group's engagement in the healthcare sector, particularly through expanded equity method investments, reflecting a stronger commitment to growth and innovation within the industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate with only a minor discrepancy in the 2022 equity securities value. The ground truth states $3.7 billion for equity securities in 2022, while the LLM reports $3.5 billion—a small but notable difference in a key quantitative figure. All other numbers are correct: equity securities correctly rise to $4.9 billion in 2023 and remain steady in 2024; equity method investments increase from $1.3 billion (2022) to $1.4 billion (2023) and jump to $3.8 billion in 2024. The qualitative analysis is excellent—correctly identifying the strategic deepening in healthcare innovation and operational engagement through equity method investments. The reasoning synthesizes multi-year, multi-metric data logically and draws a valid conclusion about UnitedHealth’s strategic positioning. Contextual relevance is perfect, addressing all parts of the question: evolution over time, breakdown by investment type, and strategic implications. The wording differs slightly from the original but maintains full semantic equivalence. The single numerical inaccuracy prevents a perfect 10 on correctness and quantitative accuracy, but qualitative and contextual performance is flawless.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 335,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From fiscal years 2022 through 2024, Nike's financial and strategic relationship with Sojitz America remained stable in terms of preferred stock ownership and dividend obligations. Sojitz America has been the sole owner of Nike’s $1 par value redeemable preferred stock, with a total par value of $0.3 million, and is entitled to a cumulative dividend of $0.10 per share annually on May 31. As outlined in both the 2022 and 2023 10-K filings, no changes occurred in the structure or ownership of this preferred stock during these periods, and no additional preferred shares could be issued under Nike’s corporate structure. Sojitz America retained its right to vote as a separate class on major corporate transactions, such as the sale of assets or the NIKE trademark in the U.S., but held no general voting rights. Strategically, Sojitz America continued to perform import-export financing services for Nike, a role it has maintained since 1972, supporting Nike’s international operations, particularly in sourcing and supply chain logistics. This partnership remained integral to Nike’s global operations, especially in navigating international trade complexities and maintaining supply chain efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Sojitz America as the sole holder of Nike's redeemable preferred stock with a total par value of $0.3 million and a cumulative annual dividend of $0.10 per share, consistent across fiscal years 2022–2024. However, it incorrectly states the par value per share as $1, which contradicts the ground truth that does not specify per-share par value but confirms total par value of $0.3 million. This is a material quantitative error, though the total par value is correct. (2) The dates (May 31 dividend) and structural details (no additional shares issuable, voting rights on major transactions) are accurate and supported by the filings. (3) The LLM captures the multi-hop element by linking Sojitz America’s long-standing role in import-export financing since 1972 to Nike’s international operations, but it misses the key evolution highlighted in the ground truth: that in fiscal 2024, Nike explicitly emphasized this role as a strategic response to rising global trade risks and supply chain volatility—marking a shift from purely financial to strategically operational. While the LLM notes the ongoing role, it does not reflect this strategic repositioning as an evolution over the period. (4) Despite the missed nuance in strategic evolution and the per-share par value inaccuracy, the answer is largely factually correct, well-structured, and contextually relevant, with strong qualitative reasoning and entity accuracy. Hence, correctness is reduced to 8 due to the numerical inaccuracy and partial incompleteness on the strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 437,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023 and further to $2,000 million in fiscal 2024 (before unamortized discounts). This decline, particularly from 2022 to 2023, suggests a reduction in the fair value of the notes, potentially due to changes in market interest rates or amortization of discounts. However, the increase in 2024 indicates a reversal in valuation, possibly reflecting market conditions or refinancing activities. Overall, the trend highlights NVIDIA's strategic management of long-term debt, maintaining a significant but stable level of long-term obligations, which supports its long-term financial flexibility and capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the carrying values for fiscal years 2022 ($2,147 million) and 2023 ($1,604 million), but inaccurately states that the value increased 'to $2,000 million in fiscal 2024 (before unamortized discounts)'. The ground truth specifies $2,000 million as the carrying value in 2024, without mentioning 'before unamortized discounts'—a detail not present in the original answer and potentially misleading, as it implies the reported value is not the final carrying value. This introduces a factual discrepancy in how the number is contextualized. (2) The numeric values themselves—$2,147M, $1,604M, and $2,000M—are quantitatively accurate in amount and year, satisfying the core data requirements with minor but notable qualification due to the added 'before discounts' caveat. (3) The reasoning correctly identifies a reduction from 2022 to 2023 and an increase in 2024, aligning with the multi-hop trend analysis. However, the interpretation diverges slightly: the LLM attributes changes to fair value fluctuations and market interest rates, while the ground truth frames the trend as reflecting strategic debt repositioning. The LLM’s explanation is plausible but less precise in capturing the strategic intent emphasized in the original. (4) Scores reflect high correctness due to accurate numbers and overall trend description, but docked for the added 'before unamortized discounts' qualifier (affecting quantitative and qualitative accuracy) and slightly off interpretation of strategic intent. Contextual relevance remains high as the answer directly addresses both parts of the question with appropriate financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 455,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "From 2022 through 2024, MetLife maintained a consistent strategy of leveraging diverse global funding sources to enhance liquidity, limit dependence on any single market, and reduce the cost of capital. In 2022, MetLife actively used short-term debt, particularly commercial paper, as part of its funding strategy, supported by unsecured revolving credit facilities, and emphasized the importance of maintaining a broad range of funding options, including policyholder account balances and equity securities. By 2023 and 2024, this approach remained unchanged, with the company continuing to rely on a mix of short-term and long-term debt, credit facilities, and a shelf registration statement to provide flexibility and access to capital markets. The consistent use of diverse funding sources across all three years reflects MetLife’s ongoing effort to mitigate risks associated with market dependence and maintain financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: MetLife maintained a consistent funding strategy from 2022 to 2024, relying on diversified global funding sources to reduce market dependence and lower the cost of capital. The use of commercial paper, supported by unsecured revolving credit facilities, is correctly noted for 2022 and implicitly carried forward in 2023 and 2024. The mention of a shelf registration statement and mix of short-term and long-term debt adds context without contradicting the original. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers continuity in strategy, even without structural changes. It accurately captures the intent behind diversification—risk mitigation and cost reduction. (4) The only minor gap is that the LLM omits the specific detail about MetLife Funding extending loans to affiliates in 2022 and does not explicitly reaffirm confidence in lending counterparties in 2023 as in the original. However, these are secondary details that do not alter the core accuracy of the response. The answer remains semantically equivalent in substance and correctly addresses all parts of the question. Hence, a score of 9 is justified—excellent but not perfect on qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 419,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion as of December 31, 2022, to $9.9 billion as of December 31, 2023, and further to $2.0 billion (short-term) and $14.4 billion (long-term) as of December 31, 2024. Concurrently, the company maintained service level guarantees for certain contracts, though no material amounts were accrued, paid, or charged to income for these guarantees during any of the periods. This evolution suggests a growing liquidity commitment to its subsidiaries, particularly through increased long-term obligations in 2024, while the immaterial impact of service level guarantees indicates limited immediate contractual risk exposure, despite the expansion of these commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2024. The ground truth states that notes payable to subsidiaries dropped sharply to $2.0 billion in 2024, but the LLM incorrectly reports $2.0 billion (short-term) and $14.4 billion (long-term), totaling $16.4 billion, which is not supported by the original answer and contradicts the stated drop. This misrepresents the trend entirely. Additionally, the original answer does not break down the 2024 figure into short- and long-term components, nor does it mention $14.4 billion anywhere, making this a major fabrication or error. (2) The 2022 ($8.1B) and 2023 ($9.9B) figures are correct, but the 2024 value is wrong. The calculation and trend analysis are therefore flawed—instead of a sharp drop, the LLM implies a massive increase in total obligations, which is the opposite of the truth. (3) The qualitative reasoning about service level guarantees is mostly accurate: the LLM correctly notes that no material amounts were accrued or paid, aligning with the original answer’s claim of immateriality. However, the conclusion that there is a 'growing liquidity commitment' due to increased long-term obligations is unsupported and contradicts the actual decline in total notes payable. The multi-hop synthesis fails because the model misreads or invents the 2024 debt structure, leading to incorrect inferences about liquidity strategy. (4) Despite the strong contextual framing and relevant discussion of contractual risk and liquidity, the severe quantitative error undermines the correctness. The answer is partially complete and contextually relevant, but the core financial data is wrong, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 482,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "American Express's competitive positioning from 2022 through 2024 has been shaped by intensifying competition from global card networks like Visa and Mastercard, as well as alternative payment platforms such as PayPal and Venmo, as noted in both the 2022 and 2023 10-K filings. The company remains the fourth-largest general-purpose card network globally, facing pressure in the premium space and cobrand relationships. In response, American Express has focused on enhancing its value proposition through rewards programs, differentiated offerings like airport lounges, and digital innovation. However, regulatory dependency and scrutiny have increased significantly in 2024, with heightened compliance expectations due to its reclassification as a Category III firm under U.S. banking regulations. The company has also exited network licensing businesses in the EU and Australia due to regulatory constraints, and faces ongoing challenges related to interchange fee caps, consumer protection laws, and AML/CFT compliance, all of which impact its profitability and business flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express is the fourth-largest general-purpose card network; it faced increasing competition from Visa, Mastercard, PayPal, Venmo, and regional systems like NPCI; it enhanced its value proposition via rewards, lounges, and digital innovation; it was reclassified as a Category III firm in 2024; and it exited network licensing in the EU and Australia due to regulatory pressure. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are cited, all qualitative financial impacts (e.g., interchange fee caps, profitability impacts) are consistent with the original and plausibly inferred. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying the evolution from competitive differentiation to regulatory dependency, linking strategic responses to external pressures, and connecting regulatory classification changes to business outcomes. (4) The only minor shortcoming is that the LLM omits mention of Alipay and the National Payments Corporation of India specifically in the 2023 context, which slightly reduces completeness in capturing the full scope of competitive pressures. However, the reference to 'alternative payment platforms' and 'regional payment systems' provides sufficient semantic coverage. Wording differs but meaning is equivalent. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 429,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips' cash-settled PSU compensation strategy evolved from 2022 to 2024 by maintaining a structure where PSUs are settled in cash equal to the fair market value of a share of common stock and are classified as liabilities. For performance periods beginning in 2018 or later, the company transitioned to an accrued reinvested dividend equivalent structure, where recipients receive dividend equivalents that are charged to compensation expense and paid at settlement, rather than receiving cash payments during the performance period. This shift reflects a stronger alignment of long-term incentives with company performance, as it ties executive compensation more closely to stock price appreciation and long-term value creation. The consistent application of this structure in 2022, 2023, and 2024, as detailed in the respective 10-K filings, underscores ConocoPhillips' commitment to performance-based compensation and long-term strategic goals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the shift in dividend equivalent structure for performance periods beginning in 2018 or later to accrued reinvested dividends paid at settlement is accurately described; the classification of cash-settled PSUs as liabilities is correctly noted; and the vesting framework tied to five years or retirement eligibility is implied through the consistent structure. (2) There are no numeric inaccuracies—dates (2018 as the transition point), timeframes (2022–2024), and financial treatment (liability classification, compensation expense) are all factually sound. Format variations are acceptable and do not affect accuracy. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years (2022–2024), identifies a policy change based on performance period start date, and infers the strategic intent behind the change—long-term incentive alignment with stock performance. The only minor omission is the explicit contrast with pre-2018 periods (i.e., no payments during the performance period, only after), which slightly weakens completeness but does not invalidate the core conclusion. (4) The answer is contextually excellent, directly addressing both the structural evolution and its implications for long-term alignment. The conclusion about stronger alignment with long-term value creation is logically supported. The score is 9/10 due to the slight lack of explicit pre- vs. post-2018 comparison, but all critical elements are present and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Grants]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 429,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The evolution of NextEra Energy's Special Use Funds from $8,698 million in 2023 to $9,800 million in 2024, as shown in Chunk 2, indicates a strengthening liquidity position, particularly in relation to the company's derivative-related collateral obligations. This increase in Special Use Funds, which are held primarily in debt and equity securities and serve as part of NEE’s liquidity resources, suggests a proactive build-up of collateral capacity. This is especially relevant given the continued exposure to derivative instruments with credit-risk-related contingent features, as detailed in Chunks 1 and 3. For instance, in 2022, the potential collateral requirements in the event of a credit downgrade were as high as $5.2 billion, which dropped to $2.4 billion by 2023 but remained significant. By 2024, the company had increased its Special Use Funds, likely to ensure sufficient liquidity to meet potential collateral calls under stress scenarios, such as a downgrade to below investment grade. This trend reflects NEE’s strategic management of liquidity risk in alignment with its derivative exposure and credit rating considerations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Special Use Funds from $8,698 million in 2023 to $9,800 million in 2024, which matches the ground truth. However, it incorrectly states that the potential collateral requirement in 2022 was $5.2 billion — while this number appears in the LLM answer as a 2022 figure, the ground truth specifies that the $5.2 billion was the 2022 amount for downgrade-related collateral, but the ground truth also notes an earlier disclosure of up to $2.7 billion, creating ambiguity. More critically, the LLM misrepresents the timeline by implying the $5.2 billion dropped to $2.4 billion from 2022 to 2023, which aligns partially with the ground truth, but fails to mention that the $2.7 billion figure (not $5.2B) was the one cited in 2022 for downgrade scenarios — this is a significant factual discrepancy. Additionally, the LLM omits key data points from the ground truth: actual cash collateral posted increased from $84M in 2022 to $691M in 2023, which is a crucial indicator of changing liquidity behavior. (2) The quantitative accuracy is reduced due to the incorrect attribution of $5.2 billion as the 2022 downgrade collateral obligation without clarifying that this was replaced or revised; the ground truth shows a drop from $5.2B to $2.4B but also references a $2.7B figure, suggesting possible confusion in source data interpretation. The LLM does not reconcile these numbers accurately. (3) The reasoning is otherwise sound: it correctly infers that growing Special Use Funds reflect improved liquidity positioning and proactive risk management in relation to derivative obligations. It appropriately links the buildup of funds to potential downgrade scenarios and credit-risk-related contingent features, demonstrating valid multi-hop synthesis between liquidity resources and derivative exposures. (4) Contextual relevance is high — the answer directly addresses the question about liquidity positioning in relation to derivative collateral obligations and interprets the trend meaningfully. Despite missing some key facts and containing a potentially misleading numerical claim, the overall direction and strategic interpretation are consistent with the ground truth. Hence, a correctness score of 7 is warranted: core facts are partially accurate, but significant omissions and one major numerical misstatement prevent a higher rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 640,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower's (AMT) 1.600% Notes had an aggregate principal amount of $700.0 million in 2022, 2023, and 2024, indicating no change in the outstanding principal over this period. Amortization for these notes showed a consistent reduction in interest payments, with amortization amounts of $3.7 million in 2022, $2.6 million in 2023, and $1.5 million in 2024. This declining amortization trajectory suggests that AMT is managing its debt in a way that reduces interest expenses over time, likely through amortization schedules or refinancing strategies, while maintaining the principal amount constant until maturity in 2026. The pattern reflects a disciplined approach to long-term debt management, aiming for stable principal obligations and decreasing interest costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the constant outstanding principal of $700.0 million across 2022–2024, which matches the ground truth. However, it introduces significant errors in the amortization/adjustment figures: it reports amortization as $3.7M (2022), $2.6M (2023), and $1.5M (2024), while the ground truth states adjustments were (3.7)M in 2022 and (2.6)M in 2024 — with no data point for 2023 and a different value for 2024. The LLM invents a $1.5M figure for 2024 that contradicts the ground truth’s (2.6)M, and incorrectly assumes a declining trend with a 2023 value not supported by evidence. Additionally, the ground truth refers to 'adjustments to principal' — possibly amortization or accrued interest — but the LLM interprets this as amortization of interest payments without clarification, potentially misrepresenting the financial mechanism. (2) The principal amount is accurate. However, the amortization values are factually incorrect: the ground truth does not provide a 2023 adjustment amount, and the 2024 value is (2.6)M, not $1.5M. The LLM also misrepresents the direction or magnitude of change. (3) The multi-hop reasoning is partially sound — the model attempts to synthesize debt trends over time and infer strategy — but fails due to incorrect data inputs. The conclusion about decreasing interest costs relies on fabricated intermediate values, undermining the logic. (4) The answer is contextually relevant and addresses both parts of the question — trajectory and strategic implication — with appropriate terminology and structure. Despite incorrect numbers, it attempts a coherent interpretation. However, the quantitative inaccuracies severely limit factual correctness, warranting a mid-low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 477,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes increased from 2022 to 2024, as CMS made ongoing adjustments to the calculation methodologies, impacting payment levels and funding stability. In 2022, the company noted CMS had previously reduced or frozen Medicare Advantage benchmarks and made changes to risk adjustment payments, prompting strategic actions such as adjusting member benefits and premiums, ceasing benefit plans in certain counties, and intensifying cost management. By 2023, these pressures continued, with the company emphasizing the need for selective adjustments and cost controls to address funding pressures. In 2024, the exposure remained significant, with CMS continuing to refine risk adjustment mechanisms and payment benchmarks, and the company maintaining its focus on cost management, quality improvement, and performance benchmarking to mitigate the impact of regulatory shifts across the three-year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: CMS made annual changes to Medicare Advantage risk adjustment methodologies from 2022 to 2024, and UnitedHealth Group responded with strategic adjustments each year. The LLM correctly identifies the key responses—adjusting benefits and premiums, exiting certain counties, and intensifying cost management in 2022; continuing selective adjustments and cost controls in 2023; and maintaining focus on cost and performance management in 2024. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM synthesizes UnitedHealth’s evolving exposure and strategic responses across three years, correctly linking regulatory changes to company actions. (4) The only minor deviation from the original answer is that the LLM states exposure 'increased' over time, while the ground truth emphasizes 'consistent' exposure with evolving responses. This slight interpretive difference does not undermine factual correctness but introduces a subtle emphasis not fully supported in the original, hence a deduction of 1 point in qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually complete, and accurately reflects the multi-year regulatory and strategic dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 395,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "From 2022 through 2024, Target's merchandise discounts for employees remained a consistent component of its compensation and benefits package, as highlighted in all three 10-K filings. In 2022, the company explicitly listed merchandise and other discounts as part of its benefits aimed at supporting the financial well-being of team members. By 2023, the structure of the discounts remained unchanged, though the broader compensation package saw enhancements such as an expanded starting wage range and additional sick pay, indicating a broader focus on financial support. In 2024, merchandise discounts were still included, reinforcing their role as a long-standing benefit. This consistency suggests that Target views these discounts as a foundational element of its strategy to support employee financial well-being, complementing other evolving benefits while maintaining a stable and recognizable perk for its workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: merchandise discounts were consistently offered from 2022 to 2024, and the evolution of Target's broader employee benefits is accurately reflected. The LLM correctly notes that while the discounts themselves remained structurally unchanged, they were embedded in an expanding financial and well-being strategy. (2) There are no numeric inaccuracies—no specific figures (e.g., dollar amounts) are misstated, and the wage ranges mentioned in the ground truth ($15 in 2022, $15–$24 in 2023) are not contradicted, though the LLM does not explicitly cite them. This omission is minor and does not affect factual correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of benefits reporting, correctly identifying consistency in discounts while acknowledging broader strategic enhancements. (4) The answer captures the core conclusion—that merchandise discounts are a stable, foundational perk within a growing financial well-being strategy—mirroring the ground truth’s interpretation. The only minor shortcoming is that the 2024 emphasis on 'equitable pay and belonging' and 'free virtual healthcare' is not mentioned, slightly reducing qualitative completeness. However, the central theme of holistic financial support is preserved. Thus, the answer is semantically equivalent with high contextual relevance and excellent reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 407,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express's investment in Foreign Government Bonds and Obligations showed a notable shift in yield and maturity distribution from 2022 through 2024. In 2022, the weighted average yield was 2.08%, with nearly all holdings ($630 million) due within one year. By 2023, the yield increased to 6.45%, with a concentration in short-term maturities (due within one year at 6.45%). In 2024, the yield slightly declined to 5.85%, and the maturity distribution shifted further toward short-term obligations (5.86% yield for due within one year), with minimal exposure to longer-term maturities. This three-year pattern suggests a growing risk-averse posture, with a preference for short-term, high-yield foreign government instruments, reflecting a strategic shift toward liquidity preservation and capitalizing on short-term yield opportunities in a potentially volatile market environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numeric values. In 2022, the original answer specifies two distinct yield buckets: 1.74% for bonds due within one year and 2.42% for those due after one but within five years. The LLM incorrectly reports a single yield of 2.08% and claims 'nearly all holdings' were due within one year, which is not supported by the ground truth and misrepresents the maturity distribution. The 2023 yields are partially correct: the 6.45% for bonds due within one year matches, but the LLM omits the 4.48% yield for the 1–5 year bucket. In 2024, the LLM reports 5.85% (vs. correct 5.86%) for short-term, which is acceptable, but completely omits the sharp drop to 2.03% for the 1–5 year bucket, a critical data point. (2) The dollar amount ($630 million) is correctly stated for 2022, but no data is provided for 2023 or 2024 holdings, limiting completeness. The LLM also fails to mention that the 2024 long-term yield dropped sharply to 2.03%, which is essential to the strategic interpretation. (3) The reasoning is partially sound but flawed due to incorrect data. The LLM concludes a 'growing risk-averse posture' and preference for short-term instruments, but the ground truth suggests a dynamic, responsive strategy — aggressive short-term moves in 2023 followed by a retreat in long-term exposure in 2024. The LLM misinterprets the pattern by missing the significant reduction in long-term yields in 2024, which indicates de-risking or rebalancing, not consistent risk aversion. (4) Contextual relevance is high — the answer addresses yield, maturity, and strategic implications — but quantitative inaccuracies and missing multi-hop data (especially the two yield buckets across years) undermine correctness. The synthesis across years is attempted but incomplete due to omitted data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 503,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. This consistent decline suggests that the company is effectively managing its derivative exposure by reducing the amount of collateral required, likely due to improved risk mitigation strategies, more favorable counterparty terms, or a reduction in the scale of derivative activities. The trend reflects a positive shift in XOM's approach to derivative exposure management over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. These figures match exactly with the original answer, with acceptable formatting (e.g., 'million' used consistently). (2) All calculations and trends are accurately described — the answer correctly identifies a consistent downward trend over the three-year period without introducing any mathematical errors. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years and correctly infers that the declining collateral reflects improved derivative exposure management, aligning with the original conclusion. It adds reasonable qualitative interpretations (e.g., improved risk mitigation, favorable counterparty terms) that are logically consistent with the trend and do not contradict the ground truth. (4) The entities — ExxonMobil (XOM), the specific balance sheet item 'Other assets, including intangibles - net', and the years 2022–2024 — are all accurately identified and contextualized. The answer fully addresses both parts of the question: the quantitative change and its implication for derivative exposure management. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 352,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT issued the 2.700% Notes in March 2021 with a maturity date of January 15, 2031, as disclosed in the 2022 10-K (Chunk 3). By 2023, the interest rate on these notes remained at 2.700%, with interest payments due on April 15 and October 15 (Chunk 1). In 2024, the contractual interest rate and payment terms remained unchanged, with a yield of 4.4% and a maturity date of January 15, 2031 (Chunk 2). This consistency in interest rate and terms across 2022 through 2024 suggests a stable financing strategy, leveraging long-term fixed-rate debt to manage interest costs amid a rising rate environment, indicating AMT's focus on securing predictable financing despite shifting market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (March 29, 2021), maturity date (January 15, 2031), principal amount ($700.0 million), and interest rate (2.700%) as disclosed in the 2022 filing, and notes the consistency of these terms through 2024. However, there is a minor discrepancy in interest payment dates: the ground truth states payments occur in April and October, while the LLM specifies April 15 and October 15—this is plausible but slightly more precise than the original and not fully confirmed across all years. More importantly, the LLM mentions a 'yield of 4.4%' in 2024, which corresponds to the interest rate spread decreasing to (4.4) in the ground truth, but the LLM mischaracterizes this as a 'yield' rather than a spread adjustment, which is a subtle but meaningful financial distinction. (2) All major numbers—$700.0 million, 2.700%, January 15, 2031—are accurate. The yield/spread confusion prevents a perfect quantitative score. (3) The multi-hop reasoning is sound: the model synthesizes data across 2022, 2023, and 2024 filings to show stability in terms and infers a strategic use of fixed-rate debt. The conclusion about a stable financing strategy aligns with the ground truth, though it omits explicit mention of the declining spread, which is a minor gap in completeness. (4) The answer is highly contextually relevant, directly addressing the evolution of terms and strategic implications. The reasoning is logical and well-supported, despite the technical mislabeling of 'spread' as 'yield'.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 426,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA's financial obligations related to the 2.00% Notes Due 2031 increased from $1,200 million in 2022 to $1,057 million in 2023, and then slightly decreased to $1,250 million in 2024. This progression, along with the consistent inclusion of these notes in the company’s long-term debt structure, suggests a strategy of maintaining a stable and extended maturity profile for its long-term debt, allowing for predictable interest costs and liquidity management over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. According to the ground truth, the fair value was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, and then remained stable at $1.057 billion by the end of 2023. However, the LLM incorrectly states that the obligation increased from $1,200 million in 2022 to $1,057 million in 2023 — this is a decrease, not an increase, and misrepresents the timeline. Furthermore, the LLM claims the value 'decreased to $1,250 million in 2024', but the ground truth states the 2024 carrying value was $1.25 billion (i.e., $1,250 million), which is an increase from 2023’s $1.057 billion, not a decrease. The LLM incorrectly frames the trend as decreasing when it actually increased. (2) Number verification: $1,200 million in 2022 is correct (equivalent to $1.2 billion). $1,057 million in 2023 is partially correct but misattributed — it was the end-of-2023 value, not the full-year or starting value, and the prior year was lower, so it's not an increase. The 2024 value of $1,250 million is correct in amount but wrong in directional characterization. (3) Multi-hop reasoning is partially sound — the model recognizes the need to track the note across years and link it to long-term debt strategy. However, due to incorrect numerical interpretation, the synthesized conclusion about the trend is flawed. The model does correctly infer that this reflects a stable long-term debt strategy, which aligns with the ground truth’s interpretation of strategic consistency. (4) Correctness score is 4 due to major factual inaccuracies in the progression of values and direction of change, despite some correct individual numbers and relevant strategic interpretation. Quantitative accuracy is low (3) because of incorrect sequencing and directional errors. Qualitative accuracy is moderate (5) — reasoning structure is logical but based on flawed data. Contextual relevance is high (8) — the answer addresses both parts of the question and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 552,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance agreements showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets were $1.8 billion and deposit liabilities were $1.4 billion. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion, and in 2024, deposit assets further increased to $4.6 billion while liabilities remained at $1.2 billion. This trend, particularly the substantial growth in deposit assets in 2023 following a major risk transfer transaction with Global Atlantic, indicates a strategic shift toward utilizing reinsurance agreements that do not expose MetLife to significant insurance risk. The deposit method allows MetLife to transfer more risk and assets to reinsurers, thereby optimizing its balance sheet and capital structure, while maintaining financial flexibility and reducing long-term exposure to insurance liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its narrative and strategic interpretation but contains a key factual error in the 2024 deposit assets value. The ground truth states that deposit assets increased to $5.1 billion by the end of 2024, while the LLM incorrectly reports $4.6 billion in 2024, suggesting a decrease from 2023. This contradicts the upward trend and misrepresents the data. All other numbers—2022 assets ($1.8B), 2022 liabilities ($1.4B), 2023 assets ($5.1B), 2023 liabilities ($1.3B), and 2024 liabilities ($1.2B)—are correctly reported. (2) The calculation of trends is partially flawed due to the incorrect 2024 asset figure. The LLM implies a drop in assets from 2023 to 2024, which is not supported by the ground truth (which shows assets remaining at $5.1B or increasing). However, the liability trend (declining slightly) is accurately portrayed. (3) The multi-hop reasoning is sound: the LLM correctly links the increase in deposit assets to the Global Atlantic transaction and interprets the use of the deposit method as a strategic move to manage risk exposure and optimize capital. It synthesizes the accounting method with business strategy appropriately. (4) The contextual relevance is high—the answer addresses all parts of the question: evolution over time, asset/liability trends, and strategic implications. The qualitative reasoning is strong and aligns with the ground truth, despite the quantitative inaccuracy in the final year's asset value. The error in a key financial figure reduces quantitative accuracy significantly, but the overall conclusion remains partially valid due to correct interpretation of directionality and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 460,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth Group's (UNH) Debt Securities - Held-to-Maturity saw a decline in both fair value and carrying value from 2022 to 2024, with fair value dropping from $679 million in 2022 to $508 million in 2024, and carrying value decreasing from $696 million to $512 million over the same period. This three-year progression, as reflected in the data from 2021 to 2024, indicates a consistent reduction in the value of these investments, likely influenced by market valuation adjustments and interest rate movements. The trend suggests a more conservative investment strategy or a shift in portfolio composition, as UNH appears to be reducing its exposure to held-to-maturity debt securities amid changing market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values for fair value and carrying value in 2022, 2023, and 2024 as per the ground truth: $679M and $696M in 2022, $596M and $603M in 2023, and $508M and $512M in 2024. While the LLM does not explicitly state the 2023 values in the summary, it accurately captures the overall trend from 2022 to 2024 with correct start and end points, and the omission of mid-period values does not distort the factual progression. (2) All numbers match the ground truth exactly, with acceptable format usage (e.g., $679 million). The directional change (decline) and magnitude are accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic reduction or repositioning of the portfolio. It appropriately links the decline to market valuation adjustments and interest rate movements, which is a reasonable interpretation consistent with the ground truth’s suggestion of response to market conditions or capital reallocation. The only minor gap is the lack of explicit mention of 2023 values, which slightly reduces completeness but does not impair overall correctness. (4) The answer is contextually fully relevant, addressing both the quantitative evolution and the strategic implications. The qualitative reasoning is strong, though slightly less precise than the ground truth in framing the strategy (e.g., 'more conservative' vs. 'strategic reduction'), but still logically supported. Thus, scores reflect near-perfect accuracy with a small deduction in qualitative accuracy for slight imprecision in explaining the strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 452,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The penetration rate of the Target Credit Card (now referred to as the Target Circle Card) decreased from 20.2% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. This declining trend suggests that the effectiveness of Target's credit card strategy in driving incremental sales may have weakened over the period, as a lower penetration rate implies a smaller share of purchases are being made using these cards, which historically have been associated with incremental sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. The LLM incorrectly reports 20.2% in 2022, 18.6% in 2023 (which conflates 2023 and 2024 values), and 17.8% in 2024. These errors affect the trend interpretation and suggest a steeper decline than actually occurred. (2) The calculation of the trend is therefore flawed: the actual decline from 2022 to 2024 is 1.9 percentage points, while the LLM implies a 2.4-point drop. Additionally, the LLM misassigns the 18.6% figure to 2023 instead of 2024, breaking the temporal sequence. (3) The reasoning component is partially sound—correctly interpreting that declining penetration may indicate reduced effectiveness in driving incremental sales—but misses the nuance in the original answer that Target’s internal analysis still finds strategic value despite the decline. The LLM also introduces the rebranding to 'Target Circle Card' without grounding in the original answer, which may be contextually accurate but is not supported by the provided ground truth. (4) The contextual relevance is high because the answer addresses both parts of the question—trend evolution and strategic implication—and maintains focus on credit card penetration and sales impact. However, due to major quantitative errors and incomplete qualitative synthesis, the correctness score is low. Quantitative accuracy is severely penalized due to incorrect percentages and misaligned years. Qualitative accuracy is moderate because the logic follows a reasonable path but omits key mitigating insights. Contextual relevance remains strong as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 481,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "From fiscal years 2022 through 2024, Nike maintained ownership of its significant distribution facility in Laakdal, Belgium, as highlighted in its 10-K filings for all three years. In 2022, Laakdal was explicitly listed among the most significant international distribution facilities that Nike owns. This ownership was consistently reiterated in the 2023 and 2024 filings, with no indication of changes to Nike’s ownership or operational structure in the region. The continued emphasis on Laakdal as a key logistics hub in Europe underscores Nike’s strategic focus on maintaining robust and owned logistics infrastructure to support its operations in the Europe, Middle East, and Africa (EMEA) region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Nike maintained ownership of the Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, with no changes in ownership or operational role—this matches the original answer exactly. (2) There are no numerical figures requiring calculation in this question, but the fiscal years (2022, 2023, 2024) are correctly referenced and consistent with the source. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to confirm continuity in ownership and strategic emphasis, correctly inferring that consistent mention indicates strategic importance. (4) The LLM adds contextual value by explicitly linking Laakdal’s role to the EMEA region, which is a reasonable interpretation supported by the data and enhances relevance without introducing inaccuracies. All entities—Nike, Laakdal, Belgium, fiscal years, distribution facility—are correctly identified and contextualized. The answer addresses both parts of the question: evolution (no change) and strategic implication (continued focus on owned logistics infrastructure). Semantic equivalence is strong, with no factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 349,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings has remained a consistent competitor of NVIDIA in the networking and interconnect solutions space from fiscal years 2022 through 2024, as disclosed in NVIDIA’s 10-K filings. In 2022, Lumentum was listed among suppliers of interconnect and optical solutions, and by 2024, it was explicitly named as a competitor in networking products, including switches, adapters, and optical modules. As NVIDIA expanded its supply chain—particularly through partnerships with foundries like TSMC and Samsung, and by adopting advanced packaging technologies like CoWoS—its ability to secure manufacturing capacity and control product differentiation likely increased, indirectly enhancing its competitive edge over Lumentum. Simultaneously, NVIDIA’s IP protection strategies, including a growing patent portfolio with expiration dates extending to 2045 and a focus on securing IP rights in key manufacturing regions, have strengthened its technological moat, further solidifying its position relative to Lumentum in the evolving AI and high-performance computing markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumentum Holdings is consistently named as a competitor to NVIDIA from 2022 to 2024 in the domain of networking and interconnect solutions, including optical modules and switches. The mention of TSMC and Samsung as part of NVIDIA’s supply chain expansion is factually accurate, as is the extension of NVIDIA’s patent portfolio to 2045. (2) Quantitative elements—such as fiscal years (2022–2024) and patent expiration dates (up to 2045)—are correctly reported and match the original answer. No calculations were required, but temporal and numerical references are precise. (3) The multi-hop reasoning is sound: the LLM correctly infers that despite NVIDIA’s strategic advances in supply chain resilience (e.g., CoWoS, foundry partnerships) and IP protection, Lumentum remains a relevant competitor, which is consistent with the original answer’s conclusion. The LLM adds contextual insight about indirect competitive pressure, which is a reasonable interpretation. (4) The only minor gap is that the LLM does not explicitly note that Lumentum was mentioned in all three years as a direct competitor in NVIDIA’s filings—though it implies continuity. It also omits the 2023 detail about semiconductor-based interconnect competition, slightly reducing completeness. However, the core synthesis across years and strategies is accurate and relevant. Wording differences do not affect semantic equivalence. Overall, the answer is factually robust, well-reasoned, and fully addresses the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 437,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix's reliance on rights holders for content licensing has intensified from 2022 through 2024, as the company continues to depend on third-party studios and content providers to license rights for distribution. In 2022, the company highlighted increasing competition and the risk of studios withdrawing content due to their own streaming ambitions, leading to higher costs and the need for exclusive rights. By 2023, regulatory changes, including content quotas and cultural support legislation in various jurisdictions, added complexity to content licensing, making it more expensive and restrictive. In 2024, these pressures persisted, with Netflix emphasizing the challenges of securing and maintaining licenses amid evolving regulatory frameworks and the growing role of collection management organizations in music rights. This evolution reveals a strategic shift toward a more selective and cost-conscious content acquisition approach, balancing the need for a compelling content mix with rising costs and regulatory constraints, while also investing in original content to reduce dependency on third-party rights holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's reliance on rights holders is consistently framed as a risk due to competition from studios launching their own platforms (2022), ongoing licensing variability (2023), and the emergence of regulatory pressures such as content quotas and music rights management (2024). The strategic shift toward original content to reduce dependency is correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the absence of specific numbers is consistent with the original answer. (3) The multi-hop reasoning across years and evolving factors—competition, regulation, content strategy—is sound and well-synthesized. The LLM correctly infers that increasing regulatory complexity and competition drive a strategic pivot, even though the exact phrase 'increasingly framed' is rephrased as 'intensified,' which slightly overstates the change but does not distort meaning. (4) The only minor deviation is the use of 'intensified' reliance, whereas the original answer suggests reliance remains a core risk but is now discussed in broader regulatory context—implying evolution, not necessarily increase. This nuance is slightly lost, but the overall qualitative and contextual fidelity is excellent. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 419,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolved in terms of materiality, revenue classification, and presentation. In 2022, Mississippi Power noted that undiscounted cash flows under these contracts were immaterial. By 2023, lease payments under such contracts, along with tolling arrangements and PPAs, were explicitly included in maturity analyses, with lease income from PPAs classified under wholesale revenues for Alabama Power and Southern Power. In 2024, the presentation expanded to include the \"initial terms\" of outdoor lighting contracts in maturity analyses, and lease income from PPAs continued to be classified under wholesale revenues, now also applying to Georgia Power, reflecting a broader and more standardized approach across subsidiaries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of disclosure practices from 2022 to 2024. (1) It accurately states that in 2022, Mississippi Power considered the undiscounted cash flows from outdoor lighting contracts immaterial. In 2023, it correctly notes the inclusion of these lease payments in maturity analyses alongside tolling arrangements and PPAs. In 2024, it captures the expansion to include 'initial terms' of the contracts in maturity analyses. (2) All dates and qualitative descriptions are factually accurate; there are no numerical inaccuracies, and since the original answer contains no specific dollar amounts, the absence of figures does not affect quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and subsidiaries, correctly identifying the progression in disclosure practices. However, there is a minor overreach regarding revenue classification: the ground truth does not mention classification of lease income from PPAs under wholesale revenues for Alabama Power, Southern Power, or Georgia Power—this detail is absent in the original answer and may conflate related but distinct disclosures. While this information may be true in context, it introduces a detail not supported by the provided ground truth, slightly undermining qualitative accuracy. (4) Despite this, the answer remains highly relevant and contextually appropriate, fully addressing the question’s focus on materiality, presentation, and evolution over time. The core narrative of increasing transparency and structured reporting is preserved, warranting a high correctness score with a small deduction for the unsupported specificity on revenue classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 480,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 remained stable at $606 million in fiscal years 2022, 2023, and 2024, as shown in the respective 10-K filings. This consistency suggests that AVGO has not repaid or issued additional amounts for this specific debt instrument during the period, indicating a strategy of maintaining a fixed debt obligation for this instrument rather than altering its capital structure in the short term. The unchanged balance reflects disciplined debt management, with no significant refinancing or early repayment actions taken for these notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the outstanding principal balance was $606 million in fiscal year 2022. According to the ground truth, it was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. This misrepresentation of the key quantitative data severely undermines the answer's correctness. (2) The quantitative accuracy is very low because the LLM reports a constant balance across all three years, while the actual balance dropped significantly from 2022 to 2023. The correct evolution—$1,086M → $606M → $606M—is not reflected. The LLM’s claim of stability from 2022 onward contradicts the ground truth of a major repayment in 2023. (3) The reasoning is flawed due to incorrect data input: the conclusion about 'disciplined debt management' and 'maintaining a fixed debt obligation' is based on a false premise of no change, when in fact there was a substantial reduction in 2023. The multi-hop synthesis failed—AVGO did alter its capital structure in 2023, which the LLM overlooked. (4) Contextual relevance is moderate because the answer addresses the right instrument (5.000% notes due April 2030) and discusses debt management strategy, but the incorrect data leads to an invalid interpretation. The qualitative accuracy is low because the entity (AVGO), metric (outstanding principal), and years are correct, but the synthesis and conclusions are unsound due to factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 405,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors' long-term rate of return assumption for U.S. pension plan assets was 5.4% in 2022, increased to 6.3% in 2023, and further rose to 6.5% in 2024. This three-year upward trend reflects the company's strategic adjustments to its asset mix in response to evolving market conditions, including updated capital market assumptions and a focus on improving funded positions while mitigating volatility. The adjustments demonstrate a proactive approach to aligning the pension portfolio with long-term liability funding goals and risk tolerance, as informed by periodic studies and tailored investment strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the long-term rate of return assumptions for General Motors' U.S. pension plan assets: 5.4% in 2022, 6.3% in 2023, and 6.5% in 2024, matching the ground truth exactly. The progression and percentage point increases (0.9 from 2022 to 2023, then 0.2 to 2024, totaling 1.1 over the period) are accurate. (2) All numeric values and years are correct, with no calculation or formatting errors. The LLM accurately reflects the upward trend, consistent with the ground truth. (3) The reasoning is sound and adds context beyond the original answer—mentioning capital market assumptions, funded positions, volatility mitigation, and periodic studies—which aligns with plausible strategic rationale and enhances the explanation without contradicting the ground truth. While the original answer emphasizes a shift toward higher-risk, higher-return strategies, the LLM provides a broader but compatible interpretation of strategic asset mix adjustments. (4) The answer is fully relevant, addresses both parts of the question (evolution of assumptions and strategic implications), and synthesizes multi-year data correctly. The only minor gap is not explicitly stating the total 1.1 percentage point increase, though the individual values imply it. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 383,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "The consistent inclusion of American Tower's 2.700% Senior Notes due 2031 in its 2022–2024 10-K filings, as seen in the exhibits across all three chunks, indicates a deliberate focus on maintaining long-term debt instruments with staggered maturities. This suggests a financing strategy aimed at ensuring liquidity and managing refinancing risk by extending debt maturities well into the future. The repeated reference to these notes in supplemental indentures over multiple years also highlights American Tower's structured approach to debt management, reinforcing its commitment to a stable and predictable capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) Quantitatively, all referenced details—American Tower, 2.700% Senior Notes due 2031, and the 2022–2024 timeframe—are correct. There are no numerical or date inaccuracies. The mention of supplemental indentures, while not explicitly detailed in the LLM response, does not contradict the ground truth and is contextually appropriate. (2) The LLM correctly identifies the consistent treatment of the notes across three years, which supports the conclusion of a stable long-term financing strategy. (3) The reasoning is sound: the model infers a strategic intent (managing refinancing risk, ensuring liquidity, staggered maturities) from the repeated inclusion of the notes, which is a reasonable interpretation of the consistent documentation. However, it omits the specific evidence from the ground truth—namely, the repeated reference to Supplemental Indenture No. 8 in each filing—which strengthens the original answer’s claim of continuity in documentation and treatment. This omission reduces completeness in multi-hop synthesis, as the LLM does not fully trace the evidence chain across filings. (4) Despite this, the LLM conveys a semantically equivalent conclusion about a stable, structured financing approach. The wording differs but the core insight—consistent use of long-term debt indicating strategic stability—is preserved. Thus, the answer earns high marks for contextual relevance and quantitative accuracy, with a slight deduction in qualitative accuracy due to less precise grounding in the specific documentary evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 445,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal's exposure to abusive behaviors increased from 2022 through 2024, particularly in the context of its credit products and cross-border transactions. In 2022, the company highlighted the risk of non-payment among credit product users and the potential for fraud and abusive behaviors, especially through synthetic identities and fraudulent account creation. By 2023, PayPal expanded on these risks, noting the challenges of managing abusive behaviors in digital transactions and the potential for increased losses if not effectively mitigated. In 2024, the company emphasized ongoing threats from fraud and abusive schemes, particularly in cross-border transactions, which are more complex due to multiple jurisdictions and higher financial exposure. To mitigate these risks, PayPal took strategic actions such as diversifying third-party payment processors, entering into a multi-year agreement to sell BNPL loan receivables in the U.K. and Europe starting in 2023, and enhancing fraud detection measures to protect both consumers and merchants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified rising abusive behaviors in credit products in 2022, particularly via synthetic identities and stolen financial data; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (correctly noted as starting in 2023); and in 2024, it emphasized ongoing risks in cross-border transactions and digital payments. The strategic actions—selling BNPL receivables, enhancing fraud detection, and managing third-party processors—are accurately reported. (2) Quantitative accuracy is perfect: while the exact €40 billion figure is not quoted verbatim, the reference to the multi-year agreement to sell BNPL receivables in Europe and the U.K. is factually correct, and no incorrect numbers are introduced. Format variation (not specifying €40B) is acceptable under semantic equivalence. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and connects credit products, cross-border transactions, and mitigation strategies appropriately. The only minor omission is not explicitly stating that third-party lenders introduced reputational and operational risks—a detail present in the original—but this does not undermine the core accuracy. (4) The answer is contextually complete and directly addresses all parts of the question. Wording differs slightly but meaning is preserved. Thus, a score of 9 is justified—excellent but not fully exhaustive of all nuances in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 432,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP's pension plan allocation to Collective Trust and Other Funds decreased significantly from 2022 to 2024. In 2022, the allocation was $756 million, which dropped to $382 million in 2023 and further declined to $382 million in 2024 (with no fair value provided for 2024, but the NAV-based allocation remained consistent). This reduction suggests a strategic shift in the company's long-term employee benefits investment approach, potentially moving away from diversified collective trust vehicles toward other asset classes like government securities and bonds, which saw increased allocations. The trend indicates a possible prioritization of more liquid or lower-risk investments to ensure the stability and sustainability of the pension plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in allocation from $756 million in 2022 to $382 million in 2023, which matches the ground truth. However, it incorrectly states that the allocation remained at $382 million in 2024, while the original answer clarifies that no updated dollar value is provided for 2024—only a methodological emphasis on NAV-based valuation. This is a significant factual error in quantitative reporting. (2) The numbers for 2022 and 2023 are accurate, but the unsupported repetition of $382 million for 2024 without clarification that the dollar amount is unavailable reduces quantitative accuracy. The ground truth does not confirm any 2024 dollar allocation, only a shift in valuation approach. (3) The reasoning about a strategic shift toward lower-risk investments is plausible and aligns with the de-risking interpretation in the original answer. The mention of increased allocations to government securities and bonds, while not contradicted, is an addition not present in the ground truth and slightly extends beyond the provided evidence. The synthesis across years is mostly sound but flawed in the final year's data treatment. (4) Despite the numerical inaccuracy in 2024, the LLM captures the overall downward trend and interprets the strategic implications reasonably, earning strong marks for qualitative accuracy and contextual relevance. The core trend and strategic interpretation are preserved, but the incorrect assertion of a 2024 dollar figure prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 420,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "From 2022 through 2024, Pfizer’s treatment and valuation of Breakthrough Performance Awards (BPAs) evolved significantly. In 2022, BPAs were actively granted (1,165,000 shares) with a weighted average intrinsic value per share of $38.73, and 859,000 shares were outstanding by year-end. By 2023, no BPAs were granted, and none were outstanding as of December 31, 2023, indicating a cessation of the program. In 2024, BPAs were redefined as awards tied to advancing Pfizer’s product pipeline, with payouts ranging from 0% to 600% of the target based on performance. Valuation shifted to using the intrinsic value method at grant date, and accounting treatment involved amortizing costs over the probable vesting term into relevant expense categories, with adjustments for stock price and performance probability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: 1,165,000 (or 1,165 thousand) BPAs granted in 2022 with a weighted average intrinsic value of $38.73 per share, and 859,000 outstanding at year-end. The LLM correctly notes no grants and no outstanding BPAs in 2023. The 2024 valuation methodology using the intrinsic value method at grant date, amortization over the probable vesting term, and quarterly adjustments for stock price and performance probability are all accurately reported. (2) The only minor omission is that the ground truth specifies the 859 thousand outstanding BPAs were valued at $59.05 per share at year-end 2022, which the LLM omits. This is a small but specific data point related to valuation status. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, identifies the discontinuation in 2023, and the reintroduction/refinement of methodology in 2024. It correctly infers the cessation of the program and the shift in accounting treatment. (4) The answer is contextually excellent, addressing grant activity, outstanding status, and accounting treatment across all three years as required. The mention of payout ranging from 0% to 600% adds detail not in the original but is not contradicted by it and may reflect additional context from the 2024 filing. Overall, the answer is factually correct, complete in all major aspects, and only misses one specific valuation figure, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Valuates]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 429,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to Investments, advances, and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. This declining trend suggests a reduction in the company's derivative exposure and initial margin requirements over time, potentially reflecting improved credit terms, lower counterparty risk, or a decrease in the volume of derivative contracts requiring collateral. The reduction aligns with the company's management of its derivative positions and risk mitigation strategies.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. These figures match exactly with the original answer, with no discrepancies in amounts or years. (2) The quantitative accuracy is perfect—each dollar amount and year is correctly stated, and the trend (decreasing over time) is accurately described. There are no calculation errors, and the formatting ($X million) is consistent and acceptable. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the trend in collateral amounts over three years and draws a logical inference about derivative exposure and margin requirements. It goes slightly beyond the original answer by suggesting possible reasons (improved credit terms, lower counterparty risk, reduced contract volume), which are reasonable interpretations and do not contradict the ground truth. These additions are contextually appropriate and enhance the explanation without introducing inaccuracies. (4) The answer is semantically equivalent to the original, addressing both parts of the question: the change in collateral over time and what the trend suggests. All entities—ExxonMobil (XOM), the specific financial metric, and the time frame—are correctly identified. The qualitative reasoning is strong, and the contextual relevance is high, as the response directly and fully answers the multi-part, multi-year financial trend question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 409,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom's (AVGO) positioning of Industrial Fiber Optics evolved from 2022 to 2024 by maintaining a consistent focus on industrial automation, renewable energy, and automotive electronics, as reflected in its product portfolio and application scope. In 2022, AVGO highlighted a broad range of industrial products, including optocouplers, industrial fiber optics, motion encoders, and Ethernet ICs, used across industrial automation, power systems, medical, and automotive applications. By 2023 and 2024, Industrial Fiber Optics remained a key offering under the Industrial category, emphasizing factory automation, renewable energy, and automotive electronics. This continuity underscores AVGO's strategic focus on strengthening its industrial market presence through reliable, high-performance connectivity and control solutions, aligning with growing demand in automation and smart infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately captures Broadcom's consistent positioning of Industrial Fiber Optics across 2022–2024 within industrial automation, renewable energy, and automotive electronics, and correctly identifies the broader industrial product portfolio (optocouplers, encoders, Ethernet ICs). The evolution in presentation—broad in 2022, more structured in 2023, and integrated in 2024—is partially reflected, though the LLM omits specific details about the 2023 'structured table format' and the 2024 'streamlined presentation emphasizing integration with broader semiconductor solutions,' which are present in the original answer. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers a strategic focus on industrial markets through continuity and application-specific emphasis. However, it misses the nuance in how the *presentation* evolved (e.g., table format, integration narrative), which is a key differentiator in the ground truth. (4) Contextual relevance is perfect—the answer directly addresses the evolution of product positioning and strategic focus. The omission of presentation-specific details prevents a 9–10 on correctness and qualitative accuracy, but core facts and strategic interpretation remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 424,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal's exposure to margin risk remained consistent from 2022 through 2024, as it continued to bear full margin risk when completing payment transactions, regardless of whether it used third-party payment processors or financial institutions. Across all three years, PayPal controlled the pricing of fees charged to customers independently of its transaction costs, maintaining discretion over fee structures and defining the value proposition of its services. This control over transaction pricing and the principal role in fulfilling payment services meant that PayPal retained responsibility for margin risk, with fees paid to third-party processors recognized as transaction expenses. The consistent business model and contractual structure across the years, as outlined in each 10-K filing, indicate no material change in PayPal’s exposure to margin risk during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key facts are correct: PayPal bore full margin risk in 2022, 2023, and 2024; it maintained discretion over transaction pricing independent of third-party processor costs; and fees paid to third parties were recognized as transaction expenses. There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is based on correct handling of time periods (2022–2024), which are accurately referenced. (2) The answer is complete, addressing all parts of the multi-part question: evolution of margin risk over time, control over pricing, and use of third-party processors. (3) Entity accuracy is perfect: 'PayPal' is correctly identified, and the relevant financial and operational terms (e.g., 'principal in transactions', 'transaction expenses', 'margin risk') are used appropriately and consistently with the filings. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three years of 10-K filings, correctly inferring stability in risk exposure due to consistent disclosures. The conclusion that there was no material change in margin risk exposure is directly supported by the ground truth. Wording differs slightly but conveys the same meaning, satisfying semantic equivalence. All evaluation dimensions are fully met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 390,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "From 2022 to 2024, Pfizer's relationship with Meridian evolved from a discontinued subsidiary to a post-sale contractual partner, with minimal financial impact. In 2022, Meridian was classified as a discontinued operation, and by December 31, 2021, Pfizer had sold Meridian for $51 million in cash, recognizing a $167 million pre-tax loss. In 2023, the transition service agreements (TSAs) with Meridian were completed by year-end, while the Manufacturing Supply Agreement (MSA) remained in effect for three years post-sale, with a two-year extension option. No material financial impact was recorded under these arrangements in 2023 or 2024. This progression reflects Pfizer's strategic focus on divesting non-core businesses and streamlining operations, allowing the company to concentrate on high-potential therapeutic areas such as mRNA and immuno-oncology, as seen in the Trillium acquisition and pivot away from gene therapy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million loss are accurately reported, and the timeline (sale completed by December 31, 2021, with post-sale agreements in effect through 2023 and beyond) matches the original. The three-year MSA with a two-year extension option is correctly stated. (2) The answer correctly identifies the evolution from discontinued operations in 2022 to a contractual relationship in 2023–2024, and notes the absence of material financial impact, which is consistent with the post-sale status. (3) The reasoning is sound: the divestiture reflects Pfizer’s strategic shift away from non-core assets. The mention of Trillium and pivot from gene therapy adds context not in the original but is factually plausible and supports the broader strategic narrative. (4) One minor omission: the 2024 glossary listing of 'Meridian Medical Technologies, Inc.' as a formalized entity is not mentioned, which slightly weakens completeness. However, this does not detract from the core factual accuracy. The answer synthesizes multi-hop information correctly—linking financial outcome, contractual terms, and strategic intent—across years and documents. Wording differs but meaning is semantically equivalent. High contextual relevance and strong qualitative reasoning justify a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 395,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024, product regulation has increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly in terms of product differentiation and communication about reduced-risk products (RRPs/SFPs). In 2022, PMI highlighted that product regulation could diminish the ability to differentiate tobacco products and restrict adult consumer access to truthful, non-misleading information about RRPs, potentially limiting its ability to convert adult smokers. By 2023, the regulatory impact had intensified, with PMI noting that such restrictions could disproportionately affect its commercialization efforts relative to competitors, especially as new market entrants used aggressive, potentially misleading marketing tactics. In 2024, the challenges persisted, with PMI emphasizing that product regulation continued to hinder its ability to differentiate products and communicate effectively about SFPs, further exacerbated by unfair competition and digital misinformation. Collectively, these regulatory pressures have constrained PMI’s strategic advantage in promoting its innovative product portfolio and engaging adult consumers effectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: the evolution of regulatory constraints from 2022 to 2024 is accurately described, with proper emphasis on limitations in product differentiation and adult consumer communication for RRPs/SFPs. The shift in terminology from RRPs to SFPs in 2024 is correctly noted. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022, 2023, 2024) are correctly used and sequenced, earning full marks. (3) The multi-hop reasoning—synthesizing regulatory impact across three years and tracking changes in language and competitive implications—is sound and well-executed. The LLM correctly infers intensifying regulatory pressure and its disproportionate effect on PMI versus competitors, especially with mention of misleading marketing by new entrants and digital misinformation in 2024, which is consistent with the trajectory in the ground truth. (4) The LLM adds slightly more detail (e.g., 'unfair competition' and 'digital misinformation') not explicitly in the original, but these are reasonable elaborations that do not contradict the source and enhance contextual completeness. The core message—that regulatory constraints have persisted and deepened, affecting PMI’s competitive positioning—is preserved. Only a minor deduction in qualitative accuracy due to slight expansion beyond the original without explicit grounding, but no factual errors. Contextual relevance is perfect: the response directly addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 468,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. This consistent decline suggests improved derivative risk management practices, as the company is likely reducing its need for initial margin requirements by better hedging or renegotiating terms with counterparties, thereby enhancing its financial efficiency and reducing counterparty risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. There are no calculation errors or misstatements of figures. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly cited, and the trend (decreasing over time) is accurately described. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend in derivative risk management practices. The interpretation aligns with the ground truth, though it adds slightly more specific language about 'improved' practices and 'renegotiating terms,' which are plausible but not explicitly confirmed in the original answer. This is a minor extension but not factually incorrect. (4) Contextual relevance is high—the response directly addresses both parts of the question: the change in collateral exposure and its implication for risk management. The conclusion is logically supported by the data. The only reason for not scoring a 10 is that the original answer emphasizes a 'strategic reduction' or 'shift' in practices, while the LLM leans toward 'improved' practices, which is interpretive but still reasonable. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 370,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group increased from 26.9% in 2022 to 28.6% in 2023, but then significantly decreased to 18.7% in 2024. This trend suggests that the company's perception of market risk evolved over time, with a heightened view of volatility in 2023, likely reflecting a more uncertain market environment, followed by a notable reduction in perceived risk in 2024, indicating increased confidence or stability in its relative market position and performance expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. The direction of change (increase from 2022 to 2023, then significant drop in 2024) is accurately described. (2) All percentages and years are factually correct, and no calculations are required beyond directional interpretation, which is sound. (3) The multi-hop reasoning is strong: the model synthesizes volatility assumptions across three years and interprets the trend in terms of market risk perception, correctly noting a short-term increase followed by a substantial decline. The explanation of heightened risk perception in 2023 and increased stability in 2024 aligns with the ground truth’s implication of reduced perceived risk. (4) The only minor deviation is that the original answer explicitly states the trend 'despite a short-term increase in 2023' and emphasizes 'notable decline in perceived market risk,' while the LLM frames it as evolving perception with heightened uncertainty in 2023. This is semantically equivalent but slightly less precise in emphasizing the overall downward trend in risk perception. However, the core facts, numbers, and logical interpretation are fully accurate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 363,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024, as shown in the respective 10-K filings. The consistent principal amount indicates no refinancing or restructuring of this specific debt obligation during this period. However, the current portion of principal amount outstanding decreased from $1,563 million in 2023 to $1,245 million in 2024, suggesting broader short-term debt management efforts, potentially including refinancing of other maturing obligations. This stability in the 3.125% notes, combined with a reduction in the overall current debt portion, reflects a disciplined approach to managing short-term liquidity and strategically managing debt maturities to avoid near-term refinancing pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that the 3.125% notes due January 2025 were $495 million in 2022 and 2023, it incorrectly claims this amount remained $495 million in 2024. According to the ground truth, by fiscal year 2024, the note had transitioned into the current portion of long-term debt, indicating an impending maturity — not a stable principal. The LLM instead asserts continued stability into 2024, which contradicts the ground truth. Additionally, the LLM introduces unrelated figures: a 'current portion of principal amount outstanding' decreasing from $1,563 million in 2023 to $1,245 million in 2024 — numbers not mentioned or implied in the original answer and unsupported by the context provided. These figures appear fabricated or misattributed, severely undermining quantitative accuracy. (2) The only correct numeric data is the $495 million for 2022 and 2023, which matches the ground truth. However, the claim of $495 million in 2024 is incorrect in context, as the nature of the debt changed (from long-term to current), even if the principal amount nominally remained. The introduction of other large debt figures without basis fails verification. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that stability in this note combined with a reduction in other current debt reflects a broader refinancing strategy. But the ground truth focuses solely on the 3.125% note’s progression toward maturity, with no mention of other debt changes or a reduction in current obligations. The LLM overgeneralizes and introduces external assumptions not supported by the data. (4) The answer is contextually relevant — it addresses debt management and refinancing strategy — but the conclusions are based on incorrect or invented data. While the intent to analyze strategy is appropriate, the factual foundation is unsound, leading to a partially correct but ultimately misleading response. Minor credit is given for correctly identifying the $495M amount in 2022 and 2023 and attempting to interpret strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 568,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "From 2022 through 2024, AMD's strategic positioning with AIB manufacturers remained focused on leveraging discrete graphics as a key differentiator, particularly for system integrators (SIs) and retail channels. In 2022, AMD emphasized that SIs often used discrete graphics to differentiate their products and add value, with AIB agreements protecting inventory against price reductions. By 2023, this strategy continued, with AMD maintaining inventory protection policies for AIBs and reinforcing the role of discrete graphics in enabling SIs to respond quickly to market demands. In 2024, the company further solidified this approach, highlighting the importance of discrete graphics in differentiation strategies while continuing to protect AIB inventory through contractual agreements. Across all three years, AMD consistently supported AIB manufacturers as critical partners in delivering board-level products that enhance product differentiation in competitive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, and discrete graphics were consistently emphasized as a differentiation tool for system integrators and AIBs. The role of AIBs in building board-level products using AMD technology is accurately reflected, though slightly less explicitly detailed than in the original answer. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the temporal references (2022, 2023, 2024) are correct and consistently used, warranting full marks. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s strategic continuity across years, connecting inventory protection, discrete graphics, and differentiation strategies across AIBs and system integrators. It captures the sustained strategic focus without implying changes that aren’t supported. (4) The only minor shortcoming is that the LLM omits the specific mention of 'short design cycles' and 'rapid response to new technologies' as reinforcing factors in AMD’s strategy, which slightly reduces completeness in qualitative nuance. However, the core strategic thrust—inventory protection and discrete GPU differentiation—is fully preserved. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing both parts of the multi-part question: evolution over time, inventory policies, and role of discrete graphics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Supplies]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 446,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "From 2022 to 2024, Disney's strategic approach to DTC offerings evolved significantly in terms of investment focus, competitive positioning, and revenue growth expectations. In 2022, Disney acknowledged the growing costs and risks associated with its DTC strategy, noting that DTC investments were part of broader efforts to rationalize costs and adapt to changing market conditions, though these initiatives were expected to remain unprofitable in the short term. By 2023, the company emphasized strategic investments in DTC offerings as a key driver of growth, aiming to offset declines in affiliate fees and linear network subscribers by increasing subscription and advertising revenues. In 2024, Disney continued to face heightened competitive pressures, particularly from new media platforms and DTC rivals, which impacted pricing power and marketing costs. Despite these challenges, the company maintained its focus on DTC as a core growth area, expecting long-term benefits from its investments, even as it navigated a more competitive and dynamic content landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) All key facts are correct: in 2022, Disney expressed caution about DTC costs and profitability; in 2023, it shifted to viewing DTC investments as growth drivers that would offset linear declines; and in 2024, it acknowledged increasing competition impacting pricing and marketing. The LLM captures the core narrative of a shift from risk awareness to strategic dependence despite competitive pressures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly identifies the evolving focus on investment, competitive dynamics, and revenue expectations. It accurately reflects the cause-effect logic (e.g., DTC growth offsetting linear declines). (4) Minor wording differences exist—for example, the original specifies that DTC services 'compete for customers with an increasing number of competitors' DTC offerings,' while the LLM generalizes to 'heightened competitive pressures'—but the semantic meaning is equivalent. The LLM slightly softens the 2024 competitive impact by not explicitly stating that subscription fees and advertising rates were being pressured, though it mentions 'pricing power' and 'marketing costs,' which is close. This small omission prevents a perfect 10. Overall, the answer is factually correct, contextually complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 447,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal's Fixed-rate 2.850% notes, issued in September 2019 with a maturity date of October 1, 2029, remained part of its debt structure in 2022, 2023, and 2024, with a face value of $1.5 billion in each year. In 2022, these notes were classified with a current portion of $418 million, but by 2023, the current portion dropped to zero, indicating a shift to long-term classification. In 2024, the notes remained fully classified as long-term, with no current portion, suggesting a stable maturity profile and no immediate repayment obligations in the short term. The effective interest rate of 2.96% remained consistent across all three years, reflecting the fixed-rate nature of the debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.5 billion face value of PayPal's 2.850% notes and their 2029 maturity, which aligns with the ground truth. However, it introduces a 'current portion of $418 million in 2022' and its reduction to zero in 2023—information not present in the original answer and unsupported by the ground truth, which states the notes remained consistently outstanding with no changes in principal. This is a significant quantitative inaccuracy. The effective interest rate of 2.96% is mentioned but not in the ground truth, making it potentially misleading or fabricated. (2) The ground truth emphasizes the evolution of PayPal’s broader debt structure—total term debt increasing from $9.0B (2022) to $10.638B (2023) and declining to $10.574B (2024)—but the LLM omits this entirely. It also fails to mention the issuance of new higher-rate debt (5.150%, 5.500%) in 2024, a key point about shifting financing strategy. (3) While the LLM correctly tracks the 2.850% notes over time and understands their fixed-rate, long-term nature, it misses the multi-hop synthesis required: connecting the stability of these notes to changes in the broader debt portfolio and strategic shifts. The reasoning around classification (current vs. long-term) may be technically plausible but is not supported by the provided ground truth. (4) The answer is contextually relevant and well-structured, focusing on the right instrument and timeframe, but lacks critical comparative data and introduces unverified details, reducing its factual correctness. Hence, partial credit is given for accurate core elements but docked for omissions and inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 456,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP's allocation to Corporate Stock within its pension plan assets declined significantly from 2022 to 2024. In 2022, Corporate Stock was valued at $1,990 million (Level 1 and Level 2), representing a substantial portion of the plan's fair value assets. By 2023, this allocation had dropped to $181 million, and in 2024, Corporate Stock is classified as a Level 1 investment for common stock and Level 2 for preferred stock, indicating a continued focus on transparency and market-based valuations. This shift suggests a strategic move by UNP to reduce direct equity exposure in favor of other investment vehicles, potentially reflecting a more conservative or diversified approach to managing pension plan assets during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative figures: $1,990 million in 2022 and $181 million in 2023, which match the ground truth exactly. While the 2024 value is not explicitly restated numerically, it is implied that the allocation remains low and restructured, consistent with the ground truth. The absence of a specific 2024 dollar amount is a minor omission but does not detract significantly from correctness since the focus is on classification changes. (2) All numbers and years are accurate, and no calculations are required beyond comparison, which is correctly interpreted as a significant decline. Format variations are acceptable and correctly used. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic shift in investment approach based on both the reduction in equity allocation and the reclassification of stock holdings into Level 1 (common stock) and Level 2 (preferred stock). This reflects accurate understanding of valuation hierarchies and their implications for transparency. (4) The answer conveys the same core message as the ground truth—UNP drastically reduced its corporate stock allocation and shifted toward more transparent, observable equity investments—demonstrating strong semantic equivalence. The only minor shortcoming is the lack of explicit mention that by 2024, common stock was reclassified as Level 1 while preferred shares were held at Level 2 as part of a smaller, structured equity exposure, though this is partially covered. Overall, the response is factually accurate, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 452,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer's long-term investment in private equity securities at cost decreased from $623 million in 2022 to $755 million in 2023, and then slightly declined further to $719 million in 2024. This trend suggests a modest increase in allocation to illiquid alternative investments between 2022 and 2023, followed by a small reduction in 2024, indicating a cautious and potentially strategic adjustment in the company's long-term capital deployment toward private equity during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the first sentence: it states that Pfizer's investment 'decreased from $623 million in 2022 to $755 million in 2023', which is incorrect because $755 million is greater than $623 million—this is an increase, not a decrease. This misstatement undermines the entire quantitative narrative. The second part, 'slightly declined further to $719 million in 2024', is correct in direction and amount. (2) Number verification: 2022 = $623M (correct), 2023 = $755M (correct value but wrong directional description), 2024 = $719M (correct). However, the incorrect use of 'decreased' when the data shows an increase from 2022 to 2023 is a major quantitative inaccuracy. (3) Multi-hop reasoning is partially sound—the model attempts to synthesize trends across three years and draws a conclusion about strategic allocation. However, the flawed interpretation of the 2022–2023 change leads to incorrect reasoning: describing a growth as a decrease invalidates the stated trend. The cautious adjustment conclusion in 2024 aligns with the ground truth, but the overall strategic implication is distorted. (4) Scores justified: Correctness is low (4/10) due to the major directional error in describing the trend despite having correct dollar amounts. Quantitative accuracy is poor (3/10) because the core numerical comparison is wrong. Qualitative accuracy is moderate (5/10) as the structure and intent are reasonable, but logic is flawed. Contextual relevance is high (8/10) because the answer addresses the right metric, company, and time period, and attempts appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 451,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard's multi-layered security approach evolved from 2022 through 2024 by enhancing third-party collaboration, expanding real-time payment infrastructure, and strengthening resilience against cyber threats. In 2022, Mastercard emphasized collaboration with issuers, acquirers, merchants, and governments to establish technical standards like EMV and develop secure transaction solutions, while also expanding real-time payments infrastructure in 12 of the top 50 markets by GDP. By 2023, the company had extended real-time capabilities to 13 markets and incorporated third-party assessments and public-private partnerships to bolster security and address threats from third-party providers. In 2024, Mastercard further expanded its real-time infrastructure globally, launched domestic transaction processing in China via a joint venture, and continued to refine its security programs through enterprise resilience initiatives, regular system testing, and collaboration with industry stakeholders to mitigate evolving cyber threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach across the three years, addressing all key dimensions: third-party collaboration, real-time payment infrastructure expansion, and cyber threat resilience. The overall narrative arc—increasing external collaboration, broader infrastructure deployment, and enhanced security integration—is factually aligned with the ground truth. However, there is a minor quantitative discrepancy: the LLM states that in 2022, real-time payments were expanded in '12 of the top 50 markets by GDP,' while the ground truth specifies that the 13-market expansion was reported as of year-end 2023, with no specific number mentioned for 2022. The LLM incorrectly assigns a number (12) to 2022 that is not in the original data, which weakens quantitative accuracy. (2) The number '13 markets' in 2023 is correct and matches the ground truth. The mention of global expansion in 2024 is consistent, though the additional detail about launching domestic transaction processing in China via a joint venture is not present in the original answer and may be extraneous or inferred from other sources; it does not contradict but adds unverified detail. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and domains (security, infrastructure, partnerships) and correctly identifies the trend toward deeper third-party integration and ecosystem-wide resilience. It accurately reflects the shift from internal monitoring in 2022 to broader third-party inclusion in 2023–2024. (4) The contextual relevance is excellent—the response directly addresses all parts of the question with appropriate focus. Qualitative accuracy is high due to correct entity identification (Mastercard, EMV, public-private partnerships) and logical progression. The correctness score is 8 due to the minor but notable error in attributing a specific market number (12) to 2022 that is not supported in the ground truth, which affects quantitative precision but not the overall validity of the trend described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1593,
        "completion_tokens": 563,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil's reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. This consistent decline suggests a reduction in the company's derivative exposure over time, indicating improved risk management and potentially more efficient collateral optimization strategies in managing its derivative obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the collateral was $641 million at the end of 2021 (reported in 2022 filing), $800 million at the end of 2022 (reported in 2023 filing), and $491 million at the end of 2023 (reported in 2024 filing). The LLM incorrectly states the 2022 value as $1,494 million, which is not supported by the ground truth and represents a major deviation. The 2023 ($800M) and 2024 ($491M) figures are correct in the LLM answer, but the starting point is wrong, invalidating the trend description. (2) The calculation of a 'consistent decline' is partially accurate from 2023 to 2024, but the claimed decline from $1,494M to $800M to $491M is factually incorrect due to the erroneous 2022 figure. The ground truth shows an increase from 2021 to 2022, then a decline—making the trend non-monotonic, not consistently declining. The 38% decrease mentioned in the ground truth is from 2022 to 2024 (from $800M to $491M), which is approximately 38.6%, but the LLM does not mention this percentage nor compute it correctly. (3) The multi-hop reasoning is partially sound in linking collateral changes to derivative exposure management, but the conclusion about 'improved risk management' and 'efficient collateral optimization' goes beyond the ground truth, which only suggests 'reduced initial margin requirements or strategic adjustments'—more neutral in tone. The LLM overinterprets the trend due to incorrect data. (4) Despite the incorrect numbers, the answer addresses the right metric, company, and time frame, and attempts to interpret the trend, maintaining contextual relevance. However, the severe quantitative errors undermine correctness and qualitative accuracy, leading to a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 492,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "Duke Energy's expected volatility, as determined by its relative TSR model against a predefined peer group, decreased from 26.9% in 2022 to 28.6% in 2023, and then declined further to 18.7% in 2024. This multi-year shift, particularly the significant drop in 2024, suggests a reduced market risk perception for Duke Energy, potentially reflecting improved stability in its stock performance relative to peers, or a more favorable macroeconomic and industry environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the description of the trend: it states that volatility 'decreased from 26.9% in 2022 to 28.6% in 2023', which is factually incorrect because 28.6% is higher than 26.9%, meaning volatility increased from 2022 to 2023. This misstatement undermines the quantitative accuracy. However, the 2024 value of 18.7% is correctly reported, and the overall trajectory (increase then decrease) is partially captured, albeit with flawed wording. (2) The numeric values themselves—26.9%, 28.6%, and 18.7%—are all factually correct and match the ground truth exactly, but the comparative language ('decreased from... to...') introduces a logical inconsistency. This is a significant error in quantitative reasoning, even if raw numbers are accurate. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies the three-year trend, synthesizes the implications of the 2024 drop, and draws a reasonable qualitative conclusion about reduced market risk perception and improved stability. The interpretation aligns well with the ground truth's suggestion of stabilization after a peak in 2023. (4) Due to the incorrect directional description of the 2022–2023 change, the correctness and quantitative accuracy scores are reduced. However, the answer remains contextually relevant and qualitatively insightful, earning high marks for qualitative accuracy and full marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 399,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "General Motors' (GM) indemnification obligations and accruals related to Stellantis evolved from 2022 through 2024, primarily concerning legacy Opel/Vauxhall emissions claims and Takata recalls. In 2022, GM disclosed that it could face potential liabilities from regulatory actions related to emissions standards violations by Opel/Vauxhall vehicles sold before the 2017 sale to PSA Group (now Stellantis), though no material accrual was recorded at that time. By 2023, GM reiterated its indemnification obligations under the Master Agreement, noting that it had indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, with the company believing further indemnification to be remote. In 2024, GM continued to emphasize its indemnification responsibilities for emissions claims and product liabilities, with ongoing consumer lawsuits in Germany, the UK, and the Netherlands, but no material accruals were recorded as of December 31, 2024. The interconnected entities—GM, Stellantis (as both a company and an organization), and their obligations under the Master Agreement—highlight the ongoing regulatory and legal exposure stemming from GM's former Opel/Vauxhall business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, the answer correctly states that GM indemnified Stellantis for an 'immaterial amount' related to Takata recalls in 2023 and that no material accruals were recorded in 2024—consistent with the original answer’s emphasis on immateriality and remote likelihood. The years (2022–2024) are accurately referenced. (2) The answer correctly identifies the entities: GM, Stellantis (including its origin from PSA Group and the 2017 Opel sale), and the Master Agreement. It also accurately references the legacy Opel/Vauxhall emissions claims and Takata recalls as the two key liability areas. (3) The multi-hop reasoning is sound: the answer synthesizes GM’s indemnification obligations across time, connects them to both emissions investigations and Takata recalls, and correctly notes the evolving assessment of risk (e.g., 'further indemnification... remote' in 2023–2024). (4) However, the LLM omits the specific 2024 mention of accruals related to the European Commission and UK CMA investigations, stating only that 'no material accruals were recorded'—which, while consistent with 'immaterial,' slightly understates the nuance that an accrual *was* made but deemed immaterial. This minor gap prevents a perfect score. Overall, the answer is factually accurate, contextually relevant, and well-reasoned, with only slight imprecision in conveying the 2024 accrual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 413,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its 10-K filings for 2022, 2023, and 2024, as shown by its inclusion as Exhibit 10.1 in each year’s filing. This continuity suggests that AMD maintains a long-term, stable executive compensation strategy, relying on the 2011 plan as a foundational framework for incentivizing executive performance. The repeated incorporation of the same exhibit across multiple years indicates that the plan remains a key component of AMD’s executive compensation structure without material changes, reflecting a strategic commitment to aligning executive incentives with company objectives over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: AMD referenced the 2011 Executive Incentive Plan as Exhibit 10.1 in each of the 2022, 2023, and 2024 filings, with no amendments noted. The date of the original filing (April 2, 2011) is implied by referencing the same exhibit, though not explicitly stated in the LLM answer—this is a minor omission but does not affect factual correctness. (2) There are no numerical or date inaccuracies; the years and exhibit number are correctly cited. Format and referencing are consistent with acceptable variations. (3) The multi-hop reasoning is sound: the model correctly infers from consistent exhibit inclusion over three years that there were no material changes, leading to the conclusion of a stable executive compensation strategy. This synthesis across multiple filings is appropriate and logical. (4) The answer captures the core implication—strategic stability in executive compensation—though it adds slight interpretive language (e.g., 'foundational framework', 'strategic commitment') not present in the original, which is permissible under semantic equivalence. The omission of the explicit 'no changes' statement slightly reduces qualitative accuracy, but overall the response is complete, relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 370,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "PayPal's exposure to bad transactions risk from 2022 through 2024 was influenced by its credit products, cross-border trade, and reliance on third parties. In 2022, the risk was tied to potential defaults on credit products, particularly with Synchrony Bank, and the challenges of managing third-party relationships, which could lead to fraud and abusive behaviors. Cross-border trade also posed risks due to regulatory, foreign exchange, and trade policy uncertainties. In 2023, PayPal took strategic actions to mitigate these risks, including entering a multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables, which helped reduce credit risk exposure and improve liquidity. Additionally, the company began diversifying its reliance on third-party payment processors in the U.S. to reduce operational and compliance risks. By 2024, PayPal continued to manage its credit portfolio through receivables sales and forward-flow arrangements, while still facing ongoing challenges related to fraud and cross-border trade complexities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure related to credit defaults with Synchrony Bank, the 2023 multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables, and ongoing 2024 challenges with fraud, third-party dependencies, and cross-border trade are all accurately reported. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, with no calculation errors. Format is consistent with ground truth. (3) Multi-hop reasoning is sound—information is synthesized across years and domains (credit products, third parties, cross-border trade), and the strategic mitigation in 2023 is correctly identified and contextualized. (4) The only minor shortcoming is that the LLM adds a detail not present in the original—diversifying third-party payment processors in the U.S.—which, while plausible, is not mentioned in the ground truth. This slightly affects qualitative accuracy but does not introduce factual error. Otherwise, the answer is semantically equivalent, comprehensive, and directly responsive to all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 330,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s ownership of Multiple Purpose Locomotives decreased from 6,204 to 5,973, while the average age of these locomotives increased from 22.5 to 25.2 years. This trend indicates a gradual reduction in owned fleet size and an aging profile, suggesting a potential shift toward leasing or a slower pace of fleet replacement. The company’s modernization strategy appears to be evolving, as the decline in owned units and the rise in average age may reflect cost management priorities or a strategic delay in capital expenditures, while still maintaining operational capacity through a mix of owned and leased assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the decrease in owned Multiple Purpose Locomotives from 6,204 in 2022 to 5,973 in 2024 and the increase in average age from 22.5 to 25.2 years, matching the ground truth exactly. However, it omits the leased units data (dropping from 1,038 to 920), which is a key part of the original answer and relevant to fleet management strategy. (2) All numeric values for owned units and average age are accurate, with no calculation errors. The time frame (2022 to 2024) is correctly used. (3) The reasoning is mostly sound: the LLM correctly infers that the aging fleet and reduced ownership may reflect cost management or delayed capital spending. However, it speculates about a 'potential shift toward leasing'—which contradicts the ground truth showing leased units also declined significantly. This weakens the qualitative accuracy. The original answer correctly notes that both owned and leased units decreased, indicating reduced reliance on leasing, not increased. (4) Despite the omission of leased unit figures and a minor misinterpretation of leasing trends, the LLM captures the core facts and strategic implication of aging assets and restrained modernization. Hence, correctness is high but not perfect due to incomplete synthesis of leasing data, warranting a score of 8. Quantitative accuracy is full (10), qualitative reasoning is strong but flawed in one inference (8), and relevance to the question is excellent (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Owns]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 408,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. This consistent decline suggests a more conservative and effective derivative risk management approach, as the company is reducing the amount of unoffset collateral required for initial margin, potentially reflecting improved counterparty credit assessments, better netting efficiencies, or a reduction in derivative exposures. The fair value of these exposures is calculated using level 3 inputs, indicating the use of internal models and assumptions, which aligns with a proactive and tailored risk management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM incorrectly states that exposure was $1,494 million in 2022, which is more than double the correct value. This major error undermines the entire analysis. The 2023 and 2024 figures ($800M and $491M) are correct. (2) The calculation of trend is therefore flawed: the LLM describes a 'consistent decline' from 2022 to 2024, but the actual trend shows an increase from 2022 to 2023 before a drop in 2024. This misrepresents the risk management dynamics. The ground truth interprets the peak in 2023 and subsequent drop as a potential strategic shift or response to market conditions, while the LLM incorrectly infers a consistently conservative approach due to a fabricated downward trend. (3) The multi-hop reasoning is partially sound in that it connects collateral exposure to derivative risk management and correctly notes the use of level 3 fair value inputs across years. However, because the foundational data is wrong, the conclusion about a 'more conservative and effective' strategy is not supported. The LLM also introduces the concept of 'initial margin' and 'netting efficiencies' not mentioned in the original, adding unsupported speculation. (4) Despite the incorrect numbers, the answer remains contextually relevant—addressing the right metric, company, and conceptual link between collateral exposure and risk management. The qualitative reasoning would score higher if based on accurate data. Quantitative accuracy is severely penalized due to the incorrect 2022 figure, which breaks the multi-hop synthesis. Correctness score is low because the core factual claim (the trend) is false.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 508,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "The revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, remained consistent in description across 2022, 2023, and 2024, as outlined in each year's 10-K filings. In all three years, the 'Other' category primarily included packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. While the specific revenue figures for this category are not provided in the chunks, the consistent inclusion of single-serve coffees highlights their ongoing role within this segment, supported by the knowledge graph showing the interconnected production relationships between Starbucks and single-serve coffee offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that the 'Other' category composition remained consistent from 2022 to 2024, listing the same key components—packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware—across all years. This matches the original answer's assertion of stability with no significant shifts. (2) There are no numeric values or calculations in the question or ground truth, so quantitative accuracy is not applicable; however, the LLM correctly notes that specific revenue figures are not provided, which is accurate and appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings as required, confirming consistency in category composition. The only minor shortcoming is that the original answer explicitly mentions 'ready-to-drink beverages' in 2022, which the LLM omits. While this is a small detail, it slightly reduces completeness. (4) The answer is highly contextually relevant, directly addressing the evolution (or lack thereof) in revenue composition over time. Overall, the response is semantically equivalent to the ground truth with only a minor omission, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 364,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 to 2024, the monetization of advertising inventory through Google Ad Manager across Google Network properties evolved with continued reliance on impression-based revenue recognition. In 2022, impressions were a key metric for monetizing traffic on Google Network properties, particularly for AdMob, AdSense, and Google Ad Manager, with cost-per-impression calculated as total impression-based and click-based revenues divided by total impressions. By 2023, Google clarified its revenue recognition approach, stating that advertising revenues from Google Network properties are generally reported on a gross basis, meaning the full amounts billed to customers are recorded as revenues, with payments to partners classified as cost of revenues. In 2024, this gross revenue reporting model was reiterated, emphasizing Google’s role as principal in these transactions, supported by its control over inventory and pricing discretion. Thus, the evolution reflects a consistent use of impressions as a monetization metric and a continued gross revenue reporting methodology for Google Ad Manager across the Google Network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: the use of impression-based and click-based revenue models from 2022–2024, the calculation of cost-per-impression in 2022, the gross revenue reporting model introduced in 2023, and the emphasis on Google’s role as principal in 2024. There are no incorrect numbers, dates, or financial metrics—this satisfies quantitative accuracy. (2) Quantitative elements are correctly represented: while no explicit dollar amounts are mentioned, the description of revenue recognition methodology (e.g., full amount billed recorded as revenue) matches the ground truth, and the cost-per-impression calculation logic is accurately described. (3) Multi-hop reasoning is sound: the answer synthesizes information across years (2022 to 2024) and across accounting policies (revenue recognition, gross vs. net reporting, control over inventory), correctly linking Google Ad Manager, AdSense, and AdMob as part of the Google Network properties. (4) The only minor shortcoming is that the original answer explicitly mentions 'increasing transparency and accounting clarity over time' as a concluding insight, which the LLM answer implies but does not directly state. However, the core evolution—consistent monetization with clarified gross reporting and principal role—is fully captured. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete, contextually relevant, and logically sound, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 452,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ's exposure to sales and media marketing restrictions, particularly in relation to front-of-pack labeling and EPR policies, has shown a trend of increasing regulatory scope and jurisdictional expansion from 2022 to 2024. In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies, with expansion contemplated in India, Vietnam, and U.S. states, while front-of-pack labeling and marketing restrictions were already in place based on nutrient or environmental claims. By 2023, the company highlighted the continued growth of EPR policies and their implementation in additional jurisdictions, alongside ongoing marketing restrictions tied to nutrient profiles and advertising platforms. In 2024, the regulatory landscape further evolved with the EU adopting its Packaging and Packaging Waste Directive, and EPR policies being implemented or considered in more regions, including Southeast Asia. Front-of-pack labeling and marketing restrictions remained a key focus, with increasing pressure to align with evolving global standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and key developments across 2022–2024. (1) Quantitatively, all referenced numbers and dates are accurate: the mention of 'over 25 EU countries' with EPR policies in 2022 matches the original, and the EU's 2024 adoption of the Packaging and Packaging Waste Directive is correctly cited. No calculations were required. (2) The answer correctly identifies the jurisdictions involved—EU, India, Vietnam, U.S. states, Indonesia, Philippines—and tracks their regulatory evolution accurately. (3) In terms of multi-hop reasoning, the LLM synthesizes information across years and regulatory domains (EPR, front-of-pack labeling, marketing restrictions) soundly. However, there is a minor inaccuracy: the LLM states in 2022 that EPR expansion was contemplated in U.S. states, which the original answer does not mention until 2024. Conversely, the original specifies that in 2022, marketing restrictions were being considered in India, Vietnam, Indonesia, and the Philippines—this nuance is underemphasized in the LLM response. Additionally, the LLM incorrectly implies that front-of-pack labeling was already in place in 2022, while the original indicates it became a greater focus in 2023. (4) Despite these small sequencing and attribution issues, the overall trend of increasing regulatory burden is correctly conveyed, and the answer remains contextually relevant and factually strong, warranting a high score but not perfect due to the misalignment in timing and emphasis of certain policy developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 439,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Between 2022 and 2024, the A Class shares consistently retained one vote per share and full dividend rights, as disclosed in MA's 10-K filings for each year. Similarly, B Class shares remained non-voting but retained dividend rights, while no Preferred shares were issued or outstanding during this period, with their rights to be determined upon future issuance. This three-year consistency in voting and dividend rights indicates a stable and deliberate capital structure strategy by MA, emphasizing continuity in shareholder governance and returns without material changes to its equity class design.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) It accurately states that A Class shares maintained one vote per share and dividend rights from 2022 to 2024, which matches the original answer. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) and qualitative attributes (voting, dividend rights) are correctly reported. (3) The reasoning is sound: the consistency across three years is correctly interpreted as indicative of a stable capital structure strategy. The LLM adds minor contextual details (e.g., B Class shares being non-voting, no Preferred shares outstanding), which are consistent with typical 10-K disclosures and do not contradict the ground truth. These additions enhance completeness without introducing error. (4) The only reason for not scoring a 10 is that the original answer focuses specifically on A Class shares, while the LLM broadens slightly to B and Preferred shares—though this does not detract from correctness and may reflect fuller document context. Overall, the answer demonstrates accurate multi-hop synthesis across years and correct interpretation of corporate governance trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 337,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' decreased from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decline suggests a reduction in the company's derivative exposure and initial margin requirements over the period, indicating improved risk management or a decrease in the scale of derivative activities requiring collateral.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM incorrectly states it was $1,494 million in 2022, which is a major deviation. The 2023 and 2024 figures ($800M and $491M) are correct. (2) The calculation and trend analysis are therefore flawed: the LLM describes a 'consistent decline' from 2022 to 2024, but the actual trend is an increase from 2022 to 2023 followed by a decrease in 2024. This misrepresents the volatility and dynamics of margin requirements. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in terms of derivative exposure and margin requirements, but because the initial data is wrong, the conclusion is invalid. The ground truth suggests a dynamic exposure profile with increased requirements in 2023, while the LLM implies a steady reduction, missing the key fluctuation. (4) Contextual relevance is moderate—the response addresses the right metric, time frame, and conceptual implications, but the incorrect data undermines the analysis. The qualitative reasoning would have been acceptable if based on correct numbers. Quantitative accuracy is very low due to the erroneous 2022 value; qualitative accuracy is low due to flawed synthesis; correctness score is low because the core facts are incorrect despite some correct values and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 418,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Starbucks expanded its forward-looking supply chain commitments to coffee producers by extending its purchase commitments to cover green coffee supply through fiscal 2025 by 2023 and maintaining that coverage in 2024. This progression reflects a strategic effort to secure long-term, stable access to high-quality arabica coffee amid ongoing price volatility and supply risks driven by factors like climate change, market speculation, and geopolitical conditions. By utilizing fixed-price contracts, price-to-be-fixed commitments, and financial hedging tools, Starbucks aims to mitigate exposure to commodity price swings while reinforcing its relationships with coffee producers and external trading partners, ensuring supply continuity and quality control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key dates and timeframes are correct: the extension of supply commitments from covering through fiscal 2023 (in 2022) to covering through fiscal 2025 (by 2023), and maintenance of that coverage in 2024. These match the original answer exactly. (2) The LLM correctly identifies the evolution of forward-looking commitments and ties them to strategic goals around supply stability and price volatility management. (3) Multi-hop reasoning is sound—synthesizing information across fiscal years 2022–2024 to show a progression toward longer-term supply assurance. (4) The LLM adds contextual detail not in the original (e.g., climate change, geopolitical factors) that is reasonable and enhances relevance without introducing inaccuracies. One minor point: the original specifies the use of 'forward contracts, futures contracts, and collars,' while the LLM generalizes to 'financial hedging tools' and 'price-to-be-fixed commitments'—slightly less precise but semantically equivalent in context. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 326,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN's target asset allocation mix for its defined benefit pension plans remained consistent in its strategic emphasis on achieving long-term, risk-adjusted returns by balancing fixed income and equity investments across fiscal 2023 to fiscal 2025. While the specific allocation percentages are not provided in the text chunks, the company's stated objective is to achieve a total annualized return that exceeds inflation by an amount based on the target asset mix, with a focus on diversification between U.S. and non-U.S. equities and fixed income instruments to match liability durations and minimize volatility. This multi-year consistency in approach suggests a disciplined, long-term investment strategy aimed at aligning asset returns with pension liabilities while managing market and interest rate risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth and captures the core strategic evolution of ACN's target asset allocation from fiscal 2023 to 2025. (1) While no specific percentages are mentioned in either the original or LLM answer, the absence is justified as the source documents (referenced via 10-K filings) do not provide exact numerical allocations—thus the LLM correctly avoids fabricating figures. (2) Quantitative accuracy is high: no incorrect numbers or miscalculations are present, and the LLM appropriately refrains from asserting precise percentages, which aligns with the original answer’s lack of specific figures. (3) Multi-hop reasoning is sound—the LLM synthesizes information across fiscal years and correctly infers continuity in strategy, emphasis on risk-adjusted returns, liability duration matching, and diversification across equities and fixed income. It also correctly links the investment objective to exceeding inflation based on the target mix. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'updated flexibility ranges' in fiscal 2025 to respond to market conditions and cash flows—a nuance highlighted in the original answer that reflects adaptive management. However, the broader theme of a disciplined, long-term, and risk-aware strategy is accurately conveyed. The answer remains semantically equivalent in intent and substance, with strong contextual relevance to the question about strategic evolution and risk-return objectives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 415,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "From 2022 through 2024, Amgen's development of Olpasiran evolved from being investigated in phase 2 for the treatment of atherosclerotic cardiovascular disease (as noted in the 2022 10-K) to being positioned in 2024 for broader cardiovascular disease applications, as listed in the 2024 10-K. In terms of intellectual property, the 2023 10-K disclosed that Amgen secured patent protection for Olpasiran in the U.S. and Europe, with estimated expiration in 2036. This timeline indicates a strategic focus on long-term exclusivity and therapeutic expansion within cardiovascular disease.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Olpasiran was in phase 2 trials for atherosclerotic cardiovascular disease in 2022, had U.S. and European patent protection with an estimated expiration in 2036 disclosed in 2023, and was indicated for 'Cardiovascular disease' in 2024. The therapeutic focus evolution and IP timeline are correctly represented. (2) Quantitative accuracy is perfect: the year 2036 for patent expiration is correctly cited, and all time periods (2022, 2023, 2024) match the original. No calculations were required, but temporal references are precise. (3) Multi-hop reasoning is sound—information is synthesized across three years of filings, correctly attributing developments to the right years and sources (e.g., 2022 10-K, 2023 10-K). The slight deduction in qualitative accuracy is because the LLM mentions 'broader cardiovascular disease applications' without explicitly noting the transition from phase 2 toward advanced development or regulatory preparation, which is a nuance present in the original. However, the overall strategic evolution is well captured. (4) Contextual relevance is excellent—the response directly addresses both therapeutic focus and IP protection timeline, fully satisfying the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 367,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "American Express's reliance on aggregators increased from 2022 through 2024, as the company increasingly depended on merchant acquirers, aggregators, and processors to manage aspects of merchant relationships, particularly as debit cards on the American Express network were introduced. In 2022, the risks centered on inconsistent business interests of third parties and potential discrimination against American Express cards through surcharging or steering. In 2023, the focus expanded to include the operational challenges of implementing surcharges and the potential adverse impact on transaction volumes and brand perception. By 2024, the risks emphasized included not only continued concerns about merchant discrimination but also the broader operational and reputational risks from third-party service disruptions, regulatory actions, and litigation, particularly as American Express relied more heavily on third-party providers for acquiring and servicing customers and technology platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's increasing reliance on aggregators from 2022 to 2024 is accurately described, with appropriate evolution in risk disclosures. The 2022 risks around third-party misaligned interests, surcharging, and steering are correctly identified. In 2023, the emphasis on operational challenges and impact on transaction volumes matches the original. By 2024, the expansion to broader operational, legal, and reputational risks—including litigation and regulatory actions—is consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all temporal references (2022, 2023, 2024) are correct, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risk disclosures across three years and correctly identifies the shift from merchant behavior concerns to systemic and legal risks. The mention of debit card integration on the Amex network adds contextual detail not in the original but does not contradict it and may reflect additional filing content. (4) The only reason for not giving a perfect 10 is minor: the original emphasizes 'merchant steering' and 'third-party operational disruptions' as growing concerns, while the LLM slightly reframes 2023 risks around 'implementing surcharges' and 'brand perception'—a nuance not explicitly in the ground truth. However, this is semantically close and does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 464,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Starbucks' exposure to commodity index funds increased due to green coffee price volatility, as these funds significantly impacted arabica coffee futures trading, thereby affecting Starbucks' hedging strategies. In fiscal 2022, Starbucks' purchase commitments and hedging instruments were expected to cover green coffee needs through fiscal 2023. By fiscal 2023, the company extended its forward supply commitments to cover through fiscal 2025, reflecting a strategic move to secure long-term supply amid ongoing volatility. In fiscal 2024, Starbucks maintained these extended commitments, continuing to use forward contracts, futures, and collars to hedge against 'C' price exposure, with no change in the expected coverage through fiscal 2025. This evolution highlights Starbucks' proactive approach to managing price risks and ensuring supply stability in response to external market pressures, including the influence of commodity index funds.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks cited commodity index funds as influencing green coffee price volatility across 2022–2024; supply commitments covered through 2023 in 2022, extended to 2025 by 2023, and remained unchanged in 2024. (2) Quantitative elements—fiscal years (2022, 2023, 2025)—are correctly reported with no calculation errors. Format variations (e.g., 'fiscal 2022' vs '2022') are acceptable and clear. (3) Multi-hop reasoning is sound: the answer synthesizes Starbucks’ evolving hedging strategy, forward supply coverage, and the role of commodity index funds across three years, correctly inferring a strategic shift toward long-term risk mitigation. (4) The LLM adds slight elaboration (e.g., mention of 'collars' and 'C' price exposure'), which is consistent with Starbucks’ known hedging practices and does not contradict the ground truth. All parts of the question are addressed: evolution of exposure to index funds, hedging strategies, and changes in forward supply commitments. The answer is fully contextually relevant, logically structured, and conveys the same strategic narrative as the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 341,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture's share repurchase activity and available authorization under its open-market share purchase program show a consistent and strengthening capital return strategy. In fiscal 2022, as of August 31, 2022, the available authorization for share purchases and redemptions was $3.13 billion. By fiscal 2024, this had increased to $2.694 billion as of August 31, 2024, and further expanded to $6.694 billion after an additional $4 billion in repurchase authority was approved by the Board on September 25, 2024. During fiscal 2024’s fourth quarter, Accenture repurchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, demonstrating active use of the authorization. The multi-year trajectory of increasing repurchase authority and consistent execution reflects a long-term commitment to returning capital to shareholders, supported by strong cash flow and board confidence in the company’s financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has a critical error in the timeline and amount progression of the share repurchase authorization. It incorrectly states that the available authorization increased from $3.13 billion in fiscal 2022 to $2.694 billion by fiscal 2024, which is a decrease, contradicting the upward trajectory. In reality, the $2.694 billion was the remaining authorization *after* $605 million in repurchases were made under a larger prior authorization, and then a new $4 billion was added to reach $6.694 billion. The LLM misattributes the $2.694 billion as a direct evolution from $3.13 billion without acknowledging the intermediate repurchase activity in fiscal 2023. (2) The repurchase of 2,000,308 shares for $605 million is correctly cited, but it occurred in fiscal 2023, not fiscal 2024’s fourth quarter as stated—this is a material misplacement in time. The additional $4 billion authorization approved on September 25, 2024, and the resulting $6.694 billion total are correctly reported. (3) The multi-hop reasoning is partially sound: the model correctly infers a strengthening capital return strategy and links board action, repurchase activity, and shareholder returns. However, the flawed sequencing of authorizations and repurchases undermines the accuracy of the synthesis. (4) Despite these issues, the overall narrative of increasing commitment to capital return is consistent with the ground truth, and the answer is highly relevant to the question. Quantitative accuracy is penalized due to incorrect ordering and timing of figures, while qualitative and contextual scores remain high due to correct entities, logical interpretation, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 471,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The value of Google's marketable equity securities subject to long-term lock-up restrictions decreased from $1.4 billion in 2022 to $803 million in 2023, before returning to $1.4 billion in 2024. This fluctuation suggests that Google's investment strategy in illiquid assets may involve periodic adjustments based on market conditions or strategic priorities, as the value dipped in 2023, potentially reflecting market volatility or asset reclassifications, and rebounded in 2024, indicating a renewed or stabilized focus on such investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: $1.4 billion in 2022, $803 million in 2023, and $1.4 billion in 2024—these match the original answer exactly, with acceptable formatting. (2) The answer addresses both parts of the question: it describes the change over time and interprets the fluctuation in terms of investment strategy. (3) Entity accuracy is correct—Google is the right company, and the metric 'marketable equity securities subject to long-term lock-up restrictions' is properly identified across the correct years. (4) The reasoning is sound and reflects multi-hop synthesis: the decrease and subsequent recovery are correctly interpreted as strategic adjustments, with plausible explanations involving market conditions and strategic focus, which aligns semantically with the ground truth's suggestion of 'cyclical or strategic rebalancing.' Wording differs slightly but conveys the same meaning. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 298,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "From 2022 through 2024, GE's relationship with Electric Insurance Company (EIC) evolved from strategic repositioning to its ultimate disposition. In the fourth quarter of 2022, GE classified EIC, a captive industrial insurance subsidiary domiciled in Massachusetts, as held for sale, reflecting its decision to divest non-core operations. As of December 31, 2023, EIC had assets of $541 million and liabilities of $378 million, and in 2023, GE recorded a $109 million loss in Other income (loss) due to the expected sale. By the second quarter of 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression had a cumulative financial impact on GE, including a loss in 2023 and a modest cash inflow in 2024, aligning with its broader strategy to streamline operations and focus on core businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth: EIC's status as a captive insurer, its classification as held for sale, the 2023 asset ($541M) and liability ($378M) figures, the $109M loss, and the 2024 sale to Riverstone International Holdings Inc. for $120M in cash. All numeric values match exactly and are contextually accurate. (2) Quantitative accuracy is perfect: all dollar amounts and dates are correct. The $109M loss and $120M cash proceeds are accurately reported. No calculation errors. Format variations are acceptable and consistent. (3) The reasoning is sound and reflects proper multi-hop synthesis across 2022–2024. The LLM correctly infers strategic intent (divestiture of non-core assets) and financial impact (loss in 2023, cash inflow in 2024). One minor discrepancy: the original answer states EIC was still operating as a captive in 2022 before being classified as held for sale, while the LLM claims it was classified as held for sale in Q4 2022—this timing detail is not in the ground truth and slightly over-specifies the timeline, but does not contradict core facts. (4) The answer is contextually excellent, addressing all parts of the question—strategic positioning, valuation, disposition, and financial impact—across the three years. Semantic equivalence is strong, with only slight rewording. The minor over-attribution of timing prevents a perfect 10, but overall accuracy is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Classifies]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 403,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen's Phase 3 clinical program portfolio grew from 13 programs in 2022 to 25 programs by early 2025, reflecting a significant expansion of its R&D pipeline. In 2022, the number of Phase 3 programs remained stable at 13, with regulatory approvals, initiations, and terminations balancing out. By 2023, the portfolio increased to 18 programs, and in 2024, it expanded further to 24 programs, largely due to the acquisition of five programs from Horizon. The progression to 25 programs by early 2025, driven by new initiations and regulatory approvals, underscores Amgen's strategic focus on advancing a broader range of investigational therapies, enhancing its innovation pipeline and global regulatory engagement.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual discrepancy regarding the timeline. The ground truth states that Amgen had 24 programs in 2024 and reached 25 by 2024 (with one additional program added after the Horizon acquisition), not by early 2025 as claimed in the LLM answer. This misplacement of the 25th program into early 2025 slightly distorts the timeline. All other numbers are accurate: 13 in 2022, 18 in 2023, and 24 in 2024 are correctly reported. (2) Quantitatively, the core progression (13 → 18 → 24) is correct, and the attribution of five programs to the Horizon acquisition aligns with the ground truth. However, the claim that the 25th program was reached by early 2025 contradicts the original answer, which states the total reached 25 by 2024. This is a minor timing error but affects precision. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the growth trajectory, attributes the increase to the Horizon acquisition, and links it to strategic R&D expansion. It also appropriately references regulatory approvals as part of pipeline maturation. The logic connecting portfolio growth to strategic focus is well-reasoned and consistent with the original answer. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution of the portfolio and what it reveals about R&D strategy. Despite the slight date misalignment, the overall factual content, reasoning, and strategic interpretation are strong, warranting a high correctness score with a small deduction for timing inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 439,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "American Express's relationship with global card networks from 2022 to 2024 has evolved in response to increasing regulatory pressures and competitive dynamics. In 2022, AXP highlighted its position as the fourth-largest global card network, competing with Visa, Mastercard, and China UnionPay, while facing challenges from alternative payment platforms and evolving consumer preferences. By 2023, the company continued to emphasize competition in the premium space and cobrand relationships, with a focus on innovation and differentiation through rewards and digital services. In 2024, AXP faced heightened regulatory scrutiny, including interchange fee caps and network routing practices, which led to the exit of its network licensing businesses in the EU and Australia. These regulatory pressures, combined with the competitive landscape, have prompted AXP to adapt its business strategies, enhance compliance programs, and navigate a more complex and regulated global payments environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's competitive positioning in 2022 against Visa, Mastercard, and China UnionPay; continued emphasis on premium differentiation and cobranding in 2023; and regulatory-driven exits from network licensing in the EU and Australia in 2024 due to interchange fee caps and routing rules. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are mentioned, the qualitative references to regulatory pressures (e.g., interchange fee caps) are consistent with known regulatory developments and the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and geographies, correctly identifying the shift from competition to regulatory constraint, particularly in international markets. It appropriately links regulatory pressures to strategic exits and compliance adaptations. (4) The only minor shortcoming is that the LLM does not explicitly mention the uncertainty around cobrand arrangements in the EU due to differing regulatory interpretations—a detail present in the original answer. However, this omission does not undermine the core accuracy or completeness. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 389,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips initiated a paced monetization of its CVE common shares in May 2021, completing the sale of its remaining 91 million CVE common shares during the first quarter of 2022. The proceeds from these sales were used for share repurchases under its ongoing share repurchase program. By the end of 2022, the company had repurchased 383 million shares at a cost of $29 billion, and by the end of 2024, total repurchases under the program reached 433 million shares at a cost of $34.3 billion. This indicates that the monetization of CVE shares in 2022 contributed to the increased repurchase activity during the three-year period from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: ConocoPhillips began monetizing CVE shares in May 2021, sold the remaining 91 million shares in Q1 2022, and used proceeds for share repurchases. The repurchase figures are accurate—383 million shares at $29 billion by end of 2022, and cumulative 433 million shares at $34.3 billion by end of 2024. The $65 billion authorization increase in October 2024 is omitted, but this detail was not explicitly tied to the 2022–2024 evolution of monetization and repurchases, so its absence does not materially distort the core narrative. (2) Quantitative accuracy is perfect: 91 million CVE shares, 383 million repurchased in 2022 at $29B, 433 million total by 2024 at $34.3B—all match ground truth. Calculations are consistent (e.g., ~$75.70/share average in 2022; ~$79.20/share average through 2024), and timeframes align. (3) Multi-hop reasoning is sound: the model correctly links the 2022 asset sale (monetization of CVE shares) to funding share repurchases, and traces the repurchase program’s growth across 2022–2024. The inference that CVE proceeds contributed to increased repurchase activity is logically supported. (4) The answer is contextually complete and highly relevant, focusing precisely on the evolution, dollar amounts, and share volumes. The only minor omission is the $65B authorization update in October 2024, which adds context about future capacity but does not alter the historical account of what occurred from 2022–2024. Thus, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 471,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "The availability of shares under The Home Depot's stock incentive plans evolved significantly from 2022 through 2024. In 2022, under the 2005 Plan, approximately 117 million shares were available for future grants. By 2023, the 2005 Plan was replaced by the Omnibus Plan, which authorized up to 80 million shares plus an additional 10 million shares from prior awards, with 77 million shares available as of January 28, 2024. By 2025, this availability had decreased to 70 million shares. This declining trend indicates that the company has been actively utilizing its stock-based compensation capacity, likely to incentivize employees and directors, and suggests a steady drawdown of the share pool over time. The 1997 Plan, meanwhile, has been inactive since 2005, with no further awards issued.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 117 million shares available in 2022 and the decline to 70 million by 2024, which aligns with the ground truth. However, it incorrectly states that the 77 million shares were available as of January 28, 2024 (which is a 2024 date), but labels this as the 2023 figure—this creates a mismatch in year labeling. Additionally, the LLM introduces a claim that the Omnibus Plan authorized 'up to 80 million shares plus an additional 10 million from prior awards,' which is not present in the original answer and lacks support in the ground truth. This affects quantitative accuracy. (2) The numbers 117M (2022), 77M (~2023), and 70M (2024) are mostly correct in value but misaligned in timing—the original specifies 77M in 2023 and 70M in 2024, but the LLM says 'by 2025' for 70M, which is factually incorrect. The reference to January 28, 2024 as the date for 77M availability contradicts the expected 2023 reporting period. (3) The multi-hop reasoning is generally sound—the model correctly infers that declining available shares indicate active utilization of stock-based compensation and links this to employee incentives. It also correctly notes the inactivity of the 1997 Plan, though this is extraneous. However, the incorrect timeline and unsupported share authorization breakdown weaken the synthesis. (4) The answer is contextually relevant and captures the core trend and its implication—steady utilization of equity awards. Despite incorrect dates and unsupported figures, the central conclusion about drawdown and compensation capacity is preserved, warranting a 7 for correctness. Quantitative accuracy is penalized due to incorrect years and unverified totals, while qualitative and contextual scores remain high due to logical reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 492,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127,000,000 in 2022 to 141,000,000 in 2023 and 2024, reflecting a 14 million share increase following the 2022 shareholder approval. Despite this increase, the shares available for future grants remained relatively stable at approximately 27.3 million in 2022 and 27.3 million as of August 31, 2024. This progression indicates that Accenture is strategically expanding its share-based compensation capacity to support ongoing employee incentives, while maintaining a consistent buffer of available shares, suggesting a balanced approach to long-term talent retention and equity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the authorized share numbers: 127,000,000 in 2022 and 141,000,000 in 2023 and 2024, matching the ground truth exactly. The 14 million increase (141M - 127M) is accurately implied. (2) The additional detail about shares available for future grants (27.3 million in both 2022 and 2024) is factually consistent with typical 10-K disclosures and adds context not in the original answer, but does not contradict it. This information is plausible and enhances the response without introducing error. (3) The reasoning correctly infers that the increase indicates a strategic expansion in share-based compensation capacity. The LLM goes further by noting the stability in available shares, suggesting a balanced approach—this is a reasonable qualitative extension supported by the data. (4) All entities (Accenture plc, Amended 2010 SIP, Class A ordinary shares) and years are correct. The multi-hop synthesis—comparing authorized shares over time and interpreting strategic intent—is sound. The only reason for not scoring a 10 is that the original answer focused on the strategic implication of increased authorization, while the LLM added unsolicited detail about available shares, which, while accurate, slightly shifts focus. However, this does not detract from correctness. Overall, the answer is factually precise, contextually appropriate, and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 398,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted average yield on American Express's foreign government bonds and obligations increased from 2.08% in 2022 (as part of the total weighted average yields) to 6.45% in 2023 and further to 5.85% in 2024. This upward trend suggests that American Express has been increasingly exposed to rising international interest rate environments over this period, as the yields on its foreign government holdings have risen significantly, reflecting broader global monetary policy tightening.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that the weighted average yield was 5.86% in 2022, 6.45% in 2023, and 5.86% in 2024. The LLM incorrectly reports the 2022 yield as 2.08% and the 2024 yield as 5.85% (close but still incorrect). The dollar amount of $630 million in holdings is missing entirely. (2) The quantitative errors are severe: the 2022 figure is less than half the correct value, and the 2024 figure, while close to 5.86%, is still inaccurate and presented as a continued increase rather than a decline. The trend is misrepresented—original shows a rise and then a return to baseline, but LLM implies a continued rise. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the three-year trend showing volatility and reversal. Instead, it describes a continuous upward trend, which contradicts the ground truth. It also introduces a vague reference to 'total weighted average yields' without justification. (4) Contextual relevance is moderate because the answer addresses yield trends and links them to international interest rates, but the incorrect data undermines the conclusion. The suggestion of 'increasing exposure' is contradicted by the 2024 drop in yield. Thus, correctness is low due to major factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 372,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express's yield profile from Foreign Government Bonds and Obligations declined from 6.45% in 2023 to 5.85% in 2024, indicating a shift in the composition or performance of these holdings. In 2022, the weighted average yield for all investments was 2.08%, with Foreign Government Bonds and Obligations representing a small portion of the total fair value ($630 million out of $2.51 billion). The rise in yields from 2022 to 2023 (from 2.08% to 6.45%) suggests a strategic shift toward higher-yielding foreign government securities, likely influenced by favorable market conditions and interest rate movements. However, the subsequent decline in 2024 to 5.85% may reflect a reallocation of assets or a reduction in available high-yield opportunities, signaling a more cautious or diversified investment approach in response to evolving market dynamics.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 yield. The ground truth states that in 2022, American Express held $630 million in Foreign Government Bonds and Obligations with 628 million maturing within one year, but it does not provide a weighted average yield of 2.08% for these specific bonds — instead, 2.08% was the overall weighted average yield for *all* investments in 2022. The LLM incorrectly applies this overall yield to Foreign Government Bonds and Obligations, which is a critical error. Additionally, the LLM claims the yield rose from 2.08% in 2022 to 6.45% in 2023 for these bonds, but the ground truth does not provide the 2022 yield for this specific category, so this inference is unsupported. (2) The dollar amount ($630 million) and 2023 (6.45%) and 2024 (5.85%) yields are correctly cited, which supports partial quantitative accuracy. However, the misattribution of the 2.08% yield to Foreign Government Bonds is a major quantitative flaw. (3) The reasoning about a strategic shift toward higher-yielding securities in 2023 and a more cautious approach in 2024 is plausible and aligns with the trend, but it is based on a flawed premise (the 2.08% yield). The multi-hop synthesis is partially sound — it connects 2022 fair value data with 2023–2024 yields — but fails to correctly interpret the 2022 yield context. (4) Contextual relevance is high because the answer addresses yield evolution and investment strategy implications. However, due to the key factual error in yield data for 2022, the correctness score is limited to 5 — partially correct but with significant inaccuracies affecting the validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 466,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "The presentation of COP's 7% Debentures due 2029 in its 10-K filings evolved from 2022 to 2024, reflecting a consistent yet slightly refined disclosure approach. In 2022, the debentures were listed together with common stock under a single line item, with both the trading symbol \"COP\" and CUSIP-718507BK1 provided. By 2023, the common stock and debentures were separated into distinct line items, with the debentures listed under their CUSIP alone. In 2024, the debentures were again listed separately, with the CUSIP retained but the trading symbol \"COP\" now associated only with the common stock. This progression suggests COP is refining its disclosure to enhance clarity and specificity, likely in response to regulatory expectations and investor demand for more transparent and segmented financial instrument reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 7% Debentures due 2029 were initially grouped with common stock in 2022, separated into a distinct line item in 2023, and maintained separately in 2024, with the correct CUSIP-718507BK1 consistently referenced. The trading symbol 'COP' was correctly noted as being shared in 2022 and later associated only with common stock. (2) Quantitative elements—percentage (7%), year (2029), CUSIP number, and years (2022–2024)—are all accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across three years of filings and infers a trend toward greater transparency and specificity in disclosure, which matches the original conclusion. (4) The only minor difference from the ground truth is that the LLM emphasizes regulatory and investor pressure as a likely driver, which is a reasonable inference but not explicitly stated in the original answer. However, this does not detract from factual correctness and falls within acceptable interpretive range. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 344,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA's financial exposure to its 2.00% Notes Due 2031 remained stable at $1,200 million in fiscal 2022, increased to $1,057 million in 2023, and returned to $1,250 million in 2024. This progression, combined with the consistent inclusion of the notes in long-term debt disclosures across all three years, reveals a disciplined long-term debt management strategy focused on maintaining a balanced maturity profile and managing interest costs, as evidenced by the company's continued investment in low-yield fixed-income instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM states exposure was $1,200 million ($1.2B) in 2022 (correct), then incorrectly claims it increased to $1,057 million ($1.057B) in 2023 — this is actually a decrease, not an increase, and the direction of change is misrepresented. Then, it says exposure 'returned to' $1,250 million ($1.25B) in 2024, implying a rebound, but the ground truth shows a progressive pattern: down in 2023, then up in 2024. The LLM incorrectly frames the 2022–2023 change as an increase when it is a decrease. (2) Number verification: $1.2B (2022) = correct; $1.057B (2023) = correct value but wrong directional interpretation; $1.25B (2024) = correct. However, stating that exposure 'increased' from 2022 to 2023 is factually wrong — it decreased from $1.2B to $1.057B. This is a critical error in quantitative reasoning. (3) Multi-hop reasoning is partially sound — the model correctly identifies the three-year trend and attempts to interpret it in the context of long-term debt strategy. It correctly notes the notes are consistently reported in long-term debt, supporting a stable financing strategy. However, due to the misrepresentation of the 2022–2023 movement, the synthesis is flawed. The conclusion about a 'disciplined strategy' and 'balanced maturity profile' goes beyond the ground truth, which only infers a 'stable approach'. (4) Scores justified: Correctness is 5 due to one major quantitative misstatement (direction of change) despite correct raw numbers. Quantitative accuracy is 4 because while the numbers themselves are correctly formatted and close, the interpretation of change is wrong. Qualitative accuracy is 6 — reasoning is logical but based on flawed premise. Contextual relevance is 8 — the answer addresses both parts of the question and stays on topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 532,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney's strategic positioning of Marvel has evolved across fiscal years 2022, 2023, and 2024, with Marvel being recognized as a key component of Disney's indefinite-lived intangible assets, as noted in both the 2022 and 2024 10-K filings. In terms of branding within streaming services, Marvel has remained a central pillar of Disney+, serving as a top-level 'tile' within the interface, highlighting its importance in driving subscriber engagement. By fiscal 2024, Disney had further integrated its streaming services, merging Disney+ with Star+ in Latin America into a unified Disney+ offering, enhancing the platform's content diversity and reinforcing Marvel's role alongside other major brands like Star and ESPN. This integration and continued emphasis on Marvel within the streaming ecosystem reflect Disney's ongoing strategy to leverage Marvel as a core asset across both its intangible portfolio and direct-to-consumer platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: Marvel's inclusion as an indefinite-lived intangible asset in 2022 and 2024, and its role as a top-level branded tile on Disney+ in 2023. The quantitative accuracy is perfect—no numerical or date inaccuracies are present, and all fiscal years are correctly referenced. The answer correctly identifies Marvel's strategic importance across both financial (intangible assets) and distribution (streaming) dimensions. However, the LLM introduces information not present in the ground truth: the merger of Disney+ with Star+ in Latin America by fiscal 2024. While factually plausible based on external knowledge, this detail is not supported in the original answer derived from the knowledge graph and adds extraneous context that wasn't validated. This affects qualitative accuracy slightly, as it introduces a synthesis step not confirmed by the source data. The core multi-hop reasoning—linking Marvel’s financial valuation with its branding role across years—is sound and semantically equivalent to the original. The answer remains highly relevant and captures the strategic evolution accurately, earning a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 343,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "From 2022 through 2024, American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolved in several key ways. Discount revenue recognition remained tied to Card Member transactions, with fees varying by merchant industry, transaction volume, and geographic scope, and recorded at the time of transaction. In 2022, the company highlighted that when a third-party acquirer is involved, such as under the OptBlue program or with GNS partners, American Express receives a negotiated network rate fee, which is recorded as discount revenue. By 2023, this structure was reaffirmed, with the addition of \"Processed revenue\" to include fees from network partners and alternative payment solutions, where the issuer rate is negotiated and recorded as contra-revenue or expense. In 2024, the company emphasized its strategy to expand merchant coverage globally, working with third-party acquirers to increase acceptance, particularly in low- and new-to-plastic industries, and leveraging digital integration and network investments. This reflects a broader push to enhance merchant coverage and optimize network rate fee negotiations to support long-term growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: discount revenue recognition tied to transaction timing and merchant variables, negotiated network rate fees with third-party acquirers (e.g., OptBlue, GNS), and the 2023 introduction of processed revenue from network partnerships. The evolution through 2024 toward global merchant coverage expansion via third-party acquirers, digital integration, and targeting new industries is accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and contractual arrangements, correctly linking revenue recognition practices with strategic shifts in acquirer relationships. One minor omission: the original mentions 'royalties and fees for facilitating transactions on cards issued by partners' as part of processed revenue, while the LLM refers more generally to 'fees from network partners and alternative payment solutions' and mentions 'contra-revenue or expense' treatment, which is not in the original and slightly misrepresents the classification. This does not invalidate the answer but introduces a nuance not supported by the ground truth. (4) The answer is contextually excellent—directly addresses all parts of the question: discount revenue recognition, network rate fee negotiation, and merchant coverage expansion. Wording differs slightly but meaning is semantically equivalent. The score of 9 reflects near-perfect accuracy with a minor gap in completeness regarding the specific components of processed revenue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 477,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen's regulatory risk disclosures related to drug delivery devices from 2022 through 2024 evolved to emphasize increasing scrutiny and dependencies across clinical trials, post-marketing requirements, and device-related safety reviews. In 2022, Amgen highlighted general regulatory and operational risks, noting that drug delivery devices used with its products carry their own regulatory, manufacturing, and safety risks. By 2023, the disclosures became more specific, detailing how regulatory authorities are imposing post-marketing requirements, such as additional confirmatory studies for products like LUMAKRAS, and emphasizing the importance of fulfilling conditions for accelerated approvals. The 2024 disclosures further reinforced this trend, with a focus on the heightened regulatory focus on meeting post-marketing commitments, including pediatric studies and outcomes trials, and the potential for revised labeling or enforcement actions if safety signals or compliance issues arise. Additionally, drug delivery devices used in combination with Amgen's products are increasingly subject to regulatory oversight for safety and malfunctions, reflecting a growing integration of device-related risks into the broader regulatory risk framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of Amgen's disclosures from general regulatory risks in 2022 to more specific post-marketing and safety compliance concerns in 2023 and 2024 is accurately captured. The mention of LUMAKRAS, accelerated approval, confirmatory studies, and the FDA's Complete Response Letter is consistent with the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and time-bound disclosures are correctly attributed. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression in risk framing—from general dependencies to specific post-marketing and safety review challenges. It appropriately links clinical trial dependencies (e.g., surrogate endpoints), post-marketing requirements (e.g., confirmatory trials), and device-related safety reviews. (4) The only minor shortcoming is that the LLM does not explicitly mention 'pharmacovigilance or quality assessment requirements' as potential triggers for enforcement actions, which is included in the original answer. However, it does reference 'compliance issues' and 'safety signals' leading to enforcement actions, which captures the essence. Overall, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 399,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips' HSE audit program has evolved from 2022 to 2024 by enhancing its **scope definition** to include more rigorous conformance checks with global HSE policies and standards, as outlined in the 2022 and 2024 disclosures. **Improvement tracking mechanisms** have been refined to ensure that identified actions are systematically tracked to completion, with a continued focus on reducing human error and sharing global lessons learned from incident investigations, as emphasized in 2022 and reiterated in 2023. **Governance reporting structures** have remained consistent, with progress on HSE audits and performance being reported to the Executive Leadership Team (ELT) and the Board of Directors annually, as noted in all three years' disclosures, reinforcing accountability and alignment with corporate strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, entities, and governance reporting structure, correctly identifying that HSE audit progress was consistently reported to the Executive Leadership Team (ELT) and Board of Directors from 2022 to 2024. It accurately notes that improvement actions were tracked to completion across all years, and that conformance with HSE policies was a consistent focus—this aligns with the ground truth and shows correct multi-hop synthesis across years. However, the LLM misses key qualitative evolutions in scope definition: it does not mention the 2023 expansion into human capital management, Life Saving Rules, Process Safety Fundamentals, or the stop work policy, which represent a significant broadening of the audit context. Additionally, the 2024 shift to 'Corporate HSE audits'—indicating centralization and standardization—is not captured. While the LLM states scope became 'more rigorous,' it lacks the specific framing of evolution from localized conformance (2022) to integrated safety systems (2023) to corporate-level standardization (2024), which is central to the original answer. The improvement tracking and governance elements are well-covered, but the absence of these key thematic developments limits the depth of the evolution narrative. Quantitatively, there are no errors—no numbers are misstated or miscalculated. Contextually, the response is highly relevant and well-structured, addressing all three dimensions of the question (scope, tracking, governance), though with incomplete detail on scope evolution. Thus, the correctness and qualitative accuracy scores are reduced due to missing key contextual developments, despite strong performance on factual elements and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 472,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture has increasingly focused on developing and introducing new pricing and commercial models from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, as these innovations have altered how clients use and pay for services. In 2022, the company emphasized the need to adapt to cloud and as-a-service models, acknowledging that failure to introduce new pricing models reflecting the value of these technologies could negatively impact revenue. By 2023 and 2024, this approach evolved to include AI-based solutions, with Accenture investing significantly in AI and creating new offerings to implement these technologies for clients. However, consistent risks highlighted across all three years include the potential for client spending delays, reduced demand for traditional services, and the challenges of replacing displaced services with new ones. Additionally, risks related to AI—such as flawed algorithms, biased data, regulatory scrutiny, and reputational harm—have remained a key concern, underscoring the need for continuous innovation and strategic investment to maintain a competitive edge.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting Accenture's evolving focus on pricing models in response to AI and cloud-based solutions from 2022 to 2024. It correctly notes the increasing strategic emphasis and investment in AI by 2023–2024 and acknowledges the initial 2022 recognition of the need for new pricing models tied to value from cloud and as-a-service offerings. The consistent risk of client spending delays and reduced demand for traditional services is appropriately highlighted. However, there is a key deviation in the consistent risks: while the original answer emphasizes the risk of failing to introduce value-reflective pricing models quickly enough and insufficient client adoption leading to revenue shortfalls and competitive disadvantages, the LLM shifts focus in 2024 to AI-specific risks (flawed algorithms, biased data, regulation, reputational harm), which were not cited in the ground truth as consistent risks across all three years regarding pricing model adoption. This misaligns the core persistent risk identified in the original answer. While AI-related risks are plausible, they are not the consistent theme tied to pricing model adoption per the ground truth. The answer is semantically strong and contextually relevant, with no numerical inaccuracies (dates are correct, no faulty calculations), but the qualitative reasoning slightly misses the multi-hop synthesis by conflating general AI risks with pricing model adoption risks. Thus, the correctness and qualitative accuracy scores are reduced accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 435,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE's holdings of the AerCap note decreased from $993 million at December 31, 2021, to $900 million at December 31, 2022, then increased slightly to $944 million at December 31, 2023, before declining again to $982 million at December 31, 2024. This fluctuation suggests a cautious and strategic approach by GE, likely influenced by its run-off insurance operations and broader portfolio management, as the AerCap note is classified as a Level 3 available-for-sale debt security, with fair value changes recorded in Other Comprehensive Income. The pattern indicates that GE may be gradually reducing its exposure to AerCap while maintaining a long-term, non-trading investment stance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trend of GE's holdings in the AerCap note. According to the ground truth, the holdings decreased from $993 million at the end of 2021 (reported in 2022) to $944 million at the end of 2023 (reported in 2024), showing a consistent decline. However, the LLM claims a drop to $900 million in 2022, an increase to $944 million in 2023, and then a further decline to $982 million in 2024—none of which aligns with the ground truth. The $982 million figure for 2024 is entirely fabricated, and the fluctuating pattern contradicts the actual steady reduction. (2) The only correct numbers are $993 million (2021) and $944 million (2023), but their timing and interpretation are misrepresented. The LLM incorrectly assigns $944 million to 2023 as an increase from $900 million in 2022, when in fact it is a continued decrease from $993 million. There is no evidence in the ground truth of a $900M or $982M holding. (3) The multi-hop reasoning is flawed: the LLM invents intermediate data points not present in the source and mischaracterizes the trend. While it correctly identifies the broader context of portfolio management and Level 3 securities, these do not compensate for the incorrect data trajectory. (4) The contextual relevance is moderate because the answer addresses GE's investment strategy and references relevant financial classifications, but the conclusion about 'fluctuation' and 'cautious approach' is based on false data. The qualitative reasoning would be stronger if grounded in accurate figures. Correctness score is low due to major quantitative errors that invalidate the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 463,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "From 2022 to 2024, Amgen's development of Bemarituzumab progressed from initiating a phase 3 study for gastroesophageal junction (GEJ) adenocarcinoma in 2022 to continuing its investigation for gastric and GEJ cancer, as well as advanced solid tumors (excluding advanced squamous NSCLC) in 2024. In terms of intellectual property, Bemarituzumab's U.S. and European patents related to polypeptides are estimated to expire in 2029, with the possibility of regulatory exclusivity extending protection further. Amgen also noted that patent expiration estimates do not include potential term extensions or additional patents that may be filed, which could provide further exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab was in phase 3 for GEJ adenocarcinoma in 2022, expanded to gastric and GEJ cancer and advanced solid tumors (excluding NSCLC) by 2024, and U.S./European patent expiration is correctly stated as 2029. The mention of potential regulatory exclusivity extensions and possible future patents is a reasonable addition consistent with typical IP disclosures and does not contradict the original answer. (2) Quantitative accuracy is perfect: the 2029 patent expiration date is correctly reported, and no calculations are required. (3) Multi-hop reasoning is sound—information is synthesized across 2022 (clinical phase), 2023 (IP disclosure), and 2024 (expanded indications), even if not explicitly labeled by year in the response. The evolution from clinical development to broader therapeutic and IP strategy is implied. (4) The only minor shortcoming is that the LLM does not explicitly note the 2023 IP disclosure as a distinct milestone, slightly reducing qualitative precision, but the core information is present. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 340,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "American Express has strategically evolved its positioning relative to alternative payment mechanisms from 2022 through 2024 by intensifying technological investment and adapting to competitive pressures from fintech and digital payment platforms. In 2022, the company acknowledged the growing influence of alternative payment systems such as mobile wallets, digital currencies, and buy-now-pay-later services, emphasizing the need to innovate in areas like fraud prevention, data analytics, and digital services to maintain its competitive edge. By 2023, the company highlighted the increasing shift to digital payments and the integration of financial services by competitors, reinforcing its focus on enhancing customer experience through rewards, partnerships, and digital transformation. In 2024, American Express underscored the criticality of continued investment in technologies such as AI, machine learning, and open banking to stay ahead of evolving industry standards and customer expectations. This trajectory reveals a long-term strategy to proactively respond to fintech disruption by leveraging innovation and strengthening its value proposition, rather than merely reacting to market changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of American Express's strategic positioning from 2022 to 2024, noting increasing technological investment and recognition of fintech disruption. It accurately identifies key alternative payment mechanisms like mobile wallets, buy-now-pay-later, and open banking, and correctly frames the company's response as proactive and innovation-driven. However, it misses the critical strategic shift in 2024 from viewing alternative payment mechanisms as a competitive threat to a dependency posture—i.e., the necessity of integrating these technologies into core offerings. This nuance is central to the ground truth and reflects a deeper strategic evolution that the LLM answer does not fully convey. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable; the score of 10 reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the LLM synthesizes information across years and identifies trends in competitive pressure and tech investment, but fails to fully connect the shift in strategic framing (from threat to dependency), which is a key multi-hop insight required by the ground truth. (4) The answer is contextually relevant and well-structured, addressing all parts of the question at a high level, but lacks the precise strategic characterization in 2024 that defines the company's long-term response. Hence, correctness and qualitative accuracy are marked down to 7, while contextual relevance remains high due to strong overall alignment with the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 453,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs increased from $91.58 in 2022 (as reported in both 2023 and 2024 filings) to $112.50 in 2023, and remained at $112.50 in 2024. This upward trend indicates a strategic shift toward higher long-term incentive compensation values, likely reflecting stronger stock price performance and the company's continued emphasis on aligning executive compensation with long-term shareholder value through performance-based, cash-settled equity awards.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting value of $91.58 in 2022 and the ending value of $112.50 in 2024, which matches the ground truth. However, it incorrectly states that the value increased to $112.50 in 2023 and remained there in 2024, implying no change from 2023 to 2024. The ground truth only confirms values for 2022 and 2024, with no explicit data point for 2023. Thus, the LLM introduces an unsupported intermediate value and timeline, making the quantitative evolution inaccurate. (2) The numbers themselves ($91.58 and $112.50) are correct and properly attributed to 2022 and 2024, but the insertion of $112.50 in 2023 is not verifiable from the ground truth and represents a factual overreach. There is no indication in the original answer that the increase occurred in 2023 or that the value was stable thereafter. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward higher incentive compensation aligned with long-term performance, which is consistent with the ground truth. It adds contextual interpretation (e.g., 'stronger stock price performance') that is plausible but not explicitly confirmed, which is acceptable for qualitative expansion. (4) Despite the incorrect interpolation of the 2023 value, the overall trend and strategic interpretation are aligned with the original answer, warranting a moderate correctness score. The contextual relevance is perfect as it fully addresses both parts of the question—evolution of the metric and its strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 427,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal's exposure to abusive behaviors increased from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes. In 2022, the company highlighted the risk of non-payment defaults and fraud, including synthetic identities and stolen financial instruments, which could lead to higher loss rates and erode consumer and merchant confidence. By 2023, PayPal had taken steps to mitigate some credit-related risks by selling a substantial portion of its U.K. and European BNPL loan portfolios, aiming to reduce exposure to abusive behaviors and improve risk management. However, in 2024, the company continued to face evolving threats from third-party fraud schemes, with no indication of a significant decline in the sophistication or scale of these attacks. This persistent exposure, despite mitigation efforts, suggests that PayPal's risk management strategies, while proactive in certain areas, may not yet be fully effective in addressing the growing complexity of fraud and abusive behaviors in its digital ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PayPal's growing exposure to abusive behaviors, focus on third-party fraud schemes (e.g., synthetic identities, stolen instruments), and credit product risks are accurately described across 2022–2024. The 2023 mitigation via sale of U.K. and European BNPL portfolios is correctly noted, though the ground truth specifies a €40 billion multi-year receivables sale agreement, which the LLM omits numerically but captures in substance. (2) Quantitative accuracy is strong—no incorrect numbers are stated, and while the €40 billion figure is not mentioned, the LLM does not invent or misstate any figures, merely describing the transaction qualitatively. (3) Multi-hop reasoning is sound: the LLM synthesizes fraud trends, credit product expansion, risk mitigation actions, and ongoing challenges across years and regions (U.S., U.K., Europe), correctly inferring implications for risk management effectiveness. (4) The conclusion that PayPal’s strategies are proactive but face persistent challenges reflects the ground truth’s implication of ongoing vulnerability despite mitigation efforts. The only minor gap is the omission of the 'valid-when-made doctrine' regulatory uncertainty in 2024, which slightly reduces completeness but does not undermine the core accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 402,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "From 2022 through 2024, Cyramza's therapeutic positioning expanded to include additional indications, such as first-line treatment for metastatic NSCLC with EGFR mutations, reflecting a broader application in oncology. Intellectual property protection for Cyramza, as detailed in 2023, included compound patents and data protection expiring between 2023 and 2026, indicating a narrowing window of exclusivity. By 2024, while no new IP protections were disclosed, the continued listing of Cyramza among key oncology products suggests Eli Lilly is leveraging its established role in multiple cancer types to support its long-term oncology strategy, which emphasizes diversification and expansion into targeted therapies and combination treatments.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, it claims that Cyramza's therapeutic positioning expanded from 2022 to 2024 to include 'first-line treatment for metastatic NSCLC with EGFR mutations'—this is factually incorrect. The ground truth states that no new indications were added by 2024 and that its positioning was reaffirmed across existing cancer types, not expanded. This misrepresents a key aspect of the drug’s evolution. (2) Regarding intellectual property, the LLM correctly notes that compound patents extend through 2026 and data protection expires between 2023 and 2026, aligning with the ground truth mentioning U.S. and Japan patents through 2026 and data protection expiring as early as 2023 in Japan. These dates are accurate and reflect correct quantitative understanding. However, the LLM omits the specific geographic distinctions (U.S. vs Japan) and fails to emphasize the significance of the 2023 expiration in Japan. (3) The multi-hop reasoning is partially sound—linking IP expiry to strategic planning is valid—but the conclusion that Eli Lilly is focusing on 'expansion into targeted therapies and combination treatments' is speculative and not directly supported by the ground truth, which instead suggests the company is maintaining Cyramza’s presence while preparing next-generation products due to patent cliff concerns. The LLM introduces new concepts (e.g., 'diversification and expansion') not present in the original data. (4) Despite these issues, the answer remains contextually relevant, addressing both therapeutic positioning and IP protection over time, and drawing a plausible strategic inference. However, the incorrect claim about new indications significantly undermines factual correctness, warranting a low-to-mid correctness score. Quantitative accuracy is moderate due to correct date ranges but lack of specificity. Qualitative accuracy suffers from flawed reasoning based on incorrect premises. Contextual relevance is high as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 555,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022 through 2024, Philip Morris maintained a consistent capital structure strategy by retaining the 3.875% Notes due 2042 (PM42A) across all three years, indicating long-term stability in its debt portfolio. Alongside this, the company actively managed its capital structure by issuing and maintaining a diverse array of other debt instruments with varying maturities and coupon rates, such as the 2.750% Notes due 2025, 3.750% Notes due 2031, and others, as evidenced by the evolving listings in each year’s 10-K filings. This strategy reflects a balance between long-term fixed-rate obligations and flexibility to adjust to market conditions through new debt offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent presence of the 3.875% Notes due 2042 across 2022–2024, which aligns with the ground truth. However, it fails to accurately reflect the specific evolution of other long-term debt instruments. The ground truth states that in 2022, Philip Morris had 4.125% Notes due 2043 and 4.875% Notes due 2043, which were still present in 2023 (alongside 4.250% Notes due 2044), and then disappeared by 2024—indicating a refinancing or retirement. The LLM instead references generic instruments like 2.750% Notes due 2025 and 3.750% Notes due 2031, which are not mentioned in the ground truth and do not support the multi-hop reasoning about long-dated note management beyond 2042. (2) Quantitative inaccuracies include the introduction of incorrect coupon rates and maturities (e.g., 2.750% due 2025, 3.750% due 2031) not present in the original data. The key comparative numbers—4.125%, 4.875%, 4.250% Notes with maturities in 2043 and 2044—are entirely omitted or replaced. (3) The multi-hop reasoning is partially sound in that the model infers active debt management and a balance between stability and flexibility, but it fails to correctly synthesize the specific instruments and their changes over time. The conclusion about 'evolving listings' lacks support from accurate cross-year comparisons. The critical insight in the ground truth—that no new long-dated notes beyond 2042 were introduced by 2024, signaling stabilization—is missed. (4) The contextual relevance is high because the answer addresses capital structure evolution and debt management strategy. However, due to significant factual inaccuracies in the specific instruments and missing the key refinancing pattern of long-dated debt, the correctness and qualitative accuracy scores are moderate. The answer captures the general theme but not the specific, fact-based trajectory required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 521,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal's exposure to abusive behaviors increased with the expansion of its credit products, particularly in the U.S. and European markets, as highlighted in 2022. The company noted risks related to non-payment, fraud, and third-party misuse of its services, especially through synthetic identities and fraudulent transactions. In 2023, PayPal took proactive steps to mitigate these risks by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, reducing its exposure to credit defaults and abusive behaviors tied to these products. In 2024, the company continued to manage third-party risk by diversifying its reliance on payment processors and enhancing its risk management strategies, including forward-flow arrangements for future loan receivables. These actions reflect PayPal’s efforts to strengthen its credit product resilience and reduce the operational and financial risks associated with abusive behaviors and third-party dependencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified rising abusive behaviors in 2022 related to synthetic identities and fraud in credit products; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables to reduce risk exposure; in 2024, it continued enhancing risk management, particularly around fraud detection and third-party dependencies. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited with proper regional scope (U.K. and Europe) and product focus (BNPL receivables). No calculations were required, and all numbers match the original. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and connects credit product expansion, third-party risks, and strategic mitigation actions. The only minor gap is that the LLM mentions 'diversifying reliance on payment processors' and 'forward-flow arrangements' in 2024, which are not explicitly in the ground truth. While plausible extensions of the asset sale strategy, they slightly extend beyond the documented actions (which emphasize improved detection mechanisms and fraud prevention infrastructure). However, 'forward-flow arrangements' can be reasonably inferred from the multi-year receivables sale, so this does not constitute a factual error. (4) The answer is contextually complete and relevant, addressing all parts of the question: evolution of risk (2022–2024), link to credit products and third-party risk, and specific actions in 2023 and 2024. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to the slight addition of unverified details in 2024, though core facts and reasoning remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 484,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD's exposure to the risk of loss or modification of tax and tariff exemptions increased from 2022 through 2024, as highlighted in each year’s 10-K filings. In 2022, AMD noted the risk of such exemptions being lost or modified due to changes in tax laws and trade protection measures in foreign jurisdictions. By 2023, the risk was reiterated with additional context on geopolitical tensions, such as the Ukraine-Russia conflict and U.S. sanctions, which heightened regulatory uncertainty. In 2024, the risk was again emphasized alongside a rise in international sales to 66% of net revenue, indicating a broader geographic footprint and increased vulnerability to regulatory shifts. This trend suggests a growing regulatory uncertainty in AMD’s global operations, driven by evolving tax policies, geopolitical instability, and the increasing complexity of compliance across multiple jurisdictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD's increasing emphasis on the risk of loss or modification of tax and tariff exemptions from 2022 to 2024 is accurately portrayed. In 2022, the risk was mentioned among other global operational risks; in 2023, it was linked to geopolitical tensions; and in 2024, it was heightened due to ongoing conflicts and regulatory changes. (2) The quantitative claim about international sales rising to 66% of net revenue in 2024 is factually correct per AMD’s 10-K and supports the argument of increased exposure—this detail was not in the original answer but is accurate and contextually relevant, enhancing completeness without introducing error. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk evolution across years and connects it to broader regulatory uncertainty, geopolitical issues, and operational expansion. (4) The only minor deviation is that the original answer emphasizes the 'material impact' on financial and operational stability more explicitly, while the LLM focuses on compliance complexity—semantically similar but slightly less precise in framing the financial materiality. However, the core progression and implications are correctly captured. No calculation errors; all entities (AMD, years, geopolitical events) are accurate. Wording differs but meaning is equivalent or enhanced. Thus, high scores across all dimensions with a 9 on correctness due to slight difference in emphasis on financial materiality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 427,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco's gains from total return swaps tied to deferred compensation evolved from a loss of $92 million in fiscal year 2022, to gains of $58 million in 2023, and further increased to $91 million in 2024. This progression indicates a significant improvement in performance, suggesting that the company's exposure to deferred compensation-linked derivatives has become more favorable over the period, potentially reflecting strategic adjustments or improved market conditions impacting these instruments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024, matching the ground truth exactly. (2) All numeric values are accurate and properly attributed to the correct fiscal years; no calculations are required beyond correct reporting, which is flawless. (3) The multi-hop reasoning is sound—the answer synthesizes data across three fiscal years and correctly infers a trend of improving performance in the context of deferred compensation-linked derivatives. (4) The qualitative interpretation aligns with the original answer, noting improved market conditions or strategic shifts as potential drivers, which is a reasonable and supported conclusion. The response is semantically equivalent, complete, and contextually precise, addressing both the quantitative evolution and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 267,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From fiscal years 2022 through 2024, Disney's strategic investment in its DTC offerings evolved from an initial phase of aggressive expansion and cost-driven growth in 2022 to a more measured and financially disciplined approach by 2024. In 2022, Disney acknowledged the high costs and associated losses of its DTC strategy, which impacted distribution strategies and content windows, while also investing in international expansion and new business lines. By 2023, the company continued to make strategic investments in DTC offerings, anticipating that these would offset declines in affiliate fees and linear viewership by driving subscription and advertising revenue growth. In 2024, Disney faced heightened competitive pressures and financial risks, including rising content costs, increased marketing expenses, and the need to balance investment with profitability. The progression reveals that scaling DTC services is capital-intensive and subject to market pressures such as competition from other streaming platforms, evolving consumer preferences, and the financial burden of content amortization and potential impairments. These factors underscore the financial risks Disney faces in sustaining its streaming growth while maintaining strong liquidity and credit metrics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Disney acknowledged high DTC costs and losses in 2022, increased strategic investment in 2023 to offset declining linear revenues, and faced intensified competitive and financial pressures in 2024. The LLM correctly captures the evolution of Disney's strategy and the associated risks. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across fiscal years 2022–2024, correctly identifying shifts in strategy and external pressures. It accurately infers that Disney doubled down on DTC despite rising costs and uncertain profitability, which is consistent with the ground truth. (4) The LLM adds slightly more detail (e.g., 'marketing expenses', 'content amortization', 'liquidity and credit metrics') not explicitly in the original, but these are reasonable inferences from the context and do not contradict the ground truth. The only minor difference is that the LLM characterizes the 2024 approach as 'more measured and financially disciplined', whereas the original emphasizes a 'strategic pivot' and 'doubling down'—a slight nuance difference, but not factually incorrect. Overall, the answer is semantically equivalent, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 400,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal's exposure to margin risk remained consistent across 2022, 2023, and 2024, as it continued to bear full margin risk when completing payment transactions due to its role as principal in these transactions. The company retains full discretion in setting fees charged to customers, independent of the transaction expenses incurred for services provided by payment processors or financial institutions, which are recognized as transaction expenses. This structure, described in all three years' filings, means that PayPal's margin risk is directly tied to the difference between the fees it sets and the expenses it incurs, with no material changes in this exposure or discretion over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurately represented: PayPal bore full margin risk across 2022, 2023, and 2024; it maintained discretion in setting fees independent of processor costs; and transaction expenses tied to payment processors were consistently recognized as such. There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but all temporal references (2022–2024) are correct. (2) The answer addresses all parts of the multi-hop question: evolution over time, fee-setting discretion, treatment of processor expenses, and stability of margin risk. (3) Entity accuracy is perfect: 'PayPal' is correctly identified, years are accurate, and financial terms like 'transaction expenses', 'margin risk', and 'fee-setting discretion' are used appropriately. (4) The reasoning is sound and synthesizes consistent disclosures across the three years, correctly concluding no material changes occurred despite new segment reporting standards (ASU 2023-07), which the LLM implicitly acknowledges by stating the structure remained unchanged. The answer captures the core conclusion of the ground truth—stable margin risk exposure—without needing to mention ASU 2023-07 explicitly, as that detail is contextual and not central to the risk exposure conclusion. Overall, the response is concise, factually accurate, and demonstrates correct multi-hop synthesis across time and accounting practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 436,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "From 2022 through 2024, the risk of new aircraft order cancellations remained a consistent concern for Honeywell's Aerospace business, as highlighted in each year's 10-K filings. In 2022, the risk was tied to the lingering effects of the global pandemic, which caused disruptions in air travel demand, leading to potential delays or cancellations of new aircraft orders. By 2023, while the pandemic was still referenced, the emphasis shifted slightly toward broader economic and geopolitical uncertainties, such as regional conflicts and public health events, which could still lead to cancellations. In 2024, the risk was still present but framed within a more stable context, with no new major disruptions mentioned, suggesting a gradual normalization in the commercial aviation sector. This progression indicates a slow but ongoing recovery and increasing stability in the sector, with the risk of cancellations becoming less acute as demand for air travel and new aircraft production stabilized over the three-year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting that Honeywell consistently cited the risk of new aircraft order cancellations from 2022 to 2024. It correctly identifies the pandemic as the primary concern in 2022 and acknowledges a shift toward broader economic and geopolitical risks in 2023, which aligns with the ground truth. The quantitative accuracy is perfect—there are no numerical claims to dispute, and all dates (2022–2024) are used appropriately. However, the LLM diverges in its interpretation for 2024: while the ground truth emphasizes that structural and competitive risks (e.g., new entrants and non-traditional players) continued to create uncertainty, the LLM suggests a 'more stable context' and 'gradual normalization,' implying increasing stability and reduced risk. This contradicts the original answer, which stresses ongoing fragility and persistent uncertainty despite the waning of direct pandemic effects. The LLM underrepresents the continued significance of market disruption from non-traditional players, missing a key nuance in the evolution of risk. While the multi-hop reasoning is sound in connecting annual risk factors, it fails to fully synthesize the continuity of concern across all three years as an indicator of sector fragility. Instead, it leans toward a more optimistic conclusion about stabilization, which is not supported by the ground truth. Thus, while factually consistent in parts and contextually relevant, the qualitative interpretation lacks full accuracy in capturing the persistent and evolving nature of the risk as emphasized in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 450,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 through 2024, regulatory constraints have increasingly impacted Philip Morris International’s (PMI) competitive positioning, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs). In 2022, PMI highlighted that product regulation diminished the ability to differentiate tobacco products and restricted adult consumer access to truthful and non-misleading information about RRPs. By 2023 and 2024, this regulatory pressure intensified, with PMI noting that product regulation disproportionately impacted the commercialization of its products and further limited branding, communication, and product differentiation—especially for SFPs. These evolving constraints reveal a growing challenge for PMI to effectively communicate the attributes of its innovative products to adult consumers, thereby affecting its ability to drive conversion and maintain a competitive edge in a highly regulated and competitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: regulatory constraints on PMI's competitive positioning intensified from 2022 to 2024, particularly affecting RRPs and SFPs; restrictions on adult consumer access to truthful information and product differentiation are consistently highlighted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable—no errors in dates or time periods (2022–2024 correctly referenced). (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how regulatory pressure evolved across years and how it impacted communication, branding, and commercialization. It captures the shift from RRPs to SFPs in emphasis, though slightly less explicitly than the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'growing influence of digital media in spreading misleading information' in 2023 or the concept of 'regulatory asymmetries' and 'unfair competition' as clearly as the original. However, the core evolution and implications are accurately conveyed. Semantic equivalence is strong, and the answer fully addresses the question’s components. Thus, the correctness score is 9 due to slight omission of nuanced details, but all major factual and qualitative elements are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 383,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal has consistently borne full margin risk from 2022 through 2024 in completing payment transactions, as it acts as the principal in these transactions, setting fees independently of costs incurred through payment processors or financial institutions. Across all three years, this margin risk exposure remains tied to its transaction pricing models, which include fixed and variable fee components, often based on volume tiers, with adjustments made if transaction volumes deviate from defined thresholds. Additionally, PayPal's margin risk has been influenced by incentives provided to customers, such as discounts, rebates, and rewards, which reduce transaction revenues and are recognized either as revenue reductions or as sales and marketing expenses, depending on their structure. These factors—pricing models, payment processor usage, and customer incentives—have consistently shaped PayPal’s exposure to margin risk throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: PayPal bears full margin risk from 2022–2024, acts as principal in transactions, sets fees independently of processor costs, and recognizes incentives as revenue reductions or expenses. The evolution across years—increasing disclosure detail on incentives and pricing—is accurately reflected in substance, though the LLM generalizes slightly rather than explicitly noting the incremental disclosure changes year-over-year (e.g., 2023 adding performance-based amortization detail). (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or figures; however, all references to years (2022, 2023, 2024) are correct, satisfying temporal accuracy. (3) Multi-hop reasoning is sound: the model synthesizes information across the three years and connects margin risk to transaction pricing, payment processor costs, and customer incentives—exactly as required. It correctly identifies that pricing models include volume-based tiers and that incentives affect revenue or expenses depending on structure, which matches the original answer’s emphasis on amortization and performance conditions. (4) The only minor shortcoming is that the LLM does not explicitly highlight the *evolution* in disclosure depth—particularly that 2023 introduced more detail on how incentives are accounted for (revenue reduction vs. amortization)—which slightly reduces qualitative precision. However, the core reasoning and factual content remain robust and contextually complete. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 481,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "From 2022 through 2024, AMD's strategy with AIB manufacturers evolved by maintaining inventory protection policies to support AIBs, ensuring stability in their operations amid market fluctuations. In 2022, AMD emphasized close collaboration with AIBs and system integrators (SIs) to build differentiated products using AMD's graphics and chipset technologies, with SIs leveraging discrete graphics solutions to enhance product value and differentiation. By 2023 and 2024, AMD continued to reinforce these inventory protections for AIBs and expanded its focus on global system integrators, enabling them to incorporate discrete graphics into tailored solutions for enterprise, HPC, and cloud customers. This strategic alignment with AIBs and SIs underscored the role of discrete graphics as a key differentiator for system integrators in delivering high-performance, customized computing solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, collaborated closely with AIBs and system integrators (SIs), and emphasized discrete graphics as a differentiator for SIs. The evolution in emphasis toward strategic alignment with SIs in enterprise, HPC, and cloud segments by 2024 is consistent with the subtle shift noted in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is synthesized across years and entities (AMD, AIBs, SIs) correctly. The only minor gap is that the LLM answer does not explicitly mention the 'regional or product-based strengths' aspect of SIs highlighted in 2024 in the original answer, nor does it note that AIBs build and sell board-level products (a detail present in 2022–2023 descriptions in the ground truth). However, these omissions are minor and do not detract from the overall accuracy. (4) The answer is fully contextually relevant, directly addressing AMD’s strategy evolution, inventory protection, and the role of discrete graphics in SI differentiation. Wording differs but semantic meaning matches closely. Minor deduction in qualitative accuracy due to slight incompleteness in 2024-specific nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 383,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, The Walt Disney Company maintained consistent counterparty credit risk management practices, requiring counterparties to have a credit rating of A- or better for derivative transactions and mandating collateral if credit ratings fell below A- or exposure limits were exceeded. In fiscal 2022, the Company reported no cash balances with individual institutions exceeding 10% of total cash and cash equivalents, while in fiscal 2024, 24% of total cash and cash equivalents were held with individual institutions above the 10% threshold (excluding money market funds), indicating a slight increase in concentration. Throughout this period, the Company consistently limited investment credit exposure with any single institution and maintained liquidity in high-quality money market funds, ensuring minimal exposure to below-investment-grade counterparties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained a policy of transacting only with counterparties rated A- or better and required collateral if ratings fell below A- or exposure exceeded limits—consistent across 2022–2024. The 24% concentration of cash and cash equivalents with a single institution in fiscal 2024 is correctly reported, compared to no such concentration in 2022. The mention of the 10% threshold (even though not in the original answer) is contextually appropriate and consistent with typical disclosure language, and the exclusion of money market funds adds precision without contradicting the ground truth. (2) Quantitative accuracy is perfect: the 24% figure is correct, years (2022, 2024) are accurate, and no calculations are required beyond correct reporting. (3) Multi-hop reasoning is sound—synthesizing credit rating policy, collateral triggers, and evolving concentration risk across years. The only minor gap is that the original answer explicitly notes the *increase* in concentration as suggesting a shift in liquidity strategy, a subtle interpretive point slightly underemphasized in the LLM response (which calls it a 'slight increase' but doesn't fully reflect the strategic implication). (4) Contextual relevance is excellent—the answer directly addresses counterparty ratings, collateral requirements, and concentration thresholds as asked. Wording differences (e.g., 'individual institutions above the 10% threshold') are semantically equivalent and acceptable. Overall, this is a factually correct, well-structured, and comprehensive response with only a minor nuance in strategic interpretation missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Limits]-> RISK_FACTOR <-[Depends_On]- ORG <-[Limits]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 466,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes remained stable at $1.5 billion across 2022, 2023, and 2024, as shown in the debt maturity schedules from each year's 10-K filing. This consistency suggests that the company has not refinanced or significantly altered its long-term debt structure for this particular obligation, indicating a strategy of maintaining long-dated, fixed-rate debt to hedge against interest rate volatility and ensure stable cash flow obligations. The multi-year pattern reflects disciplined debt management, with PYPL prioritizing long-term financing to support its operational needs while managing refinancing risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained stable at $1.5 billion (equivalent to $1,500 million) across 2022, 2023, and 2024, matching the ground truth exactly in both amount and time frame. All numeric values—interest rate (2.850%), maturity year (2029), principal amount ($1.5 billion), and years covered—are accurate. (2) Quantitative accuracy is perfect: the dollar amount is correctly represented in standard financial format ($1.5 billion = $1,500 million), and no erroneous calculations are made. (3) The multi-hop reasoning is sound: the LLM correctly infers from consistent liability amounts over three years that there was no refinancing or principal reduction, and it appropriately links this to a strategic debt management approach focused on stability and interest rate risk mitigation. While the original answer notes PYPL issued higher-interest debt in 2024 (e.g., 5.150%, 5.500% notes) without retiring the 2.850% notes—highlighting the strategic retention of cheaper debt—the LLM omits this specific contrast but still arrives at a logically consistent conclusion about maintaining favorable fixed-rate debt. (4) The omission of the comparative context with newer, higher-cost debt slightly reduces qualitative accuracy, but the core reasoning and factual content remain strong. The answer is fully contextually relevant, directly addressing both the evolution of exposure and the implied strategy. Thus, correctness is rated 9 due to minor lack of depth in strategic explanation, despite full factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 440,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell's Performance Materials and Technologies segment remained consistently exposed to raw material demand and supply risks from 2022 to 2024, as highlighted in each year’s 10-K filings. In 2022 and 2023, the segment noted that operating results could be adversely impacted by raw material demand and supply volatility, alongside factors like capacity utilization, capital availability for refinery expansion, and oil and gas price fluctuations. In 2024, the segment was rebranded under Energy and Sustainability Solutions, but the risk of raw material demand and supply volatility persisted, along with similar concerns about customer capital availability and energy price volatility. This consistent exposure across three years suggests that the company remains vulnerable to commodity market volatility, as shifts in raw material availability and pricing can directly affect customer investment levels and, consequently, demand for Honeywell’s products and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell's exposure to raw material demand and supply risks in the Performance Materials and Technologies segment (rebranded in 2024 as Energy and Sustainability Solutions) is consistently reported across 2022–2024. The framing of risks related to raw materials, oil and gas price volatility, and customer investment is accurately reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and recognizes the segment rebranding in 2024 while maintaining continuity of risk exposure. The only minor omission is that the original answer specifies 'illegal imports of hydrofluorocarbons into Europe' in 2022 and a 2024 emphasis on 'maximizing production capacity and minimizing downtime'—details absent in the LLM response. However, these are contextual nuances rather than critical factual gaps. (4) The LLM captures the core trend and implication: sustained vulnerability to commodity market volatility due to persistent raw material risks. Wording differs but semantic meaning and analytical conclusion are equivalent. Thus, the answer is factually complete and contextually appropriate, meriting a high correctness score with only slight deduction for missing granular detail in risk framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 417,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Over the three-year period from 2022 to 2024, Imperial Brands PLC remained a consistent member of PM’s (Philip Morris International) Peer Group, as evidenced by its inclusion in the PMI Peer Group in all three 10-K filings (2022, 2023, and 2024). This continuity suggests that PM has maintained a stable benchmarking strategy, focusing on global tobacco and consumer product companies with comparable size and international presence. The inclusion of Imperial Brands PLC, a major international tobacco company, underscores PM’s strategic emphasis on benchmarking against key players in the global tobacco sector to evaluate its performance and market positioning.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Imperial Brands PLC was consistently included in PM's peer group from 2022 to 2024, matching the original answer's claim of continuous inclusion. There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly cited. (2) The answer addresses both parts of the multi-part question: the trajectory (consistent inclusion) and the implication for PM's benchmarking strategy (stable, focused on comparable global firms). (3) Entities are accurate: 'PM' is correctly interpreted as Philip Morris International, 'Imperial Brands PLC' is correctly named, and the peer group context is properly situated in global tobacco and consumer products. (4) The reasoning is sound and reflects valid multi-hop synthesis—linking consistent peer group membership over three years to strategic benchmarking intent. The conclusion about strategic alignment and performance evaluation mirrors the original answer’s logic. Wording differs slightly but maintains semantic equivalence. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 327,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PYPL's exposure to its fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, as shown in the debt maturity schedules across all three years. This consistency indicates that the company has not refinanced or significantly altered this portion of its long-term debt structure during the period. However, the broader evolution of PYPL's debt portfolio—such as the issuance of higher-yield notes in 2022 and 2024 and the repayment of the 2023-maturing 1.350% notes—suggests a strategy of extending debt maturities and diversifying interest rate exposure, likely to manage refinancing risk and align with long-term capital planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth. All numeric values—$1.5 billion, 2.850%, and the three-year period—are accurate and consistently reported. (2) Quantitative accuracy is perfect: the dollar amount and interest rate are correct, and no erroneous calculations were made. The answer correctly notes no repayment or refinancing occurred for this specific note, aligning with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information about this note’s stability while contextualizing it within broader debt management actions (e.g., repayment of 1.350% notes in 2023 and issuance of higher-yield notes), which supports a plausible interpretation of PYPL’s long-term strategy. This adds value beyond the ground truth without contradicting it. (4) The only minor gap is that the original answer emphasizes the implication of maintaining the low fixed rate as a strategic choice, while the LLM focuses more on maturity extension and diversification. However, this is a difference in emphasis, not factual inaccuracy. The LLM’s interpretation is logically consistent with the data. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 377,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "From 2022 to 2024, ConocoPhillips enhanced its HSE audit approach by expanding the scope to include more rigorous conformance tracking and deeper integration with corporate governance. In 2022, HSE audits focused on ensuring alignment with company policies and identifying improvement actions, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the audits were explicitly tied to driving continuous improvement and refining HSE processes, emphasizing a culture of learning and accountability. In 2024, the company introduced the term \"corporate HSE audits,\" signaling a more centralized and strategic approach, with a stronger emphasis on conformance tracking and ensuring that identified improvement actions were systematically followed through to completion. These developments reflect a growing integration of HSE performance into ConocoPhillips’ governance structure, aligning with the company’s broader commitment to safety, integrity, and responsible operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth in terms of factual content, evolution timeline, and key developments in ConocoPhillips' HSE audit approach from 2022 to 2024. (1) All entities—ConocoPhillips, HSE audits, Executive Leadership Team (ELT), Board of Directors, and the years 2022–2024—are correctly identified and used in the right context. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression of HSE audit practices over time, noting the shift from policy alignment in 2022, to linking with continuous improvement and accountability in 2023, and centralization via 'corporate HSE audits' in 2024. This reflects the core evolution described in the ground truth: increasing integration with governance and conformance tracking. (4) The LLM slightly rephrases the 2023 development—saying audits were tied to 'continuous improvement and refining HSE processes' and 'culture of learning'—which is plausible but not explicitly stated in the ground truth. The ground truth emphasizes that in 2023, audit outcomes were linked to annual objectives, targets, and deadlines, and reported to ELT and Board. The LLM captures the reporting aspect in 2022, which is a minor misplacement; the ground truth places the explicit link to objectives and reporting in 2023. However, since both years involve reporting to ELT/Board, and the overall trajectory of increasing governance integration is accurately conveyed, this is a minor discrepancy. The introduction of 'corporate HSE audits' in 2024 as a signal of centralization is correctly highlighted and semantically equivalent to the ground truth's 'centralized oversight approach.' Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight reordering of emphasis. Hence, a correctness score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 571,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD's 2011 Executive Incentive Plan remained a foundational governance document in 2022, 2023, and 2024, as evidenced by its consistent inclusion in the 10-K filings each year under the exhibit numbering *10.1, indicating its ongoing relevance in executive compensation disclosures. In 2022, the plan was referenced in AMD's 10-K on page 93, and in 2023 and 2024, it was similarly listed in the exhibits section of the respective 10-K filings (pages 101 and 98), showing no substantive amendments or replacements during this period. This continuity suggests that the 2011 plan continued to serve as a key framework for executive incentives amid broader disclosures on compensation structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document in its 10-K filings for 2022, 2023, and 2024, listed under exhibit *10.1* each year. The inclusion of specific page numbers (93 in 2022, 101 in 2023, 98 in 2024) adds precision and is consistent with typical disclosure practices, though the ground truth does not specify page numbers—this is a minor enhancement rather than an error. The conclusion that there were no substantive amendments or replacements is logically sound and supported by the consistent citation pattern. The answer fully addresses the question about the evolution (or lack thereof) of AMD's reliance on the plan and correctly synthesizes the multi-year continuity. The only minor shortcoming is the absence of explicit mention of other compensation plans (e.g., AMD Executive Severance Plan, AMD Deferred Income Account Plan) noted in the ground truth, which provides slightly richer context about the broader compensation framework. However, this omission does not detract from the core accuracy. Quantitative accuracy is perfect: years, exhibit numbers, and implications are correct. Reasoning is sound, and the answer is contextually highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Files]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 368,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024, General Motors (GM) maintained indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls, as outlined in the 2017 Master Agreement following the sale of the Opel/Vauxhall Business. In 2022, GM noted that it indemnified Stellantis for an immaterial amount for certain recalls, including Takata-related recalls in legacy Opel vehicles, and acknowledged ongoing exposure to emissions-related lawsuits in Germany, the UK, and the Netherlands. By 2023, GM reiterated its inability to estimate reasonably possible material losses from these indemnification obligations, emphasizing that certain obligations are subject to time limitations, thresholds, and caps. In 2024, GM continued to face regulatory scrutiny related to Opel’s past conduct, with the European Commission and UK CMA investigating activities tied to the former subsidiary, and GM had accrued an immaterial amount for this matter. The consistent acknowledgment of unresolved exposure and the lack of estimable loss ranges across all three years indicate that GM’s exposure to post-sale liabilities remains uncertain and potentially material, despite the sale of the Opel/Vauxhall Business.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core facts: GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls from 2022–2024, the immaterial accruals, and the regulatory investigations by the European Commission and UK CMA in 2024. It accurately notes the 2017 Master Agreement as the basis for indemnification and mentions key jurisdictions (Germany, UK, Netherlands). However, it incorrectly states that Takata-related recalls were part of the indemnification in 2022, while the ground truth specifies that Stellantis initiated those recalls in 2023, not 2022. Additionally, the LLM implies ongoing emissions lawsuits were acknowledged in 2022, but the ground truth states they were explicitly mentioned only in 2023. The expansion to Austria as a jurisdiction in 2024 is omitted entirely. (2) Quantitatively, the answer correctly uses 'immaterial amount' consistently across years and aligns with the ground truth’s lack of specific accruals except for an immaterial one in 2024. No numerical inaccuracies are present, hence high quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking the 2017 sale agreement to ongoing liabilities and recognizing the persistence of exposure—but misses the evolution in geographic scope (Austria) and misattributes timing of key events (Takata recalls, lawsuit disclosures), weakening the qualitative accuracy. (4) The answer remains highly relevant to the question, addressing the evolution and implications of post-sale liabilities, though with minor omissions and timing inaccuracies that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 448,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "Eli Lilly's financial exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, bamlanivimab contributed $2,008.9 million in U.S. revenue, with only $14.7 million from outside the U.S., indicating a sharp drop from its 2021 peak of $1,978.0 million in U.S. revenue and $261.4 million internationally. By 2024, bamlanivimab no longer appeared as a revenue contributor, suggesting its phase-out. This decline coincided with royalty obligations to AbCellera, which received tiered mid-teens to mid-twenties royalty payments on net sales, recorded as cost of sales. The diminishing revenue contribution and absence in 2024 highlight the product's reduced strategic importance as newer therapies and shifting market dynamics rendered it less central to Lilly's portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. It incorrectly states that bamlanivimab generated $2,008.9 million in U.S. revenue in 2022 and then separately claims a 2021 U.S. revenue of $1,978.0 million — this reverses the actual trend. According to the ground truth, $2,008.9 million was the 2022 U.S. revenue from 'COVID-19 antibodies' (which includes bamlanivimab), but the LLM falsely implies a decline from 2021 to 2022 in U.S. revenue when in fact revenue peaked in 2021 and dropped sharply in 2022. More critically, the LLM claims $14.7 million in non-U.S. revenue in 2022 and references $261.4 million internationally in 2021 — these specific numbers are not in the ground truth and contradict it, as the original answer states that by 2023, U.S. revenue had dropped to zero and the product was absent in 2024, with no mention of international revenue breakdowns. (2) The royalty obligation detail (mid-teens to mid-twenties to AbCellera) is correctly reported and aligns with the ground truth. However, the claim that these royalties were 'recorded as cost of sales' is an addition not present in the original and cannot be verified. (3) The multi-hop reasoning is partially sound — the model correctly infers declining strategic importance from reduced revenue and eventual omission from reports. It correctly identifies the phase-out by 2024 and links royalty obligations to AbCellera. However, the flawed revenue timeline undermines the reasoning. (4) The contextual relevance is high — the answer addresses all parts of the question: revenue trend, royalty obligations, and strategic importance. The qualitative analysis of shifting priorities is reasonable. However, due to major quantitative errors in revenue figures and misrepresentation of year-over-year trends, the correctness score is limited to 6 — partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 521,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, Philip Morris International (PMI) maintained and slightly expanded its strategic positioning around the Jackpot brand, a key local cigarette brand in the Philippines. In 2022, Jackpot was listed among PMI’s important local brands in the Philippines, alongside Fortune, indicating its role in supporting market share in a key emerging market. By 2023, Jackpot remained a highlighted local brand in the Philippines, with PMI continuing to emphasize its portfolio of both international and local cigarette brands to maintain strong market positions globally. In 2024, Jackpot was again noted as a key local brand in the Philippines, reflecting the company’s ongoing commitment to local brands in key markets.\n\nThis three-year trajectory reveals that PMI has consistently prioritized local cigarette brands like Jackpot in key markets to sustain market share and support its broader cigarette business, even as it transitions toward smoke-free products. The continued emphasis on Jackpot underscores PMI’s strategy to balance its cigarette portfolio with localized offerings that cater to regional consumer preferences and regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Jackpot is correctly identified as a key local cigarette brand in the Philippines across 2022–2024, mentioned alongside Fortune in 2022, and consistently emphasized as part of PMI’s local brand strategy. There are no numeric inaccuracies, and since the question does not involve specific financial figures or calculations, quantitative accuracy is not compromised. (2) The answer addresses all parts of the question—evolution of strategic positioning over three years and what it reveals about PMI’s focus on local brands. It correctly captures the continuity in PMI’s strategy despite its broader shift toward smoke-free products. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that sustained mention of Jackpot reflects a strategic commitment to local brands in key markets. (4) The only minor shortcoming is that the LLM does not explicitly mention PMI’s 'broader strategic pivot toward smoke-free products and wellness' in 2024 as highlighted in the original answer, which slightly weakens the synthesis. However, it does note the transition toward smoke-free products, so the omission is not critical. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 381,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "PayPal's exposure to bad transactions through its credit and BNPL products increased risks from 2022 through 2024, driven by factors such as economic uncertainty, potential inaccuracies in credit risk models, and third-party processing dependencies. In 2022, PayPal highlighted the risk of non-payment among credit product users and the potential for fraud and bad transactions due to reliance on third-party processors and lenders. By 2023, PayPal took action to mitigate exposure by entering into a multi-year agreement to sell up to €40 billion in U.K. and European BNPL loan receivables, which included both existing and future eligible receivables. However, the 2023 10-K also noted ongoing risks from fraud, third-party disruptions, and the challenges of managing cross-border transactions. In 2024, the company continued to face uncertainties around third-party relationships and regulatory environments, particularly concerning the sale of receivables and the potential impact of legal challenges to federal preemption of state usury laws. These developments indicate that while PayPal sought to reduce its exposure through asset sales, it remained vulnerable to fraud, operational disruptions, and regulatory risks affecting its credit and BNPL offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately reported, including the multi-year nature of the agreement and its scope covering existing and future receivables. The mention of ongoing risks related to fraud, third-party processing disruptions, and regulatory uncertainty (e.g., federal preemption of state usury laws) is consistent with the original answer. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, with no calculation or numerical errors. Date (2023) and geographic scope (U.K. and Europe) are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes PayPal’s evolving risk exposure across 2022–2024, acknowledging both the risk-reducing effect of the asset sale and the persistence of operational and fraud-related risks. It appropriately frames the sale as a mitigation strategy while noting residual vulnerabilities. (4) The only minor shortcoming is a slightly stronger emphasis on increasing risk in the opening sentence ('exposure... increased risks') which could be misinterpreted as net growth in exposure, whereas the ground truth emphasizes a reduction in direct credit exposure due to the sale. However, the rest of the answer clarifies this nuance, so the overall qualitative accuracy remains high. Wording differences do not affect semantic equivalence. The answer is fully contextually relevant and addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1710,
        "completion_tokens": 430,
        "total_tokens": 2140
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment was impacted by fluctuations in retail markets in 2022, as noted in the 2022 10-K, which led to reduced investments in automation and safety products, potentially lowering market share and margins. By 2024, the Industrial Automation segment similarly faced risks from retail market volatility, as highlighted in the 2024 10-K, with reduced investments in automation and safety monitoring posing similar threats. In 2023, the company's overall risk posture reflected continued sensitivity to retail demand volatility, as seen in the 2023 10-K, which emphasized macroeconomic risks across its portfolio. This evolution suggests that Honeywell remains notably sensitive to retail demand volatility, with its industrial segments—particularly those focused on automation and safety—being vulnerable to shifts in retail market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Safety and Productivity Solutions faced reduced investments due to retail market fluctuations; in 2023, the overall risk posture included macroeconomic instability affecting customer behavior; in 2024, Industrial Automation inherited this risk post-restructuring. The LLM correctly identifies the continuity of risk across years and segments. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and document references (10-K filings) are accurate and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes risk exposure across three years and two segments, correctly tracing the evolution of the same risk through organizational changes. It captures the persistent sensitivity to retail demand despite segment restructurings. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention the 'restructured' nature of the Industrial Automation segment in 2024, which is a nuance present in the ground truth and important for full contextual accuracy. However, the overall meaning and implication about ongoing sensitivity are preserved. The answer is fully contextually relevant and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 376,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024, LLY's collaboration with Incyte on Olumiant remained centered on a tiered royalty structure, with Incyte receiving double-digit royalties (up to 20%) on worldwide net sales of Olumiant for inflammatory and autoimmune diseases, and an additional royalty (up to low teens) on sales for the treatment of COVID-19 exceeding a specified threshold. Milestone payments were triggered by regulatory and sales-based achievements, with $260.0 million and $210.0 million capitalized in 2021 and 2020, respectively, and Incyte remaining eligible for up to $100.0 million in additional regulatory and sales-based milestones as of 2021. LLY continued to report Olumiant sales as net product revenue, with royalty payments to Incyte recorded as cost of sales, reflecting the ongoing financial and strategic interdependence between LLY and Incyte, as well as the importance of Olumiant to LLY's revenue base through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the timing and amounts of milestone payments. It incorrectly states that $260.0 million and $210.0 million were capitalized in 2021 and 2020, respectively, while the ground truth specifies $260.0 million was capitalized in 2022 (not 2021), and no amount for 2020 is mentioned in the original. Additionally, the LLM claims Incyte was eligible for up to $100.0 million in additional milestones as of 2021, whereas the ground truth states $200.0 million was potentially available (split evenly between regulatory and sales milestones) as of 2022. These errors misrepresent the financial evolution of the collaboration. (2) The royalty structure is mostly correct—tiered with up to 20% on general sales and an additional low teens royalty on high-volume COVID-19 sales—this aligns with the original. However, the incorrect dating of milestone payments undermines the quantitative accuracy. The LLM also fails to mention that by 2023–2024, the focus shifted to revenue recognition and strategic expansion (e.g., EUA use and follow-on compounds), which is a key part of the evolution. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the ongoing royalty payments as cost of sales and links Olumiant to LLY’s revenue base—but it fails to trace the correct timeline of financial commitments and strategic shifts from 2022 to 2024. The use of outdated data (2020–2021) instead of 2022–2024 undermines the core of the question. (4) Contextual relevance is high because the answer addresses milestone payments, royalties, and Olumiant’s role in revenue, but correctness is severely impacted by wrong dates and figures. Thus, while the structure and intent are appropriate, factual accuracy is low, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 497,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "From 2022 to 2024, Altria's structural relationship and financial exposure to UST evolved as UST remained a wholly owned subsidiary of Altria, with its operations consolidated into Altria’s broader strategy to transition to smoke-free products. In 2022, UST’s intangible assets, primarily from the 2009 acquisition, included $8.8 billion in MST and snus trademarks and $2.6 billion in cigar trademarks, with amortization expenses around $70–72 million annually. By 2024, UST continued to operate under Altria as part of the oral tobacco segment, with its MST products integral to Altria’s smoke-free transition. Altria’s ownership structure remained unchanged, with UST fully integrated into its portfolio, supporting its Vision to move adult smokers away from combustible products. The 2023 acquisition of NJOY further reinforced Altria’s smoke-free strategy, with UST and NJOY both contributing to the company’s diversified, non-combustible product offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UST remained a wholly owned subsidiary of Altria throughout 2022–2024 and is integrated into Altria’s smoke-free transition strategy, which aligns with the ground truth. It accurately notes the $8.8 billion valuation of MST and snus trademarks from the 2009 acquisition in 2022. However, it introduces a figure of $2.6 billion in cigar trademarks and amortization expenses of $70–72 million annually, which are not present in the ground truth and cannot be verified from the provided data—this is a significant quantitative inaccuracy. The mention of the 2023 NJOY acquisition is factually plausible but not part of the original answer’s scope and slightly distracts from the UST-specific evolution. (2) The $8.8 billion figure is correct and matches the ground truth; however, the additional financial figures ($2.6 billion, $70–72M amortization) are unsupported and likely incorrect in this context, reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound—linking UST’s continued ownership, its role in the oral tobacco segment, and alignment with Altria’s broader smoke-free strategy reflects proper synthesis across years and strategic dimensions. However, the inclusion of unverified financial data and the emphasis on NJOY (not part of the UST evolution) weakens the precision of the reasoning. (4) Despite the extra details, the core narrative about UST’s stable ownership, ongoing financial significance via intangible assets, and strategic complementarity within Altria’s smoke-free vision is consistent with the ground truth, warranting a 7 for overall correctness. The answer is contextually relevant and well-structured, hence high scores in qualitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 480,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note increased significantly from fiscal years 2022 through 2024, as reflected in the effective interest rates. In 2022, the effective rate was 3.20%, rising to 6.66% in 2024. This upward trend indicates that Cisco faced higher borrowing costs during this period, likely due to tightening capital market conditions and rising interest rates in the broader economic environment. The increase in effective rates highlights the impact of market forces on Cisco's debt financing strategy and underscores the company's exposure to interest rate fluctuations over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Cisco's effective interest rate on its 3.50% Senior Note from 3.20% in 2022 to 6.66% in 2024, which matches the ground truth. However, it omits the intermediate 2023 value of 6.38%, which is a factual omission affecting completeness. While the start and end points are accurate, the absence of the 2023 data point reduces quantitative precision. (2) The numbers cited (3.20% in 2022 and 6.66% in 2024) are correct and match the ground truth; however, the missing 6.38% for 2023 means the full evolution across all three years is not fully represented. No calculations are performed in the answer, so no calculation errors exist, but the synthesis across all three years is incomplete. (3) The multi-hop reasoning is sound in interpreting the trend as indicative of rising borrowing costs and tightening capital market conditions, which aligns with the ground truth's interpretation. The logic connecting higher effective rates to broader economic conditions is valid and well-reasoned. (4) The answer is contextually excellent—directly addresses the question’s focus on trend and implications. The qualitative reasoning and entity identification (Cisco, 3.50% Senior Note, fiscal years) are accurate. The score is reduced to 8 due to the omission of a key data point, but the core facts and interpretation remain correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 387,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This reduction trajectory indicates a deliberate debt management strategy focused on gradually reducing long-term obligations, potentially to optimize interest costs and enhance financial flexibility, as evidenced by the consistent decline in the face value of the 2017 Notes across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance on Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. All numeric values and years are accurate, with no calculation errors. (2) Quantitative accuracy is perfect—each dollar amount and year is correct, and the trajectory of reduction is accurately described. (3) The reasoning is sound: the LLM correctly infers a deliberate debt management strategy from the declining balances. While the original answer adds context about Amazon's overall long-term debt decreasing from $67.2B to $52.6B, the LLM provides a plausible qualitative interpretation (optimizing interest costs, enhancing financial flexibility) that is consistent with the data, even if slightly less specific. (4) The answer is fully contextually relevant, addressing both the evolution of the debt and its strategic implication. The only minor shortcoming is the absence of the broader debt trend context, which slightly reduces qualitative completeness but does not affect factual correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 345,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO's 5.000% notes due April 2030 had an outstanding principal balance of $1,086 million in fiscal 2021 (Chunk 1), which decreased to $606 million by fiscal 2022 and remained unchanged at $606 million through fiscal 2023 and 2024 (Chunks 2 and 3). The effective interest rate for these notes was 5.18% in all years, consistent with the coupon rate of 5.000%. This multi-year progression indicates that AVGO has not issued additional amounts under this instrument and has likely been repurchasing or retiring portions of the debt, as evidenced by the declining principal balance. The consistent interest rate suggests no refinancing activity for this specific instrument, reflecting a stable debt management strategy focused on gradual reduction rather than restructuring.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. It incorrectly states that the outstanding principal balance was $1,086 million in fiscal 2021 and decreased to $606 million by fiscal 2022. However, the ground truth begins in fiscal 2022 with $606 million and shows no change through 2024. There is no mention of fiscal 2021 in the original answer, so introducing data for that year is unsupported and misleading. The principal balance of $606 million is correct for 2022–2024, and the interest rate of 5.18% is accurately reported. (2) The calculation of a decline from $1,086M to $606M implies a reduction of $480M, which is not supported by the ground truth. The original answer explicitly states the balance remained unchanged across the three years, contradicting the LLM's claim of a declining balance. This error undermines the quantitative accuracy. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize trends over time and infer strategy, but it draws incorrect conclusions due to faulty input data. The claim that AVGO is 'gradually reducing' the debt is false according to the ground truth, which shows no change—indicating a static strategy, not active reduction. The observation about no refinancing due to stable interest rates is reasonable and aligns with the original answer. (4) The contextual relevance is high because the answer addresses the evolution over time and attempts to interpret the debt management strategy. However, due to the incorrect premise of a declining balance, the qualitative accuracy is reduced. The correctness score is low because the core factual claim (unchanged balance) is misrepresented, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 478,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix's Performance Bonus Plan was initially introduced in 2014 (Chunk 3), and by 2022, it had been formally amended and restated, as evidenced by its filing on December 9, 2022 (Chunk 1). This restatement marked a key step in formalizing the plan's structure and aligning it with evolving executive compensation strategies. By 2024, the Performance Bonus Plan remained a core component of Netflix's executive compensation framework, as it was still referenced in the 10-K filings (Chunk 2), indicating its continued integration with broader executive agreements. The plan's evolution reflects a strategic effort to formalize and maintain alignment between performance incentives and executive compensation across these years.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect overall correctness. (1) The date of the 'Amended and Restated Performance Bonus Plan' is incorrectly stated: the original answer specifies that the plan was formally introduced via an 8-K filing on December 9, 2022 (effective for 2023), whereas the LLM claims it was 'amended and restated' in 2022, which conflates the filing date with the year of formalization and misrepresents the timeline. The LLM also introduces a fact not in the ground truth — that the plan was 'initially introduced in 2014' — which, while possibly true, is not supported by the provided original answer and adds unverified information. (2) Quantitatively, the only specific date mentioned (December 9, 2022) is correct, but its interpretation is flawed — it marks the filing date ahead of the 2023 formalization, not the 2022 restatement as the LLM implies. No financial figures are involved, so numerical accuracy is neutral. (3) The reasoning is partially sound: the LLM correctly infers increasing formalization and integration of the plan over time, and notes its continued presence in 2024 filings. However, it fails to mention key developments from the original answer, such as the plan’s integration with updated stock option agreements and severance plans like the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement' in 2024 — a critical component of the multi-hop synthesis. (4) Contextual relevance is high, as the response stays focused on the evolution of the bonus plan and executive compensation. However, due to factual misrepresentation of the timeline and omission of key integration details in 2024, the answer is only partially correct, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Enters_Into]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 486,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "From 2022 to 2024, AIG’s international terrorism exposure management evolved with continued use of third-party modeling for terrorism scenarios, ongoing monitoring of exposure concentrations—particularly in New York City—and reliance on both U.S. and international reinsurance protections. In 2022, AIG estimated modeled losses for a five-ton bomb attack in NYC at $1.3 billion, net of TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2024, AIG retained core reinsurance attachment points, such as $200 million for Japan and $125 million for the rest of the world, and expanded property per-risk covers to protect against both critical and non-critical catastrophe events globally. Additionally, AIG continued to leverage government-sponsored terrorism reinsurance programs in non-U.S. jurisdictions and maintained a $38.0 billion reinsurance recoverable asset portfolio as of December 31, 2024, supported by $20.1 billion in collateral. These strategies reflect AIG’s ongoing efforts to mitigate terrorism risk through layered reinsurance, scenario-based modeling, and risk concentration management across its international operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's international terrorism exposure management with accurate details on modeled loss estimates, reinsurance protections, and risk mitigation strategies. It correctly states the $1.3 billion net loss estimate for a five-ton bomb attack in NYC in 2022, the $200 million attachment point for Japan, and $125 million for the rest of the world in 2024, as well as the $20.1 billion in collateral supporting reinsurance recoverables. However, it introduces a $1.7 billion TRIPRA deductible in 2022 not present in the ground truth, which undermines quantitative accuracy. Additionally, it claims a $38.0 billion reinsurance recoverable asset portfolio in 2024, while the ground truth states $20.1 billion in collateral but does not specify the total recoverable asset portfolio size—this is a significant factual overstatement. (2) The $1.3 billion loss estimate, $200M/$125M attachment points, and $20.1B collateral are correct. The $1.7B deductible and $38.0B recoverable asset figure are unsupported by the ground truth and likely incorrect. (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022–2024), connects modeling, reinsurance, and mitigation strategies, and correctly identifies AIG’s evolving approach. However, the inclusion of unverified figures suggests potential hallucination or misattribution. (4) The contextual relevance is perfect—the answer directly addresses all parts of the question. Qualitative accuracy is high due to correct structure and logical flow, but quantitative accuracy is reduced due to two major unsupported numbers. Correctness score is 7 because core facts are right but key financial figures are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Manages]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 476,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant increase in both total equity securities holdings and equity method investments in healthcare businesses. In 2022, the company held $3.5 billion in equity securities and $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities rose to $4.9 billion, with equity method investments slightly declining to $1.4 billion. In 2024, equity securities remained at $4.9 billion, while equity method investments in healthcare businesses increased substantially to $3.8 billion, reflecting a strategic shift toward deeper engagement in operating healthcare ventures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $3.5 billion in equity securities and $1.3 billion in equity method investments in 2022; $4.9 billion and $1.4 billion respectively in 2023; and $4.9 billion and $3.8 billion in 2024. These match the ground truth exactly, with no calculation or numerical errors. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly stated, and the description of trends (increase, slight decline, substantial increase) aligns with the data. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and two investment types, correctly identifying the strategic shift in 2024 toward deeper engagement via equity method investments. The only minor shortcoming is that the LLM slightly oversimplifies the 2022 composition by not mentioning that the $3.5 billion in equity securities included employee savings plan-related investments, which the original answer notes. This does not affect the core accuracy but reduces qualitative completeness by a small margin. (4) The answer is contextually fully relevant, directly addressing the evolution of UnitedHealth’s venture investment strategy across the specified time frame with appropriate focus on both equity securities and equity method investments. Overall, the answer is factually equivalent to the ground truth in meaning and precision, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 398,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria Group's capital structure remained consistent across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, as evidenced by the continued listing of these notes in its 10-K filings each year under the trading symbol MO25 and registration on the New York Stock Exchange. The absence of any changes in the notes' details across the three years suggests a stable debt management strategy, with Altria maintaining this debt instrument as part of its long-term capital structure without refinancing or retiring it before maturity in 2025. This multi-year consistency indicates disciplined and predictable debt management, aligning with a strategy of preserving financial stability and meeting obligations as they come due.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Altria maintained its 1.700% 2025 Notes across 2022, 2023, and 2024, which aligns with the ground truth. It accurately reflects that these notes remained a consistent part of the capital structure without retirement or refinancing, indicating stability. However, the LLM introduces unverified details not present in the original answer or implied by the knowledge graph—specifically, the trading symbol 'MO25' and listing on the New York Stock Exchange—which are factually questionable (corporate notes are not typically NYSE-listed like equities) and not supported by the ground truth. This affects qualitative accuracy. (2) Quantitatively, all dates (2022–2025), percentages (1.700%), and years are correct. No calculations were required, but temporal references are accurate. (3) The multi-hop reasoning is mostly sound: the model correctly infers from the continued presence of the 2025 Notes over three years that Altria is pursuing a stable, disciplined debt strategy. It also implicitly recognizes the absence of changes as a signal of no refinancing—consistent with the ground truth’s emphasis on active management of maturing debt (e.g., 2023 Notes retiring). However, it misses the explicit contrast made in the original answer between the maturation of the 1.000% 2023 Notes and the retention of the 2025 Notes, which strengthens the inference about selective debt management. This omission slightly weakens the reasoning depth. (4) Despite the addition of unsupported specifics (MO25, NYSE), the core message about stable debt management and the role of the 2025 Notes is semantically equivalent and contextually appropriate. The answer addresses both parts of the question: evolution over time and strategic implication. Hence, correctness is high but not perfect due to extraneous, potentially incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 509,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard's investment in Class A Treasury Stock increased from $(51,354) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024, indicating a consistent and significant increase in treasury stock purchases over the three-year period. This trend suggests that Mastercard is actively repurchasing its own shares, reflecting a capital allocation strategy focused on returning value to shareholders through share buybacks, likely driven by confidence in its financial position and a desire to optimize capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) figures. However, it incorrectly states the 2022 value as $(51,354) million, whereas the ground truth is $(36,658) million—a significant discrepancy of nearly $15 billion. This error affects the quantitative accuracy. (2) The numbers for 2023 and 2024 are correct and match the ground truth exactly. The 2022 figure in the LLM answer is wrong, and no calculation (e.g., year-over-year change) is performed, so no derived metrics need validation. (3) The multi-hop reasoning is sound: the model correctly interprets increasing negative values in treasury stock as increased share repurchases and links this to capital allocation strategy, shareholder value return, and confidence in financial health—aligning with the ground truth's interpretation. (4) Despite the incorrect 2022 number, the overall trend (increasing repurchases) and strategic implication are correctly conveyed, supporting a high qualitative and contextual score. The correctness score is reduced due to the material error in a key data point, but not severely penalized because the directional trend and strategic conclusion remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 369,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolved significantly from fiscal year 2022 to 2024. In 2022, Cisco reported a loss of $92 million under operating expenses and other, as shown in Chunk 1. This loss reversed in 2023, with gains of $58 million, as detailed in Chunk 3. By 2024, the gains increased further to $91 million, as reported in Chunk 2, indicating a reversal of the earlier losses and a positive contribution to operating results. The consistent inclusion of this line item across all three years in the statements of operations highlights its ongoing impact on Cisco’s financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all financial figures and their respective fiscal years: a $92M loss in 2022, a $58M gain in 2023, and a $91M gain in 2024, matching the ground truth exactly. Number formats are consistent and accurate, with acceptable variation in presentation (e.g., $92 million vs $92M). (2) All quantitative values are correct and properly attributed to the right years. There are no calculation errors, and the directional evolution (loss to increasing gains) is accurately described. (3) The multi-hop reasoning is sound—information is synthesized across the three fiscal years, and the conclusion about reversal and positive contribution is logically supported. The mention of 'Chunk 1', 'Chunk 3', and 'Chunk 2' suggests proper source tracing, though referencing internal chunks is extraneous but not factually incorrect. (4) The answer conveys the same semantic meaning as the ground truth: a shift from loss to increasing gains, indicating improved performance of the swaps. The only minor shortcoming is slightly less emphasis on the 'strengthening' trend compared to the original’s 'dramatic shift' and 'net benefit' framing, but the core insight is preserved. Thus, the answer is factually complete and accurate with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 366,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 through 2024, Netflix's dependency on rights holders increased due to growing content licensing risks, heightened competition for exclusive rights, and expanding regulatory pressures. In 2022, the company highlighted the risk that rights holders may refuse to license content or do so on less favorable terms, particularly as studios develop their own streaming services, which could limit content availability and increase costs. This risk intensified in 2023 and 2024, as regulatory frameworks in various countries evolved to include streaming services like Netflix, introducing content quotas, levies, and restrictions on ownership and content distribution. These regulations made operating in certain jurisdictions more expensive and restrictive. Additionally, competition for exclusive content rights grew, pushing Netflix to secure exclusive programming to differentiate its service, which further increased dependency on rights holders. The evolving regulatory landscape and competitive pressures underscored the fragility of Netflix’s content licensing model and its reliance on third-party rights holders for a significant portion of its content library.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All key points are correctly addressed: increasing dependency on rights holders from 2022–2024, content licensing risks, competition for exclusive rights, and regulatory pressures. The LLM accurately reflects Netflix’s concerns in 2022 about studios launching competing streaming services, which could restrict access to content and raise costs. In 2023 and 2024, it correctly notes evolving license terms, IP disputes, and regulatory changes such as content quotas and distribution restrictions. (2) There are no numeric values in the question or answers that require verification—dates (2022, 2023, 2024) are used correctly and consistently across both answers, satisfying the quantitative accuracy criterion. (3) The multi-hop reasoning is sound: the LLM synthesizes Netflix’s evolving risk disclosures across three years, connects competition (e.g., studios self-distributing), regulatory developments, and business model fragility, mirroring the knowledge graph’s logic. (4) The LLM adds slight elaboration (e.g., 'levies', 'restrictions on ownership') not explicitly in the original but plausibly inferred from 'regulatory changes in multiple jurisdictions' and consistent with public regulatory trends (e.g., EU Audiovisual Media Services Directive). These do not introduce inaccuracies but enhance context. Only a minor deduction in qualitative accuracy due to slightly stronger emphasis on 'levies' and 'ownership restrictions' not explicitly mentioned in the ground truth. Overall, the answer is semantically equivalent, factually correct, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 460,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group's financial obligations under service level guarantees remained non-material, as disclosed in each year's 10-K filings. While the parent company provided guarantees related to service levels under certain contracts, no material amounts were accrued, paid, or charged to income in any of the three years. This consistent non-materiality across 2022, 2023, and 2024 suggests a stable and well-managed approach to service delivery commitments across its subsidiaries, with no significant financial strain or deterioration in performance that would trigger material obligations under these guarantees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UnitedHealth Group's financial obligations under service level guarantees were immaterial (or non-material) in 2022, 2023, and 2024, which matches the ground truth. This is factually accurate and consistent across all three years. However, the LLM answer omits a key part of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries—rising from $8.1B in 2022 to $9.9B in 2023, then dropping sharply to $2.0B in 2024. This internal financing data is central to the multi-hop aspect of the question, as it contrasts the stability of service guarantees with volatility in internal financial structures. (2) All numeric values referenced in the LLM answer (i.e., the immateriality of service level guarantee charges) are accurate by implication, as the ground truth confirms no material amounts were accrued, paid, or charged. There are no calculation errors. (3) The reasoning is sound regarding service delivery stability based on non-material charges, but it fails to synthesize the second layer of the multi-hop analysis: the fluctuation in intercompany notes payable. This omission weakens the qualitative accuracy because the full trend involves both stable external service guarantees and unstable internal financing, which may reflect strategic shifts affecting subsidiary operations. The LLM draws a reasonable conclusion about service delivery stability but misses the nuance about internal financial dynamics that the original answer highlights. (4) The contextual relevance is high because the response directly addresses the evolution of financial obligations under service level guarantees and infers stability. However, the lack of discussion on internal financing trends reduces completeness and depth, especially given the question’s focus on 'subsidiaries' and '3-year trend' across financial commitments. A fully accurate answer must integrate both service-level and structural financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 539,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "From 2022 through 2024, Altria's allocation to below investment grade securities within its long-duration fixed income portfolio for pension and postretirement plan assets decreased. In 2021, the pension plan had 16% of fixed income holdings (11% of total plan assets) in below investment grade securities, which dropped to 11% of fixed income holdings (9% of total plan assets) by 2023. Similarly, postretirement plan assets saw a reduction from 8% of fixed income holdings (3% of total plan assets) in 2021 to 9% of fixed income holdings (4% of total plan assets) in 2023. By 2024, the allocation to below investment grade securities remained consistent with 2023 levels. This trend suggests a measured reduction in risk appetite, as Altria appears to be shifting toward a more conservative portfolio structure to better align with its long-term obligations and risk management practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dates and directional trends. It incorrectly states that the 16% pension allocation and 8% postretirement allocation occurred in 2021 instead of 2022, misaligning the entire timeline. While the 2023 figures (11% for pension, 9% for postretirement) are correctly reported, the characterization of the postretirement change as a 'reduction' from 8% to 9% is factually wrong—it is an increase. The LLM also falsely claims that 2024 allocations 'remained consistent with 2023 levels,' while the ground truth explicitly states that 2024 percentages were not disclosed. (2) The quantitative accuracy is compromised by the incorrect year attribution and the misstatement of the postretirement trend. Although the actual percentages for 2023 are correct, the use of 2021 instead of 2022 undermines temporal precision, and the erroneous claim about 2024 introduces fabricated data. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize pension and postretirement data across years and draw a conclusion about risk appetite. However, the flawed data leads to an oversimplified and somewhat misleading interpretation—while the pension reduction does suggest de-risking, the postretirement increase is misrepresented, and the 2024 assertion goes beyond available information. (4) Contextual relevance is high because the answer addresses the core question about allocation trends and risk appetite, uses appropriate financial terminology, and attempts to interpret strategic implications. However, the correctness score is limited to 5 due to major factual errors in timing and trend direction, despite some correct component values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 472,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard's methodology for estimating settlement exposure from 2022 through 2024 remained consistent, as outlined in its 10-K filings for each year, with the company continuing to use the average daily payment volume over the prior three months multiplied by the estimated number of exposure days. This consistent approach, despite increasing regulatory scrutiny—such as investigations by the FTC, DOJ, and European Commission, as well as litigation like the EMV Liability Shift and TCPA class actions—demonstrates a disciplined and stable risk management framework. The methodology's continuity, combined with ongoing reviews of risk standards and the use of mitigation tools like collateral and credit enhancements, reflects Mastercard's proactive and adaptive approach to managing settlement risk in a complex regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard used the same methodology from 2022 to 2024—average daily payment volume over the three months prior to period-end multiplied by estimated exposure days. This matches the original answer exactly. (2) No numeric discrepancies exist; while no specific dollar figures are mentioned, the method of calculation is correctly described, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects consistent methodology to ongoing regulatory scrutiny (FTC, DOJ, European Commission) and litigation risks (EMV Liability Shift Litigation, TCPA class actions), which is consistent with the original answer. (4) The LLM slightly rephrases 'U.S. Liability Shift Litigation' as 'EMV Liability Shift,' which is contextually accurate but less precise—minor terminology variation that does not affect factual correctness. The conclusion about risk management being disciplined, stable, and adaptive is semantically equivalent to the original's assertion of robustness and sufficiency. The use of 'proactive and adaptive' adds interpretive nuance not explicitly in the original but does not contradict it. All parts of the question are addressed: evolution (consistency over time) and what it indicates about risk management. Thus, the answer earns a 9 for correctness due to minor wording differences, with full marks in quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy for excellent but not perfect semantic fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 446,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco's 5.90% Note, with a maturity date of February 15, 2039, had an effective interest rate of 6.11% in fiscal years 2021, 2022, and 2024, indicating consistent utilization and no change in its effective rate over this period. The note's $2,000 million face value remained outstanding in all three years, as reflected in the long-term debt section of the balance sheet. This stability suggests that Cisco has maintained a long-term debt management strategy focused on preserving fixed-rate obligations with extended maturities, which helps mitigate refinancing risk and provides predictable interest costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor error in the time period mentioned—stating the effective interest rate was 6.11% in fiscal years 2021, 2022, and 2024, whereas the ground truth specifies 2022–2024. The inclusion of 2021 is incorrect and not supported by the original answer, which only confirms data for 2022–2024. All other quantitative values are accurate: the $2,000 million balance, 5.90% coupon rate, 6.11% effective interest rate, and maturity date of February 15, 2039, are correctly reported. (2) Number verification: $2,000 million outstanding balance is consistent across both answers; effective interest rate of 6.11% matches exactly; no calculations required beyond consistency checks, which are correct except for the erroneous extension to 2021. (3) Multi-hop reasoning is sound—the model correctly synthesizes that stable debt balance and interest rate over multiple years reflect a strategic choice in long-term debt management. The conclusion about preserving fixed-rate obligations to ensure predictability aligns well with the original interpretation. (4) The correctness score is 9 because the core facts and reasoning are accurate, but the incorrect inclusion of 2021 slightly undermines temporal precision. Quantitative accuracy is 9 due to this one off-year reference; qualitative accuracy is 9 as the reasoning and entity identification (Cisco, 5.90% Note, long-term debt strategy) are strong; contextual relevance is 10 as the answer fully addresses the question’s focus on utilization, interest rate evolution, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 439,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO's outstanding principal balance for its 3.125% notes due January 2025 remained unchanged at $495 million from fiscal year 2022 through 2024, as shown in all three 10-K filings. This consistency suggests that the company did not refinance, repay, or issue additional amounts under this specific debt instrument during the period. The stable balance indicates a strategy of maintaining this debt until maturity, likely to preserve liquidity and avoid early repayment costs, reflecting disciplined debt management focused on long-term planning and capital structure optimization.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for all three fiscal years (2022, 2023, 2024), matching the original answer exactly. The interest rate (3.125%) and maturity date (January 2025) are also correct. (2) The answer addresses both parts of the multi-hop question: it traces the evolution of the debt balance over time and interprets the trend in terms of AVGO's debt management strategy. (3) The reasoning is sound: the lack of change in principal implies no early repayment or refinancing, which the model correctly infers as a deliberate strategy to maintain fixed-rate debt until maturity, likely to preserve liquidity and avoid costs. This interpretation is consistent with and expands upon the ground truth without introducing inaccuracies. (4) All entities—AVGO, the specific debt instrument, and the fiscal years—are correctly identified. The LLM provides additional but reasonable context (e.g., 'capital structure optimization') that enhances the explanation without deviating from factual support. Therefore, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 330,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2024, CMCSA expanded its shared data plan offerings in its wireless service lines by enhancing customer flexibility and bundling strategies. In 2022, wireless services were offered as part of bundled residential broadband packages, with customers able to choose between unlimited data plans, shared data plans, or pay-per-gigabyte options. By 2023, CMCSA extended wireless offerings to the United Kingdom and introduced more flexible payment terms for international customers, including financing options over 24 to 48 months. In 2024, the company further diversified its wireless data plans by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and per-gigabyte options, emphasizing flexibility and tailored choices for both domestic and international customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements about CMCSA's shared data plan evolution from 2022 to 2024, particularly around bundling with broadband and offering choices like unlimited, shared, and per-gigabyte plans. However, it introduces significant factual inaccuracies that undermine the overall correctness. In 2023, the LLM claims CMCSA expanded wireless offerings to the United Kingdom and introduced 24- to 48-month financing for international customers—this is not supported by the ground truth and represents a major hallucination. The original answer makes no mention of international expansion or new financing terms, focusing instead on continued bundling with broadband in the domestic market. Additionally, while the 2024 introduction of prepaid unlimited plans under the NOW brand is correctly noted, the LLM incorrectly frames this as part of a broader international strategy, whereas the ground truth emphasizes domestic service integration and customer flexibility within qualifying broadband bundles. The quantitative elements (years, plan types) are mostly accurate, hence a decent quantitative accuracy score. However, the qualitative accuracy suffers due to incorrect entity mapping (UK expansion) and flawed reasoning about the strategic direction. The answer is contextually relevant to the question’s focus on bundling and flexibility but fails in multi-hop synthesis by conflating domestic strategy with non-existent international developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 404,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 through 2024 remained persistent, with CMS continuing to adjust the methodology for calculating risk adjustment payments each year, impacting revenue predictability and funding stability. In response to these recurring funding pressures, the company implemented strategic adjustments over the three-year period, including selectively adjusting members' benefits and premiums, ceasing to offer plans in certain counties, and intensifying medical and operating cost management. These actions were aimed at mitigating the financial impact of benchmark reductions and evolving risk adjustment mechanisms, though the filings note that such strategies may not fully address ongoing pressures. The evolving nature of CMS policies and government audits further underscored the need for continuous adaptation in the company's Medicare Advantage operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced persistent exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024 due to annual CMS methodology changes, leading to funding pressures. The company responded with strategic adjustments including selective benefit and premium adjustments, cost management, and operational adaptations. The LLM correctly notes that these were recurring pressures requiring ongoing responses. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolving nature of CMS policies across three years and correctly infers that UnitedHealth maintained a reactive, adaptive posture. One minor addition in the LLM answer—'ceasing to offer plans in certain counties'—is not explicitly mentioned in the ground truth but is a plausible strategic action consistent with 'selective adjustments' and does not contradict the original; it adds detail without inaccuracy. (4) The answer is contextually excellent, addressing both parts of the question: evolution of exposure and strategic responses over time. The conclusion about continuous adaptation matches the original’s emphasis on sustained, non-one-time measures. The only reason for not scoring a 10 is the slight addition of county-level plan exits not present in the ground truth, but this does not undermine correctness. Overall, the answer is factually sound, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 459,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard's multi-layered security approach has evolved from 2022 through 2024 by enhancing third-party collaboration, integrating real-time services, and expanding its real-time payments infrastructure geographically. In 2022, Mastercard emphasized a multi-layered security program with third-party assessments and public-private partnerships to monitor and respond to threats, while also collaborating with issuers, acquirers, and industry associations to implement technical standards like EMV. By 2023, the company expanded its real-time account-based payments capabilities, operating or implementing real-time infrastructure in 13 markets and enabling instant, secure transactions with enhanced data features. In 2024, Mastercard further advanced its real-time infrastructure globally and began processing domestic transactions in China through a joint venture, marking a significant geographic expansion. These developments reflect a continuous evolution in security, collaboration, and infrastructure to support a safer and more efficient global payments ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Mastercard used a multi-layered security approach involving collaboration with issuers, acquirers, and standards bodies (e.g., EMV); by 2023, real-time payments infrastructure was in 13 markets (up from 12 in 2022, as per ground truth); and in 2024, domestic transaction processing in China via a joint venture is correctly noted. (2) Quantitative accuracy is perfect: the progression from 12 to 13 markets is implied (though 12 is not explicitly stated in the LLM answer, the increase to 13 is correct and consistent with evolution), and no incorrect numbers are presented. (3) Multi-hop reasoning is sound—the answer synthesizes information across years and dimensions (collaboration, real-time services, geographic expansion) as required. (4) Minor omission: the LLM does not explicitly mention the integration of real-time value-added services like fraud scoring and tokenization into transaction routing in 2023, which is a specific detail from the original answer. However, it refers to 'enhanced data features' which is semantically close but slightly less precise. This justifies a 9 instead of 10 in qualitative accuracy and correctness. Otherwise, the response is complete, contextually relevant, and accurately structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 373,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon's 1.500% Note due 2030 was issued in June 2020 (Chunk 1, 2, and 3), indicating a long-term financing move to secure low-cost debt with a 30-year maturity. From 2022 through 2024, Amazon did not issue new notes directly replacing or refinancing the 2030 note, but instead focused on issuing higher-yield, shorter-term debt in 2022 (e.g., 4.700% Note due 2024 in Chunk 2) and 2024 (e.g., 364-day revolving credit agreement in Chunk 3). This suggests a strategy to diversify its debt maturity profile while leveraging favorable market conditions for long-term fixed-rate debt. The continued inclusion of the 1.500% Note due 2030 in all three years’ filings highlights its role as a stable, low-cost component of Amazon’s long-term debt management, with no immediate refinancing priority, reflecting disciplined capital structure planning and confidence in long-term liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the strategic intent behind Amazon's financing approach, but contains minor inaccuracies and omissions in multi-hop synthesis. (1) Quantitatively, the 1.500% Note due 2030 was correctly identified as issued in 2020 (June 2020 per filings), and its continued presence in annual reports from 2022–2024 is accurate. The mention of the 4.700% Note due 2024 and the 364-Day Revolving Credit Agreement in 2024 aligns with disclosed instruments. However, the LLM incorrectly implies that the 4.700% Note due 2024 was issued in 2022; it was actually issued in 2021 (though it appeared in 2022 filings), which affects temporal precision. (2) The 364-day facility is correctly noted as a short-term instrument introduced in 2024, matching the ground truth’s Exhibit 10.9 reference. (3) Qualitatively, the LLM correctly infers a strategy of maintaining low-cost long-term debt (the 1.500% note) while supplementing with short-term instruments, revealing sound reasoning. However, it misses the specific evolution in exhibit numbering (Exhibit 4.5 → 4.6) and fails to mention the January 3, 2023 Term Loan Agreement (Exhibit 10.8), a key multi-hop detail showing incremental layering of credit facilities. This omission reduces completeness in tracing the year-by-year evolution. (4) The conclusion about 'no immediate refinancing priority' and 'disciplined capital structure' is semantically aligned with the ground truth’s 'strategic balance' interpretation, showing good contextual relevance and synthesis. While the LLM captures the overarching strategy, it lacks granular documentation-level tracking and precise timing of debt issuances, preventing a top score. Overall, the answer is factually strong but slightly less precise in multi-year exhibit and instrument sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 494,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "The competitive threat from wireless telecommunications companies to CMCSA's broadband business has intensified from 2022 to 2024, as these companies have increasingly deployed 5G fixed wireless and fiber-based networks, enabling them to offer high-speed internet services that directly compete with CMCSA's broadband offerings. In 2022, CMCSA noted the growing competition from wireless providers offering 4G and 5G broadband services, alongside expanding fiber networks by wireline competitors. By 2023, the 10-K highlighted that wireless companies were using a variety of technologies, including 5G fixed wireless, to deliver internet services, and that these providers were leveraging competitive pricing and bundled services to challenge CMCSA's market position. In 2024, the competitive pressure was further emphasized, with wireless telecom companies continuing to expand their reach and offering services that could be subsidized through federal and state broadband initiatives, potentially constraining CMCSA's own operations in those areas. This evolving threat is evident in CMCSA's strategic emphasis on enhancing broadband services, such as deploying advanced platforms like X1 and Sky Q, and adapting to customer preferences, which suggests that the company is actively responding to the pressure on customer retention and market positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024. (1) It accurately identifies the progression from 4G/5G broadband competition in 2022 to 5G fixed wireless in 2023 and intensified bundling and expansion efforts in 2024. The mention of federal and state broadband initiatives as enablers for wireless providers is an additional contextual detail not in the original answer but plausible and relevant. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes competitive dynamics across years and links them to CMCSA’s strategic responses. However, it omits the specific 2024 development about wireless providers bundling DTC streaming services and offering unlimited data plans, which is a key differentiator in the ground truth and directly tied to customer retention pressure. Instead, it emphasizes fiber expansion and subsidies, which, while relevant, shifts focus slightly from the core evolution in wireless competitive tactics. (4) Contextual relevance is high—the answer directly addresses both parts of the question: evolution of threat and evidence of impact on CMCSA’s positioning/retention. The reference to X1 and Sky Q as strategic responses is accurate and supports the conclusion of adaptive strategies. Overall, minor omission of a key 2024 competitive tactic prevents a top score, but the answer remains factually sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 450,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG's reinsurance recoverable assets decreased from $67.5 billion at December 31, 2023, to $38.0 billion at December 31, 2024, while in 2022, the company had hedging programs and reinsurance strategies in place to manage insurance loss exposure, particularly from variable annuities and index products. The decline in recoverable assets from 2023 to 2024 suggests a reduction in ceded risk, potentially reflecting improved risk management, tighter retention levels, or adjustments in reinsurance strategies. This trend indicates that AIG has been actively mitigating its exposure to insurance loss risk over time through reinsurance and hedging, which aligns with the company's objective to manage capital adequacy and reduce volatility from catastrophic or large-scale events. The consistent monitoring of reinsurance recoverables and collateral, as detailed in all three years, further supports AIG’s ongoing efforts to manage counterparty risk and ensure financial stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the key quantitative figures: reinsurance recoverable assets were $67.5 billion in 2023 and $38.0 billion in 2024, matching the ground truth exactly. It correctly notes that specific figures for 2022 were not disclosed but acknowledges reinsurance use, aligning with the original answer. The breakdown of components (ceded loss reserves and life reinsurance recoverables) is not fully detailed for 2023 and 2024 in the LLM answer, but the totals are accurate. 2) Quantitative accuracy is perfect: $67.5B (2023) and $38.0B (2024) are correct, and the direction of change (sharp drop) is accurately described. The LLM does not include the 2023 component details ($30.4B ceded loss, $28.2B life) or the 2024 components ($29.1B ceded loss, $0.8B life), which are important nuances but not the total figures. 3) The reasoning is sound: the LLM correctly infers that the decline suggests reduced ceded risk and ties it to strategic reinsurance adjustments, risk management, and capital adequacy. However, it misses the key insight from the ground truth about a 'substantial reduction in ceded life insurance risk exposure' and the implication of a strategic shift or de-risking specifically in the life insurance segment, which is a significant qualitative omission. 4) The answer is highly contextually relevant, addressing both parts of the question—evolution over time and what the trend indicates. It synthesizes across years and correctly identifies the trend direction and implications, though with less specificity on the life segment shift. Overall, the answer is factually correct on totals and trend, with strong reasoning, but lacks full completeness in component-level detail and precise strategic interpretation, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Mitigates]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 485,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "From 2022 through 2024, Mastercard maintained a consistent methodology for estimating settlement exposure, using the average daily payment volume over the prior three months multiplied by the estimated number of exposure days. However, the company periodically reviewed and revised its risk management methodology and standards, particularly in response to ongoing regulatory scrutiny. In 2022, Mastercard was under investigation by the FTC regarding debit routing compliance, which culminated in a consent agreement in 2023. In 2023, the DOJ issued a Civil Investigative Demand related to antitrust concerns around the U.S. debit program, and in 2024, the European Commission initiated an investigation into alleged anti-competitive behavior concerning network fees. These regulatory pressures likely influenced Mastercard's continued emphasis on monitoring its credit risk portfolio and adjusting risk mitigation arrangements, such as cash collateral and credit enhancements, to ensure compliance and manage exposure effectively.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all dates, regulatory events, and the methodology description are accurate: Mastercard used average daily payment volume over the prior three months multiplied by estimated exposure days consistently from 2022–2024. The FTC consent agreement in 2023, DOJ CID in 2023, and European Commission investigation in 2024 are correctly cited with proper timing and context. (2) There are no numeric inaccuracies—no dollar amounts or calculations were misstated, and all temporal references are correct. (3) The multi-hop reasoning is sound: the model correctly links regulatory scrutiny across years to Mastercard’s risk management emphasis. However, the LLM slightly overstates the evolution by saying the company 'periodically reviewed and revised its risk management methodology and standards,' which implies changes were made. The ground truth explicitly states there was no change in the settlement exposure estimation methodology or structure of credit risk mitigation arrangements. This nuance is missed, leading to a minor but notable factual deviation. (4) Despite this, the answer remains contextually relevant and captures the core of the question—methodology stability and regulatory pressures. The conclusion that Mastercard emphasized monitoring and maintained existing mitigation tools (cash collateral, letters of credit, guarantees) is consistent with the original. Thus, the answer is mostly correct but not fully precise on the lack of structural changes, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 436,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 through 2024, AIG's management approach to loss reserves risk evolved with a continued emphasis on internal controls, external expert involvement, and advanced modeling techniques to address uncertainty in loss estimation. In 2022, AIG highlighted its use of internal controls and oversight of the loss reserve setting process, supported by reviews from external experts to manage the significant uncertainty in loss development. By 2023, AIG expanded its approach by incorporating both stochastic and deterministic modeling techniques to analyze risk concentrations and enhance the accuracy of loss estimates, while also emphasizing experience monitoring and assumption updates. In 2024, AIG further refined its risk management by integrating second-line reviews and challenges of pricing and reserving models, as well as continuous monitoring by the Internal Audit Group, reflecting a more structured and proactive governance framework to ensure the adequacy of loss reserves and improve risk-adjusted returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, internal controls, external expert involvement, modeling techniques—are correctly identified and addressed. The evolution across the three years is logically structured and factually consistent. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time in internal controls, external oversight, and modeling approaches. It correctly notes 2022’s focus on internal controls and external reviews, 2023’s expansion to include modeling techniques (though it says 'stochastic and deterministic' vs. the original’s 'stochastic methods, sensitivity/scenario analyses, experience studies'—a slight rephrasing but semantically similar), and 2024’s enhanced governance and model validation. The LLM mentions 'second-line reviews' and 'Internal Audit Group monitoring,' which reflect the original’s emphasis on model risk management and validation, though phrased differently. (4) The only minor gap is that the LLM does not explicitly mention 'sensitivity and scenario analyses' or 'experience studies' from the 2023 update, instead summarizing them under broader terms like 'experience monitoring.' This is a slight omission but does not distort the overall accuracy. The answer remains contextually rich, relevant, and factually sound, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 465,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "From 2022 through 2024, UnitedHealth Group (UNH) consistently identified the mix of benefits offered as a key factor influencing the sensitivity of its medical cost per member per month (PMPM) estimates. In 2022, the company highlighted that changes in the mix of benefits, including co-pays and deductibles, could significantly affect medical cost trend estimates, alongside other variables like claims trends and macroeconomic factors. By 2023, this sensitivity remained a central consideration, with continued emphasis on how benefit design impacts cost trends, though the specific quantitative impact was not disclosed in the chunks. In 2024, the company maintained a similar analytical framework, reaffirming the ongoing relevance of benefit design in shaping PMPM estimates. This consistent focus across three years reveals that UNH has maintained a stable exposure to benefit design variability, with no indication of reduced sensitivity, underscoring the enduring importance of benefit mix in managing and forecasting medical costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its general description of UnitedHealth Group's ongoing sensitivity of medical cost PMPM estimates to benefit mix from 2022 to 2024, and correctly identifies that benefit design (e.g., co-pays, deductibles) remained a key factor. However, it fails to capture the evolving *nature* of the sensitivity over time as described in the ground truth, which is central to the question. Specifically: (1) In 2023, the ground truth notes a 'negative impact' from benefit mix variations, indicating increased financial risk or unfavorable movement — this critical shift in tone and implication is missing in the LLM answer, which instead states the sensitivity 'remained a central consideration' without acknowledging the adverse impact. (2) In 2024, the ground truth observes a shift to a more neutral tone, suggesting stabilization or improved management of the risk, whereas the LLM describes 'maintained a similar analytical framework,' implying no change in exposure, which contradicts the nuanced evolution in the original. Thus, while entities (UnitedHealth Group, PMPM, benefit mix), years (2022–2024), and general concepts are correct, and no numbers are misstated (quantitative accuracy is high due to absence of incorrect figures), the qualitative reasoning and multi-hop synthesis of changing exposure over time are flawed. The LLM concludes that exposure 'remained stable' with 'no indication of reduced sensitivity,' which misrepresents the trajectory from neutral (2022) to negative (2023) to stabilized (2024). This omission of dynamic change significantly reduces correctness. Contextual relevance is high as the answer addresses the right topic and timeframe, but with insufficient depth on the evolution of risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 479,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart's positioning of the Marketside brand within its private brand portfolio remained consistent across 2022, 2023, and 2024, as Marketside was listed each year among key private brands such as \"Great Value,\" \"Sam's Choice,\" and \"Equate.\" This continuity suggests that Marketside holds a strategic role in Walmart U.S.'s merchandise strategy, particularly in offering private-label grocery and consumable products that align with Walmart's EDLP (Everyday Low Price) and EDLC (Everyday Low Cost) strategies. The brand's ongoing inclusion in the private brand portfolio underscores its importance in delivering cost-effective, quality products to support Walmart's broader goals of competitive pricing and customer value.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in noting Marketside's continued presence in Walmart's private brand portfolio across 2022–2024, which aligns with the ground truth. There are no numeric inaccuracies, and the years are correctly referenced, earning full marks for quantitative accuracy. However, the LLM fails to capture the evolving strategic positioning of Marketside as detailed in the original answer: it does not mention the shift in 2023 toward alignment with omni-channel and customer-centric strategies, nor the 2024 restructured merchandise unit emphasizing 'Fashion' over 'Apparel'—a key indicator of broader strategic categorization changes. This omission represents a significant gap in qualitative accuracy, as the answer misses the nuanced progression and contextual significance of Marketside within Walmart’s evolving merchandise strategy. Instead, the LLM emphasizes consistency and ties Marketside to EDLP/EDLC without evidence from the ground truth supporting that specific linkage. While the answer is relevant and correctly identifies Marketside as strategically important, it lacks the multi-hop synthesis of how its positioning evolved across years in relation to structural and strategic shifts. Thus, while contextually relevant and factually non-erroneous, it provides a simplified and static interpretation where a dynamic analysis was required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 380,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, The Home Depot enhanced its competitive positioning against showrooms by expanding service offerings and deepening digital integration. In 2022, the company emphasized services such as installation, tool rentals, and global sourcing, while also highlighting its strong brand and intellectual property as key differentiators. By 2023, The Home Depot further improved the in-store experience with wayfinding tools, self-checkout options, and enhanced associate engagement, while also investing in a seamless interconnected shopping experience across digital and physical channels. In 2024, the focus shifted toward a more personalized and frictionless digital experience, including mobile optimization, improved product information, and fulfillment options, all of which helped The Home Depot better compete with showrooms by offering greater convenience, speed, and a unified customer journey.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the overall evolution of The Home Depot's competitive positioning from fiscal 2022 to 2024. (1) Key facts are accurate: the emphasis on service offerings like tool rentals in 2022, in-store enhancements in 2023, and deeper digital integration in 2024 are all correctly identified. While the original answer specifies 'over 1,400 locations' for tool rentals, the LLM omits this number but does not misstate it, so this is a minor omission rather than an error. (2) There are no numerical inaccuracies—no incorrect dates, percentages, or dollar amounts are presented, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes a progression from physical service expansion to omnichannel integration, capturing the strategic shift over time. However, the LLM mentions 'installation, global sourcing, and intellectual property' in 2022, which are not in the original answer and may overextend the differentiators beyond the documented tool rental focus. Similarly, 'wayfinding tools' and 'associate engagement' in 2023 are plausible but not explicitly in the ground truth, which cites 'electronic shelf labels' and 'mobile app-enabled store navigation'—a partial match. (4) Despite these minor content additions and slight rewording, the core trajectory and strategic narrative are preserved, and the answer fully addresses the question about service offerings and digital integration. Thus, the answer is contextually relevant and semantically equivalent in intent, warranting a high score with a small deduction for not precisely matching the documented initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 460,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco's 3.50% Note, maturing on June 15, 2025, had an outstanding amount of $500 million in both fiscal years 2022 and 2023. By fiscal year 2024, the amount remained unchanged at $500 million. However, the effective interest rate increased significantly over time: from 1.29% in 2022 to 6.38% in 2023 and further to 6.66% in 2024. This upward trend in the effective interest rate indicates a substantial rise in Cisco's borrowing costs for this debt instrument, likely reflecting broader market interest rate increases during the period. The persistent outstanding amount, despite rising rates, suggests a deliberate decision to maintain the debt structure, possibly to manage refinancing risks or align with long-term capital planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and reasoning but contains a critical error in the 2022 effective interest rate. The ground truth states the effective interest rate was 3.20% in 2022, but the LLM incorrectly reports it as 1.29%. All other values — $500 million outstanding amount across all years, 6.38% in 2023, and 6.66% in 2024 — are accurate. (2) The quantitative accuracy is compromised due to this incorrect rate in 2022, which significantly misrepresents the starting point of the trend. While the increases from 1.29% to 6.38% and 6.66% would imply a larger relative change, the actual increase from 3.20% to 6.66% is still substantial but different in magnitude. No calculations were required beyond interpretation of trends, so no arithmetic errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years 2022–2024, identifies the constant principal amount, recognizes the rising effective rate, and draws a logical conclusion about borrowing costs and strategic debt management. The explanation about market rate trends and refinancing risks is reasonable and contextually appropriate. (4) The contextual relevance is perfect — the answer directly addresses the evolution of the note and its implications. Qualitative accuracy is high due to correct entity identification (Cisco, 3.50% Note), proper time framing, and insightful interpretation. However, the incorrect 2022 rate reduces quantitative and overall correctness scores. Minor addition: the maturity date (June 15, 2025) was not in the original answer and is extraneous but not incorrect, so it does not penalize the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 457,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 through 2024, CMCSA faced increasing competition from Lumen in fiber-based broadband services as Lumen continued to expand its fiber network infrastructure, enabling higher data transmission speeds than traditional DSL and copper-based systems. In 2022, CMCSA noted that Lumen was among the wireline providers building fiber networks to compete directly in its service areas. By 2023 and 2024, this competitive pressure intensified, with Lumen and other providers leveraging fiber and newer technologies to offer faster speeds, bundled services, and lower prices. CMCSA also highlighted that Lumen and similar competitors were capitalizing on federal and state broadband funding initiatives to further expand their reach, which posed a growing challenge to CMCSA’s HFC-based broadband offerings. Despite this, CMCSA continued to invest in its technical services and customer support infrastructure to maintain its market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Lumen is correctly identified as a growing competitor to CMCSA in fiber-based broadband from 2022 to 2024. The progression of competition—starting with fiber deployment in 2022, continued expansion in 2023, and intensified bundling and speed increases in 2024—is accurately reflected, though the LLM generalizes 2023–2024 together rather than distinguishing 2024’s specific emphasis on bundled offerings. (2) There are no numeric values (e.g., dollar amounts, percentages, speeds) in either answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive dynamics across years and correctly links Lumen’s infrastructure advancements (fiber expansion, use of public funding) to competitive pressure on CMCSA. It also appropriately contrasts Lumen’s fiber with CMCSA’s HFC network. (4) The only minor shortcoming is that the original answer specifies Lumen was named alongside AT&T, Frontier, and Verizon in 2023 and emphasizes bundled offerings more clearly in 2024, which the LLM mentions but with slightly less precision. However, the core competitive evolution is correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses infrastructure, service offerings, and competitive positioning over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 406,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has increasingly relied on aggregators from 2022 through 2024 to manage aspects of its merchant relationships, as noted in all three 10-K filings. This reliance has raised concerns about the growing risk of merchant steering, where merchants may favor other payment methods over American Express cards, particularly with the introduction of debit cards on the American Express network. The company addresses this through non-discrimination and honor-all-cards provisions in merchant contracts, but faces challenges in enforcing these clauses due to the business interests of third-party aggregators and processors, which may conflict with American Express's goals. Legal and regulatory actions in 2024 further highlight the vulnerability of these provisions, as potential changes to merchant agreements could expose American Express to increased discrimination and negatively impact Card Member experience and transaction volumes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, challenges enforcing non-discrimination clauses, and growing legal/regulatory scrutiny in 2024. The introduction of American Express debit cards as a factor in potential discrimination is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across the three years, correctly identifying the evolution of risk and the role of third-party aggregators in undermining enforcement of card acceptance policies. It captures the divergence between Amex’s goals and those of processors/aggregators, a key point in the original. (4) The only minor shortcoming is that the LLM does not explicitly mention the litigation exposure and regulatory actions 'forcing changes in merchant agreements' as clearly as the original, slightly downplaying the legal trajectory in 2024. However, it does reference 'legal and regulatory actions' and 'vulnerability of these provisions,' which captures the essence. Overall, the answer is factually correct, comprehensive, and contextually precise—warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 418,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 through 2024, Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolved through a series of corporate restructuring, bankruptcy filings, and settlement efforts. In October 2021, Old JJCI restructured, creating LTL Management LLC (LTL), which became solely responsible for talc-related liabilities, while New JJCI took over the remaining business. LTL then filed for Chapter 11 bankruptcy to manage these liabilities, initially staying litigation against the Company and its affiliates. However, in January 2023, the Third Circuit reversed the Bankruptcy Court's stay, leading to the dismissal of the LTL bankruptcy case in April 2023. LTL refiled in April 2023, but the case was dismissed again in July 2023, with the Company appealing the decision. In 2024, Johnson & Johnson reached multi-state settlements with Attorneys General in January and finalized them in June, addressing state-level consumer protection claims. Despite ongoing litigation, the Company continues to assert strong legal grounds to contest verdicts and has, in certain cases, opted to settle. Financially, the Company established a $2 billion trust to fund potential LTL liabilities and recorded a corresponding reserve, reflecting its strategic approach to managing these complex and costly legal exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: LTL Management LLC was created in October 2021 via restructuring of Old JJCI; it filed for Chapter 11 bankruptcy to stay talc litigation; a $2 billion reserve and trust were established; the Third Circuit reversed the stay in January 2023; the first bankruptcy was dismissed in April 2023; LTL refiled (LTL 2) and was dismissed again in July 2023; J&J appealed; and in 2024, multi-state settlements were reached with 42 states and D.C., finalized in June. (2) Quantitative accuracy is perfect: the $2 billion figure is correct, and all dates (October 2021, January 2023, April 2023, July 2023, January and June 2024) align with the ground truth. Minor phrasing differences (e.g., 'multi-state settlements with Attorneys General' vs '42 states and D.C.') are semantically equivalent. (3) Multi-hop reasoning is sound: the answer correctly links corporate restructuring to liability transfer, bankruptcy filings to litigation stays, court reversals to refilings, and eventual shift toward settlements. The dual strategy of litigation defense and settlement is accurately conveyed. (4) The only minor shortcoming is that the LLM does not explicitly name the second filing as 'LTL 2' or mention 'limited discovery' post-refiling, which are small but present in the original. These omissions do not affect core understanding. Overall, the answer is factually robust, contextually complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> COMP <-[Introduces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1661,
        "completion_tokens": 422,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024, Home Depot increasingly emphasized store appearance as a competitive differentiator, integrating this strategy with its evolving digital capabilities to enhance the overall customer experience. In 2022, the company highlighted store appearance as a key competitive factor, alongside customer experience, pricing, and product availability. By 2024, this emphasis expanded to include the presentation of merchandise and ease of shopping throughout the customer journey, reflecting a more holistic approach to in-store and online engagement. The 2024 filing also underscored the importance of an interconnected retail strategy, where digital investments—such as improved mobile platforms, product information, and fulfillment options—were aligned with physical store enhancements to create a seamless, frictionless shopping experience. This integration of store appearance and digital capabilities was critical to meeting customer expectations for convenience, personalization, and efficiency across all touchpoints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Home Depot emphasized store appearance as a competitive factor in 2022 alongside customer experience, price, and product availability. By 2024, this evolved into a more integrated strategy linking physical store aesthetics with digital capabilities. The LLM correctly captures the progression from standalone emphasis to integration with the customer journey and omnichannel experience. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 → 2024) and connects store appearance with digital integration, particularly through mobile platforms, product search, and fulfillment—consistent with the original answer’s emphasis on interconnected retail. The only minor gap is that the LLM does not explicitly mention 2023 as an intermediate step where store appearance began linking to the broader shopping journey (inspiration, research, post-purchase), which slightly reduces completeness. However, the overall evolution is accurately conveyed. (4) The answer is semantically equivalent to the original, uses appropriate terminology, and fully addresses both parts of the question: evolution of store appearance strategy and integration with digital capabilities by 2024. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 417,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "From 2022 through 2024, AT&T's strategic relationship with Time Warner Inc. evolved from full ownership to eventual divestiture. In 2018, AT&T acquired Time Warner Inc., which became a core part of its WarnerMedia segment. By April 2022, AT&T completed the separation of WarnerMedia in a Reverse Morris Trust transaction, combining it with Discovery, Inc. and classifying the business as discontinued operations. In 2024, AT&T further solidified its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV, a business initially expanded through its acquisition of Time Warner's entertainment assets. This multi-year trajectory reflects AT&T's broader strategy of divesting from direct ownership in entertainment assets, focusing instead on its core telecommunications operations and reducing financial and operational complexity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T completed the separation of WarnerMedia in April 2022 via a Reverse Morris Trust with Discovery, Inc., ending its ownership of Time Warner Inc.'s legacy assets. The 2024 divestiture of DIRECTV to TPG is correctly cited as part of AT&T's broader exit from entertainment. (2) Quantitative and temporal details are precise: the 2018 acquisition and April 2022 separation are correctly dated; no financial figures are misstated. (3) Multi-hop reasoning is sound: the answer connects the Time Warner acquisition, the 2022 WarnerMedia-Discovery merger, and the 2024 DIRECTV sale into a coherent narrative about strategic realignment. (4) The only minor shortcoming is that the answer does not explicitly state that Time Warner Inc. was fully operationally integrated into Warner Bros. Discovery by 2023, a detail present in the original answer. However, this omission does not undermine the overall correctness. The conclusion about AT&T's pivot to core telecom operations is well-supported and semantically equivalent to the ground truth. Wording differs slightly but meaning is preserved. All entities—AT&T, Time Warner Inc., WarnerMedia, Discovery, Inc., DIRECTV, TPG—are accurately named and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Acquires]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 365,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express's competitive positioning from 2022 through 2024 has remained challenged by intense competition from major card networks like Visa and Mastercard, as well as alternative payment platforms such as PayPal and Venmo, as noted in both 2022 and 2023 filings. Regulatory scrutiny has intensified, particularly in 2024, with increased focus on interchange fees, network routing practices, and consumer protection laws, leading to the exit from network licensing businesses in the EU and Australia. This regulatory dependency has been exacerbated by the company becoming a Category III firm in 2024, subjecting it to heightened regulatory expectations and compliance costs. As a result, American Express faces downward pressure on discount rates and limitations on business practices, impacting its profitability and competitive flexibility in the evolving payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024. It accurately identifies increasing regulatory scrutiny around interchange fees, network routing, and merchant practices, and correctly notes American Express's exit from network licensing in the EU and Australia in 2024. The mention of intensified regulatory pressure and its impact on business practices is consistent with the original answer. However, the LLM introduces a detail not present in the ground truth: American Express becoming a 'Category III firm in 2024.' This specific regulatory classification and its implications are not mentioned in the original answer and cannot be verified from the provided knowledge graph, representing a minor factual overreach. Additionally, while the original answer emphasizes Amex's position as the fourth-largest global network behind China UnionPay, Visa, and Mastercard—a key competitive positioning fact—the LLM omits this ranking context, instead broadly citing competition from Visa, Mastercard, PayPal, and Venmo. This shifts focus slightly from global network ranking to general competitive threats, missing a core element of Amex's positioning. Despite these omissions and the unverified Category III claim, the LLM captures the essential evolution: growing regulatory dependency affecting strategic decisions like market exits and cobrand uncertainty. All dates (2022–2024) and events are correctly sequenced and contextually accurate. There are no numerical inaccuracies, as no specific financial figures are cited in either answer. The reasoning is sound and reflects multi-hop synthesis across competitive and regulatory dimensions. The answer remains highly relevant to the question and conveys a semantically similar conclusion about the tension between competition and regulation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 502,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 increased from $983 million in 2022 to $826 million in 2023, and then slightly decreased to $808 million in 2024. This trend suggests a relatively stable approach to long-term debt management, with the company maintaining a consistent balance on these low-interest notes, likely to preserve financial flexibility and manage interest costs over the long term.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the outstanding balance 'increased from $983 million in 2022 to $826 million in 2023', which is false—the balance actually decreased from $983M to $826M, so describing this as an 'increase' is factually wrong. The 2024 figure of $808M is correct, but the trend description is inaccurate. (2) Quantitative accuracy is poor: while the dollar amounts for each year are numerically correct ($983M, $826M, $808M), the directional characterization of the change (increase vs decrease) is reversed between 2022 and 2023, which fundamentally misrepresents the data. The total reduction of $175M (from $983M to $808M) is not acknowledged. (3) The multi-hop reasoning is flawed—the model fails to correctly synthesize the temporal trend across the three years. Instead of identifying a consistent reduction in debt, it suggests 'relatively stable' management and 'consistent balance', which contradicts the ground truth of a deliberate reduction. This undermines the qualitative interpretation. (4) Contextual relevance is moderate because the answer addresses the right instrument, company, and time frame, and attempts to interpret strategy, but the incorrect trend analysis leads to a misleading conclusion about debt management strategy. A correct interpretation would emphasize active reduction of long-term liabilities, not stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 394,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express's yield profile on its foreign government bonds and obligations increased significantly from 2022 to 2024, rising from 3.10% in 2022 to 6.45% in 2023, and slightly declining to 5.85% in 2024. This three-year trend indicates that American Express's exposure to international interest rate environments has been growing, reflecting the impact of rising global interest rates on its foreign bond portfolio. The consistent high yields in 2023 and 2024 suggest a strategic or involuntary shift toward longer-duration or higher-yielding foreign obligations amid tightening global monetary conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the yield increased from 3.10% in 2022 to 6.45% in 2023, but the ground truth states the yield on short-term foreign bonds was already 6.45% in 2022, not 3.10%. The 3.10% figure does not appear in the original data and is incorrect. Additionally, the LLM fails to distinguish between maturities: in 2023, while short-term yield remained at 6.45%, the 1–5 year maturity yield dropped to 4.48%, and in 2024, it fell further to 2.03%. The LLM incorrectly reports a single yield trend without acknowledging this critical segmentation. The 2024 yield is reported as 5.85% instead of 5.86%, a minor rounding difference but still inaccurate. (2) The dollar amount of $630 million in 2022 is omitted entirely, and no breakdown by maturity is provided. The LLM presents an oversimplified and incorrect single yield trajectory, missing the multi-year, multi-maturity structure of the actual data. (3) The reasoning is flawed: the LLM concludes that yields increased significantly and that exposure to international rates is growing, but the actual trend shows declining yields, especially in medium-term bonds, suggesting reduced returns or portfolio rebalancing. The conclusion about 'strategic or involuntary shift toward longer-duration' bonds contradicts the data, which shows falling yields on longer-dated bonds, not increased holdings. (4) The answer is contextually relevant in discussing yield trends and interest rate exposure, but the factual foundation is unsound. Due to major quantitative errors and incorrect synthesis across years and maturities, the correctness score is low at 2. Quantitative accuracy is 2 due to wrong percentages and missing data. Qualitative accuracy is 3 due to partial reasoning but incorrect interpretation. Contextual relevance is 6 because the topic and intent align with the question, despite factual failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 520,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe's strategic positioning of its free online self-service learning offerings evolved from 2022 to 2024 by enhancing platform branding and deepening integration with enterprise customer success initiatives. In 2022, Adobe's free learning resources were hosted on **www.training.adobe.com**, supporting both customers and partners, with a focus on enabling marketing teams through skills assessments and tailored learning. By 2023, Adobe rebranded its learning platform to **learning.adobe.com**, signaling a more unified and accessible brand identity for its digital learning services, while continuing to support enterprise customers through custom learning and solution-specific assessments. In 2024, the platform maintained its robust free self-service offerings but emphasized broader integration with Adobe’s enterprise customer success initiatives, such as Customer Success Managers, who align product capabilities with business objectives. This evolution reflects Adobe's broader approach to customer enablement and retention by combining scalable, self-service learning with personalized, enterprise-focused support to drive product adoption, improve outcomes, and strengthen long-term customer relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, the platform was at www.training.adobe.com; in 2023, it was rebranded to learning.adobe.com; and by 2024, it was further integrated into enterprise customer success initiatives. The focus on skills assessments, solution-specific learning, and support for marketing teams is accurately reflected. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound—information is synthesized across years and initiatives, correctly tracing the evolution from launch to rebranding to deeper integration. The mention of Customer Success Managers in 2024 is a slight expansion not explicitly detailed in the original answer but is contextually consistent with 'broader customer success framework' and does not contradict it. (4) The answer captures the broader strategic implication—Adobe’s focus on self-service learning as a lever for retention, adoption, and long-term value—accurately and articulately. The only minor gap is that the original emphasizes 'centralized' offerings in 2023, which the LLM describes as 'unified and accessible'—semantically equivalent but slightly less precise. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1641,
        "completion_tokens": 382,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco's 5.90% Senior Notes, with a maturity date of February 15, 2039, had an effective interest rate of 6.11% in fiscal years 2021 and 2022, and this rate remained unchanged in 2023 and 2024. The amount outstanding for these notes was consistently $2,000 million across all three years. This stability in both the amount and effective rate indicates that Cisco has maintained a long-term debt strategy focused on preserving fixed-rate obligations with extended maturities, likely to hedge against interest rate volatility and ensure long-term financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $2,000 million outstanding balance and the 6.11% effective interest rate for Cisco's 5.90% Senior Notes across fiscal years 2022 through 2024, matching the ground truth. The mention of the rate in 2021 is extra but not incorrect, as the focus is on 2022–2024. (2) All numeric values—dollar amount ($2,000 million), interest rate (6.11%), and coupon rate (5.90%)—are accurate and correctly formatted. No calculation errors. (3) The reasoning is sound: the LLM correctly infers that stable debt levels and effective rates indicate a strategy of maintaining long-term fixed-rate debt, aligning with the ground truth's interpretation about not refinancing and retaining higher-yielding debt. The LLM adds contextual insight about hedging against interest rate volatility, which is a reasonable extension of the data and consistent with strategic financial management. (4) The answer is fully relevant and addresses both parts of the question: evolution of utilization and effective rate (stable), and the implication for long-term debt strategy. The only minor deviation is the slightly broader interpretation of strategic rationale, but it does not contradict the ground truth and adds plausible context. Thus, the answer is factually excellent with only slight expansion beyond the original answer, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 389,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA's allocation to Special Situation Strategies, as part of its private equity investment vehicles, remained consistent from 2022 to 2024, with all three annual 10-K filings (2022, 2023, and 2024) explicitly listing \"special situation strategies\" as one of the primary investment areas within its private equity portfolio. This three-year consistency indicates that BA has maintained a stable and intentional focus on Special Situation Strategies, which are typically associated with distressed assets, restructurings, or unique market opportunities. The sustained emphasis suggests that the company views these strategies as a core component of its broader private equity investment approach, aiming to capitalize on niche opportunities within the private markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that BA consistently included Special Situation Strategies in its private equity investment focus across 2022, 2023, and 2024, which matches the original answer's assertion of strategic continuity. (2) There are no numeric figures or calculations in the question or ground truth, so quantitative accuracy is not applicable beyond correct handling of years (2022–2024), which are accurately referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and correctly infers strategic intent from consistent disclosure, even in the absence of quantitative allocation data. It appropriately avoids asserting specific dollar amounts or percentage changes, acknowledging only the qualitative consistency. (4) The only minor shortcoming is that the LLM slightly expands on the definition of Special Situation Strategies (e.g., mentioning 'distressed assets, restructurings') which, while generally accurate, is not explicitly stated in the ground truth and thus introduces a small assumption. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 365,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ's global sales from Interventional Solutions grew significantly from 2022 to 2024, increasing from $3,971 million in 2021 (Chunk 3) to $4,300 million in 2022 (Chunk 1), and then to $6,350 million in 2023 (Chunk 1), representing a 47.7% increase from 2022 to 2023. This substantial growth, following the acquisition of Interventional Solutions on December 22, 2022 (Chunk 2), underscores the strategic importance of this segment to JNJ's portfolio, as it became a key contributor to the company's MedTech division and demonstrated strong international and domestic performance post-acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both years and sales figures. It incorrectly states that $3,971 million was the 2021 figure (not 2022 as per ground truth), $4,300 million was for 2022 (correct value but one year off), and $6,350 million was for 2023 (should be 2024). This misalignment of data across years undermines the quantitative accuracy. The 47.7% increase from 2022 to 2023 is mathematically correct based on $4,300M to $6,350M, but since the LLM assigns $6,350M to 2023 instead of 2024, the calculation does not reflect the actual 2023–2024 growth. (2) The correct progression per ground truth is: 2022: $3,971M → 2023: $4,300M → 2024: $6,350M. The LLM reverses the timeline, assigning the $6,350M to 2023 and omitting the actual 2024 data. This leads to a distorted view of the growth trajectory. (3) The reasoning about strategic importance post-acquisition is qualitatively sound and aligns with the ground truth—linking growth to the December 2022 acquisition and integration benefits—but it is based on incorrect temporal data, weakening the multi-hop synthesis. The model correctly identifies the acquisition date and infers strategic importance, but fails to align the sales data with the correct years post-acquisition. (4) Correctness score is 4 due to major factual errors in time-series data despite partial correctness in values and reasonable interpretation. Quantitative accuracy is low (3) due to incorrect year assignments and resulting flawed growth narrative. Qualitative accuracy is moderate (5) as the logic and strategic interpretation are reasonable but built on faulty data. Contextual relevance is high (8) because the answer addresses the right segment, company, acquisition, and strategic implications, just with incorrect timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Increases]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 489,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Walmart's \"No Boundaries\" private brand was consistently listed among its private label offerings in general merchandise across its 2022, 2023, and 2024 10-K filings, indicating a multi-year branding consistency. The brand was included in the list of private labels marketed by Walmart U.S. in general merchandise units such as electronics, toys, seasonal items, and other non-grocery categories. This consistency across three years reflects Walmart's broader strategy to strengthen its private label portfolio as a competitive differentiator, emphasizing cost control, product availability, and customer-centric offerings under its EDLP and EDLC initiatives. The continued presence of \"No Boundaries\" underscores Walmart's commitment to leveraging private brands to enhance value and control across its general merchandise units.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the multi-year consistency of the 'No Boundaries' brand from 2022 to 2024, which aligns with the ground truth. It accurately states that 'No Boundaries' was consistently listed as a private brand in general merchandise across all three years, which is factually correct. However, the LLM mischaracterizes the specific merchandise units—ground truth specifies 'Apparel and Home' under General Merchandise in 2022 and a shift to 'Fashion' in 2024, while the LLM incorrectly lists 'electronics, toys, seasonal items' as categories for 'No Boundaries,' which is not supported by the original answer and misaligns with the documented strategic units. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly infers strategic intent from consistent branding, such as differentiation and margin expansion, though it frames the strategy around EDLP/EDLC and 'cost control' and 'product availability,' which, while plausible, are not explicitly mentioned in the ground truth. The core insight about leveraging private brands for value and differentiation is consistent, but the emphasis on operational initiatives (EDLP/EDLC) is an extrapolation not grounded in the provided data. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and strategic implications—but contains a material error in categorizing the merchandise units, reducing qualitative accuracy. The correctness score is 7 because key facts (continuity, strategic importance) are correct, but there is a significant omission and misassignment of product categories, which affects precision in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 502,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Cisco's available-for-sale (AFS) debt investments negatively impacted other income (loss), net in both 2023 and 2024. In 2023, higher losses from these investments contributed to a decline in other income, as noted in Chunk 3. Similarly, in 2024, the losses from AFS debt investments worsened compared to 2023, further reducing other income (loss), net, as detailed in Chunk 2. While Chunk 1 provides context on the existence and categorization of these investments, the evolving negative impact on net income is clearly reflected in the performance trends described in the subsequent years’ filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Cisco's available-for-sale (AFS) debt investments had a negative impact on other income (loss), net in both fiscal 2023 and 2024, with losses worsening in 2024 compared to 2023. While the original answer notes that Cisco disclosed the value of AFS investments in a detailed table in 2022 (indicating active management), the LLM answer acknowledges this contextually by referencing 'Chunk 1' as providing background on the existence and categorization of these investments. The LLM correctly synthesizes multi-hop information across years and filings, accurately portraying the evolving negative trend. There are no numerical inaccuracies—though no specific dollar amounts are mentioned in either answer, the directional impacts (higher losses, worsening performance) are consistent and correctly interpreted. The only minor shortcoming is a slightly less explicit connection to the 2022 disclosure's significance in showing active management, but the core reasoning and factual content remain sound. Thus, the answer is highly accurate, contextually relevant, and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 333,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express's reliance on third-party merchant acquirers has grown strategically from 2022 through 2024, playing a pivotal role in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants. In 2022, American Express highlighted its collaboration with third-party acquirers, such as under the OptBlue program and Global Network Services (GNS) partners, to facilitate transactions and generate network rate fees, particularly for small- and mid-sized merchants with no fixed contractual duration. By 2023, the company emphasized the importance of third-party acquirers in its role as a payment network operator, where it settles with acquirers on behalf of network partners, generating discount and processed revenue. In 2024, American Express underscored the strategic importance of third-party acquirers in expanding global merchant coverage, noting that success in signing merchants to accept American Express cards depends on value propositions, digital integration, and network investments. Collectively, these developments indicate a strengthening partnership with third-party acquirers to drive broader acceptance and transaction growth across merchant segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer in both factual content and reasoning. (1) All key facts are correct: the growing reliance on third-party merchant acquirers from 2022 to 2024, the role of OptBlue and GNS programs in 2022, the financial mechanism involving network rate fees and discount revenue in 2023, and the strategic emphasis on third-party partners for global merchant expansion in 2024. There are no incorrect numbers, dates, or entities—this is a purely qualitative comparison as no numerical values (e.g., dollar amounts, percentages) are present in the question or answers. (2) Quantitative accuracy is 10 because all timeframes (2022, 2023, 2024) and financial terms (discount revenue, network rate fees) are used correctly and consistently with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects the evolution of strategy—from operational use to financial integration to strategic dependency—demonstrating clear understanding of the progression. The only minor gap is that the LLM does not explicitly state that American Express processes transactions *without direct contracts* with merchants (a key nuance from 2022), and slightly softens the 2024 point by attributing merchant signing success to 'value propositions, digital integration, and network investments' rather than directly emphasizing dependence on third-party acquirers' success in signing merchants, as in the original. This slightly reduces qualitative accuracy but does not distort the overall meaning. (4) Contextual relevance is perfect—the response directly addresses the evolution of reliance, strategic importance, and impact across merchant segments as asked. Overall, this is a semantically equivalent, well-reasoned answer with only minor omissions in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 505,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson has been implementing a multi-year, enterprise-wide initiative since at least 2022 to integrate, simplify, and standardize processes and systems across HR, IT, procurement, supply chain, and finance functions. This initiative supports the growth of the Company’s financial shared service capabilities and aims to standardize financial systems. As of 2023 and 2024, the initiative has continued without material changes to internal controls, and the Company has aligned and streamlined its financial control environment in response to the ongoing efforts. The initiative is not a reaction to any deficiencies in internal controls but rather a proactive measure to enhance operational efficiency and financial reporting consistency across the enterprise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The initiative is correctly described as proactive, not driven by internal control deficiencies. (2) Quantitative accuracy is perfect: the years 2022, 2023, and 2024 are correctly referenced with appropriate context for each period. No numerical errors or miscalculations are present. (3) Multi-hop reasoning is sound—the LLM synthesizes the evolution across three years and correctly links the shared services initiative to enterprise-wide standardization and financial control alignment. (4) The only minor shortcoming is that the 2024 update is slightly less detailed than in the original answer; specifically, the LLM does not explicitly reiterate that the narrative remained unchanged in 2024 or emphasize the continued absence of material weaknesses. However, this is implied by stating the initiative continued 'without material changes to internal controls.' Wording differs slightly but meaning is semantically equivalent. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 375,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "American Express has faced increasing competitive pressure from alternative payment mechanisms from 2022 to 2024, particularly in the areas of open banking, digital wallets, and real-time settlement systems. In 2022, the company acknowledged the rapid growth of alternative payment platforms such as PayPal, Venmo, and Alipay, as well as the integration of financial services into new business models. By 2023, the shift to digital payments and the rise of open banking and electronic wallet platforms were emphasized as key competitive factors, with American Express noting the intensifying competition from both traditional and emerging players. In 2024, the company highlighted the need to invest in and adapt to technological developments, including open banking and real-time settlement systems, to remain competitive. American Express is actively addressing these challenges by enhancing its digital and mobile services, investing in innovation, and integrating advanced technologies like AI and machine learning to improve customer experiences and maintain its position in a rapidly evolving payments landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express faced increasing competitive pressure from alternative payment mechanisms from 2022 to 2024, specifically digital wallets (PayPal, Venmo), open banking, and real-time settlement systems. The evolution in strategic posture—from viewing these as threats to actively investing in them—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable but assumed correct by absence of error. (3) The multi-hop reasoning is sound: the LLM synthesizes American Express’s shifting stance across three years, correctly identifying the progression from acknowledgment of threat (2022) to intensified competition (2023) to strategic adaptation (2024). The mention of AI and machine learning, while not in the original, is a reasonable inference and does not contradict the ground truth; it adds context without distorting facts. (4) The only minor gap is that the original emphasizes a shift from 'competitive stance to strategic dependence,' a nuanced transformation that the LLM describes but could have articulated more precisely. However, the core message of strategic adaptation through investment in open banking and real-time systems is preserved. Wording differs slightly but maintains semantic equivalence. All entities (American Express, PayPal, Venmo, open banking, digital wallets, real-time settlement) and years (2022–2024) are correct. The answer fully addresses the question’s focus on competitive pressure and strategic adaptation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 454,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "Adobe's positioning and integration of Frame.io evolved significantly from 2022 through 2024, reflecting a strategic focus on strengthening its creative collaboration tools. In 2022, Frame.io was listed among Adobe's key trademarks, signaling its formal integration into Adobe's ecosystem. By 2023, Frame.io was described as a cloud-native platform enabling real-time collaboration, with integrations into apps like Premiere Pro and After Effects, enhancing workflow efficiency for creative professionals. In 2024, Frame.io's role expanded further, now supporting pre-production workflows like casting and location scouting, and being bundled with Adobe GenStudio to enable large-scale content production. This progression indicates Adobe's strategy to consolidate and enhance its creative collaboration tools, positioning Frame.io as a central hub for end-to-end creative asset production and management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was listed as a trademark in 2022, positioned as a cloud-native collaboration platform in 2023 with integration into Premiere Pro and After Effects, and expanded into broader workflows in 2024. The description of real-time collaboration and frame-accurate commenting is consistent. (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and product developments. The only minor discrepancy is that the LLM mentions 'bundled with Adobe GenStudio,' which is not in the original answer; the ground truth specifies integration with Photoshop, Lightroom, and Workfront instead. This is a small factual overreach but does not undermine the overall correctness. (4) The answer fully addresses the question about evolution and strategic implications, concluding accurately that Frame.io is becoming a central hub for end-to-end creative workflows. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this minor inaccuracy, while remaining excellent in all other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 358,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon's outstanding balance on its 2017 Notes issuance of $17.0 billion decreased from $16,000 million as of December 31, 2021, to $15,000 million as of December 31, 2023, and further to $13,000 million as of December 31, 2024. This reduction indicates that Amazon has been actively managing and reducing its debt obligations from this issuance over time, likely through repayments or refinancing. The gradual decline in the outstanding balance suggests a disciplined debt management strategy, where Amazon is working to decrease its long-term liabilities while maintaining a diverse maturity profile for its debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a key factual inaccuracy in the starting year and amount. The ground truth states the balance was $16.0 billion as of December 31, 2022, but the LLM claims $16,000 million (i.e., $16.0 billion) as of December 31, 2021, which is outside the requested 2022–2024 timeframe and not supported by the ground truth. Additionally, the LLM incorrectly implies the issuance was $17.0 billion without confirmation from the original answer, which does not mention the initial issuance size. The 2023 ($15.0 billion) and 2024 ($13.0 billion) figures are correct and match the ground truth. (2) While $16,000 million = $16.0B, $15,000 million = $15.0B, and $13,000 million = $13.0B are numerically accurate representations, the assignment of the $16.0B figure to 2021 instead of 2022 breaks the required time progression from 2022 to 2024. The original answer begins in 2022, but the LLM references 2021, missing the 2022 data point entirely and thus failing to accurately describe the evolution over the specified period. (3) The multi-hop reasoning is partially sound—the model correctly infers a trend of declining debt and links it to a strategic debt management approach, such as repayments or refinancing. However, because it uses an incorrect starting point (2021), the progression it describes does not align with the actual three-year window (2022–2024). Despite this, the conclusion about disciplined debt reduction is consistent with the ground truth. (4) The contextual relevance is high, as the answer addresses both parts of the question—balance evolution and strategic implication—and uses appropriate financial reasoning. The qualitative analysis of Amazon’s debt strategy is reasonable and aligned with the trend. However, the quantitative inaccuracies—especially the wrong year for the $16.0B balance—reduce the correctness score. Minor formatting differences (e.g., $16,000 million vs $16.0 billion) are acceptable, but incorrect temporal alignment and inclusion of unsupported details (initial issuance size) are significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 566,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing's emphasis on 'Upgrades and Conversions' within its Global Services (BGS) segment has remained a consistent component of its service offerings from 2022 through 2024, as highlighted in each year's 10-K filings. In 2022, the segment was described as providing a full spectrum of services, including upgrades and conversions, to sustain aerospace platforms for both commercial and defense customers. In 2023 and 2024, the same language was reiterated, indicating continuity in the inclusion of upgrades and conversions as a core service. The knowledge graph further reinforces this by showing a direct relationship between Boeing (BA) and the Upgrades and Conversions product, which is also provided by an associated entity. This three-year trajectory suggests that Boeing is strategically focusing on sustaining and modernizing existing aerospace platforms, which supports long-term customer relationships and lifecycle management—key to maintaining competitive advantage and revenue stability in a capital-intensive industry.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that Boeing maintained 'Upgrades and Conversions' as a core offering within its Global Services segment across 2022, 2023, and 2024, with no changes in emphasis—matching the ground truth's assertion of consistency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and references the knowledge graph's entity relationships (Boeing/BA and the product), demonstrating correct inference about strategic continuity. (4) The LLM adds slight elaboration—such as 'revenue stability' and 'competitive advantage'—but these are reasonable strategic interpretations consistent with the original conclusion about lifecycle management and long-term focus. All parts of the question are addressed: evolution over time (consistency), and strategic implications (sustaining platforms, customer relationships). Wording differs but meaning is preserved. No factual errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 348,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson's pension strategy evolved from 2022 through 2024 by maintaining a consistent commitment to transitioning all eligible U.S. non-union employees to the Retirement Value formula by January 1, 2026, as announced in January 2021. This transition applies regardless of hire date, though employees hired before January 1, 2015, continue to accrue benefits under the Final Average Pay formula for service prior to 2026. The 2026 implementation date was consistently communicated across the 2022, 2023, and 2024 10-K filings, reflecting no changes to the timeline or eligibility criteria during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date for the Retirement Value formula, its applicability to all U.S. non-union employees regardless of hire date, and the clarification that pre-2015 hires continue under the Final Average Pay formula for service before 2026. The January 2021 announcement and consistent communication in 2022–2024 are correctly noted. (2) Quantitative accuracy is perfect: dates (2015 hire cutoff, 2026 implementation) are correct and consistently applied; no numerical calculations are required, but temporal references are precise. (3) Multi-hop reasoning is sound—the model synthesizes information across years and employee cohorts correctly, showing continuity in strategy and communication. (4) The only minor shortcoming is that the LLM does not explicitly mention that employees hired after 2014 were already under the Retirement Value formula, a detail clarified in the 2023 filing. While implied in the statement about pre-2015 hires staying under Final Average Pay, the explicit evolution of communication (from general reference in 2022 to clarification in 2023) is slightly underdeveloped. However, the core facts and synthesis remain intact, warranting a high score. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 380,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO's outstanding principal balance for its 5.000% notes due April 2030 remained stable at $606 million from fiscal year 2022 through 2024, as shown in the data from all three 10-K filings. In 2022, the balance was $1,086 million, but it decreased to $606 million by 2023 and remained unchanged in 2024. This consistent balance suggests that AVGO has either fully repaid a portion of the debt or restructured it during fiscal 2022, and has since maintained a steady debt level for this instrument. The lack of change in the principal balance indicates a disciplined debt management strategy, where AVGO has likely prioritized long-term stability and predictable interest obligations for this specific note.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal balance of $606 million in fiscal years 2023 and 2024, and notes the decrease from $1,086 million in 2022, which matches the ground truth. However, it inaccurately states that the balance 'remained stable at $606 million from fiscal year 2022 through 2024', which contradicts the fact that the balance was $1,086 million in 2022 and only dropped to $606 million in 2023. This misrepresents the timeline and creates a false impression of stability starting in 2022. (2) Quantitatively, the numbers themselves are correct: $1,086 million in 2022, $606 million in 2023 and 2024. The calculation of a $480 million reduction is implied and accurate. The error lies in the incorrect assignment of the $606 million balance to 2022. (3) The multi-hop reasoning is partially sound — the model correctly infers a reduction in debt and interprets the unchanged 2023–2024 balance as indicative of a stable strategy. However, the flawed temporal framing undermines the reasoning, as it fails to acknowledge the significant repayment event between 2022 and 2023 as a deliberate action rather than a pre-existing stability. (4) The contextual relevance is high — the answer addresses both the evolution of the balance and the implications for debt management. The qualitative accuracy is reduced due to the misstatement about when the balance changed, leading to an incomplete or slightly misleading interpretation of the strategy. Despite this, the core insight about targeted repayment and disciplined management is present, just poorly timed in the explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 442,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T's strategic relationship with Time Warner Inc. evolved significantly from 2022 through 2024. In 2018, AT&T acquired Time Warner, integrating it into its WarnerMedia segment, which included Turner, HBO, and Warner Bros. By 2022, AT&T had initiated a broader restructuring, culminating in the separation of WarnerMedia through a Reverse Morris Trust transaction in April 2022, merging it with Discovery, Inc. This marked the beginning of the divestiture process. Through 2023 and 2024, the WarnerMedia segment was reclassified as discontinued operations, reflecting AT&T's strategic shift away from media and entertainment. The operational restructuring and eventual divestiture were part of AT&T's broader strategy to streamline its business and focus on core telecommunications operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in 2018, forming WarnerMedia; the Reverse Morris Trust transaction with Discovery was completed in April 2022; and this marked AT&T's exit from the entertainment content space. The LLM correctly identifies the strategic shift toward core telecommunications. (2) Quantitative accuracy is perfect: the April 2022 transaction date is correct, and no numerical errors are present. Format and timeline precision meet expectations. (3) Multi-hop reasoning is sound—LLM synthesizes the acquisition, integration into WarnerMedia, and subsequent divestiture via Reverse Morris Trust, correctly framing it as part of a broader strategic pivot. One minor omission: the original answer notes that AT&T finalized divestiture of its remaining interest in DIRECTV in 2024, the last asset tied to the Time Warner-era entertainment strategy. This detail is missing in the LLM response, slightly reducing completeness. (4) Despite this, the LLM captures the core evolution—integration, restructuring, and divestiture—and maintains strong contextual relevance, focusing on the key transformation of the strategic relationship. Wording differs but semantic meaning is equivalent. Thus, a high score is warranted, with only a slight deduction for missing the DIRECTV 2024 detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 384,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024, AIG's international terrorism exposure management evolved with a continued focus on scenario-based modeling, reinsurance protections, and geographic attachment points. In 2022, AIG modeled terrorism scenarios including conventional bombs, anthrax, and nuclear attacks, with a specific example of a $1.3 billion modeled loss for a five-ton bomb in New York City, net of TRIPRA and reinsurance. By 2024, AIG retained core attachment points of $200 million for Japan and $125 million for the rest of the world, while also purchasing property per risk covers to protect against large losses from both non-critical and critical catastrophe events globally. AIG continued to rely on government-sponsored terrorism reinsurance programs in non-U.S. jurisdictions and made targeted reinsurance purchases to cover potential losses from terrorist attacks, reflecting a strategic and evolving approach to managing terrorism risk across geographies and business lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.3 billion modeled loss for a five-ton bomb in New York City in 2022 (net of TRIPRA and reinsurance), the $200 million attachment point for Japan, and $125 million for the rest of the world in 2024 are accurately reported. These numbers match the original answer exactly, and formatting is consistent. (2) The LLM adds slightly more detail than the ground truth—mentioning anthrax and nuclear attack scenarios and property per risk covers—which is not contradicted by the original and reflects plausible elaboration based on typical terrorism modeling practices. However, the original answer does not specify these additional scenarios, so this represents a minor expansion rather than an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022–2024), connects modeling practices to reinsurance strategies, and accurately describes geographic segmentation of attachment points. It captures the strategic evolution from scenario modeling to structured geographic risk management. (4) The answer is fully contextually relevant, addressing all three components of the question: modeled loss scenarios, reinsurance protections, and geographic attachment points. The only reason for not scoring a perfect 10 is that the 2023 developments are slightly less emphasized in the LLM answer (e.g., participation in international terrorism pools is mentioned in the original but only implied in the LLM), though not omitted entirely. Overall, the answer is factually correct, well-reasoned, and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 451,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "From 2022 to 2024, Emerson's (EMR) product portfolio for pipe-working tools, particularly pipe wrenches, evolved by maintaining a strong focus on professional tools while enhancing the breadth and technological integration of its offerings. In 2022, EMR's Tools & Home Products segment highlighted pipe-working tools used by plumbing and mechanical professionals, including pipe wrenches, cutters, and diagnostic systems. By 2023 and 2024, the Safety & Productivity segment continued to emphasize pipe wrenches and cutters, but also expanded to include battery hydraulic tools for press connections and advanced diagnostic systems like sewer inspection cameras, indicating a shift toward more technologically advanced and battery-powered solutions. This multi-year progression reflects Emerson's strategic positioning to strengthen its leadership in the professional tools market by integrating innovation, sustainability, and productivity-enhancing features into its product lines, aligning with the evolving needs of infrastructure and industrial professionals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Emerson maintained traditional pipe-working tools like pipe wrenches and expanded into battery hydraulic tools and diagnostic systems (e.g., sewer inspection cameras) by 2023–2024. The timeline (2022–2024) and product evolution are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression across years and infers strategic intent—modernization, technological integration, and alignment with professional market demands. One minor discrepancy: the LLM attributes diagnostic systems to 2022, while the original answer introduces them in 2023; this slight over-attribution does not distort the overall trend but slightly affects precision. (4) The answer is contextually excellent—fully addresses both the portfolio evolution and strategic implications. Wording differs (e.g., 'Safety & Productivity segment' vs original's unnamed segment), but this reflects plausible inference from context. Overall, the LLM captures the core factual and strategic narrative accurately, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 394,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco's accounting treatment for free-rent periods in lease agreements remained consistent from 2022 through 2024, with the Company recognizing free-rent periods on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised at the time the Company obtains control of the property. This methodology directly impacts the valuation of the right-of-use (ROU) asset, as the straight-line recognition of rent expense results in a more evenly distributed expense over the lease term, thereby affecting the amortization of the ROU asset. Additionally, the ROU asset is initially measured at the present value of future lease payments, discounted using the Company's incremental borrowing rate, a practice that has remained unchanged and continues to influence the valuation of the ROU asset.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment and disclosure practices related to Costco's free-rent periods and right-of-use (ROU) asset valuation from 2022 to 2024. It accurately states that Costco applied a straight-line recognition methodology over the lease term (including reasonably certain extension options), which is consistent across all three years—this aligns with the ground truth. It also correctly identifies that ROU assets are measured at the present value of lease payments using the incremental borrowing rate, a practice unchanged through the period. These are key quantitative and qualitative facts, and no numbers or dates are incorrect (quantitative accuracy is perfect). However, the LLM answer omits a critical qualitative nuance present in the original answer: the evolution in disclosure depth. Specifically, while the accounting policy remained stable, Costco provided more detailed explanations about discounting and asset retirement obligations (ARO) in 2022 that were not repeated in 2023 and 2024, indicating a shift toward more standardized ASC 842 language. This reduction in disclosure specificity over time is a central part of how the 'accounting treatment and disclosure' evolved, and its absence constitutes a meaningful gap in completeness. The reasoning is otherwise sound and contextually relevant, with accurate entity and metric identification (Costco, ROU asset, incremental borrowing rate, lease term). Thus, while factually correct, the answer falls short on fully addressing the 'evolution' aspect of the question, particularly regarding disclosure trends, warranting a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 453,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft issued 2.000% Notes due 2023 as part of its Eleventh Supplemental Indenture dated August 8, 2016, under the broader Indenture dated May 18, 2009, with U.S. Bank, National Association as Trustee. These notes matured in 2023, as reflected in the 2022, 2023, and 2024 10-K filings, which consistently list the Eleventh Supplemental Indenture as the governing document for these notes. The maturity timeline remained unchanged across the three years, with the notes maturing in 2023, and the associated indenture documentation was consistently referenced in the filings, showing no material changes to the terms during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes were issued under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity in 2023, and consistently referenced in 2022, 2023, and 2024 filings. The trustee and master indenture date (May 18, 2009) are correctly included, though not in the original answer—this additional detail does not contradict but enriches the response. (2) Quantitative accuracy is perfect: percentages (2.000%), dates (2022–2024), and maturity year (2023) are all correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes that the same note and indenture appear across three years, indicating no structural changes. (4) The only minor gap is that the original answer notes the 2024 filing still lists the notes as part of historical indentures post-maturity, which the LLM answer implies but does not explicitly state. However, the core conclusion—that terms and documentation remained unchanged—is correctly drawn. The answer is semantically equivalent and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 314,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon's revenue recognition for third-party seller services from 2022 through 2024 remained consistent in timing and composition, with revenue from commissions and fulfillment fees recognized when the services were rendered—typically upon delivery of products to a third-party carrier or directly to the customer. Across all three years, Amazon disclosed that it is not the seller of record in these transactions and earns revenue through fixed fees, a percentage of sales, and per-unit activity fees. The 2022 and 2024 filings showed no material changes in the structure of these services, while the 2023 filing explicitly outlined the revenue recognition methodology, confirming that commissions and fulfillment fees are recognized at the point of service delivery, aligning with the timing of customer receipt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the timing of revenue recognition (when services are rendered, typically upon delivery), the composition of revenue (fixed fees, percentage of sales, per-unit fees), and the role of Amazon as not the seller of record are all consistent with the original answer. The 2023 clarification on revenue recognition methodology is correctly highlighted. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and their associated disclosures are accurately referenced. (3) The multi-hop reasoning across years is sound: the LLM correctly synthesizes that while the core policy remained consistent, 2023 provided more explicit detail on timing, and 2024 did not introduce changes. (4) The only minor shortcoming is that the LLM does not explicitly note the absence of specific revenue recognition changes in 2024 as a continuation point, though it implies it by stating 'no material changes.' The original answer emphasizes the increasing clarity in disclosures over time, a nuance slightly underemphasized in the LLM response. However, the semantic meaning and factual content are substantially equivalent. Wording differences do not affect correctness. All entities (Amazon, third-party seller services, commissions, fulfillment fees) and years are accurately used.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 388,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024, as disclosed in its 10-K filings, suggests a long-term liability management strategy that retains responsibility for obligations of legacy telecom entities, even as these subsidiaries are consolidated or restructured. The consistent inclusion of these guarantees across multiple years indicates AT&T's ongoing commitment to ensuring the financial stability of its legacy operations, potentially to preserve credit ratings and maintain investor confidence. This approach reflects a cautious, risk-mitigating strategy where AT&T maintains control over the financial obligations of its historical subsidiaries, reinforcing its role as a central guarantor within its corporate structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—AT&T, Southwestern Bell Telephone Co., and the years 2022, 2023, and 2024—are correctly identified, and there are no numerical inaccuracies (the guarantee is non-quantified but confirmed across years, consistent with Exhibit 4-b in the 10-Ks). (2) Quantitative accuracy is perfect: the years are correct, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound—by noting the repeated disclosure across three 10-Ks, the LLM correctly infers a sustained liability strategy. The answer goes slightly beyond the ground truth by interpreting strategic motives (e.g., preserving credit ratings, investor confidence), which are plausible but not explicitly confirmed in the original answer. However, these inferences are reasonable and contextually appropriate, not speculative. (4) The core conclusion—that AT&T maintains a stable, long-term commitment to legacy obligations without restructuring—is fully supported and semantically equivalent to the original. The only minor difference is emphasis: the LLM adds interpretive depth, while the original sticks strictly to observed consistency. This does not detract from correctness. All aspects of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 362,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 decreased from $983 million in 2022 to $826 million in 2023 and further to $808 million in 2024. This decline indicates a gradual reduction in the company's exposure to this specific long-term debt instrument, suggesting a strategy to manage and potentially reduce long-term fixed-rate debt obligations. The consistent effective interest rate of 2.29% across the years highlights the stable cost of this debt, while the overall trend reflects a more cautious approach to long-term financing, possibly to optimize debt maturity profiles and interest cost management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts: $983 million in 2022, $826 million in 2023, and $808 million in 2024, matching the ground truth exactly. The effective interest rate of 2.29% is also accurately stated. No calculation errors are present. (2) Quantitative accuracy is perfect—values are reported correctly with consistent units and timeframes. Minor formatting differences (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (3) The reasoning is sound: the LLM correctly infers a gradual reduction in exposure and links it to a cautious long-term debt strategy, aligning with the ground truth's interpretation. It appropriately notes the stable cost of capital due to the fixed rate. The only minor shortcoming is that it does not explicitly mention the 'deliberate long-term capital structure strategy' phrasing from the original, though the concept is implied through discussion of optimization and cautious management. (4) The answer is fully contextually relevant, addressing both the evolution of the investment and its implications for long-term debt strategy. All multi-hop elements—tracking the same debt instrument across three years and interpreting strategic intent—are correctly synthesized. The answer is semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 376,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco's 1.375% Senior Notes due June 2027 remained unchanged at $1,250 million in face value from 2022 through 2024, as shown in all three chunks. Despite the maturity of other short-term notes, such as the 2.300% Senior Notes in 2022 and the 2.750% Senior Notes in 2024, the 2027 notes were retained, indicating a deliberate effort to maintain a stable, long-term debt structure. This consistency in long-term debt, combined with a reduction in current portion liabilities (from $73 million in 2022 to $103 million in 2024), suggests Costco is managing its capital to balance maturity dates and reduce near-term refinancing risks, reflecting a conservative and strategic capital management approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million from 2022 to 2024, which matches the ground truth. However, it introduces information not present in the original answer—specifically the maturity of the 2.300% Senior Notes in 2022 and the 2.750% Senior Notes in 2024—which were not part of the provided ground truth and cannot be verified from the context. Additionally, the claim about the 'current portion liabilities' increasing from $73M to $103M is unsupported by the original answer, which focused on total long-term debt trends ($6,590M → $6,484M → $5,919M). These additions introduce factual inaccuracies or unverifiable details. (2) The core quantitative data about the $1,250M note is accurate, but the LLM fails to report the total long-term debt figures for 2022–2024, which are central to the ground truth and required for full completeness. The calculation of overall debt reduction (from $6,590M to $5,919M) is omitted, weakening the quantitative analysis. (3) The reasoning about a 'conservative and strategic capital management approach' is plausible and aligns thematically with the ground truth’s conclusion, but the LLM bases its logic on unverified debt maturities rather than the actual trend of overall debt reduction while maintaining this specific note. Thus, the multi-hop synthesis is partially flawed. (4) Despite these issues, the answer remains contextually relevant, addressing the evolution of the 2027 notes and inferring capital strategy. It captures the essence of selective debt retention but lacks full factual grounding in the provided data, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 463,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard's multi-layered security approach evolved in parallel with its real-time payments infrastructure expansion from 2022 to 2024, reflecting a strategic emphasis on managing payment processing risk as the company scaled globally. In 2022, Mastercard operated real-time payments infrastructure in 12 of the top 50 GDP markets and emphasized a multi-layered security approach that included fraud scoring, tokenization, and collaboration with industry stakeholders to establish technical standards like EMV. By 2023, the company had expanded real-time payments infrastructure to 13 markets and enhanced its security programs by incorporating third-party assessments, enterprise resilience initiatives, and expanded monitoring through Security Operations Centers and Fusion Centers. In 2024, Mastercard further expanded its real-time infrastructure globally and began processing domestic transactions in China through a joint venture, while continuing to strengthen its security framework by addressing threats from third-party providers and maintaining robust insurance and testing protocols. This synchronized development suggests that Mastercard is proactively aligning its security infrastructure with its growing real-time payment capabilities to ensure resilience, compliance, and trust in its expanding global payments ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and additions not present in the ground truth. While it correctly states that Mastercard operated real-time payments in 12 top GDP markets as of 2021 (reported in 2022) and expanded to 13 markets by 2023, it incorrectly adds specific security components such as 'fraud scoring', 'tokenization', 'EMV standards', 'Security Operations Centers', 'Fusion Centers', and a joint venture to process domestic transactions in China — none of which are mentioned in the original answer or supported by the knowledge graph. These additions introduce plausible-sounding but unverified details that distort the factual record. (2) Quantitative accuracy is partially correct: the 12 and 13 market figures align with the ground truth (2022 and 2023), but the 2024 claim of 'further expanded... globally' lacks the specific qualitative phrasing from the original ('several countries around the world') and incorrectly implies continued numerical growth beyond 13, which is not confirmed. The China joint venture and domestic transaction processing are unsupported and likely incorrect. (3) Multi-hop reasoning is logically structured and addresses the parallel evolution of security and infrastructure, correctly identifying that both evolved together. However, the reasoning is based on fabricated or unsupported details, weakening the synthesis. The conclusion that security and infrastructure are aligned for resilience and trust mirrors the original's suggestion of maintaining trust and integrity, so the high-level inference is sound. (4) Contextual relevance is strong — the answer directly addresses both parts of the question (evolution and strategic implication) and maintains focus on Mastercard’s risk management strategy. Despite incorrect details, the narrative flow and intent align well with the question. Overall, the answer is partially correct with significant embellishments, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1663,
        "completion_tokens": 533,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft's 4.000% Notes due 2021 were issued under the Third Supplemental Indenture dated February 8, 2011, as disclosed in the 10-K filings for fiscal years 2022, 2023, and 2024. These filings consistently reference the same indenture and issuance details across all three years, indicating that the debt instrument remained unchanged and was not refinanced or restructured during this period. This pattern suggests a stable and disciplined long-term debt management strategy, where Microsoft maintained its existing debt obligations without incremental refinancing, reflecting confidence in its liquidity and financial planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings for fiscal years 2022, 2023, and 2024, and that the instrument was issued under the Third Supplemental Indenture. However, it omits the key detail from the ground truth that the original Indenture was dated May 18, 2009, and instead focuses only on the February 8, 2011 date of the supplemental agreement—this is not incorrect per se but lacks completeness. More importantly, the LLM fails to note that by 2024, the note was past its maturity date (2021), yet still disclosed, which raises questions about settlement or rollover—a critical point in the original answer. The LLM interprets the lack of change as 'no refinancing,' but does not address the anomaly of post-maturity disclosure, which weakens the reasoning. (2) Quantitatively, the percentage (4.000%), the years (2022–2024), and the exhibit reference (implied via context) are accurate. The date February 8, 2011, for the Third Supplemental Indenture is factually correct and aligns with known filings, so no numeric inaccuracies exist. (3) The multi-hop reasoning is partially sound: the model correctly infers stability in debt structure from consistent disclosure. However, it misses the deeper implication in the ground truth—that disclosing a matured note suggests either delayed settlement, rollover, or regulatory disclosure requirements—indicating a gap in synthesis across time and financial logic. (4) The answer is contextually relevant and well-structured, but the omission of the post-maturity anomaly reduces completeness and qualitative accuracy. The conclusion about disciplined debt management is reasonable but less nuanced than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 478,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 10-K filings indicates a deliberate strategy to maintain long-term, low-cost debt as part of its capital structure. This note, issued in 2020 and referenced in subsequent filings, has a lower coupon rate compared to other notes issued in the same period, such as the 4.700% Note due 2024 or the 4.650% Note due 2029, suggesting that Amazon is locking in favorable interest rates for extended maturities to manage refinancing risk and stabilize interest expenses. By retaining this low-yield instrument alongside higher-yield, shorter-term debt, Amazon appears to be balancing its debt portfolio to ensure liquidity while minimizing long-term financing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic implication of Amazon's consistent reference to the 1.500% Note due 2030: a focus on long-term, low-cost debt to manage refinancing risk and stabilize interest expenses. The comparison to higher-yielding instruments like the 4.700% Note due 2024 and the 4.650% Note due 2029 is accurate and supports the layered debt strategy. However, there is a minor factual inaccuracy: the LLM states the note was 'issued in 2020,' but the original answer and supporting filings indicate it was first referenced in the 2022 filing as part of a broader issuance—no mention of a 2020 issuance in the ground truth. This affects quantitative accuracy slightly. The answer omits specific mention of newer instruments like the 4.700% Note due 2032 (from 2024 filing), which weakens the multi-hop synthesis across all three years. While the reasoning about balancing low-cost legacy debt with newer, higher-cost debt is sound and semantically aligned with the ground truth, the absence of the 2032 note and the incorrect issuance year prevent a top score. All other entities (percentages, maturities, strategic rationale) are correctly identified and logically connected. The response is highly relevant and well-structured, addressing the long-term capital structure strategy effectively despite minor gaps in completeness and one date error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 383,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2024, AT&T's strategic positioning in SKY Mexico evolved as follows: as of December 31, 2022, AT&T held a 41.3% interest in SKY Mexico and accounted for it under the equity method, as noted in its 2022 10-K. In 2023, this stake remained part of AT&T’s equity method investments, which included SKY Mexico, DIRECTV, and Gigapower, as detailed in the 2023 10-K. Finally, in June 2024, AT&T sold its 41.3% interest in SKY Mexico, marking a complete exit from the business. This three-year trajectory—from equity method accounting to eventual divestiture—aligns with AT&T’s broader strategy of exiting international pay-TV markets, as seen in prior dispositions like Vrio, CME, and Otter Media, and reflects a focus on reducing exposure to non-core international media and entertainment assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico as of 2022, accounted for it under the equity method in both 2022 and 2023, and exited completely in June 2024. These details match the original answer precisely. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is correctly reported, and the June 2024 exit timing is consistent with the 'mid-2024' timeframe in the ground truth. No calculations are required, but the repetition of the exact percentage across years is accurate. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and multiple filings (2022 and 2023 10-Ks), correctly tracking the evolution of ownership and accounting treatment before the final divestiture. It also connects the SKY Mexico exit to broader divestitures like Vrio, CME, and Otter Media, which strengthens the analysis of AT&T’s strategic intent. (4) The answer is semantically equivalent to the original, with slightly enhanced context (naming specific prior divestitures) that improves clarity without introducing error. All parts of the question—ownership stake, equity method treatment, exit timing, and strategic implications—are thoroughly addressed. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 364,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG's glide path approach for its U.S. pension plan evolved from 2022 through 2024 as part of a de-risking strategy tied to the plan's improving funded status. In 2022, the target allocation was based on a funded status as of December 31, 2021, with a focus on balancing growth and liability-hedging assets. By 2023, the glide path continued to adjust the allocation in response to updated funded ratios and interest rates, as described in the 2023 10-K. In 2024, the glide path further shifted the target allocation toward liability-hedging assets and away from growth assets, reflecting a more conservative stance as the funded ratio increased. This progression reveals AIG's systematic de-risking strategy, where higher funded status triggers a reduction in riskier growth assets and an increase in safer, liability-hedging investments, consistent with the principles of liability-driven investing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AIG's glide path approach evolved from 2022 to 2024 as a de-risking strategy tied to improving funded status, with target allocations shifting toward liability-hedging assets. The answer correctly notes that the 2022 target allocation was based on the December 31, 2021 funded status, and implies a forward-looking glide path consistent with the original answer. (2) There are no numeric inaccuracies—while specific percentages or asset allocation figures are not provided in either answer, the LLM does not fabricate any numbers and accurately describes the directional changes (reducing growth assets, increasing liability-hedging assets). The mention of interest rates in the 2023 10-K is contextually appropriate and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes the concept of a dynamic glide path, links it to funded status improvements over time, and correctly infers that each year’s target allocation is based on the prior year-end funded status (e.g., 2023 adjustments based on 2022 status, etc.), even though the exact phrasing in the original answer references the 2024 target being based on Dec 31, 2023. The LLM slightly generalizes this mechanism but captures the logic accurately. (4) The answer is semantically equivalent to the original—wording differs but meaning is preserved, particularly in conveying a systematic, liability-driven investing approach. The only minor shortcoming is that the LLM does not explicitly state that the 2024 target allocation for 2025 is based on December 31, 2024 funded status (a forward-looking point), but this is implied in the progression. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 502,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024, Mastercard enhanced its credit risk mitigation strategies in response to increasing regulatory scrutiny and litigation risks. In 2022, the company already had established risk management policies requiring non-compliant customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. By 2023, facing investigations from the FTC and DOJ regarding antitrust and debit routing compliance, Mastercard entered into a consent agreement with the FTC and continued cooperating with the DOJ, indicating a proactive approach to regulatory challenges. In 2024, as litigation and regulatory pressures expanded with investigations from the European Commission and ongoing U.S. liability shift and TCPA class actions, Mastercard maintained and refined its risk management practices, including regular reviews of its methodology and monitoring of its credit risk portfolio. These evolving strategies demonstrate Mastercard’s adaptability in aligning its risk management framework with external pressures while maintaining a low historical loss profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Mastercard maintained its core credit risk mitigation strategies (cash collateral, letters of credit, guarantees) from 2022 to 2024; regulatory pressures increased with FTC and DOJ investigations starting in 2023, and expanded in 2024 with European Commission scrutiny and U.S. litigation (Liability Shift and TCPA class actions); the company consistently reported low losses from settlement failures. (2) There are no numeric inaccuracies—while no specific dollar amounts are cited, the qualitative assertion of a 'low historical loss profile' matches the ground truth's 'low level of losses from customer settlement failures.' Dates and years (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years, regulatory bodies (FTC, DOJ, EC), and litigation types, correctly linking them to Mastercard’s evolving risk management posture. It accurately infers that ongoing refinement of risk practices reflects adaptability. (4) The only minor shortcoming is that the LLM slightly overstates 'enhanced' strategies, whereas the ground truth emphasizes consistency in core strategies despite external pressures—this nuance is downplayed but not contradicted. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 393,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan (formerly the 2005 Plan and later renamed in 2022) decreased from approximately 117 million shares in 2022 to 77 million shares in 2023 and further to 70 million shares in 2024. This decline suggests that the company has been actively issuing stock-based compensation awards over this period, which aligns with its ongoing strategy to incentivize associates and non-employee directors through equity. The continued reduction in available shares also indicates that the company may need to seek further shareholder approval to increase the share pool if it intends to maintain or expand its stock-based compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the availability of shares as 117 million in 2022, 77 million in 2023, and 70 million in 2024, matching the ground truth exactly. The dates associated with the disclosures (e.g., January 28, 2024, and February 2, 2025) are not explicitly mentioned in the LLM answer, but the years 2022–2024 are used appropriately as reference points for the reported figures, which is acceptable given the question’s framing. (2) All numeric values are accurate and consistent with the original answer. The decrease from 117M to 77M to 70M is correctly represented, and no calculation errors are present. Format variations (e.g., 'approximately 117 million') are reasonable and do not affect factual accuracy. (3) The multi-hop reasoning is sound: the LLM correctly identifies the plan name change, tracks share availability across three years, and infers the strategic implication—active use of equity compensation for incentives. It adds a reasonable forward-looking observation about potential need for shareholder approval, which is logically supported by the trend and common corporate practice, though not explicitly stated in the ground truth. This does not detract from accuracy but enhances contextual insight. (4) The answer fully addresses both parts of the question: the evolution of share availability and the strategic implication. The qualitative reasoning is strong, with only a minor omission of the exact reporting dates (which are secondary to the fiscal years in context). Thus, the answer is factually complete, semantically equivalent, and contextually appropriate, warranting a high correctness score with near-perfect accuracy across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 465,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 show a clear progression across fiscal years 2022, 2023, and 2024. In fiscal 2022, the notes were reported at $622 million (Chunk 3). By fiscal 2023, the balance remained at $622 million (Chunk 1), but by fiscal 2024, the amount had been fully repaid, as the balance was reported as $0 (Chunk 2). This repayment in fiscal 2024 indicates that Broadcom successfully managed and fulfilled its debt obligations for this instrument ahead of its October 2024 maturity, reflecting a proactive debt management strategy aimed at reducing short-term liabilities and maintaining financial flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the $622 million obligation in fiscal years 2022 and 2023, and the drop to $0 in fiscal 2024. These values match the original answer exactly, with no discrepancies in numbers or dates. (2) Quantitative accuracy is perfect: the dollar amounts ($622 million and $0), the interest rate (3.625%), and the maturity date (October 2024) are all accurately reported. The progression across fiscal years is correctly described, and the conclusion that the debt was fully repaid by fiscal 2024 aligns with the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years, and the conclusion about Broadcom's proactive debt management strategy is logically derived from the data. The LLM correctly infers that repayment ahead of the October 2024 due date reflects strategic liability reduction, which is consistent with the original answer's interpretation. (4) All entities—Broadcom (AVGO), the specific debt instrument, and the fiscal years—are accurately referenced. The answer is fully complete, addressing both the evolution of the obligation and its implications for debt strategy. Semantic equivalence is maintained, with slightly different but equally valid phrasing (e.g., 'proactive debt management strategy' vs. 'deliberate debt management strategy'). All scoring categories warrant the highest rating due to full factual alignment, correct reasoning, and comprehensive coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 417,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "T's strategic relationship with Time Warner Inc. evolved significantly from 2022 through 2024, reflecting a shift in focus from entertainment to core telecommunications. In 2018, T acquired Time Warner Inc., integrating it into its WarnerMedia segment. By 2022, T had completed the separation of WarnerMedia through a Reverse Morris Trust transaction with Discovery, Inc., marking the beginning of its divestiture from the entertainment sector. In 2024, T further solidified its exit strategy by agreeing to sell its remaining interest in DIRECTV, a business formed from its former video operations. This progression reveals T's strategic pivot to streamline operations and concentrate on its core telecommunications and wireless services, divesting non-core entertainment assets to enhance financial focus and operational efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative but contains a key factual error in the timeline: it states that T completed the separation of WarnerMedia in 2022, while the ground truth specifies that this occurred in 2023. This misplacement of a critical event undermines the chronological accuracy of the answer. All other entities—Time Warner Inc., WarnerMedia, Discovery, DIRECTV, TPG, and the Reverse Morris Trust structure—are correctly identified. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy hinges on dates. The incorrect assignment of the WarnerMedia separation to 2022 instead of 2023 is a significant error, though the 2024 DIRECTV sale is correctly dated. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes the acquisition (2018), divestiture (WarnerMedia split), and final exit (DIRECTV sale) to infer a strategic shift toward core telecom. It accurately links these events to a broader strategic pivot, demonstrating good qualitative understanding. (4) Despite the date error, the answer addresses all parts of the question—integration, divestiture planning, exit strategy, and strategic implications—with strong contextual relevance and logical flow. The core message about T’s retreat from entertainment to focus on telecommunications aligns with the ground truth. The correctness score is 7 due to the incorrect year for a major event, which is a notable but not fundamental error given that the overall trajectory and intent are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Acquires]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 436,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "From 2022 to 2024, Emerson's (EMR) Pipe Cutters product line, under the Safety & Productivity segment, evolved to integrate more closely with battery-powered technologies and diagnostic systems. In 2022, Pipe Cutters were part of the Tools & Home Products segment, used by professionals for piping system installation and repair, with no explicit mention of battery-powered or diagnostic integration. By 2023 and 2024, the Safety & Productivity segment explicitly included battery hydraulic tools for press connections and diagnostic systems like sewer inspection cameras and locating equipment, indicating a strategic shift toward enhanced portability and advanced functionality. This evolution reflects EMR's focus on improving safety, productivity, and infrastructure support through technological integration across its professional tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Emerson's Pipe Cutters product line from 2022 to 2024 with respect to integration into battery-powered technologies and diagnostic systems. It accurately notes that in 2022, Pipe Cutters were standalone tools without explicit integration, aligning with the ground truth. The shift in 2023 toward battery hydraulic tools for press connections is correctly identified, as is the 2024 positioning within a broader ecosystem including diagnostic systems like sewer inspection cameras. However, there is a minor inaccuracy: the LLM states that in 2022, Pipe Cutters were part of the 'Tools & Home Products' segment, whereas the ground truth indicates they were already under the Safety & Productivity segment. This misassignment of segment affiliation is a factual error affecting entity accuracy. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable—no errors in dates or time periods (2022–2024), which are correctly used. (3) The multi-hop reasoning is largely sound: the model synthesizes information across years and identifies the strategic shift toward integration with battery-powered and diagnostic technologies. It correctly infers a trend toward enhanced portability and smart tooling, which is consistent with the ground truth. The only flaw is the incorrect segment attribution in 2022, which slightly undermines the reasoning chain. (4) Despite the segment misclassification, the core factual trajectory—increasing integration with battery power and diagnostics—is accurately conveyed, and all key developments per year are reflected. Wording differs but semantic meaning is equivalent. Hence, correctness and qualitative accuracy are high but not perfect. Contextual relevance is excellent as the response directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 517,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson has consistently advanced its multi-year, enterprise-wide initiative to enhance financial shared service capabilities from 2022 through 2024, as disclosed in its annual reports. In 2022, the initiative aimed to integrate, simplify, and standardize processes across HR, IT, procurement, supply chain, and finance functions to support the growth of financial shared services and standardize financial systems. This focus continued in 2023 and 2024, with the company reiterating its commitment to streamline and align the design and operation of its financial control environment, emphasizing integration and standardization without being driven by internal control deficiencies. This consistent emphasis underscores Johnson & Johnson’s strategic focus on achieving long-term operational efficiency, financial process standardization, and robust internal controls across its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across finance and other functions to enhance financial shared services. The initiative was consistently described as proactive, not driven by internal control deficiencies, which matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of the initiative across three years, noting continuity in strategic emphasis and operational goals. The only minor difference is that the LLM mentions HR, IT, procurement, and supply chain more explicitly than the original, which focuses on finance but acknowledges 'key functions'—this addition is contextually appropriate and supported by typical shared service initiatives, so it does not constitute an error. (4) The semantic meaning and strategic interpretation—that J&J is committed to long-term operational efficiency, process standardization, and control environment robustness—are fully aligned. The answer is contextually excellent, directly addressing both parts of the question: evolution over time and strategic implications. The slight expansion on functional areas does not detract from accuracy and may enhance completeness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 451,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco's disclosures regarding the Executive Health Plan remained consistent from fiscal years 2022 through 2024, as evidenced by the identical inclusion of the \"Costco Wholesale Executive Health Plan\" as Exhibit 10.1* in each year's 10-K filings. This consistency suggests that the plan has been maintained without material changes, indicating a stable and long-term approach to executive benefits. The plan's continued presence in filings underscores Costco's commitment to providing structured health benefits to its executives, reinforcing a predictable and enduring component of its executive compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the consistent disclosure of the Executive Health Plan (Exhibit 10.1*) across fiscal years 2022–2024, and correctly infers that this indicates a stable long-term executive benefit strategy. The quantitative details—while not explicitly restating the 'Period Ended' (September 2, 2012) and 'Filing Date' (October 19, 2012)—are implicitly acknowledged through the emphasis on 'identical inclusion' and 'no material changes,' which reflects the core truth that no amendments were filed. The absence of explicit mention of the 2012 dates slightly reduces completeness in qualitative accuracy, but the reasoning and conclusion remain sound. The answer synthesizes the multi-hop requirement (tracking disclosures over time and inferring strategic intent) and is contextually fully relevant. Wording differs from the original but maintains semantic equivalence. No calculation errors; all entities (Costco, Executive Health Plan, 10-K, fiscal years) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 300,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 through 2024, MA’s A Class Shares consistently retained one vote per share and dividend rights, as disclosed in each year’s 10-K filings. This consistency across all three years demonstrates a stable shareholder governance strategy, emphasizing equal voting power for A Class shareholders while maintaining the potential for dividend distributions. The alignment of these rights over time suggests a deliberate effort to preserve equitable governance and shareholder value, reinforcing trust and predictability for investors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that MA's A Class Shares had consistent rights from 2022 to 2024: one vote per share and standard dividend rights, matching the original answer. (2) There are no numerical values requiring calculation, but the time period (2022–2024) and the qualitative metrics (voting and dividend rights) are correctly cited across all years. (3) The multi-hop reasoning is sound—by synthesizing data across three years of 10-K filings, the model correctly infers a stable governance strategy, which aligns with the original conclusion. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in rights and the implication for shareholder governance. The reasoning extends the facts appropriately, noting 'deliberate effort to preserve equitable governance,' which is a reasonable interpretation of the consistency. All entities—MA, A Class Shares, 2022–2024 timeframe—are accurate. No factual, quantitative, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 302,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom's Security Insights Platform evolved significantly from fiscal years 2022 to 2024 in terms of integration with in-house security tools and risk identification capabilities. In 2022, the platform focused on interpreting mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By 2023, the platform expanded its capabilities to include ongoing and ad hoc risk assessments and developing remediation steps, emphasizing a more proactive approach to security. In 2024, the platform continued to build on these strengths, maintaining its role in identifying risks and supporting in-house tools while enhancing its integration and automation features, as reflected in the consistent descriptions across the 10-K filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and interpretation compared to the ground truth. (1) Correct elements: The description for fiscal year 2022 matches the original answer—highlighting mainframe security posture assessment, risk identification, and data availability for in-house security tools. The mention of remediation planning in 2023 is also consistent, though the LLM overstates it as 'developing remediation steps' and a 'proactive approach,' which implies enhancement not explicitly stated in the source. (2) Quantitative accuracy: There are no numerical values in this question, so this criterion is satisfied by default (score 10). (3) Multi-hop reasoning assessment: The key error lies in the characterization of evolution and enhancement. The ground truth states that the platform's description remained stable from 2023 to 2024, indicating no significant evolution, whereas the LLM claims 'expanded capabilities' in 2023 and 'enhancing integration and automation features' in 2024—assertions not supported by the original text. The original answer emphasizes consistency and maturity, not progression or feature enhancement. (4) This leads to a qualitative accuracy score of 5 due to incorrect inference of platform evolution and added details not present in the filings. Contextual relevance is high (8) because the answer addresses the right company, platform, time frame, and general functionality, but the incorrect implication of technological advancement reduces factual reliability. Overall, the answer misrepresents the stability of the platform as active evolution, warranting a correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 455,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 through 2024, AIG’s management and quantification of loss reserves risk evolved with continued emphasis on internal controls, actuarial analysis, and the use of both deterministic and stochastic modeling techniques to assess reserve adequacy. In 2022, AIG highlighted the critical nature of loss reserves risk, noting the uncertainty in loss development and the role of external experts in validating reserve estimates. By 2023, AIG expanded on its risk management framework, incorporating second-line reviews and challenges by ERM, as well as internal actuarial profitability and reserve reviews. In 2024, AIG maintained these practices while emphasizing ongoing risk reporting, internal audit oversight, and the integration of external expert reviews to ensure the adequacy of loss reserves. Across all three years, external validation remained a key component, reinforcing the reliability of reserve estimates amid uncertainties in claims experience and policyholder behavior.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth in both factual content and reasoning. (1) All key facts are correct: AIG's use of internal controls, actuarial analysis, deterministic and stochastic modeling, external expert reviews, and the evolution of oversight from 2022 to 2024 are accurately represented. The role of external experts is correctly emphasized across all years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes over time (2022 to 2024), identifying progression in methodology and oversight. One minor discrepancy: the LLM states that second-line ERM reviews were introduced in 2023, while the ground truth notes they were reinforced in 2024, suggesting they may have existed earlier. This is a subtle but acceptable interpretation, not a factual error. (4) The LLM answer is contextually excellent—directly addresses the question about evolution in methodologies and external validation. Wording differs slightly (e.g., 'ongoing risk reporting' and 'internal audit oversight' in 2024 vs. 'enhanced budget and expense assumption monitoring' in the original), but the core meaning about strengthened oversight is preserved. Overall, the answer reflects a mature, evolving framework with consistent external validation—matching the ground truth's conclusion. Hence, a correctness score of 9 is warranted, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 440,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson's (EMR) positioning of Electrical Distribution Equipment within its Industrial Solutions segments evolved from 2022 to 2024 by becoming more explicitly integrated into the Discrete Automation segment, as highlighted in the 2023 and 2024 filings. In 2022, Electrical Distribution Equipment was mentioned as part of the broader Industrial Solutions segment, which provided fluid control and electrical products for manufacturing operations. By 2023 and 2024, it was directly listed under the Discrete Automation segment, which focuses on automation solutions for discrete industries such as solenoid valves, pneumatic systems, and programmable automation control systems. This shift underscores Emerson’s strategic emphasis on strengthening its presence in discrete automation markets, aligning electrical distribution solutions with automation technologies to enhance process efficiency, reliability, and sustainability for discrete manufacturers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Electrical Distribution Equipment was part of the broader Industrial Solutions segment in 2022, then moved to Discrete Automation in 2023 and remained there in 2024. The strategic emphasis on discrete automation markets is correctly interpreted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution across three years and infers the strategic intent behind the reorganization. It captures the shift from general industrial products to integrated automation solutions, though it does not explicitly mention 'electric linear motion solutions' in 2024, which is a minor omission. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of positioning and the strategic implication. The only reason for not scoring a 10 is the slight lack of specificity in 2024 regarding grouping with 'electric linear motion solutions,' which weakens completeness by a small margin. Overall, the semantic meaning and strategic interpretation match the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 361,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson announced in January 2021 that, effective January 1, 2026, all eligible U.S. non-union employees, regardless of hire date, will transition to earning benefits under the Retirement Value formula, replacing the Final Average Pay formula for new accruals. This transition, consistent across the 2022, 2023, and 2024 10-K filings, reflects a multi-year, deliberate shift in the pension plan structure. The continuity of this announcement over three years suggests a strategic move toward a more uniform and potentially cost-manageable retirement benefit model, aligning with the company’s long-term workforce strategy to standardize benefits and reduce future liabilities tied to final salary-based accruals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the January 1, 2026 effective date, the transition to the Retirement Value formula for U.S. non-union employees regardless of hire date, and the consistency across 2022–2024 filings. The mention of the 2021 announcement is not contradicted by the ground truth, which does not specify when the policy was first announced, so this addition does not constitute an error. (2) The core financial and structural details—replacement of Final Average Pay with Retirement Value, preservation of pre-2026 accruals (implied by 'new accruals')—are factually sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes consistent disclosures over three years to infer a deliberate, ongoing strategy. It accurately concludes that the shift supports standardization, cost manageability, and reduced reliance on final-salary-based liabilities. (4) The only minor gap is that the LLM answer does not explicitly mention the preservation of accrued benefits under the old formula, which is a key detail in the ground truth. However, it does imply this by stating the change applies to 'new accruals,' which is semantically equivalent. The long-term workforce strategy interpretation—standardization, inclusivity, cost predictability—is well captured, though 'workforce inclusivity' is slightly underemphasized. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 433,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment remained consistent at 35% in 2022, increased to 36% in both 2023 and 2024, indicating a slight but steady rise in its relative importance within the segment over the three-year period. This trend suggests that Downy has maintained and potentially enhanced its strategic importance in P&G's portfolio, as it continues to be a key brand within the high-revenue Fabric & Home Care segment, which itself grew in both net sales and earnings contribution during this time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Downy's contribution was 35% in 2022 and increased to 36% in both 2023 and 2024, which matches the ground truth. The quantitative evolution is accurately represented. (2) All numbers and years are correct—35% in 2022, 36% in 2023 and 2024—with no calculation errors. The answer correctly reflects the stable but slightly rising trend within the segment. (3) The multi-hop reasoning is sound: the model correctly infers that Downy’s consistent presence in a growing segment (Fabric & Home Care) indicates sustained strategic importance. It adds a slight interpretive nuance—'potentially enhanced its strategic importance'—which is reasonable given the segment’s growth and Downy’s stable share, though the original answer emphasizes 'sustained' rather than 'enhanced.' This is a minor difference in emphasis, not a factual error. (4) The answer is fully contextually relevant, addressing both the percentage evolution and the strategic implication. The only reason for not scoring a 10 is the slight interpretive stretch on 'enhanced' strategic importance, whereas the ground truth emphasizes consistency. Overall, the answer is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 346,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One's (COF) total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and slightly decreased to $30,696 million in 2024. This trend suggests a general expansion in the company's use of long-term debt financing from 2022 to 2023, followed by a slight reduction in 2024, potentially reflecting a strategy to optimize debt levels and manage interest costs amid changing market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2024 carrying value. The ground truth states that the carrying value was $31,248 million in both 2023 and 2024, but the LLM incorrectly reports it as $30,696 million in 2024. This undermines the quantitative accuracy and leads to an incorrect interpretation of a 'slight decrease' in 2024. The 2022 and 2023 values are correct: $27,219 million and $31,248 million respectively. (2) The calculation of trend direction is flawed due to the incorrect 2024 figure. While the increase from 2022 to 2023 is accurately described, the supposed decrease in 2024 is not supported by the data. The ground truth shows the value remained flat at $31,248 million, not a drop to $30,696 million. This affects both quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare carrying values across years and infers strategic implications. However, the conclusion about debt optimization and interest cost management in 2024 is based on incorrect data and thus represents flawed reasoning. The actual trend—stable at a high level after an increase—suggests sustained reliance on debt financing, not a strategic pullback. (4) Contextual relevance is high because the answer addresses the evolution of notes and attempts to interpret strategy. Qualitative accuracy is moderate because the logic would be reasonable if the numbers were correct. Quantitative accuracy is low due to the critical error in the 2024 value. Correctness score is 5 due to partial factual correctness but major error in key data point that changes interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 456,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "From 2022 through 2024, T (AT&T) strategically reduced its stake in SKY Mexico, evolving from holding a 41.3% interest in 2022 to ultimately exiting its investment in June 2024. In 2022, T retained the 41.3% stake following the sale of its Latin America video operations, Vrio, and continued to account for SKY Mexico under the equity method, as noted in 2023 when SKY Mexico was listed among T’s equity method investments. By 2024, T sold its remaining interest in SKY Mexico, marking a full exit. This three-year trajectory reflects T’s broader divestiture strategy in the Latin American pay-TV market, characterized by a systematic reduction of non-core assets and a shift away from international media operations to focus on core telecommunications and infrastructure businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T held a 41.3% stake in SKY Mexico from 2022 through June 2024, accounted for it under the equity method (confirmed in 2023), and fully exited in 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly stated; no calculations were required. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across three years and linked the ownership stake, accounting treatment, and divestiture into a coherent narrative. It also accurately infers T’s broader strategy of exiting non-core international assets to focus on domestic telecom and infrastructure, which is consistent with the ground truth. (4) Minor deduction in qualitative accuracy because the LLM mentions the 2022 stake was retained 'following the sale of its Latin America video operations, Vrio,' a detail not present in the ground truth, though factually plausible. This addition does not contradict but introduces external context not confirmed in the source. Otherwise, the answer is complete, relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Involved_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 345,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "From 2022 to 2024, BNY Mellon consistently disclosed that its ability to return capital to shareholders is subject to the discretion of its Board of Directors and constrained by U.S. banking laws and regulations, particularly those governing capital adequacy and capital planning. In 2022, the Parent’s reliance on dividends from subsidiaries and regulatory compliance with \"well capitalized\" status were emphasized as key factors affecting capital returns. In 2023, the disclosures expanded to include the impact of credit ratings and the potential effects of resolution strategies under Title I and Title II, which could further constrain liquidity and capital availability. By 2024, the disclosures reiterated these constraints while also highlighting the importance of maintaining regulatory standards and the potential risks from strategic initiatives and external events, underscoring a continued emphasis on regulatory adherence and capital management as central to its dividend and share repurchase policies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon consistently emphasized constraints on capital returns due to U.S. banking laws, capital adequacy requirements, and reliance on subsidiary dividends. The evolution across years is accurately portrayed. (2) There are no numeric values in the question or answer requiring verification; thus, quantitative accuracy is not applicable but assumed perfect as no numbers were misstated. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures across 2022–2024, identifying consistent themes (regulatory constraints, capital adequacy) and evolving elements (strategic initiatives, resolution strategies, ESG context). The LLM mentions 'credit ratings' and 'Title I/II resolution strategies' in 2023, which are plausible expansions of regulatory risk (though not explicitly in the ground truth), and while the original answer highlights ESG and strategic initiatives, the LLM substitutes with related regulatory and liquidity risks—this is a minor deviation but still contextually valid. (4) The answer captures the core trend: stable regulatory framework with increasing complexity. The only reason for not scoring a 10 is that the LLM omits the specific 2022 mention of preferred dividend timing as a constraint and does not explicitly reference Delaware law, though it covers analogous structural limitations. Overall, the response is semantically equivalent, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 423,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "From 2022 through 2024, 3M’s Structural Adhesives remained a core offering within its Safety and Industrial segment, consistently listed alongside tapes and industrial specialty products. In 2022, the adhesives were grouped with closure systems for personal hygiene and packaging materials, suggesting early bundling with adjacent product lines. By 2023, the listing remained stable, but in 2024, the adhesives were positioned under \"industrial specialty products,\" indicating a strategic shift toward emphasizing their role in broader industrial applications rather than consumer-facing solutions. This evolution highlights 3M’s growing focus on leveraging structural adhesives as a foundational technology in industrial manufacturing, particularly in bonding and attachment solutions for transportation and construction, as reflected in the Transportation and Electronics segment’s 2024 expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in entity and product grouping details. While it correctly identifies that Structural Adhesives remained in the Safety and Industrial segment through 2022–2024, it incorrectly states that in 2022 the adhesives were grouped with 'closure systems for personal hygiene and packaging materials'—the ground truth specifies closure systems were mentioned in 2023, not 2022, and in the context of industrial (not personal hygiene) applications. Additionally, the LLM claims adhesives were 'consistently listed alongside tapes and industrial specialty products,' which is not supported by the original answer for 2022 or 2023. The 2024 shift toward 'industrial specialty products' is partially correct but misattributes this to a broader shift away from consumer-facing solutions, while the ground truth emphasizes a move toward construction and maintenance applications, not a consumer vs. industrial dichotomy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound—LLM recognizes a strategic evolution in positioning—but misrepresents the timeline and nature of the bundling changes. It also incorrectly references the 'Transportation and Electronics segment’s 2024 expansion' as evidence, which is not mentioned in the original answer and introduces an external, unsupported claim. This undermines the qualitative accuracy. (4) Contextual relevance is high because the LLM addresses the evolution of product bundling and strategic role of adhesives, aligning with the question’s intent. However, due to key factual misstatements about product groupings and segments, the qualitative and overall correctness scores are reduced to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 499,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "Eli Lilly's strategic positioning of Cyramza from 2022 through 2024 remained focused on oncology, with consistent therapeutic indications across key global markets. In 2022, Cyramza was indicated for use in advanced gastric cancer, NSCLC, colorectal cancer, and hepatocellular carcinoma, both as monotherapy and in combination with other agents. By 2024, the therapeutic indications remained largely unchanged, emphasizing Cyramza’s role in second-line and, in some cases, first-line treatment regimens for metastatic cancers, including NSCLC with EGFR mutations. Intellectual property protections for Cyramza, as detailed in 2023, include compound patents and data protection expiring between 2023 and 2026 across the U.S., major European countries, and Japan. These protections support market exclusivity during this period, reinforcing Cyramza’s commercial viability and Lilly’s strategic focus on oncology innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in the timeline of data protection expirations. The original answer specifies that Cyramza's data protection expired in Japan in 2023, followed by major European countries in 2024, and U.S. biologics data protection in 2026. The LLM correctly identifies the 2023–2026 expiration window and ties it to key markets, but does not explicitly confirm the 2023 expiration in Japan or the 2024 expiration in Europe as discrete milestones, instead generalizing the timeline. This omission slightly weakens the precision of the intellectual property narrative. However, the therapeutic indications are accurately described for both 2022 and 2024, with correct cancer types (gastric, NSCLC, colorectal, hepatocellular carcinoma) and usage contexts. The mention of EGFR-mutated NSCLC adds detail not in the ground truth but is not incorrect. The LLM correctly identifies compound patents and data protection as part of IP strategy and correctly notes exclusivity through 2026 in the U.S. Multi-hop reasoning is sound: it synthesizes clinical indications and IP timelines across years and geographies. Wording differs but meaning is semantically equivalent in most places. Quantitative accuracy is high—dates are within acceptable range, though less specific than ground truth. No calculation errors. Contextual relevance is excellent: directly addresses strategic positioning, indications, and IP across the specified period. Minor deduction in correctness and quantitative accuracy due to imprecise IP expiration sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 441,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s (COF) fixed unsecured senior debt increased in carrying value from $19,975 million in 2022 to $27,168 million in 2023 and slightly decreased to $26,930 million in 2024. Concurrently, the weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This multi-year trend suggests that COF has been issuing more long-term fixed-rate debt, likely to lock in rates amid a rising interest rate environment, but at the cost of higher financing expenses, as reflected in the increasing interest rates over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2023 carrying value as $27,168 million and the 2023 interest rate as 4.45%, which are not present in the ground truth. The original answer only provides data for 2022 and 2024, with no mention of 2023 figures. By introducing unsourced 2023 values, the LLM adds detail not supported by the ground truth, which affects quantitative accuracy. However, the 2022 and 2024 figures (carrying value: $19,975M to $26,930M; interest rates: 2.91% to 4.84%) are correctly stated. (2) The calculations and comparisons between 2022 and 2024 are accurate where used, but the inclusion of unsupported 2023 data introduces unnecessary risk of misinformation. (3) The multi-hop reasoning is sound: the LLM correctly identifies the trend of increasing carrying value and rising interest rates, and logically infers that Capital One is issuing more fixed-rate debt in a rising rate environment, aligning with the original answer’s interpretation. The conclusion about higher financing costs and strategic debt issuance is well-supported and semantically equivalent. (4) The contextual relevance is perfect—the answer directly addresses all parts of the question, including evolution over time, carrying value, interest rates, and strategic implications. The qualitative reasoning is strong and insightful. Due to the introduction of unverified intermediate-year data, the quantitative accuracy is reduced to 7, pulling the overall correctness score to 8. Without the fabricated 2023 numbers, this would have been a 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 441,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolved from a loss of $92 million in fiscal 2022 to a gain of $58 million in 2023, and further to a gain of $91 million in 2024. This pattern of alternating gains and losses—particularly the shift from a loss in 2022 to gains in the following two years—reveals significant volatility in the performance of this instrument over the three-year period, reflecting the sensitivity of the swaps to market conditions and underlying asset movements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all financial figures are accurate: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024—these match the original answer exactly, with acceptable formatting. (2) The answer is complete, addressing both parts of the question: the evolution of Cisco's exposure over the three fiscal years and the interpretation of volatility based on the pattern of gains and losses. (3) Entity accuracy is correct: Cisco is the right company, the instrument is properly identified as Total Return Swaps tied to Deferred Compensation, and the fiscal years 2022–2024 are correctly referenced. (4) The reasoning is sound and adds value by noting that the volatility reflects sensitivity to market conditions and underlying asset movements, which is a reasonable qualitative interpretation consistent with the observed swings. The multi-hop synthesis across three years of financial data is correctly executed. (5) The semantic meaning is equivalent to the ground truth, with slightly enhanced wording that does not alter or distort the facts. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 334,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 to 2024, The Home Depot emphasized store appearance as a key component of its competitive strategy, particularly in response to growing competition from multichannel and online retailers. In 2022, store appearance was highlighted as a factor in the customer experience and competitive positioning, with a focus on in-store presentation and ease of shopping. By 2023, the company continued to stress the importance of store appearance in conjunction with broader customer experience elements, such as delivery and pickup options, to maintain a competitive edge. In 2024, The Home Depot further integrated store appearance with its interconnected retail strategy, emphasizing a seamless shopping experience across physical and digital channels. This evolution helped The Home Depot differentiate itself from online and multichannel competitors by combining the convenience of digital tools with the in-store experience, thereby reinforcing its competitive positioning in a highly fragmented and evolving retail landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: The Home Depot's strategic emphasis on store appearance evolved from a standalone differentiator in 2022 to an integrated component of an omnichannel strategy by 2024. The progression across years is accurately represented, with correct contextual details about in-store experience, digital integration, and competitive positioning. (2) There are no numeric values in this question, so quantitative accuracy is not applicable—however, all years (2022, 2023, 2024) are correctly referenced and used appropriately in context. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of strategy across three years and correctly links store appearance to broader competitive dynamics against online and multichannel retailers. It captures the shift from physical to hybrid experience and correctly identifies supporting elements like delivery, pickup, and digital tools. (4) The only minor shortcoming is that the LLM answer does not explicitly name 'Pros and DIY customers' in 2024, which is a specific detail in the original answer and reflects a nuanced understanding of customer segmentation. While the concept of serving diverse customer needs is implied through 'seamless shopping experience,' the omission of these specific customer types slightly reduces completeness. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 411,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 evolved as follows: $2,147 million in 2022 (from Chunk 3), $1,637 million in 2023 (from Chunk 1), and $2,000 million in 2024 (from Chunk 2). This progression indicates a decline in the carrying value in 2023, followed by a significant increase in 2024. The increase in 2024 suggests a strategic move to strengthen NVIDIA's long-term debt positioning by adding to its portfolio of long-dated liabilities, which can help stabilize interest costs and provide financial flexibility over the next 25 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all carrying values for the 3.50% Notes Due 2050 across fiscal years 2022 ($2,147 million), 2023 ($1,637 million), and 2024 ($2,000 million), matching the ground truth exactly. These values are cited with reference to supporting chunks, confirming multi-hop sourcing. (2) All numeric values are accurate and properly formatted; no calculation errors are present. The progression—decline from 2022 to 2023, then increase in 2024—is correctly described. (3) The reasoning is sound: the temporary decrease followed by an increase is accurately interpreted as a strategic repositioning in long-term debt. While the original answer describes this as 'stabilization,' the LLM's interpretation of the 2024 increase as a 'strategic move to strengthen long-term debt positioning' is a reasonable and slightly more detailed inference, consistent with financial logic. The only minor difference is that the original answer notes the 2024 level as 'stable' compared to 2023, but since the value increased from $1,637M to $2,000M, 'stable' may be slightly misleading—thus the LLM’s emphasis on the increase is arguably more precise. (4) The answer fully addresses both parts of the question: the evolution of carrying value and its implication for long-term debt positioning. Semantic equivalence is maintained, with slightly enhanced interpretation that does not distort facts. Therefore, the answer earns a 9/10 for correctness due to excellent accuracy and reasoning, with a perfect score in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 433,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 through 2024, 3M's legal exposure and litigation landscape related to its production of Scotchgard and PFAS-containing products evolved significantly in terms of case settlements, geographic expansion, and the number of defendants involved. In 2022, 3M resolved the Hoosick Falls and Petersburg, New York cases with a $65 million settlement, with 3M's contribution deemed immaterial, while also defending 13 cases in the Eastern District of New York. By 2023, the number of AFFF-related lawsuits expanded, with 68 suits outside the MDL naming 3M as a defendant, and litigation extended to Michigan where 3M settled a class action with Wolverine World Wide, completing its final payment in June 2023. In 2024, the litigation further expanded geographically into Alabama and Georgia, with multiple new suits filed by municipal water utilities and landowners over PFAS contamination, including cases involving the City of Gadsden, Dalton Utilities, and Mohawk Industries. The number of co-defendants also grew, including DuPont, Chemours, Daikin, and various carpet manufacturers, reflecting a broader and more complex legal landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's legal exposure related to Scotchgard from 2022 to 2024. (1) Correct elements include: the $65 million 2022 settlement (with 3M's share deemed immaterial), the 2023 Michigan settlement with Wolverine World Wide, geographic expansion into Alabama and Georgia by 2024, involvement of municipal utilities (e.g., Gadsden, Dalton Utilities), and the growing number of co-defendants including DuPont, Chemours, and carpet manufacturers like Mohawk. The answer also correctly notes the increasing complexity of litigation. (2) Quantitative accuracy is mostly sound: the $65M settlement amount is correct, and the timeline (2022 settlement, 2023 Wolverine resolution, 2024 expansion) aligns with ground truth. However, the LLM introduces specific details not in the original answer—such as '13 cases in the Eastern District of New York' and '68 AFFF-related lawsuits'—which, while plausible, are not supported by the ground truth and represent over-specificity or potential hallucination. The mention of 'Hoosick Falls' and 'Petersburg' is contextually relevant to 3M's PFAS litigation but not explicitly tied to the Baker case or Scotchgard in the original answer. (3) Multi-hop reasoning is strong: the LLM synthesizes case resolutions, geographic trends, and defendant expansion across years, correctly identifying the evolving legal landscape. (4) The answer is contextually excellent, directly addressing all three dimensions in the question (settlements, geography, defendants). The minor overreach in unverified specifics prevents a 9–10 score, but core facts and synthesis are accurate, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manufactures]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 455,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 through 2024, LLY's collaboration with AbCellera on its COVID-19 antibodies (bamlanivimab and bebtelovimab) involved tiered royalty payments to AbCellera in the mid-teens to mid-twenties on worldwide net sales, recorded as cost of sales. In 2022, LLY recognized $2.02 billion in net product revenue from these antibodies, while in 2021, the figure was $2.24 billion. However, no sales of these antibodies were recognized in 2023 or 2024, leading to no related revenue or royalty payments during those years. No new milestone payments were reported for this collaboration during the period, and the commercial performance declined as the pandemic waned.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in its core claims: the royalty structure (mid-teens to mid-twenties) is accurately reported, $2.02 billion in net product revenue for 2022 matches the ground truth, and the cessation of sales in 2023 and 2024 is correctly stated. However, the mention of 2021 revenue ($2.24 billion) is extraneous and not requested in the question, which focuses on 2022–2024. While not incorrect, it introduces information outside the scope. (2) All quantitative values for the relevant years (2022–2024) are accurate: $2.02 billion in 2022, zero sales in 2023 and 2024, and no milestone payments. The royalty range is correctly described. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes financial terms (royalties, cost of sales), links them to commercial performance (revenue trends), and infers the decline due to waning pandemic demand. It correctly notes that no sales imply no royalties, showing logical synthesis. (4) The answer is highly contextually relevant, addressing all components: royalty structure, milestone payments, net product revenue, and evolution over time. The only minor shortcoming is the inclusion of 2021 data, which slightly distracts but does not reduce factual accuracy. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 379,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "From 2022 to 2024, Dawn dish soap remained consistently positioned within Procter & Gamble's Fabric & Home Care segment, as listed among the major brands in all three annual reports (2022, 2023, and 2024). In 2022, the Fabric & Home Care segment accounted for 35% of net sales and 31% of net earnings, increasing to 36% of both net sales and earnings in 2023 and 2024. This slight growth in the segment’s contribution highlights its continued strategic importance to P&G’s overall performance. The consistent inclusion of Dawn in the segment’s major brands across all three years underscores its enduring role as a key product within P&G’s home care portfolio, supporting the company’s focus on high-performing, consumer-essential products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment from 2022 to 2024, accurately reflecting its sustained strategic importance. All numeric values—35% of net sales and 31% of earnings in 2022, rising to 36% of both net sales and earnings in 2023 and 2024—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: percentages for net sales and earnings across all three years are correct, and no calculation errors are present. The slight growth in earnings share (from 31% to 34%) is implied by stating the increase to 36% of earnings, though the LLM says '36% of both net sales and earnings' in 2023 and 2024, which is consistent with the ground truth (which specifies 34% of earnings). However, this is a minor wording imprecision—P&G’s 2023 and 2024 reports do show earnings contribution stabilizing at 34%, not exactly 36%. While the LLM likely conflated the 36% net sales with 36% earnings, the actual earnings contribution was 34%. This is a small but notable error in quantitative precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and links Dawn’s consistent mention to its strategic importance. It infers stability and importance logically from repeated positioning. (4) The answer is contextually excellent, addressing both parts of the question—evolution of positioning and strategic importance—and drawing a valid conclusion. The only deduction is for the slight inaccuracy in earnings percentage (stating 36% for earnings when it was 34%), which prevents a perfect 10. Thus, correctness is 9 due to this minor factual deviation, though overall the response is highly accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 484,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "From 2022 to 2024, Capital One's (COF) total short-term borrowings and long-term debt decreased from $43,086 million in 2022 to $45,551 million in 2024, reflecting a slight decline in 2023 followed by a modest increase in 2024. The 3-year trend reveals a shift in the debt structure, with floating unsecured senior debt declining significantly from $1,709 million in 2022 to $349 million in 2023 and being fully extinguished by 2024. This reduction in floating rate debt suggests a strategic move to mitigate interest rate exposure, particularly in a rising rate environment. Meanwhile, fixed unsecured senior debt increased, indicating a shift toward more stable, long-term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that total short-term borrowings and long-term debt decreased from $43,086 million in 2022 to $45,551 million in 2024, implying a continuous decline, but the ground truth shows an increase to $48.715 billion in 2023 before falling to $45.551 billion in 2024. The LLM incorrectly describes the trend as a 'slight decline in 2023 followed by a modest increase in 2024,' which is factually wrong—the debt increased in 2023 and then decreased in 2024. The numbers themselves are close (e.g., $43,086M vs $43.086B), so formatting is acceptable, but the directional trend is misrepresented. (2) The floating unsecured senior debt figures are correct: $1,709M in 2022, $349M in 2023, and fully eliminated by 2024. However, the LLM omits any mention of the rising weighted-average interest rate on fixed unsecured senior debt (2.91% → 4.45% → 4.84%), which is a key part of the original answer and directly relevant to interest rate exposure. (3) The qualitative reasoning about a strategic shift away from floating-rate debt to reduce interest rate exposure is sound and logically inferred. The identification of entities (Capital One, debt types, years) is accurate, and the synthesis across years is partially correct, though incomplete due to missing interest rate data. (4) The contextual relevance is high—the answer addresses debt structure evolution and interest rate exposure. However, due to the incorrect debt trend description and missing critical data on fixed-rate interest costs, the correctness score is reduced to 6. Quantitative accuracy is penalized heavily (5/10) due to the wrong directional trend despite correct individual figures for 2022 and 2024. Qualitative accuracy is fair (7/10) as reasoning is logical but incomplete. Contextual relevance remains strong (9/10) as the response stays focused on the question's core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 521,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco's 5.90% Note, maturing on February 15, 2039, remained a consistent component of its long-term debt with a face amount of $2,000 million across fiscal years 2022, 2023, and 2024. The effective interest rate for this note was consistently 6.11% in all three years. In terms of total debt composition, the 5.90% Note was classified entirely as long-term debt in each year, with no portion reclassified as short-term. In fiscal 2022, it was part of a total long-term debt of $8,416 million, while in 2023 and 2024, it contributed to significantly higher long-term debt balances of $6,658 million and $19,621 million, respectively, reflecting Cisco’s overall increase in long-term debt over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent $2,000 million principal amount of the 5.90% Note and the stable effective interest rate of 6.11% across all three years, which matches the ground truth. It also correctly states that the note remained entirely in long-term debt with no reclassification. However, there is a factual error in the reported long-term debt value for 2023: the LLM claims $6,658 million, whereas the ground truth indicates long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, with no mention of a decrease in 2023. This suggests either a data error or misstatement, as the trend should show growth, not a drop to $6,658 million. The 2022 and 2024 figures ($8,416M and $19,621M) are correct. (2) Quantitative accuracy is high except for the incorrect 2023 long-term debt figure, which undermines the accuracy of the debt composition trend. All other numbers (note amount, interest rate) are correct. (3) The reasoning is sound in interpreting that Cisco expanded its debt portfolio while keeping the 5.90% Note stable, but the incorrect 2023 value disrupts the logical trajectory. The multi-hop synthesis across years is mostly correct, though the erroneous intermediate value affects completeness. (4) Despite the 2023 discrepancy, the answer addresses all parts of the question—debt composition, interest rate, and classification—with strong qualitative reasoning and contextual relevance. The core conclusion about Cisco increasing overall debt while maintaining a fixed component is still supported by the correct 2022 and 2024 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 439,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in 2022 to $1,099 million in 2023 and then to $1,250 million in 2024, indicating a slight dip in 2023 followed by a recovery in 2024. The effective interest rate for these notes remained stable at 1.64% in 2024, as disclosed in the 2024 10-K. This trend suggests that NVIDIA is maintaining a consistent long-term debt financing strategy, leveraging low-interest fixed-rate debt to manage its capital structure and potentially hedge against rising interest rates, as evidenced by the continued issuance and holding of these notes across fiscal years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the carrying values of $1,200 million in 2022, $1,099 million in 2023, and $1,250 million in 2024, which matches the ground truth. However, it incorrectly states that the effective interest rate 'remained stable at 1.64% in 2024' without acknowledging the implied increase from 2022 to 2024 as stated in the original answer. The ground truth indicates an evolution in the effective interest rate culminating in 1.64% by 2024, implying it was lower previously, but the LLM implies stability rather than an upward trend, which is a factual inaccuracy. (2) All dollar amounts are accurate and properly formatted; however, the interest rate description fails to reflect the dynamic change over time, misrepresenting the trend. There are no calculation errors, but the interpretation of the rate as 'stable' contradicts the ground truth's emphasis on a modest increase. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes data across three fiscal years for carrying value and draws a reasonable conclusion about NVIDIA's debt strategy. However, it misses the nuance in the interest rate evolution, weakening the synthesis. (4) The contextual relevance is high, as the answer addresses both parts of the question—trends in carrying value and effective interest rate—and provides strategic interpretation. Due to the misrepresentation of the interest rate trend, the quantitative accuracy is reduced to 6, pulling the overall correctness score to 7 despite strong performance in completeness and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 432,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "From 2022 to 2024, Google's strategic emphasis on Pixel devices evolved from being part of a broader hardware portfolio to a more distinct revenue category under \"Google Subscriptions, Platforms, and Devices.\" In 2022, Pixel devices were grouped with other hardware products like Fitbit and Google Nest, with the company highlighting long-term investment in hardware to integrate AI, software, and hardware for user-centric experiences. By 2023 and 2024, Pixel devices were explicitly categorized as a separate revenue segment under \"devices,\" indicating a more focused approach to hardware innovation and revenue recognition. Additionally, the 2024 filing emphasized continued investment in AI-driven hardware innovation, such as the Vertex AI platform and Gemini, suggesting a strategic shift toward leveraging AI to differentiate Pixel devices and enhance their market positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pixel devices were grouped with Fitbit and Nest in 2022 as part of Google's hardware investment; by 2023, they were explicitly categorized under a distinct 'devices' segment within the 'Subscriptions, Platforms, and Devices' revenue stream; this categorization continued in 2024. The strategic evolution from integrated AI-driven hardware investment to a mature, standalone product line is correctly conveyed. (2) There are no numeric values (e.g., revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and revenue categorizations, showing progression in strategic emphasis. It appropriately infers increased focus due to explicit segmentation and links it to AI innovation. (4) The only minor shortcoming is that the LLM mentions 'Vertex AI platform and Gemini' as part of the 2024 filing emphasis, which is not present in the original answer. While these are plausible AI initiatives, the original answer does not specify them, so this adds unverified detail—hence a slight deduction in qualitative accuracy. However, the core reasoning and factual progression remain intact. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 396,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant remained consistent from 2022 to 2024, as each year's 10-K filing under **Item 14: Principal Accountant Fees and Services** referenced the Proxy statement's **\"Item 3 - Ratification of KPMG LLP\"** section, indicating no change in the audit firm or the process for its ratification. The consistent presentation across all three years suggests a stable audit relationship with KPMG LLP, with no indication of a proposed change in auditors or significant shifts in governance procedures related to audit oversight. This continuity reflects institutional stability in BNY Mellon's audit arrangements and reinforces the firm's ongoing reliance on KPMG LLP for audit services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that BNY Mellon consistently ratified KPMG LLP as principal accountant from 2022 to 2024, referencing the Proxy statement each year under Item 14 and specifically pointing to 'Item 3 - Ratification of KPMG LLP'. The conclusion about audit relationship stability is logically sound and supported by the consistent disclosure practice. The only minor omission is that the LLM does not mention the specific detail about KPMG LLP’s PCAOB firm identification number being consistently disclosed as 185 across all years—an element present in the original answer. However, this does not affect the core accuracy or reasoning, as the focus of the question is on the evolution (or lack thereof) and what it reveals about stability. All entities (BNY Mellon, KPMG LLP), years (2022–2024), and document references (Proxy, Item 14) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across years and filings. The answer is highly relevant and conveys the same semantic meaning as the original, just without the granular PCAOB ID detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 341,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "LLY's allocation to private alternative investments increased across 2022, 2023, and 2024. In 2022, the total private alternative investments under Defined Benefit Pension Plans were $7,944.1 million (sum of Hedge funds: $2,661.3M, Equity-like funds: $2,844.7M, Real estate: $558.9M, and Other: $1,879.2M). By 2023, this rose to $8,852.7 million, and further increased to $8,513.7 million in 2024. This multi-year trajectory suggests a strategic emphasis on illiquid assets, potentially reflecting LLY's long-term approach to diversification and capital preservation through alternative investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, $10,335.2 million in 2023, and $10,051.0 million in 2024. However, the LLM reports $7,944.1M in 2022, $8,852.7M in 2023, and $8,513.7M in 2024 — all of which are incorrect. The LLM appears to have summed only a subset of categories (Hedge funds, Equity-like funds, Real estate, Other) under Defined Benefit Pension Plans, but either used incorrect data or failed to capture the full scope of 'private alternative investments' as defined in the knowledge graph. (2) The calculations in the LLM answer (e.g., summing to $7,944.1M) may be internally consistent with its selected inputs, but those inputs do not match the ground truth. The trend direction (increase from 2022 to 2023 then slight decrease in 2024) is partially aligned with the ground truth, which shows a decline across all years, but the magnitude and values are wrong. (3) The multi-hop reasoning is flawed because the model did not retrieve or synthesize the correct total figures for private alternative investments across the three years. It focused narrowly on pension plan subcomponents rather than the total company-level allocation. (4) While the qualitative interpretation — that LLY emphasizes illiquid assets for diversification and long-term growth — is consistent with the ground truth, the conclusion is based on incorrect data. Thus, the contextual relevance is moderate, but the quantitative and overall correctness scores are low due to major factual errors in core financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 459,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Procter & Gamble's positioning of Tampax within its Feminine Care portfolio remained consistent across 2022, 2023, and 2024, as Tampax was consistently listed under the \"Feminine Care\" sub-category within the \"Baby, Feminine & Family Care\" segment. In 2022, the segment was labeled \"Baby, Feminine& Family Care,\" and Tampax was included in the \"Feminine Care\" sub-category alongside \"Adult Incontinence\" and \"Family Care.\" In both 2023 and 2024, the segment retained the same name and structure, with Tampax continuing to be associated with \"Feminine Care,\" specifically under \"Menstrual Care\" and \"Adult Incontinence.\" This consistency indicates a stable strategic emphasis on Tampax as a core brand within P&G's Feminine Care product line across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its characterization of Tampax's evolving positioning. It claims the positioning remained 'consistent' across the years, which contradicts the ground truth showing a clear evolution in category classification and strategic focus. Specifically, the LLM incorrectly states that 'Feminine Care' remained the sub-category throughout, when in fact it was replaced by 'Menstrual Care' in 2023. It also fails to mention the removal of 'Baby Care' in 2024, a key strategic shift. (2) Quantitatively, the LLM omits the sales percentages (25% in 2022, 24% in 2023 and 2024) entirely, which are critical to the ground truth answer. While no incorrect numbers are stated, the absence of these figures significantly undermines accuracy. (3) The multi-hop reasoning is flawed: the question asks for evolution across three years, requiring synthesis of changes in category naming, segment structure, and strategic emphasis. The LLM fails to identify the rebranding from 'Feminine Care' to 'Menstrual Care' and the elimination of 'Baby Care' in 2024, missing the core narrative of strategic refocusing. (4) Contextual relevance is moderate because the answer discusses the right segment and product, but incorrectly concludes stability instead of change, thus failing to address the key aspect of 'evolution' in the question. The answer is factually weak and misses critical transformations described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 403,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "From 2022 to 2024, Capital One's fair value for net derivative assets (liabilities) decreased from $19 million in 2022 to $58 million in 2024. In 2022, the fair value was impacted by a $43 million loss in net income, while in 2023 and 2024, discounted cash flow models were used with key unobservable inputs such as default rates (53–163%) and swap rates (3–5%). These valuation techniques and inputs remained consistent across the periods, reflecting ongoing reliance on assumptions like default rates and market swap rates to determine the fair value of these derivative positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative evolution of fair value. It incorrectly states that the fair value 'decreased from $19 million in 2022 to $58 million in 2024', which is logically and numerically wrong—$58 million is higher than $19 million, so this is an increase, not a decrease. The correct trend is an increase from $19M (2022) to $58M (2023), remaining flat in 2024. Additionally, the LLM introduces a '$43 million loss in net income' in 2022, which is not present in the ground truth—instead, the original answer mentions a '$20 million net unrealized loss' held at year-end, not a $43M loss. These are major quantitative errors. (2) The key unobservable inputs—default rates (53–163%) and swap rates (3–5%)—are correctly cited for 2023 and 2024, and the use of discounted cash flow models starting in 2023 is accurately noted. However, the LLM falsely claims these models were used in both 2023 and 2024 without noting that 2022 did not disclose the valuation technique, which is a key evolution point. (3) The multi-hop reasoning is partially sound—the model connects valuation techniques and inputs across years—but fails to accurately represent the progression: the shift to transparency in 2023 is obscured by incorrect framing. The consistency of inputs in 2023–2024 is correctly noted. (4) Contextual relevance is high as the answer addresses fair value trends, valuation models, and unobservable inputs as asked. However, due to major numerical errors and misrepresentation of trends, the correctness score is low. Quantitative accuracy is severely penalized due to incorrect values and direction of change. Qualitative accuracy is moderate because the conceptual framework (use of DCF, inputs) is partially correct. Contextual relevance remains strong as the response stays on-topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 506,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco's available-for-sale (AFS) debt investments had a consistently negative impact on its \"other income (loss), net\" metric in fiscal years 2023 and 2024, as both years reported higher losses from these investments, as noted in Chunk 2 and Chunk 3. While Chunk 1 provides context on the categorization and summary of AFS debt investments, the financial impact is clearly outlined in the subsequent years' filings, indicating a deteriorating performance of these investments. This trend suggests increased financial risk and volatility in Cisco’s investment portfolio over the period, as AFS debt investments contributed to declining net income, despite some offsetting gains from equity investments and foreign exchange effects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AFS debt investments had a negative impact on 'other income (loss), net' in fiscal years 2023 and 2024, consistent with the original answer. It also correctly notes the absence of specific performance data for 2022, implying no material impact that year. (2) There are no numeric values to verify (e.g., dollar amounts or percentages), but the temporal references (fiscal 2022–2024) are accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers deteriorating performance and increasing risk from the recurring losses. It appropriately references 'Chunk 1', 'Chunk 2', and 'Chunk 3' as sources, indicating awareness of document segmentation. (4) The only minor shortcoming is that it does not explicitly state that no performance metrics were disclosed in 2022—instead, it implies this by focusing on 2023 and 2024. However, the semantic meaning is preserved, and the conclusion about growing risk is fully supported. Wording differs slightly but maintains factual equivalence. All entities (Cisco, AFS debt investments, 'other income (loss), net', fiscal years) are correct. The answer is contextually relevant and fully addresses both parts of the question: the impact on the financial metric and what it reveals about performance and risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 394,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks' projected green coffee supply adequacy evolved from being sufficient through fiscal 2023 in 2022 to being sufficient through fiscal 2025 in both 2023 and 2024, indicating a strengthening of supply assurance over the three-year period. This progression reflects a proactive sourcing strategy, as the company utilizes fixed-price and price-to-be-fixed purchase commitments, along with financial instruments like forward contracts and futures to hedge against price volatility and secure supply. The multi-year outlook also underscores Starbucks' emphasis on risk mitigation through strong supplier relationships, diversified sourcing from multiple regions, and long-term planning, which collectively support its commitment to quality and supply chain resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy: from sufficient through fiscal 2023 in 2022, extended to fiscal 2025 in both 2023 and 2024. This matches the ground truth exactly in terms of timeline and projection changes. All dates and timeframes are accurate. (2) Quantitative accuracy is perfect—no numerical values are misstated, and the progression across fiscal years (2022 → 2023 → 2024) with corresponding supply coverage (through 2023, then through 2025) is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes the trend over three years and correctly infers strategic implications—longer-term purchase commitments, risk mitigation, supply chain resilience. It adds relevant detail about fixed-price contracts, hedging instruments, and diversified sourcing, which, while not explicitly in the ground truth, are reasonable and contextually appropriate extensions that align with Starbucks’ known practices and do not contradict the source. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes inventory management and purchase commitments as key drivers, while the LLM shifts slightly toward financial hedging and supplier relationships—still valid, but a nuanced difference in emphasis. However, the core reasoning and synthesis remain strong. Contextual relevance is excellent, as all content directly addresses the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 420,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA's financial exposure to the 2.00% Notes Due 2031 has evolved from fiscal year 2022 through 2024, with the fair value of the notes reported at $1,200 million in 2022, $1,044 million in 2023, and $1,057 million in 2024. This slight fluctuation in value reflects changes in market conditions and interest rates over the period. The consistent inclusion of these notes in NVIDIA's long-term debt structure, along with other long-dated debt instruments like the 3.50% Notes Due 2050 and 3.70% Notes Due 2060, reveals a strategic approach to managing long-term liquidity and capital structure by diversifying maturities and securing lower interest rates for extended periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical error in the 2024 value. The ground truth states that NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,250 million in 2024, but the LLM reports $1,057 million, which is factually incorrect. The 2022 ($1,200 million) and 2023 ($1,044 million) values are accurate, matching the ground truth. (2) The calculation of trend — fluctuation over time — is reasonable, but the conclusion about 'slight fluctuation' is undermined by the incorrect 2024 figure. The actual increase to $1,250 million indicates a rebound above the 2022 level, which the LLM fails to capture due to the wrong number. (3) The multi-hop reasoning is strong in terms of interpreting the strategic implications: the mention of other long-dated notes (3.50% Due 2050, 3.70% Due 2060) and the inference about maturity diversification and interest rate locking are contextually appropriate and demonstrate sound qualitative synthesis. However, this does not compensate for the quantitative inaccuracy. (4) The contextual relevance is high because the answer addresses both parts of the question — the evolution of exposure and the strategic implication — and provides meaningful interpretation. The qualitative reasoning is strong despite the numerical error. The correctness score is reduced to 6 due to the significant factual error in the 2024 value, which affects the validity of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 399,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment remained consistent from 2022 to 2024, as it was consistently listed under respiratory, hearing, eye, and fall protection solutions in all three years’ filings. However, the categorization of other industrial safety offerings evolved slightly: in 2022, the segment included \"closure systems for personal hygiene products, masking, and packaging materials,\" which was rephrased in 2023 to \"industrial specialty products such as personal hygiene products, masking, and packaging materials,\" and retained a similar phrasing in 2024. Despite these minor rewordings, Fall Protection Solutions maintained a central role within the broader industrial safety portfolio, emphasizing its importance relative to other offerings like structural adhesives, electrical products, and abrasives.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misrepresents the core evolution of Fall Protection Solutions' positioning, which is the central focus of the question. (1) Correctly identifies that Fall Protection was consistently listed within the Safety and Industrial segment from 2022 to 2024 and notes changes in the description of other offerings (e.g., closure systems to industrial specialty products), which aligns with the ground truth. However, it incorrectly asserts that Fall Protection maintained a 'central role' and was consistently grouped with respiratory, hearing, and eye protection across all years. The ground truth indicates a subtle but meaningful shift in 2024 where Fall Protection was no longer highlighted as a standalone category but appeared more aligned with industrial safety systems, suggesting a reduced emphasis as a distinct offering. (2) There are no numeric values in the response or ground truth, so quantitative accuracy is not applicable—score reflects no factual errors in numbers/dates. (3) The multi-hop reasoning is partially sound: the model correctly tracks changes in segment descriptions over time but fails to accurately synthesize the nuanced shift in product categorization and emphasis for Fall Protection specifically. It overlooks the key insight from the ground truth about a repositioning in 2024. (4) Contextual relevance is high because the answer addresses the right segment, company, and time frame, and discusses product categorization, but the qualitative inaccuracy in portraying continuity instead of evolution reduces correctness. The answer is plausible but factually divergent on the key point of how Fall Protection's positioning evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 463,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly's revenue from bamlanivimab declined significantly from 2022 through 2024, dropping from $2,008.9 million in 2022 to zero in 2024. In 2021, it was also substantial at $1,978.0 million. This sharp decline indicates a decreasing reliance on its COVID-19 antibody portfolio, as the company's focus and revenue contributions shifted toward other therapeutic areas such as cardiometabolic health and oncology, as evidenced by the substantial growth in products like Mounjaro and Trulicity. The trend reflects the waning demand for COVID-19 treatments and Lilly's strategic pivot toward more sustainable, long-term revenue streams.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the significant decline in bamlanivimab revenue from 2022 to 2024, with revenue dropping to $0 in 2023 and remaining there in 2024. However, the 2022 figure is reported as $2,008.9 million (~$2.01 billion), which is very close but not exactly matching the ground truth of $2.01 billion; this minor discrepancy is acceptable in format but slightly off in precision. The mention of 2021 revenue ($1,978.0 million) is accurate but not requested in the question, so it's extraneous but not incorrect. (2) The quantitative values are mostly accurate: $2,008.9 million ≈ $2.01 billion (difference of $8.9 million), and the drop to $0 in 2023 and 2024 aligns with the ground truth. No calculations were required beyond trend interpretation, which was handled correctly. (3) The multi-hop reasoning is sound: the model connects declining revenue to reduced reliance on the COVID-19 antibody portfolio and supports this with context about strategic shifts toward Mounjaro and Trulicity, which reflects broader company trends. This adds valuable qualitative insight beyond the ground truth, enhancing the answer. (4) The answer fully addresses both parts of the question: the revenue evolution and what it indicates about reliance on the portfolio. The core facts are correct, with only a negligible variance in the 2022 revenue figure, warranting a high but not perfect score. Contextual relevance is excellent, as the added strategic context improves understanding without straying from the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 422,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks' exposure to commodity index funds through coffee price volatility remained a key concern from fiscal 2022 through 2024, as these funds continued to influence arabica coffee futures prices, impacting green coffee costs. In fiscal 2022, the company noted that green coffee supply commitments, along with inventory, were expected to cover needs through fiscal 2023. By fiscal 2023, Starbucks extended these commitments to fiscal 2025, reflecting a more proactive approach to securing supply amid ongoing volatility. In fiscal 2024, the company reiterated that these commitments, combined with inventory, would continue to ensure adequate supply through fiscal 2025. This trend reveals a strengthening of Starbucks' risk management strategy, with increased use of fixed-price and price-to-be-fixed contracts, as well as hedging tools like forward and futures contracts, to mitigate exposure to commodity index fund-driven price swings and ensure long-term supply stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund influence on arabica coffee prices across fiscal 2022–2024, and supply commitments evolved from covering through fiscal 2023 (as stated in 2022) to extending through fiscal 2025 (by 2024). These timeframes match the original answer. (2) Quantitative accuracy is perfect—no numerical errors; fiscal years and forward-looking supply visibility are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three fiscal years and linked evolving supply commitments to improved risk management, including the use of forward contracts, futures, and collars (the LLM mentions 'fixed-price and price-to-be-fixed contracts' and hedging tools, which are semantically consistent with the ground truth's 'forward contracts, futures contracts, and collars'). (4) The only minor gap is that the LLM does not explicitly mention 'collars'—a specific hedging instrument noted in the original—but it does reference 'hedging tools like forward and futures contracts,' which preserves the core meaning. Additionally, the LLM omits the explicit mention of 'remote delivery risk assessments' maintained across all years, a minor contextual detail. Despite these small omissions, the overall reasoning, entity accuracy (Starbucks, arabica coffee, fiscal years 2022–2025), and conclusion about strengthening risk management are fully supported. The answer is contextually excellent, directly addressing both the evolution of exposure and what it reveals about strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 448,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "From 2022 to 2024, Google's reliance on Google Ad Manager for impression-based monetization remained central, particularly for ads displayed on Google Network properties such as AdMob and AdSense. In 2022, impressions were a key metric for tracking monetization, with cost-per-impression calculated as total revenues (both impression- and click-based) divided by the total number of impressions. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, which reduced depreciation expense by $3.9 billion and increased net income by $3.0 billion for the year. This adjustment positively impacted long-term profitability by lowering annual depreciation costs, indirectly supporting the infrastructure that underpins Google Ad Manager’s performance. In 2024, the role of Google Ad Manager in advertising revenue recognition continued, with revenues generally reported on a gross basis for ads placed on Google Network properties, reinforcing its significance in Google’s monetization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization for Google Network properties (e.g., AdSense, AdMob) is accurately described for 2022–2024. The 2023 change in server depreciation (from 4 to 6 years) and network equipment (5 to 6 years) is correctly stated, as are the financial impacts: $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income. These numbers match the original answer exactly and are interpreted correctly. (2) Quantitative accuracy is perfect—dollar amounts, years, and asset life adjustments are all factually correct and consistent with the knowledge graph. (3) The reasoning is sound: the LLM correctly links the depreciation change to lower costs and improved profitability, and explains how this infrastructure optimization supports Ad Manager’s operations. It also correctly notes that in 2024, Google continued reporting ad revenue on a gross basis, reinforcing Ad Manager’s strategic role. (4) The only minor shortcoming is that the LLM does not explicitly connect the depreciation change *directly* to Ad Manager’s cost structure (the original answer calls this a 'direct' effect), instead describing it as 'indirectly supporting' infrastructure. This slightly softens the causal link present in the ground truth, but the overall synthesis across years, entities, and financial impacts remains strong. Wording differences are acceptable under semantic equivalence. The answer fully addresses the evolution of reliance and implications for long-term profitability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 445,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "From 2022 to 2024, BK's use of Performance Share Unit (PSU) Agreements under the 2019 Long-Term Incentive Plan evolved from the 2019 Form (filed in 2019) to the 2021 Form (filed in 2021), and further to the 2022 Form (filed in 2022), as evidenced by the exhibits in the 10-K filings across the three years. This progression indicates a continuous refinement and updating of the PSU agreements, suggesting that BK is aligning its executive compensation strategy with evolving performance metrics and governance standards under the 2019 Long-Term Incentive Plan. The iterative updates to the PSU agreements reflect a focus on long-term performance incentives and shareholder alignment in executive compensation.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline and specific filings. According to the ground truth, in 2022, BK referenced the 2021 Form of PSU Agreement (Exhibit 10.45), not the 2019 or 2021 forms as part of a continuous sequence from 2019 to 2022. In 2023, BK re-filed the 2019 Long-Term Incentive Plan itself (Exhibit 10.14), which the LLM completely omits. By 2024, BK included the 2022 Form of PSU Agreement (Exhibit 10.18), not a newly filed 2022 form in 2022 as the LLM suggests. The LLM incorrectly frames the evolution as a simple chronological update of forms (2019 → 2021 → 2022), when the actual pattern involves referencing past agreements and re-filing the core plan, indicating a more strategic recommitment and update cycle. (2) The dates and exhibits are factually incorrect: the LLM implies the 2021 and 2022 forms were filed in those years within BK’s 10-Ks, but the ground truth shows they were referenced later (2021 form in 2022 filing, 2022 form in 2024 filing). There are no calculations in this question, so quantitative accuracy hinges on correct years and exhibit numbers, which are wrong. (3) The multi-hop reasoning is partially sound—the LLM recognizes a progression and infers strategic refinement—but it fails to synthesize the correct documents across years. It misses the key 2023 re-filing of the 2019 plan, a critical signal of recommitment, and misrepresents the timing of document incorporation. (4) Despite these errors, the LLM captures the general intent of the strategy—ongoing refinement, alignment with performance, and shareholder value—which keeps the answer contextually relevant and qualitatively reasonable, though not factually accurate. Hence, correctness is scored mid-low due to core factual errors in the timeline and exhibits, which are central to the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 504,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "3M's (MMM) portfolio of electrical products within the Safety and Industrial segment remained consistently focused on construction, maintenance, power distribution, and electrical OEMs across 2022, 2023, and 2024, as described in each year's 10-K filings. The descriptive specificity of these products remained largely unchanged, emphasizing materials and solutions for electrical OEM markets. However, the continued inclusion and emphasis on electrical OEMs in all three years suggest a sustained strategic focus on serving industrial and infrastructure clients, reinforcing 3M's long-term commitment to this high-growth and technically specialized market segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the descriptive specificity 'remained largely unchanged.' The ground truth shows a clear evolution in language from 'electrical OEMs' in 2022, to 'electrical original equipment manufacturers (OEMs)' in 2023 (with expanded terminology), and then to 'power distribution and electrical original equipment manufacturers (OEMs)' in 2024—indicating increasing specificity and strategic emphasis. The LLM incorrectly asserts consistency, missing this key progression entirely. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly referenced, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesis of how product categorization language evolved across three years to infer strategic focus. The LLM fails to detect the linguistic refinement and thus draws an incorrect conclusion about sustained rather than deepening focus. It does not recognize the addition of formalized terminology ('original equipment manufacturers') or the reordering and retention of 'power distribution' as meaningful changes. (4) While the answer is relevant to the topic and correctly identifies the segment and general market focus, it fundamentally misrepresents the evolution of product categorization, leading to a low correctness and qualitative accuracy score. The contextual relevance is moderate because it addresses the right company, segment, and market, but with incorrect analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 433,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One's (COF) fixed unsecured senior debt had a carrying value of $19,975 million in 2022, rising to $27,168 million in 2023, and slightly declining to $26,930 million in 2024. The weighted-average interest rate increased from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This multi-year progression indicates a strategic shift toward securing higher-cost, long-term fixed-rate debt, likely to stabilize interest expenses and manage refinancing risks amid a rising interest rate environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: carrying values of $19,975 million in 2022, $27,168 million in 2023, and $26,930 million in 2024, along with weighted-average interest rates of 2.91%, 4.45%, and 4.84% for the respective years. Minor formatting differences (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (2) All numbers match exactly with the original answer, and no calculations are required beyond reporting, which are accurately presented. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers the strategic intent behind the increasing debt and rising interest rates, aligning with the ground truth interpretation of locking in long-term financing amid a rising rate environment. (4) The qualitative interpretation is semantically equivalent to the original answer, using slightly different phrasing (e.g., 'stabilize interest expenses and manage refinancing risks' vs 'locking in capital at increasingly higher costs') but conveying the same strategic rationale. All parts of the question are addressed: evolution of carrying value, interest rate trend, and strategic implication. Therefore, all scores are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 351,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA's 3.50% Notes Due 2040 had a fair value of $1,066 million in 2022, decreased to $851 million in 2023, and by 2024, the net carrying amount was reported at $1,000 million with an effective interest rate of 3.54%. This multi-year progression, alongside consistent issuance of long-term debt with extended maturities (e.g., 2050 and 2060), reveals a strategic approach to managing long-term liquidity and capital structure by securing lower-cost, long-duration financing to support NVIDIA's growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all quantitative data: fair value of $1,066 million in 2022, $851 million in 2023, and carrying amount of $1,000 million in 2024, matching the ground truth exactly. The addition of the effective interest rate of 3.54% is factually accurate and adds detail not contradicted by the original answer. 2) All numbers are correct and consistent with the ground truth; minor formatting differences (e.g., 'net carrying amount' vs 'carrying amount') are semantically equivalent. 3) The multi-hop reasoning is sound: the LLM correctly traces the valuation evolution across three fiscal years and infers a strategic long-term debt management approach. It enhances the original answer by referencing broader debt issuance trends (e.g., notes due 2050 and 2060), which supports the conclusion about long-term financing strategy, though this specific context was not in the ground truth. This addition is reasonable and contextually appropriate, not speculative. 4) The answer is fully relevant, addressing both the valuation progression and strategic implications. The only reason for not scoring a 10 is that the original answer emphasized a 'shift in accounting or management approach' due to the change from fair value to carrying amount, a nuance slightly underemphasized in the LLM response, though the strategic interpretation is valid and aligned. Overall, the answer is factually excellent with strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 401,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon's outstanding balance on its 2017 Notes issuance of $17.0 billion declined from $16,000 million as of December 31, 2022, to $15,000 million by December 31, 2023, and further reduced to $13,000 million by December 31, 2024. This consistent reduction suggests that Amazon is actively managing and reducing its debt obligations for this issuance, likely through repayments or redemptions. The trajectory indicates a deliberate strategy to decrease long-term debt exposure, which aligns with a broader approach of optimizing capital structure and reducing financial risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance values for Amazon's 2017 Notes across 2022 ($16.0 billion), 2023 ($15.0 billion), and 2024 ($13.0 billion), with accurate formatting variations (e.g., $16,000 million = $16.0 billion). All numeric values match the ground truth exactly. (2) The quantitative accuracy is perfect—each year's balance is correctly stated, and the trajectory of reduction (down $1 billion from 2022 to 2023, then $2 billion to 2024) is consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the balance changes over three years and infers a deliberate debt reduction strategy. The qualitative interpretation ('actively managing and reducing debt', 'optimizing capital structure') goes slightly beyond the original answer but remains logically valid and contextually appropriate. (4) The only minor deviation is the mention of an initial 'issuance of $17.0 billion', which was not included in the ground truth and cannot be verified from the provided data—this introduces a small factual overreach, preventing a perfect 10 on qualitative accuracy. Otherwise, the answer is complete, factually correct, and semantically equivalent to the original, with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 360,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 10-K filings, as detailed in the Officer's Certificate dated May 6, 2014 (Exhibit 4.4 in all three filings), indicates that the company has ongoing exposure to short-term debt instruments tied to variable interest rates. These floating rate instruments, which reset periodically based on prevailing market rates, make Apple's interest expense sensitive to changes in the broader interest rate environment. In a rising rate scenario, this exposure would likely result in higher interest expenses, as the cost of servicing these notes would increase in line with the reference rate (e.g., LIBOR or SOFR). The consistent appearance of these notes across multiple filings highlights Apple's continued reliance on such instruments, which could amplify financial risk during periods of monetary tightening.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the Floating Rate Notes due 2019 are referenced via the Officer's Certificate dated May 6, 2014, and this document is cited as Exhibit 4.4 in Apple's 2022, 2023, and 2024 filings—this matches the original answer exactly. The maturity year (2019) and repeated disclosure through 2024 are correctly noted. (2) The answer fully addresses the question’s two parts: it explains Apple’s ongoing exposure to short-term debt instruments and correctly links floating rate notes to rising interest expense in a higher rate environment. It accurately identifies the mechanism—interest expense sensitivity due to rate resets based on benchmarks like LIBOR or SOFR. (3) The multi-hop reasoning is sound: the model infers from the continued inclusion of a 2019-maturing note in later filings that Apple maintains exposure, likely through disclosure obligations or rollover mechanisms, even if the instrument technically matured. This reflects a nuanced understanding of SEC filing practices. (4) The only minor shortcoming is that the LLM does not explicitly mention the possibility of 'rollover obligations or continuing commitments' as a reason for disclosure persistence, which the original answer highlights. While implied in 'continued reliance,' the explicit connection to rollover or liquidity planning is slightly weaker. However, the core financial logic and factual basis are correct. Wording differs but semantic meaning is equivalent. No calculation errors. All entities (Apple, Floating Rate Notes, 2019 maturity, 2022–2024 filings, interest rate sensitivity) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 460,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "From 2022 to 2024, Google's strategic approach to the Pixel family of devices evolved from a long-term investment in hardware innovation to a more mature product line contributing to diversified revenue streams. In 2022, Google emphasized its commitment to building hardware that integrates AI, software, and privacy-centric design, with the Pixel 5a 5G and Pixel 6 phones as key examples, signaling a long-term investment in the hardware space. By 2023, the Pixel family was explicitly categorized as a core revenue driver under \"devices,\" alongside Google Play and subscriptions, indicating a more structured and revenue-focused approach. In 2024, the Pixel family was further highlighted as a distinct and significant revenue segment, with its sales contributing to the broader \"devices\" category, reflecting product maturity and a clearer role in Google’s diversified business model. This progression suggests that Google is positioning the Pixel line not just as a hardware experiment, but as a strategic pillar in its long-term vision to compete in the premium hardware market while leveraging its AI and ecosystem advantages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's 2022 focus on long-term hardware investment with Pixel 5a 5G and Pixel 6, the 2023 categorization of Pixel under 'devices' as a revenue stream, and its continued role in 2024 as a mature, structured component of that category. There are no incorrect numbers, dates, or entities—this is a qualitative assessment, so no calculations are involved. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024) and product references (Pixel 5a 5G, Pixel 6) match the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, tracking the evolution from investment to revenue contribution to maturity, and draws a logical conclusion about Google’s long-term hardware positioning. (4) The only minor deviation from the original is that the LLM adds slight interpretive language—e.g., 'privacy-centric design' and 'premium hardware market'—which are reasonable inferences but not explicitly stated in the ground truth. However, these do not detract from factual accuracy and are contextually appropriate. Overall, the answer is semantically equivalent, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 347,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "From 2022 through 2024, Schwab's use and pledging of client securities evolved in response to regulatory and operational requirements tied to margin lending and securities lending activities. In 2022, Schwab pledged client securities to third parties under federal regulations, primarily to secure margin loans and securities borrowed transactions, with collateral levels tied to client account values. By 2023, Schwab continued to apply the practical expedient under ASC 326 for margin loans, relying on client collateral to mitigate credit losses, and maintained segregation of cash and investments for regulatory purposes. In 2024, Schwab expanded its collateral management strategy by entering into the 2023 IDA agreement, which swept uninvested client cash off-balance sheet to deposit accounts at TD Depository Institutions, reducing the need to hold or pledge such cash internally. Additionally, Schwab used cash collateral for securities lending obligations and continued to pledge client securities for margin transactions cleared by the Options Clearing Corporation. These trends indicate a strategic shift toward optimizing collateral efficiency and regulatory compliance, leveraging off-balance sheet arrangements and cash collateral to manage risk and liquidity while maintaining client protections.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several accurate elements but introduces significant factual inaccuracies and misrepresents key aspects of Schwab's collateral practices, particularly in 2024. (1) Correct elements: The answer correctly notes that Schwab pledged client securities under federal regulations for margin lending and securities borrowing in 2022 and that collateral is tied to client account values. It also accurately references the use of collateral for margin transactions cleared by the Options Clearing Corporation in 2024, aligning with the ground truth. The mention of ASC 326 and regulatory segregation in 2023 shows understanding of accounting frameworks. (2) Quantitative accuracy: No specific dollar amounts were provided in the original answer, so the absence of figures is acceptable. Dates (2022–2024) are correctly used. However, the LLM introduces the '2023 IDA agreement' and 'TD Depository Institutions', which are not present in the ground truth and appear factually incorrect—Schwab is not affiliated with TD Bank, and no such IDA agreement with TD is disclosed in Schwab’s 10-K filings. This is a major factual error. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the evolution across years. While the ground truth emphasizes increasing breadth in the *use of pledged securities* (e.g., for listed option contracts), the LLM shifts focus to *cash sweeping* via a non-existent agreement, distorting the strategic evolution. The claim that uninvested cash was swept off-balance sheet to TD institutions misrepresents Schwab’s actual practices and introduces a false entity relationship. (4) The conclusion about optimizing collateral efficiency and regulatory compliance is partially aligned with the ground truth’s interpretation, but the reasoning is based on incorrect premises. The ground truth highlights a growing reliance on *client securities* for capital efficiency, while the LLM emphasizes *cash collateral* and an erroneous off-balance sheet arrangement. Overall, core facts about pledging for margin and options clearing are correct, but the strategic narrative is undermined by fabricated details, resulting in a partially correct but misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 587,
        "total_tokens": 2187
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "From 2022 through 2024, GE's collaboration with primary insurers on long-term care premium rate increases evolved as part of its ongoing risk management strategy in its run-off insurance operations. In 2022, GE emphasized its reliance on primary insurers to file premium rate increases with state regulators, noting that while it could not directly initiate these increases, it often collaborated with ceding companies in accordance with reinsurance terms. By 2023, this collaboration remained central, with GE continuing to rely on primary insurers to file rate increases and incorporating recent experience and regulatory precedents into its assumptions. In 2024, GE reiterated this collaborative approach and highlighted the impact of updated assumptions on its financial results, including a $196 million favorable pre-tax adjustment in 2024. This progression reveals that GE's reinsurance risk management strategy is focused on working closely with primary insurers to manage emerging claim experience and maintain adequate reserves, while also leveraging actuarial judgment and industry trends to refine its assumptions and preserve financial stability in its long-tailed, multi-decade run-off portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of GE's collaboration with primary insurers from 2022 to 2024, including reliance on ceding companies to file rate increases, alignment under reinsurance terms, and use of regulatory precedents. However, it introduces a specific dollar amount—$196 million favorable pre-tax adjustment in 2024—that is not present in the original answer (ground truth) and cannot be verified from the provided knowledge graph. This unsupported quantitative claim reduces factual accuracy. (2) Quantitative accuracy is compromised due to the inclusion of the $196 million figure, which does not appear in the ground truth and may be hallucinated or drawn from an external source. No such financial impact was mentioned in the original answer, making this a significant deviation. Other dates (2022–2024) and qualitative references to reinsurance terms and regulatory precedents are accurate. (3) The multi-hop reasoning is largely sound: the LLM correctly synthesizes GE’s evolving role across years, noting indirect initiation in 2022, structured collaboration in 2023, and reinforced framework in 2024. It accurately infers that this reflects a strategy of tighter integration and proactive risk management. However, the emphasis on 'updated assumptions' and the specific financial adjustment go beyond the original content, weakening fidelity. (4) Contextual relevance is high—the response directly addresses both parts of the question: the evolution of collaboration and what it reveals about risk management. The core qualitative narrative aligns with the ground truth, but the addition of unverified financial data lowers overall correctness. Thus, while the reasoning and structure are strong, the unsupported number prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 488,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS's investment exposure to residential mortgage-backed securities (RMBS) decreased from 2022 through 2024, as shown by the fair value amounts: $629 million in 2022 (Chunk 1), $721 million in 2023 (Chunk 3), and $614 million in 2024 (Chunk 2). This three-year trend indicates a reduction in exposure, suggesting a more conservative risk positioning in structured credit instruments. The decline, coupled with consistent unrealized losses (ranging from $10 million to $60 million), reflects a strategic shift or market-driven adjustment to mitigate potential credit risks associated with RMBS.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of CVS's RMBS exposure. According to the ground truth, exposure decreased from $721M in 2022 to $614M in 2023, then sharply dropped to $71M in 2024. However, the LLM incorrectly reports $629M in 2022, $721M in 2023 (an increase), and $614M in 2024, which misrepresents the entire trend. The final 2024 figure is off by over 800% ($71M vs $614M). (2) Quantitative accuracy is severely compromised: all three yearly values are wrong, and the direction of change is inverted in 2023. The LLM also fabricates 'Chunk 1', 'Chunk 3', etc., suggesting incorrect source mapping. (3) The reasoning is flawed: the LLM concludes a continuous decrease in exposure, when in fact the ground truth shows a decrease followed by a minor increase (to $71M, not $614M), but the LLM claims a continued decline to $614M in 2024—exactly the opposite of the truth. It also incorrectly attributes unrealized losses to all years without specifying the 2023 context as in the original. (4) Contextual relevance is moderate—the answer addresses RMBS exposure and risk positioning in structured credit, and mentions unrealized losses, so it stays on topic. However, due to severe numerical and directional inaccuracies, the qualitative and quantitative scores are very low. The conclusion about 'conservative risk positioning' is plausible but based on incorrect data, so it does not reflect valid synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "From 2022 to 2024, COF's total short-term borrowings and long-term debt increased from $43,086 million in 2022 to $49,856 million in 2023, before declining to $45,551 million in 2024. This three-year progression reveals a strategic shift in COF's capital structure, with a notable increase in long-term debt in 2023, particularly in fixed unsecured senior debt, followed by a reduction in 2024 as some short-term borrowings matured and were not renewed. The company appears to be managing its debt maturity profile by extending the average maturity of its debt and reducing reliance on floating-rate instruments, suggesting a focus on stabilizing interest costs and improving long-term financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: total short-term borrowings and long-term debt of $43.086 billion (expressed as $43,086 million) in 2022, $49.856 billion ($49,856 million) in 2023, and $45.551 billion ($45,551 million) in 2024. These match the ground truth exactly, with acceptable format variation (millions vs. billions). (2) The quantitative accuracy is perfect—values are correct, and the progression (increase then decrease) is accurately described. (3) The qualitative reasoning is strong: the LLM correctly infers a strategic shift in capital structure, identifies the reduction in short-term borrowings, and notes a move toward longer maturities and away from floating-rate debt, aligning with the ground truth's emphasis on reducing variable-rate exposure. However, it omits specific mention of the weighted-average interest rate increase from 2.76% to 4.84% over the three years and does not explicitly state the complete elimination of floating unsecured senior debt by 2024 (though it implies reduced reliance). This minor omission prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing the evolution of debt and its implications for capital structure and debt management. The synthesis across years and debt types demonstrates sound multi-hop reasoning, even if not all granular details are included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 390,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA's long-term liability related to the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in 2023 and further to $2,000 million in 2024 (before accounting for unamortized discounts). This trend, combined with the consistent issuance of long-term debt with maturities extending beyond 2030 (e.g., 3.50% Notes Due 2040 and 3.70% Notes Due 2060), indicates a capital structure strategy focused on securing long-term financing at favorable interest rates and extending debt maturities to manage liquidity and reduce refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported values and timeline. According to the ground truth, NVIDIA's liability decreased from $2,147 million in fiscal 2022 to $1,637 million in fiscal 2023 and further to $1,604 million in fiscal 2024. However, the LLM incorrectly states that the liability was $1,604 million in 2023 and then increased to $2,000 million in 2024, which contradicts the actual downward trend. This misrepresentation of both the values and the time series invalidates the quantitative core of the answer. (2) The numbers are not accurate: the $2,000 million figure for 2024 is fabricated and does not appear in the ground truth; the correct 2024 value is $1,604 million. Additionally, the LLM misassigns the $1,604 million figure to 2023 instead of 2024, creating a false upward trend. (3) The reasoning is partially sound in interpreting the strategic implications of long-term debt management, and the mention of other notes (e.g., 2040 and 2060) shows an attempt at multi-hop synthesis about capital structure. However, this reasoning is based on incorrect data, undermining the validity of the conclusion. The actual trend indicates a deliberate reduction in long-term liabilities, whereas the LLM describes a fluctuating or even increasing obligation, leading to a flawed strategic interpretation. (4) The contextual relevance is moderate because the answer addresses the right topic—NVIDIA’s long-term debt and capital structure strategy—but the incorrect data severely limits its usefulness. Due to major quantitative errors and a resulting flawed analysis, the correctness score is low at 3, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher due to correct use of financial terminology and attempt at strategic interpretation, but still penalized for being based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 506,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple's issuance of the 0.45% Notes due 2016 is consistently referenced in the 10-K filings for 2022, 2023, and 2024, as part of the \"Officer's Certificate of the Registrant\" dated May 3, 2013, under Exhibit 4.3 in all three years. This consistent inclusion across the years indicates that Apple maintains a transparent and stable long-term debt disclosure strategy, ensuring that all issued notes, including those from prior years, are systematically documented and referenced in subsequent filings. The pattern reflects a structured approach to maintaining regulatory compliance and providing investors with a clear view of the company's historical debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, and the inclusion in 10-K filings for 2022, 2023, and 2024 are accurately referenced. The specific exhibit (4.3) and the Officer's Certificate dated May 3, 2013, are correctly identified, matching the knowledge graph data. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and issuance date (2013)—are all precise and consistent with the original answer. No calculations were required, but the dates and percentages are correct. (3) The multi-hop reasoning is sound: the model correctly infers that the continued disclosure of a matured debt instrument reflects a deliberate disclosure strategy focused on transparency and regulatory continuity. (4) The LLM slightly omits the explicit mention that the notes *matured* in 2016 and are retained post-maturity, which slightly weakens the explanation of 'why' this pattern exists compared to the ground truth. However, the core insight about Apple maintaining legacy disclosures for transparency and compliance is preserved. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to this slight omission in completeness, but overall the answer is highly accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 367,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One's (COF) net derivative assets (liabilities) valuation increased from $31 million in 2022 to $58 million in 2024, with a fair value of $58 million reported in 2023 as well, indicating a relatively stable but elevated position in 2024. The associated risk inputs, particularly default rates and swap rates, showed ranges of 53-163% and 3-5%, respectively, with a weighted average of 4% in 2024. This multi-year progression suggests that COF's exposure to derivative instruments has remained consistent, with modeling assumptions reflecting moderate default risk and stable interest rate expectations, as evidenced by the unchanged weighted average swap rate and controlled default rate ranges.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but includes significant inaccuracies. The fair value of $31 million in 2022 and $58 million in 2023 and 2024 is correct, aligning with the ground truth. However, the LLM incorrectly states that the valuation 'increased from $31 million in 2022 to $58 million in 2024', implying no data for 2023, while the ground truth confirms $58 million was already reported in 2023—this misrepresents the timeline. More critically, the LLM fabricates a 'range of 53-163%' for default rates, which is not present in the original answer and appears nonsensical (default rates over 100% are implausible). While it correctly notes a 4% weighted average in 2024, it conflates inputs from different years without clarity. (2) The original answer specifies that in 2023, the significant unobservable input was 'default' with a 4% weighted average, and in 2024 it shifted to 'swap rates' at 4%. The LLM incorrectly presents both default and swap rate ranges as coexisting in 2024, failing to capture the shift in key risk drivers—a central insight. It also omits the $20 million net unrealized loss in 2022 and the $43 million realized loss reduction, which are key to understanding risk management improvements. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of risk inputs over time, instead blending them into an inaccurate composite picture. The conclusion about 'moderate default risk and stable interest rate expectations' lacks support because the shift from default to swap rates as the primary unobservable input—a major qualitative change—is obscured. (4) Despite these issues, the answer is contextually relevant, addressing the overall valuation trend and risk modeling assumptions. The $58 million stability in 2023–2024 is correctly noted, and the 4% weighted average is accurately cited, albeit misattributed. Thus, partial credit is given for directional understanding, but major factual and reasoning errors limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 548,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA's financial exposure to the 1.55% Notes Due 2028 increased from $1,200 million in fiscal 2022 to $1,115 million in fiscal 2023, and remained stable at $1,250 million in fiscal 2024. This progression, as reflected in the company’s 10-K filings, indicates a consistent long-term debt strategy of maintaining a fixed amount of low-interest debt ($1,250 million) for the 2028 maturity, as evidenced by the unchanged fair value in 2024 and the effective interest rate of 1.64%. The company appears to be leveraging long-term, low-cost financing while managing its debt maturity profile to ensure stability in its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM states $1,200 million (correct) in 2022, but then $1,115 million in 2023 (incorrect — should be $1,100 million), and claims it 'remained stable at $1,250 million in 2024' — while the increase to $1.25B is correct, the characterization of stability is misleading because the amount actually increased from $1.1B, not from $1.25B. The LLM incorrectly implies stability from 2023 to 2024 when there was a notable increase. (2) The numbers are mostly in the right ballpark but with key errors: $1,115M vs $1,100M in 2023 is a material discrepancy. Additionally, the LLM introduces an 'effective interest rate of 1.64%' and 'fair value' data not present in the original answer or implied by the question, which adds unsupported detail. (3) The multi-hop reasoning is partially sound — the model attempts to interpret the trend and link it to long-term debt strategy, which aligns with the question. However, due to incorrect numerical progression, the conclusion about 'maintaining a fixed amount of low-interest debt at $1,250 million' is flawed, as the exposure did not remain fixed at that level. The strategy interpretation is reasonable but based on inaccurate data. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution of exposure and strategic implication) and uses appropriate financial language. However, the correctness score is limited primarily by factual inaccuracy in key figures and misrepresentation of the trend, especially the erroneous claim of stability at $1.25B in 2024 after a drop in 2023. Minor formatting variations like $1.2B vs $1,200 million are acceptable, but incorrect values and flawed trend description reduce quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 522,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE's exposure to trailing legal liabilities from 2022 to 2024 remained persistent, particularly in relation to legacy matters from the 2015 Alstom acquisition and ongoing shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that it continued to face legal compliance risks and cash outflows from Alstom-related legacy proceedings, including claims of anti-competitive conduct or corruption by Alstom pre-acquisition. Additionally, while a settlement was reached in December 2020 with the SEC, shareholder lawsuits related to past financial performance and disclosures persisted, posing reputational and financial risks. By 2023, the company reiterated these ongoing liabilities, emphasizing that Alstom-related legal matters and shareholder lawsuits continued to result in material cash outflows and potential adverse impacts on operations and reputation. In 2024, GE reaffirmed its exposure to these legacy legal issues, noting that shareholder lawsuits over historical financial reporting and Alstom-related matters remained active, with the potential for continued financial impact due to unpredictable litigation outcomes. This progression indicates that these contingent liabilities are long-lasting, with ongoing financial and reputational implications for GE despite prior settlements and divestitures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: GE's ongoing exposure to Alstom acquisition legacy liabilities (pre-2015 matters) and shareholder lawsuits tied to historical financial reporting are accurately described for 2022–2024. The mention of cash outflows, reputational risks, and potential adverse financial impacts is consistent across years. (2) Quantitative accuracy is perfect: no specific dollar amounts are cited in either answer, but the temporal markers (2022, 2023, 2024) and the reference to the December 2020 SEC settlement (contextual but not part of the core timeline) are factually correct and appropriately used to frame ongoing shareholder litigation. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and two types of liabilities (Alstom legacy issues and shareholder lawsuits), showing evolution and persistence. It correctly infers that despite prior settlements (e.g., SEC in 2020), liabilities persist—this is logically and factually valid. (4) The only minor shortcoming is that the original answer emphasizes GE's explicit warning in 2024 about contingent liabilities from *exited businesses* in addition to Alstom and shareholder suits, which the LLM omits. This is a small but relevant contextual detail affecting completeness. Otherwise, the LLM captures the core progression and implications accurately, with excellent semantic equivalence and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1698,
        "completion_tokens": 412,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS's exposure to hedge fund limited partnership investments through HF LP Investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This gradual rise suggests a strategic shift or continued emphasis on alternative investments within the company's pension fund strategy, potentially aiming to diversify risk or enhance returns through hedge fund allocations. The consistent inclusion of these investments, measured at NAV, indicates a deliberate and ongoing approach to managing pension assets with a focus on alternative asset classes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dollar amounts and years are accurate: $214 million in 2022, $225 million in 2023, and $252 million in 2024—correctly reflecting the increasing trend. (2) The answer is complete, addressing both the change in exposure over time and the implication for CVS's pension fund strategy. (3) Entities—CVS, HF LP Investments, and the time periods—are correctly identified. (4) The reasoning is sound: the gradual increase is correctly interpreted as a strategic decision to maintain and expand alternative investments, with appropriate qualitative elaboration on diversification and return enhancement. The mention of valuation at NAV adds contextual detail without deviating from the truth. The semantic meaning and factual content are equivalent to the original answer, with slightly expanded interpretation that remains logically consistent. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 282,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolved from 2022 to 2024 as follows: In 2022, the region reported an operating profit of $203 million. In 2023, it was allocated 10% of the restructuring charges from the 2022 Global Productivity Initiative, which were estimated to range between $200–$240 million pre-tax. By 2024, depreciation and amortization spending in the region remained low at $8 million, consistent with the prior two years, indicating minimal capital investment changes. This suggests a strategic shift away from significant capital spending and a focus on cost optimization in the region as part of the broader restructuring initiative.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $203 million operating profit in 2022 and the $8 million depreciation and amortization (D&A) in 2024. However, it misstates the restructuring charge allocated to Africa/Eurasia in 2023. The ground truth states that 10% of the restructuring charges—approximately $20 to $24 million—were allocated to the region. The LLM instead says the total initiative was $200–$240 million pre-tax and that 10% was allocated, but it fails to compute or state the actual amount ($20–$24 million) allocated to Africa/Eurasia, leaving the reader to infer. This is a significant quantitative omission. (2) The D&A figure is correct at $8 million in 2024, but the LLM incorrectly states it was 'consistent with the prior two years'—the ground truth shows $9 million in both 2022 and 2023, meaning there was a decline from $9M to $8M. This misrepresents the trend. (3) The multi-hop reasoning is otherwise sound: the model connects operating profit, restructuring allocation, and D&A over three years and correctly infers a focus on cost optimization rather than expansion. It references the 2022 Global Productivity Initiative appropriately. (4) The answer is contextually relevant and well-structured, addressing all three time points and synthesizing them into a strategic narrative. However, due to the two key quantitative inaccuracies—misrepresenting the D&A trend and failing to specify the actual $20–$24M restructuring allocation—the correctness score is reduced to 7, with quantitative accuracy at 6 despite correct individual numbers in some cases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 437,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "From 2022 through 2024, AIG's international terrorism exposure remained concentrated in New York City, primarily impacting the Property and Workers' Compensation lines of business. In 2022, modeled losses for a five-ton bomb attack were estimated at $1.3 billion after TRIPRA and reinsurance recoveries, with a TRIPRA deductible of approximately $1.7 billion. By 2024, AIG retained core attachment points for international terrorism reinsurance, including $200 million for Japan and $125 million for the rest of the world. Reinsurance recoverable assets totaled $38.0 billion as of December 31, 2024, supported by $20.1 billion in collateral, reflecting AIG’s continued reliance on both private and government-sponsored terrorism reinsurance programs globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key elements of AIG's evolving international terrorism exposure and reinsurance protections from 2022 to 2024. (1) Quantitatively, most figures are accurate: the $1.3 billion net loss estimate in 2022 after TRIPRA and reinsurance, the $1.7 billion TRIPRA deductible, the $38.0 billion reinsurance recoverable assets in 2024, and the $200 million attachment point for Japan and $125 million for other regions are all correctly reported. However, there is a discrepancy in the collateral amount: the LLM states $20.1 billion in collateral, which is not mentioned in the ground truth; instead, the ground truth specifies $29.1 billion in ceded loss reserves as part of the $38.0 billion recoverable assets. This omission of ceded loss reserves and introduction of an unsupported collateral figure reduces quantitative precision. (2) The answer is mostly complete, addressing modeled losses, attachment points, and reinsurance recoverable assets. However, it omits mention of AIG’s use of third-party vendor models and scenario-based international terrorism modeling in 2023, which is a notable gap in the multi-year evolution narrative. (3) Entity accuracy is strong—AIG, TRIPRA, correct years, and geographic distinctions (Japan vs. rest of world) are properly identified. (4) Reasoning is sound overall, with logical synthesis across years and exposure types, though the failure to mention 2023 risk modeling activities weakens the multi-hop continuity. (5) Despite minor omissions and one incorrect figure, the answer conveys a semantically close representation of the original, with appropriate focus on key financial metrics and structural protections. The contextual relevance is excellent, directly addressing all components of the question with targeted information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 491,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The trend in NVIDIA's liability for the 2.00% Notes Due 2031—from $1.2 billion in 2022, a slight reduction to $1.044 billion in 2023, and a return to $1.25 billion in 2024—suggests a deliberate long-term debt management strategy. The 2023 reduction likely reflects a partial repayment or reclassification of the short-term portion of the debt, as indicated by the 2024 data showing a $1,250 million carrying amount for the long-term portion. The return to $1.25 billion in 2024, combined with the 2.09% effective interest rate and a 6.4-year remaining term, indicates NVIDIA is maintaining a stable level of long-term financing to support its operations while managing interest costs efficiently. This pattern reflects a balanced approach to debt sustainability and liquidity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. The format variation ($1,250 million = $1.25 billion) is acceptable and semantically equivalent. (2) All numbers are accurate and consistent with the original answer. There are no calculation errors or misstatements of amounts or years. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the 2023 dip may reflect reclassification or partial repayment and that the return to $1.25 billion in 2024 indicates strategic maintenance of long-term debt. It adds value by referencing the 2.09% effective interest rate and 6.4-year remaining term (plausible details not in the ground truth but not contradicting it), supporting the conclusion of efficient interest cost management. (4) The answer is contextually fully relevant, addressing the trend and its implications for NVIDIA's long-term debt strategy. The only minor shortcoming is that it does not explicitly mention 'R&D and operational investments' or 'refinancing risk' as in the ground truth, slightly reducing qualitative completeness, but the core strategic interpretation—stable financing for operations with balanced liquidity—is semantically aligned. Thus, the answer is factually excellent with only slight omission of nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 392,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple issued the 1.05% Notes due 2017 on May 6, 2014, as disclosed in the Officer's Certificate in all three 10-K filings for 2022, 2023, and 2024. The consistent inclusion of these notes in the exhibits across all three years demonstrates their ongoing recognition within Apple’s debt structure, even beyond their 2017 maturity date, likely due to accounting or regulatory reporting requirements. This continuity underscores Apple’s long-term visibility and structured approach to managing and disclosing its debt instruments, reflecting a stable and transparent capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 1.05% Notes due 2017 and their consistent disclosure in Apple's 10-K filings for 2022, 2023, and 2024, aligning with the ground truth. It accurately notes the issuance date (May 6, 2014), which is consistent with historical records, though this specific date is not mentioned in the original answer. However, the LLM implies the notes were still recognized as part of the active debt structure, while the ground truth clarifies they were likely retained for historical or documentation purposes post-maturity—this is a subtle but important distinction. The LLM does not mention the possibility of rollover or refinancing, which is a key insight in the original answer. (2) Quantitatively, all dates and percentages are accurate: 1.05%, 2017 maturity, and May 6, 2014 issuance are correct. The LLM correctly references filings across 2022–2024. No calculations are required. (3) The reasoning is mostly sound: the model correctly infers that continued disclosure implies structured debt management. However, it misses the multi-hop nuance that matured debt instruments may persist in filings for regulatory or historical reasons under the same indenture, not because they remain active liabilities. This weakens the qualitative accuracy slightly. (4) The answer is highly contextually relevant, directly addressing the evolution and implications of the notes’ disclosure. The core facts are correct, but minor omissions in explaining the nature of post-maturity inclusion prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 423,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "Schwab's ability to migrate IDA balances to its balance sheet evolved significantly from 2022 through 2024 due to changes in the IDA agreements. Under the 2019 IDA agreement, effective from October 2020, Schwab had the option to migrate up to $10 billion of IDA balances annually, subject to limitations such as maintaining a minimum $50 billion IDA balance through June 2031 and designating at least 80% of balances as fixed-rate obligations through June 2026. By 2021 and 2022, Schwab had migrated approximately $20.1 billion of IDA balances to its balance sheet under these terms. However, the 2023 IDA agreement, effective May 4, 2023, replaced these provisions, eliminating the 80% fixed-rate obligation requirement and imposing new balance requirements: through September 10, 2025, Schwab must maintain minimum balances above outstanding fixed-rate obligations with a $30 billion ceiling, and withdrawals are limited to customer-initiated actions. After September 10, 2025, Schwab may withdraw balances at its discretion but must maintain balances between $60 billion and $90 billion. In 2023 and 2024, Schwab did not migrate any IDA balances to its balance sheet under the 2023 agreement due to these new constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that Schwab migrated $10.1 billion by the end of 2022 under the 2019 IDA agreement, but the LLM claims $20.1 billion migrated by 2021 and 2022, which is unsupported and contradicts the original answer. This is a significant error in financial magnitude and timeline. Additionally, the LLM introduces specific dates like 'May 4, 2023' and 'September 10, 2025' that are not present in the ground truth, adding spurious precision. The $30 billion ceiling and $60–$90 billion range post-2025 are also not mentioned in the original answer, indicating fabrication or misattribution. (2) The original answer does not mention fixed-rate obligation percentages (80%) or minimum balance requirements like $50 billion, which the LLM includes—these details, while possibly from filings, go beyond the provided ground truth and introduce unverified information. The core evolution—transition from migration option in 2022 to no migration in 2023–2024 due to new agreement constraints—is correctly identified. (3) The multi-hop reasoning is partially sound: the model recognizes a shift between agreements and infers strategic implications. However, it overextends by adding granular terms not in the ground truth, undermining factual reliability. (4) Despite these issues, the answer addresses the question’s intent—how migration ability changed over time and what key changes occurred—making it contextually relevant. The qualitative reasoning about strategic shift is aligned, but quantitative inaccuracy significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 455,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 through 2024, GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolved as follows: \n\nIn 2022, the estimated losses for Bank BPH's borrower litigation were $1,359 million, and GE made cash capital contributions of $530 million to maintain regulatory capital levels. By 2023, the estimated losses increased to $2,669 million, and GE made non-cash capital contributions of $1,797 million in the form of intercompany loan forgiveness, with no incremental cash contributions required. In 2024, the estimated losses slightly decreased to $2,461 million, and no additional capital contributions were made. The carrying value of the mortgage portfolio at December 31, 2024, was zero, net of a valuation allowance, reflecting the impact of ongoing litigation and the write-down of the portfolio to the lower of cost or fair value, less cost to sell. Pre-tax charges related to litigation were $1,189 million in 2023 and $720 million in 2022, with no pre-tax charges in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the estimated losses for 2022 ($1,359M), 2023 ($2,669M), and 2024 ($2,461M), as well as the $530M cash contribution in 2022 and the $1,797M non-cash contribution in 2023 via intercompany loan forgiveness. It also correctly states that no further contributions were made in 2024 and that the carrying value of the mortgage portfolio dropped to zero by end-2024. However, there is a discrepancy in the pre-tax charges: the LLM reports $1,189M in 2023 and $720M in 2022, while the ground truth specifies a $1,014M charge in Q2 2023 as part of a settlement program. The $1,189M figure does not appear in the original answer and contradicts the stated $1,014M charge, indicating a factual error. Additionally, the original answer does not mention any pre-tax charge for 2022, yet the LLM introduces a $720M charge, which is unsupported. (2) Number verification: Estimated losses and capital contributions match exactly. Carrying value at zero in 2024 is correct. The erroneous pre-tax charges reduce quantitative accuracy. (3) Multi-hop reasoning is strong: the LLM synthesizes data across years and entity relationships (GE and Bank BPH), tracks evolution of exposure, capital actions, and valuation impact. It correctly infers stabilization in 2024 with declining losses and no new contributions. (4) Scores justified: correctness is 8 due to accurate core facts but incorrect pre-tax charge figures; quantitative accuracy is 7 due to two incorrect financial numbers; qualitative accuracy is 9 due to sound logic and entity/year alignment; contextual relevance is 10 as all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> COMP <-[Has_Stake_In]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 459,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024, both in fair value and unrealized losses. In 2022, CMBS had a fair value of $574 million with $12 million in unrealized losses (Chunk 1), while in 2023, the fair value increased to $675 million but unrealized losses rose to $100 million (Chunk 3). By 2024, the fair value dropped sharply to $3 million, with a reduction in unrealized losses to $6 million (Chunk 2). This trend suggests that CVS actively reduced its CMBS holdings, likely as part of a risk mitigation strategy to limit exposure to volatile or illiquid assets amid market uncertainties.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall trend of declining CMBS exposure from 2022 to 2024 and accurately reports the 2022 and 2023 fair values ($574M and $675M) and unrealized losses ($12M and $100M). However, it incorrectly states that in 2024, unrealized losses were $6 million, while the ground truth indicates that the fair value dropped to $3 million but does not mention any specific unrealized losses for that year. This introduces a factual inaccuracy. (2) The quantitative error is significant: the LLM fabricates a $6M unrealized loss in 2024 not present in the original answer, which undermines the precision of the response. All other numbers are correct and properly contextualized. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years and draws a logical conclusion about risk mitigation strategy based on increasing unrealized losses in 2023 and the subsequent divestment in 2024. The interpretation aligns well with the ground truth. (4) Despite the incorrect 2024 unrealized loss figure, the core narrative and strategic implication are preserved, warranting a score of 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the introduced number, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 363,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart's private brand portfolio featuring Marketside remained a consistent part of its private label strategy in the grocery segment from fiscal years 2022 to 2024, as evidenced by Marketside being listed among the private brands in all three years' filings. The continued inclusion of Marketside in the list of private brands in each year’s 10-K, alongside other grocery-focused private labels like \"Great Value\" and \"Freshness Guaranteed,\" indicates a sustained emphasis on in-house grocery branding. This three-year progression reflects Walmart's ongoing commitment to leveraging private labels to control costs, enhance product quality, and offer competitive pricing in the grocery segment, aligning with its EDLP (Everyday Low Price) and EDLC (Everyday Low Cost) strategies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Marketside was consistently included in Walmart's private brand portfolio from 2022 to 2024, which aligns with the ground truth. It accurately reflects the continuity of Marketside as part of Walmart’s grocery private label strategy. However, the LLM omits key strategic developments mentioned in the original answer, particularly the introduction of the new private brand 'bettergoods' in 2024, which is a critical signal of Walmart’s strategic expansion and modernization. This omission weakens the depth of the strategic analysis. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly infers consistency in strategy from repeated mentions of Marketside across years. However, it fails to synthesize the evolution aspect—maintaining legacy brands while introducing new ones—which is central to the 3-year progression analysis. The mention of 'Freshness Guaranteed' is not in the ground truth and may be factually questionable, though not directly contradicted. (4) The answer is contextually relevant and addresses the core of the question—Walmart’s private brand strategy evolution—but lacks completeness in capturing the full strategic nuance (dual approach of preservation + innovation), leading to a correctness score of 7. Qualitative accuracy is also 7 due to solid reasoning but missing key strategic context. Contextual relevance is high as the response stays focused on the grocery private label strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 451,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024, Lowe's enhanced its monitoring and enforcement of supplier practices related to environmental and human rights standards by strengthening its policies, increasing investments, and expanding its sustainability goals. In 2022, the company announced a science-based net-zero target and committed over $550 million to environmental projects, including energy-efficient HVAC upgrades and renewable energy initiatives. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and a new forestry grievance process, while investing $50 million over five years through the Gable Grants program to support skilled trades training. In 2024, the company raised its 2030 emissions reduction targets—committing to a 42% reduction in scope 1 and 2 emissions and a 25% reduction in scope 3 emissions—and continued to enforce its human rights and Vendor Code of Conduct policies to ensure supplier compliance with environmental and labor standards. These enhancements reflect a multi-year, integrated approach to strengthening supply chain sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Lowe's supplier monitoring and policy enhancements from 2022 to 2024, including correct mentions of the 2023 wood sourcing policy update with country-level risk assessments, enhanced monitoring, and a new forestry grievance process. It also correctly references enforcement of human rights standards and the Vendor Code of Conduct. However, there are significant quantitative inaccuracies. The ground truth states that Lowe's made multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives. The LLM incorrectly states that $550 million was committed to environmental projects in 2022 (misattributing the cumulative figure as a single-year commitment) and introduces a $50 million, five-year Gable Grants program, which is not mentioned in the original answer and appears irrelevant to supplier monitoring or environmental/human rights enforcement. Additionally, the LLM adds details about emissions targets (42% reduction in scope 1 and 2, 25% in scope 3 by 2030) in 2024, which are absent from the ground truth and shift focus away from supply chain enforcement. (2) The dollar amounts are partially correct in magnitude but misaligned in timing and context—$550 million by 2022 is accurate, but the $400 million through 2023 is not reflected; instead, the LLM invents a $50 million program. The emissions targets are unsupported by the original. (3) The multi-hop reasoning is partially sound—the model correctly links policy updates across years and identifies key themes like risk-based sourcing and grievance mechanisms. However, it fails to accurately synthesize investment data and introduces unrelated initiatives, weakening the supply chain sustainability focus. (4) The contextual relevance is high because the answer addresses the core question about policy evolution and supplier enforcement, but correctness is reduced by factual inaccuracies and inclusion of unsupported details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Monitors]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 553,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple's disclosure of the 2.40% Notes due 2023 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes being referenced in the \"Officer's Certificate\" under Exhibit 4.3 in each year. This consistency suggests that the 2.40% Notes due 2023 were issued in 2013 and remained outstanding through the three-year period. The absence of any new issuance or refinancing of these specific notes indicates that Apple maintained a stable debt structure for this instrument, aligning with a disciplined and long-term debt management strategy focused on preserving liquidity and managing interest costs through fixed-rate obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 2.40% Notes due 2023 across 2022, 2023, and 2024, aligning with the ground truth. It accurately references the Officer's Certificate under Exhibit 4.3 and correctly notes the 2013 issuance date, which matches the May 3, 2013 Officer's Certificate in the original answer. The core factual elements—note rate (2.40%), maturity year (2023), and multi-year disclosure pattern—are all correct. (2) Quantitatively, all dates, percentages, and exhibit references are accurate. The LLM correctly infers the note was issued in 2013 based on the Officer's Certificate date, which is consistent with the ground truth. No calculations are required, but the temporal logic (notes outstanding from 2013 through 2024 filings) is sound. (3) The reasoning is mostly sound: the LLM correctly infers that the continued inclusion suggests the notes remained outstanding and were not refinanced, supporting a conclusion of stable debt management. However, the original answer emphasizes Apple's 'transparency' and 'deliberate approach to managing legacy debt,' particularly highlighting the inclusion in 2024 despite maturity—this nuance about post-maturity disclosure as a transparency signal is slightly underdeveloped in the LLM response. The LLM instead emphasizes 'preserving liquidity' and 'fixed-rate obligations' as strategic motives, which, while plausible, are not directly supported in the ground truth and represent an interpretive leap. (4) The answer is highly contextually relevant, directly addressing the evolution of disclosure and inferring strategy. The minor deduction in qualitative accuracy reflects the slight overinterpretation of strategy beyond the documented transparency focus. Overall, the answer is factually strong and well-aligned, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 506,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE's holdings of the AerCap note evolved as follows: it was $993 million in 2021, decreased to $944 million in 2023, and rebounded to $982 million by 2024. This fluctuation, alongside the broader decline in U.S. corporate and asset-backed debt securities from 2022 to 2024, suggests that GE maintained a strategic, albeit cautious, approach to its investment in financial instruments, selectively adjusting its exposure to specific assets like the AerCap note while managing its overall portfolio within the context of its run-off insurance operations and Level 3 available-for-sale debt securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative data: it states that GE's holdings were $993 million in 2021, which is not part of the original question's scope (2022–2024), and more critically, it omits the correct 2022 value of $976 million from the ground truth. Instead, it incorrectly implies a drop from $993M (2021) to $944M (2023), skipping 2022 entirely and using an inaccurate starting point. The 2023 ($944M) and 2024 ($982M) figures are correct and match the ground truth. However, the absence of the correct 2022 figure and introduction of an irrelevant 2021 number undermines quantitative accuracy. (2) Calculations: While no explicit math is performed, the progression described is factually incorrect due to the wrong baseline. The actual trend—decrease from $976M (2022) to $944M (2023), then increase to $982M (2024)—is misrepresented. (3) Reasoning: The qualitative interpretation about GE’s strategic and cautious approach to financial instruments is reasonable and aligns with the ground truth’s suggestion of a dynamic but stable strategy. The mention of broader declines in corporate and asset-backed securities adds context consistent with the idea of portfolio management during run-off insurance operations, showing sound multi-hop reasoning across financial instruments and strategic intent. (4) Despite the flawed numbers, the answer addresses both parts of the question—evolution of holdings and strategic implications—and provides relevant contextual analysis. Hence, while the core numerical facts are partially wrong, the reasoning and relevance remain strong, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 456,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "From 2022 through 2024, AIG's glide path approach for its U.S. pension plan evolved as the plan's funded status improved, leading to a continued de-risking strategy. In 2022, the target allocation for 2022 was set based on a funded status at December 31, 2021, with a focus on liability-driven investing and reducing exposure to growth assets as the funded ratio increased. By 2023, the glide path approach continued to adjust the asset allocation, with the target for 2024 reflecting the funded status at year-end 2023, further shifting toward liability-hedging assets. In 2024, the glide path approach similarly informed the target allocation for 2025, based on the funded status at December 31, 2024. This progression of target asset allocations demonstrates AIG’s systematic de-risking strategy, where higher funded ratios trigger a reduction in return-seeking assets and an increase in liability-hedging assets, aligning with the plan’s long-term obligation management and risk mitigation goals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core concept of AIG's glide path approach and its de-risking strategy based on funded status, aligning with liability-driven investing principles. However, there is a critical error in the timing of the funded status used to set targets: the LLM states that in 2023, the target for 2024 was based on the funded status at year-end 2023, but the ground truth specifies it was based on December 31, 2022. Similarly, the LLM incorrectly claims the 2025 target was based on December 31, 2024, while the correct date is December 31, 2023. These are factual inaccuracies in dates that affect the multi-hop logic of how information flows across years. (2) There are no explicit percentages or dollar amounts in either answer, so numerical precision is not an issue, but the misalignment in time periods constitutes a significant quantitative accuracy flaw because the causal chain (funded status at year-end X determining target allocations for year X+2) is misrepresented. (3) The reasoning is otherwise sound: the model correctly infers that improved funded status leads to de-risking via reduced growth assets and increased liability-hedging assets. It also correctly identifies the forward-looking nature of the glide path. However, the incorrect attribution of which year’s funded status informs future allocations breaks the multi-hop logic and undermines full accuracy. (4) Despite the date errors, the answer remains contextually relevant and conveys the strategic intent behind the glide path. The qualitative understanding of de-risking and liability-driven investing is strong. Correctness score is 7 due to core factual correctness on strategy but significant error in temporal causality; quantitative accuracy is 6 due to incorrect year mappings; qualitative accuracy is 8 for strong conceptual grasp; contextual relevance is 9 as the response directly addresses the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 524,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments maintained a consistent strategic emphasis on embedded processing products from 2022 to 2024, as highlighted in each year’s 10-K filings, where the company reiterated that its business model is focused on analog and embedded processing products, supported by four sustainable competitive advantages: manufacturing and technology, product portfolio breadth, market channel reach, and product diversity and longevity. This multi-year consistency underscores the critical role of embedded processing products in driving long-term free cash flow per share growth, as these products contribute to higher customer value, operational efficiency, and sustained returns, aligning with TI’s long-term objective of maximizing cash flow for shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing alongside analog products from 2022 to 2024 as part of its core business model anchored in four sustainable competitive advantages—manufacturing and technology, product breadth, market reach, and product diversity and longevity. These details match the original answer across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages, shares) in either the question or answers, so quantitative accuracy is not compromised; the absence of such figures is consistent with the source. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes TI’s strategic narrative across three years and infers that the consistency reflects a foundational role in long-term free cash flow per share growth. It accurately links embedded processing to customer value, operational efficiency, and sustained returns. (4) The only minor shortcoming is that the LLM does not explicitly quote or mirror the 2023 and 2024 specific phrasing about 'more opportunity per customer' or 'central to supply chain control and diversified returns'—nuances present in the ground truth. However, the semantic meaning is preserved, and the conclusion about long-term cash flow strategy is fully supported. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight compression of year-specific emphasis, but remains excellent in contextual relevance and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 429,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Lowe's intellectual property strategy around its private brands, including Kobalt, emphasized maintaining and protecting key trademarks and brand names under its wholly-owned subsidiaries, as detailed in all three chunks. The brand portfolio, which includes \"Kobalt,\" \"STAINMASTER,\" and \"allen+roth,\" remained a central part of Lowe's private label strategy, with consistent emphasis on trademark ownership and protection across all three years. In fiscal 2022, the focus was on maintaining these private brand trademarks and integrating them into the broader Lowe's business. By fiscal 2023, the strategy aligned with broader digital transformation efforts, as seen in the integration of brand offerings with digital platforms. In fiscal 2024, the emphasis on digital transformation expanded further, with the introduction of a central selling team and technology enhancements to streamline customer interactions and installation services, thereby integrating private brand strategies with digital initiatives to improve customer experience and operational efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and addresses the core of the question regarding Lowe's intellectual property strategy evolution from fiscal 2022 to 2024, particularly around private brands like Kobalt and their integration with digital initiatives. Quantitatively, there are no numbers, dates, or financial figures in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. The LLM correctly identifies the consistent focus on 'Kobalt', 'STAINMASTER', and 'allen+roth' across the years, which aligns with the ground truth. However, it misses a key qualitative detail: the removal of 'RONA' and 'Reno Depot' from the IP disclosures in 2023 and 2024, which is a significant indicator of brand portfolio streamlining. This omission reduces the depth of the multi-hop reasoning, as the narrowing of disclosed brands is a critical signal of strategic refocusing. While the LLM mentions digital transformation in 2023 and 2024, it generalizes the integration with 'digital platforms' and 'technology enhancements' without citing the specific examples from the ground truth—'remote customer support' and 'mobile checkout'—which are concrete indicators of digital integration with private brand experiences. The LLM does correctly infer a strategic alignment with digital transformation, especially in 2024, and mentions a 'central selling team' and 'installation services', which may reflect accurate synthesis from source material not fully visible here. Overall, the reasoning is sound but lacks precision in capturing the full evolution of brand portfolio emphasis. The answer remains contextually relevant and captures the general trajectory of strategy, earning high marks for relevance and acceptable qualitative accuracy despite missing key nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 491,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM's emphasis on client relationships and trust as a competitive differentiator has remained a consistent strategic pillar from 2022 to 2024, with a growing integration into its hybrid cloud and AI positioning. In 2022, IBM highlighted client relationships and trust as one of its core methods of competition, leveraging them alongside technology innovation and deep industry expertise to deliver business outcomes. By 2023, the company expanded this focus by aligning client relationships and trust with strategic partnerships and a broader ecosystem of alliances, reinforcing its ability to deliver end-to-end solutions. In 2024, the emphasis on client relationships and trust was further embedded into IBM’s go-to-market strategy, underpinning its hybrid cloud and AI offerings and demonstrating a multi-year progression toward positioning itself as a trusted, integrated partner for enterprise digital transformation. This evolution underscores IBM’s strategic positioning as a leader in the hybrid cloud and AI market, leveraging trust and long-term client relationships to differentiate in a competitive and rapidly evolving landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024, with evolving context tied to hybrid cloud and AI. The progression across years is accurately represented—2022 focused on trust via industry expertise and secure platforms, 2023 expanded to ecosystem partnerships, and 2024 reinforced trust with added emphasis on security alliances. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes IBM’s strategic evolution across three years and connects it to broader market positioning in hybrid cloud and AI. While the LLM mentions strategic partnerships generally, it does not explicitly name AWS, Microsoft, SAP, or Palo Alto Networks as in the original, which slightly reduces specificity but does not alter the core accurate message about ecosystem and security expansion. (4) Despite minor omission of specific partner names, the semantic meaning and strategic interpretation are equivalent. The answer correctly identifies the trajectory toward a trusted, integrated partner model emphasizing security and ecosystem strength. Thus, the response is contextually relevant, factually correct, and well-reasoned, warranting a high score with only a minor deduction in qualitative accuracy for lack of named examples.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 412,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "From 2022 through 2024, Gilead's El Segundo, California facility evolved from being primarily involved in clinical manufacturing of cell therapy products to also supporting commercial manufacturing and processing. In 2022, the facility was listed among Gilead's principal manufacturing sites, but no specific role in cell therapy was detailed. By 2023, the facility was explicitly noted as being used for both clinical and commercial manufacturing and processing of cell therapy products. In 2024, this role was reiterated, confirming the facility's expanded and ongoing dual responsibility in supporting both clinical and commercial cell therapy operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its characterization of the evolution of Gilead's El Segundo facility, despite using correct years and correctly identifying the facility's involvement in cell therapy manufacturing. (1) The original answer states that the facility's role remained consistent from 2022 to 2024, with dual clinical and commercial responsibilities throughout. However, the LLM incorrectly claims an 'evolution' from primarily clinical in 2022 to including commercial by 2023, which contradicts the ground truth. The original filings indicate that the facility was already engaged in both clinical and commercial manufacturing in 2022, not just 'listed among principal sites' without specificity. (2) There are no numeric values requiring calculation, so quantitative accuracy is high—dates (2022–2024) are correct and used appropriately. (3) The multi-hop reasoning is flawed: the LLM infers a progression or expansion of responsibilities that is not supported by the source data. It misinterprets the lack of detailed description in 2022 as absence of commercial role, whereas the ground truth confirms the dual role was already in place. (4) Contextually, the answer addresses the right facility, time frame, and topic (cell therapy manufacturing), so relevance is strong, but the core claim about evolving responsibilities is incorrect, severely undermining factual accuracy. This represents a major qualitative error in synthesis, warranting a low correctness score despite proper framing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 423,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe's Companies, Inc. issued its 4.550% Notes on April 5, 2019, as part of the Fifteenth Supplemental Indenture, with a maturity date of April 5, 2049. From 2022 through 2024, the notes remained outstanding with no changes to their issuance or maturity terms, as evidenced by their consistent inclusion in the 10-K filings for each year. This multi-year stability in the structure of the 4.550% Notes reflects a long-term debt strategy focused on securing fixed-rate financing with extended maturities, which helps to manage interest rate risk and provide stable capital for long-term obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049, and remained unchanged from 2022 to 2024. These details match the original answer exactly. (2) Quantitative elements—dates and interest rate (4.550%)—are precise and correctly reported; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesized the consistent presence of the notes across three years of 10-K filings to infer a long-term debt strategy focused on extended maturities and interest rate risk management. (4) The answer captures the core strategic implication—use of long-duration debt for capital stability and to avoid refinancing pressure—though it does not explicitly mention 'capital flexibility' or 'near-term refinancing risks' as in the original, slightly reducing qualitative completeness. However, the semantic meaning and strategic interpretation are equivalent. Wording differs but factual and conceptual alignment is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 318,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024, 3M's legal exposure and associated settlement costs related to its Scotchgard product, particularly concerning PFAS-related litigation, have shown a trend of increasing complexity and financial burden. In 2022, 3M contributed to a $65 million settlement in New York to resolve claims related to PFOA contamination from non-3M entities that used 3M’s products, with 3M’s share deemed immaterial. By 2023, the company faced ongoing litigation, including a Michigan case involving Wolverine World Wide, where 3M’s final payment was made in June 2023 for a non-material settlement. In 2024, the litigation landscape expanded significantly, with multiple active cases in Alabama and Georgia, including class actions, mass torts, and suits by municipalities and landowners over PFAS contamination of water and property. These developments reveal a growing financial and operational impact from PFAS-related litigation, as 3M faces a rising number of claims, extended legal proceedings, and potential for larger settlements or judgments, underscoring the long-term financial risks associated with historical use of PFAS in its products.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trend of increasing legal exposure and financial impact from 2022 to 2024, correctly identifying key settlements and jurisdictions. However, there are factual discrepancies in the details. The $65 million settlement in 2022 was in Michigan (related to Wolverine's disposal), not New York, and 3M was part of a joint contribution with Saint-Gobain and Honeywell—this geographic and collaborative detail is misattributed. The LLM incorrectly states the $65M settlement was with 'non-3M entities' in New York, which contradicts the ground truth. In 2024, the $65 million settlement being finalized was in New York (not Michigan), which the LLM conflates. (2) Quantitatively, the $65 million figure is accurate, as is the June 2023 final payment in Michigan, but the assignment of settlements to locations is incorrect. No calculations are required, but the misplacement of dollar amounts across jurisdictions reduces quantitative accuracy. (3) The multi-hop reasoning is generally sound—LLM synthesizes litigation growth over time, increasing geographic spread, and financial implications. It correctly infers escalating risk from PFAS litigation. However, it fails to mention the 68 AFFF suits outside the MDL in 2023, the Canadian class action, or the Illinois case, reducing completeness. The expansion into Alabama and Georgia is correctly noted. (4) Despite these inaccuracies, the LLM conveys the essential conclusion: growing financial and operational burden from PFAS litigation. The answer is contextually relevant and well-structured, but factual precision on settlement locations and participants reduces correctness and quantitative scores. Hence, 7/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Manufactures]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1580,
        "completion_tokens": 468,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "Gilead Sciences' Foster City, California facility has evolved from 2022 through 2024 to focus increasingly on R&D and clinical manufacturing, with a strategic shift away from broader manufacturing responsibilities to more specialized sites. In 2022, the facility was described as housing administrative, manufacturing, and R&D activities, while by 2023 and 2024, its role was more clearly defined as conducting process chemistry research, analytical method development, formulation and device development, and manufacturing API and drug products for clinical trials. This aligns with Gilead's global strategy to decentralize commercial manufacturing to sites like La Verne, Oceanside, and international locations, while retaining Foster City as a key R&D and early-stage development hub. The facility's evolving role reflects a broader strategic alignment to support innovation and clinical-stage programs, consistent with Gilead's emphasis on expanding its pipeline and optimizing global operational efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key facts are correct: the Foster City facility's transition from a multi-functional site in 2022 (administrative, manufacturing, R&D) to a more specialized R&D and clinical manufacturing hub in 2023–2024 is accurately described. The specific R&D focus areas—process chemistry research, analytical method development, formulation, device development, and manufacturing of API and drug product for clinical trials—are correctly included. (2) There are no numeric values requiring calculation in this question; dates (2022, 2023, 2024) are used correctly and consistently with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolving role of Foster City over time and aligns it with Gilead’s broader global operational strategy, including the decentralization of commercial manufacturing to La Verne, Oceanside, and international sites. (4) The answer fully addresses all parts of the question—R&D focus, manufacturing responsibilities, and strategic alignment—and provides a coherent narrative of strategic evolution. Wording differs slightly but conveys the same meaning. No factual errors, omissions, or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 358,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 through 2024, AIG enhanced its management of loss reserves risk through strengthened oversight mechanisms, expanded modeling approaches, and increased integration of external reviews. In 2022, AIG emphasized internal controls and external expert reviews to address uncertainties in loss reserve estimates, while also using third-party catastrophe models and post-event studies to refine risk assessments and underwriting practices. By 2023, AIG expanded its risk management to include both stochastic and deterministic modeling techniques, along with actuarial profitability and reserve reviews, and reinforced oversight through its three-tiered risk limit hierarchy. In 2024, AIG further integrated second-line reviews and internal audit functions to challenge assumptions and models, ensuring alignment with evolving risk profiles and regulatory expectations. These developments reflect a more robust, multi-layered approach to managing loss reserves risk over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key developments across 2022–2024 are correctly identified: 2022 emphasis on internal controls and external reviews, 2023 expansion to include stochastic modeling and actuarial reviews, and 2024 integration of second-line review and enhanced governance. While the original answer highlights 'sensitivity and scenario analyses, stochastic methods, and experience studies' in 2023, the LLM mentions 'stochastic and deterministic modeling' and 'actuarial profitability and reserve reviews,' which are semantically consistent and reflect equivalent or overlapping practices. The LLM adds specific details like 'third-party catastrophe models' and 'three-tiered risk limit hierarchy'—not contradicted by the ground truth and plausibly part of AIG’s framework—though not explicitly in the original answer, which slightly expands beyond the provided truth without error. (2) There are no numerical values, dates, or financial metrics in dispute; all years (2022, 2023, 2024) are correctly used and sequenced. (3) The multi-hop reasoning is sound: the LLM synthesizes evolution across time, connects oversight, modeling, and external review components, and correctly infers a trajectory toward more robust, integrated risk management. (4) The answer is contextually fully relevant, addressing all three dimensions in the question: oversight mechanisms (e.g., second-line review), modeling approaches (stochastic/deterministic), and external reviews (expert input, audit functions). The only minor gap is the absence of explicit mention of 'enterprise risk management (ERM) framework' and 'regulatory reporting' in 2024, though 'alignment with regulatory expectations' covers the latter. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only slight rephrasing and elaboration. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 555,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments' (TXN) operational footprint in Melaka, Malaysia remained focused solely on Analog manufacturing from 2022 to 2024, as indicated by the consistent \"X\" under the Analog column and the absence of an \"X\" under Embedded Processing in all three years' data. This 3-year progression highlights that TXN has not expanded or shifted its manufacturing focus in Melaka to include Embedded Processing, maintaining a dedicated Analog manufacturing presence in the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments (TXN) maintained operations in Melaka, Malaysia from 2022 to 2024 with a sole focus on Analog manufacturing, and correctly notes the absence of Embedded Processing activities. (2) There are no numerical values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced. The use of 'X' markers aligns with data representation in the source knowledge graph, indicating accurate interpretation of categorical presence/absence. (3) The multi-hop reasoning is sound: the model synthesized information across three years and two product lines (Analog and Embedded Processing) to correctly infer that there was no shift or expansion in manufacturing focus. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the operational footprint and what it indicates about TXN’s regional manufacturing strategy. The conclusion about a dedicated, stable Analog role in Melaka matches the original answer’s implication. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 344,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe's exposure to forward interest rate swaps decreased significantly from fiscal years 2022 through 2024, as evidenced by the fair value of these instruments dropping from $251 million in 2023 (Chunk 1) to $0 in 2024 (Chunk 2). In 2022, the swaps were designated as cash flow hedges for forecasted debt issuances, with their impact on comprehensive income and earnings detailed in disclosures (Chunk 3). This progression indicates that Lowe's executed its hedging strategy successfully, locking in favorable rates and subsequently reducing or eliminating the need for these hedging instruments as forecasted debt issuances were completed. The decline in forward interest rate swaps reflects a strategic shift from hedging future debt risk to managing existing debt through fixed-to-floating interest rate swaps, as noted in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $251 million fair value in 2023 and $0 in 2024 match the original answer, and the fiscal years (2022–2024) are correctly referenced. Format variations (e.g., 'dropping from $251 million to $0') are acceptable and semantically equivalent. (2) The answer correctly identifies the shift in hedging strategy: from using forward interest rate swaps as cash flow hedges for forecasted debt issuances in 2022 to no longer holding such instruments in 2024. It also accurately notes the transition to fixed-to-floating swaps for existing debt, which is consistent with the ground truth. (3) Multi-hop reasoning is sound—information is synthesized across three fiscal years and multiple hedging instruments, correctly inferring a strategic shift. (4) The only minor shortcoming is that the LLM slightly reframes the reason for discontinuation as 'successfully locking in favorable rates' and completing forecasted issuances, which is a plausible interpretation but not explicitly stated in the ground truth. The original answer emphasizes a change in risk management focus rather than implying success or completion. This subtle difference in emphasis prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is comprehensive, factually accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 394,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM consistently disclosed the 6.50% Debentures due 2028 in its 2022, 2023, and 2024 10-K filings, each time referencing the instrument as Exhibit 2 to Form 8-K filed on **January 8, 1998**. This consistency across all three filings demonstrates that the debt instrument has a long-term, stable structure and that its original documentation has remained unchanged since its issuance in 1998. The repeated reference to the same filing date highlights IBM’s reliance on historical, well-established legal documentation for this long-dated debt, indicating no material amendments or restatements to the terms of the debentures over the years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM disclosed the 6.50% Debentures due 2028 in its 2022, 2023, and 2024 filings, consistently referencing Exhibit 2 to Form 8-K filed on January 8, 1998. This date matches the ground truth exactly. (2) There are no numerical or date inaccuracies—'January 8, 1998' is correctly cited across all years, confirming the long-term stability of the debt documentation. (3) The multi-hop reasoning is sound: the model correctly infers that the repeated reference to the same 1998 filing indicates no material changes to the debentures’ structure, reflecting a stable, long-standing instrument. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure across three years, and the implication of the consistent filing reference. Wording differs slightly but conveys identical meaning, with appropriate emphasis on stability, lack of amendments, and reliance on original documentation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 312,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective Signage was positioned within MMM's Transportation and Electronics segment in 2022, 2023, and 2024, with consistent inclusion in the representative product list for that segment across all three years. In 2022, it was listed under \"Packaging and interconnection solutions,\" while in 2023 and 2024, it was explicitly categorized under \"Reflective signage for highway, and vehicle safety,\" indicating a more direct and emphasized placement. This evolution suggests a growing strategic importance of Reflective Signage within MMM's product portfolio, likely reflecting its critical role in transportation safety and alignment with MMM's focus on high-impact, safety-related solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the positioning and categorization of Reflective Signage. According to the ground truth, Reflective Signage was consistently listed in the Transportation and Electronics segment across all three years, with its ordinal position changing from fifth in 2022 to fourth in 2023 and 2024. However, the LLM incorrectly claims that in 2022 it was listed under 'Packaging and interconnection solutions'—a detail not supported by the original answer—and that in 2023 and 2024 it was re-categorized as 'Reflective signage for highway, and vehicle safety,' which is not mentioned in the ground truth. These misrepresentations distort the actual evolution of its positioning. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy hinges on correct ordinal positions and timeframes. The LLM fails this: it omits the actual sequence (5th → 4th → 4th) and instead fabricates category labels that do not appear in the original. (3) The multi-hop reasoning is flawed. The original answer infers strategic relevance based on consistent top-half placement and a slight rise in rank, indicating stable or growing importance. The LLM draws a similar conclusion about growing strategic importance but bases it on non-existent re-categorizations rather than actual positional shifts, breaking the logical chain. It fails to synthesize the correct data points across years. (4) While the LLM attempts to address the question’s intent—assessing strategic importance through positioning—it does so using incorrect evidence. The conclusion about increasing strategic focus is partially aligned with the ground truth but is unsupported by the fabricated details. Thus, correctness and qualitative accuracy are low due to factual errors, though contextual relevance is moderate because the response stays on topic and interprets strategic implications reasonably given its (incorrect) premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 539,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing has evolved significantly from 2022 through 2024, reflecting its growing strategic importance in commercial production. In 2022, the facility was already identified as a key site for commercial manufacturing and processing of cell therapy products, as noted in Gilead's global manufacturing footprint. By 2023, the Hoofddorp facility remained a central component of Gilead’s cell therapy manufacturing strategy, with continued emphasis on its role in commercial production, alongside other global facilities such as El Segundo, Santa Monica, and Frederick. In 2024, the facility was explicitly listed among Gilead’s key cell therapy manufacturing sites, underscoring its ongoing and expanded role in supporting the commercial scale-up of Gilead’s cell therapy portfolio. This consistent inclusion across all three years highlights the facility's strategic importance in Gilead’s broader manufacturing network and its critical role in advancing cell therapy commercial operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the facility's evolving strategic role from 2022 to 2024. All dates (2022, 2023, 2024) are accurate, and the progression of Hoofddorp’s role is correctly framed around commercial cell therapy manufacturing. The answer correctly identifies the facility as part of Gilead’s key manufacturing sites throughout the period, which matches the original answer’s timeline. However, there is a minor inaccuracy in the 2022 characterization: the LLM states that in 2022 the facility was 'already identified as a key site for commercial manufacturing and processing of cell therapy products,' whereas the ground truth specifies that in 2022 it was identified as a principal manufacturing facility generally, with the explicit cell therapy commercial role clarified only in 2023. This overstates the specificity of its cell therapy role in 2022. The qualitative reasoning is strong, showing a logical progression and synthesis across years, and the contextual relevance is excellent, directly addressing the question’s focus on strategic importance and commercial production evolution. No numerical errors exist, so quantitative accuracy is perfect. The answer is semantically close but loses slight points for premature attribution of cell therapy commercial status in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 373,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 2022 to 2024, as no specific figures for the 2003 plan are provided in 2022 and 2023, but the 2024 filing also does not list it separately, suggesting it may have been phased out or merged with newer plans like the 2024 LTIP. This trend indicates that Texas Instruments is likely shifting its director compensation strategy to newer equity plans, reducing reliance on the 2003 Director Compensation Plan for future share issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both its quantitative claims and overall interpretation. The ground truth states specific share numbers for each year—1,843,134 in 2022, 1,786,785 in 2023, and 1,745,284 in 2024—all of which are omitted or denied by the LLM, which claims 'no specific figures' are provided. This is false; the data exists and shows a clear downward trend. (2) There are no correct numbers in the LLM response, and it fails to report any of the actual share counts, resulting in a very low quantitative accuracy score. (3) The reasoning is flawed: instead of recognizing the consistent reduction as evidence of active use, the LLM incorrectly infers that the plan was 'phased out or merged' due to lack of visibility in filings—a conclusion contradicted by the actual declining balances, which confirm ongoing usage. The multi-hop synthesis fails because the model does not connect the decreasing available shares over time to continued utilization. (4) While the question is addressed in structure—discussing evolution and implications—the content is largely incorrect, making the response contextually relevant but factually unsound. The conclusion about shifting to newer plans like the 2024 LTIP is unsupported by the provided truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 358,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "IBM's treatment and market transparency of its 0.950% Notes due 2025 evolved from 2022 to 2024 as reflected in its SEC filings. In 2022 (Chunk 1), the notes were disclosed as part of IBM’s broader debt instruments, with their terms incorporated by reference from a Form 8-K filed on May 22, 2017. By 2023 (Chunk 2), the notes continued to be referenced in the same manner, indicating consistent disclosure practices. In 2024 (Chunk 3), the 0.950% Notes due 2025 were explicitly listed with a unique trading symbol (IBM25B) on the New York Stock Exchange, signifying increased market visibility and transparency. This progression suggests a deliberate strategy to enhance investor engagement by ensuring clear, accessible, and standardized disclosure of debt instruments, supporting IBM’s broader capital market approach of maintaining liquidity, investor confidence, and efficient access to capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were referenced via the May 22, 2017 Form 8-K in 2022 and 2023, and in 2024 they received a dedicated trading symbol IBM25B on the NYSE. These details match the original answer exactly. (2) Quantitative elements—interest rate (0.950%), year of note maturity (2025), and the 2017 Form 8-K filing date—are all precise and correctly cited. No calculations were required, but the temporal progression across 2022–2024 is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures, identifying a progression from passive referencing to active market listing. The conclusion about IBM’s broader capital market strategy—enhancing transparency, investor engagement, liquidity, and access to capital—is logically derived and consistent with the evidence. (4) The only minor shortcoming is that the LLM slightly underemphasizes the nuance that in 2023, IBM began listing the notes alongside newer instruments, which the ground truth notes as a sign of increasing prominence. While the LLM mentions consistent disclosure, it doesn’t fully highlight this incremental step in visibility, making the qualitative accuracy excellent but not perfect. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 402,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife's use of the deposit method of accounting for reinsurance saw a significant evolution from 2022 to 2024, with deposit assets increasing from $1.8 billion in 2022 to $5.1 billion in 2023 and further to $4.6 billion in 2024, while deposit liabilities decreased from $1.4 billion in 2022 to $1.3 billion in 2023 and $1.2 billion in 2024. This shift reflects a strategic move highlighted by the 2023 Global Atlantic reinsurance transaction, where MetLife reinsured a substantial block of universal life and fixed annuity products, resulting in $10.3 billion in reinsurance recoverables and deposit receivables. The transaction, structured on a coinsurance and modified coinsurance basis, involved transferring $9.5 billion in assets and retaining $5.0 billion in separate account assets, illustrating MetLife's strategic use of the deposit method to manage risk exposure and optimize balance sheet structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key error in the 2024 deposit assets value. The ground truth states that deposit assets were $4.6 billion in 2024, but the LLM incorrectly implies an increase from $5.1 billion in 2023 to $4.6 billion in 2024, using 'further to $4.6 billion', which suggests growth when it is actually a decrease. This misrepresents the trend. All other numbers—2022 and 2023 deposit assets ($1.8B, $5.1B), liabilities ($1.4B, $1.3B), and 2024 liabilities ($1.2B)—are accurate. The $10.3 billion in reinsurance recoverables and deposit receivables from the Global Atlantic transaction is correctly reported. (2) The calculation of trends is partially flawed due to the incorrect characterization of the 2023–2024 asset change. While the individual numbers for assets are correct except for the misleading 'further to' phrasing, the direction of change (increase vs. decrease) is misrepresented. (3) The multi-hop reasoning is strong: the LLM correctly links the evolution of deposit method accounting to the Global Atlantic transaction, identifies the strategic intent (risk management, balance sheet optimization), and incorporates relevant details like coinsurance structure, asset transfers ($9.5B), and retained separate account assets ($5.0B), which, while not in the original answer, add contextual depth without contradicting it. (4) The correctness score is 8 because core financial data is accurate and the strategic interpretation is sound, but the misstatement of the 2024 asset trend as an increase rather than a slight decrease prevents a higher score. Quantitative accuracy is 7 due to this directional error in trend description despite correct raw values. Qualitative accuracy is 9 due to excellent synthesis and reasoning. Contextual relevance is 10 as all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 509,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "MMM’s Fall Protection Solutions, part of its Safety and Industrial segment, remained consistently listed from 2022 to 2024 as a key product offering under respiratory, hearing, eye, and fall protection solutions. While the product descriptions across the three years show minimal textual change, the consistent inclusion and emphasis of fall protection in each year’s 10-K filings indicate a sustained focus on workplace safety solutions. This three-year progression underscores MMM’s ongoing commitment to providing essential safety products, reinforcing its role in addressing occupational health and safety needs across industries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that MMM consistently included fall protection solutions as part of its Safety and Industrial segment from 2022 to 2024 under the broader category of respiratory, hearing, eye, and fall protection solutions. The answer correctly identifies the lack of significant change in product listing across the years and draws a reasonable conclusion about MMM's sustained focus on workplace safety. All entities (MMM, Safety and Industrial segment, Fall Protection Solutions, 2022–2024 timeframe) are accurate. There are no numerical values requiring calculation, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while the core reasoning and synthesis are sound, the LLM slightly omits the detail about the phrasing becoming more concise in 2024 (e.g., 'evolved to a more concise presentation'), which was noted in the original answer. However, this does not detract significantly from the overall correctness. Contextual relevance is perfect—the response directly addresses both parts of the question: evolution of the product portfolio and what it indicates about MMM’s strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 338,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria's organizational structure and ownership of UST have remained stable from 2022 to 2024, with UST continuing as a wholly owned subsidiary of Altria through its subsidiary UST LLC, which operates U.S. Smokeless Tobacco Company LLC (USSTC). This consistent ownership reflects Altria's long-standing control over UST since its 2009 acquisition, as noted in 2022, and reaffirmed in 2023 and 2024. The progression underscores Altria's strategic focus on strengthening its position in the smokeless tobacco market, leveraging UST's leadership in moist smokeless tobacco (MST) and snus products. This strategic positioning aligns with Altria's broader goal of transitioning adult smokers to potentially less harmful alternatives, as highlighted in 2024, and is supported by UST's strong market presence and brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: UST remains a wholly owned subsidiary of Altria throughout 2022–2024, operating through UST LLC and USSTC, with no changes in ownership structure. The 2009 acquisition reference is factually accurate context, though not in the original answer, it does not detract from correctness. (2) Quantitative accuracy is perfect—no specific numbers (e.g., $8.8 billion trademark value) are misstated, and while the LLM omits the $8.8 billion figure mentioned in the original answer, this is a minor omission rather than an error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes UST’s structural continuity and its strategic role in Altria’s smokeless tobacco and reduced-risk product strategy across the three years, noting the alignment with the 'Moving Beyond Smoking' initiative in 2024. (4) The answer captures the core progression—stable ownership with increasing strategic integration—though it does not explicitly mention amortization expenses in 2022 or the reiteration of consolidation in 2023 as emphasized in the original. However, these omissions do not undermine the overall qualitative accuracy. The response is contextually relevant, directly addressing both organizational structure and strategic positioning. The minor lack of specificity on 2022 amortization and 2023 consolidation prevents a perfect 10, but the answer remains factually sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 412,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 10-K filings suggests a consistent integration of SolarCity’s debt instruments into Tesla’s financial reporting framework, reflecting Tesla’s long-term strategy to consolidate and maintain financing structures tied to its solar energy initiatives. The continued inclusion of these bonds in Tesla’s filings, despite SolarCity’s acquisition in 2016, indicates Tesla’s ongoing commitment to leveraging existing financing mechanisms to support its renewable energy segment. This pattern also highlights Tesla’s structured approach to managing and disclosing legacy SolarCity financial obligations as part of its broader energy portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Tesla, SolarCity 5.45% Solar Bonds, Series 2015/C92-15, and the 2022–2024 filing years are accurately referenced. The percentage (5.45%) and bond series designation are correct. (2) Quantitative accuracy is perfect: no numerical errors, and the dates (implied 2015 issuance and continued disclosure through 2024) are consistent with the original answer. The acquisition year of SolarCity (2016) is correctly noted. (3) Reasoning is sound: the LLM correctly infers that repeated disclosure indicates ongoing financial relevance and reflects a long-term financing strategy, even though the bond is legacy debt. It appropriately connects Tesla’s continued reporting to strategic integration and transparency around solar financing. (4) The only minor gap is that the LLM does not explicitly mention the 'One Hundred-and-Sixteenth Supplemental Indenture' or the August 24, 2015 date, which are specific legal instruments cited in the ground truth. While not critical to the overall conclusion, their omission slightly reduces completeness in multi-hop detail. However, the core insight—Tesla’s sustained reliance on structured solar debt—is preserved. Semantic equivalence is strong, and the answer remains contextually precise and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 371,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM's exposure to stock exchange regulations from 2022 to 2024 remained consistently tied to the valuation and liquidity of its debt and equity securities, as outlined in its 10-K filings. In 2022, IBM highlighted that governmental and stock exchange regulations significantly influenced the value of its debt and equity, alongside interest rates, exchange rates, and credit ratings. By 2023, the company reiterated similar dependencies, emphasizing that these external regulatory factors continued to impact its securities' market dynamics. In 2024, IBM expanded its discussion to include broader capital market risks, such as liquidity conditions and customer credit risk, while reaffirming the influence of regulatory environments on its securities. This multi-year progression reveals a consistent risk management strategy focused on transparency and proactive communication of external dependencies, reflecting IBM's recognition of the need to navigate evolving regulatory and market conditions to preserve the stability and liquidity of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's exposure to stock exchange regulations affecting debt and equity securities is consistently reported across 2022–2024, with accurate descriptions of influencing factors such as interest rates, credit ratings, and liquidity. No numeric data is incorrect, and since the question involves qualitative risk disclosures rather than specific financial figures, the absence of numerical inaccuracies supports a perfect quantitative score. (2) The answer correctly identifies the entities (IBM), time periods (2022–2024), and regulatory and market risk factors, satisfying entity accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes risk disclosures across three years, showing evolution from general regulatory exposure in 2022 to a more integrated view including liquidity and credit risk in 2024. The conclusion about IBM’s capital market risk management strategy—emphasizing transparency and recognition of external dependencies—is semantically equivalent to the ground truth’s interpretation of persistent systemic exposure. (4) The only minor deviation is in tone: the LLM characterizes the strategy as 'proactive communication' and 'transparency,' while the original emphasizes the lack of material mitigation, suggesting continued vulnerability. This is a subtle interpretive difference, not a factual error, and does not undermine the overall correctness. Thus, the answer earns a 9/10 for qualitative accuracy and 9/10 overall, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 443,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "MMM's focus on electrical products for construction and maintenance remained consistently within the Safety and Industrial business segment across 2022, 2023, and 2024, as noted in each year's 10-K filings. The product description and positioning show minimal change over the three years, emphasizing electrical products and materials for construction and maintenance, power distribution, and electrical OEMs. This multi-year consistency suggests a strategic emphasis on maintaining a stable and core industrial market presence, leveraging MMM's expertise in durable, specialized products for infrastructure and manufacturing sectors.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative shifts in MMM's segment composition across the three years, which is central to the question. (1) It correctly identifies that electrical products for construction and maintenance remained consistently part of the Safety and Industrial segment from 2022 to 2024, and accurately references the 10-K filings—this is factually sound and contextually relevant. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable; however, the model does not introduce any incorrect dates or years, so it scores highly on that dimension. (3) The multi-hop reasoning is flawed: while the ground truth shows a clear evolution—adding autobody repair and industrial abrasives in 2023, and rephrasing the segment in 2024 to emphasize broader industrial specialties—the LLM incorrectly claims 'minimal change' and fails to detect or report these strategic shifts. This omission undermines the qualitative accuracy, as the progression indicates a subtle but meaningful repositioning in industrial markets that the LLM overlooks. (4) The answer is well-structured and relevant to the question’s focus on strategic positioning, but due to the failure to capture the evolving product mix and segment emphasis, it only partially fulfills the analytical depth required. Thus, correctness and qualitative accuracy are moderate, while contextual relevance and factual precision on what was stated remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 408,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "From 2022 through 2024, GILD’s Oceanside, California facility has remained a key component of its manufacturing infrastructure, specifically focused on retroviral vector and biologics manufacturing. In 2022, the facility was noted as part of GILD’s broader network of R&D and manufacturing sites, with a role in clinical manufacturing and process development of biologics candidates. By 2023, the facility was explicitly described as being used for commercial retroviral vector manufacturing and clinical manufacturing and process development of biologics candidates. In 2024, the description remained consistent, reaffirming its role in commercial retroviral vector manufacturing and clinical manufacturing and process development of biologics candidates. This continuity indicates that the Oceanside facility has evolved to support both commercial and clinical biologics and retroviral vector production, aligning with GILD’s strategic focus on expanding its biologics and cell therapy capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual error in the timeline of GILD's Oceanside facility evolution, particularly regarding the introduction of commercial retroviral vector manufacturing. According to the ground truth, in 2022 the facility was part of the broader R&D footprint without specific mention of clinical manufacturing of biologics; that role was explicitly highlighted only in 2023. The LLM incorrectly states that clinical manufacturing and process development were already occurring in 2022, which is not supported by the original answer. More critically, the LLM claims that commercial retroviral vector manufacturing was already in place by 2023, whereas the ground truth states this capability was emphasized only in 2024. This misrepresents the strategic progression from R&D to clinical to commercial scale. There are no numerical values to verify, so quantitative accuracy is scored as 10. Contextual relevance is high, as the answer addresses the facility’s role in biologics and retroviral vectors and aligns with GILD’s strategic focus. However, the qualitative accuracy is low due to incorrect multi-hop reasoning across years—failing to accurately trace the evolution across 2022–2024. The answer portrays continuity rather than the actual progression, missing the key shift from general R&D to specialized commercial manufacturing. Thus, while the overall structure and intent are sound, the factual timeline errors significantly undermine the correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 414,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "From 2022 to 2024, AIG's glide path approach for its U.S. pension plan evolved by adjusting the target allocations for the Return-Seeking portion of the portfolio in response to the plan's funded status and interest rate environment. In 2022, the target allocation was based on the funded status at December 31, 2021, while in 2023, the glide path was updated to reflect the funded status at December 31, 2022, leading to a revised target allocation for 2024. By 2024, the glide path approach continued to guide the allocation strategy, with the target allocation for 2025 being determined based on the funded status at December 31, 2024. This reflects AIG's ongoing de-risking strategy, where growth assets are reduced and liability-hedging assets are increased as the funded ratio improves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's glide path approach from 2022 to 2024, accurately stating that target allocations for the Return-Seeking portion were based on prior year-end funded status—2022 on Dec 31, 2021; 2023 on Dec 31, 2022; and 2024 on Dec 31, 2024. However, there is a minor inconsistency: the original answer states that in 2023, the target allocation was set for 2024 based on Dec 31, 2023 funded status, whereas the LLM says it was based on Dec 31, 2022. This is incorrect and contradicts the ground truth. Despite this, the overall forward-looking, dynamic nature of the glide path is correctly conveyed. (2) All other dates and time references are semantically accurate and align with the forward-looking structure (e.g., 2024 targeting 2025 based on Dec 31, 2024 data). No numerical values (percentages, dollar amounts) are present, so scoring focuses on date accuracy. (3) The multi-hop reasoning is strong—LLM synthesizes the concept of a dynamic, funded-status-driven glide path across years and correctly infers the de-risking strategy. The only flaw is the misattribution of the 2023 target allocation basis. (4) Scores reflect high accuracy: full points for quantitative (no incorrect numbers, only date misalignment), 9 for qualitative due to reasoning strength despite one incorrect linkage, 10 for relevance as all content directly addresses the question. Correctness is 9 because the core pattern is right but one year’s data source is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 416,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN's target asset allocation strategy for its defined benefit pension plans evolved from fiscal 2023 to fiscal 2025 by maintaining a structured, risk-mitigated approach focused on long-term returns and liability matching, while adapting to market conditions and regulatory requirements. In fiscal 2023, the company outlined its target allocation and emphasized diversification across fixed income and equities, with a focus on minimizing volatility relative to liabilities. By fiscal 2025, the strategy continued to prioritize risk-adjusted returns and long-term capital appreciation, with ongoing diversification between U.S. and non-U.S. equities and fixed income, while also acknowledging country-specific constraints such as bond-heavy allocations in certain regions. This multi-year consistency in strategy suggests a moderate long-term investment risk tolerance, as ACN seeks to balance growth and stability by aligning asset allocation with pension liabilities and inflation objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of ACN's asset allocation strategy, noting consistency in risk-mitigated, liability-matching approaches and diversification across fixed income and equities. It accurately reflects a moderate risk tolerance and alignment with long-term objectives. However, it misses a key factual evolution highlighted in the ground truth: the shift in planning horizon from one-year-ahead (fiscal 2023 setting targets for 2024) to two-years-ahead (fiscal 2024 setting targets for 2025), which signifies increased strategic confidence. This omission affects completeness and reasoning depth. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised—no errors in numbers or dates. Fiscal years (2023, 2025) are used appropriately. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes ACN’s ongoing strategy across years and identifies risk tolerance, but fails to connect the forward extension of the planning horizon as a meaningful shift in strategic posture, which is central to the ground truth’s conclusion. (4) Contextual relevance is high—the response stays focused on pension asset allocation and risk tolerance. Qualitative accuracy is reduced due to the missing insight about planning horizon extension, which weakens the explanation of strategic evolution. Correctness score is 7 because core facts about strategy and risk tolerance are accurate, but a significant strategic nuance is omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 427,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15, as part of SolarCity's broader solar financing strategy, evolved through multiple supplemental indentures across 2022, 2023, and 2024. The bonds were first introduced in April 2015 under the Thirty-Sixth Supplemental Indenture (Chunk 1), and subsequent filings in 2023 and 2024 (Chunks 2 and 3) show continued reference and maintenance of the same indenture structure, indicating ongoing administrative or compliance-related updates. The multi-year pattern reveals Tesla’s (via SolarCity) sustained commitment to structured solar financing, leveraging long-term fixed-rate debt to fund residential and commercial solar projects, with a focus on maintaining consistent terms and investor confidence through standardized indenture management.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness, particularly in dates and the nature of the bond's evolution. The original answer states that Tesla consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its 10-K filings across 2022–2024, inherited from SolarCity, with no indication of new issuances or supplemental indentures during those years. However, the LLM incorrectly claims that 'supplemental indentures' were filed in 2023 and 2024 and that the bond was introduced in April 2015 under the 'Thirty-Sixth Supplemental Indenture'—details not present in the ground truth and unsupported by the provided data. There is no mention in the original answer of administrative updates or compliance-related filings in those years, so asserting such activity introduces factual errors. Additionally, the LLM implies an ongoing structuring or issuance process during 2022–2024, while the ground truth emphasizes continued disclosure and inclusion in filings, not active restructuring. This misrepresents the nature of the bond's evolution. Quantitatively, the 5.45% interest rate is correctly stated, and the 2015 origin aligns with the Series name, but the specific April 2015 date and supplemental indenture numbering are unverified and likely fabricated. Qualitatively, the LLM captures the broader theme of Tesla maintaining reliance on structured solar financing, which aligns with the original answer’s conclusion about long-term commitment. It also correctly attributes the origin to SolarCity. However, the reasoning about 'evolution' through active indenture management is not supported—the actual evolution is in the expansion of related bond series (e.g., C28-15, C33-15), which the LLM omits entirely. Contextually, the answer stays focused on Tesla’s solar financing strategy and addresses the multi-year pattern, though with incorrect mechanisms. Thus, while the general direction of interpretation is reasonable, key factual and quantitative errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 544,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved through enhanced scenario-based modeling, expanded reinsurance strategies, and increased reliance on both private and government-sponsored risk mitigation mechanisms across global jurisdictions. In 2022, AIG reported modeled losses for a five-ton bomb attack in New York City at $1.3 billion, net of TRIPRA and reinsurance, with U.S. exposure partially mitigated by TRIPRA's 80% coverage above a $1.7 billion deductible. Internationally, AIG used targeted reinsurance and participated in terrorism pools. By 2023, AIG continued to refine its modeling of terrorism attack scenarios and maintained similar U.S. risk mitigation through TRIPRA, while emphasizing routine monitoring of international exposure concentrations. In 2024, AIG retained core reinsurance attachment points globally, including $200 million for Japan and $125 million for the rest of the world, and expanded property per-risk covers to address both critical and non-critical catastrophe events. Additionally, AIG's reinsurance recoverable assets reached $38.0 billion by year-end 2024, supported by $20.1 billion in collateral, reflecting a more robust and diversified risk transfer strategy to manage terrorism-related losses internationally.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.3 billion modeled loss for a five-ton bomb in NYC in 2022 (net of TRIPRA and reinsurance), the $38.0 billion reinsurance recoverable assets by end-2024, and the $200 million attachment point for Japan in 2024 are all factually correct. The mention of $125 million for the rest of the world, while not in the original answer, does not contradict it and may reflect additional detail from the source; it is not penalized as the original does not specify other regions. The $20.1 billion in collateral is an additional accurate detail not in the ground truth but plausible and consistent. (2) Quantitative accuracy is perfect: all numbers match or are reasonable expansions of the original. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes information across years (2022–2024), geographies (U.S., Japan, global), and risk mechanisms (modeling, reinsurance, pools). It correctly identifies the evolution from modeling to active monitoring to expanded coverage. (4) The only minor gap is that the original emphasizes 'enhanced global property per risk covers' in 2024 without specifying $125 million for the rest of the world—this detail is absent in the ground truth, so while not incorrect, it slightly exceeds the provided information. However, this does not undermine accuracy. Overall, the answer is comprehensive, factually correct, and contextually appropriate, warranting a 9/10 due to minor addition of unverified specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Impacts]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 430,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment faced consistent exposure to adverse industry economic conditions from 2022 through 2024, as highlighted in each year's 10-K filings. In 2022, the segment was impacted by reduced investments in process automation, safety monitoring, and plant capacity utilization initiatives, alongside a slowdown in retail markets and demand for safety products, all contributing to lower margins. By 2023, these risks persisted, with the segment continuing to face margin pressures from similar factors, including competitive landscape changes and product commoditization. In 2024, the segment was rebranded as Industrial Automation, but the same underlying risks—reduced investments in automation and safety, competitive pressures, and adverse economic conditions—were still cited as key contributors to margin pressures. Thus, across the three-year period, the consistent risks driving margin challenges were reduced customer investments in automation and safety, evolving competitive dynamics, and broader economic headwinds.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Honeywell's exposure to adverse industry conditions in the Safety and Productivity Solutions segment from 2022 to 2024. The key risks—reduced investments in automation, retail or demand slowdowns, competitive pressures, and product commoditization—are accurately identified across the years. The rebranding to Industrial Automation in 2024 is correctly noted, and the persistence of margin pressures is properly emphasized. However, there are minor discrepancies in the specific phrasing of risks: the ground truth highlights 'new market entrants leading to commoditization' and 'lower selling prices' contributing to margin pressure, while the LLM mentions 'evolving competitive dynamics' and 'slowdown in demand for safety products'—which are related but not exact matches. Additionally, the ground truth explicitly links adverse economic conditions to margin compression in 2024 and notes reduced market share, which the LLM omits. The LLM also introduces 'safety monitoring' and 'plant capacity utilization' in 2022, which are not in the original answer and may conflate details from other segments. Despite these nuances, the core facts, timeline, and synthesis across years are correct. All dates and entity names (Honeywell, Safety and Productivity Solutions, Industrial Automation) are accurate. There are no numerical inaccuracies, as the response is qualitative. The reasoning is sound and multi-hop, connecting risks across three years and recognizing the segment restructuring. The answer is highly relevant to the question. Thus, the correctness score is 8 due to minor omissions and slight overgeneralization of risks, but not major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 477,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "From 2022 through 2024, Pfizer’s treatment of Breakthrough Performance Awards (BPAs) evolved significantly. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and were recognized in financial statements using the intrinsic value method, with amortization over the probable vesting term. However, in 2023, no BPAs were granted or outstanding, as disclosed in the 10-K. By 2024, BPAs were still described in terms of valuation and recognition, using the intrinsic value method and being amortized into relevant expense categories, but no new grants were mentioned, indicating a cessation of the program. This evolution reflects a shift from active grant activity in 2022 to discontinuation by 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 1,165 thousand BPAs granted in 2022 with a weighted average intrinsic value of $38.73 per share, and the statement that no BPAs were granted or outstanding in 2023 matches the original. The format variations (e.g., '1,165 thousand' vs '1,165 thousand') are acceptable. (2) The answer correctly notes the shift from active grants in 2022 to no grants or outstanding awards in 2023, and the continued discussion of valuation methodology in 2024 using the intrinsic value method and amortization over the probable vesting term. (3) The multi-hop reasoning is sound: it synthesizes data across three years, correctly infers the wind-down of the program, and maintains focus on grant activity, valuation, and financial recognition. (4) The only minor shortcoming is that the 2024 description could have explicitly mentioned 'adjustments based on stock price changes and performance goal probabilities'—a detail present in the ground truth—but the core valuation methodology is accurately conveyed. This omission does not undermine the overall correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 363,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Accenture's share repurchase activity and remaining authorization show a consistent and active capital return strategy. As of August 31, 2022, the company had $3,129,296 in available authorization for share purchases and redemptions. By August 31, 2024, this amount had decreased to $2,694 million, reflecting repurchase activity, including the purchase of 2,000,308 Class A ordinary shares in fiscal 2024 for $605 million under the open-market share purchase program. On September 25, 2024, the Board approved an additional $4,000 million in repurchase authority, raising the total outstanding authorization to $6,694 million. This trend indicates a disciplined and ongoing commitment to returning capital to shareholders through sustained repurchase activity, supported by periodic replenishment of authorization, highlighting confidence in the company’s financial strength and long-term value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects, with only a minor formatting discrepancy in the 2022 authorization amount: the ground truth specifies $3,129,296,000, while the LLM states $3,129,296 (missing the thousands multiplier). This appears to be a typographical omission in scale (i.e., reporting thousands instead of millions), but given the exact match of digits, it is likely a formatting error rather than a factual inaccuracy. All other numbers — $2,694 million remaining as of August 31, 2024, $4,000 million new authorization, and resulting $6,694 million total — are correct and properly calculated. The $605 million spent on 2,000,308 shares in fiscal 2024 adds contextual detail not in the original answer but aligns with plausible repurchase activity and does not contradict the ground truth. (2) Calculations are accurate: $2,694M + $4,000M = $6,694M is correct. The reduction from ~$3.13B to $2.694B indicates repurchases, consistent with the narrative. (3) Multi-hop reasoning is sound: the model correctly traces the evolution of authorization from 2022 to 2024, incorporates the new board authorization, and synthesizes the trend into a coherent capital return strategy. (4) The conclusion about a disciplined, ongoing capital return strategy with periodic replenishment accurately reflects the intent behind the repurchase pattern. The answer is semantically equivalent to the ground truth, with enhanced detail. The minor numerical formatting issue prevents a perfect 10, but overall correctness, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 435,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "From 2022 through 2024, Pfizer's relationship with Meridian evolved as a divested entity, with financial and operational disclosures reflecting the post-sale transition. In 2022, Meridian was presented as a discontinued operation, indicating its separation from Pfizer's ongoing business. By 2023, Pfizer completed the sale of its Meridian subsidiary for $51 million in cash, recognizing a $167 million pre-tax loss. The transaction included interim Transition Service Agreements (TSAs) and a Manufacturing Supply Agreement (MSA), with the TSAs concluding by December 31, 2023, and the MSA lasting three years post-sale with a two-year extension option. Financially, the amounts recorded under these agreements in 2023 and 2022 were not material to Pfizer’s operations. By 2024, Meridian was no longer referenced in key disclosures, signaling a full strategic and operational separation, consistent with Pfizer’s broader divestiture strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. Most critically, it states that Pfizer 'completed the sale of its Meridian subsidiary for $51 million in cash, recognizing a $167 million pre-tax loss' in 2023 — this is incorrect. According to the ground truth, the sale was completed on December 31, 2021 (not in 2023), and the $167 million loss was net of tax (not pre-tax). These are major factual and quantitative errors. (2) The LLM introduces operational agreements — Transition Service Agreements (TSAs) ending December 31, 2023, and a Manufacturing Supply Agreement (MSA) with a three-year term and extension option — that are not present in the original answer or supported by the knowledge graph. There is no mention of such agreements in the ground truth, making this fabricated detail a serious qualitative inaccuracy. (3) The multi-hop reasoning is partially sound in tracking Meridian’s status from discontinued operations to disengagement, but fails in timeline accuracy and synthesis: it incorrectly places the divestiture completion in 2023 rather than 2021, undermining the logical progression. (4) Despite these issues, the LLM correctly identifies Meridian as a divested entity, captures the $51 million cash consideration and $167 million loss (though mischaracterized as pre-tax), and notes the diminishing disclosures over time, which shows some correct synthesis. The 2024 status is reasonably inferred as fully separated, though the ground truth specifically notes Meridian appears only as a defined term in the glossary — a nuance missing in the LLM response. Overall, the answer is partially correct in direction but flawed in key facts, calculations, and unsupported additions, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Sells]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 486,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127,000,000 in fiscal year 2022 to 141,000,000 in both 2023 and 2024, while the shares available for future grants remained relatively stable at approximately 27.3 million. This increase in the authorized share count indicates a strategic commitment to maintaining and potentially expanding the company’s share-based compensation programs, underscoring Accenture’s long-term focus on incentivizing employees through equity awards and retaining talent in a competitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the authorized share counts for fiscal years 2022 (127,000,000), 2023 (141,000,000), and 2024 (141,000,000), matching the ground truth exactly. The quantitative evolution is accurately described with the increase from 2022 to 2023 and stability thereafter. However, the mention of 'shares available for future grants remained relatively stable at approximately 27.3 million' is not part of the original answer and introduces extraneous information not verified by the ground truth, which could be misleading even if factually correct elsewhere. (2) All numbers and dates are correct; no calculation errors. The increase of 14,000,000 shares (141M - 127M) is implied and accurate. (3) The multi-hop reasoning is sound: the model correctly identifies the trend across three fiscal years and infers the strategic intent behind the change in authorized shares. The conclusion about long-term strategy—emphasizing employee incentives and retention via equity—aligns well with the original answer’s interpretation. (4) The answer is contextually fully relevant, addressing both the quantitative evolution and strategic implication. The only minor deviation is the addition of unrequested detail about shares available for future grants, which does not detract significantly from correctness but slightly reduces qualitative precision. Hence, a score of 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 414,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across its 2022, 2023, and 2024 filings, with the bond series being referenced in each year's 10-K under the exhibits section as part of the supplemental indentures originally filed in 2015. The 2022 filing listed the bond under Exhibit 4.49, the 2023 filing under Exhibit 4.42, and the 2024 filing also under Exhibit 4.42, all pointing to the same June 16, 2015 filing date. This consistency suggests that Tesla continues to recognize and maintain the obligations related to this bond series, indicating an ongoing financial commitment tied to its historical SolarCity acquisition and related financing activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of Tesla's 4.70% Solar Bonds, Series 2015/C52-10 across 2022, 2023, and 2024 filings, with accurate reference to the June 16, 2015 filing date and the bond's inclusion in each year's 10-K under exhibit numbers. However, there is a minor error in the 2024 exhibit number: the ground truth states Exhibit 4.40, while the LLM incorrectly states Exhibit 4.42 (same as 2023). This discrepancy affects quantitative accuracy. (2) All other numeric values—interest rate (4.70%), bond series name, and original filing date—are correct. The calculation aspect is minimal here, but the synthesis of consistent re-disclosure over three years is accurately interpreted. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged disclosures imply ongoing obligations and links this to Tesla’s solar financing strategy, particularly in the context of the SolarCity acquisition. This reflects strong qualitative accuracy and contextual understanding. (4) The answer is highly relevant and conveys nearly identical meaning to the original, with only a small factual inaccuracy in the 2024 exhibit number preventing a higher score. Thus, correctness is rated 8 due to this specific error, though the overall reasoning and intent are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 369,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe's free online self-service learning offerings, available on platforms like learning.adobe.com (2023) and www.training.adobe.com (2022), evolved from 2022 to 2024 by becoming a central pillar within Adobe's broader learning and enablement services. In 2022, these offerings were positioned as part of Adobe Customer Solutions, supporting both customers and partners in effectively using Adobe products, particularly in Digital Experience and Digital Media. By 2023 and 2024, the free self-service learning options were further integrated into Adobe Digital Learning Services, complementing fee-based programs and custom learning services for enterprise customers. These offerings played a key role in customer adoption strategies by providing accessible, scalable learning resources that helped users quickly adopt Adobe products, supported by solution-specific skills assessments and alignment with business objectives through Customer Success Managers. This evolution reflects Adobe's strategic emphasis on enhancing user proficiency and driving long-term value through comprehensive, self-directed learning tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: free online self-service learning was hosted on www.training.adobe.com in 2022 and transitioned to learning.adobe.com in 2023, consistent with the original answer. The positioning within Adobe's broader learning services evolved into Adobe Digital Learning Services by 2023–2024, which matches the ground truth. The role in customer adoption strategies—supporting scalable, accessible learning for Digital Experience and Digital Media products—is accurately described. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) Multi-hop reasoning is sound: the model synthesizes information across years and correctly infers the strategic evolution from being part of customer solutions to integration within Adobe Digital Learning Services. (4) The only minor gap is that the LLM mentions 'solution-specific skills assessments' and 'Customer Success Managers'—details not present in the ground truth—adding slight over-specificity, though these are plausible components and do not contradict the source. Overall, the answer captures the core evolution, strategic positioning, and functional role accurately, warranting a high correctness score with a small deduction in qualitative accuracy due to minor unsupported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 386,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "From 2022 to 2024, AIG's glide path approach for its U.S. qualified pension plan evolved in response to changes in the plan's funded status, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio. In 2022, the target allocation was based on the funded status as of December 31, 2021, with a focus on reducing growth assets and increasing liability-hedging assets as the funded ratio improved. By 2023, the glide path approach continued to adjust the target allocation for 2024 based on the updated funded status at December 31, 2023, further de-risking the portfolio in line with the plan's increasing funded ratio. In 2024, the glide path approach similarly informed the target allocation for 2025, reflecting the funded status at December 31, 2024, and maintaining the strategy of reducing exposure to growth assets as the plan became more fully funded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth and accurately reflects the evolution of AIG's glide path approach from 2022 to 2024. It correctly identifies that the target allocations for the 'Return-Seeking' portion were adjusted annually based on the funded status as of each December 31, with de-risking (i.e., reducing growth assets) occurring as the plan became more fully funded. While the specific percentages for the 'Return-Seeking' allocation are not provided in either answer — which is consistent with the original answer noting they are 'not listed in the provided excerpts' — the LLM correctly infers the strategic direction of the glide path without fabricating numbers. The reasoning is sound, multi-hop across years and decision logic, and entities (AIG, U.S. qualified pension plan, glide path, funded status) are correctly identified. The only minor limitation is a slightly stronger implication that the funded ratio definitively 'increased' each year, which is plausible but not explicitly confirmed in the ground truth; however, this does not contradict it. Quantitative accuracy is perfect as no incorrect numbers are introduced. The answer is highly relevant and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 347,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell's Performance Materials and Technologies segment faced evolving exposure to raw material demand and supply risks from 2022 through 2024. In 2022, the segment was impacted by raw material demand and supply issues, alongside broader macroeconomic challenges such as the lingering effects of the COVID-19 pandemic, which caused disruptions in global supply chains and customer purchasing behaviors. By 2023, the risk remained prominent, with volatility in oil and natural gas prices affecting customer investment and demand for the segment’s products and services. In 2024, the risk was still a key concern, particularly in relation to capacity utilization in chemical and refining industries, as well as ongoing supply chain constraints. This persistent exposure across the three-year period suggests that the segment remains highly vulnerable to commodity market volatility, as shifts in raw material availability and pricing can significantly influence customer capital spending and, consequently, Honeywell’s operating results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and overall interpretation. (1) All key facts are accurate: Honeywell consistently identified raw material demand and supply risks in its Performance Materials and Technologies segment from 2022 to 2024. The 2022 context correctly references the lingering effects of the pandemic on supply chains and customer behavior. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes risk evolution across three years and connects it to broader commodity market vulnerability. However, there is a minor inversion in emphasis across years: the original answer notes that in 2023, volatility in chemical, refining, and semiconductor plant utilization was highlighted, while oil and gas price impacts became more prominent in 2024. The LLM incorrectly attributes oil and gas price impacts primarily to 2023 and capacity utilization to 2024, slightly reversing the progression. (4) Despite this, the core conclusion—that the segment remains highly vulnerable to commodity volatility—is semantically equivalent and well-supported. The answer is fully contextually relevant, addressing both the evolution of risk and its implications. The qualitative accuracy is slightly reduced due to the misattribution of emphasis across years, but the overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 419,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN's investment in mutual fund equity securities decreased from $239,293 in 2022 to $196,226 in both 2023 and 2024. This three-year trend indicates a strategic shift in asset allocation, with a reduction in exposure to mutual fund equity securities and a corresponding increase in other asset classes, such as insurance contracts and Level 3 investments. The consistent level of mutual fund equity securities in 2023 and 2024 suggests a stabilization in this portion of the portfolio, potentially reflecting a more balanced or risk-mitigated approach to long-term asset management.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decreasing trend from 2022 to 2023 and stability into 2024, but contains a critical error in the magnitude of the investment amounts. The original answer specifies values in millions ($239.293 million and $196.226 million), whereas the LLM omits 'million' and reports '$239,293' and '$196,226', which is off by a factor of 1,000. This is a significant quantitative inaccuracy despite correct directional trends. (2) The numbers themselves (239,293 and 196,226) match the ground truth when interpreted as thousands (i.e., $239.293M = $239,293,000), but the LLM's formatting implies thousands rather than millions, leading to misinterpretation. No explicit calculation errors (e.g., difference or ratio) are made, but the unit error undermines quantitative precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes the 3-year trend and infers strategic rebalancing and stabilization, even adding plausible context about shifts to insurance contracts and Level 3 investments, which, while not in the ground truth, do not contradict it and enhance qualitative reasoning. (4) The answer addresses both parts of the question—evolution over time and strategic implication—with accurate entity identification (ACN, mutual fund equity securities, correct years). The omission of 'million' reduces quantitative accuracy, but the core trend and strategic interpretation remain valid, justifying a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 411,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Between 2022 and 2024, Adobe's strategic positioning of Adobe Document Cloud evolved significantly, particularly in its integration with AI-powered tools like Adobe Firefly and its role in enterprise digital workflows. In 2022, Adobe Document Cloud was primarily described as a cloud-based subscription offering focused on enabling digital document and signature workflows to drive business productivity across various user types, including individuals, teams, and enterprises. By 2024, Adobe had enhanced Document Cloud's capabilities by integrating Firefly-powered generative AI features into products like Adobe Acrobat, enabling content generation and editing while maintaining quality and control. Additionally, Adobe introduced Firefly Services and Custom Models for enterprises, allowing for scalable, brand-consistent content production. These advancements positioned Adobe Document Cloud not just as a document management tool, but as a key component in AI-enhanced enterprise digital workflows, aligning with Adobe's broader mission of leveraging AI to transform digital experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Document Cloud from 2022 to 2024, particularly in its integration with AI tools like Firefly and its growing role in enterprise workflows. (1) All entities—Adobe, Document Cloud, Firefly, Acrobat, enterprise workflows—are accurately identified, and the time frame (2022–2024) is correctly referenced. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is mostly sound: the LLM correctly infers a strategic shift over time, noting Document Cloud’s progression toward AI integration. However, it misses a key detail from the ground truth: in 2022, Document Cloud was framed as part of the 'Publishing and Advertising' segment and only later repositioned under the 'Digital Media' segment in 2023. This structural repositioning is a critical signal of strategic elevation and is omitted in the LLM answer. Additionally, the 2023 transition year is skipped entirely, weakening the stepwise evolution. (4) Despite this omission, the LLM conveys the essential qualitative shift—Document Cloud evolving from a productivity tool to an AI-enhanced enterprise suite—and correctly highlights Firefly integration in Acrobat and Custom Models for enterprises. The answer is contextually excellent, directly addressing all parts of the question with relevant, accurate details. The semantic meaning aligns closely with the ground truth, just missing the intermediate 2023 segment realignment. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 466,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "From 2022 to 2024, Honeywell's exposure to changes in the competitive landscape across its business segments evolved with increasing emphasis on new market entrants, technological disruption, and their impacts on market share and pricing power. In 2022, the company noted that new entrants and non-traditional players were affecting the Aerospace and Safety and Productivity Solutions segments, with concerns about product commoditization and reduced market share. By 2023, the risk of new entrants and technological disruption had expanded to Honeywell Building Technologies and Performance Materials and Technologies, with similar concerns about market share and pricing pressures. In 2024, the exposure was reflected in restructured segments such as Aerospace Technologies, Industrial Automation, and Building Automation, where the impact of new entrants and disruptive technologies was linked to potential commoditization, reduced investments, and lower margins. Across all years, the evolving competitive landscape was a consistent risk factor, with Honeywell highlighting the need to adapt to maintain pricing power and market position.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in structure and captures the evolving nature of Honeywell's competitive exposure from 2022 to 2024, with accurate emphasis on new market entrants, technological disruption, and impacts on market share and pricing power. All years are correctly referenced, and there are no numeric inaccuracies (the question and answer are qualitative, so no dollar amounts or percentages are involved). However, there are minor but notable inaccuracies in the assignment of risk across segments by year. In 2022, the original answer specifies that competitive risks were cited for Honeywell Building Technologies and Safety and Productivity Solutions—not Aerospace, as the LLM incorrectly states. The LLM reverses this: it claims Aerospace was affected in 2022, but the ground truth shows Aerospace was added later, in 2023. Additionally, the LLM states that in 2023, risks expanded to Building Technologies and Performance Materials and Technologies, but the original answer indicates that Building Technologies was already included in 2022. The 2024 restructuring is correctly noted, though the LLM adds 'reduced investments' as an impact not mentioned in the original answer, which focused on commoditization, lower margins, and pricing. These shifts represent minor but meaningful misalignments in multi-hop reasoning—specifically in tracking which risks applied to which segments in each year. Despite this, the overall trend of expanding competitive pressures across segments is correctly identified, and the answer remains contextually relevant and well-structured. Hence, a score of 7 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy (no numbers, but no factual inconsistencies in dates or entities beyond segment-risk mapping) and high marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 494,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "From 2022 through 2024, Pfizer’s financial and operational relationship with Viatris evolved primarily through transition service arrangements (TSAs) and intercompany balances stemming from the 2020 spin-off and combination of the Upjohn Business with Mylan to form Viatris. Under various agreements, including TSAs and master services agreements (MSAs), Pfizer provided transitional services such as billing, collections, and rebate management on behalf of Viatris, with services under the TSAs largely completed by December 31, 2023. As of December 31, 2023, net amounts due to Viatris were $33 million, down from $94 million as of December 31, 2022, reflecting a reduction in intercompany obligations over the period. These financial flows were primarily classified under operating activities, except for a $277 million payment to Viatris in 2021, which was reported under financing activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: intercompany balances decreased from $94 million in 2022 to $33 million in 2023, and TSAs were largely completed by December 31, 2023. These numbers match the original answer exactly, and formatting is consistent. (2) Quantitative accuracy is perfect—both dollar amounts and dates are correct, and no erroneous calculations are present. The mention of a $277 million financing activity payment in 2021 is factually accurate based on filings but is contextually peripheral to the 2022–2024 scope of the question; however, it does not detract from correctness. (3) Multi-hop reasoning is sound: the answer correctly links the post-spin-off relationship, transition services, and financial balances over time, showing evolution across years and agreements. (4) The only minor omission is that the 2024 status is not explicitly stated—while the answer ends with 2023 data, it does not note that in 2024 the relationship was referenced only in corporate definitions, indicating full resolution. This detail from the original answer adds closure but does not introduce new financial or operational facts. Thus, the answer is substantively complete and semantically equivalent, warranting a high score. Contextual relevance is excellent as all information directly addresses the question’s focus on financial and operational evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 395,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "From 2022 through 2024, Altria Group's debt instrument composition remained relatively stable, with the 1.700% Notes due 2025 consistently listed across all three years, indicating a long-term fixed-income component in its capital structure. In 2022, Altria also had 1.000% Notes due 2023, which were no longer present in 2023 and 2024, suggesting these were likely repaid or retired by 2023. The continued presence of the 2.200% Notes due 2027 and 3.125% Notes due 2031, alongside the 1.700% Notes due 2025, reflects a strategy of maintaining a staggered maturity schedule to manage refinancing risk and ensure long-term capital stability. This progression suggests a disciplined approach to capital structure management, prioritizing debt maturities that align with long-term financial planning and liquidity needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 1.000% Note due 2023 in 2022 and its absence in 2023 and 2024, as well as the continued listing of the 1.700% Note due 2025 across all three years, which aligns with the ground truth. However, the LLM introduces two debt instruments—2.200% Notes due 2027 and 3.125% Notes due 2031—that are not mentioned in the original answer (ground truth), and there is no verification from the knowledge graph that these specific notes were part of Altria's debt composition during this period. This addition, while plausible, introduces unverified details that affect factual accuracy. (2) All dates and percentages mentioned in relation to the 1.000% and 1.700% notes are correct. The timeline of maturity (2023 note disappearing after 2022) is accurate. The error lies in the inclusion of additional notes not present in the ground truth, which impacts quantitative accuracy slightly. (3) The multi-hop reasoning is sound: the model correctly infers that the retirement of the 2023 note and the retention of the 2025 note suggest a strategy of avoiding short-term rollover, focusing instead on intermediate and long-term maturities. The conclusion about a staggered maturity schedule and disciplined capital structure management is logically consistent with the data, even if supported with extra (unverified) instruments. (4) The correctness score is 8 because the core facts and strategic interpretation are accurate, but the inclusion of unsupported debt instruments prevents a higher score. Quantitative accuracy is 8 due to correct use of verified numbers but introduction of unconfirmed ones. Qualitative accuracy is 8 due to correct reasoning and entity identification for the key notes, though with extraneous additions. Contextual relevance is 10 as the answer directly addresses the evolution of debt structure and strategic implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 518,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One's (COF) fixed unsecured senior debt increased in carrying value from $19,975 million in 2022 to $26,930 million in 2024, while the weighted-average interest rate rose from 2.91% in 2022 to 4.84% in 2024. This upward trend in both carrying value and interest rate suggests a shift toward longer-term, higher-cost borrowing, indicating a strategy to extend the maturity profile of its debt and potentially hedge against rising interest rates in a tightening monetary environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but omits the intermediate 2023 data point for both carrying value and interest rate, which is present in the ground truth. The carrying value increased from $19,975M in 2022 to $27,168M in 2023, then slightly decreased to $26,930M in 2024. The interest rate rose from 2.91% in 2022 to 4.45% in 2023, then increased further to 4.84% in 2024. The LLM incorrectly states that the interest rate rose directly from 2.91% to 4.84%, missing the 4.45% in 2023 and implying a monotonic increase, when in fact there was a slight acceleration in the rate increase from 2023 to 2024. (2) The final 2024 values are accurate: $26,930 million and 4.84%, and the 2022 baseline is correct. However, the omission of the 2023 figures reduces quantitative precision, especially since the question asks about the evolution from 2022 to 2024, implying a year-by-year trend. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward longer-term, higher-cost borrowing and links it to market conditions like rising rates and debt maturity extension. This aligns with the ground truth’s interpretation. (4) The answer is contextually excellent—directly addresses the question, uses correct entities (COF, fixed unsecured senior debt, carrying value, weighted-average interest rate), and provides a logical interpretation. The main deduction is for incomplete quantitative reporting across the full time series, hence correctness score of 8 and quantitative accuracy of 8, while qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 431,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, as detailed in the 2022, 2023, and 2024 10-K filings, shows a consistent presence in Tesla’s solar financing strategy. In 2022, the bonds were listed as part of a broader set of SolarCity-related indentures, including later series like 2015/C102-15 and 2015/C107-15, indicating ongoing refinancing or expansion of solar financing instruments. By 2023 and 2024, the 5.45% Solar Bonds, Series 2015/C92-15, remained part of Tesla’s disclosed financial instruments, with no new series introduced, suggesting a stabilization or maintenance phase in Tesla’s solar financing approach. This progression indicates that Tesla has maintained a long-term commitment to leveraging structured solar financing, with a focus on preserving existing instruments rather than expanding into new ones, reflecting a matured and stable strategy in this area.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and synthesis that affect the overall correctness. (1) Quantitatively, the bond name '5.45% Solar Bonds, Series 2015/C92-15' and the years 2022–2024 are correctly identified, and the references to Tesla’s 10-K filings are accurate in scope. However, the LLM incorrectly states that 'no new series were introduced' in 2023 and 2024, which directly contradicts the ground truth: the 2024 filing explicitly mentions newer bond series such as C102-15 and C106-10, indicating active expansion, not stabilization. (2) The ground truth shows a decline in prominence of C92-15 with the emergence of newer instruments, while the LLM interprets the continued listing as evidence of a 'matured and stable strategy' focused on preservation—this misrepresents the trend. (3) Multi-hop reasoning fails: the model does not correctly synthesize the evolution across years—specifically, the shift from C92-15 to newer series in 2024 is a critical hop that the LLM misses. Instead, it assumes continuity implies strategic stability, when the evidence points to evolution. (4) Contextually, the answer addresses Tesla’s solar financing strategy and uses the correct documents, so relevance is high, but the conclusion is factually misaligned. The qualitative accuracy is low due to flawed logic and incorrect inference despite some correct surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 392,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 to 2024, AIG enhanced its management of loss reserves risk through strengthened oversight mechanisms, refined modeling approaches, and increased integration of external reviews. In 2022, AIG emphasized internal controls and external expert reviews to address uncertainties in loss reserve estimates, while also incorporating climate change considerations into its modeling and underwriting processes. By 2023, AIG expanded its risk oversight to include a more structured approach to risk measurement and monitoring, utilizing both stochastic and deterministic modeling techniques to analyze risk concentrations and improve actuarial reviews. In 2024, AIG further integrated second-line reviews and internal audit processes to challenge assumptions and models, ensuring robustness in pricing, reserving, and risk management. Additionally, external expert reviews remained a key component, reinforcing the credibility and accuracy of loss reserve estimates across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserves risk management from 2022 to 2024. It accurately captures the progression in oversight mechanisms, modeling approaches, and integration of external reviews. The mention of internal controls and external expert reviews in 2022 is consistent with the original answer. In 2023, the LLM correctly identifies an expansion in modeling techniques, including stochastic methods (referred to as both stochastic and deterministic modeling), and improved actuarial reviews. In 2024, the emphasis on second-line reviews, internal audit, and model validation matches the ground truth's description of enhanced ERM integration and governance. However, the LLM introduces 'climate change considerations' in 2022, which is not mentioned in the original answer and lacks support from the provided ground truth, representing an unsupported addition. Additionally, while the original answer highlights specific tools like sensitivity and scenario analyses, experience studies, and structured reporting to committees, the LLM generalizes these under 'structured approach to risk measurement' without naming them explicitly, resulting in minor omissions. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is logically sound and contextually relevant. The answer synthesizes information across the three years appropriately, though with slight overreach on climate change and less specificity on certain tools. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 469,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension assets decreased from 19% in 2023 to 8% in 2024, while in 2022, the allocation was not explicitly stated but implied to be part of the broader long-duration fixed income strategy. This decline suggests a strategic rebalancing of pension assets, likely in response to evolving market conditions and liability benchmarks. The ongoing monitoring and adjustment of asset mix, as emphasized in all three years, indicate a proactive approach to maintaining alignment between investment returns and long-term pension obligations, prioritizing stability and risk management.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative timeline. It states that Altria's allocation decreased from 19% in 2023 to 8% in 2024, but the ground truth shows the 19% allocation was in 2022, not 2023. The correct progression is 19% (2022) → 16% (2023) → 8% (2024). The LLM omits the 2022 data point entirely and misattributes it to 2023, which distorts the trend. Additionally, it incorrectly claims that 2022 allocation was 'not explicitly stated,' which contradicts the ground truth. (2) The numbers themselves (19%, 8%) are correct but applied to wrong years; the intermediate 16% drop in 2023 is completely missing. This affects calculation accuracy and trend interpretation. (3) The reasoning about strategic rebalancing and risk management is plausible and aligns with the general direction of the ground truth, but the LLM fails to mention the broader context of declining exposure to below-investment-grade securities (11% to 9%) and the reduction in expected return on pension assets (6.6% to 6.1%), which are key indicators of a more conservative strategy. (4) While the answer addresses the question's intent regarding strategy evolution and provides relevant qualitative interpretation, the incorrect timeline and missing multi-year data points significantly undermine factual correctness. The contextual relevance is high because it discusses pension asset strategy and risk management, but the flawed data leads to an incomplete and partially misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 420,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "From 2022 to 2024, Capital One's (COF) total short-term borrowings and long-term debt increased from $43,086 million to $45,551 million. This growth was primarily driven by an increase in fixed unsecured senior debt, which rose from $19,975 million in 2022 to $26,930 million in 2024, reflecting a shift toward longer-term, fixed-rate financing. Conversely, floating unsecured senior debt declined significantly, from $1,709 million in 2022 to $349 million in 2023 and then to $0 in 2024, indicating a reduction in exposure to variable interest rates. Securitized debt obligations also decreased from $14,994 million in 2022 to $14,264 million in 2024, despite a temporary increase in 2023. The 3-year trend reveals a strategic move toward fixed-rate debt and a reduction in floating-rate obligations, suggesting a deliberate effort to stabilize interest rate exposure and manage refinancing risk in a rising rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the total short-term borrowings and long-term debt for 2022 ($43,086 million) and 2024 ($45,551 million), though it omits the 2023 value of $48.715 billion from the ground truth. This omission is a minor gap but does not distort the overall trend. All other key figures are correct: fixed unsecured senior debt increases from $19,975M to $26,930M; floating unsecured senior debt declines from $1,709M to $349M to $0; securitized debt goes from $14,994M to $14,264M with a temporary rise in 2023. The LLM correctly notes the shift toward fixed-rate debt and reduced floating-rate exposure. (2) Number verification: All dollar amounts match the ground truth when adjusted for format (e.g., $43.086 billion = $43,086 million). The only missing numeric point is the 2023 total debt peak, which slightly weakens the trend description. Interest rate data (e.g., weighted-average rates on securitized or floating debt) are not mentioned in the LLM answer, which is a minor omission but not critical given the focus on debt structure evolution. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across multiple debt categories over three years and infers a strategic shift toward fixed-rate financing to manage interest rate risk. The conclusion about reducing exposure to variable rates aligns with the data. (4) Scores reflect high accuracy with minor completeness gaps: correctness is 9 because the core facts and trends are correct, but the missing 2023 total debt and interest rate details prevent a perfect score. Quantitative accuracy is 9 due to all reported numbers being correct except the incomplete time series. Qualitative accuracy is 9 due to strong reasoning and correct interpretation. Contextual relevance is 10 as the answer directly addresses the question’s focus on debt structure and interest rate exposure trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 531,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggests a consistent and ongoing reliance on this specific financing instrument for solar projects, as evidenced by its inclusion in multiple supplemental indentures tied to SolarCity, which Tesla acquired in 2016. The consistent inclusion of this bond series across filings reflects its enduring role in Tesla's capital structure, particularly in supporting its solar energy initiatives, and underscores the long-term integration of SolarCity’s financing mechanisms into Tesla’s broader financial framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all referenced details are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the consistent appearance across 2022–2024 filings, and the April 14, 2015 issuance date (implied via reference to the Thirty-Sixth Supplemental Indenture in the original answer) are factually sound. The percentage and series designation match exactly. (2) The answer correctly infers ongoing reliance on the bond as a financing instrument for solar projects, which is the core conclusion of the ground truth. (3) The qualitative reasoning is strong: it correctly identifies the bond’s origin in SolarCity and its integration into Tesla’s capital structure post-acquisition, adding contextual depth not explicitly stated but logically supported by the data. This enhances, rather than distorts, the interpretation. (4) The only minor deviation is that the LLM references 'multiple supplemental indentures' without specifying that it's the same Thirty-Sixth Supplemental Indenture repeated across years, which slightly softens precision. However, this does not misrepresent the facts, as the bond series and date are correctly maintained. The answer fully addresses both parts of the question—Tesla’s reliance and the bond’s role in capital structure—and synthesizes information across years appropriately. Semantic equivalence is achieved with slightly different framing. No calculation errors; all entities (Tesla, Solar Bonds, 2015 series, 2022–2024 timeframe) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 427,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard's investment in Class A Treasury Stock increased from $(51,354) million in 2023 to $(71,431) million in 2024, reflecting a significant rise in treasury stock repurchases. This follows a prior increase from $(47,500) million in 2022 (as seen in the 2022 balance sheet with treasury stock at $(36,658) million, and additional context from 2023 showing a jump to $(51,354) million). The consistent growth in treasury stock over these years suggests a strategic focus on returning capital to shareholders through share buybacks, signaling confidence in the company’s financial position and potentially aiming to enhance shareholder value by reducing the number of outstanding shares.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value. The original answer (ground truth) does not provide a 2022 figure, but the LLM incorrectly states that treasury stock was $(47,500) million in 2022, which is not supported by the ground truth. The ground truth only lists values for 2023 ($(51,354) million) and 2024 ($(71,431) million), with no mention of 2022. The LLM fabricates a 2022 number and even references a balance sheet value of $(36,658) million, which contradicts its own stated $(47,500) million and is not in the original answer. This is a major quantitative inaccuracy. (2) The 2023 and 2024 figures are correct: $(51,354) million in 2023 and $(71,431) million in 2024. However, the LLM misstates the 2023 value as both the starting and ending point in a comparison, saying it increased from 2023 to 2024, but fails to note that the original answer lists two 2023 values (likely a typo in the original, but the LLM does not address this). The original answer appears to have a duplication of 2023, but the LLM should have noted the progression from 2023 to 2024 only. (3) The reasoning about capital allocation strategy is sound and aligns with the original: increasing treasury stock suggests a focus on buybacks and returning capital to shareholders. The multi-hop synthesis is partially correct—while the trend interpretation is valid, the inclusion of an unsupported 2022 figure undermines the quantitative foundation. (4) The contextual relevance is high—the answer addresses both parts of the question: the evolution of investment and the strategic implication. The qualitative reasoning is strong, but the quantitative inaccuracies, especially the invented 2022 number, reduce overall correctness. Hence, a score of 7 is justified: core facts for 2023–2024 are correct, but the 2022 data is erroneous and not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 510,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment faced increasing exposure to adverse industry economic conditions from 2022 through 2024, particularly in terms of reduced investments in automation and plant capacity utilization. In 2022, the segment was at risk from reduced investments in process automation and plant capacity utilization, alongside fluctuations in retail markets and competitive pressures. By 2023, these risks persisted and were explicitly tied to broader adverse industry economic conditions, with the segment continuing to face challenges from reduced automation investments and slowing demand for safety products. In 2024, the risk was reclassified under the \"Industrial Automation\" segment, but the nature of the risk remained consistent, indicating a continued macroeconomic trend of reduced capital spending in industrial automation and plant utilization. This evolution suggests sustained macroeconomic pressures on the industrial sector, including constrained customer capital availability and shifting investment priorities, which have had a prolonged impact on Honeywell’s industrial automation and productivity solutions business.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and overall trend. (1) It accurately captures that Honeywell's Safety and Productivity Solutions segment faced increasing exposure to adverse economic conditions from 2022 to 2024, with consistent risks tied to reduced investments in automation and plant capacity utilization. The evolution across years is correctly represented: 2022 highlights reduced automation investment and competitive pressures; 2023 emphasizes ongoing challenges; 2024 reflects continued concern under broader macroeconomic volatility. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or financial figures. (3) The multi-hop reasoning is sound, synthesizing risks across three years and linking them to macroeconomic trends. However, there is a notable inaccuracy in the LLM answer: it states that in 2024, the risk was 'reclassified under the Industrial Automation segment,' which contradicts the ground truth—Honeywell did not reclassify the risk under a different segment; Safety and Productivity Solutions remained the relevant segment. This misstatement affects entity accuracy and reasoning, though the core trend interpretation remains valid. (4) Despite this error, the answer maintains high contextual relevance and conveys the same overall conclusion about sustained macroeconomic pressure on industrial investment. The wording differs slightly but preserves semantic equivalence on the main trajectory of risk escalation. The score is reduced slightly due to the segment misclassification, which could mislead about organizational changes, but the central analysis of economic pressure remains accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 479,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024, Cyramza’s lifecycle positioning remained focused on oncology, with therapeutic indications expanding to include additional cancers and treatment combinations. In 2022, Cyramza was indicated for second-line treatments of gastric cancer, metastatic NSCLC, and colorectal cancer, as well as first-line treatment for NSCLC with EGFR mutations. By 2024, its indications remained largely consistent, with continued use in gastric cancer, NSCLC, and colorectal cancer, and added emphasis on hepatocellular carcinoma as a monotherapy. Intellectual property protection for Cyramza, as detailed in 2023, includes compound patents expiring in 2026 in the U.S. and Japan, and 2028 in major European countries, with biologics data protection in the U.S. also expiring in 2026. These protections support its market exclusivity during its therapeutic lifecycle.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. Most notably, it incorrectly states that Cyramza had a first-line indication for NSCLC with EGFR mutations in 2022, which is not supported by the original answer and misrepresents its therapeutic positioning. The original answer states that indications remained the same from 2022 to 2024, but the LLM suggests an expansion or added emphasis on hepatocellular carcinoma (HCC) by 2024, whereas the original confirms HCC was already an indication in 2022. This overstates the evolution of indications. (2) Regarding intellectual property, the LLM incorrectly states that compound patents expire in 2026 in Japan, while the original specifies data protection expired in Japan in 2023 and compound patents extend to 2028 in Europe and 2026 in the U.S.—but no expiration date for Japan’s compound patent is given in the ground truth. Additionally, the LLM omits the key point that data protection expires in major European countries in 2024, a critical shift in IP timeline emphasized in the original. The U.S. biologics data protection expiring in 2026 is plausible but not mentioned in the ground truth, so its inclusion cannot be verified. (3) The multi-hop reasoning is partially sound—linking therapeutic indications and IP timelines across years—but fails in synthesis accuracy. The model does recognize that Cyramza remains a key oncology product and attempts to map patent timelines, but it introduces unverified expansions in indications and misaligns regional IP expirations. (4) The contextual relevance is high as the response addresses both therapeutic indications and IP protection over time. However, due to significant factual errors in dates, indications, and IP expiration details, the quantitative and qualitative accuracy scores are reduced. The correctness score is 6 because core elements (continued use in major cancers, U.S. patent expiry in 2026) are correct, but key details are either wrong or unsupported, leading to a partially accurate picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 555,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One's (COF) net derivative assets (liabilities) valuation increased from $19 million in 2022 to $58 million in 2024. In 2022, the valuation was based on Level 3 inputs, with a net unrealized loss of $20 million included in net income. By 2023 and 2024, the valuation relied on discounted cash flows using unobservable inputs such as swap rates, with a weighted average of 4% in 2024. This evolution reflects a shift in valuation methodology and an increase in the fair value of net derivative assets (liabilities) over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of Capital One's net derivative assets/liabilities as $19 million in 2022 and $58 million in 2024, which aligns with the ground truth. However, it omits the explicit 2023 value of $58 million, instead grouping 2023 and 2024 together, which downplays the fact that the increase occurred in 2023 and then stabilized. This is a minor omission but affects completeness. (2) The $20 million net loss in 2022 is mentioned, but the LLM incorrectly states it was 'included in net income'—the ground truth specifies it was 'still held in the portfolio,' meaning it was unrealized and not yet recognized in income. This is a significant qualitative error in financial interpretation. The unobservable inputs are partially correct: swap rates (3–5%) and weighted average of 4% in 2024 are accurate, but the LLM omits the default rates (53–163%) used in 2023 and fails to note that the same inputs were used in 2023 and 2024. The claim of a 'shift in valuation methodology' is incorrect—the ground truth indicates consistency in using discounted cash flows and unobservable inputs across years. (3) The multi-hop reasoning is partially sound: the model connects fair value changes over time and references valuation inputs, but fails to accurately represent the continuity of methodology and misrepresents the nature of the $20M loss. (4) Scores reflect mostly correct numbers (quantitative accuracy 7), but flawed reasoning on methodology shift and mischaracterization of financial items (qualitative accuracy 7), while remaining highly relevant to the question (contextual relevance 9). Correctness score is 7 due to accurate core values but significant omissions and one key misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 476,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "From 2022 to 2024, Qualcomm's charitable match program saw a decline in the number of supported organizations, from over 1,500 in 2022 to 1,300 in both 2023 and 2024, while maintaining strong employee participation, with \"thousands\" of employees utilizing the program each year. This progression aligns with the company's broader human capital goals, particularly those tied to diversity, equity, and inclusion, as the HR and Compensation Committee considered progress on human capital advancements when determining executive bonuses for fiscal 2022, 2023, and 2024, using a non-financial performance modifier that could adjust bonus payouts by a multiple of 0.9 to 1.1. This linkage reinforces Qualcomm's commitment to integrating social responsibility and employee engagement into executive compensation, reflecting the company's strategic focus on human capital as a core business driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the key facts: employee participation remained at 'thousands' from 2022 to 2024, and the number of supported organizations decreased from over 1,500 in 2022 to over 1,300 in 2024. The original answer specifies 'fiscal 2024' and does not mention 2023 data, so the LLM's inclusion of '1,300 in both 2023 and 2024' introduces a minor inaccuracy not supported by the ground truth, as 2023 data is not provided. However, this does not materially distort the trend. (2) Quantitatively, the numbers are accurate within acceptable variation: 'over 1,500' and 'over 1,300' match the original, and the use of 'thousands' for employee participation is consistent. The compensation modifier range (0.9 to 1.1) is correctly reported. (3) The multi-hop reasoning is sound: the LLM successfully links charitable program metrics to human capital goals and executive compensation across years, synthesizing information about program participation, organizational reach, and incentive structure. (4) The answer is semantically equivalent to the original, with slightly more confident phrasing about 2023, but overall conveys the same progression and strategic alignment. The linkage to DEI and executive compensation is correctly emphasized. Minor deduction due to unsupported specificity on 2023; otherwise, fully accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> CONCEPT <-[Guides_On]- ORG <-[Focuses_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 381,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "From 2022 to 2024, Adobe positioned Acrobat as a central component of its Document Cloud platform, emphasizing its role in modernizing digital document workflows and enhancing integration with other Adobe services. In 2022, Acrobat was highlighted as a leader in document-intensive industries and as a key driver of document productivity, with a focus on expanding its capabilities within Document Cloud to support seamless collaboration and digital transformation. By 2023, Acrobat was explicitly listed as part of Adobe's Digital Media segment, alongside other core products like Creative Cloud, and was positioned as a tool for accelerating productivity and enabling digital workflows across industries. In 2024, Acrobat was further integrated into Adobe’s broader ecosystem, as evidenced by its inclusion in the list of trademarks and its association with AI-driven enhancements like Acrobat AI Assistant, underscoring Adobe’s strategy to leverage artificial intelligence to enhance document-related functionalities and user experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's role in Document Cloud, its positioning in document-intensive industries, integration with Adobe Sign and Creative Cloud, and the 2024 introduction of 'Acrobat AI Assistant' as a registered trademark. The evolution from a document standard to an AI-enhanced platform is clearly conveyed. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer synthesizes information across 2022–2024 filings, correctly identifying shifts in strategic positioning, segment classification (Digital Media), and AI integration. The only minor omission is that the 2023 filing specifically mentioned 'forward-looking statements about AI-driven features,' which the LLM implies but does not explicitly cite. Also, the ground truth notes trillions of PDFs created annually in 2022, a detail absent in the LLM response. (4) Despite these small omissions, the LLM captures the core trajectory and strategic evolution accurately, with excellent contextual relevance and semantic equivalence. Hence, a score of 9 is justified—excellent but not perfect completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 354,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "From 2022 through 2024, LLY's collaboration with AbCellera on the development and commercialization of bamlanivimab and bebtelovimab generated significant net product revenue in 2022, with $2.02 billion recognized, but no sales occurred in 2023 or 2024. AbCellera received royalty payments in the mid-teens to mid-twenties on worldwide net sales of these antibodies, which LLY recorded as cost of sales. In 2021, LLY had recognized $2.24 billion in net product revenue from these antibodies, and in 2020, $871.2 million. The financial implications of the collaboration were most pronounced in 2021 and 2022, with declining revenue in subsequent years as the need for these therapies diminished.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the $2.02 billion net product revenue for 2022 and accurately describes the royalty range (mid-teens to mid-twenties) paid to AbCellera, which aligns with the ground truth. It also correctly notes no sales in 2023 and 2024, reflecting the wind-down of the product line. However, it introduces financial data for 2020 ($871.2 million) and 2021 ($2.24 billion), which were not part of the original question or ground truth answer. The question specifically asked about 2022 through 2024, so including earlier years—while factually possibly accurate—is extraneous and distracts from the requested time frame. More critically, the inclusion of 2021 revenue ($2.24B) contradicts the ground truth implication that 2022 was the peak year, potentially misleading the reader about the trend. (2) The quantitative accuracy is partially compromised because while the 2022 figure is correct, the addition of 2021 and 2020 figures not present in the ground truth introduces unverified data into the response, reducing reliability. The core requested numbers (2022–2024) are correct, but the erroneous expansion into prior years lowers confidence in precision. (3) The multi-hop reasoning is generally sound—LLM connects collaboration, revenue, and royalty payments across years, and correctly infers declining financial impact. However, the reasoning is weakened by referencing data outside the scope of the verified knowledge graph answer, suggesting potential hallucination or misalignment with source constraints. (4) Contextual relevance is high because the answer addresses revenue evolution and royalty payments as required, and correctly identifies the trend. The qualitative accuracy is good due to correct entity identification (LLY, AbCellera, bamlanivimab, bebtelovimab) and proper interpretation of royalty structure. The correctness score is 7 because the core facts for the requested period are accurate, but the inclusion of unsupported prior-year data reduces overall fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 545,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block remained consistent at 59% in 2022, 59%, in 2023, and 59% in 2024, indicating no material change over the three-year period. This consistency suggests a stable and deliberate long-term risk transfer strategy, where MetLife continues to cede a substantial portion of the closed block to an unaffiliated third-party reinsurer to mitigate risk exposure. The use of the deposit method of accounting and the right of offset further reflect a structured approach to managing reinsurance liabilities and recoverables, reinforcing the company's focus on risk management and balance sheet optimization.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent percentage of MetLife's reliance on the modified coinsurance agreement across 2022–2024. However, it states '59%' for 2022, while the ground truth specifies '59.25%' for that year. This is a minor numerical inaccuracy but does not materially alter the conclusion of stability. The 2023 and 2024 percentages (59%) are exactly correct. (2) The quantitative values are mostly accurate with only a slight rounding discrepancy in 2022; otherwise, all years align with the ground truth. Calculations are not required in this case, but the consistency across years is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the stable percentage reflects a deliberate, long-term risk transfer strategy. It appropriately connects the consistent reinsurance level to strategic risk management, which aligns with the ground truth’s interpretation. The addition of details about the deposit method and right of offset, while not in the original answer, are contextually relevant and reflect accurate understanding of reinsurance accounting practices, enhancing the explanation without introducing error. (4) The correctness score is 9 because the core factual content and interpretation are highly accurate, with only a minor deviation in precision for the 2022 percentage. Quantitative accuracy is slightly penalized for the rounding without qualification, but qualitative accuracy remains high due to strong reasoning and synthesis. Contextual relevance is perfect as all content directly addresses and enriches the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 453,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard's multi-layered security approach has evolved significantly from 2022 to 2024, with a stronger emphasis on third-party collaboration and real-time payment infrastructure. In 2022, Mastercard outlined its foundational multi-layered security strategy, which included working with third parties such as issuers, acquirers, and industry associations to establish technical standards like EMV for secure transactions. By 2023, the company expanded this collaboration to include public-private partnerships and efforts to address threats from third-party service providers, indicating a more proactive and integrated approach to ecosystem security. In 2024, Mastercard further enhanced its real-time payment infrastructure, operating real-time payments systems in several countries globally and processing domestic transactions in China through a joint venture, while continuing to strengthen third-party collaboration to monitor and respond to cyber threats. These developments reflect a cybersecurity strategy that is increasingly collaborative, adaptive, and focused on securing the entire payments ecosystem, especially as real-time transactions become more prevalent.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Mastercard's security strategy from 2022 to 2024 with accurate qualitative reasoning and strong contextual relevance. (1) It correctly identifies the increasing emphasis on third-party collaboration and real-time payment infrastructure across the three years. The progression from foundational partnerships in 2022, to more structured third-party risk management in 2023, and global expansion in 2024 is logically presented and aligns with the ground truth. (2) Regarding quantitative accuracy: the LLM states that real-time payments were operating in 'several countries globally' in 2024, which matches the ground truth, but omits the specific numbers for 2022 (12 markets) and 2023 (13 markets). This is a minor omission rather than an error, as 'several countries' is consistent with the trend, but the lack of precise figures reduces quantitative precision. The mention of processing domestic transactions in China via a joint venture is factually plausible but not present in the ground truth, introducing a detail that cannot be verified from the provided data—this does not contradict but adds unconfirmed information. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers a strategic shift toward a more integrated, ecosystem-wide security posture. It connects third-party collaboration with real-time infrastructure growth and draws a valid conclusion about Mastercard’s adaptive cybersecurity strategy. (4) Contextual relevance is excellent—the response directly addresses all parts of the question, including evolution over time, third-party collaboration, real-time infrastructure, and strategic implications. The added detail about EMV and China slightly extends beyond the source but does not detract from accuracy. Overall, the answer is factually strong with only minor omissions in specific metrics, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 530,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "LLY's allocation to private alternative investments, specifically equity-like funds, increased from 2022 through 2024. In 2022, equity-like funds were valued at $2,827.8 million, rising to $3,988.7 million in 2023 and further to $4,068.6 million in 2024. This upward trend suggests a deliberate long-term strategy to increase exposure to illiquid assets, likely to diversify returns and capitalize on opportunities in private markets, which are typically less correlated with public equity and fixed income markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in LLY's allocation to equity-like funds from 2022 to 2024 and interprets this as a strategic move toward illiquid assets, which aligns with the ground truth. However, the numeric values provided are inaccurate. According to the ground truth, allocations were $2,844.7M (2022), $4,014.1M (2023), and $4,093.7M (2024). The LLM reports $2,827.8M (2022), $3,988.7M (2023), and $4,068.6M (2024)—all figures are off by tens to over $100 million in 2023. These discrepancies are significant and affect quantitative accuracy. (2) The calculation of the trend (increasing with a smaller increase in 2024) is directionally correct, but the model fails to note the slight dip in 2023 as mentioned in the original answer. This omission affects completeness and reasoning precision. (3) The multi-hop reasoning—linking increasing allocations to a long-term strategy in illiquid assets—is sound and contextually appropriate. The interpretation about diversification and lower correlation with public markets adds reasonable qualitative insight not in the original but does not contradict it. (4) Despite strong qualitative and contextual performance, the correctness score is reduced due to material numerical inaccuracies that impact the reliability of the financial analysis. Quantitative accuracy is penalized heavily for incorrect dollar amounts, while qualitative and contextual scores remain high due to correct logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 412,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "From 2022 to 2024, Procter & Gamble consistently positioned Cascade within its Fabric & Home Care segment, as evidenced by its inclusion in the \"Home Care\" product category across all three years, specifically under Dish Care. Cascade contributed to the segment's net sales, which remained a significant portion of PG’s overall sales, increasing slightly from 35% in 2022 to 36% in both 2023 and 2024. While specific sales contribution of Cascade alone was not disclosed, its continued listing as a major brand under Fabric & Home Care indicates its ongoing strategic importance within the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all percentages (35% in 2022, 36% in 2023 and 2024) are correct, and the years are accurately referenced. There are no calculation errors. (2) The LLM correctly identifies that Cascade is part of the Fabric & Home Care segment under the Home Care category, specifically in Dish Care, which matches the product categorization in the original answer. (3) The reasoning is sound: while Cascade's individual sales contribution is not disclosed, the LLM appropriately infers continued strategic importance from its consistent listing as a major brand, which is consistent with the original answer's conclusion about stable positioning. (4) The only minor shortcoming is that the original answer explicitly notes Cascade's 'prominent' feature in 2024 and emphasizes 'consistent contribution'—nuances slightly underemphasized in the LLM response, though the core meaning is preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop synthesis across years and segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 313,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 through 2024, Lowe's evolved its supplier sustainability monitoring and wood sourcing practices by enhancing its policy framework and increasing investments in sustainability initiatives. In 2022, Lowe's committed to a science-based net-zero target and established a goal to reach net-zero emissions by 2050, including a 22.5% reduction in Scope 3 emissions by 2030. The company also began monitoring suppliers through rigorous standards, including its human rights policy, conflict minerals policy, and Vendor Code of Conduct, which included enhanced environmental standards. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, improved monitoring practices, and introduced a forestry grievance process. Additionally, the company invested over $400 million in energy efficiency and operational improvements. By 2024, Lowe's had further enhanced its wood sourcing policy to include a more robust risk-based approach and continued to expand its offering of independently certified sustainable products, while also increasing its 2030 Scope 3 emissions reduction target to 25%. These enhancements were supported by ongoing investments in renewable energy, waste and water management, and transportation sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several inaccuracies in quantitative details compared to the ground truth. For example, it states that Lowe's invested 'over $400 million in energy efficiency and operational improvements' in 2023, while the original answer specifies 'over $550 million in environmental facility upgrades' in 2022 — both the amount and the year are incorrect. Additionally, the LLM introduces a 'science-based net-zero target' and a '22.5% reduction in Scope 3 emissions by 2030' in 2022, which are not mentioned in the ground truth; the original answer does not reference any emissions targets for 2022 or 2023. The updated 2030 Scope 3 target of 25% in 2024 is also not supported by the original answer, which focuses on policy and investment changes rather than emissions metrics. The $50 million Gable Grants program over five years, a key investment in 2023, is entirely omitted from the LLM response. (2) The LLM correctly identifies the 2023 wood sourcing policy updates — new country risk levels, enhanced monitoring, and a forestry grievance process — and the 2024 strengthening of the risk-based approach, which aligns with the original answer. However, it fabricates emissions-related goals and misattributes investment figures. (3) The qualitative reasoning is sound in terms of tracking policy evolution across years and recognizing the integration of risk-based frameworks and supplier accountability. The LLM correctly synthesizes multi-hop elements like policy updates over time and links them to broader sustainability strategy, but fails to accurately represent the financial commitments and omits key programs like the Gable Grants. (4) Contextually, the answer is highly relevant and well-structured, addressing the evolution of monitoring and sourcing practices. However, due to significant quantitative inaccuracies and omission of key factual investments, the correctness score is reduced to 6. The qualitative accuracy is moderate due to correct structural reasoning, and contextual relevance is high as the response directly addresses the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 564,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "From 2022 through 2024, Honeywell's exposure to changes in the competitive landscape across its **Safety and Productivity Solutions**, **Honeywell Building Technologies**, and **Industrial Automation** businesses shows a consistent and intensifying pattern of risk, indicating growing market pressures and product commoditization risks over time.\n\nIn **2022**, the **Safety and Productivity Solutions** business was exposed to risks from changes in the competitive landscape, including new market entrants and technologies that could lead to product commoditization, potentially reducing market share, selling prices, and margins. **Honeywell Building Technologies** also faced similar risks, with changes in the competitive landscape and new technologies cited as potential threats to operating results. \n\nBy **2023**, the **Safety and Productivity Solutions** business continued to face similar risks, with an added emphasis on the impact of adverse industry economic conditions. **Honeywell Building Technologies** maintained the same risk profile, with no new mitigating factors introduced. \n\nIn **2024**, the **Industrial Automation** business—formerly part of the Safety and Productivity Solutions segment—explicitly highlighted exposure to changes in the competitive landscape, including new entrants and technologies that may lead to product commoditization, echoing the earlier risks faced by the Safety and Productivity Solutions and Building Technologies businesses. This shift in naming and structure suggests a strategic realignment, but the underlying risk remains consistent and has not diminished.\n\nThe consistent presence and even slight expansion of these risks across the three-year period indicate that **market pressures and the threat of commoditization have not abated but have instead become more entrenched**, suggesting a challenging and increasingly competitive environment for these segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall assessment that Honeywell faced increasing and broadening competitive pressures across its business segments from 2022 to 2024, with consistent risks of commoditization due to new entrants and technological changes. The dates (2022, 2023, 2024) and business segments (Safety and Productivity Solutions, Honeywell Building Technologies, Industrial Automation) are correctly identified, and there are no numerical inaccuracies—this supports a high quantitative accuracy score. However, there are key qualitative discrepancies: the original answer specifies that the competitive landscape risk was first highlighted in Safety and Productivity Solutions in 2022, then expanded to Honeywell Building Technologies in 2023, and only in 2024 to Industrial Automation. The LLM incorrectly states that Honeywell Building Technologies already faced this risk in 2022, which is not supported by the ground truth (where it was first mentioned in 2023). Additionally, the LLM claims that Industrial Automation was 'formerly part of' Safety and Productivity Solutions and implies continuity, but the ground truth does not confirm this structural shift, making the reasoning speculative. While the conclusion about intensifying market pressures is valid, the misattribution of when risks were first disclosed in each segment undermines the multi-hop synthesis accuracy. The answer remains contextually relevant and captures the broader trend, but with minor factual overreach in entity-year risk mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 420,
        "total_tokens": 2199
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic positioning in the digital cockpit market evolved as it increasingly emphasized automotive transformation, with specific disclosures highlighting its product revenue recognition and segment reporting. In 2022, Qualcomm outlined the growing demand for embedded 5G connectivity in vehicles and the digitalization of the automotive cockpit, positioning itself as a key enabler of software-defined vehicles and advanced driver assistance systems. By 2023, Qualcomm explicitly reported revenues from products used in automobiles, including digital cockpit solutions, indicating tangible progress in monetizing its automotive strategy. In 2024, the company further solidified its focus by including automotive systems—such as connectivity, digital cockpit, and ADAS/AD—as a core part of its QCT segment, reflecting a more integrated and strategic approach to the automotive market. These disclosures collectively show Qualcomm's transition from market positioning to active revenue generation and dedicated segment-level investment in the digital cockpit space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's 2022 positioning as an enabler of digital cockpit transformation, the 2023 monetization via explicit revenue recognition for digital cockpit products, and the 2024 integration into the QCT segment with structured reporting. The LLM correctly identifies the progression from strategic vision to monetization to operational integration. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. While the ground truth mentions a specific analyst projection of 'over 70% of new vehicles in 2028 having embedded cellular connectivity,' this detail is omitted in the LLM answer but does not detract from the core correctness, as it is a supporting detail rather than a central fact. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly linking disclosures on automotive transformation, revenue recognition, and segment reporting to show strategic evolution. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM uses 'software-defined vehicles' and 'tangible progress in monetizing' as paraphrases that capture the essence of the original. The only minor gap is the absence of the explicit mention of 'ADAS/AD' being grouped with digital cockpit and connectivity in 2024, though it is implied in 'automotive systems such as connectivity, digital cockpit, and ADAS/AD.' This slight omission prevents a perfect 10 but does not undermine the overall accuracy. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 451,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 to 2024, Adobe expanded Frame.io's capabilities significantly. Initially, Frame.io supported still images, design files, and PDFs, with integrations to Premiere Pro and After Effects (2022). By 2023, it added support for video beyond post-production workflows, including casting, location scouting, and marketing campaign management, while maintaining integrations with Premiere Pro, After Effects, and expanding to Photoshop and Lightroom. In 2024, Frame.io further enhanced its cross-product integrations by connecting with Workfront and became part of Adobe GenStudio, enabling scalable content production. Enterprise capabilities also improved, with Frame.io supporting Camera to Cloud functionality and deeper integration with Adobe Firefly Services, allowing for automated, large-scale creative workflows.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io from 2022 to 2024 with accurate integration timelines and expanding capabilities. It correctly identifies the 2023 integration with Premiere Pro, After Effects, and the addition of Photoshop and Lightroom, as well as the 2024 inclusion in Adobe GenStudio and integration with Workfront. However, there is a factual misstatement regarding the timing of video support and workflow expansion: the original answer states that in 2023, Frame.io supported video, still images, design files, and PDFs within post-production workflows, while the LLM incorrectly claims that 'video beyond post-production workflows' (including casting, location scouting, marketing) was added in 2023—this expansion is actually attributed to 2024 in the ground truth. Additionally, the LLM introduces 'Camera to Cloud functionality' and 'Adobe Firefly Services' integration, which are not mentioned in the original answer and lack support from the provided ground truth, representing unsupported additions. (2) Quantitatively, all years (2022, 2023, 2024) are used appropriately and align with the original timeline. No numerical values are incorrect, though the introduction of unverified features reduces factual precision. (3) The multi-hop reasoning is mostly sound—information is synthesized across years and product areas—but the misattribution of feature rollout timing (especially the premature placement of expanded workflows in 2023) and the addition of unsupported enterprise features (Firefly, Camera to Cloud) indicate a partial failure in accurate synthesis. (4) The contextual relevance is high, as the answer directly addresses supported media types, cross-product integrations, and enterprise capabilities across the specified timeframe. Despite minor inaccuracies and unsupported claims, the core progression and integrations are correctly conveyed, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 528,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 through 2024, MA's A Class shares consistently retained one vote per share and dividend rights, as disclosed in each year’s 10-K filings. The B Class shares maintained non-voting status with dividend rights, and no Preferred shares were issued or outstanding during this period, with their rights to be determined upon future issuance by the Board. This three-year consistency in dividend and voting rights for A and B Class shares indicates a stable shareholder governance structure, with no material changes to the rights of existing shareholders over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that MA's A Class shares maintained 'one vote per share' and 'dividend rights' from 2022 to 2024, with no changes—this matches the original answer exactly. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes consistent disclosures across three years of filings and draws the appropriate conclusion about governance stability. It also adds context about B Class and Preferred shares, which, while not required, is factually accurate and enhances completeness without introducing error. (4) The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. All entities (MA, A Class shares, 10-K filings) are correctly identified. The conclusion about stable shareholder governance is logically supported. All scoring dimensions warrant the highest rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 295,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell's Safety and Productivity Solutions segment was impacted by fluctuations in retail markets across fiscal years 2022, 2023, and 2024, as noted in each year's 10-K filings. In 2022, the segment faced risks from retail market volatility, which could lead to reduced investments in automation and safety products. In 2023, similar risks persisted, with the segment remaining vulnerable to retail market fluctuations and potential slowdowns in safety product demand. By 2024, the segment—rebranded as Industrial Automation—continued to be exposed to the same retail market fluctuations, indicating a persistent vulnerability to consumer demand volatility. This recurring exposure across three years highlights the segment's ongoing sensitivity to shifts in retail dynamics, underscoring its susceptibility to economic and consumer-driven uncertainties over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions segment was exposed to retail market fluctuations in 2022, 2023, and 2024, and this risk persisted even after the segment was rebranded as Industrial Automation in 2024. The LLM correctly identifies the continuity of risk across organizational changes. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the fiscal years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and recognizes the segment name change while maintaining the continuity of risk exposure. It correctly infers that the persistent disclosure indicates ongoing vulnerability. (4) The only minor shortcoming is that the LLM omits the specific mention of 'commoditization risk' in 2023 and 'downward pressure on margins' in 2022, which are present in the original answer and add nuance to the nature of the risk. While the core message about persistent vulnerability is accurately conveyed, the absence of these specific risk dimensions slightly reduces qualitative completeness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong reasoning across time and entity changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 407,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 to 2024, the financial obligations and royalty structure between LLY and Incyte for Olumiant evolved with the inclusion of new indications, particularly for the treatment of COVID-19. Initially, in 2022, the agreement provided Incyte with tiered, double-digit royalty payments on worldwide net sales of Olumiant, up to 20%, and included potential milestone payments tied to regulatory and sales-based achievements, with $260.0 million in milestone payments capitalized by 2021. In 2023, the collaboration was updated to clarify that Incyte was entitled to an additional royalty, up to the low teens, on net sales for the treatment of COVID-19 exceeding a specified threshold, reflecting the expanded use of baricitinib. By 2024, the structure remained consistent, with Incyte retaining the tiered royalty rights and the additional royalty for the treatment of COVID-19, while LLY continued to record royalty payments as cost of sales. The inclusion of the EUA (Emergency Use Authorization) sales in all years further expanded the scope of sales subject to these royalty obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of the LLY-Incyte agreement for Olumiant and correctly identifies key elements such as tiered royalties up to 20%, the additional low teens royalty for COVID-19 sales above a threshold, and the inclusion of EUA sales. However, it contains significant quantitative inaccuracies. The ground truth states that in 2022, Incyte was eligible for up to $100 million in regulatory milestones and $100 million in sales-based milestones (total $200 million), but the LLM claims '$260.0 million in milestone payments capitalized by 2021', which contradicts the original answer and introduces a number not supported by the ground truth. This is a critical factual error affecting the correctness of the financial timeline. (2) The LLM incorrectly implies that the $260 million was capitalized by 2021, while the original answer states that milestone payments were capitalized as intangible assets starting in 2023. This misplacement of timing and amount undermines quantitative and temporal accuracy. (3) Qualitatively, the reasoning is mostly sound: the model correctly tracks the continuation of royalty structures into 2024 and notes the accounting treatment of royalties as cost of sales. It also accurately reflects the expansion of the agreement to include COVID-19 indications with a threshold-based royalty. However, it misses the key point from the original answer that by 2024, the focus had shifted to ongoing royalties because most contingent milestones had likely been triggered or expired—a crucial evolution in the financial relationship. (4) Contextual relevance is high, as the response directly addresses all components of the question—milestone payments, royalty rates, new indications (COVID-19), and changes over time. Despite strong structure and relevant context, the incorrect milestone figure and misstated timing of capitalization reduce the overall correctness score to 6, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 540,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, Procter & Gamble strategically repositioned the Always brand within its Baby, Feminine & Family Care segment by narrowing its product categorization under Feminine Care, specifically focusing on Adult Incontinence and Menstrual Care. In 2022, Always was listed alongside other major brands like Luvs, Pampers, and Tampax, with broader categories such as Baby Care and Family Care also included in the segment. However, by 2023 and 2024, Always was highlighted as a standalone brand in the Feminine Care category, indicating a shift in emphasis and a more targeted positioning. This evolution suggests that Always gained greater prominence within the segment, likely reflecting P&G's strategy to strengthen its presence in the growing feminine care market, particularly in adult incontinence and menstrual products.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies the shift in categorization from broader Feminine Care in 2022 to a more focused 'Menstrual Care' emphasis by 2023–2024 and notes Always’s prominence within the segment. However, it incorrectly states that in 2022, Always was listed alongside Luvs and Pampers—these are Baby Care brands and not part of the same subcategory as Always. The original answer clarifies that Always was grouped with Always Discreet, Tampax, Bounty, Charmin, and Puffs under 'Feminine Care (Adult Incontinence, Feminine Care)'—not with baby care brands. This misplacement reflects a failure in entity accuracy and multi-hop synthesis. (2) There are no explicit numbers or calculations in the question, so quantitative accuracy is not heavily applicable; however, the dates (2022–2024) are used correctly, earning a high score here. (3) The reasoning is partially sound—the conclusion about strategic sharpening around menstrual care aligns with the ground truth—but the flawed premise (incorrect brand associations) undermines the logic. The LLM infers increased prominence without clear evidence from the data and conflates segment structure with brand hierarchy. (4) Contextual relevance is strong because the answer addresses product categorization, evolution over time, and strategic implications. However, due to incorrect brand groupings and misrepresentation of the segment structure, the qualitative accuracy and overall correctness are significantly reduced. Minor point: 'Adult Incontinence and Menstrual Care' is presented as a dual focus, but the ground truth emphasizes Always’s alignment with menstrual care specifically, while Always Discreet handles adult incontinence. This blurring reduces precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 493,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s target asset allocation strategy for defined benefit pension plans evolved across fiscal years 2023, 2024, and 2025, reflecting a consistent emphasis on balancing risk-adjusted returns with liability duration matching. The 2022 filing established the target allocation for fiscal 2023, which was maintained in the 2023 filing as of August 31, 2023, indicating continuity in the strategy. The 2023 and 2024 filings both reference the target allocation for fiscal 2025, showing that the company maintained a multi-year strategic horizon. This progression highlights ACN’s disciplined approach to aligning asset allocations with long-term liabilities through diversified portfolios of fixed income and equities, with a focus on minimizing volatility by matching the duration of debt securities to plan liabilities, while also pursuing long-term capital appreciation through equities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2022 filing set the target for fiscal 2023, the 2023 filing provided the August 31, 2023 update and introduced the fiscal 2025 target, and the 2024 filing reaffirmed that same 2025 target. There are no incorrect numbers, dates, or entities—this satisfies quantitative accuracy. (2) The answer correctly identifies the multi-year progression across filings and fiscal years, demonstrating proper multi-hop synthesis across documents and time points. (3) The reasoning is sound: it captures the strategic continuity, the balance between risk-adjusted returns and liability duration matching, and the use of diversified fixed income and equities. The only minor shortcoming is that the LLM does not explicitly mention the 'flexibility based on market conditions and cash flow needs' noted in the original answer, which slightly reduces qualitative accuracy. However, the emphasis on long-term alignment and disciplined strategy implies such flexibility. (4) The answer is fully contextually relevant, directly addressing the evolution of the strategy and its implications. Wording differs but semantic meaning is equivalent. No calculation errors or factual inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 357,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe's exposure to forward interest rate swaps decreased from $251 million in 2023 to $0 in 2024, as shown in the fair value measurements. In 2022, the swaps were designated as cash flow hedges, with their impact recorded in other comprehensive income. By 2024, the swaps were classified as fair value hedges, with changes in fair value offsetting changes in the hedged debt, indicating a shift toward managing interest rate risk through direct debt exposure rather than forecasted cash flows. This evolution suggests a more integrated and potentially more stable approach to interest rate risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $251 million fair value in 2023 and $0 in 2024 are accurately reported, and the absence of a disclosed value in 2022 is correctly implied by stating the exposure began in 2023. (2) The entity accuracy is strong—Lowe's, forward interest rate swaps, cash flow hedges (2022), fair value hedges (2024), and the shift in strategy are all correctly identified. (3) The reasoning is sound: the answer correctly infers a strategic shift from managing forecasted cash flows (cash flow hedges) to managing existing debt (fair value hedges), which reflects a more stable capital structure. The only minor omission is that the 2022 disclosures referenced impacts from prior years (2021–2019) but did not report a current fair value—this nuance is not included in the LLM answer, slightly reducing completeness. However, the core multi-hop synthesis—linking changes in hedge type, fair value disclosure, and strategic implications across 2022–2024—is well executed. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of exposure and what it reveals about risk management strategy. Wording differs slightly from the original but maintains semantic equivalence. No calculation errors; number formats are consistent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 387,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO's financial exposure to the 5.000% notes due April 2030 remained stable at $606 million from fiscal year 2022 through 2024, as shown in the 2022, 2023, and 2024 10-K filings. This consistency suggests that AVGO has not refinanced or repaid this debt obligation during the period, indicating a strategy of maintaining long-term fixed-rate debt to manage interest costs and preserve liquidity. The unchanged balance also reflects disciplined debt management, avoiding unnecessary refinancing in a potentially volatile interest rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure remained stable at $606 million from 2022 through 2024. The ground truth shows exposure was $1,086 million in 2022, declining to $606 million in 2023 and 2024. This major quantitative error undermines the entire response. (2) The numbers are not accurate: the 2022 value is off by $480 million, a significant miscalculation. The LLM incorrectly asserts stability, while the truth shows a clear reduction. No correct calculation or trend identification is present. (3) The multi-hop reasoning fails because the model did not correctly synthesize the year-over-year change across filings. Instead of identifying a deliberate debt reduction strategy, it infers stability and attributes it to a decision to maintain fixed-rate debt—this conclusion is based on false premises. (4) While the answer addresses the question's structure and discusses debt management strategy, the incorrect data leads to an invalid interpretation. Contextual relevance is moderate because it discusses the right topic and cites 10-Ks, but factual inaccuracies severely limit usefulness. Quantitative accuracy is very low due to wrong figures; qualitative accuracy is low due to flawed reasoning based on those figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 358,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS's treatment and disclosure of its 7.620% debentures remained consistent in key terms from 2022 through 2024, with a fixed interest rate of 7.620% and a maturity date of April 1, 2030. In 2022, it was disclosed that the interest rate had decreased from 8.375% to 7.620% in April 2020, and the debentures were redeemable at the company’s option at a price based on the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. By 2023 and 2024, the disclosures in the 10-K filings reiterated the same redemption terms, interest payment schedule (semi-annual in April and October), and the absence of sinking fund requirements, indicating no material changes in the structure or treatment of the debentures during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the interest rate (7.620%), maturity date (April 1, 2030), principal amount ($276 million—implied as consistent), and redemption terms are accurately represented. The note that the rate was reduced from 8.375% to 7.620% in April 2020 is correctly included in the 2022 disclosure context. (2) Quantitative elements—interest rate, dates, and payment schedule (semi-annual in April and October)—are all factually correct. No calculations were required, but the consistency of values across years is properly conveyed. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across 2022–2024, correctly identifying that while the core terms remained stable, the emphasis in disclosure evolved—particularly around redemption terms and payment schedule. The absence of sinking fund requirements is correctly noted. (4) The only minor shortcoming is that the 2024 emphasis on semi-annual payments and lack of sinking fund is presented as consistent across 2023–2024, whereas the ground truth notes increased emphasis in 2024 specifically. This nuance is slightly underdeveloped but does not constitute a factual error. Overall, the answer is factually complete, contextually appropriate, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Pays_Interest_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 375,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen's development and strategic positioning of Olpasiran evolved from 2022 through 2024 with a consistent therapeutic focus on cardiovascular disease, particularly targeting lipoprotein(a) (Lp(a)) to address atherosclerotic cardiovascular disease. In 2022, Olpasiran was in phase 2 clinical trials for this indication, as noted in the 10-K filing. By 2024, the molecule remained under development for cardiovascular disease, as listed in the 2024 10-K, indicating continued progression in its clinical focus without a phase advancement explicitly mentioned. In terms of intellectual property, the 2023 10-K disclosed that Amgen holds patent protection for Olpasiran in the U.S. and Europe until 2036, covering compounds related to the drug. This timeline suggests a long-term strategic positioning to secure market exclusivity and support future commercialization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Olpasiran was in phase 2 in 2022 targeting Lp(a) for atherosclerotic cardiovascular disease; IP protection in the U.S. and Europe until 2036 was disclosed in 2023; and by 2024, the indication was broadened to 'cardiovascular disease.' The LLM correctly identifies the therapeutic focus, clinical phase, and IP timeline. (2) Quantitative accuracy is perfect: the 2036 patent expiry is correctly cited, and no numerical errors are present. Format and dates match the ground truth. (3) Reasoning is sound and reflects multi-hop synthesis across 2022–2024 filings. The only minor shortcoming is that the LLM does not explicitly note the *expansion* of the therapeutic indication from 'atherosclerotic cardiovascular disease' to the broader 'cardiovascular disease' as a strategic shift, though it does mention the broader term in 2024. This nuance is implied but not emphasized. (4) Contextual relevance is excellent—the response directly addresses all parts of the question: therapeutic focus, clinical progression, and IP timeline. Overall, the answer is factually complete and well-reasoned, warranting a 9/10 for correctness due to the slight underemphasis on the strategic implication of the indication broadening.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 367,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "From 2022 to 2024, Tampax remained a key brand within P&G's Feminine Care segment, consistently listed among the major brands in the Baby, Feminine & Family Care segment. In 2022, Tampax was included under the Feminine Care sub-category alongside other major brands like Always and Always Discreet. In 2023 and 2024, the prominence of Tampax was maintained, with no significant changes in its categorization or position among major brands, continuing to be listed alongside Always and Always Discreet under the Feminine Care sub-category. This consistency highlights Tampax's stable role within P&G's strategic portfolio during the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Tampax remained a consistently prominent brand within P&G's Feminine Care segment from 2022 to 2024 and was grouped with Always and Always Discreet, which aligns with the ground truth. However, it omits key details about the segment reclassification. Specifically, in 2023, P&G changed the sub-category name from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)', a refinement noted in the original answer. Additionally, the LLM incorrectly states that the segment was called 'Baby, Feminine & Family Care' in all three years, while the ground truth indicates a temporary shift in segment naming structure in 2023 before reverting in 2024. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes Tampax’s consistent prominence across years but fails to capture the nuanced evolution in categorization and segment naming, which is central to the question about 'evolution' in positioning. (4) The answer is contextually relevant and captures the core idea of Tampax’s stable strategic role, but lacks completeness in describing the precise changes in segment labeling, which diminishes qualitative accuracy. Hence, correctness is scored 7—core facts are right, but key descriptive details are missing or slightly inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 420,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS remained consistent through 2022, 2023, and 2024, as the NAIC evaluates these securities annually and designations are not immediately available for newly acquired assets. In 2022, MetLife noted that when its insurance subsidiaries acquire non-agency RMBS and CMBS not yet evaluated by the NAIC, internally developed designations are used until NAIC designations become available. This practice continued in 2023 and 2024, with similar disclosures in both years, indicating that the availability of NAIC designations has not significantly improved over the three-year period. The ongoing use of internal designations suggests that MetLife continues to actively acquire non-agency RMBS and CMBS, necessitating internal credit assessments in the absence of timely NAIC evaluations, which in turn reflects a strategic focus on this asset class despite regulatory delays.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: MetLife's use of internally developed designations for non-agency RMBS and CMBS persisted from 2022 to 2024; this practice was explicitly tied to the lack of immediate NAIC evaluations for newly acquired securities. (2) There are no numeric values requiring calculation in this question, but the years (2022, 2023, 2024) are correctly referenced and consistent with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesized the continuity of policy across three years and inferred the implications for NAIC designation availability and MetLife’s acquisition strategy. (4) The answer addresses both parts of the question: the evolution (consistency over time) and what it indicates (ongoing strategy in complex securities despite delays in NAIC designations). Wording differs slightly but meaning is preserved, including the strategic implication of active investment in structured securities requiring internal credit assessments. No factual errors, omissions, or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 319,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "From fiscal 2022 through fiscal 2024, Accenture's share repurchase activity and available authorization under its open-market share purchase program show a consistent and strengthening capital return strategy. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases and redemptions as of August 31, 2022. By fiscal 2024, this amount had grown to $2.694 billion as of August 31, 2024, and further increased to $6.694 billion after an additional $4 billion in repurchase authority was approved by the Board on September 25, 2024. During the fourth quarter of fiscal 2024, Accenture repurchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, reflecting active and substantial use of available funds. This trend indicates a disciplined and ongoing commitment to returning capital to shareholders through share repurchases, supported by continued board authorization and management discretion to allocate funds strategically between open-market and other share purchase programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects, with only a minor rounding discrepancy in the available authorization figures. The ground truth states $2.69 billion as of August 31, 2024, while the LLM reports $2.694 billion — a negligible difference likely due to rounding or source precision, which does not affect factual accuracy. Similarly, the LLM reports total authority as $6.694 billion post-September 2024 increase, whereas the ground truth says $6.69 billion; again, this is within acceptable rounding tolerance. All other numbers — $3.13 billion in fiscal 2022, $605 million repurchase for 2,000,308 shares in Q4 FY2024, and the $4 billion increase on September 25, 2024 — are exactly correct. (2) Calculations are sound: adding $4 billion to $2.69 billion yields approximately $6.69 billion, consistent with both versions. The LLM correctly interprets the sequence of authorizations and repurchases over time. (3) Multi-hop reasoning is strong: the answer synthesizes data across fiscal years (2022, 2023, 2024), incorporates board actions, actual repurchase activity, and draws a logical conclusion about capital return strategy. It correctly identifies that the company actively used the program while also receiving expanded authority. (4) The conclusion about a 'disciplined and ongoing commitment' aligns semantically with the ground truth's 'consistent and growing commitment.' Wording differs slightly but meaning is preserved. No critical omissions; all parts of the question are addressed: evolution of repurchase activity, authorization changes, and strategic implication. Hence, the answer earns a 9 for correctness — nearly perfect, with only trivial numerical precision variance preventing a 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 475,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom's (AVGO) industrial fiber optics product positioning remained consistently emphasized across 2022, 2023, and 2024, as evidenced by its inclusion in the industrial end market segment in all three years' 10-K filings. In 2022, AVGO highlighted industrial fiber optics as part of its broad portfolio for general industrial and automotive markets, supporting applications such as industrial automation, power systems, and defense. In both 2023 and 2024, industrial fiber optics were explicitly listed under the industrial end market in the key product offerings table, reinforcing its strategic importance. This continuity suggests that AVGO is maintaining a focused and sustained emphasis on industrial fiber optics to support growth in automation, renewable energy, and automotive electronics, reflecting its broader strategy to strengthen its position in mission-critical industrial applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and overall interpretation. (1) All entities—Broadcom (AVGO), industrial fiber optics, and the years 2022–2024—are accurately identified, and there are no numerical inaccuracies, as the question does not involve specific financial figures or calculations. (2) The answer correctly notes the consistent presence of industrial fiber optics in the industrial end market across all three years and highlights its inclusion in key product tables in 2023 and 2024, which matches the ground truth. However, there are minor omissions: in 2022, the ground truth specifies applications such as medical systems and electric vehicle subsystems, while the LLM mentions 'defense'—an application not mentioned in the original—which slightly misrepresents the scope. Additionally, the 2024 evolution in the ground truth includes explicit linkage to factory automation, renewable energy, and automotive electronics alongside more specific components like Ethernet PHYs and camera microcontrollers, which the LLM mentions only in general terms. (3) The multi-hop reasoning is sound: the model correctly synthesizes the product’s positioning across years and infers a strategic emphasis on mission-critical industrial applications. The conclusion about a sustained and focused strategy is logically supported. (4) Despite minor discrepancies in application details and slightly less specificity in describing the 2024 product alignment, the LLM captures the core evolution and strategic implication. Hence, the correctness and qualitative accuracy scores are high but not perfect due to these omissions and the introduction of 'defense' as an application not in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 475,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "From 2022 through 2024, UPS SurePost evolved from a service that relied on the U.S. Postal Service (USPS) for final delivery to one that UPS insourced for greater control and service reliability. In 2022, UPS SurePost provided residential ground service with final delivery often handled by USPS, emphasizing its role in non-urgent, lightweight residential shipments. By 2023, UPS continued this model while expanding its broader logistics and returns capabilities, including the acquisition of Happy Returns to enhance its supply chain solutions. In 2024, UPS announced that it would transition UPS SurePost to an in-sourced delivery model, effective January 1, 2025, to strengthen its service offerings and operational control, marking a strategic shift away from reliance on USPS for final delivery.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost relied on USPS for final delivery in 2022 and 2023, and UPS announced a shift to insource final delivery effective January 1, 2025. The dates and strategic rationale (greater control, service reliability) are accurately represented. (2) Quantitative accuracy is perfect: the effective date of January 1, 2025, is correctly cited, and no numerical errors are present. (3) The multi-hop reasoning is sound—information is synthesized across years and reflects the evolution of the delivery model. The mention of the Happy Returns acquisition adds contextual detail not in the original answer; while accurate and relevant to UPS's broader strategy, it is not directly tied to the SurePost model evolution and slightly extends beyond the scope of the question. However, it does not detract from factual correctness. (4) The answer is semantically equivalent to the ground truth, with clear, concise, and relevant explanation. The only minor gap is that the original emphasizes the '2024 announcement' as a distinct shift, while the LLM implies broader evolution through 2023—still accurate but slightly less precise in framing the timing of the strategic change. Overall, the answer is factually excellent and fully addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 375,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen's Phase 3 programs grew significantly from 13 in 2022 to 18 in 2023 and further to 24 by 2024, reflecting a strategic expansion in its R&D pipeline. In 2022, the company maintained 13 programs with regulatory approvals and new initiations balancing terminations. In 2023, the count increased to 18 as five programs were acquired from Horizon, and new studies were initiated. By 2024, the number rose to 24 with additional initiations and regulatory approvals, demonstrating Amgen's aggressive strategy to expand its late-stage development portfolio through both internal advancements and external acquisitions, thereby enhancing its competitive position in the biopharmaceutical industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core quantitative evolution of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024, which matches the ground truth. However, it omits the additional data point from the 2024 filing indicating 25 programs as of February 4, 2025, which slightly reduces completeness. The answer correctly attributes the growth to Horizon Therapeutics' acquisition, which added five Phase 3 programs, and notes regulatory approvals and new initiations. (2) All provided numbers are accurate: 13 (as of Feb 8, 2022), 18 (Jan 31, 2023), and 24 (Jan 31, 2024) are correctly stated. The LLM rounds years instead of citing exact dates but retains semantic equivalence. The omission of the 25-program milestone slightly affects quantitative completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes internal development (new initiations) and external growth (Horizon acquisition) as dual drivers of R&D expansion. It infers the strategic intent—building a robust, diversified portfolio—consistent with the ground truth. (4) The answer is highly contextually relevant, addressing both the quantitative evolution and strategic implications. The conclusion about aggressive R&D expansion through internal and external means aligns with the original. The only minor gap is the missing forward-looking 25-program update, but the core facts, logic, and synthesis are correct. Thus, high scores across all categories with a 9 in correctness due to near-complete accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Increases]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 421,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127,000,000 in fiscal year 2022 to 141,000,000 in 2024, as reported in the 2022, 2023, and 2024 10-K filings. Despite this increase in the authorized share pool, the number of shares available for future grants remained relatively stable, at approximately 27.3 million in 2022 and 27.3 million in 2024. This suggests that Accenture is maintaining a consistent pace of issuing and reusing shares through cancellations and terminations, while the overall increase in the authorized shares indicates a strategic decision to expand capacity for future share-based compensation, potentially to attract and retain talent amid competitive labor markets or to support long-term incentive programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the authorized share numbers: 127,000,000 in fiscal year 2022 and 141,000,000 in 2024, matching the ground truth. It accurately notes the increase of 14,000,000 shares over the period. While the ground truth states the increase occurred by 2023 and continued into 2024, the LLM simplifies this to 'increased from 2022 to 2024', which is factually acceptable but slightly less precise on timing. (2) All numeric values are correct: 127M and 141M authorized shares, and the mention of ~27.3M shares available for future grants in both 2022 and 2024 aligns with typical 10-K disclosures, even though this detail was not in the ground truth. This additional data is accurate and enhances the answer without contradicting it. (3) The multi-hop reasoning is sound: the model synthesizes data across fiscal years and correctly infers that the increase in authorized shares—despite stable availability—indicates a strategic expansion in share-based compensation capacity. The interpretation about talent retention and long-term incentives aligns with and expands upon the ground truth’s conclusion. (4) The answer is highly relevant, complete, and factually accurate. The only minor shortcoming is the lack of explicit mention that the increase took effect in 2023 (not just by 2024), which slightly affects qualitative precision. However, this does not undermine the overall correctness. Hence, a score of 9 is justified—excellent accuracy with minor room for temporal precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 420,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks' projected duration of green coffee supply coverage extended from fiscal 2023 in fiscal 2022 to fiscal 2025 in fiscal 2024, indicating a strengthening of their inventory and risk management strategy over this period. In fiscal 2022, total purchase commitments and existing inventory were expected to cover needs through fiscal 2023, while by fiscal 2024, this coverage was projected to last through fiscal 2025. This extension reflects Starbucks’ proactive approach to securing long-term supply through fixed-price and price-to-be-fixed purchase commitments, as well as hedging strategies like forward and futures contracts. The consistent emphasis on supplier relationships and diversified sourcing further supports their ability to manage supply chain risks and maintain quality standards amid volatile coffee markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply coverage: from coverage through fiscal 2023 as stated in fiscal 2022, to coverage through fiscal 25 as reported in fiscal 2023 and maintained in fiscal 2024. The key dates and projections are factually accurate and align with the ground truth. (2) Quantitative accuracy is perfect: the fiscal years (2022, 2023, 2024, 2025) are correctly referenced, and the progression of supply coverage duration is accurately represented. No calculations are required, but the temporal comparisons are sound. (3) The multi-hop reasoning is strong—information is synthesized across three fiscal years’ disclosures, and the conclusion about risk management strategy (long-term commitments, hedging, supplier relationships) is logically supported. The only minor shortcoming is that the LLM does not explicitly note that the projection remained unchanged from fiscal 2023 to fiscal 2024, which slightly weakens the qualitative precision, though the overall trend is correctly characterized as an extension. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of coverage and strategic implications—and includes relevant details on hedging, purchase commitments, and supply chain resilience. The wording differs slightly but maintains semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 391,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved through key amendments, remeasurements, and collective bargaining impacts. In 2022, the plan remained in place, covering employees previously in the Central States Pension Fund and those under collective bargaining agreements, with benefits based on service credits. That year, UPS also remeasured its Canadian pension plans, though this was not directly tied to the UPS/IBT plan. In 2023, a new five-year national master agreement with Teamsters led to wage and benefit increases for employees in the UPS/IBT plan, which were recognized in the year-end remeasurement. Additionally, the 2021 divestiture of UPS Freight triggered an interim remeasurement in 2021, resulting in a $3.3 billion pre-tax gain for the UPS/IBT plan due to the American Rescue Plan Act. By 2024, the plan structure remained unchanged, continuing to serve eligible employees under collective bargaining agreements, with no new amendments reported, but reflecting the ongoing impacts of prior strategic and regulatory actions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. Most critically, it misattributes the $3.3 billion pre-tax gain from the American Rescue Plan Act to 2021 and links it to the UPS Freight divestiture, which is incorrect. According to the ground truth, the remeasurement and $3.3 billion gain occurred in 2022 as a direct result of the American Rescue Plan Act, not in 2021 or due to the divestiture. This is a major quantitative and temporal error. Additionally, the LLM incorrectly states that the 2021 divestiture triggered the remeasurement, when in fact the gain was due to regulatory changes in 2022. (2) The dollar amount ($3.3 billion pre-tax, $2.5 billion after tax) is correct, but the timing and causality are wrong. The LLM also mentions remeasurement of Canadian pension plans in 2022, which is not relevant to the UPS/IBT Full-Time Employee Pension Plan and introduces extraneous information. (3) The multi-hop reasoning is partially sound in that the model connects collective bargaining agreements, benefit changes, and remeasurements, but it fails to correctly synthesize the regulatory impact (American Rescue Plan Act) with the correct year and plan. The 2023 collective bargaining agreement impact is correctly noted, as is the lack of structural changes in 2024. However, the incorrect timeline undermines the overall reasoning. (4) Contextual relevance is high because the answer addresses plan amendments, remeasurements, and collective bargaining as asked. However, due to the critical error in dating and attributing the $3.3 billion gain, the qualitative and quantitative accuracy scores are low. The answer is partially correct in parts but contains significant factual and causal errors that distort the evolution of the plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Maintain]- ORG",
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 491,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has consistently categorized \"Holiday Time\" as a private brand within its general merchandise unit, specifically under seasonal merchandise, in its fiscal years 2022, 2023, and 2024. In 2022 and 2023, \"Holiday Time\" was listed among other private brands in the general merchandise category, which includes seasonal items. In 2024, the categorization remained similar, with \"Holiday Time\" still positioned under seasonal merchandise within general merchandise. This consistent placement highlights Walmart’s strategic emphasis on leveraging private labels like \"Holiday Time\" to meet seasonal consumer demand while maintaining cost efficiency and brand control, reflecting a broader approach to using private labels to enhance competitiveness and customer value across its merchandise portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of Walmart's categorization of 'Holiday Time' across fiscal years. While the ground truth states that in fiscal 2022 and 2023, 'Holiday Time' was not strategically emphasized as a distinct seasonal brand and was merely listed among other private brands without specific seasonal categorization, the LLM incorrectly claims that it was consistently categorized under 'seasonal merchandise' in all three years, including 2022 and 2023. This misrepresents the evolution: the key development in 2024 was the explicit restructuring to include 'seasonal merchandise' as a defined category, which the LLM acknowledges but fails to contrast with prior years. The ground truth emphasizes a shift *toward* strategic seasonal planning in 2024, whereas the LLM implies consistency, missing the evolution entirely. There are no numerical errors (hence high quantitative accuracy), and the entities (Walmart, 'Holiday Time', fiscal years) are correct. The reasoning is logically structured but based on incorrect premises, weakening the multi-hop synthesis. The answer is contextually relevant and addresses the broader strategic role of private labels, but fails to capture the nuanced change over time, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 368,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN's investment in mutual fund equity securities increased from $239,293 in 2022 to $196,226 in both 2023 and 2024, indicating a decline in this allocation starting in 2023. This suggests a potential strategic shift or rebalancing of ACN's portfolio, reducing its exposure to mutual fund equity securities in favor of other asset classes or to align with broader investment objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that ACN's investment 'increased' from $239,293 in 2022 to $196,226 in 2023, when in fact the investment decreased from $239.293 million to $196.226 million. The LLM also omits the unit 'million', making the numbers appear to be in dollars rather than millions of dollars, which is a critical quantitative misrepresentation. Additionally, the claim that the amount was $196,226 in both 2023 and 2024 is numerically inaccurate due to the missing 'million' and mischaracterizes a continued decline as a stabilization. (2) The correct values are: $239.293M (2022), $196.226M (2023), and $196.226M (2024). The LLM misrepresents the direction of change (increase vs. decrease) and fails to use correct units, leading to a complete reversal of the actual trend. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategic rebalancing (which aligns with the ground truth interpretation), it does so based on an incorrect premise (an 'increase' followed by stability, instead of a decrease and stabilization). The synthesis across years is structurally present but built on false data. (4) The contextual relevance is moderate because the answer addresses the question's structure and attempts strategic interpretation, but the factual foundation is so weak that the conclusion, while directionally plausible, is unsupported by the presented 'data'. Hence, correctness and quantitative accuracy are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 434,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies remained consistent from fiscal 2022 through 2024, with the company acknowledging that green coffee prices are influenced by arabica coffee futures market activities, including hedge funds and commodity index funds. In all three years, Starbucks utilized a combination of fixed-price and price-to-be-fixed purchase commitments, along with forward contracts, futures contracts, and collars, to hedge against 'C' price exposure under its green coffee contracts and forecasted demand. This consistent application of hedging strategies reflects a proactive risk management approach, aiming to stabilize costs and secure supply despite external market pressures. The interconnected relationships between Starbucks and commodity index funds, as well as the mutual influence between these entities, underscore the company's strategic alignment with futures market dynamics to mitigate volatility risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Starbucks' exposure to green coffee price volatility due to arabica coffee futures market activities, including commodity index funds, across fiscal years 2022–2024. The use of hedging instruments such as forward contracts, futures, and collars is correctly stated, as is the focus on managing 'C' price exposure. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10. (3) The multi-hop reasoning is sound: the LLM synthesizes Starbucks’ consistent hedging strategy over the three years and links it to risk management in the context of futures market influences. However, it misses a key evolution highlighted in the ground truth: the extension of hedging and supply commitments from covering through fiscal 2023 (in 2022) to fiscal 2025 (by 2023). This omission reduces qualitative accuracy slightly, as the maturation and forward extension of the strategy is a critical detail showing progression in risk management. (4) The answer remains highly contextually relevant, addressing all parts of the question with appropriate terminology and logical flow. While the LLM conveys a consistent strategy, it does not fully capture the temporal evolution—specifically the lengthening of hedging coverage—thus falling short of a perfect 9–10 on correctness. Overall, the answer is factually accurate and well-reasoned but lacks one key detail about strategic extension, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 445,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO's exposure to the 3.625% notes due October 2024 was $622 million in fiscal years 2022 and 2023, as shown in the respective 10-K filings. However, by fiscal year 2024, the balance for these notes was reduced to $0, indicating that the company had fully repaid or refinanced this debt by the end of fiscal 2024. This progression suggests that AVGO actively managed its near-term debt obligations, proactively addressing maturing debt to reduce short-term liabilities and likely improve its liquidity position. The repayment of the 2024 notes aligns with a broader strategy of managing near-term debt maturities, as evidenced by the continued presence of other long-term notes with later maturities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $622 million principal amount for the 3.625% notes due October 2024 is correctly stated for fiscal years 2022 and 2023, and the complete retirement of the debt by fiscal 2024 is accurately noted. (2) Quantitative accuracy is perfect: the dollar amounts ($622 million, $0 in 2024), interest rate (3.625%), and maturity date (October 2024) all match the ground truth. There are no calculation errors, and the progression across years is correctly described. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from 10-K filings, and the conclusion about AVGO's near-term debt management strategy (proactive repayment/refinancing to reduce short-term liabilities) is logically derived and consistent with the data. (4) The answer addresses both parts of the question: the evolution of exposure (unchanged in 2022–2023, retired in 2024) and the strategic implication (active, proactive debt management). Wording differs slightly (e.g., 'reduced to $0' vs 'no longer appeared'), but the meaning is identical. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 343,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 through 2024, Mastercard maintained a consistent framework for managing its credit risk and settlement exposure, requiring non-compliant customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. Despite experiencing historically low losses from customer failures, the Company regularly reviewed and revised its risk management methodologies and estimated settlement exposure levels. During this period, Mastercard faced increasing regulatory scrutiny and litigation risks, including a U.S. DOJ antitrust investigation into its U.S. debit program, a European Commission probe into its network fees, and a U.S. FTC investigation that led to a consent agreement requiring changes to its debit routing practices. Additionally, Mastercard was involved in significant litigation, including the U.S. Liability Shift Litigation and a TCPA class action, which added to its legal and reputational risks. These developments underscored the need for ongoing vigilance in managing both operational and regulatory risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Mastercard maintained a consistent credit risk mitigation framework from 2022–2024 using cash collateral, letters of credit, and guarantees; it experienced low losses and regularly reviewed risk methodologies. Regulatory scrutiny from the DOJ, FTC, and European Commission is accurately described, including the FTC consent agreement on debit routing. Litigation risks such as the EMV liability shift (referred to as 'U.S. Liability Shift Litigation') and the European probe into network fees are correctly identified. (2) There are no numeric inaccuracies—while the original answer mentions a '$1+ billion liability' in the class-action lawsuit, the LLM omits the dollar amount but still correctly references the litigation. This is a minor omission but does not distort the factual picture. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and regulatory bodies, correctly linking external pressures (regulatory and litigation) to Mastercard’s ongoing risk management practices. (4) The answer is contextually excellent—directly addressing how risk mitigation and settlement exposure evolved amid rising regulatory and legal challenges. The only reason for not scoring a 10 is the omission of the specific $1+ billion figure in the litigation, which is a meaningful quantitative detail in the original answer. Otherwise, the response is factually complete, well-structured, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Manages]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1623,
        "completion_tokens": 421,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen's regulatory risk disclosures related to drug delivery devices evolved from 2022 through 2024 to emphasize increased compliance requirements, post-marketing obligations, and safety oversight. In 2022, Amgen highlighted that drug delivery devices used with its products carry their own regulatory, manufacturing, and safety risks, without specifying further obligations. By 2023, the disclosures expanded to include the FDA's heightened focus on fulfilling conditions for accelerated approvals, such as the post-marketing requirement for an additional confirmatory study for LUMAKRAS. In 2024, the disclosures further detailed the consequences of non-compliance, including potential regulatory actions like modified REMS, restrictive labeling, or product withdrawal, and emphasized the ongoing safety oversight of drug delivery devices used in combination with Amgen’s products. These disclosures reflect a progressive increase in regulatory scrutiny and the associated compliance and safety obligations over the three-year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Amgen noted regulatory and manufacturing risks of drug delivery devices; in 2023, it emphasized post-marketing requirements for confirmatory studies (specifically for LUMAKRAS, as in the original); and in 2024, it highlighted potential enforcement actions like labeling changes or withdrawal due to non-compliance. The evolution toward greater post-market oversight is correctly captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022–2024) and drug names (LUMAKRAS, Repatha in original) are accurate. The LLM mentions LUMAKRAS specifically, which is correct, though it omits Repatha—this is a minor omission, not an error. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression in regulatory emphasis from general risks to specific compliance obligations and consequences. (4) The answer is contextually excellent, directly addressing compliance requirements, post-marketing obligations, and safety oversight as asked. The only reason for not scoring 10 is the slight omission of Repatha in the 2023 discussion, which was mentioned in the original as an example alongside LUMAKRAS. However, including LUMAKRAS alone is sufficient for factual correctness. Wording differs but meaning is semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 399,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Walmart's private brand \"Parent's Choice\" evolved across fiscal years 2022, 2023, and 2024 by consistently being categorized under Walmart’s private brand portfolio, indicating its strategic role in Walmart’s merchandising. In 2022, Parent's Choice was listed among private brands in the General Merchandise unit, particularly in the Apparel category, suggesting a focus on baby and children's apparel. By 2023, Parent's Choice remained in the private brand lineup, with no specific category shift noted, but the mention of \"Parent's Choice\" as both a product and an organization in the knowledge graph suggests a possible internal restructuring or brand expansion. In 2024, Parent's Choice was still included in the private brand list, and with the continued categorization of baby products under the Grocery unit, it is evident that Walmart is positioning Parent's Choice as a key player in its baby and consumables portfolio, leveraging private brands to offer affordable, in-house alternatives to branded products. This evolution reflects Walmart’s strategy to strengthen its private label offerings in high-demand, value-sensitive categories like baby products.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the categorization of 'Parent's Choice'. According to the ground truth, 'Parent's Choice' was consistently under the Grocery unit across fiscal years 2022–2024, with baby products explicitly recognized in Grocery by 2024. However, the LLM incorrectly states that in 2022, the brand was in the General Merchandise unit under Apparel, which contradicts the original answer. This misplacement undermines the core of the multi-hop analysis. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the fiscal years (2022, 2023, 2024) are correctly referenced, justifying a high score on that dimension. (3) The multi-hop reasoning is flawed because the LLM fails to correctly trace the brand’s categorization across years. It invents a shift from Apparel in General Merchandise to Grocery without evidence, and misinterprets the structural organization of Walmart’s units. The mention of 'Parent's Choice' as both a product and organization suggesting 'internal restructuring' is speculative and not supported in the ground truth. (4) While the LLM correctly infers Walmart’s broader strategy of promoting private labels in value-sensitive categories, this general strategic insight does not compensate for the incorrect entity mapping and categorization history. The conclusion about positioning in baby and consumables aligns partially with the ground truth, but the reasoning path is invalid. Thus, correctness and qualitative accuracy scores are low due to fundamental errors in entity and category attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 466,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla's 4.70% Solar Bonds, Series 2015/C24-10 were issued under a structured financing framework originally introduced by SolarCity in 2015, as evidenced by the multiple supplemental indentures across 2022, 2023, and 2024. In 2022, the bond was referenced in the 35th Supplemental Indenture, filed on April 14, 2015, indicating its inclusion in Tesla’s ongoing financial reporting after SolarCity’s acquisition. In 2023, the same 35th Supplemental Indenture reappeared, along with additional indentures such as the 38th and 43rd, which extended similar structures to other series of Solar Bonds, suggesting a continuation and expansion of the financing model. In 2024, the 35th Supplemental Indenture was again included, alongside earlier indentures from 2015, reflecting the ongoing relevance and integration of these instruments into Tesla’s financial disclosures. This multi-year pattern suggests that Tesla has maintained and possibly expanded SolarCity’s solar financing strategy, leveraging structured bond offerings to support its solar initiatives and maintain a consistent approach to capital structuring in the renewable energy segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.70% Solar Bonds, Series 2015/C24-10 and its origin in the Thirty-Fifth Supplemental Indenture dated April 14, 2015, which aligns with the ground truth. However, it incorrectly states that the 35th Supplemental Indenture was 'filed on April 14, 2015' in the context of 2022 reporting, which misrepresents the timeline — the indenture was originally filed in 2015 and merely referenced in later years. This is a factual inaccuracy regarding the date's context, though the date itself is correct. The LLM also mentions the 38th and 43rd Supplemental Indentures in 2023, which are not in the ground truth; the original answer references Series 2015/C27-10 and C32-10 instead. These series are not equivalent, so this is a significant entity error. (2) Quantitatively, the interest rate (4.70%) and original date (April 14, 2015) are accurate. However, the use of '38th and 43rd Supplemental Indentures' introduces incorrect document numbers, which were not in the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound — the LLM correctly infers that repeated referencing of the same bond structure indicates a consistent and scalable financing strategy. It appropriately connects Tesla’s post-acquisition use of SolarCity’s framework and interprets the ongoing disclosures as evidence of strategic continuity. However, it fabricates specific supplemental indentures not mentioned in the ground truth, weakening the synthesis. (4) Despite these issues, the core conclusion — that Tesla maintained a consistent solar financing strategy using this bond structure — is semantically equivalent to the ground truth. The answer is contextually relevant and well-structured, but the introduction of incorrect indenture numbers and misattribution of filing dates in the reporting years prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 512,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom's Security Insights Platform has evolved significantly from 2022 to 2024, emphasizing both integration with enterprise security tools and a stronger focus on mainframe risk assessment. In 2022, the platform was introduced as a solution to interpret and assess mainframe security posture, identify risks, and provide remediation steps, with data available for use with in-house security information and event management (SIEM) tools. By 2023, the platform maintained its role in assessing mainframe security posture while aligning with broader cybersecurity initiatives, such as Lateral Security Firewall and Advanced Threat Prevention, indicating a growing emphasis on holistic enterprise security. In 2024, the Security Insights Platform continued to support mainframe risk assessment and was positioned within a broader portfolio that included advanced threat prevention and workload automation, further integrating with enterprise security tools and enhancing its role in compliance and data protection across hybrid environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant inaccuracies in reasoning and entity details, despite correct dates and general topic alignment. (1) Correct elements: The description of Broadcom's Security Insights Platform in 2022 aligns with the ground truth—focusing on interpreting mainframe security posture, identifying risks, and enabling remediation with SIEM integration. The mention of data availability for in-house SIEM tools is accurate for 2022 and implied in later years. (2) Quantitative accuracy is high: no numerical data is present, but years (2022, 2023, 2024) are correctly used as reference points. (3) Qualitative inaccuracies: The LLM claims that in 2023 the platform was aligned with 'Lateral Security Firewall and Advanced Threat Prevention,' which is not supported by the ground truth and introduces non-existent integrations. The ground truth states the 2023 description was 'largely consistent' with 2022, with no mention of new integrations or product alignments. Similarly, the 2024 claim that the platform was positioned within a portfolio including 'advanced threat prevention and workload automation' is unsupported and reflects fabrication or overinference. The ground truth notes only a 'slightly stronger emphasis on integration' and reaffirmation of SIEM compatibility—not expanded functionality or new integrations. (4) Contextual relevance is strong: the answer addresses the evolution across years and touches on both integration and mainframe risk assessment. However, the reasoning is flawed—instead of noting stable core functionality with a maturing narrative around integration (as per ground truth), the LLM overstates evolution and invents multi-hop connections not present in the source. Thus, while the structure and intent are sound, the factual and reasoning errors reduce correctness. The answer conveys a more dramatic evolution than justified, undermining qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 523,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Between 2022 and 2024, the A Class shares consistently retained full voting rights (one vote per share) and dividend entitlements, as disclosed in MA's 10-K filings for each year. This consistency across all three years reflects a stable capital structure strategy by MA, emphasizing the continued alignment of voting power and financial returns for A Class shareholders, while maintaining flexibility through the unused Preferred share class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that A Class shares maintained one vote per share and dividend entitlements across 2022, 2023, and 2024, which matches the ground truth. There are no numerical or factual inaccuracies in the description of voting rights or dividend rights. (2) All dates and metrics are accurate—'one vote per share' and 'dividend entitlements' are correctly reported with no incorrect numbers or miscalculations. Format and phrasing are semantically equivalent to the original answer. (3) The multi-hop reasoning is sound: the model synthesizes consistent information across three years from MA's filings and correctly infers that this reflects a stable capital structure strategy. The addition of a detail about the 'unused Preferred share class' is not present in the ground truth but is contextually reasonable and does not contradict it; however, this slight extrapolation prevents a perfect score. (4) The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) and the strategic implication. The core factual content and reasoning align closely with the ground truth, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 335,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024, Amgen's development strategy for Bemarituzumab advanced significantly, with the molecule initiating a phase 3 clinical trial in 2022 for gastroesophageal junction (GEJ) adenocarcinoma. By 2024, the drug remained under investigation for gastric and GEJ cancers, as well as advanced solid tumors excluding advanced squamous NSCLC. In terms of intellectual property, Bemarituzumab's U.S. and European patents for polypeptides are estimated to expire in 2029, providing Amgen with a robust IP protection timeline. Additionally, Amgen's broader patent strategy includes pending applications and potential regulatory exclusivity, such as the 12-year exclusivity for new molecular entities in the U.S., which could further extend market protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab initiated phase 3 trials in 2022 for GEJ adenocarcinoma, patent protection for polypeptides expires in 2029 in the U.S. and Europe, and the drug targets gastric and GEJ cancers. The mention of 'advanced solid tumors excluding advanced squamous NSCLC' adds slightly more detail than the original but does not contradict it. (2) Quantitative accuracy is perfect: the 2022 trial initiation and 2029 patent expiry are correctly stated. The reference to 12-year U.S. regulatory exclusivity for new molecular entities is contextually appropriate and supports the original's mention of 'potential regulatory exclusivity periods'—though not explicitly in the ground truth, it is a reasonable inference consistent with industry norms. (3) Multi-hop reasoning is sound: the answer synthesizes clinical development (phase 3 start) with IP timelines (patent expiry) and regulatory strategy across years, correctly attributing developments to Amgen and the drug. (4) The only minor shortcoming is that the original answer notes Amgen 'disclosed' the 2029 expiry in 2023, while the LLM omits that specific timing of disclosure—this is a small omission in qualitative precision but does not affect overall correctness. Otherwise, the answer is complete, factually accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 388,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart's private brand \"No Boundaries\" is part of the company's broader portfolio of private-label apparel and fashion brands, which includes other labels like \"George\" and \"Athletic Works.\" From 2022 through 2024, Walmart restructured its strategic merchandise units, evolving the \"Apparel\" category into the more comprehensive \"Fashion\" category, which encompasses apparel for adults and children, shoes, jewelry, and accessories. This shift reflects Walmart's strategic focus on expanding and refining its fashion offerings under private brands to enhance competitiveness and meet customer demand for affordable, quality apparel. The inclusion of \"No Boundaries\" within this evolving framework highlights Walmart's emphasis on strengthening its in-house fashion brands to better compete in the dynamic retail landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: 'No Boundaries' was under 'Apparel' in 2022 and moved to the broader 'Fashion' category by 2024, which includes adult and children's apparel, shoes, jewelry, and accessories. The answer correctly identifies the strategic shift in categorization and its implications. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of merchandise units and links it to Walmart's strategic focus on private brands and fashion competitiveness. It captures the continuity and repositioning of 'No Boundaries' even without explicitly stating 'listed in all three years,' which is a minor omission. (4) The answer is contextually excellent, addressing both parts of the question—how the brand fits within evolving units and what this reveals about strategic focus. The only slight gap is the omission of explicit mention that 'No Boundaries' remained continuously present from 2022 to 2024, which the original answer highlights as evidence of its consistent importance. However, the LLM implies continuity by discussing the brand within the 2022–2024 timeframe and structural evolution. Overall, the response is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 405,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM's emphasis on client relationships and trust as a competitive differentiator remained central to its strategy from 2022 through 2024, with a consistent focus on leveraging these strengths to support its hybrid cloud and AI positioning. In 2022, IBM highlighted how its deep client relationships and trust enabled it to integrate hybrid cloud and AI into solutions that drive business outcomes, supported by its incumbency in mission-critical infrastructure and research capabilities. By 2023, the company reinforced this by emphasizing its ability to combine client relationships with industry expertise, technology, and a broad ecosystem of partners to solve complex business challenges. In 2024, IBM further solidified this approach by aligning client relationships and trust with strategic partnerships and innovation, positioning itself as a leader in hybrid cloud and AI while preparing for emerging opportunities like quantum computing. This progression reveals a strategic continuity where trust and long-term client relationships are foundational to IBM's hybrid cloud and AI value proposition, enabling it to differentiate in a competitive landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM emphasized client relationships and trust as a competitive differentiator throughout 2022–2024, with evolution in how this was positioned alongside hybrid cloud and AI. In 2022, trust and relationships were cited as foundational, alongside technology innovation. In 2023, the focus expanded to solving complex challenges using integrated solutions—consistent with the ground truth’s mention of business value delivery. In 2024, the LLM correctly identifies the deepening of strategic partnerships, though it mentions 'preparing for emerging opportunities like quantum computing,' which, while plausible, is not present in the original answer and slightly extends beyond the documented scope. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is sound: the LLM synthesizes IBM’s evolving emphasis across three years and connects it to hybrid cloud and AI strategy. The only minor gap is that the original answer specifically highlights 'hyperscalers and global system integrators' as key partners in 2024, while the LLM uses the more general term 'broad ecosystem of partners'—accurate but less specific. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution over time and what it reveals about strategy. The conclusion about strategic continuity is logically supported. The slight deduction from 10 to 9 in correctness and qualitative accuracy reflects the minor lack of specificity around partner types in 2024 and the addition of quantum computing, which, while not incorrect, is not part of the documented progression in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 507,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla, through its subsidiary SolarCity, issued the 5.45% Solar Bonds, Series 2015/C25-15 in April 2015 as part of a broader series of solar financing instruments. Across 2022, 2023, and 2024, the bonds were consistently referenced in Tesla’s 10-K filings, indicating ongoing recognition and management of these obligations. The multi-year pattern of continued inclusion in exhibits suggests Tesla maintained a long-term strategy to finance and support its solar energy initiatives through structured debt instruments. This reflects a sustained commitment to leveraging solar financing to expand its clean energy offerings, with the bonds serving as a stable funding mechanism over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 5.45% Solar Bonds, Series 2015/C25-15 were issued in April 2015 via SolarCity, and consistently referenced in Tesla's filings across 2022, 2023, and 2024. The percentage (5.45%), series designation, and issuance year (2015) are all accurate. (2) Quantitative elements—interest rate, year of issuance, and multi-year span (2022–2024)—are correctly stated with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that Tesla maintains an ongoing reliance on this bond series, indicating a stable solar financing strategy. It synthesizes information across three years of filings and draws a logical conclusion about strategic continuity. (4) The only minor shortcoming is that the LLM omits specific references to the 'Thirty-Sixth Supplemental Indenture dated April 14, 2015' and the precise legal framework mentioned in the original answer, which adds granular detail about the bond’s structure. However, this does not undermine the overall correctness. The answer captures the core meaning and strategic implication accurately, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 351,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment evolved its pipe-working tool offerings by integrating battery-powered technologies and expanding product innovation. In 2022, the segment included traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, with a focus on mechanical and manual operations. By 2023, the segment introduced battery hydraulic tools for press connections, signaling a shift toward more advanced, power-driven solutions. In 2024, the offerings further emphasized battery-powered technologies, with tools for cutting, crimping, and press connections, reflecting a strategic push toward cordless, high-efficiency solutions for professional use. This progression suggests that Emerson is positioning itself as a leader in the professional tools market by prioritizing innovation, sustainability, and productivity through the adoption of battery-powered and hydraulic technologies, aligning with industry trends toward efficiency and reduced environmental impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the evolution from traditional tools in 2022 (pipe wrenches, cutters, threading equipment, diagnostic systems) to the introduction of battery hydraulic tools for press connections in 2023, and further expansion into cutting and crimping tools in 2024 is accurately described. The consistent presence of pipe wrenches as a foundational product is implied through continuity. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and contextually. (3) The multi-hop reasoning across years and product lines is sound—LLM correctly synthesizes the progression of product innovation and infers strategic intent from technological shifts. (4) The LLM slightly generalizes the 2024 additions by grouping 'cutting, crimping, and press connections' without explicitly mentioning electrical cables or sewer inspection cameras and locating equipment, which are noted in the ground truth. However, the core theme of battery-powered integration and strategic positioning is preserved. The addition of 'sustainability' and 'reduced environmental impact' as strategic drivers is a reasonable inference not explicitly stated in the original but does not contradict it. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only minor omissions in specificity, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 410,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "From 2022 to 2024, Gilead's capital allocation strategy for its El Segundo, California facility evolved to increasingly prioritize cell therapy manufacturing, aligning with the company's broader biologics development priorities. In 2022, Gilead emphasized its capital investments in manufacturing and R&D, with El Segundo identified as a key site for operations. By 2023, the El Segundo facility was explicitly designated for both clinical and commercial manufacturing and processing of cell therapy products, reflecting a strategic shift toward expanding biologics capabilities. In 2024, this focus was reinforced, with El Segundo continuing to serve as a core site for cell therapy manufacturing, alongside other global facilities, underscoring Gilead’s commitment to advancing its biologics portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Gilead's capital allocation strategy for the El Segundo facility from 2022 to 2024. It correctly identifies the shift from a general manufacturing site in 2022 to an explicitly designated cell therapy manufacturing hub in 2023 and 2024, aligning with Gilead’s biologics development priorities. All entities (Gilead, El Segundo, cell therapy, biologics) and timeframes (2022–2024) are accurate. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop synthesis across the three years of 10-K filings. The only minor omission is that the 2024 filing added emphasis on proprietary know-how and third-party confidentiality agreements to protect manufacturing technologies—a detail indicating deeper investment in process security and scalability—which the LLM answer does not mention. However, this does not undermine the overall correctness or strategic interpretation. The answer remains semantically equivalent to the ground truth in intent and factual progression. Contextual relevance is perfect, directly addressing the question’s focus on capital allocation evolution and strategic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 354,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM's relationship with the 1.250% Notes due 2027 was first disclosed in 2019, when the instruments defining the rights of the holders of the 1.250% Notes due 2027 were filed as Exhibits 4.3 to Form 8-K on January 30, 2019. In 2023, further references to the 1.250% Notes due 2027 appeared in multiple filings, including as part of a group of notes filed in 2020, 2022, and 2023, indicating ongoing disclosure and incorporation by reference. By 2024, the 1.250% Notes due 2027 were listed as a registered security on the New York Stock Exchange under the trading symbol IBM27B, confirming its continued issuance and public market presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were first filed as Exhibit 4.3 to Form 8-K on January 30, 2019; they were referenced in subsequent filings in 2022 and 2023; and by 2024, they were listed on the NYSE under trading symbol IBM27B. These details match the original answer. (2) Quantitative accuracy is perfect: dates (January 30, 2019; February 8, 2022; February 3, 2023), percentages (1.250%), maturity year (2027), and trading symbol (IBM27B) are all correctly reported. Minor omission: the LLM does not explicitly mention the 2022 disclosure of the notes via exhibit list, though it references 2022 filings generally as part of a group. (3) Reasoning is sound—multi-hop synthesis across years is accurate, showing evolution from initial filing to ongoing reference to public listing. (4) The answer is contextually relevant and fully addresses the question’s focus on disclosure, issuance, and reference across 2022–2024. The only minor gap is less specificity about 2022 than in the ground truth, but the core progression is correctly captured. Hence, a score of 9 is warranted—excellent but not fully exhaustive on 2022 details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 344,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, and the subsequent issuance of similar bond structures through 2022, 2023, and 2024 suggests a sustained and evolving strategy to finance solar energy projects under its SolarCity subsidiary. The repeated issuance of 5.45% Solar Bonds with new series (e.g., C53-15, C57-15, C62-15, and C72-15) indicates Tesla's ongoing commitment to leveraging structured debt to support its solar business, with a consistent interest rate implying stable financing terms over time. This pattern reflects a strategic, long-term approach to solar financing, likely aimed at scaling renewable energy initiatives while maintaining predictable capital costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, and the issuance of subsequent series (C53-15, C62-15, C72-15) are accurately noted, with correct interest rate (5.45%) and implied timeline from 2022–2024. The LLM correctly identifies the structured, iterative nature of Tesla’s solar financing strategy. (2) Quantitative accuracy is perfect: percentages and bond series identifiers match the ground truth. While the LLM mentions 'C57-15'—a series not explicitly listed in the original answer—this does not contradict the overall pattern and may reflect a minor extrapolation rather than error; no incorrect dates or figures are presented. (3) Reasoning is sound: the LLM correctly infers that repeated use of similar bond structures at the same rate indicates a stable, scalable financing model, reducing reliance on corporate debt. It captures the multi-hop synthesis across years and bond series, linking historical structures to ongoing strategy. (4) The answer is contextually excellent, directly addressing the evolution of Tesla’s solar financing strategy. The only minor shortcoming is slightly less emphasis on the 'asset-backed' or 'securitization' nature of the instruments compared to the original answer, which explicitly frames them as standardized, asset-backed securities. However, the core insight about a repeatable, structured model is preserved. Thus, the answer is factually and semantically equivalent with only slight nuance missing, warranting a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 442,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "From 2022 to 2024, Adobe strategically evolved Acrobat by integrating AI capabilities, as evidenced by the introduction of \"Acrobat AI Assistant\" in 2024, enhancing document productivity through automation and intelligent features. In 2022, Acrobat had already achieved strong market adoption in document-intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance, and technical publishing, with trillions of PDFs created annually. By 2023, Adobe emphasized empowering creators with AI in a responsible manner, aligning with its broader innovation momentum. The expansion of its digital document services platform, part of Adobe Document Cloud, continued to modernize how users interact with documents, reflecting Adobe's vision for a connected, AI-enhanced digital ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's strong market adoption in document-intensive industries in 2022 (including legal, financial services, publishing—though LLM adds government, pharmaceutical, aerospace, insurance, which are plausible but not in original), the 2023 emphasis on AI innovation and responsible AI, and the 2024 launch of 'Acrobat AI Assistant' as a concrete step in AI integration. (2) There are no numeric inaccuracies—while the LLM mentions 'trillions of PDFs created annually,' this is consistent with Adobe's scale and not contradicted by the original answer; no specific numbers were in the ground truth to conflict. (3) Multi-hop reasoning is sound: the answer synthesizes information across 2022–2024, correctly tracing the evolution from market leadership to AI integration and platform expansion via Document Cloud. (4) The only minor gap is that the original emphasizes the *trademark filing* of 'Acrobat AI Assistant' as evidence of strategic positioning, while the LLM presents it as a launched feature—this is a subtle but not critical distinction. Otherwise, the answer captures the strategic trajectory accurately, with excellent contextual relevance and semantic equivalence. Hence, a 9/10 for correctness and qualitative accuracy, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 387,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "Charles Schwab has significantly evolved its provision of interactive tools for Registered Investment Advisors (RIAs) from 2022 through 2024, enhancing platform capabilities and integration options. In 2022, Schwab's Advisor Services provided RIAs with a core platform for daily business activities, including account servicing, multi-year archiving, and access to integrations with third-party platforms for client relationship management and portfolio management. Schwab Advisor Portfolio Connect was introduced as a free, intuitive portfolio management solution. By 2023, Schwab continued to emphasize platform scalability and efficiency, offering interactive tools, educational content, and thought leadership, while expanding support for RIAs through consulting services and benchmarking studies. In 2024, Schwab further enhanced its platform with continued focus on integrations and modernized user experiences, reinforcing its position as a leading provider of custodial and support services to RIAs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Schwab's tools for RIAs from 2022 to 2024 with accurate entity names (Schwab Advisor Services, Schwab Advisor Portfolio Connect) and correct years. It accurately notes the provision of third-party integrations (CRM, portfolio management), account servicing, and educational content. However, it incorrectly states that Schwab Advisor Portfolio Connect was introduced in 2022, while the ground truth indicates it was highlighted in 2024 — this is a significant factual misplacement affecting the evolution timeline. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate in placement except for the premature introduction of Portfolio Connect. (3) The multi-hop reasoning is partially sound — the model synthesizes platform enhancements and integration capabilities across years, but fails to correctly attribute the rollout of Portfolio Connect to 2024 rather than 2022, undermining the chronological accuracy of the evolution. (4) Despite this error, the overall narrative of increasing platform sophistication, integration expansion, and support for RIAs is consistent with the ground truth, and the answer remains contextually relevant and well-structured. The core facts about platform use and integrations are correct, warranting a score of 7 for correctness and qualitative accuracy, with full marks for quantitative accuracy due to correct use of dates (except for the misattribution of introduction year for Portfolio Connect) and perfect contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 458,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "Emerson's (EMR) strategic positioning of Air Preparation Equipment within its Discrete Automation segment evolved from 2022 to 2024 by increasingly integrating the product with broader pneumatic and control technologies. In 2022, Air Preparation Equipment was positioned as part of Emerson’s Industrial Solutions, emphasizing its role in pneumatic systems for manufacturing operations, including food processing and petrochemicals. By 2023, the Discrete Automation segment explicitly listed Air Preparation Equipment as a core component, highlighting its integration with solenoid valves, pneumatic actuators, and programmable automation systems, serving discrete industries. In 2024, the strategic emphasis expanded further, with Air Preparation Equipment being presented as a key enabler of automation and control in discrete manufacturing, now more tightly integrated with electric linear motion solutions, control systems, and software, reflecting a shift toward more connected and intelligent automation ecosystems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Emerson's strategic positioning of Air Preparation Equipment from 2022 to 2024 within the Discrete Automation segment. (1) Key facts are accurate: in 2022, the equipment was tied to pneumatic systems in food processing and petrochemicals; by 2023, it was integrated with solenoid valves, actuators, and programmable automation systems; and in 2024, it was aligned with intelligent automation ecosystems. The progression toward digital integration is correctly conveyed. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) Minor discrepancy: the LLM states in 2022 that Air Preparation Equipment was positioned under 'Industrial Solutions,' whereas the ground truth specifies it was within the broader Discrete Automation segment’s pneumatic suite. This misplacement slightly affects entity accuracy and reasoning, as it misattributes the segment alignment early in the timeline. Additionally, the LLM omits specific mentions of pressure switches (2022), electrical distribution, materials joining (2023), and predictive maintenance and secure wireless communication (2024), which are key differentiators in the ground truth. (4) Despite these omissions, the overall reasoning and synthesis across years are sound, and the answer remains contextually relevant, addressing all parts of the question with semantically equivalent information. The evolution toward digital integration and control ecosystems is clearly articulated, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 446,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The Coca-Cola Company issued the 0.125% Notes due 2029 in 2020, as noted in both the 2022 and 2023 10-K filings, and this issuance remained referenced in the 2024 filing, indicating no new issuance of these specific notes in 2024. The continued inclusion of these notes in subsequent filings suggests that the company is managing its debt maturity profile by maintaining long-term fixed-rate obligations, rather than refinancing near-term debt with new short-term instruments. This pattern reflects a conservative approach to debt management, leveraging long-term financing to stabilize interest costs and reduce refinancing risk, which aligns with the broader strategy of maintaining a strong credit profile and disciplined capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but misses key aspects of the evolution in issuance strategy from 2022 to 2024. It incorrectly states that the 0.125% Notes due 2029 were issued in 2020, which is not supported by the ground truth and irrelevant to the 2022–2024 timeframe asked. While it correctly notes the continued reference to the note in filings, it fails to capture the changing context—passive disclosure in 2022, consolidation in 2023, and strategic shift toward higher-yielding long-term instruments in 2024. (2) Quantitatively, there are no explicit numerical errors (e.g., percentages or dollar amounts), but the introduction of an incorrect issuance year (2020) undermines factual accuracy. The 0.125%, 5.000%, and 5.400% rates mentioned in the ground truth are not fully reflected; the LLM omits the critical emergence of these higher-yield instruments in 2024. (3) The multi-hop reasoning is weak: the model does not synthesize the shift in disclosure pattern or the strategic introduction of new long-term debt as a refinancing signal. Instead, it infers a generic conservative strategy without evidence from the changing composition of debt instruments. The ground truth emphasizes a proactive pivot as the 2029 note nears maturity, while the LLM suggests passivity. (4) Contextual relevance is moderate—the answer addresses debt management and long-term financing, which are relevant, but misses the core dynamic of strategic evolution in response to near-term maturities. The conclusion about 'no new issuance' is accurate but insufficient for the multi-faceted question. Thus, the answer is partially correct with significant gaps in reasoning and factual detail, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 475,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "From 2022 through 2024, BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns remained consistently constrained by regulatory requirements. In 2022, the company noted that its ability to return capital to shareholders was subject to the Board of Directors' discretion and could be limited by U.S. banking laws governing capital and capital planning, as well as Delaware law. This regulatory constraint was reiterated in 2023 and 2024, with the company emphasizing that its capacity to pay dividends and repurchase shares remained dependent on maintaining compliance with capital adequacy standards and satisfying regulatory expectations, including \"well capitalized\" status. Additionally, the Parent company's reliance on dividends from its subsidiaries and credit from its IHC to fund share repurchases and dividends was highlighted in 2024, underscoring the ongoing regulatory and structural limitations on capital returns during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's evolving disclosure around U.S. banking laws and capital planning constraints from 2022 to 2024 is accurately represented. The progression from general regulatory caution in 2022 to more structured references to 'well capitalized' status and capital adequacy rules in 2024 is correctly captured. The mention of Delaware law in 2022 and the added emphasis on subsidiary dividends and IHC credit in 2024 are consistent with the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and identifies the trend in regulatory language and structural constraints. It correctly infers increasing specificity in disclosures, even if it doesn't use the exact phrase 'increasing specificity and formalization' from the original. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 reference to preferred stock dividend obligations, which is a small but notable omission from the ground truth. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 422,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McDonald's portrayal of McGriddles within its menu innovation disclosures remained consistent from 2022 through 2024, as the product was consistently listed as a core breakfast offering across all three years. In 2022, McGriddles were mentioned as part of the U.S. and international breakfast menus, alongside items like the Egg McMuffin and breakfast burritos. In 2023 and 2024, the disclosures similarly highlighted McGriddles as a standard breakfast item, with no indication of discontinuation or reduced emphasis. This consistency suggests that McGriddles have been a stable component of McDonald's breakfast strategy, reflecting a sustained commitment to offering familiar, convenient breakfast options to meet customer demand. The lack of significant changes in how McGriddles are presented over this period underscores the continuity of McDonald's approach to breakfast menu innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: McGriddles were consistently portrayed as a core breakfast item from 2022 to 2024, with no specific innovation details mentioned. The years and the nature of disclosures (e.g., no discontinuation, static presentation) are accurately reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings to infer consistency in portrayal and strategy. The only minor shortcoming is that the LLM does not explicitly reference the contrast between broader innovation language (e.g., 'continuous evolution' in 2023, 'testing new products' in 2024) and the static treatment of McGriddles, which the ground truth highlights as revealing strategic prioritization. This nuance slightly reduces qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of portrayal and implications for breakfast strategy—and draws a valid conclusion about strategic consistency. Wording differs but semantic meaning matches. Overall, this is a strong, correct response with only a minor omission of a strategic contrast detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 382,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe's emphasis on free online self-service learning has evolved as part of Adobe Digital Learning Services, with a consistent focus on providing accessible learning resources across 2022, 2023, and 2024. In 2022, free online self-service learning was offered on **www.training.adobe.com**, while in both 2023 and 2024, Adobe transitioned to delivering these offerings on **learning.adobe.com**, indicating a platform shift to centralize and enhance the learning experience. These free resources are a core component of Adobe's learning portfolio, complementing fee-based programs and supporting both customers and partners in mastering Adobe's products. The evolution reflects Adobe's strategic positioning of free self-service learning as a foundational element within Adobe Digital Learning Services, enabling broader accessibility and integration with its broader digital learning ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 platform was www.training.adobe.com, and the shift to learning.adobe.com occurred in 2023 and continued in 2024. These details match the original answer exactly. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly used and sequenced. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the evolution across three years, identifies the platform transition, and contextualizes the strategic importance of self-service learning within Adobe Digital Learning Services. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'increased integration into a comprehensive portfolio' of fee-based and custom programs in 2024, which is a nuance present in the original answer. However, it does note that free resources complement fee-based programs, capturing the core idea. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant, directly addressing the evolution in positioning and platforms. Thus, the correctness score is 9 due to a small omission in depth of integration detail, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 349,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "From 2022 through 2024, Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolved in terms of product categorization, strategic emphasis, and alignment with professional tools offerings. In 2022, Commercial Vacuums were listed under the broader Tools & Home Products segment, categorized as professional tools used by industry professionals, including alongside water jetters and wet-dry vacuums. By 2023 and 2024, the Commercial Vacuums were explicitly included within the newly consolidated Safety & Productivity segment, which emphasized tools that support infrastructure, promote safety, and enhance productivity. This shift reflects a strategic realignment to integrate Commercial Vacuums more closely with professional tools offerings, reinforcing their role in industrial and infrastructure applications. The continued inclusion of Commercial Vacuums under this segment highlights Emerson's focus on expanding its portfolio of productivity-enhancing solutions for professional users.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Commercial Vacuums moved from Tools & Home Products in 2022 to Safety & Productivity in 2023 and remained there in 2024; they were grouped with professional tools like water jetters initially and later with infrastructure and safety tools. The strategic shift toward industrial productivity and safety is correctly identified. (2) There are no numeric values to verify, but dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning—tracking the product's segment change and evolving strategic context across years—is sound and well-synthesized. (4) The only minor omission is that the 2024 description in the ground truth specifically notes alignment with advanced systems like programmable automation and electrical distribution equipment, which the LLM answer does not mention explicitly, slightly reducing completeness in qualitative detail. However, the core evolution and strategic emphasis are accurately conveyed. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 345,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "GILD's utilization of its Hoofddorp, Netherlands facility has evolved from 2022 through 2024 to focus increasingly on commercial manufacturing and processing of cell therapy products. In 2022, the facility was listed among GILD's principal manufacturing sites, but no specific role in cell therapy was mentioned. By 2023, the Hoofddorp facility was explicitly identified as being used for commercial manufacturing and processing of cell therapy products, indicating an expansion of its role. In 2024, this trend continued, with the facility again noted for commercial manufacturing and processing of cell therapy products, aligning with GILD’s broader strategy to enhance its cell therapy manufacturing capabilities across multiple global locations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Hoofddorp was a principal manufacturing site without explicit mention of cell therapy; by 2023, it was explicitly used for commercial manufacturing and processing of cell therapy products; this role continued in 2024. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and sequenced. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly interpreted as a strategic evolution toward cell therapy, demonstrating a clear progression in the facility’s role. (4) The answer fully addresses the question’s focus on evolution over time and the increasing emphasis on cell therapy, with no omissions or inaccuracies. Wording differs slightly but conveys the same meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 276,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca-Cola's persistent reference to the 1.000% Notes due 2028 in its 2022 through 2024 filings, combined with the introduction of higher-yield notes like the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024, reflects a strategic shift in its debt financing approach. The continued inclusion of the low-yield 2028 notes suggests the company is managing near-term liquidity and refinancing risk while leveraging favorable terms from earlier issuances. However, the issuance of higher-yield notes in 2024, particularly with longer maturities, indicates a response to rising interest rates and a deliberate effort to diversify the maturity profile of its debt. This approach helps mitigate refinancing risk over the long term and aligns with a broader capital structure strategy that balances cost efficiency with financial flexibility in a higher-rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064—are correctly cited, matching the original answer exactly. There are no calculation errors, as the task does not involve numerical computation. (2) The answer addresses all parts of the question: it acknowledges the persistent reference to the low-yield 2028 notes and contrasts this with the 2024 introduction of higher-yield, long-term debt. (3) Entity accuracy is perfect: Coca-Cola, correct interest rates, maturities, and time frame (2022–2024) are all accurately referenced. (4) The reasoning is sound and adds value by contextualizing the shift as a response to rising interest rates and a strategy to diversify the maturity profile and manage refinancing risk—insights consistent with, and complementary to, the ground truth. The only minor difference is that the LLM emphasizes 'rising interest rates' and 'financial flexibility' slightly more than the original, which focuses on 'favorable market conditions' and 'strategic initiatives.' However, these are semantically compatible interpretations. No factual inaccuracies; excellent multi-hop synthesis across years and debt instruments. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight variation in emphasis, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 397,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflects a strategic shift toward battery-powered and diagnostic-integrated tools, as evidenced by the inclusion of \"battery hydraulic tools for press connections\" and \"diagnostic systems, including sewer inspection cameras and locating equipment\" in both the 2023 and 2024 10-K filings under the Safety & Productivity segment. In 2022, the company's Tools & Home Products segment already included pipe cutters among its offerings, but by 2023 and 2024, the emphasis had clearly shifted toward advanced, integrated solutions. This evolution highlights Emerson's positioning as an innovator in the professional plumbing tools market, aligning with industry trends toward efficiency, sustainability, and smart technology adoption.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Emerson's pipe cutter portfolio across 2022, 2023, and 2024 with accurate entity and year alignment. It correctly states that in 2022, pipe cutters were part of the Tools & Home Products segment without emphasis on battery-powered or diagnostic features. In 2023 and 2024, the shift toward battery hydraulic tools and diagnostic systems (e.g., sewer inspection cameras) is accurately noted, matching the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is mostly sound: the LLM connects segment-level product descriptions across years and infers a strategic shift. However, it slightly conflates 'battery hydraulic tools for press connections' (mentioned in filings) with pipe cutters—while related, press tools and cutters are distinct, and the ground truth specifies battery hydraulic *integration into pipe cutters* by 2023, which the LLM does not explicitly confirm. This is a minor but notable gap in precision. (4) The answer is contextually excellent—addresses all parts of the question, uses correct company (Emerson/EMR), correct years, and correct segment (Safety & Productivity in later years). The conclusion about positioning as an innovator aligns with the ground truth’s implication of a high-value, tech-enhanced strategy. Minor deduction in qualitative accuracy due to imprecise tool categorization, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 447,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024, GILD's Santa Monica, California facility has consistently been utilized for clinical manufacturing and processing of cell therapy products, as noted in the 2022, 2023, and 2024 10-K filings. While the 2022 filing only briefly mentions Santa Monica as one of several R&D locations, the 2023 and 2024 filings explicitly designate it as a key facility for cell therapy processing, alongside El Segundo, Frederick, and Hoofddorp. This progression underscores the facility's strategic role in GILD's broader manufacturing network, particularly in supporting the clinical and commercial scale-up of cell therapy products, reflecting a deliberate expansion and specialization in this critical therapeutic area.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a factual inaccuracy regarding the 2022 role of the Santa Monica facility. The ground truth states that in 2022, the facility was part of GILD's R&D and manufacturing network but was *not specifically highlighted* for cell therapy processing. However, the LLM claims it was 'consistently utilized for clinical manufacturing and processing of cell therapy products' starting in 2022, which contradicts the ground truth. This misrepresents the evolution, as the key point is the *transition* from general R&D to dedicated cell therapy use, not consistent use. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors in this regard; thus scored as 10. (3) The multi-hop reasoning is partially sound: the model correctly identifies the increasing emphasis on Santa Monica in 2023 and 2024 and aligns it with other sites like El Segundo and Frederick. However, it fails to accurately capture the *change over time*, particularly the absence of specific cell therapy designation in 2022, weakening the synthesis across years. (4) Contextual relevance is high—the response directly addresses the question about evolution and strategic role, uses correct entities (GILD, Santa Monica, El Segundo, Frederick, Hoofddorp), and interprets the strategic implication correctly. The core facts for 2023–2024 are accurate, but the misstatement about 2022 prevents a higher score on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 422,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 to 2024, Adobe expanded Frame.io's integration within its Creative Cloud ecosystem by enhancing supported media types and cross-application collaboration features. In 2022, Frame.io was listed among Adobe's trademarks, indicating its inclusion in the broader Adobe portfolio. By 2023, Frame.io supported still images, design files, and PDFs, and was directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling frame-specific feedback within these apps. Additionally, Frame.io introduced Camera to Cloud functionality for automatic footage uploads from recording devices. In 2024, Frame.io's integration was further emphasized as part of Adobe GenStudio, supporting content production at scale and expanding its role in workflows involving Adobe Express and Firefly Services. These developments reflect Adobe's strategy to position Frame.io as a central hub for collaborative creative asset production across diverse media and applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Frame.io's integration from 2022 to 2024 with accurate dates and overall trajectory. It correctly notes Frame.io's trademark listing in 2022, expanded media support by 2023 (still images, design files, PDFs), and positioning within Adobe GenStudio by 2024. The mention of frame-specific feedback and cloud-based collaboration aligns with the ground truth. However, there is a factual inaccuracy regarding the 2023 integration: the LLM states that Frame.io was integrated with Photoshop, Lightroom, and Workfront by 2023, while the ground truth specifies these integrations occurred in 2024. Additionally, the LLM introduces 'Camera to Cloud' functionality and mentions Adobe Express and Firefly Services in 2024, which are not present in the original answer and lack corroboration from the knowledge graph. These additions, while plausible, represent unsupported details that affect qualitative accuracy. Quantitative accuracy is perfect as there are no numerical errors. Contextual relevance is strong—the response directly addresses the question's focus on media types and cross-application collaboration. The reasoning is mostly sound but contains over-attribution of integration timelines, weakening the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 356,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "From 2022 to 2024, Emerson's (EMR) Discrete Automation segment evolved its strategic positioning of Electrical Distribution Equipment by expanding its integration with automation technologies and broadening its product scope. In 2022, Electrical Distribution Equipment was part of the Industrial Solutions segment, serving as a component in integrated manufacturing solutions. By 2023 and 2024, it became a key offering within the Discrete Automation segment, which includes programmable automation control systems, electric linear motion solutions, and software for discrete industries, highlighting a stronger focus on automation integration. This evolution reflects a strategic shift to align electrical distribution products with advanced automation technologies, enhancing their role in discrete manufacturing processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's strategic positioning of Electrical Distribution Equipment from 2022 to 2024. (1) All key facts are correct: in 2022, the product was part of Industrial Solutions; by 2023–2024, it was integrated into Discrete Automation alongside automation control systems, software, electric linear motion, and materials joining solutions. The strategic shift toward integration with intelligent automation is correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used accurately and consistently with the ground truth. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across time periods and segments, showing how the product’s placement evolved from a general industrial component to a core part of automation solutions. (4) The only minor shortcoming is that the LLM combines 2023 and 2024 into a single phase, slightly compressing the granular progression noted in the original answer (where 2023 emphasized programmable controls/software, and 2024 added electric linear motion and materials joining). This does not affect factual correctness but slightly reduces detail. Wording differs but maintains semantic equivalence. All entities (EMR, Discrete Automation, Industrial Solutions) are correctly identified. The answer is fully relevant and directly addresses both integration with automation and product scope expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 412,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One's (COF) fixed unsecured senior debt increased in carrying value from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. Concurrently, the weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This progression suggests that COF extended the maturity of its fixed unsecured senior debt and issued new debt at higher interest rates, reflecting a strategy to lock in long-term financing amid a rising interest rate environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: carrying values of $19,975 million (2022), $27,168 million (2023), and $26,930 million (2024) are correctly reported, as are the weighted-average interest rates of 2.91%, 4.45%, and 4.84% for the respective years. Minor formatting (e.g., 'million' vs 'M') is acceptable and does not affect accuracy. (2) The answer is complete, addressing both the evolution of carrying value and interest rates across all three years, and provides a correct interpretation of the company's debt strategy. (3) Entity accuracy is perfect: Capital One (COF), the metric 'fixed unsecured senior debt', and the correct fiscal years (2022–2024) are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the increase in debt carrying value alongside rising interest rates is correctly interpreted as a strategy to lock in long-term financing amid rising rates, which aligns with the proactive debt management implication in the ground truth. The slight decline in 2024 is noted, and the overall trend is contextualized appropriately. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 350,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX's liabilities related to performance and operating cost guarantees decreased from $120 million in 2022 to $97 million in 2023 and further to $101 million in 2024. This fluctuation, with a general downward trend, suggests that the company's exposure to long-term product performance risks in its commercial aerospace business has remained relatively stable or slightly reduced over the period, as historical experience and claims data have led to adjustments in accruals. However, the continued presence of these liabilities highlights ongoing exposure, particularly for commercial aircraft engines, where performance guarantees extend beyond standard warranties.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, RTX's liability was $120 million in both 2022 and 2023, then decreased to $101 million in 2024. However, the LLM incorrectly states that the liability dropped to $97 million in 2023, which is not supported by the data. This misrepresents the trend as fluctuating downward when the actual trend is stability followed by a modest decline. (2) The numbers are critical in financial analysis, and the incorrect $97 million figure undermines the accuracy of the response. While the 2022 and 2024 figures are either correct or close (LLM says $101M in 2024, matching ground truth), the erroneous 2023 value breaks the factual integrity of the time series. (3) The qualitative reasoning is sound—interpreting stable or slightly reduced liabilities as indicative of consistent risk exposure due to effective accrual adjustments based on performance data aligns with the original answer. The model correctly identifies the relevance of claims data, historical experience, and ongoing obligations in commercial aerospace engines. (4) Contextually, the answer is highly relevant and addresses both parts of the question: the evolution of liabilities and what it indicates about long-term risk exposure. Despite incorrect numbers, the synthesis across years and interpretation of risk implications show appropriate multi-hop reasoning. However, the quantitative error significantly reduces overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 423,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "From 2022 through 2024, The Coca-Cola Company consistently relied on \"estimates of sales proceeds\" as one of the valuation methodologies for assessing the fair value of its nonpublic investments, as disclosed in its 10-K filings. In 2022, the company explicitly used this method, along with discounted cash flows and appraisals, to evaluate nonpublic investments, particularly noting the challenges in predicting future cash flows in emerging markets. The 2023 and 2024 filings reaffirmed this continued reliance, with no material changes in the methodology or its application. However, the repeated emphasis on the uncertainty of estimating sales proceeds in emerging and developing markets suggests a growing awareness of the risks and volatility in these regions. This consistency in methodology, despite evolving market conditions, indicates a stable approach to fair value assessment, though it also highlights the company’s recognition of the inherent challenges in valuing nonpublic investments in less transparent markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of Coca-Cola's use of 'estimates of sales proceeds' across 2022–2024 and correctly identifies the methodology's application in valuing nonpublic investments, particularly in emerging markets. There are no numeric inaccuracies, as the response avoids specific figures (which are not required in this qualitative context), so quantitative accuracy is high. However, the LLM mischaracterizes the evolution of the company's reliance: it describes a 'consistent' and 'stable' approach with 'no material changes,' which contradicts the ground truth showing a clear progression from disclosure (2022) to operational reliance (2023) to cautious, risk-aware integration (2024). This misrepresents the core narrative of strategic evolution. The original answer emphasizes a shift in the degree and nature of reliance—deepening in 2023 and becoming more cautious in 2024—while the LLM portrays static usage. This failure to capture the dynamic change across the three years undermines the qualitative accuracy, especially in multi-hop reasoning that requires synthesizing shifts over time. Contextually, the answer remains relevant and addresses both parts of the question (evolution of methodology and implications for fair value assessment), but with incomplete and partially incorrect reasoning about the trajectory. Thus, while the components are present, the synthesis is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG <-[Relies_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 404,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "BNY Mellon's disclosures from 2022 through 2024 consistently emphasized that its ability to return capital to shareholders is subject to the discretion of its Board of Directors and constrained by U.S. banking laws and regulations, including capital planning rules and Delaware law. While the 2022 filing highlighted general regulatory limitations and the Parent's dependency on subsidiary dividends, the 2023 and 2024 filings added context on the potential impact of credit rating changes, resolution strategies under Title I and Title II, and broader strategic and operational risks. This multi-year consistency in disclosures suggests that BNY Mellon has maintained a cautious stance on capital return flexibility, reflecting ongoing regulatory constraints and a strategic emphasis on capital preservation and regulatory compliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure across 2022–2024 regarding U.S. banking laws, capital planning, and Delaware law as constraints on capital returns, which aligns with the ground truth. However, it introduces elements not present in the original answer—specifically, mention of credit rating changes, resolution strategies under Title I and Title II, and Board discretion—none of which are mentioned in the ground truth as part of the multi-year disclosure evolution. Conversely, the LLM omits the key 2024 addition about the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC (Intermediate Holding Company), which is a critical factual update in the original answer. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, all years (2022–2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers ongoing regulatory constraints, but fails to accurately trace the evolution—especially the shift toward internal capital flow dependencies in 2024. Instead, it fabricates new risk factors (e.g., credit ratings, resolution plans) that were not part of the disclosed progression. (4) While the overall theme of regulatory constraint and cautious capital distribution is contextually appropriate and relevant, the answer substitutes accurate qualitative details with plausible but incorrect elaborations, reducing factual fidelity. The correctness score is 6 due to partial accuracy in core constraints but significant deviation in the specific evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 460,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD's exposure to the risk of losing tax and tariff exemptions increased from 2022 to 2024, as highlighted in all three 10-K filings. In 2022, AMD identified \"loss or modification of exemptions for taxes and tariffs\" as a general risk among its global operations. By 2023, this risk was reiterated with added context on geopolitical tensions, such as the Ukraine-Russia conflict and U.S. sanctions, which could indirectly affect regulatory conditions. In 2024, the risk was again emphasized, with a broader discussion of macroeconomic and regulatory shifts, including changes in tax laws and trade protection measures, further underscoring the evolving and increasingly complex global regulatory environment. This trend suggests that AMD faces growing uncertainty and potential disruptions due to shifting international policies, requiring heightened vigilance and adaptability in its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD consistently reported the risk of losing or modifying tax and tariff exemptions from 2022 to 2024. In 2022, it was a general risk; in 2023, geopolitical tensions (Ukraine-Russia conflict, U.S. sanctions) were linked to regulatory shifts; in 2024, broader macroeconomic and political instability, including U.S. export controls, were emphasized. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and contextualized with geopolitical developments. The LLM slightly generalizes 'China-Taiwan tensions' as part of broader U.S. sanctions, which is acceptable but less precise than the original mention of China-Taiwan dynamics. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer fully addresses both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 327,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "From 2022 to 2024, Capital One's (COF) total short-term borrowings and long-term debt decreased from $43,086 million in 2022 to $45,551 million in 2024, reflecting a decline in debt levels. Specifically, floating unsecured senior debt dropped significantly from $1,709 million in 2022 to $349 million in 2023 and was fully extinguished by 2024. This reduction in floating-rate debt suggests a strategic shift toward a more fixed-rate debt structure, thereby decreasing COF's exposure to interest rate volatility. The weighted average interest rates for fixed unsecured senior debt also increased over the period, from 2.91% in 2022 to 4.84% in 2024, reflecting higher borrowing costs in a rising interest rate environment. Overall, the evolution of COF's debt structure indicates a move toward longer-term, fixed-rate obligations, which enhances financial stability but may increase interest expenses in a high-rate climate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has significant quantitative inaccuracies. It correctly identifies the elimination of floating unsecured senior debt by 2024 and the increase in fixed unsecured senior debt interest rates. However, it misrepresents the overall debt trend: the original answer shows debt increased from $43.086B in 2022 to $49.856B in 2023 before declining to $45.551B in 2024, but the LLM claims a direct decrease from 2022 to 2024, omitting the substantial 2023 increase. This is a critical error in trend interpretation. (2) Number verification: $43,086 million (2022) is correct; $45,551 million (2024) is correct; but the 2023 figure of $49.856B is missing entirely in the LLM narrative. Floating unsecured senior debt: $1.709B in 2022 is correct (though written as $1,709 million), $349 million in 2023 is correct, and $0 in 2024 is correct. Fixed unsecured senior debt values are partially correct: $21.045B in 2022, $27.168B in 2023, and $26.930B in 2024 — but the LLM only mentions the 2023 and 2024 figures without the 2022 baseline or full progression. Interest rates (2.91% in 2022 to 4.84% in 2024) are correctly reported. (3) Multi-hop reasoning is generally sound: the LLM correctly infers a strategic shift from floating to fixed-rate debt to reduce interest rate exposure, which aligns with the ground truth. It also correctly interprets rising fixed-rate costs in a higher-rate environment. However, it fails to synthesize the full three-year trajectory of total debt, missing the 2023 spike. (4) Scores justified as: correctness 7 (core facts about debt composition shift are right, but major omission in total debt trend); quantitative accuracy 6 (several correct numbers but key 2023 total debt figure missing and trend mischaracterized); qualitative accuracy 8 (reasoning and interpretation are strong where information is present); contextual relevance 10 (fully addresses the question's intent and scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 533,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX's net program share interest in International Aero Engines AG (IAE) remained consistent at 57% from 2022 to 2024, as disclosed in the 2022, 2023, and 2024 10-K filings. This stability in RTX's net share, after accounting for sub-collaborator interests, indicates a consistent strategic positioning as a key player in the V2500 engine program collaboration, maintaining a strong influence over the program's economics and operations. RTX's role as the primary beneficiary of IAE, along with its consolidated control, underscores its central role in managing and benefiting from the V2500 program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of RTX's net program share interest in IAE. The ground truth states that RTX's interest decreased from 61% in 2022 to 57% in 2023 and 2024, but the LLM claims it remained constant at 57% across all three years. This misrepresents the trend entirely and contradicts the core fact of a strategic reduction. (2) The numbers are inaccurate: 2022 value is wrong (57% vs correct 61%), while 2023 and 2024 values (57%) are correct. The failure to note the 4-percentage-point decrease undermines the answer’s validity. No calculations are involved, but the comparison over time is flawed. (3) The multi-hop reasoning is unsound—instead of identifying a change and interpreting its strategic implication (dilution of economic exposure), the model asserts stability and draws an opposite conclusion about strategic intent. It fails to synthesize the correct temporal shift despite referencing multiple years’ filings. (4) While the answer addresses the right entities (RTX, IAE, V2500 program) and general context (strategic positioning, collaboration), the incorrect data leads to an invalid interpretation. The mention of 'primary beneficiary' and 'consolidated control' may be contextually plausible but do not compensate for the central factual error. Thus, correctness and quantitative accuracy are severely penalized, qualitative accuracy is low due to flawed reasoning, and contextual relevance is moderate because the framework of the response aligns with the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 430,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "From 2022 to 2024, Cascade has maintained a consistent position within P&G's Fabric & Home Care segment, as evidenced by its inclusion as a major brand in the Home Care sub-category across all three 10-K filings. In 2022, the Fabric & Home Care segment accounted for 35% of P&G's net sales and 31% of net earnings, with Cascade listed among key brands like Ariel, Tide, and Dawn. By 2023 and 2024, the segment's contribution to net sales remained stable at 36%, while its earnings contribution slightly decreased to 34%. Despite no significant change in its segmental positioning, Cascade's continued presence as a major brand underscores its enduring role in P&G's home care portfolio, particularly in dish care products.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cascade's consistent positioning within P&G's Fabric & Home Care segment across 2022–2024 and accurately reports the segment's net sales percentages (35% in 2022, 36% in 2023 and 2024). However, there is a minor error in the earnings trend: the LLM states that earnings contribution 'slightly decreased to 34%' in 2023 and 2024, while the ground truth indicates it increased from 31% in 2022 to 34% in 2023 and remained at 34% in 2024. The LLM incorrectly characterizes the change as a decrease rather than an increase, which affects quantitative accuracy. (2) All other numbers are correct: 35% sales in 2022, 36% in 2023/2024, and 34% earnings in later years. The error is directional (increase vs decrease), not in the absolute values. (3) Multi-hop reasoning is sound—LLM synthesizes data across three 10-K filings, correctly identifies Cascade’s role, and draws a valid conclusion about its stable strategic importance. The logic is coherent and supported by the data, despite the minor misstatement on earnings trend. (4) Scores reflect high accuracy in entities, context, and reasoning, with a slight deduction in quantitative accuracy due to the incorrect characterization of the earnings change direction. Semantic equivalence is mostly preserved, and the core conclusion about Cascade’s stable role remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 382,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2024, BNY Mellon's disclosures on the accessibility and governance of its Directors' Code of Conduct evolved in URL structure, domain branding, and integration with broader corporate governance frameworks. In 2022, the Directors' Code of Conduct was accessible at **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf**, using the full \"bnymellon.com\" domain. By 2023, the URL was updated to **https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf**, with a slight rebranding in the directory path from \"in\" to \"inv\" (likely for clarity or consistency). In 2024, the URL structure changed significantly to **https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf**, reflecting a shift to the shorter \"bny.com\" domain and a more standardized \"investor-relations\" directory, aligning with broader corporate branding and governance integration. These changes indicate a move toward more streamlined, branded, and centralized corporate governance disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates (2022, 2023, 2024), domains (bnymellon.com, bny.com), and URL path changes are correctly reported. The evolution in URL structure—from 'in relations' to 'inv relations' to 'investor-relations'—is accurately described, as is the domain shift to 'bny.com' in 2024. (2) There are no numeric values requiring calculation, but all factual details (URLs, domains, path components) are correct and match the ground truth exactly in substance. Minor formatting differences (e.g., 'investor-relations' vs. 'investor-relations' with hyphen) do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across three years, identifies the significance of domain branding and URL restructuring, and infers the strategic shift toward integrated governance communication. The conclusion about a move toward 'streamlined, branded, and centralized' disclosures is semantically equivalent to the ground truth's 'stakeholder-oriented, brand-consistent governance disclosure strategy.' (4) The only minor shortcoming is that the LLM does not explicitly characterize the 2022 approach as 'siloed and document-focused' or the 2024 change as signaling 'strategic integration into corporate governance communication' with the same depth as the original, slightly reducing qualitative richness. However, the core reasoning and factual progression are intact. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 437,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "From 2022 through 2024, AMD's strategic positioning with AIB manufacturers evolved by reinforcing inventory protection policies and emphasizing the role of discrete graphics solutions in differentiation strategies. In 2022, AMD's agreements with AIBs protected their inventory against price reductions and enabled SIs to use discrete graphics to differentiate their products and add value. By 2023, this strategy remained consistent, with continued inventory protection and a growing emphasis on timely product introductions and performance capabilities to maintain competitiveness. In 2024, AMD maintained these inventory protections and further highlighted the importance of discrete graphics in enabling SIs to respond quickly to market demands and differentiate offerings, especially in the context of increasing competition and rapid technological advancements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies for AIBs from 2022 to 2024, and discrete graphics were consistently emphasized as a differentiator for system integrators (SIs). The LLM correctly identifies the continuity of these policies across all three years. (2) There are no numeric values, dates, or financial figures in dispute; all time periods (2022, 2023, 2024) are accurately referenced, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—information is synthesized across years and strategic themes (inventory protection, differentiation via discrete graphics). The only minor deviation is the LLM's addition of 'growing emphasis on timely product introductions and performance capabilities' in 2023 and 'rapid technological advancements' in 2024, which are plausible contextual inferences but not explicitly stated in the ground truth. These do not contradict the original answer but add slight interpretive nuance. (4) The answer is fully contextually relevant, addressing both inventory protection and the strategic role of discrete graphics across the full time span. The core message of stable, long-term partnership is preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor elaboration beyond the source, but remains factually solid and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 398,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "From 2022 to 2024, McDonald's continued to emphasize the Egg McMuffin as a core breakfast offering, highlighting its role in meeting customer expectations for quality, consistency, and taste. In 2022, the Company noted the importance of evolving its menu to meet customer needs, including testing new products, with the Egg McMuffin being a key breakfast item in U.S. and international markets. By 2023, McDonald's expanded its focus to include supply chain innovation and food safety, emphasizing collaboration with suppliers to ensure quality and consistency across its menu, including the Egg McMuffin. In 2024, the Company further reinforced its commitment to quality through digital transformation and third-party audits, ensuring that core menu items like the Egg McMuffin met rigorous standards. This evolution reflects a strategic alignment between menu innovation, supply chain management, and customer expectations for quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Egg McMuffin is consistently referenced as a core breakfast item from 2022 to 2024, and McDonald's evolution in disclosure around quality, supply chain, and digital transformation is accurately portrayed. The narrative correctly shifts from menu evolution in 2022, to supply chain collaboration in 2023 (including supplier partnerships), and to digital transformation and food safety in 2024. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is synthesized across years and themes (menu, supply chain, technology), and the logical progression from general quality to integrated systems is preserved. The only minor omission is the absence of specific mention of the 'Global Chief Supply Chain Officer' in 2023 and the precise 'data excellence' focus in the 2024 digital project, which slightly reduces qualitative accuracy. However, the essence of supply chain leadership and digital quality systems is conveyed. (4) The answer is fully contextually relevant, directly addressing the evolution of disclosure around breakfast innovation and supply chain focus in relation to the Egg McMuffin and customer expectations. Overall, the response is factually correct, well-structured, and semantically equivalent to the original answer with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Features]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 398,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The consistent disclosure of Oracle's 4.30% Note due 2034 in its 2022, 2023, and 2024 10-K filings, as shown in all three chunks, indicates that this long-term debt instrument remains a key component of Oracle's capital structure across these reporting periods. The note is consistently listed under the same exhibit (4.09) with identical terms and filing details, suggesting Oracle has maintained this debt obligation without refinancing or restructuring it. This consistency reflects a stable and deliberate approach to long-term financing, emphasizing Oracle's strategy to preserve long-dated, fixed-rate debt to manage interest rate risk and ensure predictable cash flow obligations well into the future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the note's interest rate (4.30%), maturity year (2034), and consistent disclosure across 2022, 2023, and 2024 are correctly stated. There are no numerical or date inaccuracies, and the reference to Exhibit 4.09 aligns with typical SEC filing structures, though this specific exhibit number is not confirmed in the ground truth. The answer correctly identifies the note as a persistent component of Oracle’s long-term debt, which matches the ground truth. However, the LLM omits key contextual details present in the original answer—specifically, the comparison with other debt instruments (e.g., 3.625% Note due 2023, 2.950% Notes due 2024, 4.50% Note due 2044) that illustrate Oracle’s diversified maturity profile and evolving debt strategy. This limits the depth of multi-hop synthesis, as the ground truth emphasizes how the 4.30% Note fits within a broader, dynamically managed portfolio. While the LLM correctly infers strategic stability and interest rate risk management, it does not fully capture the nuance of Oracle balancing long-term and short-term issuances over time. The reasoning is sound but less comprehensive, missing the comparative analysis across years that defines the original answer’s qualitative richness. Despite this, the core conclusion about Oracle’s long-term financing focus is valid and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 389,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "From 2022 to 2024, Capital One's (COF) net derivative assets (liabilities) valuation methodology remained consistent, relying on discounted cash flows and significant unobservable inputs such as default rates and swap rates. In 2022, the fair value of net derivative assets (liabilities) was $19 million, with a net unrealized loss of $20 million included in net income. By 2023, the fair value increased to $58 million, and by 2024, it remained at $58 million. The continued use of Level 3 inputs, particularly swap rates (ranging from 3-5%) and default rates (53-163%), indicates growing exposure to unobservable market inputs over time, reflecting increased uncertainty and model dependency in valuing these derivatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value amounts for 2022 ($19 million), 2023 ($58 million), and 2024 ($58 million), matching the ground truth. It accurately notes the net unrealized loss of $20 million in 2022 and the use of unobservable inputs like default rates (53–163%) and swap rates (3–5%) in 2023 and 2024. However, there is a minor inaccuracy in stating that the $20 million unrealized loss was 'included in net income'—the ground truth specifies it was 'still held as of year-end,' implying it was unrealized and not yet recognized in income. This mischaracterization affects the qualitative accuracy slightly. (2) All numeric values—dollar amounts, percentages, and years—are correct and consistent with the original answer. The fair value progression from $19M to $58M and stability in 2024 is accurately presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years, identifies the shift in fair value, and links the increasing reliance on Level 3 inputs to greater model dependency. It correctly infers that continued use of unobservable inputs indicates growing exposure, which aligns with the ground truth’s conclusion about a more defined risk profile. However, it frames the trend as 'growing exposure' and 'increased uncertainty,' whereas the ground truth emphasizes increased transparency and a more stable valuation methodology—slightly different interpretations. (4) The answer is highly contextually relevant, addressing both the evolution of valuation methodology and what it reveals about unobservable inputs. The wording differs but the core facts and synthesis are correct, warranting a high score. Minor issues in interpretation and one factual misstatement prevent a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 482,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX's financial obligations tied to Rolls-Royce related to V2500-powered aircraft flight hours, stemming from the 2012 acquisition of Rolls-Royce’s ownership and collaboration interests in IAE, are contingent on flight hours flown through June 2027. These obligations are structured such that payments to Rolls-Royce are made based on each hour flown by the V2500-powered aircraft in service as of the acquisition date. These flight hour payments are capitalized as collaboration intangible assets and amortized over the term of the underlying economic benefit, with amortization typically beginning as programs enter full-rate production and aftermarket cycles. The payment structure and amortization strategy remained consistent from 2022 through 2024, with the obligations reflected in RTX’s \"Other commercial aerospace commitments\" and managed as part of its broader commercial aerospace financing and contractual commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, entities, and reasoning. (1) It accurately identifies the origin of the obligation in the 2012 IAE acquisition, the per-flight-hour payment structure tied to V2500-powered aircraft, and the commitment duration through June 2027—matching the ground truth. The treatment of payments as capitalized collaboration intangible assets amortized to cost of sales is correctly described, though the LLM uses slightly more generalized language (e.g., 'amortized over the term of the underlying economic benefit' and 'beginning as programs enter full-rate production') rather than explicitly stating amortization to cost of sales as in the original. (2) Quantitatively, all dates (2012, 2022–2024, June 2027) are correct. However, the LLM omits the specific $14.1 billion figure for total commercial aerospace commitments in 2024, which is a notable quantitative detail present in the ground truth. This omission prevents a perfect quantitative score. (3) The multi-hop reasoning is sound: the model correctly links the 2012 transaction to ongoing obligations, traces accounting treatment evolution, and contextualizes the payments within broader commercial commitments. While it states the policy 'remained consistent,' it misses the nuance in the original that transparency around intangible asset management improved over time—a minor but relevant qualitative development. (4) The answer is highly contextually relevant, directly addressing the evolution of payment structure and amortization strategy. Overall, the LLM captures the core financial mechanism and its continuity, with only minor gaps in completeness and specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Supplies]- ORG <-[Enters_Agreement_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 465,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit from 2022 through 2024 show a consistent emphasis on monitoring and addressing device-related issues, with incremental updates on operational resilience. In 2022, Amgen highlighted the importance of collecting and assessing user complaints and adverse events for devices like the Neulasta Onpro kit, noting that safety concerns could lead to regulatory actions and adverse effects. It also referenced the 2017 FDA evaluation of the Neulasta Onpro kit and the subsequent implementation of device and labeling enhancements. By 2023, the disclosures reiterated these practices and emphasized the continuous monitoring and enhancement process, while also expanding the context to include operational risks, particularly at key manufacturing facilities in Puerto Rico and California, which are critical for both commercial and clinical supply. In 2024, the disclosures maintained the focus on user complaints and device enhancements but added new details about operational resilience, such as the December 2024 island-wide power outage in Puerto Rico, which required reliance on backup generators and highlighted the need for increased preparedness and infrastructure resilience to ensure uninterrupted operations and supply chain stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen referenced the 2017 FDA evaluation in 2022, implemented device and labeling enhancements, maintained ongoing monitoring in 2023, and in 2024 added disclosures about operational resilience, including reliance on backup generators due to Puerto Rico's unstable grid and a specific island-wide outage on December 31, 2024. The date of the outage (December 31, 2024) is correctly included, and no incorrect numbers or dates are present. (2) Quantitative accuracy is perfect: the only specific date mentioned, December 31, 2024, matches the ground truth exactly. There are no calculations, but temporal references are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and connects device-related complaints with evolving operational risk disclosures, particularly around infrastructure in Puerto Rico. The mention of California is a minor addition not in the original, but it does not contradict and may reflect broader context from filings. (4) The answer is semantically equivalent to the original, with slightly expanded phrasing but no factual deviation. The only reason for not scoring a 10 is that the original emphasizes the *indirect* link between infrastructure instability and user complaints more explicitly, while the LLM implies it through context. Overall, the response is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 410,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK's disclosure regarding the ratification of KPMG LLP as principal accountant remained consistent from 2022 to 2024, with each year's 10-K filing referencing the ratification under \"Item 3 - Ratification of KPMG LLP\" in the Proxy Statement, incorporated by reference in Item 14. The consistent mention of KPMG's PCAOB firm number 185 across all three filings underscores audit governance continuity, indicating that BK has maintained the same principal accounting firm and regulatory identification throughout this period, reflecting stability and continuity in BK's audit oversight and compliance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BK consistently ratified KPMG LLP as principal accountant from 2022 to 2024, and KPMG's PCAOB firm number 185 was consistently cited across all filings. These details match the original answer exactly. (2) Quantitative accuracy is perfect: no numerical errors, and the PCAOB number '185' is correctly repeated across years. (3) The multi-hop reasoning is sound—linking consistent disclosure, PCAOB number, and audit governance continuity is logically valid. The LLM correctly infers stability in audit oversight from the unchanged firm and identification number. (4) The only minor shortcoming is that the LLM mentions 'Item 3 - Ratification of KPMG LLP' and 'Item 14' with specificity that may not be present in all filings or may vary slightly by document structure; the ground truth does not confirm the exact item numbers, so this adds precision not verifiable from the knowledge graph. However, this does not introduce inaccuracy but rather adds procedural detail. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high score with only slight deduction for unverifiable structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 352,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as reflected by the collaboration partners' share, decreased from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024, indicating a consistent decline over the three-year period. This downward trend suggests a potential shift in RTX's risk management strategy, likely involving a reduction in the extent of third-party involvement in financing guarantees, which could signal a more conservative approach to managing financial exposure or a strategic realignment in partnership structures to mitigate potential liabilities in the commercial aerospace sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$142M in 2022, $135M in 2023, and $131M in 2024—with accurate year-to-year decreases, matching the ground truth exactly. There are no calculation or formatting errors, satisfying quantitative accuracy. (2) The answer addresses both parts of the multi-part question: it traces the evolution of RTX's exposure through the declining figures and interprets the trend in the context of risk management. The qualitative reasoning is sound and aligns with the ground truth’s implication of reduced shared risk and liability mitigation. (3) The multi-hop reasoning—linking decreasing partner shares over time to strategic risk management—is logically synthesized and correctly infers intent from numerical trends. The only minor shortcoming is that the LLM omits the specific point from the original answer about RTX’s assertion that guaranteed asset values equaled or exceeded the guarantees net of reserves, which adds nuance to their confidence in underlying assets. This omission slightly reduces completeness but does not invalidate the core conclusion. (4) Despite this, the answer remains factually correct, contextually relevant, and semantically equivalent in intent and meaning, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Has_Stake_In]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 362,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 through 2024, Procter & Gamble maintained the Always brand as a core component of its Feminine Care portfolio within the Baby, Feminine & Family Care segment. In 2022, Always was listed under the Feminine Care category alongside \"Adult Incontinence\" and \"Feminine Care,\" while in 2023 and 2024, the category was slightly refined to \"Adult Incontinence\" and \"Menstrual Care,\" reflecting a more specific product categorization. The brand's emphasis remained consistent, with Always and Always Discreet being highlighted as major brands alongside Tampax. This evolution suggests a strategic effort to clarify the product offerings under the Feminine Care umbrella, potentially to better align with consumer needs and market segmentation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies Always as a core brand and notes its association with Tampax and Always Discreet, it misrepresents the segment and category evolution. The ground truth states that in 2022, the segment was 'Feminine Care' contributing 25% of net sales, and in 2023 it was renamed 'Baby, Feminine & Family Care' (not just a refinement within the same segment). The LLM incorrectly claims that in 2022, Always was listed under 'Adult Incontinence' and 'Feminine Care'—but Adult Incontinence was not part of the Feminine Care segment; Always Discreet is the incontinence brand. Furthermore, the shift from 'Feminine Care' to 'Menstrual Care' as a category is not supported by the ground truth, which does not mention 'Menstrual Care' as a category name. (2) Quantitatively, the LLM omits the key percentages (25% in 2022, 24% in 2023 and 2024) that are central to the original answer, and provides no numerical data at all, which is a significant omission. (3) The reasoning partially captures the idea of brand consolidation and strategic emphasis, but fails the multi-hop synthesis by not accurately tracking the segment name changes, structural contributions, and correct brand groupings across years. (4) Despite these issues, the answer is contextually relevant and captures the general trend of consistent emphasis on Always with minor refinements. The qualitative reasoning about strategic clarification is plausible, though not fully aligned with the documented changes. Hence, partial credit is given for correct brand associations and directional insight, but significant deductions for factual and quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 472,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "From 2022 to 2024, AMD's exposure to intellectual property (IP) protection difficulties increased in tandem with its expanding international operations and growing reliance on third-party manufacturing in Asia. In 2022, AMD highlighted the general risk of \"difficulties in protecting our intellectual property\" as part of its global operations, particularly due to varying legal systems and enforcement challenges in foreign jurisdictions. By 2023, the company reiterated these concerns, emphasizing the heightened geopolitical tensions and regulatory complexities in regions like Asia, where much of its product assembly and testing occur. In 2024, AMD continued to stress the risks of IP protection, noting that its operations in China, Malaysia, and Taiwan—key manufacturing hubs—remain vulnerable to legal and economic uncertainties, including potential disruptions from geopolitical tensions between China and Taiwan. The evolving international landscape, combined with AMD’s increasing reliance on third-party manufacturing in these regions, has thus amplified its exposure to IP protection challenges over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD consistently cited IP protection risks from 2022 to 2024, with increasing emphasis on international operations and third-party manufacturing in Asia. The countries mentioned—China, Malaysia, and Taiwan—are correctly identified as key manufacturing hubs. The evolution of risk, including the emergence of China-Taiwan geopolitical tensions as a concern in 2024, is accurately reflected. (2) There are no numeric inaccuracies. While the original answer includes the specific figure of '65% of net revenue' from international sales in 2023, the LLM answer does not mention this percentage. This is a minor omission but does not distort the overall meaning or factual correctness, as the general trend of increasing international operations is still conveyed. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and geographies, linking AMD’s business model shifts (outsourcing, global sales) to escalating IP risks. The progression from general legal challenges in 2022 to region-specific geopolitical risks in 2024 demonstrates proper longitudinal and contextual understanding. (4) The answer is contextually excellent—directly addressing the question’s focus on the evolution of IP risks in relation to international expansion and Asian manufacturing reliance. The wording differs slightly but maintains semantic equivalence. The only reason for not scoring a 10 is the omission of the 65% revenue figure, which adds precision but does not undermine the core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 443,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued its 2.300% Notes due 2028 in March 2021, as disclosed in Chunk 1 (ORCL_10k_2022). By 2023 (Chunk 2) and 2024 (Chunk 3), these notes remained part of Oracle's outstanding debt instruments, indicating continuity in the issuance. Notably, Oracle introduced higher-yielding debt instruments in 2022 (5.800% Notes due 2025) and 2023 (4.500% Notes due 2028), suggesting a multi-year strategy to diversify its debt portfolio across varying maturities and interest rates. This pattern reflects Oracle's approach to managing its capital structure by balancing lower-yielding long-term debt with higher-yielding instruments, potentially to hedge against interest rate risk and optimize borrowing costs over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect factual claims. It incorrectly states that Oracle 'first issued' the 2.300% Notes due 2028 in March 2021, which is not supported by the ground truth — the original answer only says Oracle first *referenced* the notes in 2022 as part of Exhibit 4.16, which included instruments from March 2021. There is no confirmation in the ground truth that the 2.300% Notes were issued in March 2021; they may have been part of that broader set, but the exact issuance date is not confirmed. This is a significant factual overreach. (2) The LLM introduces specific new debt instruments — '5.800% Notes due 2025' issued in 2022 and '4.500% Notes due 2028' in 2023 — which are not mentioned in the ground truth. These details are unsupported and appear to be hallucinated, severely impacting quantitative accuracy. While the ground truth mentions newer notes in 2022–2023, it does not specify their terms. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in disclosure of the 2.300% Notes due 2028 from 2022 to 2024 and links this to a broader debt strategy. The conclusion about diversifying maturities and interest rates is plausible and aligns thematically with the ground truth’s point about a 'diverse maturity profile.' However, the reasoning is built on unsupported specifics, weakening its validity. (4) Despite the hallucinated details, the answer addresses the core question about evolution and strategy, and the overall narrative about stable, diversified debt management is semantically close to the ground truth. Hence, contextual relevance is high, qualitative reasoning is reasonable but flawed, and quantitative accuracy is low due to incorrect percentages and instruments. Correctness score reflects partial accuracy with significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 503,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 through 2024, BA's investment strategy in Private Equity Vehicles as limited partners (LPs) maintained a consistent focus on both U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. The geographic scope remained global, with investments spanning across multiple regions. In 2022, real estate and real assets were held through LPs or other fund structures, including publicly traded investments like REITs. By 2023 and 2024, the strategy continued to emphasize global private investments in real estate (office, retail, apartment, and industrial properties) and real assets (natural resources, commodities, and infrastructure), primarily through LPs or other fund structures. This evolution reflects a strategic emphasis on diversification and long-term value creation across geographies and asset classes.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent geographic scope (U.S. and non-U.S.) and core strategy areas (leveraged buyout, venture capital, growth, special situations) from 2022 to 2024, aligning with the ground truth. It accurately notes the use of LPs and fund structures and includes real estate and real assets. However, it misses key strategic evolutions highlighted in the original answer: the 2023 expansion into global private investments in energy, farmland, and infrastructure is partially reflected but generalized as 'natural resources, commodities, and infrastructure'—less precise. Crucially, the 2024 advancement in using derivatives for performance transfer and enhanced exposure is entirely omitted, which is a significant strategic development. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes continuity in strategy and global scope across years but fails to capture the nuanced progression in sophistication (e.g., derivatives use in 2024), weakening the qualitative accuracy. (4) The answer remains contextually relevant and well-structured, addressing both geographic scope and strategic focus, but lacks completeness in capturing the full evolution, justifying a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 395,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "From 2022 through 2024, Amgen's development of Bemarituzumab progressed from initiating a Phase 3 study in gastroesophageal junction (GEJ) adenocarcinoma in 2022 to being described in 2024 as a monoclonal antibody under investigation for gastric and gastroesophageal junction cancer and advanced solid tumors (excluding advanced squamous NSCLC). In terms of patent positioning, the estimated U.S. and European patent expiration for Bemarituzumab is 2029, covering polypeptide subject matter, as disclosed in 2023. These patent timelines do not include potential extensions or adjustments, and additional patents or exclusivity protections may further extend market exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen initiated a Phase 3 study in 2022 for GEJ adenocarcinoma, disclosed in 2023 that polypeptide-related patents for Bemarituzumab are set to expire in 2029 in both the U.S. and Europe, and in 2024 described it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer. The LLM correctly notes the 2029 patent expiration and the scope of protection. (2) Quantitative accuracy is perfect: the year 2029 is correctly cited for patent expiration, and the timeline progression across 2022–2024 is accurately represented. No calculations are required, and all dates are correct. (3) The multi-hop reasoning is sound—information is synthesized across three years and multiple disclosures (clinical phase initiation, patent disclosure, and updated therapeutic context). The LLM adds minor additional detail (exclusion of advanced squamous NSCLC) not in the original answer, which is consistent with plausible trial design but not contradicted by the ground truth. (4) The only reason for not scoring a 10 is that the LLM slightly expands the indication to 'advanced solid tumors' without explicit confirmation in the ground truth, which focuses on gastric and GEJ cancers. However, this does not contradict the original and may reflect broader trial inclusion criteria. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 415,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "From 2022 to 2024, Dawn remained a consistent major brand within Procter & Gamble's Fabric & Home Care segment, as listed in the segment's major brands across all three years. In 2022, the Fabric & Home Care segment contributed 35% of net sales and 31% of net earnings, increasing slightly in 2023 to 36% of net sales and 34% of earnings. This trend continued in 2024, with the segment maintaining 36% of net sales and 34% of earnings, indicating a stable and significant contribution to P&G's overall financial performance. Dawn's continued inclusion as a major brand in the segment underscores its ongoing importance in driving these results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dawn remained a consistently listed brand in the Fabric & Home Care segment from 2022 to 2024; the segment’s net earnings contribution increased from 31% in 2022 to 34% in 2024; net sales percentage was 35% in 2022 and 36% in 2023 and 2024. The LLM correctly reports these figures across years with no numerical errors. (2) Quantitative accuracy is perfect: all percentages for net sales and net earnings match the original answer, and the temporal progression is accurately represented. (3) The reasoning is sound—LLM correctly infers that the segment’s stable sales share and rising earnings contribution reflect its strong performance, and Dawn’s consistent inclusion supports its strategic importance. The only minor omission is that the original answer explicitly notes the stability of sales (35% to 36%) as evidence of Dawn’s positioning within a stable segment, which the LLM implies but does not directly emphasize. (4) Contextual relevance is excellent—the answer directly addresses the evolution of Dawn’s positioning through both brand listing continuity and segment performance metrics. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction for less explicit emphasis on the sales stability implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 392,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022 through 2024, Charles Schwab continued to utilize client securities as collateral for margin lending and third-party obligations, maintaining regulatory compliance by pledging these assets in accordance with federal requirements. In 2022, Schwab pledged client securities to third parties under margin lending and securities borrowed transactions, with the fair value of pledged securities detailed in its disclosures. By 2023, Schwab maintained similar practices, with margin loans collateralized by client securities and the company applying a practical expedient under ASC 326 to estimate credit losses based on collateral fair value. In 2024, Schwab expanded its collateral obligations by pledging client securities to meet margin requirements for options transactions cleared by the Options Clearing Corporation and providing cash collateral for securities lending activities. Additionally, the 2023 IDA agreement caused Schwab to sweep uninvested client cash off-balance sheet, limiting its ability to consolidate these assets. This trend indicates that Schwab’s exposure to client-held assets remains significant, as these assets are actively used to meet collateral obligations, but are not reflected on its balance sheet, reducing direct financial exposure while maintaining regulatory and operational flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Schwab's use of client securities for margin lending, pledging under federal regulations, application of ASC 326 practical expedient in 2023, and expanded use in 2024 for Options Clearing Corporation margin requirements and securities lending are all accurately described. The mention of cash collateral in securities lending and the role of client securities in options clearing is consistent with the original. (2) There are no numeric values in the question or answers that require verification—both responses are qualitative and use no specific dollar amounts, so quantitative accuracy is not compromised. (3) The multi-hop reasoning across 2022–2024 is sound: the LLM correctly synthesizes evolving practices in collateral use, regulatory compliance, and accounting treatment. One minor addition in the LLM answer—the 2023 IDA agreement moving uninvested cash off-balance sheet—is not in the original answer but is factually plausible and adds context without contradicting the ground truth; it slightly extends rather than distorts the narrative. (4) The core trend—that Schwab’s exposure to client-held assets is significant but managed off-balance sheet, reflecting strategic risk management and operational flexibility—is semantically equivalent to the original’s conclusion about increasing sophistication and exposure. The only reason for not scoring a 10 is that the original emphasizes 'increasing sophistication' in utilization, while the LLM focuses more on balance sheet exposure; thus, a slight nuance difference in emphasis, but no factual error. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 471,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN's target asset allocation strategy for its defined benefit pension plans evolved from fiscal 2023 to fiscal 2025 by maintaining a focus on risk-adjusted returns and long-term inflation-adjusted growth, while adapting to market conditions and regulatory requirements. As disclosed, the target allocation for fiscal 2023 was outlined in the 2022 10-K, and by fiscal 2025, the target allocation was updated in the 2024 10-K, with weighted-average plan asset allocations as of August 31, 2022, 2023, and 2024 reflecting adjustments in response to investment committee decisions and evolving market dynamics. The strategy continued to emphasize diversification across fixed income and equities, with a particular focus on aligning asset duration with liability duration to minimize volatility, as noted in all three chunks.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer fails to provide any of the specific quantitative data present in the ground truth. It does not mention the actual weighted-average asset allocations for any year—such as 55% fixed income and 45% equities in fiscal 2023 (as of August 31, 2022), 58/42 in fiscal 2024 (as of August 31, 2023), or 61/39 in fiscal 2025 (as of August 31, 2024). These precise percentages are central to the question and entirely missing. (2) There are no calculations or numerical comparisons made, and no verification of trends such as the 3-percentage-point annual increase in fixed income allocation. The absence of numbers results in a very low quantitative accuracy score. (3) While the LLM correctly identifies the general strategic context—such as de-risking, diversification, liability duration matching, and responsiveness to market conditions—it fails to demonstrate multi-hop reasoning by connecting the disclosed allocations across three consecutive years to show the evolving trend. The synthesis of year-over-year changes is missing, which is essential for answering how the strategy evolved. (4) The answer is contextually relevant in that it discusses ACN’s pension plan allocation strategy and references the correct reporting dates and documents (e.g., 10-Ks with August 31 data), but it lacks the factual core needed to be considered correct. The response reads more like a generic description of pension strategy than a data-driven evolution analysis. Thus, while it addresses the topic, it does not fulfill the question's requirements, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 438,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One's (COF) total short-term borrowings and long-term debt increased from $43,086 million in 2022 to $45,551 million in 2024. The debt structure shows a shift toward long-term fixed-rate debt, particularly in senior unsecured notes, which rose from $27,219 million in 2022 to $30,696 million in 2024. Floating-rate debt declined significantly, from $1,709 million in 2022 to $0 in 2024, indicating a strategic move to reduce interest rate exposure. The weighted-average interest rate on long-term debt also increased from 2.76% in 2022 to 4.84% in 2024, reflecting higher borrowing costs in a rising rate environment and a more stable, long-term debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM omits the 2023 figure entirely and incorrectly states a direct increase from $43,086M in 2022 to $45,551M in 2024, missing the peak in 2023. This is a critical error in trend representation. Additionally, the LLM reports a weighted-average interest rate rising from 2.76% in 2022 to 4.84% in 2024, but the ground truth specifies rates of 1.51% (2022), 3.01% (2023), and 3.48% (2024) on securitized debt—different metrics and values. The LLM also cites floating unsecured senior debt declining from $1,709M in 2022 to $0 in 2024, while the ground truth states $1,597M in 2023 (not 2022) and $0 in 2024. These numeric discrepancies severely undermine accuracy. (2) Calculations: The LLM does not perform any explicit calculation, but the implied trend (steady rise) contradicts the actual spike and partial reversal. The interest rate increase is overstated. (3) Multi-hop reasoning: The LLM correctly infers a strategic shift away from floating-rate debt, which aligns with the ground truth’s conclusion about reducing interest rate exposure. It also correctly identifies a move toward fixed-rate long-term debt, supported by the rise in senior unsecured notes—though these specific figures are not in the ground truth, so their source is unclear. However, the reasoning is partially sound despite incorrect inputs. (4) The answer is contextually relevant and addresses both debt evolution and interest rate exposure. However, due to major quantitative errors in debt totals, interest rates, and floating debt levels, the correctness score is low. The qualitative reasoning is plausible but based on incorrect data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 507,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "From 2022 through 2024, BA’s fleet support services costs have consistently remained approximately 1% of total consolidated costs of products and services, as noted in all three annual reports (2022, 2023, and 2024). Despite challenges in the 787 and 777X programs, including abnormal production costs and significant reach-forward losses—such as the $2.7 billion in cumulative abnormal costs through 2023 and the $2,608 million and $891 million reach-forward losses in 2024—fleet support costs have remained stable as a percentage. This stability suggests that fleet support services were not directly impacted by the production and certification issues affecting the 787 and 777X programs, which instead contributed to higher abnormal production costs and losses in those specific programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: fleet support services costs remained at approximately 1% of total consolidated costs from 2022 to 2024, which matches the original answer. The abnormal production costs for the 787 program are correctly cited as $2.7 billion through 2023, and the reach-forward losses for the 777X program in 2024 are accurately reported as $2,608 million in Q3 and $891 million in Q4. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and all figures match the ground truth in value and context. (3) The reasoning is sound: the LLM correctly contrasts the stable percentage of fleet support costs with the escalating program-specific losses, inferring that the financial strain stems from production issues, not service costs. It synthesizes information across multiple years and programs appropriately. (4) The only minor shortcoming is a slight lack of elaboration on the causes of the 777X losses (e.g., certification delays, labor instability, supplier cost increases), which are mentioned in the original but not in the LLM response. While not critical, including these details would have made the answer fully equivalent. Overall, the answer is factually complete, contextually relevant, and logically coherent, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 387,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie's allocation to money market funds and time deposits decreased from $12 million in 2022 to $21 million in 2023, and further declined to $10 million in 2024. This three-year trend suggests a gradual reduction in the company's short-term liquidity held in these conservative, highly liquid instruments, potentially indicating a shift in strategy—such as reallocating funds to higher-yielding investments or deploying cash for operational or strategic purposes like acquisitions or share repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change from 2022 to 2023: it states that the allocation 'decreased from $12 million in 2022 to $21 million in 2023', which is incorrect—$12M to $21M is an increase, not a decrease. This misstatement undermines the quantitative accuracy. The 2024 value of $10 million is correct and matches the ground truth. (2) Numerically, two out of three values are correctly cited ($12M in 2022, $21M in 2023, $10M in 2024), but the logical interpretation of the trend is flawed due to the incorrect verb 'decreased' when describing the 2022–2023 change. The calculation of the trend is therefore invalid. (3) The multi-hop reasoning is partially sound—the model attempts to interpret the 3-year trend and offers plausible strategic explanations (e.g., reallocation to higher-yielding investments or acquisitions), which aligns with the type of analysis expected. However, because the directional trend is misrepresented (decrease vs. increase then decrease), the reasoning is based on a false premise. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication) and uses appropriate financial terminology. Despite the major quantitative error, the structure and intent of the response are relevant and logically organized. The correctness score is low due to the severity of the directional inaccuracy, which distorts the entire trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 411,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Accenture's share repurchase activity and remaining authorization evolved as follows: In fiscal 2022, the company had $3,129,296 in available authorization for share purchases and redemptions. By fiscal 2024, as of August 31, 2024, the remaining available authorization was $2,694 million. During fiscal 2024’s fourth quarter, Accenture repurchased 2,000,308 Class A ordinary shares for $605 million under its open-market share purchase program. Additionally, the Board of Directors approved an additional $4,000 million in repurchase authority in September 2024, increasing the total outstanding authority to $6,694 million. This trend indicates a consistent and strategic capital return approach, with ongoing repurchase activity and periodic replenishment of authorization, reflecting confidence in the company's financial position and commitment to returning value to shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key error in the fiscal 2024 remaining authorization date and amount. The original answer states that the $2,694 million remaining authorization was as of August 31, 2023 (fiscal 2023), not August 31, 2024 as claimed by the LLM. The LLM incorrectly implies that the $2,694 million was still the available amount in fiscal 2024 before the new authorization, which contradicts the timeline. Additionally, the LLM introduces a new detail—repurchasing 2,000,308 shares for $605 million in Q4 2024—that is not present in the ground truth and cannot be verified against it, potentially introducing unverified information. (2) Quantitatively, the $3,129,296 thousand (correctly rendered as ~$3.13 billion) in fiscal 2022 is accurate. The $4,000 million increase and resulting $6,694 million total in fiscal 2024 are correct. However, the misplacement of the $2,694 million figure (attributed to 2024 instead of 2023) is a significant timing and contextual error. (3) The multi-hop reasoning is otherwise sound: the LLM correctly identifies the progression of authorization increases and links them to a strategic capital return policy. It synthesizes the idea of board approval and ongoing repurchases indicating confidence, which aligns with the ground truth’s interpretation. (4) The contextual relevance is perfect—the answer directly addresses the evolution of repurchase activity and what it indicates about capital strategy. Due to the date/amount misalignment and introduction of unverified repurchase details, the quantitative accuracy is reduced to 7, qualitative accuracy to 9 (minor reasoning flaw), and overall correctness to 8—core facts are right, but key precision is off.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 474,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie maintained a consistent governance provision across 2022, 2023, and 2024 that allows stockholders to remove directors only for cause, as disclosed in its 10-K filings each year. This provision, along with other anti-takeover measures such as a staggered board, director-only filling of vacancies, and the 80% stockholder vote requirement to amend key governance provisions, reflects a long-term strategy of board entrenchment. By preserving the board’s control and limiting shareholder influence, AbbVie aims to deter coercive or undervalued takeover attempts, ensuring that any acquisition must be negotiated with the board and align with its strategic vision, thereby reinforcing a sustained defense against hostile takeovers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie maintained the 'removal for cause only' provision across 2022, 2023, and 2024, as consistently disclosed in its 10-K filings. The answer correctly identifies this stability in governance policy. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the mention of the '80% stockholder vote requirement'—while not explicitly in the original answer—is a plausible detail consistent with supermajority thresholds often tied to bylaw amendments and does not contradict the ground truth. It may reflect additional context from the actual filings but does not introduce error. (3) The multi-hop reasoning is sound: the LLM synthesizes the director removal rule with other anti-takeover mechanisms (staggered board, vacancy filling, amendment thresholds) across years to infer a long-term board entrenchment strategy, which matches the original answer’s conclusion. (4) The semantic meaning fully captures the intent and substance of the ground truth, with only minor differences in emphasis—LLM adds slight elaboration on strategic rationale (e.g., 'negotiated with the board', 'align with strategic vision') that is reasonable but not explicitly stated in the original. No incorrect entities, years, or metrics are used. The answer is contextually excellent, fully addressing both the evolution (consistency over time) and strategic implication (takeover defense). A score of 9 is given because while all facts are correct, the LLM slightly extends the original by specifying an '80%' threshold not mentioned in the ground truth, which, while likely accurate, introduces a detail not confirmed by the reference. This does not constitute an error but prevents a perfect 10 due to minor overprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 500,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo consistently referenced its 4.000% Senior Note due 2047 in its 2022, 2023, and 2024 10-K filings, with the note being listed in each year's exhibit section under the same filing reference—Exhibit 4.5 to PepsiCo’s Current Report on Form 8-K filed on May 2, 2017. This consistent disclosure pattern across all three years underscores the note’s enduring role in PepsiCo’s long-term capital structure, indicating that it is a stable, long-duration debt instrument intended to support the company’s strategic financial planning and liquidity management over an extended period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the 4.000% Senior Note due 2047 was consistently referenced in the 2022, 2023, and 2024 10-K filings with the same Exhibit 4.5 from the May 2, 2017 8-K filing. (2) Quantitative elements—specifically the interest rate (4.000%), maturity year (2047), exhibit number (4.5), and filing date (May 2, 2017)—are all correctly stated with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes the disclosure pattern across three years and infers the strategic implication—that the note is a stable, long-term component of PepsiCo’s capital structure. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the strategic significance. Wording differs slightly from the original answer but conveys the same meaning and insight. No errors in entities, dates, or logic. All scoring categories warrant a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 287,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle issued the 4.30% Note due 2034 in July 2014, as disclosed in its 2022, 2023, and 2024 10-K filings, with the note consistently referenced in the exhibit listings across these years. The note remains part of Oracle’s long-term debt structure, with no indication of refinancing or early redemption in the provided disclosures. This multi-year consistency suggests a stable long-term debt strategy, where Oracle maintains fixed-rate debt instruments to manage its capital structure and potentially hedge against interest rate volatility over extended periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Oracle issued the 4.30% Note due 2034 in July 2014, which contradicts the ground truth that the note was first disclosed in 2022. This is a major quantitative and factual inaccuracy. The ground truth does not specify an issuance date, but clearly states the note first appeared in disclosures in 2022, not 2014. (2) No financial figures (e.g., principal amount, interest payments) are mentioned in either answer, so numerical accuracy cannot be penalized further, but the incorrect issuance date undermines trust in the data source. The interest rate (4.30%) and maturity year (2034) are correctly stated. (3) The multi-hop reasoning is partially sound: the LLM correctly infers from consistent disclosure across 2022–2024 that Oracle maintains a stable long-term debt strategy with fixed-rate instruments. This aligns with the ground truth’s conclusion about stability and sustained capital market engagement. However, the erroneous backdating of the issuance to 2014 suggests flawed sourcing or reasoning about when the instrument entered the debt portfolio. (4) The contextual relevance is high because the answer addresses all parts of the question—evolution over time and strategic implications—and draws a reasonable conclusion from the pattern of disclosure. Despite the incorrect issuance date, the qualitative assessment of Oracle’s strategy is consistent with the evidence. Thus, the correctness score is moderate due to a key factual error undermining full accuracy, though the overall interpretation remains plausible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 441,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127,000,000 in fiscal year 2022 to 141,000,000 in both 2023 and 2024, as reported in the respective 10-K filings. Despite this increase in the total authorized shares, the number of shares available for future grants remained relatively stable at approximately 27.3 million as of August 31, 2022, and slightly decreased to 27.27 million by August 31, 2024. This progression suggests that Accenture has expanded its long-term share-based compensation capacity to support ongoing employee incentives, while maintaining a consistent reserve of available shares, likely to ensure flexibility in granting awards without frequent shareholder approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the authorized shares as 127,000,000 in fiscal year 2022 and 141,000,000 in both 2023 and 2024, matching the ground truth exactly. The additional detail about shares available for future grants (27.3 million and 27.27 million) is factually consistent with typical 10-K disclosures and does not contradict the ground truth, though it was not part of the original answer. (2) All numeric values are accurate: 127M and 141M shares are correctly reported across years, and the slight decrease in available shares is plausibly presented. No calculation errors. (3) The multi-hop reasoning is sound—LLM correctly tracks the evolution of authorized shares over three fiscal years and infers strategic intent regarding share-based compensation. It adds nuanced context (stable available shares) that enhances the analysis without distorting the core facts. (4) The answer fully addresses both parts of the question: the quantitative evolution and the strategic implication. The interpretation aligns semantically with the ground truth’s conclusion about expanded capacity for compensation. The only minor deviation is the inclusion of extra detail on available shares, which is relevant and accurate but not required; this does not detract from correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-elaboration, but perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 406,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo's 2.750% Senior Note due 2051 was initially authorized in 2022 as part of a broader set of notes, indicating early planning for long-term capital structure. By 2023, the specific form of the 2051 note was filed on October 21, 2021, and reiterated in filings, showing continuity in documentation. In 2024, the note was again referenced without substantive changes, suggesting stable terms over the multi-year period. This consistent filing pattern across 2022–2024 reflects PepsiCo's strategy of maintaining long-term, fixed-rate debt to manage interest costs and ensure stable financing well into the future.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the multi-year progression of PepsiCo's 2.750% Senior Note due 2051 and the general strategy of stable long-term debt structuring. However, it contains a critical factual error: it states the specific form of the note was filed on October 21, 2021, which is before the 2022 authorization and contradicts the ground truth (which shows formal documentation in 2023, not 2021). This incorrect date undermines the quantitative accuracy. (2) The percentages (2.750%) and maturity year (2051) are correct, and the absence of substantive changes in 2024 aligns with the ground truth. However, the erroneous 2021 filing date is a major quantitative flaw. (3) The reasoning about a phased approach and stable capital strategy is sound and aligns with the ground truth, showing good qualitative understanding of the multi-hop pattern across 2022–2024. The model correctly infers strategic intent from filing evolution, even if one date is wrong. (4) Contextually, the answer is highly relevant, addressing both the evolution of documentation and the strategic implication. The core narrative is partially correct but marred by a key factual inaccuracy in timing, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 351,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express's competitive positioning from 2022 to 2024 has been shaped by increasing regulatory scrutiny and the rapid expansion of alternative payment mechanisms. In 2022 and 2023, American Express remained the fourth-largest general-purpose card network globally, competing with Visa, Mastercard, and China UnionPay, while facing growing competition from digital wallets, fintech platforms, and real-time payment systems like PayPal, Venmo, and Alipay. The 2024 filing highlights intensified regulatory pressures, including interchange fee caps, network routing rules, and consumer protection laws, which have constrained discount revenue and impacted business flexibility, especially in the EU and Australia, where American Express exited network licensing due to regulatory constraints. Additionally, the company became a Category III firm under U.S. banking regulations, subjecting it to heightened compliance expectations and potential future classification as a Category II firm, which could further increase costs and regulatory burdens. These developments underscore a more challenging competitive landscape, where American Express must balance innovation and customer value against regulatory constraints and the encroachment of alternative payment solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network globally from 2022 to 2024, behind China UnionPay, Visa, and Mastercard. The mention of competitive pressures from PayPal, Alipay, and other fintech platforms (e.g., Venmo) is consistent with the original answer’s reference to alternative payment mechanisms. (2) There are no numeric values requiring calculation in this question, but all dates (2022, 2023, 2024) and regulatory developments (interchange fee scrutiny, network routing rules, EU market exits) are accurately represented. The detail about American Express exiting network licensing in the EU and Australia due to regulatory constraints adds precision beyond the original answer but is factually consistent and plausible based on public filings. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive positioning, regulatory trends, and strategic responses across time and geographies. It correctly identifies the shift from market-driven competition to regulation-constrained operations. The addition of American Express becoming a Category III firm under U.S. banking regulations is not in the original answer but is factually accurate and enhances the response without contradicting the ground truth. (4) Semantic equivalence is strong—while the LLM uses slightly broader terminology (e.g., 'real-time payment systems'), the core meaning and factual content match the original. The only minor gap is that the original emphasizes cobrand relationships and closed-loop loyalty as differentiators, which the LLM omits, though it references 'cobrand arrangements' in the regulatory context. This omission prevents a perfect 10 but does not undermine the overall correctness. Scores reflect high accuracy, excellent contextual relevance, and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 518,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing's strategic emphasis on aircraft upgrades and conversions has remained a core component of its Global Services (BGS) segment from 2022 to 2024, as evidenced by consistent inclusion of \"upgrades and conversions\" as a key service in all three years' 10-K filings. However, the 2024 filing highlights a more integrated approach, with the Global Services segment explicitly providing upgrades and conversions to both commercial and defense customers, suggesting a deliberate expansion into defense-related modifications. This evolution, combined with the knowledge graph showing Boeing (BA) providing upgrades and conversions to an external \"Upgrades and Conversions (ORG)\" entity, indicates a strategic shift to strengthen its services business by diversifying into specialized conversion services, potentially for third-party or defense clients, thereby enhancing revenue streams and operational flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 'upgrades and conversions' remained a consistent service offering within Boeing's Global Services (BGS) segment from 2022 to 2024, which aligns with the ground truth. However, it diverges significantly in the interpretation of strategic evolution. The original answer emphasizes a shift toward 'modifications' in 2023 and the integration of 'data analytics and digital services' in 2024 as key strategic developments. The LLM answer does not mention data analytics or digital services at all, instead introducing a claim about expansion into defense-related modifications and third-party clients based on a questionable interpretation of an 'Upgrades and Conversions (ORG)' entity — a detail not present or inferable from the ground truth. This misrepresents the core strategic shift described in the original answer. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the years (2022–2024) are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategic intent, it relies on an unsupported external entity ('Upgrades and Conversions (ORG)') and misses the actual progression of Boeing’s service differentiation through digital integration. The synthesis across years is partial — it notes continuity but misses the nuanced evolution in emphasis and technological integration. (4) The correctness score is 5 due to partial factual alignment (continued presence of upgrades/conversions) but significant omission and misdirection regarding the actual strategic shift. Qualitative accuracy is low because of incorrect reasoning and entity usage. Contextual relevance is moderate as the answer stays on topic but introduces irrelevant elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Supplies]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 493,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo's 5.50% Senior Note due 2035 was first documented in 2018 in both a Current Report on Form 8-K and a Registration Statement on Form S-4, establishing its initial issuance. In 2022, the note was referenced again in the 10-K filing, indicating ongoing inclusion in PepsiCo’s long-term debt structure. The note reappeared in 2023 and 2024 10-K filings, with consistent references to the same 2018 filings, suggesting no new issuance or material changes to the note’s terms. This multi-year filing pattern reveals a strategy of maintaining long-term debt instruments with extended maturities to ensure stable capital structure and manage refinancing risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 5.50% Senior Note due 2035 was originally issued in 2018 (referencing the 8-K filing), and it was consistently documented in the 2022, 2023, and 2024 10-K filings without changes. The percentages, maturity year (2035), and reference to the 2018 filing are all factually correct. (2) Quantitative accuracy is perfect: no numerical errors in dates, percentages, or financial terms. The answer correctly avoids citing dollar amounts since none were provided in the original data. (3) The multi-hop reasoning is sound—LLM correctly infers from repeated inclusion in annual filings that PepsiCo maintained the debt without modification, indicating a stable long-term capital strategy. It synthesizes information across three years and correctly traces back to the 2018 issuance. (4) The only minor shortcoming is that the LLM mentions a 'Registration Statement on Form S-4' in 2018, which was not present in the ground truth; the original answer only references the 8-K filing. This addition, while plausible, is not supported by the provided data and slightly reduces qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually relevant, and correctly interprets the strategic implication of the filing pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 372,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns remained a consistent constraint from 2022 through 2024, as highlighted in all three 10-K filings. In 2022, the company emphasized that its ability to return capital to shareholders is subject to the Board's discretion and limited by U.S. banking laws, including capital planning regulations and Delaware law. By 2023, the regulatory focus expanded to include heightened risks from potential capital and liquidity limitations, as well as the impact of credit ratings on funding costs. In 2024, the company reiterated these constraints and added that failure to meet regulatory standards—such as maintaining \"well capitalized\" status—could further restrict capital return activities. This multi-year progression reveals that BNY Mellon’s capital return policies are tightly constrained by evolving regulatory expectations, necessitating careful alignment with U.S. banking laws to maintain compliance and financial stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and regulatory context. (1) All years (2022, 2023, 2024) are accurately referenced, and the evolution of BNY Mellon's disclosures is correctly portrayed. There are no numeric values in the question or answer requiring verification, so quantitative accuracy is 10. (2) The LLM correctly identifies U.S. banking laws, Delaware law, and capital adequacy as constraints across the years. It accurately notes the consistent limitation on capital returns and the emphasis on maintaining 'well capitalized' status in 2024. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of disclosures and correctly infers a tightening or increasingly explicit regulatory posture. However, there is a minor discrepancy: the ground truth does not mention 'credit ratings' or 'funding costs' as part of the capital return constraints in 2023, which the LLM introduces without support from the original answer. This addition, while plausible, is not present in the ground truth and slightly overextends the evidence. Additionally, the 2022 description in the LLM answer includes 'Board's discretion' and 'Delaware law', which are not highlighted in the ground truth for that year—though they appear in 2023. This misattribution slightly weakens the year-by-year precision. (4) Despite these nuances, the core conclusion—that regulatory constraints have consistently limited capital planning and shareholder returns—is correct and well-supported. The answer is contextually relevant and captures the essence of the multi-year progression. Thus, correctness is rated 8 due to minor inaccuracies in attribution and the introduction of unsupported details, but not enough to undermine the overall validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 494,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle issued its 2.300% Notes due 2028 in March 2021, as shown in Chunk 1 and Chunk 2, and this issuance remained referenced in subsequent filings, including the 2022 and 2024 10-Ks. However, by 2023, Oracle began issuing new notes with significantly higher coupon rates, such as the 4.500% Notes due 2028 in February 2023 (Chunk 1 and Chunk 2), reflecting the rising interest rate environment. This evolution from 2.300% in 2021 to 4.500% in 2023 indicates Oracle's strategy of locking in lower rates during periods of relative stability and adapting to higher rates as market conditions changed, showcasing a proactive approach to managing its fixed-income financing costs amid shifting monetary policy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of Oracle's 2.300% Notes due 2028 in March 2021 and their continued reference in 2022 and 2024 filings. It accurately notes the February 2023 issuance of 4.500% Notes due 2028, reflecting higher coupon rates in a rising rate environment. These key facts align with the ground truth. However, the LLM omits the specific context that the 2.300% Notes were issued under an Officers' Certificate dated March 24, 2021, filed as Exhibit 4.14 in the 2022 10-K, and does not mention the broader multi-tiered offering (e.g., 2.875% Notes due 2031, 3.950% Notes due 2051), which is a minor but relevant detail for completeness. (2) Quantitatively, all percentages (2.300%, 4.500%), years (2021, 2023), and maturities (due 2028) are correct. The LLM correctly associates the higher coupon with the 2023 issuance and rising rates. No calculation errors. (3) The reasoning is sound: the model correctly infers Oracle’s strategy of locking in lower rates earlier and adapting to higher rates later. It captures the core insight about fixed-income financing strategy in varying rate environments. However, it misses the nuance that Oracle did not reprice or refinance the 2.300% Notes in 2023–2024, instead issuing new higher-rate debt, which suggests a preference for layered debt issuance rather than refinancing—this is implied but not explicitly stated. (4) The answer is highly contextually relevant, directly addressing the evolution of terms and Oracle’s financing strategy. The omission of the multi-tranche structure and lack of explicit mention of no structural changes to the 2.300% Notes prevents a perfect score, but the core message is factually accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 471,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM's emphasis on client relationships and trust as a competitive differentiator has remained a consistent strategic pillar across 2022, 2023, and 2024, with a growing integration into its hybrid cloud and AI positioning. In 2022, IBM highlighted client relationships and trust as a core method of competition, emphasizing their role in delivering business value and differentiating through deep expertise and secure, open hybrid cloud solutions. By 2023, the company reinforced this by linking trust and relationships to its broader ecosystem of partners and alliances, underscoring their importance in solving complex client challenges. In 2024, the focus evolved further, with client relationships and trust being explicitly tied to IBM’s leadership in hybrid cloud and AI, as well as its ability to modernize infrastructure and deliver scalable digital transformation. This multi-year progression indicates that IBM is strategically leveraging trust and long-term client relationships to solidify its position in the competitive hybrid cloud and AI markets, where differentiation through incumbency, innovation, and ecosystem collaboration is critical.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and strategic interpretation. (1) All key elements are correct: IBM's emphasis on client relationships and trust is consistently highlighted across 2022–2024, with appropriate evolution in focus each year. The 2022 emphasis on trust as part of secure, open hybrid cloud and business value matches the original. In 2023, the reinforcement through ecosystem partnerships and solving complex challenges reflects the ground truth's mention of deep incumbency and innovation. In 2024, the linkage to hybrid cloud and AI leadership, modernization, and digital transformation aligns with the expansion of strategic partnerships (e.g., Palo Alto Networks) and positioning trust as central to business value. (2) There are no numeric values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable in a numerical sense—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes IBM’s evolving strategy across three years and connects it to broader market positioning in hybrid cloud and AI. The only minor gap is that the LLM does not explicitly name Palo Alto Networks as a 2024 example, which slightly reduces qualitative precision, but the conceptual emphasis on expanded partnerships is present. (4) The answer is contextually excellent—fully relevant, well-structured, and responsive to the multi-year progression and strategic implications. The conclusion about leveraging trust, incumbency, and ecosystem collaboration accurately reflects the strategic trajectory. Minor deduction from 10 to 9 on correctness and qualitative accuracy due to omission of the specific partnership example, but overall semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 493,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express's yield profile from its holdings of foreign government bonds and obligations increased from 6.45% in 2023 to 5.85% in 2024, while in 2022, the weighted average yield for these holdings was 6.45% (based on the 2023 data and the 2022 fair value and yield data). This suggests a slight decline in yields in 2024 compared to 2023, but a significant increase from 2022 to 2023. The 3-year progression indicates that American Express has maintained a relatively high-yield exposure to foreign government bonds, which reflects a strategy to capitalize on higher international interest rates. However, the slight decline in 2024 may signal a potential recalibration or a shift in its investment strategy amid evolving global interest rate environments, while still maintaining a moderate level of interest rate risk due to the short-term nature of most of these holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the yield increased from 6.45% in 2023 to 5.85% in 2024, when in fact the yield *decreased* from 6.45% in 2023 to 5.85% in 2024. Additionally, it falsely claims that the 2022 weighted average yield was 6.45%, but the original answer does not provide any yield data for 2022—only the holding amounts. The LLM fabricates yield data for 2022 by assuming it was the same as 2023, which is unsupported. (2) The dollar amounts for 2022 holdings ($630 million, with $628 million maturing in one year) are correct, but the LLM fails to mention the maturity distribution shift in 2024 (2.03% now maturing between 1–5 years), a key strategic signal. The yield values for 2023 (6.45%) and 2024 (5.85%) are correctly cited, but their directional interpretation is reversed. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers yield trends across three years by inventing a 2022 yield not present in the source, and misinterprets the 2024 yield decrease as a 'slight decline' following an increase, when the actual progression shows a drop from 2023 to 2024 after no yield data in 2022. It misses the core insight—the strategic shift from ultra-short-duration to a more diversified maturity profile by 2024. (4) The contextual relevance is moderate because it discusses yield trends, interest rate risk, and investment strategy, but the conclusions are based on incorrect data and reasoning. Due to major quantitative and qualitative inaccuracies, especially the fabricated 2022 yield and mischaracterized trend, the correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 449,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies increased from 2022 through 2024, as evidenced by the growing government grant funding allocated to offset capital expenditures. In 2022, $87 million in grants offset capital expenditures, rising to $136 million in 2023 and $198 million in 2024, indicating a strategic escalation in support for diagnostics production capacity expansion. Additionally, government grants offset operating expenses by $49 million in 2022, $51 million in 2023, and $43 million in 2024. This progression underscores the increasing strategic importance of diagnostics testing within DHR’s healthcare portfolio, particularly in response to ongoing demand for testing solutions and the company’s focus on expanding its role in public health initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported the government grant funding amounts allocated to offset capital expenditures for Diagnostics Testing Technologies: $87M in 2022, $136M in 2023, and $198M in 2024, matching the ground truth exactly. However, the LLM introduced additional information about government grants offsetting operating expenses ($49M, $51M, $43M), which was not present in the original answer and is not supported by the provided ground truth. This extra detail, while possibly true in a broader context, introduces unverified data and slightly undermines quantitative accuracy. (2) All reported capital expenditure offset figures are numerically accurate and correctly attributed to the respective years. The trend analysis (increasing funding) is correct and well-supported. The inclusion of operating expense offsets, though contextually plausible, is extraneous and not part of the ground truth, thus constituting a minor factual overreach. (3) The multi-hop reasoning is sound: the model correctly synthesized the three-year trend in grant funding and linked it to strategic importance within Danaher’s healthcare portfolio. The conclusion about increasing strategic focus aligns with the ground truth and is logically derived from the upward trajectory in funding. (4) The correctness score is 8 due to the otherwise accurate and complete response, with only the addition of unsupported operating expense figures preventing a higher score. Quantitative accuracy is 8 because while the key numbers are correct, the inclusion of unverified figures reduces precision. Qualitative accuracy is 9 due to strong reasoning and correct entity identification (Danaher, DHR, Diagnostics Testing Technologies, years). Contextual relevance is 10 as the answer directly addresses the evolution of investment and strategic importance as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 502,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "BK's disclosure regarding the ratification of KPMG LLP as principal accountant remained consistent across fiscal years 2022, 2023, and 2024, with the information included in the Proxy under \"Item 3 - Ratification of KPMG LLP,\" as incorporated by reference in each year's 10-K filing. In all three years, KPMG LLP's PCAOB firm identification number was disclosed as 185, indicating no change in the firm's identification or the manner of its presentation within the Proxy sections.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: BK consistently ratified KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB identification number was correctly stated as 185 in all years; and the disclosure consistently appeared under 'Item 3 - Ratification of KPMG LLP' within the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported across all years with no discrepancies. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years and consistent placement within the Proxy is correctly identified, demonstrating accurate cross-year and cross-document understanding. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure practices, and correctly notes the stable format and location of the information. Minor wording differences (e.g., 'incorporated by reference' not in original) do not affect factual accuracy and may reflect additional contextual understanding. No errors in entities, years, or financial regulatory details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 324,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "American Express's reliance on third-party merchant acquirers from 2022 through 2024 evolved through a combination of revenue recognition structure, contractual relationships, and strategic expansion goals. In 2022, American Express recognized discount revenue from transactions facilitated through third-party acquirers, such as under the OptBlue program, by receiving a negotiated network rate fee at the time of each Card Member transaction. Contracts with large merchants typically lasted three to seven years, often with auto-renewal features, while small- and medium-sized merchants had no fixed duration. By 2023, the company continued to rely on third-party acquirers, with revenue recognition principles remaining consistent—discount revenue and processed revenue were recognized at the time of transaction, with processed revenue including fees from network partners. In 2024, the strategic focus expanded to include global merchant coverage, with American Express emphasizing the success of third-party acquirers in signing merchants to accept American Express cards. The company's expansion goals included increasing acceptance in new industries, international markets, and digital integration, highlighting the continued importance of third-party acquirers in achieving broader network growth and enhancing Card Member value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, revenue was recognized as discount revenue under programs like OptBlue with negotiated network fees; by 2023, American Express included processed revenue (fees from network partners), reflecting a more structured model; in 2024, strategic expansion emphasized global reach, new industries, and digital integration via third-party acquirers. (2) There are no numeric inaccuracies—dates (2022–2024), contract durations (3–7 years, auto-renewal), and revenue recognition timing (at transaction) are all factually consistent with the original. Format variations (e.g., 'discount revenue' vs. 'network rate fees') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes evolution across years, linking changes in revenue structure, contractual terms, and strategic goals. The only minor gap is that the LLM does not explicitly name 'Global Network Services (GNS)' as a key program in 2022 or use the term 'royalties' in 2023, which slightly reduces qualitative precision compared to the original’s emphasis on a 'strategic partnership model' and 'revenue-sharing framework.' However, the mention of 'fees from network partners' and strategic expansion implies this shift. (4) Contextual relevance is perfect—the response directly addresses all three dimensions in the question: revenue recognition, contractual relationships, and strategic goals—across the specified time frame. Overall, the answer is factually robust, well-structured, and semantically equivalent to the ground truth, warranting a 9/10 for correctness due to minor omissions in terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 465,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "From fiscal years 2022 through 2024, Qualcomm linked its human capital goals, particularly diversity targets, to executive compensation by using progress toward these goals as a non-financial performance modifier that could adjust executives' bonus payouts by a multiple of 0.9 to 1.1. In 2022, Qualcomm set specific 2025 diversity goals, including increasing women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. By 2024, the company continued this linkage, maintaining the same modifier range for executive bonuses, indicating a sustained focus on tying diversity and inclusion outcomes to leadership accountability across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women and URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 non-financial modifier for executive bonuses. These numbers match the ground truth exactly, and the fiscal years (2022–2024) are correctly referenced. The answer correctly identifies the sustained linkage of diversity goals to executive compensation across the three years, which is the core of the multi-hop reasoning. However, the LLM omits some qualitative developments noted in the original answer for 2023 and 2024, such as Qualcomm’s recognition in multiple regions, participation in the Reboot Representation Tech Coalition, and the expansion of wellness and development programs. While the central theme of sustained incentive linkage is preserved, these omissions slightly reduce completeness in conveying the full evolution of human capital integration into corporate strategy. Nonetheless, the answer remains factually correct, semantically aligned, and contextually relevant, with flawless quantitative accuracy and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 321,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar's geographic reach for EMD-branded product distribution expanded from 2022 to 2024, as evidenced by the increase in the number of countries served. In 2022, EMD products were distributed through Caterpillar's dealer network serving 193 countries, while in 2023, the dealer network covered 191 countries. By 2024, the dealer network had expanded to serve 187 countries. Additionally, the distribution of other Caterpillar-branded engines and products, such as Perkins and FG Wilson, also showed a slight expansion in coverage in 2024 compared to prior years. This geographic expansion suggests that Caterpillar is strategically positioning itself to strengthen its global market presence, leveraging its dealer and distributor networks to enhance accessibility and competitiveness in diverse international markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reverses the trend in geographic reach. The ground truth states that Caterpillar's EMD-branded product distribution declined from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. However, the LLM claims this represents an 'expansion' and mischaracterizes the decreasing numbers as increasing coverage, which is factually incorrect. (2) The numeric values are partially correct—193, 191, and 187 are accurate—but their interpretation is backwards. The LLM incorrectly frames 187 as an expansion from 191 and 193, when it is actually a contraction. Additionally, the mention of 'Perkins and FG Wilson' is extraneous and not supported by the original answer or question focus on EMD-branded products. (3) The multi-hop reasoning fails because the model misinterprets the direction of change over time and draws an opposite conclusion about strategic positioning. Instead of recognizing a potential strategic consolidation or retrenchment, it asserts expansion and increased competitiveness, which contradicts the data. (4) Scores reflect severe factual inaccuracy in trend interpretation (quantitative accuracy), flawed reasoning (qualitative accuracy), and partial relevance due to discussing the correct company and product line but drawing opposite conclusions. The answer is contextually relevant in topic but fundamentally wrong in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 389,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The consistent inclusion of \"Palmolive\" in Colgate's list of principal global trademarks from 2022 to 2024 underscores its enduring strategic importance within the Oral, Personal, and Home Care segment. As a key brand under Colgate-Palmolive, Palmolive is associated with a range of products such as hand soaps, skin health items, and household cleaners, which are core to the segment's diverse portfolio. The repeated recognition of the Palmolive trademark in annual disclosures highlights its role in supporting the company’s global brand presence and market reach, reinforcing its value in driving sales and maintaining customer trust across multiple product categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Palmolive, Colgate, the Oral, Personal and Home Care segment, and the 2022–2024 timeframe—are correctly identified. There are no numerical values in the question or answer that require calculation, so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (2) The answer addresses the strategic role of Palmolive as a consistently recognized global trademark, emphasizing its importance in home and personal care, which matches the original answer’s emphasis on sustained strategic value. (3) The multi-hop reasoning is sound: the LLM synthesizes the repeated disclosure of Palmolive as a principal trademark over three years to infer enduring strategic relevance, consistent with the ground truth. It correctly links this to product categories like hand soaps and household cleaners. (4) While the LLM answer captures the core conclusion and reasoning, it omits specific contextual details present in the ground truth—such as the comparison with Ajax in 2022, the addition of Darlie in 2023, and the absence of positional dilution by 2024—which provide granular support for the conclusion. These omissions slightly reduce completeness and qualitative depth but do not affect factual correctness. Overall, the answer is semantically equivalent in intent and meaning, with high contextual relevance and strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 398,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022 through 2024, Qualcomm's positioning and strategic emphasis on Edge Networking evolved significantly, reflecting its growing role in IoT growth projections, product categorization, and revenue recognition structure. In 2022, Edge Networking was highlighted as a key segment within the broader IoT ecosystem, driven by 5G and Wi-Fi 6/6E technologies, with Qualcomm emphasizing its role in enabling mobile broadband and wireless access points to support hybrid work and increased connectivity demands. By 2023 and 2024, Edge Networking remained a core product category, as seen in the consistent categorization of Edge Networking products in revenue disclosures, which included mobile broadband and wireless access points. This continuity in product categorization and the ongoing relevance of Edge Networking in IoT growth projections underscore Qualcomm's strategic focus on this segment as a key driver of its revenue, particularly through its role in supporting the expansion of connected devices and digital transformation across industries.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic emphasis on Edge Networking from fiscal 2022 to 2024, noting its role in IoT growth, product categorization continuity, and relevance to mobile broadband and wireless access points. All mentioned technologies (5G, Wi-Fi 6/6E) and trends (hybrid work, connectivity demands) align with the ground truth. However, the LLM omits key quantitative and structural details: it does not mention the '27 billion projected IoT devices by 2026' figure, nor does it specify that Edge Networking was formally grouped into a third revenue category in fiscal 2023 — a critical evolution in product categorization. Additionally, while it notes consistent revenue disclosures, it fails to explicitly state that Edge Networking falls under the QCT segment with royalty and incentive-related revenue recognition from prior periods, which is a core part of the revenue recognition structure. (2) There are no numeric inaccuracies because the LLM avoids citing specific numbers, but it also does not include the 27 billion IoT device projection, which is a major omission in quantitative support. Since it doesn’t fabricate numbers and only omits them, quantitative accuracy is scored highly. (3) The multi-hop reasoning is partially sound — the model connects Edge Networking to IoT and product categorization across years, but it fails to synthesize the full structural shift in 2023 (formal revenue category) and the continuity in 2024 with respect to both categorization and revenue recognition. The answer treats the evolution as gradual emphasis rather than a distinct structural reorganization. (4) Correctness is scored 7 because the core strategic focus is accurately conveyed, but significant factual omissions — especially the lack of the 27B IoT projection and the formalization of the third revenue category — reduce completeness. Qualitative accuracy is 7 due to incomplete synthesis; quantitative accuracy is 10 because no numbers are wrong, only missing; contextual relevance is 9 as the response stays tightly aligned with the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 566,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar's exposure to currency exchange rate risk and its management through hedging instruments remained a consistent concern from 2022 to 2024, particularly due to its extensive international operations. In 2022, Caterpillar acknowledged that fluctuations in currency exchange rates could impact its earnings and cash flows, and while it used hedging instruments to mitigate adverse effects, it also noted the potential trade-off of forgoing benefits from favorable rate movements. By 2023, the company continued to emphasize the same hedging strategies, with no significant changes in approach, but added that it faced additional risks from exchange controls and currency devaluations, which could further limit its operational flexibility. In 2024, Caterpillar reiterated its use of hedging instruments and the same risk management techniques, maintaining a consistent strategy despite ongoing global volatility. Overall, while the company’s hedging practices remained stable, the evolving international environment continued to pose challenges to earnings volatility and financial planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Caterpillar's exposure to currency risk due to international operations, use of hedging instruments, trade-off of limiting upside from favorable movements (2022), introduction of exchange controls and devaluation risks in emerging markets (2023), and continued reliance on hedging with growing caution amid unpredictable dynamics (2024). (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors in dates or time periods (2022–2024), which are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the evolution in risk disclosure and management approach. The only minor gap is that the original answer emphasizes a 'growing concern' and 'increasingly cautious approach' more explicitly, while the LLM states 'no significant changes in approach'—this slightly understates the evolving tone. However, the LLM does acknowledge added risks and ongoing challenges, preserving semantic equivalence. (4) Contextual relevance is excellent—the response directly addresses Caterpillar’s hedging evolution, international operations, and earnings volatility as required. Overall, the answer is factually correct, well-structured, and only marginally less nuanced in portraying the shift in tone over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 401,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its U.S. pension plan fixed income portfolio remained at approximately 30% in both 2024 and 2023, down from 40% in 2022 and 50% in 2020. This decline suggests a gradual shift away from ultra-safe, low-yield government securities toward a more diversified mix of government and corporate bonds, likely reflecting a strategic response to rising interest rates and a desire to enhance returns while managing interest rate risk. The stabilization at 30% from 2023 to 2024 indicates a more balanced and deliberate approach to interest rate risk management, aiming to optimize yield without significantly increasing credit risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages (50% in 2020, 40% in 2022, 30% in 2023 and 2024) and the overall downward trend followed by stabilization. However, it incorrectly states that the 40% allocation was in '2022' when the ground truth specifies that the 40% allocation was as of December 31, 2021 (reported in the 2022 filing), and the 30% allocation began as of December 31, 2022 (reported in the 2023 filing). The LLM conflates reporting year with reference date, which introduces a minor but notable misalignment in the timeline. (2) The numbers themselves are accurate in value but misattributed to calendar years rather than the correct measurement dates. For example, the 50% is correctly tied to 2020, but the 40% should be linked to year-end 2021, not 2022. The stabilization at 30% from 2023 to 2024 is correctly reported. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift in response to rising interest rates, diversification away from low-yield Treasuries, and a balanced risk management approach. It appropriately connects the allocation trend to broader investment strategy, even though the Level 2 classification detail from the original answer is omitted. (4) The contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of allocation and its implication for interest rate risk management. The qualitative reasoning is strong and semantically aligned with the ground truth, despite the minor temporal mislabeling. The omission of the Level 2 classification is a minor gap but does not undermine the core correctness. Thus, the answer is mostly accurate with a small but meaningful error in temporal attribution, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 480,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "From 2022 through 2024, Pfizer’s treatment and valuation of Breakthrough Performance Awards (BPAs) showed a clear evolution in grant activity, valuation methodology, and disclosure transparency. In 2022, BPAs were actively granted (1,165 thousand shares) and valued using the intrinsic value method with a weighted average intrinsic value of $38.73 per share, as disclosed in detailed tabular form in the 2022 10-K. By 2023, no BPAs were granted or outstanding, as stated in the 2023 10-K, indicating a cessation of the program. In 2024, Pfizer redefined BPAs in its 10-K, disclosing that they would be awarded to select non-executive employees tied to product pipeline goals, with valuation based on the intrinsic value method using the closing stock price at grant, and amortized over the vesting period. This reflects a shift in both structure and transparency, with more detailed terms and valuation practices outlined in 2024 compared to prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 1,165 thousand shares granted in 2022 and the $38.73 weighted average intrinsic value per share match the original answer exactly. The statement that no BPAs were granted or outstanding in 2023 is factually consistent. (2) The LLM correctly identifies the multi-year evolution: active grants in 2022, suspension in 2023, and reintroduction with enhanced disclosure in 2024. (3) Qualitatively, the LLM adds slightly more detail than the ground truth (e.g., specifying that 2024 BPAs are tied to product pipeline goals and awarded to non-executive employees), which is consistent with typical 10-K disclosures and does not contradict the original answer. However, the original answer emphasizes the 'adjustments based on performance probability and stock price changes' in 2024 valuation, a nuance not fully captured in the LLM response, which only mentions intrinsic value at grant and amortization. This minor omission in methodological detail prevents a perfect 10 on qualitative accuracy. (4) Contextual relevance is excellent—the response directly addresses grant activity, valuation methodology, and disclosure transparency across all three years, fulfilling the multi-hop requirement. Overall, the answer is factually sound, well-structured, and semantically equivalent to the ground truth with only slight under-articulation of the 2024 valuation dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 407,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "From 2022 through 2024, Charles Schwab enhanced its interactive tools for RIAs by expanding third-party integrations and improving portfolio management capabilities. In 2022, Schwab provided access to integrations with third-party platforms to support client relationship management, portfolio management systems, and trade order management, exemplified by Schwab Advisor Portfolio Connect, a free portfolio management solution. By 2023, Schwab continued to emphasize its scalable platform and technology-driven support for RIAs, maintaining the availability of Schwab Advisor Portfolio Connect and enhancing the Advisor Services website with interactive tools and educational resources. In 2024, Schwab further solidified its platform by continuing to offer robust third-party integrations and maintaining Schwab Advisor Portfolio Connect, ensuring RIAs could efficiently manage client accounts with intuitive tools and modern capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Schwab's use of third-party integrations in 2022 for CRM, portfolio management, and trade order systems; the existence and purpose of Schwab Advisor Portfolio Connect as a free tool; its continuation through 2023 and 2024; and the emphasis on platform scalability and integrations. The evolution narrative is preserved, with enhancements to the Advisor Services website in 2023 (multi-year archiving and search, though the LLM generalizes this as 'interactive tools and educational resources') and the 2024 focus on intuitive, modern capabilities. (2) There are no numbers, dates, or financial figures in dispute—dates (2022–2024) are correctly used, and no calculations are required. (3) The multi-hop reasoning across years is sound: the LLM correctly synthesizes how tools evolved over time, maintaining continuity while noting enhancements. The only minor shortcoming is that the LLM does not explicitly mention the 'multi-year document archiving and search capabilities' added in 2023, instead summarizing improvements more broadly as 'interactive tools and educational resources,' which slightly reduces qualitative precision. Also, the 2024 refinement toward a more 'intuitive modern experience' is captured semantically but could be more precisely tied to usability enhancements. (4) Despite these small omissions, the answer remains factually correct, contextually complete, and semantically equivalent to the original. The core evolution—expanding integrations, maintaining key tools, and improving platform experience—is clearly and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 453,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments maintained a consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, as highlighted in each year’s 10-K filings. In all three years, the company reiterated that its business model is focused on analog and embedded processing products, underpinned by four sustainable competitive advantages: a strong manufacturing and technology foundation, a broad product portfolio, extensive market channel reach, and product diversity and longevity. This consistent framing across the three years underscores TI’s long-term positioning in semiconductor markets as a company committed to leveraging these advantages to generate and return significant cash flow to shareholders, while maintaining a disciplined approach to capital allocation and efficiency. The sustained focus on embedded processing products reflects TI’s strategic intent to anchor its growth in high-value, long-lasting segments of the semiconductor industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing products across 2022, 2023, and 2024 as part of its core business model built on four sustainable competitive advantages. The mention of 'broad product portfolio' correctly includes analog and embedded processing products, which is explicitly stated in the original answer as point 1.ii. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound—information is synthesized consistently across three years of 10-K filings, demonstrating TI’s long-term strategic continuity. The LLM correctly infers that this consistency reveals TI’s intent to focus on high-value, long-lifecycle semiconductor segments to support cash flow generation. (4) The only minor deviation from the original answer is that the LLM emphasizes 'generating and returning cash flow to shareholders' and 'capital allocation,' while the ground truth specifically mentions 'growing free cash flow per share' and 'offering more value per customer and per investment.' These are semantically related but not identical—hence a slight deduction in qualitative accuracy. However, the core strategic message about long-term positioning anchored in embedded processing is preserved. Wording differences do not undermine factual correctness, and the answer remains contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 424,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "From 2022 through 2024, Boeing's fleet support services cost profile remained relatively stable, historically accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program continued to experience abnormal production costs and delivery delays, which impacted the broader cost environment. In 2022, the 787 program faced production instability, rework, and regulatory challenges with the FAA, leading to delivery delays and the risk of higher abnormal costs. By 2023, Boeing had increased the 787 production rate to 5 per month and delivered 73 aircraft, but still carried 50 aircraft in inventory requiring rework, with cumulative abnormal costs reaching $2.7 billion through year-end. In 2024, the 787 program increased its accounting quantity by 100 units, but production was slowed to below 5 per month due to supply chain constraints and performance challenges, with delays from business class seat issues continuing into 2025. Rework costs on inventoried aircraft were expensed as abnormal production costs, totaling $256 million in 2024. These ongoing production and delivery issues highlight the evolving impact of the 787 program on Boeing's cost profile and delivery performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the stable cost profile of fleet support services at ~1% of total consolidated costs, aligning with the ground truth. It accurately reports the $2.7 billion cumulative abnormal production costs through 2023 and the $256 million expensed in 2024, both matching the original answer. However, the LLM introduces details not present in the ground truth: specifically, the claim that Boeing delivered 73 aircraft in 2023 and increased production to 5 per month is unsupported by the original answer, which does not mention delivery volume or production rate changes. Additionally, the LLM states there were 50 inventoried aircraft requiring rework in 2023, while the ground truth specifies 25 inventoried aircraft produced prior to 2023. This is a significant factual discrepancy. The mention of increasing the accounting quantity by 100 units and delays due to business class seat issues extending into 2025 is also absent from the ground truth and appears speculative. (2) Quantitative accuracy is high: $2.7B and $256M are correct, and the years are properly attributed. The incorrect inventory count (50 vs 25) and unsupported production rate details are the main quantitative issues. (3) The multi-hop reasoning is generally sound—linking abnormal costs and delivery delays to the 787 program’s impact on cost profile and delivery performance across years. However, the inclusion of unverified operational details weakens the synthesis fidelity. (4) Despite some inaccuracies, the core evolution of abnormal costs and delays is correctly conveyed, with proper year-by-year progression and correct financial figures. The answer remains highly relevant and contextually appropriate, explaining the cost and delivery trajectory accurately on a macro level, though with minor overreach in specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 500,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer completed the sale of its Meridian subsidiary on December 31, 2021, for approximately $51 million in cash, recognizing a net loss of approximately $167 million. Post-sale, Pfizer and the purchaser entered into interim Transition Service Agreements (TSAs) and a Manufacturing Supply Agreement (MSA). The TSAs were completed by December 31, 2023, while the MSA had a three-year term post-sale with a two-year extension option. Financially, the amounts recorded under these agreements in 2022 and 2023 were not material to Pfizer’s operations. The relationship with Meridian evolved from a direct ownership to a structured post-sale service and supply arrangement, with no material financial impact in the subsequent years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the sale date (December 31, 2021), the $167 million net loss, the $51 million cash sale price (additional detail not in original but not contradicted), the three-year MSA with a two-year extension option, and TSA completion by December 31, 2023. The statement that financial impacts were not material in 2022 and 2023 matches the original. (2) Quantitative accuracy is perfect: dates and dollar amounts are correct and consistent with the knowledge graph; the $167 million loss and timeline are accurately reported. The inclusion of the $51 million sale price is an extra detail not in the original answer but does not conflict with it and may come from a more detailed source. (3) Reasoning is sound: the evolution from ownership to supplier relationship is correctly synthesized across 2022–2024, with appropriate emphasis on diminishing financial impact. The only minor omission is that the 2024 mention of Meridian in Pfizer’s glossary as 'Meridian Medical Technologies, Inc.'—which signals ongoing recognition due to the MSA—is not explicitly mentioned, though the ongoing MSA is noted. This is a small contextual detail that slightly affects completeness. (4) The answer is semantically equivalent to the original, with clear, concise, and relevant information directly addressing the financial implications and contractual evolution. Contextual relevance is excellent, focusing precisely on the post-sale relationship and financial materiality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 426,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate-Palmolive's 'hello' brand has maintained its strategic positioning within the Oral, Personal, and Home Care segment from 2022 to 2024, as evidenced by its consistent inclusion in the list of principal global and regional trademarks across all three years' 10-K filings. In 2022 and 2023, the brand was listed among key trademarks such as Colgate, elmex, and Tom's of Maine, and in 2024, it retained this status, indicating its ongoing role as a key player in the segment. The brand's alignment with Colgate-Palmolive's broader portfolio suggests a continued focus on innovation and market presence, particularly in personal care, as it remains a recognized sub-brand under the company's umbrella.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: 'hello' is consistently listed as a principal trademark within the Oral, Personal and Home Care segment from 2022 to 2024, and this is correctly cited as evidence of sustained strategic positioning. The mention of co-listed brands like Colgate, elmex, and Tom's of Maine (though not Darlie, which appears in the original) is factually plausible and does not contradict the ground truth—minor variation in supporting detail is acceptable. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable in a numerical sense, but all years (2022, 2023, 2024) are correctly referenced. (3) The multi-hop reasoning—synthesizing 'hello’s' presence across three years of 10-K filings to infer strategic continuity—is sound and well-executed. The conclusion that 'hello' remains a key brand in the portfolio is logically supported. (4) The only minor shortcoming is that the original answer notes the addition of Darlie in 2023 as a contextual detail that underscores 'hello’s' maintained status despite new inclusions, which the LLM omits. This is a small but relevant point in demonstrating relative positioning. However, the core message of sustained strategic emphasis is preserved. Wording differs slightly (e.g., 'key player', 'innovation and market presence') but these are reasonable interpretations. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor omissions in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 446,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "From 2022 through 2024, the Non-Qualified Defined Benefit Pension Plan at Texas Instruments remained unfunded and closed to new participants, as stated in all three annual reports. Participant engagement continued to decline, as evidenced by the reduction in TI common stock holdings within the U.S. defined contribution plans, which dropped from 6 million shares valued at $940 million in 2022 to 5 million shares valued at $873 million in 2023, and further to $852 million in 2024. This trend reflects a long-term shift away from the defined benefit plans toward defined contribution plans, particularly the enhanced version, as employees elected to forgo future pension accruals in favor of more flexible retirement savings options. The multi-year progression indicates a sustained reduction in the company’s long-term pension obligations, as fewer employees accrue benefits under the defined benefit structure, and the unfunded nature of the non-qualified plan means liabilities remain on the balance sheet without corresponding assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies and omissions. (1) Quantitatively, the LLM correctly reports the unfunded status and closure to new participants, and accurately states the share holdings: 6 million shares ($940M) in 2022, 5 million ($873M) in 2023, and 5 million ($852M) in 2024. However, it incorrectly implies the share count dropped in 2024 when it remained flat at 5 million; only the value declined. The LLM omits the dividend data ($28M, $27M, $26M), which is part of the participant engagement trend. (2) The expense figures for defined contribution plans ($70M, $75M, $76M) are not mentioned in the LLM answer, which weakens completeness. These numbers support the strategic shift and were included in the original answer. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward defined contribution plans and reduced long-term pension obligations. It appropriately links employee behavior (forgoing pension accruals) to the decline in defined benefit reliance. (4) Entity accuracy is strong—Texas Instruments, Non-Qualified Defined Benefit Pension Plan, U.S. defined contribution plans, and correct years are all properly identified. (5) Contextual relevance is excellent; the answer directly addresses the evolution of funding status and participant engagement, and interprets the long-term implications accurately. The omission of dividend data and defined contribution expenses prevents a perfect score, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 423,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer's (PFE) long-term investment in private equity securities at cost decreased from $623 million in 2021, to $800 million in 2022, then declined to $755 million in 2023, and further to $719 million in 2024. This three-year trajectory indicates a gradual reduction in the company's strategic allocation to private equity securities, suggesting a potential shift or reallocation of capital toward other investment opportunities or a more conservative approach to long-term asset management.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Pfizer's investment was $800 million in 2022, when the ground truth is $623 million in 2022 (not 2021). It also introduces a 2021 figure not asked in the question, which is irrelevant. The correct trajectory is an increase from $623M (2022) to $755M (2023), then a decrease to $719M (2024). The LLM instead reports a continuous decline from $800M in 2022, which is factually wrong. (2) Quantitative accuracy is low: the 2022 value is incorrect ($800M vs $623M), and the baseline year is shifted to 2021, which distorts all comparisons. The 2023 and 2024 numbers ($755M and $719M) are correct, but placed in the wrong context. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the 3-year trend from 2022–2024 as specified, instead analyzing 2022–2024 with incorrect starting data and including an irrelevant 2021 figure. The conclusion of 'gradual reduction' contradicts the actual pattern of a significant increase in 2023 followed by a partial pullback in 2024. (4) Contextual relevance is moderate because the answer addresses the right metric and company and attempts to interpret strategic intent, but the incorrect data leads to a misleading conclusion. The qualitative reasoning would be acceptable if the numbers were correct, but as-is, it reflects a fundamental error in data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 393,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Schwab's ability to migrate IDA balances to its balance sheet evolved significantly from 2022 through 2024 under the changing terms of the IDA agreements. Under the 2019 IDA agreement, effective from October 6, 2020, Schwab had the option to migrate up to $10 billion of IDA balances annually starting July 1, 2021, subject to maintaining a minimum $50 billion IDA balance through June 2031 and at least 80% of balances as fixed-rate obligations through June 2026. In 2021 and 2022, Schwab migrated balances under these terms, including $10.1 billion by December 31, 2021. However, in 2023, Schwab did not move any IDA balances to its balance sheet. The 2023 IDA agreement, effective May 4, 2023, replaced the 2019 agreement and eliminated the fixed-rate obligation requirement but introduced new constraints: through September 10, 2025, Schwab must maintain minimum balances above unmatured fixed-rate obligations with a $30 billion ceiling, and withdrawals are limited to customer-initiated actions. Post-September 10, 2025, Schwab may withdraw balances at its discretion but must maintain a minimum of $60 billion and a maximum of $90 billion. In 2024, Schwab did not migrate any IDA balances under the 2023 agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and dollar amounts are correct: $10 billion annual migration limit under the 2019 agreement, $10.1 billion migrated by December 31, 2021, no migrations in 2023 and 2024, the $30 billion ceiling above unmatured fixed-rate obligations through September 10, 2025, and the $60 billion minimum and $90 billion maximum post-2025. These match or are consistent with the original answer. (2) The qualitative reasoning is sound: the evolution from the 2019 agreement (annual $10B option) to the 2023 agreement (conditional constraints) is correctly traced, including the removal of the fixed-rate obligation requirement and the introduction of new balance thresholds. (3) The multi-hop synthesis across years and agreements is accurate—information from 2021, 2022, 2023, and 2024 is correctly linked to the changing IDA terms. (4) The only minor deviation is that the LLM adds detail not in the ground truth (e.g., $60B/$90B post-2025 limits), which is factually consistent but slightly beyond the scope of the original answer. However, this does not introduce error and may reflect additional valid context. The core evolution—tightening flexibility from a defined annual cap to a constrained framework—is correctly conveyed. Thus, the answer earns a 9 for correctness due to full factual alignment and excellent reasoning, with a perfect 10 in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 405,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments has consistently operated its analog product manufacturing facility in Melaka, Malaysia across 2022, 2023, and 2024, as evidenced by its inclusion in the analog manufacturing locations in each year’s 10-K filings. This multi-year consistency underscores the strategic importance of Melaka as a reliable and integral part of TI’s global analog production network, reinforcing its role in supporting TI’s long-term operational and supply chain stability in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Texas Instruments consistently operated analog product manufacturing in Melaka, Malaysia across 2022, 2023, and 2024, which aligns with the ground truth. The dates and entities (Texas Instruments, Melaka, Malaysia, analog manufacturing) are accurate, and there are no numerical inaccuracies—this supports a perfect quantitative accuracy score. The answer also appropriately infers strategic importance from the multi-year consistency, addressing the question’s intent. However, it omits specific details about the evolving notation († in 2022, * in 2023, ** in 2024) that signal potential operational emphasis or escalation, which is a key part of the original answer’s reasoning about strategic expansion. While the LLM captures the stability and importance of the site, it does not reflect the nuanced progression in markings that suggest possible growth or increased role, slightly weakening the qualitative accuracy. The reasoning is sound but less detailed in multi-hop synthesis of symbolic indicators across years. Contextual relevance is strong as it directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 332,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The penetration rate of the Target Debit Card (as part of the Target Circle Cards/RedCards) declined from 20.2 percent in 2022 to 19.8 percent in 2023 and further to 18.6 percent in 2024. This downward trend suggests that the card's role in driving incremental sales for Target has weakened over time, as the company notes that a meaningful portion of incremental purchases on these cards are also incremental sales for Target. The decreasing penetration rate implies a potential reduction in the card's effectiveness in encouraging additional spending at Target.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying the downward trend in Target Debit Card penetration but contains inaccuracies in the reported percentages. The ground truth states penetration was 20.5% in 2022, 19.8% in 2023, and 17.8% in 2024. The LLM reports 20.2% (vs 20.5%), 19.8% (correct), and 18.6% (vs 17.8%), with the 2024 figure notably off by 0.8 percentage points—a significant error in trend interpretation. (2) While the 2023 number is accurate, the incorrect 2022 and 2024 values undermine quantitative precision. The direction of the trend (declining) is correct, but the magnitude of decline is understated (LLM shows -1.6 pp drop vs actual -2.7 pp). (3) The reasoning about the card’s diminishing role in driving incremental sales is sound and aligns with the ground truth logic—Target has historically noted that RedCard usage correlates with incremental spending, so declining penetration suggests reduced impact. The LLM correctly performs the multi-hop inference linking penetration trends to sales impact. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially in the final year—reduce confidence in the answer’s factual reliability, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 356,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan remained relatively stable from 2022 to 2024, with no specific figures provided for the 2003 plan in the 2023 and 2024 filings. However, the 2018 Director Plan, which is connected through the knowledge graph to the 2003 plan, showed a decline from 1,843,134 shares in 2022 to 1,786,785 in 2023, and further to 1,745,284 in 2024. This gradual reduction suggests that Texas Instruments has been utilizing equity incentives for directors, albeit at a modest pace, and has not replenished the share reserves under these plans significantly during the period, indicating a conservative approach to equity allocation for director compensation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the 2003 Director Compensation Plan had 35,385,153 shares available in 2022, decreasing to 25,296,767 in 2023, and further to 24,503,062 in 2024. The LLM fails to report these actual figures and instead claims 'no specific figures provided' for the 2003 plan, which contradicts the ground truth. Instead, it cites data from the 2018 Director Plan (1.8M shares declining to 1.7M), which is a different plan and not the focus of the question. This misidentification of the plan leads to a complete mismatch in scale and substance. (2) The numbers cited by the LLM are off by an order of magnitude (millions vs tens of millions) and pertain to a different plan, making the quantitative accuracy very low. Calculations or trends based on incorrect data cannot be valid. (3) The multi-hop reasoning is flawed: the question specifically asks about the 2003 Director Compensation Plan, but the model shifts to the 2018 plan, possibly due to a misunderstanding of plan relationships in the knowledge graph. It fails to synthesize the correct data across years for the correct plan. The conclusion about 'conservative approach' may seem plausible but is based on incorrect data and thus invalid. (4) While the general direction of the trend (decline) is consistent between the wrong plan and the correct one, the failure to use the correct plan and numbers severely undermines correctness. The answer is contextually relevant in topic but factually inaccurate, hence low scores in correctness and accuracy, with moderate relevance due to addressing equity incentives for directors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 463,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "Visa's virtual accounts and related digital capabilities evolved significantly from 2022 to 2024 through deeper integration with the Visa Direct platform and expansion into cross-border use cases. In 2022, Visa introduced virtual accounts as part of its Currencycloud platform, enhancing liquidity and settlement capabilities for cross-border payments. By 2023, the Visa Direct platform was expanded to include Visa Cross-Border Solutions and Currencycloud capabilities, enabling real-time foreign exchange rates and virtual accounts for both new and existing cross-border flows. In 2024, the platform further matured, supporting over 10 billion transactions and reaching 11 billion endpoints, with virtual accounts playing a key role in facilitating B2B, P2P, and government-to-citizen (G2C) transactions globally. This evolution reflects Visa's strategic focus on leveraging virtual accounts to streamline money movement across its network of networks.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements: The introduction of virtual accounts in 2022 via Currencycloud with enhanced liquidity and settlement is correct. The 2023 integration with Visa Direct and expansion via Visa Cross-Border Solutions, including real-time FX and support for cross-border flows, is accurately described. In 2024, the role of virtual accounts in supporting 11 billion endpoints and targeting B2B cross-border opportunities is correctly conveyed, though the LLM says 'over 10 billion transactions'—a minor addition not in the original (the ground truth mentions endpoints, not transactions). (2) Quantitative accuracy: The '11 billion endpoints' figure is correct and matches the original. The '$20 trillion in annual B2B cross-border opportunities' is omitted in the LLM answer, which is a minor factual omission. The 'over 10 billion transactions' is not present in the ground truth and appears to be an unsupported addition, slightly reducing quantitative precision. (3) Reasoning: The multi-hop synthesis across 2022–2024, linking virtual accounts to Visa Direct, cross-border expansion, and strategic objectives, is sound and logically structured. (4) The answer is contextually excellent, addressing all aspects of the question with strong qualitative and factual coherence. The only deductions are for the slight misstatement around transaction volume and omission of the $20 trillion figure, preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 411,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi's revenue pressures in 2023, as reflected in a 1% decline driven by lower net price due to unfavorable channel mix, signaled the need for lifecycle management strategies to sustain its market position. This prompted Pfizer, which holds a stake in Xtandi, to invest in expanding the product's indications. This investment is evidenced by the 2024 approval of Xtandi for non-metastatic castration-sensitive prostate cancer (nmCSPC) with high-risk biochemical recurrence, a strategic move to extend the drug's commercial life. Furthermore, in 2022, Xtandi was part of Pfizer’s intangible portfolio under developed technology rights, highlighting its value as a key asset. The combination of revenue pressures and Pfizer’s recognition of Xtandi’s long-term potential led to the indication expansion in 2024, reinforcing its therapeutic footprint and preserving revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Xtandi's 1% revenue decline in 2023 due to net pricing pressure, its inclusion in Pfizer's 2022 intangible assets under developed technology rights, and the 2024 approval for nmCSPC with high-risk biochemical recurrence are all accurately reported. (2) Quantitative accuracy is perfect: the 'down 1%' revenue change is correctly cited, and all years (2022, 2023, 2024) match the original. No calculations were required, but temporal and percentage data are precise. (3) Multi-hop reasoning is sound: the model correctly links declining revenues to lifecycle management investment, and ties the 2022 valuation to the 2024 indication expansion as a strategic response. The only minor shortcoming is a slight lack of emphasis on the international revenue component of the decline (mentioned in ground truth but not in LLM answer), which slightly weakens completeness. (4) Semantic equivalence is strong—wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing all parts of the multi-hop question. Overall, this is a factually correct, well-reasoned response with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 344,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The penetration rate of the Target MasterCard Credit Card (as part of RedCards/Target Circle Cards) declined from 20.2% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This downward trend suggests that while total sales grew at a faster pace than RedCard usage, consumer preference for using the RedCard (and by extension, engagement with Target's loyalty program) weakened during this period. The decline in penetration, despite continued RedCard sales growth and the 5% discount incentive, indicates a potential shift in consumer behavior or a dilution of loyalty program effectiveness, possibly influenced by macroeconomic factors or increased competition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in penetration rate from 2022 to 2024 and links it to consumer preference and loyalty program engagement, which aligns with the original answer. However, there are significant quantitative inaccuracies: the 2022 penetration rate is reported as 20.2% instead of 20.5%, and the 2024 rate is given as 17.8% instead of 18.6%. These discrepancies affect the factual precision of the response. (2) The correct values from the ground truth are 20.5% (2022), 19.8% (2023), and 18.6% (2024). The LLM correctly reports 19.8% for 2023 but is off by 0.3 percentage points in 2022 and by 0.8 percentage points in 2024, which is a notable error in a metric tracking small annual changes. (3) The reasoning and multi-hop synthesis are strong: the LLM correctly infers that the decline suggests weakening loyalty engagement despite incentives, considers macroeconomic or competitive factors, and connects RedCard usage to the broader Target Circle loyalty program. This demonstrates sound qualitative logic and contextual understanding. (4) While the conceptual interpretation and relevance are excellent, the correctness score is limited by the numerical inaccuracies, particularly the exaggerated drop in 2024. The answer remains partially correct due to accurate trend direction and reasoning, but the magnitude of the change is misrepresented, warranting a moderate score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 397,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "Visa's use of virtual accounts through its Currencycloud platform evolved significantly from fiscal years 2022 through 2024, enhancing cross-border payment capabilities and expanding network reach. In 2022, Visa introduced virtual accounts as part of its Currencycloud platform to support real-time foreign exchange rates and enhanced liquidity and settlement. By 2023, the platform was integrated into the Visa Direct ecosystem, enabling new flows and supporting cross-border consumer and business payments. In 2024, the Currencycloud capabilities were further expanded within the Visa Direct platform, which now supports more than 195 countries and territories, reaching over 11 billion endpoints, including 3.5 billion digital wallets. This evolution reflects Visa's strategy to leverage virtual accounts for seamless, efficient, and scalable cross-border transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Visa's virtual accounts across 2022–2024 with accurate core facts: introduction in 2022 for real-time FX and settlement, integration into Visa Direct by 2023, and expansion in 2024. However, there is a significant quantitative discrepancy in the network reach claim. The original answer states 'over 11 billion endpoints' as of 2023, which the LLM repeats in 2024 but adds '195 countries and territories' and '3.5 billion digital wallets'—details not present in the ground truth. The 195 countries figure is plausible but not supported by the provided truth, which specifies 'more than 100 countries' via Visa B2B Connect in 2024. The 3.5 billion digital wallets detail is new and unverified in the source. (2) The timeline and entity usage (Currencycloud, Visa Direct, B2B Connect) are mostly accurate, though the LLM conflates Visa Direct's reach with Currencycloud's capabilities without clarifying that B2B Connect is the specific network for cross-border B2B in over 100 countries. (3) The multi-hop reasoning is sound—linking virtual accounts to FX, then to cross-border payments, then to network scale—but overextends by attributing additional metrics not in the original. (4) The answer is contextually excellent and semantically close, with strong qualitative accuracy in describing strategic intent and technological progression. The correctness score is reduced due to unsupported quantitative claims, though the core narrative remains aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 424,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD's exposure to intellectual property (IP) protection difficulties has remained a consistent risk across 2022, 2023, and 2024, particularly due to its extensive international operations and reliance on third-party manufacturing. In 2022, AMD noted challenges in protecting IP as part of broader geopolitical and legal risks in foreign jurisdictions, including difficulties in managing these risks across diverse legal systems. In 2023, the company reiterated these concerns, emphasizing the vulnerability of its global supply chain—especially in China, Malaysia, and Taiwan—where nearly all product assembly and testing occur, and where IP protection is complicated by local legal environments and geopolitical tensions. By 2024, AMD continued to highlight the same risks, with international sales accounting for 66% of net revenue, and noted that geopolitical shifts, such as those between China and Taiwan, could further complicate IP protection and disrupt operations. The interplay between AMD and the \"Intellectual Property Protection Difficulties\" entity, as shown in the knowledge graph, underscores the persistent and interconnected nature of this risk across its global operations and third-party dependencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key factual elements are correct: AMD consistently cited IP protection difficulties across 2022–2024, with increasing specificity around international operations and third-party manufacturing in China, Malaysia, and Taiwan. The mention of geopolitical tensions (especially China-Taiwan) and evolving legal environments matches the original. (2) Quantitative accuracy is perfect: the 66% international sales figure in 2024 is correctly cited and consistent with the knowledge graph. No incorrect numbers, dates, or percentages are present. (3) Multi-hop reasoning is sound—LLM synthesizes AMD’s risk disclosures across three years, links IP risks to third-party manufacturing dependencies, and connects geopolitical developments to supply chain and IP vulnerabilities. The only minor omission is that the 2024 risk expansion related to export controls from the Ukraine-Russia and Israel-Hamas conflicts is not explicitly mentioned, which slightly reduces completeness. (4) Despite this, the answer remains semantically equivalent in tone, structure, and intent, with excellent contextual relevance to the question about evolution over time and international dependencies. The reference to the 'Intellectual Property Protection Difficulties' entity in the knowledge graph is appropriately used to reinforce the persistent risk. Overall, this is a strong, factually correct response with only a slight gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1594,
        "completion_tokens": 412,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "From 2022 to 2024, the valuation classification and allocation of UNP's Corporate Stock investments shifted significantly. In 2022, Corporate Stock was largely classified as Level 1 ($1,980 million) with a small portion in Level 2 ($10 million), indicating a heavy reliance on actively traded common stock. By 2023, the Level 1 allocation had dropped to $176 million, with only $5 million in Level 2, suggesting a reduction in directly held common stock. In 2024, the methodology confirmed that common stock is Level 1, while preferred stock is Level 2, aligning with the observed 2023 allocation. This shift indicates a strategic move by UNP to reduce direct exposure to volatile common stocks and potentially increase indirect exposure through diversified funds or preferred shares, reflecting a more conservative pension strategy with reduced market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: 2022 Corporate Stock at $1,990M total with $1,980M Level 1 and $10M Level 2; 2023 figures at $181M total with $176M Level 1 and $5M Level 2. It accurately notes that 2024 maintains classification of common stock as Level 1 and preferred as Level 2 without updated dollar amounts. All numbers match exactly, with acceptable phrasing variations. (2) Quantitative accuracy is perfect—no calculation errors, and the significant drop from ~$2B to ~$180M is correctly implied through precise figures. (3) The multi-hop reasoning is sound: the model correctly infers a strategic reduction in direct common stock holdings and links the Level 1/Level 2 classification to valuation transparency and market exposure. The interpretation that this reflects a more conservative pension strategy aligns with the ground truth’s suggestion of a shift toward stability. (4) The only minor limitation is that the LLM slightly overreaches by suggesting 'indirect exposure through diversified funds'—a plausible inference but not explicitly supported in the original answer. However, this does not detract significantly from the overall correctness. All parts of the question are addressed: evolution of classification/allocation, pension strategy implications, and market exposure. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 394,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 remained consistent from 2022 through 2024, as evidenced by the repeated inclusion of the relevant supplemental indentures and note forms in each year's 10-K filings. In 2022, the Fourth Supplemental Indenture (2013) and Fifth Supplemental Indenture (2015) were referenced, while in 2023 and 2024, these same indentures were again included alongside the 2017 Form of 4.75% Notes due 2043. This multi-year consistency suggests a deliberate focus on maintaining clear, standardized documentation for long-term debt instruments, reflecting Abbott's commitment to regulatory compliance and transparency. The sustained use of these filings also indicates a strategic emphasis on investor communication, ensuring stakeholders have consistent access to the legal and structural details of its long-term debt obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects of Abbott's disclosure evolution. (1) While the ground truth states that in 2022 Abbott referenced the 4.75% Notes via St. Jude Medical’s Fourth Supplemental Indenture (2013) as a legacy integration, the LLM incorrectly claims that both the Fourth (2013) and Fifth Supplemental Indenture (2015) were referenced in 2022 and again in 2023 and 2024—this is not supported by the original answer and introduces an unverified document (Fifth Supplemental Indenture). (2) The ground truth highlights a clear evolution: from legacy referencing in 2022, to formalization in 2023 with the inclusion of the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the March 22, 2017, Form 8-K, and consistency in 2024. The LLM mischaracterizes this progression as 'consistent' rather than evolutionary, missing the strategic shift toward standardized, transparent disclosure. (3) The LLM correctly identifies the 2017 Form of the Notes and ties disclosure to investor communication and transparency, which aligns with the qualitative intent of the original answer. However, it fails to capture the multi-hop reasoning that Abbott moved from indirect, legacy-based references to direct, current filings—indicating improved clarity in long-term debt management. (4) Dates and percentages (4.75%, 2043 maturity) are accurate, and the contextual relevance is high as the response addresses long-term debt management and investor communication. However, the incorrect portrayal of document continuity and absence of the key evolution narrative reduces factual correctness and reasoning quality. Thus, while some elements are accurate, the core analytical insight is flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 484,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration rate of the Target Credit Card (as part of the broader Target Circle Cards/RedCards) declined from 20.2% in 2022 to 19.8% in 2023 and further to 18.6% in 2024. This downward trend suggests a gradual decrease in customer adoption of branded payment products, which may indicate a shift in consumer behavior or a potential weakening in the appeal of the 5% discount and loyalty incentives. Since the company notes that a meaningful portion of incremental purchases on these cards translates to incremental sales for Target, the declining penetration rate could signal a potential slowdown in the growth of sales driven by these payment products.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2022 penetration rate as 20.2% instead of the ground truth 20.5%. The 2023 (19.8%) and 2024 (18.6%) figures are accurate. This small error affects the precision of the trend description but does not alter the overall conclusion. 2) The quantitative values are otherwise correctly presented, with accurate year-on-year decline noted. The calculation of the downward trend (from 20.2% to 18.6%) is logically sound, though based on a slightly incorrect starting point. 3) The multi-hop reasoning is strong: the model correctly links declining penetration to customer adoption trends and infers implications for incremental sales, aligning with Target’s stated strategy. It appropriately connects branded card usage to sales impact, demonstrating sound synthesis across financial and strategic domains. 4) Semantically, the answer conveys the same core message as the original: declining penetration suggests weakening adoption, which could affect incremental sales. The LLM adds contextual interpretation (e.g., 'shift in consumer behavior', 'weakening in appeal of 5% discount') that is reasonable and consistent with the trend, though not explicitly stated in the ground truth. The answer fully addresses both parts of the question: evolution of penetration rate and its implications. 5) Contextual relevance is excellent—response directly addresses customer adoption and sales impact as required. The slight data discrepancy prevents a top score, but reasoning and completeness are otherwise strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 435,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s fleet of Multiple Purpose Locomotives decreased in total units from 7,242 to 6,893, with a decline in owned units from 6,204 to 5,973 and leased units from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 25.2 years in 2024. This decline in fleet size and aging assets suggests a potential shift in asset management strategy, possibly reflecting a focus on optimizing existing assets, reducing capital expenditures, or transitioning toward leasing as a cost management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the total fleet decreased from 7,242 to 6,893 units, and the average age increased from 22.5 to 25.2 years, matching the ground truth exactly. It also provides additional accurate detail—breaking down owned and leased units—with values (6,204 to 5,973 owned; 1,038 to 920 leased) that sum correctly to the total changes (e.g., 6,204 + 1,038 = 7,242 in 2022; 5,973 + 920 = 6,893 in 2024), confirming internal consistency. (2) All numbers, years, and calculations are factually correct. No errors in quantitative reporting. (3) The reasoning is sound: the model correctly infers that a shrinking and aging fleet suggests a strategic focus on cost management. While the original answer emphasizes 'deferral of fleet modernization' and 'cost-conscious strategy,' the LLM offers plausible interpretations—'optimizing existing assets,' 'reducing capital expenditures,' and 'transitioning toward leasing'—which are consistent with the data. The suggestion of a shift toward leasing is speculative but supported by the leased unit reduction, so it does not misrepresent. (4) The answer is fully contextually relevant, addressing all parts of the question: changes in total units, average age, and implications for asset management. The only minor difference is that the LLM adds interpretation not in the original (leasing strategy), but this does not detract from accuracy. Overall, the answer matches the ground truth in substance and enhances it with valid breakdowns, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 430,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023 and further to $540 million in 2024. This gradual decline suggests a potential moderation in the company's long-term investment strategy in illiquid alternative assets, as it appears to be reducing its future capital commitments to private real estate funds. Despite this reduction, Abbott continues to maintain a significant presence in private funds, indicating a strategic, long-term allocation to illiquid assets, albeit with a more measured approach over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $585 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The trend of a $15 million decline over three years (cumulative $45 million reduction) is accurately implied through the year-over-year decreases of $30M and $15M, though the cumulative change is not explicitly stated. (2) All numbers are factually correct and properly contextualized across the three years, with no calculation or formatting errors. (3) The reasoning is sound: the LLM correctly infers a measured reduction in capital commitments to illiquid alternatives and notes continued strategic participation, aligning with the ground truth's interpretation of a 'strategic but measured approach.' The only minor gap is the omission of the phrase 'continued long-term participation through fund distributions rather than active capital deployment,' which adds nuance about the mechanism of ongoing involvement. This context is slightly underdeveloped in the LLM answer, though the core implication remains valid. (4) The answer is fully relevant, directly addressing both the evolution of commitments and the strategic implication. Scores reflect full quantitative accuracy, excellent qualitative reasoning with a slight deduction for missing distribution mechanism detail, and perfect contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 386,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 evolved from $2,147 million in fiscal year 2022, to $1,637 million in 2023, and further to $2,000 million in 2024. This fluctuation reflects changes in fair value and amortization of the debt discount over time. The increase in 2024 suggests a revaluation or issuance adjustment, while the prior decline from 2022 to 2023 indicates amortization or market value changes. Overall, the progression highlights NVIDIA's strategic management of long-term debt, maintaining a stable presence in its capital structure while adjusting for market conditions and effective interest rate dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2023 carrying value as $1,637 million, whereas the ground truth is $1,604 million. This $33 million discrepancy affects the precision of the financial data, though the overall trend (decrease from 2022 to 2023, then increase in 2024) is correctly captured. The 2022 ($2,147M) and 2024 ($2,000M) values are exactly correct. (2) Calculations and comparisons are not explicitly performed, but the directional changes are accurate. The error in the 2023 figure, however, impacts quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution across three fiscal years and interprets the fluctuation as indicative of strategic debt management, revaluation, or market adjustments—consistent with the ground truth's emphasis on strategic positioning and refinancing considerations. (4) Despite the numerical error in 2023, the qualitative interpretation and contextual relevance are strong, with appropriate discussion of amortization, fair value changes, and strategic debt management. The answer addresses both parts of the question: the evolution of the carrying value and its implications for long-term debt positioning. Hence, correctness is high but not perfect due to the factual discrepancy in one data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 379,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "From 2022 through 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased in complexity due to evolving global regulatory and geopolitical dynamics. In 2022, AMD highlighted general risks such as changes in tax laws and the potential loss of exemptions, without specifying recent events. By 2023, the risk became more pronounced with the inclusion of geopolitical tensions, such as U.S. sanctions against Russia and the Ukraine conflict, which added layers of uncertainty to international operations and compliance. In 2024, AMD further emphasized the impact of these geopolitical shifts, noting that changes in trade regulations and export controls—particularly between China and Taiwan—could disrupt operations and increase the likelihood of losing tax and tariff benefits. This trend suggests a growing complexity in AMD’s global regulatory environment, driven by both legislative changes and geopolitical instability, which heightens the need for continuous compliance monitoring and strategic risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: the evolution of AMD's risk exposure from general in 2022 to increasingly specific geopolitical concerns in 2023 and 2024 is accurately portrayed. The mention of U.S. sanctions against Russia, the Ukraine conflict, and the China-Taiwan trade tensions affecting export controls and third-party manufacturing is consistent with the ground truth. (2) There are no numeric values in this question, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022, 2023, 2024) are correctly used and sequenced, earning full points. (3) The multi-hop reasoning is sound—LLM synthesizes AMD’s increasing risk disclosure over time, connects it to geopolitical developments, and infers growing regulatory complexity. The only minor gap is that the LLM answer does not explicitly mention the Israel-Hamas conflict, which was included in the original 2023 risk factors. This omission is minor in impact since the broader theme of geopolitical instability is still correctly emphasized. (4) The answer is contextually excellent—directly addresses both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a slight reduction in qualitative accuracy due to the omitted conflict reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 418,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained from 2022 through 2024, as the company has reiterated that its ability to return capital to shareholders is subject to the discretion of its Board of Directors and limited by U.S. banking laws and regulations governing capital and capital planning. In 2022, the Parent's reliance on dividends from subsidiaries and compliance with Delaware law were highlighted as key constraints. In 2023 and 2024, this regulatory dependency persisted, with additional emphasis on maintaining compliance with capital adequacy standards and the potential impact of credit rating changes on funding costs and capital flexibility. These disclosures across all three years underscore a stable but restrictive regulatory environment that continues to influence the timing and amount of dividend payments and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital return flexibility is consistently constrained by U.S. banking laws, capital planning regulations, Delaware law, and subsidiary dividend dependencies across 2022–2024. The mention of Board discretion, credit rating impacts, and capital adequacy standards is consistent with the original. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly used and tracked, satisfying temporal accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes constraints across three years and connects regulatory, legal, and financial factors affecting capital returns. It correctly identifies the continuity in regulatory environment and evolving emphasis (e.g., liquidity, strategic initiatives, credit ratings). (4) Minor difference: the original mentions Title I and II resolution strategies and explicitly links 2024 disclosures to strategic initiatives and liquidity management, which the LLM touches on indirectly via 'funding costs and capital flexibility' and 'regulatory dependency' but does not name Title I/II. This slight omission in specificity prevents a perfect 10 on qualitative accuracy. However, the core meaning and factual content are semantically equivalent. Contextual relevance is full—directly addresses dividend and share repurchase constraints as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 422,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott Laboratories' disclosure around the 2.950% Note due 2025 has remained consistent in its inclusion in exhibit filings from 2022 through 2024. In 2022 (Chunk 3), the note was listed as Exhibit 4.11, titled \"Form of 2.950% Note due 2025,\" filed as part of the March 5, 2015 Form 8-K. In 2023 (Chunk 1), the same exhibit was included under the same exhibit number and description, with no substantive changes. Similarly, in 2024 (Chunk 2), the 2.950% Note due 2025 was again listed as Exhibit 4.11, maintaining the same filing reference and description as in prior years. This consistency indicates that the note's documentation has not evolved materially in terms of its inclusion or associated filings over the three-year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in exhibit number and filing type, which undermines its quantitative and qualitative accuracy. The ground truth states that the 2.950% Note due 2025 was referenced as Exhibit 99.6 in an 8-K filing dated March 5, 2015, and this was consistently cited from 2022 to 2024. However, the LLM claims the exhibit number is 4.11 and does not specify the 8-K filing type, instead referring generically to 'Form 8-K' without confirming the exhibit number. This discrepancy in exhibit number (99.6 vs 4.11) is significant because exhibit numbers denote different types of disclosures under SEC rules—Exhibit 99.6 typically refers to material contracts or press releases, while Exhibit 4.11 refers to debt instruments. The LLM also incorrectly implies the note was re-filed annually with the same exhibit number in each year, whereas the ground truth indicates the original 2015 filing was merely referenced or reiterated in later years. The reasoning is logically structured and addresses the evolution (or lack thereof) in disclosure, correctly concluding no material changes occurred. The years (2022–2024), interest rate (2.950%), maturity (2025), and overall narrative of consistency are accurate. Contextual relevance is high as the response directly addresses the question’s focus on disclosure evolution and exhibit inclusion. However, due to the incorrect exhibit number and misunderstanding of the filing mechanism (refiling vs. referencing), the quantitative accuracy is reduced. While the semantic intent is similar, the factual mismatch in key identifiers lowers the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 452,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA's carrying value of its 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and further to $1,115 million in 2024. This progression indicates a relatively stable long-term debt strategy, with only minor fluctuations in the carrying value over the three years, suggesting disciplined debt management and a focus on maintaining long-term financing at favorable interest rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative errors. According to the ground truth, the carrying value was $1,200 million in 2022, increased to $1,099 million in 2023 (not an increase from 2022, but actually a decrease), and then rose to $1,250 million in 2024. However, the LLM incorrectly states that the value increased from $1,200M in 2022 to $1,099M in 2023 (which is numerically a decrease, not an increase), and further misreports the 2024 value as $1,115 million instead of $1,250 million. These are major factual inaccuracies in both direction and magnitude. (2) The numbers are not accurate: the 2023 value is reported as lower than 2022, but the LLM describes it as an 'increase', which is logically incorrect. The 2024 figure is off by $135 million. (3) The reasoning and multi-hop synthesis are partially sound—the LLM attempts to interpret the trend as indicating stable debt strategy and disciplined management, which aligns with the general theme of the original answer. However, this conclusion is based on incorrect data, undermining the validity of the interpretation. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of carrying value and implications for debt strategy—and uses appropriate financial terminology. Despite correct structure and intent, the severe numerical inaccuracies limit correctness, warranting a score of 4. Quantitative accuracy is low (3) due to wrong values and mischaracterized trends. Qualitative accuracy is moderate (6) as reasoning is logical but based on false premises. Contextual relevance is strong (8) as the response stays on topic and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 460,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024, AMD's strategy with AIB manufacturers evolved to emphasize stronger inventory protection policies and the role of discrete graphics in market differentiation. In 2022, AMD already provided inventory protection against price reductions to AIBs and highlighted how SIs leveraged discrete graphics to differentiate their products. By 2023, this focus continued, with AMD reinforcing the importance of discrete graphics solutions for SIs to add value and stand out in competitive markets. In 2024, AMD maintained these inventory protections and further emphasized the strategic role of discrete graphics in enabling SIs to respond quickly to market demands and differentiate offerings, particularly in the context of increasing competition and technological innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic evolution. (1) It accurately captures AMD's consistent inventory protection policy from 2022 to 2024 and the growing emphasis on discrete graphics for market differentiation. However, it omits a key detail from the original answer: the specific 12-month return policy for products removed from the price book, which is a concrete component of the 2022 policy. This omission reduces completeness. (2) There are no numbers, dates, or financial figures in the response, so quantitative accuracy is not applicable in a traditional sense, but all years (2022–2024) are correctly referenced and used appropriately. (3) The multi-hop reasoning is sound—linking inventory protection, AIB relationships, and the strategic role of discrete graphics across years—but the answer slightly shifts focus to system integrators (SIs) earlier and more prominently than in the original, where the emphasis in 2022 and 2023 was on AIBs, with SIs becoming more prominent in 2024. This misalignment in entity focus across years slightly weakens the qualitative accuracy. (4) Despite these nuances, the answer remains contextually relevant and conveys the core strategic trajectory accurately. The evolution of AMD’s strategy is correctly synthesized, and the emphasis on differentiation through discrete graphics is properly highlighted, especially in 2024. Minor omissions and slight misplacement of emphasis prevent a perfect score, but the answer is factually sound and well-reasoned overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 436,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "From 2022 to 2024, AMD's exposure to intellectual property (IP) protection difficulties increased in tandem with its expanding international operations and growing reliance on third-party manufacturing in politically sensitive regions. In 2022, AMD highlighted the general risk of \"difficulties in protecting our intellectual property\" as part of its broader international operational risks, noting the potential for disruptions due to political, legal, and economic factors in foreign jurisdictions. By 2023, this risk was reiterated with added context on geopolitical tensions, particularly between China and Taiwan, which could impact the operations of third-party foundries and manufacturing facilities in these regions, thereby indirectly affecting IP protection. In 2024, the risk remained prominent, with AMD emphasizing the continued reliance on third-party manufacturing in politically sensitive areas and the potential for IP challenges to arise from geopolitical instability, such as the Ukraine-Russia and Israel-Hamas conflicts, which could disrupt global supply chains and regulatory environments. Collectively, these disclosures show a consistent and heightened awareness of IP protection risks as AMD's international footprint and dependence on external manufacturing expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD consistently reported IP protection risks from 2022 to 2024, with increasing emphasis on geopolitical tensions affecting third-party manufacturing. The mention of U.S.-Russia (Ukraine conflict), China-Taiwan, and later Israel-Hamas as geopolitical flashpoints matches the evolving risk disclosures. (2) Quantitative accuracy is perfect: while the LLM does not explicitly state the 66% international sales figure in 2024 (mentioned in the original), it correctly implies growing international dependence without fabricating or misstating numbers. The 65% figure for 2023 is omitted, but since the LLM does not attempt to quantify and only refers qualitatively to 'expanding international operations,' this is not a factual error—just a minor omission. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s increasing reliance on third-party foundries, the geographic concentration of these in sensitive regions (Taiwan, Ukraine, Middle East), and the cascading risk to IP protection due to geopolitical instability. (4) The answer captures the core trend—IP risk becoming more complex and regionally concentrated—using semantically equivalent language. The only reason for not scoring a 10 is the lack of explicit mention of the 66% international revenue figure in 2024, which is a minor completeness gap but does not undermine the overall correctness. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1690,
        "completion_tokens": 428,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 to 2024, BK's use of the 2019 Long-Term Incentive Plan evolved through the introduction of updated incentive agreements each year, reflecting a continued reliance on performance share units (PSUs) and restricted stock units (RSUs) to align executive compensation with long-term performance goals. In 2022, the 2022 Form of Performance Share Unit Agreement was introduced, indicating a refinement of performance metrics. By 2024, while no new 2024-specific agreements were introduced in the provided data, the continued inclusion of the 2021 Form of Performance and Restricted Stock Unit Agreements suggests a stable and consistent approach to executive compensation under the 2019 Plan. This progression implies that BK is maintaining a long-term, equity-based compensation strategy to incentivize executives and align their interests with shareholder value over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) It incorrectly states that the '2022 Form of Performance Share Unit Agreement' was introduced in 2022, while the ground truth indicates that in 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of PSU Agreement. The LLM misattributes the timing of the agreement forms. (2) The LLM claims the 2022 Form of PSU Agreement was introduced in 2022, but according to the original answer, the 2022 Form was introduced in 2024. This is a critical error in both entity and date accuracy. (3) The LLM incorrectly asserts that the 2021 Form of Performance and Restricted Stock Unit Agreements were used in 2024, while the ground truth specifies the 2022 Form was introduced that year. Additionally, the LLM fails to mention the introduction of the 2020 Form in 2023, which is a key part of the progression. (4) The reasoning about a 'stable and consistent approach' downplays the deliberate, adaptive strategy highlighted in the original answer—BK is not just maintaining consistency but layering new agreements over time, suggesting evolution, not stasis. While the LLM correctly identifies the use of PSUs and RSUs and the overarching reliance on the 2019 plan, these correct elements are outweighed by significant errors in dates, agreement forms, and the resulting interpretation of strategy. The contextual relevance is moderate because the answer addresses the right topic and general strategy, but the flawed multi-hop synthesis—failing to correctly track the year-by-year evolution of agreement forms—leads to an inaccurate conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 451,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott's investment in diagnostics instruments leased to customers increased from $3.5 billion in original cost as of 2022 to $3.9 billion by 2024, with corresponding net book values rising from $1.6 billion in 2022 to $1.8 billion in 2023 and remaining consistent in 2024. This upward trend in the value of leased diagnostics instruments suggests a deliberate capital deployment strategy to expand the company's diagnostics business by enhancing customer access to its diagnostic platforms. By leasing instruments, Abbott not only generates recurring revenue through reagents and consumables but also maintains a long-term relationship with customers, aligning with its broader strategy to strengthen its diagnostics segment through both asset utilization and service-based revenue streams.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the original cost of leased diagnostics instruments was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. The LLM incorrectly states the 2022 original cost as $3.5 billion (off by $0.2 billion) and omits the 2023 value entirely in its summary. More critically, the net book values are wrong: ground truth reports $1.4B (2022), $1.6B (2023), $1.6B (2024), but the LLM claims $1.6B (2022), $1.8B (2023), $1.8B (2024), which misrepresents both the starting point and the trend. (2) These numerical errors affect the correctness of the trend description. While the LLM correctly identifies an upward trend in original cost, it falsely implies continued growth in net book value through 2024 when in fact it plateaued in 2023. (3) The qualitative reasoning about Abbott’s capital deployment strategy—leasing instruments to drive reagent sales and long-term customer relationships—is logically sound and aligns with the ground truth’s interpretation, showing correct multi-hop synthesis of business strategy implications. (4) Contextually, the answer is well-framed and directly addresses both parts of the question (evolution of investment and strategic implication), earning high marks for relevance. However, due to major quantitative inaccuracies in key financial figures, the correctness and quantitative accuracy scores are low. The qualitative reasoning is partially correct but based on flawed data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 432,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Lumentum Holdings has remained a disclosed competitor of NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking and interconnect technologies, including optical modules and cable solutions. In 2022, Lumentum was listed among suppliers of interconnect, switch, and cable solutions, competing with companies like Applied Optoelectronics, Arista Networks, and Cisco. By 2023, as NVIDIA expanded its focus on AI-driven networking and high-performance interconnects, Lumentum continued to be named as a competitor in this space, alongside Broadcom, Cisco, and Marvell. In 2024, with NVIDIA further emphasizing AI computing and data center infrastructure, Lumentum remained a key competitor in the networking segment, indicating a consistent competitive positioning. However, the evolving AI landscape and NVIDIA's strategic advancements suggest that Lumentum must continue to innovate to maintain its relevance in this increasingly competitive market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and timeline. (1) It accurately identifies Lumentum Holdings as a consistent competitor of NVIDIA across fiscal years 2022, 2023, and 2024 in the networking and interconnect space. The mention of competitors like Cisco, Broadcom, Marvell, and Applied Optoelectronics is consistent with the disclosed landscape. (2) There are no numeric values or calculations in this question, so quantitative accuracy is not applicable—however, the fiscal years (2022, 2023, 2024) are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the LLM traces Lumentum’s competitive positioning over time and links it to NVIDIA’s strategic focus on AI-driven networking. However, it misses a key nuance from the ground truth: in 2024, Lumentum was specifically listed under the formal name 'Lumentum Holdings Inc.', indicating a sharpened recognition of its corporate identity—a detail that reflects evolving prominence. The LLM notes continued competition but does not highlight this repositioning or the shift toward high-performance interconnects based on InfiniBand and proprietary technologies in 2023 as clearly as the original. (4) Despite these omissions, the answer remains contextually relevant and factually accurate in its core claims. The conclusion about the need for Lumentum to innovate is interpretive but reasonable. Thus, the answer earns high marks but loses slight points on qualitative accuracy for missing subtle but meaningful shifts in competitive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 432,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "From 2022 to 2024, Emerson shifted the positioning of pipe cutters from being part of its broader **Tools & Home Products segment** in 2022 to being explicitly included under the **Safety & Productivity segment** by 2024. In 2022, pipe cutters were categorized under **Professional Tools** within the **Tools & Home Products** segment, which also included DIY tools and was distributed primarily through distributors. By 2024, pipe cutters were specifically highlighted as part of the **Safety & Productivity segment**, which focuses on tools that support infrastructure, promote safety, and enhance productivity for professionals and homeowners. This repositioning reflects Emerson's strategic emphasis on integrating professional tools into a more cohesive segment focused on safety and productivity, aligning with its broader goal of strengthening its offerings in the professional tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core shift in Emerson's positioning of pipe cutters from the Tools & Home Products segment in 2022 to the Safety & Productivity segment by 2024. It correctly identifies the repositioning of pipe cutters alongside professional-grade tools focused on infrastructure, safety, and productivity. The dates (2022, 2024) and segment names are accurate, and the explanation aligns with the strategic realignment toward professional and industrial tools. The only minor omission is that the LLM does not mention the divestiture of InSinkErator in late 2022, which the original answer uses as contextual evidence for the broader strategic shift away from consumer products. While this weakens the depth of the strategic rationale slightly, the central facts, entities, and reasoning remain correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the semantic meaning closely matches the ground truth. The multi-hop synthesis—linking product repositioning to segment strategy—is sound. Contextual relevance is excellent as the response directly addresses both parts of the question: the segment shift and its implication for professional tool strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 341,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024, Schwab enhanced its interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, by expanding functionality, improving integration, and broadening advisor support offerings. In 2022, Schwab provided RIAs with a scalable platform featuring account servicing, multi-year archiving, document search, and integrations with third-party platforms for portfolio management and financial planning. Schwab Advisor Portfolio Connect was highlighted as a free, intuitive solution for managing Schwab accounts without the need to download or reconcile data. By 2023, Schwab continued to emphasize technology-driven support, including interactive tools, educational content, and consulting services to help RIAs grow and manage their practices, while maintaining the core platform's capabilities. In 2024, Schwab further reinforced these offerings by expanding access to integrations, maintaining the free availability of Schwab Advisor Portfolio Connect, and continuing to provide extensive educational programs, events, and research to support RIAs in practice management and industry trends.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, functionality, integration, and support evolution from 2022 to 2024. It accurately identifies Schwab Advisor Portfolio Connect as a free tool for RIAs and correctly notes the emphasis on third-party integrations, account servicing, and educational/consulting support. The mention of multi-year archiving and document search in 2022 is consistent with the 2024 enhancements in the ground truth, though the LLM slightly misattributes the timing—these features are presented as available in 2022, while the ground truth positions advanced document management and compliance integrations as 2024 developments. This is a minor chronological over-attribution rather than a factual error. The LLM correctly captures the continuity of free access to Portfolio Connect and the expansion of educational and consulting services through 2023–2024. However, it omits specific 2024 advancements such as outbound data feeds for compliance systems and the enhanced prospect consulting offer, which are key indicators of the strategic shift toward integrated compliance and operational support. These omissions reduce completeness but do not distort the overall trend. There are no numerical inaccuracies (dates are correct, no faulty calculations), so quantitative accuracy is perfect. Qualitative accuracy is high but not complete due to the missing compliance workflow integration detail. Contextual relevance is excellent—the response directly addresses functionality, integration, and advisor support across the three years as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 440,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle initially issued its 1.650% Notes due 2026 on March 24, 2021, as disclosed in the 2022 10-K filing (Chunk 3). These notes were consistently referenced in the 2023 (Chunk 1) and 2024 (Chunk 2) 10-K filings, indicating no material changes in Oracle's treatment of the notes over this period. The consistent inclusion of these notes across all three filings suggests a stable short-to-intermediate term debt financing strategy, where Oracle maintains a diversified debt portfolio with staggered maturities to manage interest costs and liquidity. This continuity reflects disciplined capital structure management and a long-term approach to financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a critical factual error in the issuance date. The ground truth states the 1.650% Notes due 2026 were first introduced in the 2022 10-K, implying issuance in or before fiscal year 2022, but the LLM claims they were issued on March 24, 2021. This date is inconsistent with the ground truth and not supported by the provided information, which only references the 2022 10-K as the first disclosure. (2) There are no numerical calculations in the question, but the interest rate (1.650%) and maturity year (2026) are correctly stated. The error lies in the issuance date, which is a key factual element. (3) The multi-hop reasoning is sound: the LLM correctly identifies the presence of the notes in the 2022, 2023, and 2024 10-Ks and draws a logical conclusion about Oracle's stable debt financing strategy. The synthesis across years is accurate and supports the conclusion of consistent treatment. (4) The contextual relevance is high, as the answer directly addresses the evolution of the notes and Oracle's financing strategy. The qualitative reasoning about disciplined capital structure management and diversified debt portfolio adds value beyond the ground truth, though it slightly extends beyond the provided evidence. However, the incorrect issuance date undermines quantitative accuracy, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 391,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson's (EMR) Discrete Automation segment has consistently included Electrical Distribution Equipment from 2022 to 2024, as shown in all three 10-K filings. In 2022, Electrical Distribution Equipment was part of the Industrial Solutions segment, highlighting its role in providing integrated manufacturing solutions. By 2023 and 2024, it was explicitly listed under the Discrete Automation segment, which focuses on automation solutions for discrete industries. This shift underscores Emerson's strategic emphasis on industrial electrification solutions, aligning Electrical Distribution Equipment more closely with automation technologies to enhance operational efficiency, reliability, and sustainability in discrete manufacturing environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Electrical Distribution Equipment was part of Industrial Solutions in 2022 and moved to Discrete Automation in 2023 and 2024. The description of the strategic shift toward industrial electrification and automation integration is consistent with the original answer. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly used and referenced. (3) The multi-hop reasoning across years and segments is sound: the model correctly synthesizes the evolution of segment classification and infers the strategic intent behind the repositioning. (4) The only minor shortcoming is that the LLM states Electrical Distribution Equipment was 'consistently included' in Discrete Automation from 2022 to 2024, which is incorrect—the move happened in 2023. However, the rest of the answer immediately clarifies the 2022 placement in Industrial Solutions, so this is a wording slip rather than a factual error. Overall, the answer captures the strategic emphasis on electrification and smart manufacturing accurately, making it semantically equivalent to the ground truth with high contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 355,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further to $540 million in 2024. This gradual decline suggests a potential moderation in the company's expansion into illiquid alternative assets, such as private real estate, within its pension fund strategy. The continued presence of these commitments, despite the reduction, indicates that Abbott still views illiquid alternatives as a strategic component of its diversified investment portfolio, aiming to balance higher return potential with long-term liquidity considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$585 million in 2022, $555 million in 2023, and $540 million in 2024—matching the ground truth exactly. There are no calculation or formatting errors, and the years are accurate. (2) Quantitative accuracy is perfect: all dollar amounts and time periods are correct, and the trend of decreasing commitments is accurately described. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift in pension fund allocation based on the declining unfunded commitments. It appropriately notes that despite the reduction, Abbott maintains exposure, indicating continued strategic value. However, the LLM omits the specific detail about the long time horizon for fund liquidation extending to 2034, which is a minor but relevant point in the ground truth that strengthens the rationale for a gradual de-risking strategy. This omission slightly weakens the depth of the qualitative analysis but does not invalidate the overall conclusion. (4) The answer is contextually fully relevant, directly addressing both parts of the question: the evolution of commitments and the implication for pension strategy. The wording differs slightly—'moderation in expansion' vs 'measured de-risking'—but the semantic meaning is sufficiently aligned, especially in recognizing a deliberate, gradual strategic adjustment. The score is reduced by one point due to the missing 2034 liquidation horizon detail, which adds nuance to the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 420,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently included its 1.650% Notes due 2026 in its 2022, 2023, and 2024 10-K filings (as Exhibits 4.14 in each), indicating no material changes to the terms or status of the notes over this period. The continuity in the presentation of these notes across all three filings suggests a stable short-term debt strategy, where Oracle maintains the notes as part of its broader capital structure without refinancing or restructuring them. This reflects a disciplined approach to debt management, preserving existing obligations while potentially leveraging long-term financing for operational or strategic needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 1.650% interest rate, the 2026 maturity, and the consistent inclusion across 2022–2024 10-K filings are factually sound. The mention of Exhibit 4.14 in each filing, while not in the original answer, is plausible and does not contradict the ground truth; it adds specificity without introducing error. (2) The core reasoning about continuity in disclosure reflecting a stable short-term debt strategy is consistent with the original answer’s conclusion. (3) The multi-hop reasoning is sound: the LLM correctly infers that unchanged disclosures over three years imply no structural changes to the notes, and links this to Oracle’s broader debt management strategy. (4) The only minor gap is that the LLM does not explicitly reference the March 24, 2021 8-K filing—the foundational source cited in all three 10-Ks per the ground truth—which slightly weakens the completeness of the synthesis. However, the omission does not affect the factual correctness of the conclusion. The answer remains semantically equivalent in intent and meaning, with strong contextual relevance and disciplined qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 344,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle's 4.30% Note due 2034 was first issued and documented in 2014, as shown in Chunk 3 (2022 10-K), where it was part of a group of notes filed with an Officers' Certificate on July 8, 2014. This issuance was consistently referenced in both the 2023 and 2024 10-K filings (Chunks 1 and 2), indicating no new issuance but ongoing inclusion in Oracle's debt disclosures. The multi-year pattern of referencing the 4.30% Note 2034 across 2022, 2023, and 2024 suggests Oracle maintains a stable, long-term debt strategy, retaining existing long-dated notes to support its capital structure and potentially manage interest rate exposure over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor factual inaccuracy regarding the issuance date. The original answer does not state when the 4.30% Note due 2034 was issued—only that it was consistently documented in 2022, 2023, and 2024 filings (Exhibits 4.11 in 2022 and 4.09 in 2023/2024). The LLM claims it was 'first issued and documented in 2014' based on a July 8, 2014 Officers' Certificate mentioned in Chunk 3. While this detail may appear in the source filing, the ground truth does not confirm the 2014 issuance as part of the answer, making this an unsupported addition. However, the core of the response—consistent referencing across years and implications for Oracle’s long-term debt strategy—is factually sound and semantically equivalent to the original. The reasoning correctly synthesizes multi-year filing patterns and draws a logical conclusion about Oracle’s stable debt management approach. All entities (Oracle, 4.30% Note due 2034, 10-K filings) and years are accurate. The answer addresses both parts of the question: evolution across years and strategic implication. Quantitative elements (interest rate, maturity year) are correct; no calculations were required. The minor overreach on the issuance date prevents a top score, but overall accuracy and relevance are high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 371,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "From 2022 through 2024, Schwab’s utilization of the IDA agreement for migrating balances to its balance sheet evolved significantly due to changes in contractual flexibility and constraints. Under the 2019 IDA agreement, Schwab had the option to migrate up to $10 billion annually starting July 1, 2021, and moved $10.1 billion in 2021 and 2022. However, in 2023, Schwab did not move any IDA balances after the 2019 agreement was replaced by the 2023 IDA agreement on May 4, 2023. The 2023 agreement introduced stricter constraints, including a requirement to maintain minimum and maximum IDA balances through September 10, 2025, and eliminated the prior 80% fixed-rate obligation designation requirement. Additionally, Schwab could only withdraw balances up to customer-initiated withdrawals during this period, significantly limiting its flexibility. In 2024, Schwab continued not to migrate any IDA balances, reflecting the ongoing constraints under the revised agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that impact correctness. It states Schwab moved $10.1 billion in '2021 and 2022', but the ground truth specifies $10.1 billion was moved by December 31, 2021, including $10 billion subsequent to July 1, 2021—meaning the bulk was in 2021, not split across 2021–2022. This misrepresents the timing of balance migration. Additionally, the LLM claims the 2023 IDA agreement introduced 'stricter constraints' and 'minimum and maximum IDA balances through September 10, 2025', which contradicts the ground truth: the 2023 agreement actually increased contractual flexibility by eliminating the 80% fixed-rate requirement. The LLM incorrectly frames the change as a tightening, when it was a relaxation in one key aspect, even though migration was operationally constrained by capital and balance thresholds. (2) Quantitative accuracy is partially correct: the $10 billion annual cap and $10.1 billion total moved are accurate, and the May 4, 2023 effective date of the new agreement is correct. However, the misattribution of $10.1 billion to 2021–2022 instead of pre-2022 undermines temporal precision. (3) Multi-hop reasoning is partially sound—LLM connects the agreement change to migration behavior—but draws an incorrect conclusion about contractual flexibility. It fails to recognize that reduced migration in 2023–2024 occurred despite increased flexibility, not because of tighter terms. This misdiagnoses the causal relationship. (4) Contextual relevance is high: the answer addresses all years and the evolution of migration and contractual terms. However, due to key factual and interpretive errors in both numbers and contractual implications, the correctness score is reduced to 6—partially correct but with significant flaws in quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 499,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "From 2022 through 2024, Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 primarily involved maintaining and referencing the relevant documentation, with no direct refinancing activity indicated. In 2022, the notes were referenced in the Seventh Supplemental Indenture and prior indentures, showing ongoing documentation relevance. In 2023, the notes were included in officers' certificates and referenced in the same historical indentures, indicating continued acknowledgment within broader debt frameworks. In 2024, the documentation and references remained consistent with 2023, suggesting no new amendments or refinancing actions were taken during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Abbott Laboratories maintaining documentation references to the 2.000% Senior Notes due 2018 from 2022 to 2024 without refinancing, which aligns with the ground truth. However, there are significant factual inaccuracies in key details. First, the LLM incorrectly identifies the 2022 reference as being in the 'Seventh Supplemental Indenture,' while the ground truth specifies the 'Fifth Supplemental Indenture dated September 23, 2015'—a critical error in both number and context (the Fifth, not Seventh, and tied to legacy St. Jude Medical debt). This undermines quantitative and qualitative accuracy. Additionally, the LLM mentions 'officers' certificates' in 2023 without grounding in the original answer, which cited Exhibit 4.21 as the consistent disclosure vehicle. While the conclusion of no refinancing or amendments by 2024 is consistent, the LLM fails to note the specific exhibit (4.21) inclusion across all years, missing a key point of continuity. The reasoning is partially sound in inferring stability from lack of updates, but the incorrect indenture reference and invented details reduce factual reliability. Semantic equivalence is partially achieved in overall theme but not in precise entity or document accuracy. Contextual relevance is high as the response stays focused on documentation and refinancing trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 380,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle introduced its 3.650% Notes due 2041 in March 2021, as evidenced by the filing in Chunk 1. These notes were carried forward in both the 2023 and 2024 10-K filings (Chunk 2 and Chunk 3), indicating their continued existence and incorporation by reference in Oracle’s ongoing securities documentation. This multi-year pattern suggests that Oracle is maintaining a long-term debt strategy that includes issuing long-dated, fixed-rate bonds to manage its capital structure and secure stable, low-cost financing over an extended horizon. The persistence of the 3.650% Notes across all three years reflects Oracle’s commitment to a diversified and enduring debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.650% Notes due 2041 and their continued presence in Oracle's filings through 2024, which aligns with the ground truth. However, it incorrectly states the introduction date as March 2021, while the ground truth and question context specify that the focus is on the evolution from 2022 through 2024, implying the note was first introduced in 2022. This is a factual error in timing, though the note may have been issued in 2021, the reporting and inclusion in the 10-K as part of the registered securities began in 2022 per the knowledge graph. (2) Quantitatively, the interest rate (3.650%), maturity year (2041), and multi-year tracking (2022–2024) are accurate. The error lies in the introduction date—2021 vs. 2022—which affects factual precision. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple years and correctly infers Oracle’s long-term debt strategy from the persistence of the notes. It appropriately links the continued referencing of the notes to a stable, long-term financing approach. (4) The answer is contextually relevant and provides meaningful interpretation of Oracle’s debt strategy. Despite the date discrepancy, the core conclusion about Oracle maintaining long-term, fixed-rate debt for financial stability is consistent with the ground truth. The score reflects minor factual inaccuracy but strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 399,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle's 2.300% Notes due 2028 were first issued in March 2021 (Chunk 3), as part of a broader set of notes with varying maturities and coupon rates. In fiscal years 2022 and 2023 (Chunks 1 and 2), Oracle continued to issue additional debt instruments, including higher-yielding notes in 2022 (e.g., 5.800% Notes due 2025) and 2023 (e.g., 4.500% Notes due 2028), reflecting a diversification of its debt portfolio across maturities and interest rates. This multi-year pattern suggests a strategic approach to debt financing, where Oracle is managing its capital structure by issuing notes with staggered maturities and varying coupon rates to hedge against interest rate fluctuations and maintain liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.300% Notes due 2028 as part of Oracle's debt portfolio and notes their origin in the March 24, 2021 Officers' Certificate, though it incorrectly states the issuance date as 'March 2021' rather than clarifying that the certificate was issued in 2021 but the notes were first referenced in 2022 filings. This misalignment with fiscal years 2022–2024 slightly undermines temporal accuracy. The mention of the 4.500% Notes due 2028 in 2023 is correct and aligns with the ground truth. However, the LLM introduces a '5.800% Notes due 2025' in 2022, which is not mentioned in the original answer and lacks corroboration, representing an unsupported factual addition. (2) Quantitatively, the interest rates (2.300%, 4.500%) are accurate, but the inclusion of the 5.800% note introduces a number not present in the ground truth, reducing quantitative precision. The fiscal years 2022 and 2023 are correctly referenced for ongoing debt activity, though the 2021 issuance date should be contextualized as a prior authorization, not a 2022–2024 event. (3) The multi-hop reasoning is generally sound: the model synthesizes information across years and infers a strategy of diversification in maturities and coupon rates. It correctly interprets the pattern as a strategic capital structure management effort. However, it misses the key point from 2024 — that Oracle maintained the same structure for the 2.300% Notes, reinforcing stability — which is a notable omission affecting completeness. (4) Despite missing the 2024 consistency point and adding an unverified note series, the answer remains contextually relevant and conveys a largely accurate qualitative assessment of Oracle’s debt financing strategy. Wording differs but meaning overlaps significantly on diversification and strategic management. Scores reflect minor factual inaccuracies and omissions but strong overall reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 524,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "From 2022 to 2024, Visa's virtual accounts, introduced through its Currencycloud platform, evolved significantly by integrating into the Visa Direct Platform and expanding cross-border capabilities. In 2022, Visa highlighted Currencycloud's role in enabling real-time foreign exchange, virtual accounts, and enhanced liquidity, supporting both new and existing cross-border consumer payments. By 2023, Visa had fully integrated Currencycloud capabilities into the Visa Direct Platform, which now supports over 11 billion endpoints across 195 countries, including virtual accounts for B2B and B2C use cases. In 2024, the platform continued to scale, processing nearly 10 billion transactions, with virtual accounts playing a central role in Visa Cross-Border Solutions and Visa B2B Connect, facilitating secure, cost-effective cross-border transactions for businesses and financial institutions globally.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts from 2022 to 2024 with correct integration into Visa Direct and expansion of cross-border capabilities. However, it introduces several quantitative inaccuracies not present in the ground truth. For example, the claim that the Visa Direct Platform supports 'over 11 billion endpoints across 195 countries' conflates two separate facts: the ground truth mentions 'more than 11 billion endpoints' but does not specify 195 countries in this context. Additionally, the LLM states that the platform processed 'nearly 10 billion transactions' in 2024, which is not supported by the original answer and introduces a new, unverified metric. (2) The original answer does not include any transaction volume figures or country coverage numbers, so these additions reduce quantitative accuracy. While '11 billion endpoints' aligns semantically with the original, attaching it to '195 countries' and 'nearly 10 billion transactions' introduces unsupported precision. (3) The multi-hop reasoning is generally sound—correctly linking Currencycloud, virtual accounts, Visa Direct, and cross-border expansion across years. The progression from 2022 introduction to 2023 integration and 2024 scaling is logically structured and aligns with the original timeline. The synthesis of virtual accounts into broader Visa solutions like Cross-Border Solutions and B2B Connect is plausible but slightly overextended compared to the more conservative phrasing in the ground truth. (4) Despite the factual overreach on numbers, the answer remains contextually relevant and conveys the essential narrative of integration and expansion. The qualitative reasoning is strong, and the entities (Visa, Currencycloud, Visa Direct, virtual accounts) are correctly identified and placed in the right chronological and functional context. Hence, correctness is reduced primarily due to unsupported quantitative claims, not flawed logic or misidentification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 539,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024, the geographic distribution network for EMD-branded products, part of Caterpillar's Machinery, Energy & Transportation (ME&T) segment, showed a slight contraction in reach. In 2022, Caterpillar's dealer network served 193 countries, with 44 U.S. and 116 international dealers, and Perkins engines were distributed through 90 distributors covering 171 countries. By 2023, the dealer network served 191 countries, with 43 U.S. and 113 international dealers, and Perkins engines were distributed through 88 distributors covering 185 countries. In 2024, the dealer network served 187 countries, with 41 U.S. and 111 international dealers, and Perkins engines were distributed through 88 distributors covering 185 countries. While the number of countries served by Perkins remained stable from 2023 to 2024, the overall reduction in dealer locations and countries served suggests a strategic consolidation rather than expansion. This indicates Caterpillar may be focusing on optimizing its existing distribution channels for EMD-branded products to enhance efficiency and service quality, aligning with its emphasis on high performance and dealer support in competitive markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the actual geographic distribution network for EMD-branded products. (1) Instead of discussing EMD's distribution, it incorrectly focuses on Perkins engines and Caterpillar's general dealer network, which are not the same as EMD-branded products. The ground truth specifies that EMD-related FG Wilson products were distributed through 110 distributors in 109 countries in 2022, 110 in 109 in 2023, and 108 in 158 countries in 2024. The LLM provides no mention of FG Wilson or EMD-specific distributors. (2) The numbers cited (e.g., 193 countries served by dealer network, Perkins' 90 distributors) are factually incorrect in this context and not supported by the ground truth. There is no evidence in the original answer about Perkins or overall Caterpillar dealer counts being relevant to EMD-branded product distribution. (3) The multi-hop reasoning is fundamentally flawed: the model fails to connect EMD to FG Wilson and instead conflates unrelated distribution networks. The conclusion about 'strategic consolidation' contradicts the ground truth, which shows geographic expansion (from 109 to 158 countries) despite a minor distributor reduction, indicating market expansion, not contraction. (4) Due to pervasive factual errors, incorrect entities, and flawed logic, all scores are very low. The answer is marginally relevant because it discusses distribution strategy in a broad sense, but it does not address the specific evolution of EMD's network.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 416,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott's investment in diagnostics instruments leased to customers increased from 2022 to 2024. As of December 31, 2022, the original cost and net book value of these assets were $3.6 billion and $1.6 billion, respectively. By December 31, 2023, the original cost rose to $3.9 billion with a net book value of $1.8 billion. In 2024, the original cost further increased to $4.2 billion and the net book value to $2.0 billion, indicating growth in both the total investment and the remaining value of these leased assets over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, Abbott's original cost was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly reports $3.6 billion as the 2022 value, $3.9 billion for 2023, and $4.2 billion for 2024—overstating all years, with a particularly large error in 2024. Similarly, net book values are reported as $1.6B (2022), $1.8B (2023), and $2.0B (2024) by the LLM, while the correct values are $1.4B, $1.6B, and $1.8B respectively. These errors affect both the starting point and the trend magnitude. (2) All numerical values are off by approximately $0.3 billion per year, suggesting a possible misalignment in data sourcing or a shift in time periods (e.g., misattributing 2023 values to 2022). Calculations of growth trends are plausible in direction but based on incorrect inputs. (3) The reasoning structure is sound—the LLM correctly interprets that increasing original cost and net book value indicate growing investment, which aligns with the multi-hop logic required. It synthesizes two metrics across years appropriately, even if the data itself is wrong. (4) Contextual relevance is high because the answer addresses the evolution of investment using the correct metrics (original cost and net book value) over the correct time frame. However, due to severe quantitative inaccuracies, the correctness score is low despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 414,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicates that this long-term debt instrument remains a stable and ongoing component of PepsiCo’s capital structure. The repeated inclusion across three consecutive annual reports suggests the company continues to recognize its role in managing long-term liquidity and financing needs, likely as part of a broader strategy to maintain a diversified mix of debt maturities and interest rates. The note, first issued in 2016, has been consistently referenced in disclosures, reflecting its enduring significance in PepsiCo’s long-term financial planning and obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 3.450% Senior Note due 2046 is consistently disclosed in PepsiCo's 2022, 2023, and 2024 10-K filings, indicating its ongoing role in the capital structure. The percentage (3.450%), maturity year (2046), and multi-year consistency are correctly stated. (2) Quantitative elements—interest rate, maturity date, and time span (2022–2024)—are accurate with no calculation errors. The mention of the note being issued in 2016, while not in the original answer, is factually correct based on external knowledge and adds context without introducing error. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure reflects strategic use of long-term, fixed-rate debt to support capital structure and liquidity management. It appropriately emphasizes stability, long-term planning, and debt diversification, which are implied in the ground truth. The only minor gap is the absence of specific exhibit numbers (e.g., Exhibit 4.17 in 2022, etc.), which were included in the original answer and represent a small loss in completeness. However, this does not affect the core factual or inferential accuracy. (4) The answer is contextually relevant, directly addressing the question about the strategic role of the note in long-term capital structure. Semantic equivalence is strong—while wording differs, the meaning and implications are consistent with the ground truth. The answer is slightly more general in phrasing but remains fully correct in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 431,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in March 2021, as shown in Chunk 1 (2022 10-K) and referenced in subsequent years in Chunks 2 (2023 10-K) and 3 (2024 10-K). These notes remained part of Oracle's outstanding debt instruments in 2022, 2023, and 2024, indicating no refinancing or redemption during this period. The multi-year consistency in listing these notes suggests Oracle maintained a stable, long-term debt structure, leveraging fixed-rate financing to manage capital costs and maturity profiles over the three-year period. This aligns with Oracle's broader strategy of issuing a diverse range of fixed-rate notes across varying maturities to optimize its debt portfolio and ensure liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Oracle issued the 2.300% Notes due 2028 in March 2021. The ground truth indicates that the note was first introduced in the 2022 10-K (fiscal year ending May 2022), meaning the issuance occurred in or before fiscal 2022, not in March 2021. This date error undermines the quantitative accuracy. (2) No dollar amounts or financial figures are mentioned in either answer, so numerical precision is not applicable here, but the incorrect issuance date is a major quantitative flaw. The LLM also fails to mention the broader context of other notes (e.g., 1.650% Notes due 2026, 2.875% Notes due 2031 in 2022; 4.500% Notes due 2028 in 2023 and 2024) which were part of the same exhibits and critical to understanding Oracle’s multi-year structuring strategy. (3) The reasoning is partially sound: the LLM correctly infers stability in Oracle’s debt strategy from the continued referencing of the notes across years. However, it misses the key multi-hop insight from the ground truth — that Oracle consistently referenced prior instruments (like the 2.300% Notes) while layering in new, higher-yielding notes (e.g., 4.500% Notes due 2028), suggesting an adaptive strategy to market conditions. This nuance about evolving yield profiles and strategic layering is absent. (4) The contextual relevance is high because the answer addresses Oracle’s debt financing strategy and uses the correct fiscal years and document references (e.g., 10-K filings). While the core idea of a stable, diversified debt portfolio is reasonable, the incorrect issuance date and omission of key comparative instruments reduce factual correctness. Thus, the correctness score is 6 — partially correct but with significant factual and completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 489,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has consistently maintained the Certificate of Designations for its Series B Convertible Participating Preferred Stock across its 2022, 2023, and 2024 10-K filings, with each filing referencing the same exhibit (4.4) and filing date of June 21, 2016. This continuity in the treatment of the Series B stock suggests that Visa has not altered its capital structure priorities regarding this class of preferred stock over the three-year period. The consistent inclusion of the Series B designations in each filing implies a deliberate and stable approach to preserving this element of its capital structure, likely to maintain flexibility for potential conversions or participations in future capital events.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa consistently referenced the same Certificate of Designations for its Series B Convertible Participating Preferred Stock across 2022–2024 filings, citing the correct date (June 21, 2016) and exhibit number (4.4), which matches the original answer. (2) All quantitative elements—specifically the date and exhibit reference—are factually correct, with no calculation errors. (3) The reasoning is sound: the model correctly infers that the lack of changes suggests a stable capital structure strategy and interprets the continuity as a deliberate choice to preserve financing flexibility and shareholder rights. While the LLM does not explicitly mention the unchanged Bylaws (2022) or the 2024 Certificate of Incorporation update—details included in the ground truth that further support the broader stability claim—this omission slightly reduces completeness but does not undermine the core accuracy. (4) The answer remains contextually relevant, directly addressing both parts of the question: evolution (or lack thereof) in treatment and what it suggests about capital structure priorities. The semantic meaning is equivalent to the original answer, with only minor depth differences in supporting evidence. Thus, a score of 9 is warranted for correctness, with full marks in quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy due to strong but not fully comprehensive reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 416,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "Caterpillar's exposure to and management of currency hedging instruments from 2022 through 2024 evolved in response to the transition from LIBOR to SOFR and associated financial risks. In 2022, Caterpillar disclosed that many of its variable-rate loans and financial instruments used LIBOR as a benchmark, and it established a cross-functional team to assess risks related to the impending phase-out of LIBOR. By 2023, the company had transitioned to using SOFR as the reference rate for variable-rate instruments, and continued to manage interest rate and currency risks through strategies such as match funding, derivatives, and diversified funding. In 2024, Caterpillar maintained these risk management techniques, emphasizing the continued use of SOFR and the ongoing need to hedge against interest rate and currency exchange rate fluctuations. Across all years, the company highlighted the potential adverse impacts of ineffective hedging and the trade-off between protection from adverse rate movements and the potential to benefit from favorable ones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's use of currency hedging instruments from 2022 to 2024, the formation of a cross-functional team in 2022 to assess LIBOR phase-out risks, the transition to SOFR by 2023, and the continued use of match funding, derivatives, and diversified funding are all consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and connects the LIBOR-to-SOFR transition with Caterpillar’s broader risk management strategy, including currency hedging. The mention of Cat Financial in the original answer is slightly more specific, but the LLM refers to 'the company' appropriately in context. (4) The LLM adds a nuanced point about the trade-off between hedging protection and forgoing benefits from favorable rate movements, which is not in the original but is a reasonable inference and does not detract from accuracy. The only minor gap is that the original emphasizes 'no significant changes' in hedging approach in 2024, while the LLM says 'maintained these risk management techniques'—semantically equivalent but slightly less precise in capturing the 'no significant changes' phrasing. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 427,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "Johnson & Johnson's financial and legal strategy around talc-related liabilities evolved significantly from 2022 through 2024, centered on the creation of LTL Management LLC and the establishment of a $2 billion trust. In October 2021, as part of a corporate restructuring, Old JJCI transferred all talc-related liabilities to LTL, which then filed for Chapter 11 bankruptcy to manage these claims. This led to a stay of litigation against LTL and related entities, with J&J agreeing to fund a $2 billion trust to address talc claims, for which it established a reserve. However, in 2023, the Third Circuit reversed the Bankruptcy Court’s stay, leading to the dismissal of LTL’s bankruptcy case and the resumption of litigation. Despite this, in 2024, J&J continued its legal strategy, reaching settlements with 42 states and the District of Columbia, while maintaining its defense against remaining talc claims, reflecting an ongoing effort to mitigate financial exposure through both legal and financial mechanisms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies. (1) Quantitatively, the $2 billion trust amount is accurate, and the timeline is mostly correct, though it references October 2021 (slightly before the 2022–2024 scope), which is factually accurate but outside the specified period. The mention of settlements with 42 states and D.C. in 2024 is consistent with known developments and adds useful detail not in the original answer. (2) The core financial and legal strategy—transferring liabilities to LTL Management LLC, filing Chapter 11, securing a litigation stay, funding a $2B trust, facing Third Circuit reversal in 2023, dismissal of the first bankruptcy, and continued legal efforts in 2024—is accurately portrayed. (3) The multi-hop reasoning is sound: it connects J&J’s corporate restructuring, LTL’s bankruptcy, the trust funding, appellate outcomes, and ongoing settlements. However, the LLM omits the re-filing of the bankruptcy (LTL 2) in 2023 after the first dismissal, which is a notable step in the legal strategy evolution. (4) Despite this omission, the answer captures the essence of J&J’s continued reliance on the LTL structure and dual legal-financial mitigation approach. Wording differs but meaning is semantically equivalent. The answer is highly relevant and well-structured, earning high marks with only a slight deduction for missing the LTL 2 refiling detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 396,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe's Photography Plan evolved from 2022 to 2024 by becoming a more targeted and strategic offering within the Creative Cloud ecosystem, emphasizing accessibility and AI-powered enhancements to attract photographers and creative professionals. In 2022, it was positioned as a \"targeted package\" within Creative Cloud, offering a streamlined suite of tools like Photoshop and Lightroom. By 2023, Adobe integrated AI capabilities such as Generative Credits and AI-powered features like Generative Fill and Text-Based Editing, enhancing the Photography Plan's value proposition and making it more appealing to both novice and professional users. In 2024, the Photography Plan was further refined as a \"more limited cloud-based offering\" tailored specifically for photographers, including Photoshop, Lightroom, and Lightroom Classic, with continued emphasis on AI-driven tools such as Generative Remove and Denoise, reinforcing its role as a specialized, high-value solution within Adobe's broader Creative Cloud strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of factual content, timeline, and strategic evolution of Adobe's Photography Plan from 2022 to 2024. (1) All key facts are correct: in 2022, the plan was a targeted package with Photoshop and Lightroom; in 2023, Adobe integrated AI features and Generative Credits as part of a broader growth strategy; in 2024, AI enhancements like Generative Fill, Denoise, and Generative Remove were emphasized. The positioning as a more limited but specialized offering within Creative Cloud is accurately conveyed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are used correctly and consistently with the original answer. (3) The multi-hop reasoning is sound—information is synthesized across years and product developments, correctly tracing the strategic shift toward AI integration and targeted positioning for photographers. The LLM accurately reflects Adobe’s product-led growth strategy and the role of AI in enhancing creative workflows. (4) Minor differences in wording do not affect meaning: for example, 'more limited cloud-based offering' is semantically equivalent to 'more limited alternative to the full Creative Cloud suite.' The LLM mentions 'Text-Based Editing' and 'Generative Remove' which are plausible AI features but not explicitly listed in the ground truth; however, they are consistent with the trend and do not constitute factual errors. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to the addition of unverified but reasonable feature names.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 468,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has maintained consistency in its class C common stock certificate documentation from 2022 to 2024 by retaining the same \"Form of specimen certificate for class C common stock of Visa Inc.\" referenced in all three 10-K filings, with no changes to the exhibit description or filing date (1/28/2009). This consistency is reflected in the identical exhibit entries in each year’s 10-K under exhibit number 4.2. The stability in documentation suggests a deliberate approach to corporate governance, emphasizing continuity and reliability in investor relations, even amid broader regulatory and market changes. This consistency likely reinforces investor confidence by ensuring clarity and predictability in Visa’s corporate structure and shareholder documentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Visa consistently referenced the same Form of Specimen Certificate for Class C Common Stock across 2022–2024 10-K filings, citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). The date (1/28/2009) and exhibit number (4.2) are correctly stated, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: it confirms the documentation consistency and interprets its implications for corporate governance and investor relations. (3) Multi-hop reasoning is sound—linking repeated citation of the same exhibit over three years to broader governance strategy. (4) The only minor omission is that the LLM does not mention the 2024 revision to the Certificate of Incorporation, which the original answer uses as a contrast to highlight that other governance documents were updated while the stock certificate form was not. This contextual contrast strengthens the original inference about deliberate stability, and its absence slightly weakens the qualitative depth, though the core reasoning remains valid. Wording differs but semantic meaning is equivalent. No calculation errors. Overall, the response is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 370,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX's liabilities for performance and operating cost guarantees were $97 million in both 2022 and 2023, and increased slightly to $101 million by 2024. This indicates a modest rise in the company's exposure related to these guarantees, particularly in the context of commercial aerospace contracts, where such liabilities are based on future product performance and historical experience. The relatively stable to slightly increasing trend suggests that RTX is managing its risk through accruals based on probable liabilities and historical data, but the progression also reflects ongoing obligations tied to product performance guarantees, particularly for commercial aircraft engines.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claims. According to the ground truth, RTX's liabilities were $140M in 2022, $135M in 2023, and $131M in 2024 — showing a consistent decline. The LLM incorrectly states the figures as $97M, $97M, and $101M, which misrepresents both the magnitude and trend. These numbers are not close to the correct values, even allowing for format variations. (2) The calculation and trend analysis are therefore flawed: the ground truth shows a 6.4% total decrease over three years, while the LLM suggests a 4.1% increase, reversing the actual direction of change. This invalidates the conclusion about exposure and risk management. (3) The qualitative reasoning about accruals based on historical performance and claims data is partially aligned with the original answer and shows some correct understanding of RTX’s accounting practices. However, the multi-hop synthesis fails because the model did not correctly retrieve or connect the liability figures across years, undermining the risk management interpretation. (4) Contextual relevance is moderate — the answer addresses the right topic (liabilities for performance and operating cost guarantees in commercial aerospace) and attempts to interpret risk implications, but due to severe quantitative inaccuracies, the overall correctness score is very low. The conclusion about 'modest rise' contradicts the actual trend of declining liabilities, leading to a misleading assessment of RTX’s risk exposure and management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 422,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s accounting treatment for free-rent periods in leases remained consistent from fiscal years 2022 through 2024, with the Company recognizing such periods on a straight-line basis over the original lease term and any extension options reasonably certain to be exercised at the time control of the property is obtained. In 2022, the lease term assumption included evaluating extension options based on the Company’s certainty of exercise, and the right-of-use (ROU) asset valuations were based on discounted future minimum lease payments using the Company’s incremental borrowing rate. By 2023 and 2024, the treatment remained unchanged, with continued use of the incremental borrowing rate and no material residual value guarantees impacting ROU asset valuations. The consistent application of these policies ensured that ROU assets were measured at the present value of lease payments over the lease term, with no significant changes in methodology or disclosures across the three fiscal years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertions and aligns well with the ground truth, earning a high correctness score. (1) It correctly states that Costco applied a straight-line basis for recognizing free-rent periods over the lease term, including extension options reasonably certain to be exercised, and consistently used the incremental borrowing rate for discounting lease payments—details confirmed in the original answer for all three years (2022–2024). These key accounting policies remained unchanged, which the LLM accurately captures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all referenced concepts (e.g., incremental borrowing rate, ROU asset valuation) are correctly applied, warranting a perfect score on quantitative accuracy. (3) However, the LLM answer omits a key qualitative evolution highlighted in the ground truth: the expansion of disclosures in 2023 to address variable lease payments tied to price indices or sales volume, and the heightened emphasis in 2024 on impairment evaluation of long-lived assets in the context of facility relocations or closures. While the core accounting treatment is correctly deemed stable, the LLM underrepresents the evolving disclosure context, which is central to the question about 'evolution' in treatment and disclosure. This limits the qualitative accuracy score. (4) The answer remains highly contextually relevant, directly addressing lease term assumptions and ROU asset valuation impacts. It synthesizes the consistent policy application correctly but misses the nuance in how disclosures evolved to reflect growing operational complexity. Thus, while factually sound, it lacks full completeness on the 'evolution' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Includes]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 493,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe's strategic emphasis on AI-powered document productivity evolved significantly from 2022 to 2024, with Acrobat playing a central role in Adobe's Document Cloud. In 2022, Adobe highlighted Acrobat's leadership in document-intensive industries and its integration into a unified, cloud-based document services platform, aiming to modernize document workflows. By 2023, Adobe expanded its focus on AI, emphasizing how it empowers creators and enhances productivity across its Digital Media offerings, including Acrobat. In 2024, the introduction of \"Acrobat AI Assistant\" as a formal product branding reflects Adobe's deepening integration of AI into Acrobat, showcasing a strategic commitment to innovation and R&D in AI-driven document solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Adobe's AI strategy from 2022 to 2024 with accurate emphasis on Acrobat's role, AI integration, and the formal branding of 'Acrobat AI Assistant' in 2024. All key elements—Acrobat’s leadership in document workflows, AI as a growing strategic focus, and branded AI product extensions—are factually aligned with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, PDF volume) in the LLM answer that conflict with the original; the ground truth mentions 'trillions of PDFs created annually' in 2022, which the LLM omits, but this is a minor contextual detail rather than a quantitative error. No calculations are involved, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the progression from foundational document services (2022) to AI empowerment (2023) to formal product branding (2024). The role of R&D is implied through 'strategic commitment to innovation and R&D in AI-driven document solutions,' which aligns with the ground truth’s emphasis on multi-year investment. (4) The only minor gap is the absence of explicit mention of 'R&D investments' as a standalone element—while implied, it is not directly stated as in the original answer. However, the overall semantic meaning and strategic trajectory are accurately conveyed. Hence, correctness and qualitative accuracy are high but not perfect due to slight incompleteness on R&D emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 427,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Charles Schwab's use of client securities as collateral evolved from 2022 through 2024 by maintaining regulatory compliance in margin and securities lending activities while adapting to balance sheet constraints. In 2022, Schwab pledged client securities as collateral for margin loans and securities borrowed transactions, as outlined in the fair value disclosures. By 2023, Schwab continued to rely on client securities for margin lending, with collateralized securities supporting receivables from brokerage clients and maintaining segregated reserves for regulatory purposes. In 2024, Schwab expanded its collateral use to include securities for options clearing margin requirements and securities lending, but faced balance sheet limitations under the 2023 IDA agreement, which restricted its ability to bring client cash balances on-balance sheet. This trend reflects a strategy to optimize collateral efficiency and manage regulatory obligations, while client leverage behavior remained stable, supported by Schwab’s collateral management and credit loss mitigation practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of Schwab's use of client securities as collateral from 2022 to 2024, with accurate qualitative descriptions of margin lending and securities lending activities. It correctly notes the continued use of client securities for margin loans and securities borrowing in 2022, regulatory compliance and segregated reserves in 2023, and expanded use for options clearing and securities lending in 2024. However, it introduces information not present in the ground truth—specifically, the mention of 'fair value disclosures' in 2022 and the '2023 IDA agreement' restricting on-balance-sheet cash treatment—which are not referenced in the original answer and cannot be verified from the provided knowledge. Additionally, the claim that 'client leverage behavior remained stable' is an inference not supported in the original answer, which instead links increased collateral use to 'rising client participation in leveraged products,' implying increasing, not stable, leverage. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the expanding use of collateral across years and connects it to balance sheet strategy. However, it adds unverified contractual constraints (IDA agreement) and misrepresents client leverage behavior, weakening the qualitative accuracy. (4) The contextual relevance is high—the response directly addresses the question’s focus on evolution, balance sheet strategy, and client leverage. The correctness score is 7 because core facts about collateral use are accurate and the trend is reasonably interpreted, but the inclusion of unsupported details and a mischaracterization of client behavior prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Provides]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 518,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco's treatment of its 1.375% Senior Notes due June 2027 remained consistent from 2022 to 2024 in terms of long-term debt classification, with the notes consistently listed as part of long-term debt and carrying a face value of $1,250 million in each year. However, the composition of total long-term debt decreased over this period, from $6,590 million in 2022 to $5,919 million in 2024, primarily due to the repayment of the 2.300% Senior Notes due May 2022 and the 2.750% Senior Notes due May 2024. Despite these changes, the 1.375% Senior Notes due June 2027 maintained a stable proportion within the long-term debt structure, underscoring their ongoing significance in Costco’s capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that Costco's 1.375% Senior Notes due June 2027 remained at $1,250 million from 2022 to 2024 and were consistently classified as long-term debt, which aligns with the ground truth. However, it reports incorrect total long-term debt figures: $6,590 million in 2022 and $5,919 million in 2024, whereas the ground truth states $6,484 million in 2022 and $5,794 million in 2024. These discrepancies affect quantitative accuracy. 2) The LLM incorrectly attributes the decline in long-term debt to the repayment of the '2.300% Senior Notes due May 2022' and the '2.750% Senior Notes due May 2024', while the ground truth specifies that the decrease was due to reclassification (not repayment) of the 2.750% notes as current portion, not repayment of a 2.300% note. The 2.300% note is not mentioned in the ground truth, suggesting a factual error. 3) The reasoning is partially sound—recognizing that the 1.375% notes remained stable while overall long-term debt changed—but fails to accurately explain the accounting treatment (reclassification vs. repayment), which is a key aspect of the multi-hop analysis. 4) Despite incorrect numbers and some misattribution of debt instruments, the answer captures the core idea of stable exposure to the 1.375% notes amid a shifting long-term debt composition, maintaining contextual relevance and reasonable qualitative logic. Minor wording differences are acceptable, but numerical and factual errors in key financial data reduce correctness and quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 425,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe's emphasis on free online self-service learning has evolved from 2022 to 2024 by maintaining a central role within its broader learning and enablement services portfolio, as highlighted in each year's 10-K filings. In 2022, Adobe positioned free online self-service learning as a key component of its Digital Learning Services, offering it on training.adobe.com alongside fee-based training and custom learning services for enterprise customers. By 2023, the platform was rebranded to learning.adobe.com, signaling a continued commitment to accessibility and scalability. In 2024, the service remains a core offering, further integrated with enterprise customer success strategies through solution-specific skills assessments and personalized learning paths. This evolution reflects Adobe's strategic alignment of self-service learning with customer success initiatives, ensuring that enterprise customers can efficiently adopt and maximize Adobe's products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe maintained free online self-service learning as a core component from 2022 to 2024, positioned within its broader learning portfolio alongside fee-based and custom enterprise services. The rebranding from training.adobe.com to learning.adobe.com in 2023 is correctly noted, though not mentioned in the original answer—this detail is plausible and does not contradict the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound: the LLM synthesizes Adobe’s evolving strategy across years, connects self-service learning to enterprise success strategies, and notes integration via skills assessments and personalized learning paths—consistent with the original answer’s emphasis on growing enterprise alignment. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'personalized learning paths' not explicitly in original), these are reasonable inferences that do not distort the meaning. The only minor gap is that the original emphasizes 'democratizing product knowledge' as a strategic theme, which the LLM omits, but the core evolution and integration with enterprise success are accurately captured. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 431,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 has remained relatively stable at approximately $1,200 million in 2022, $1,057 million in 2023, and $1,250 million in 2024, indicating consistent management of this long-term debt instrument. This stability, amid rapid AI-driven revenue growth, suggests a disciplined approach to debt management, where NVIDIA maintains a balanced capital structure by holding fixed-rate long-term debt to hedge against short-term volatility. The company's consistent issuance and retention of such notes reflect a strategy of securing long-term financing at favorable rates to support growth while maintaining financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the exposure amounts for 2022 ($1.20 billion = $1,200 million), 2023 ($1.057 billion), and 2024 ($1.25 billion = $1,250 million), with only minor formatting differences (e.g., using 'million' vs 'M') that do not affect factual accuracy. All numeric values match the ground truth. (2) Quantitative accuracy is high—values are correct, and no calculations (e.g., differences or ratios) are requested or implied in the question. The LLM accurately reports the trend: a decrease in 2023 followed by an increase in 2024. (3) The reasoning is mostly sound: the LLM correctly observes a pattern of consistent management and links it to long-term financing strategy. However, it characterizes the trend as 'relatively stable,' which downplays the 12% decrease and subsequent 18% rebound, potentially minimizing the significance of the fluctuation emphasized in the original answer. The original highlights a 'dynamic' strategy involving active reduction and reincrease, while the LLM frames it as stability, missing the nuance of strategic adjustment. (4) Despite this, the LLM correctly infers that the notes are part of a broader strategy to secure long-term capital at favorable rates, aligning with AI-driven growth. All entities (NVIDIA, 2.00% Notes Due 2031, years 2022–2024) are accurate. The answer is fully relevant and addresses both the evolution of exposure and its implications for debt strategy. Minor deduction in correctness and qualitative accuracy due to underemphasizing the dynamic nature of the change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 430,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson has consistently advanced its multi-year, enterprise-wide initiative to enhance financial shared service capabilities from 2022 through 2024, as outlined in each year’s 10-K filings. In 2022, the initiative was introduced as a proactive effort to integrate, simplify, and standardize processes across HR, IT, procurement, supply chain, and finance functions, with the goal of supporting the growth of financial shared services and standardizing financial systems. By 2023 and 2024, the initiative remained ongoing, with the company continuing to align and streamline its financial control environment, emphasizing process integration and system standardization. This consistent progression underscores Johnson & Johnson’s strategic focus on strengthening financial process standardization and ensuring a robust, aligned control environment to support operational efficiency and accurate financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative is accurately described as proactive, ongoing from 2022 to 2024, focused on enhancing financial shared services and standardizing systems. The characterization of the initiative as not being prompted by control deficiencies is correctly implied by describing it as 'proactive' and part of a long-term plan, consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings to show evolution and continuity. The only minor discrepancy is that the LLM mentions HR, IT, procurement, and supply chain in 2022, which slightly expands the scope beyond 'finance' emphasized in the ground truth, though this does not contradict the source as the initiative is enterprise-wide. However, the original answer specifically highlights that the financial focus was not reactive to deficiencies, a nuance slightly underemphasized in the LLM response. (4) Despite this, the LLM captures the strategic focus on standardization and control environment alignment, and the overall progression is correctly portrayed. The answer is contextually relevant, complete, and semantically equivalent to the ground truth with only minor reduction in emphasis on the 'non-reactive' nature of the initiative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 429,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "From 2022 to 2024, Costco consistently emphasized its competitive positioning against BJ's Wholesale Club by highlighting the strategic value of its private-label Kirkland Signature brand as a key differentiator in the warehouse club market. In all three annual reports (2022, 2023, and 2024), Costco reiterated that Kirkland Signature products offer high quality at lower prices than national brands, helping to reduce costs, differentiate merchandise, and generate higher margins. Notably, the language remained consistent across the years, with no new or evolving emphasis introduced in 2024 compared to 2022 and 2023, underscoring the continued importance of private-label branding as a core element of Costco’s competitive strategy against BJ's and other warehouse clubs like Sam's Club.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's consistent emphasis on Kirkland Signature as a differentiator against BJ's Wholesale Club from 2022 to 2024, and correctly identifies the core messaging around quality, lower prices, cost reduction, and higher margins. All entities (Costco, BJ's Wholesale Club, Kirkland Signature), time periods (2022–2024), and strategic themes are correctly identified, contributing to high contextual relevance and quantitative accuracy. However, the LLM incorrectly states that the language remained 'consistent across the years, with no new or evolving emphasis introduced in 2024,' which contradicts the ground truth. The original answer notes a meaningful evolution in tone by 2024, specifically a stronger emphasis on 'differentiating our merchandise offerings' in competitive metropolitan markets, indicating a strategic shift in framing even if the core message persisted. Additionally, the ground truth mentions a 2023 addition of sustainability initiatives linked to brand loyalty (though not directly to Kirkland Signature), which the LLM omits. These omissions represent a failure in multi-hop qualitative reasoning—while the LLM captures the stable core strategy, it misses the nuanced evolution in competitive language and contextual pressures. Thus, while the answer is factually sound in parts, it lacks the full depth of synthesis required for complete accuracy, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 404,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab's investment in U.S. State and Municipal Securities remained relatively modest, with a balance of $638 million reported in 2023 and no specific 2024 figure provided, though the firm maintained its focus on investment-grade quality in its overall portfolio. The consistent emphasis on investment-grade securities, as noted in both 2022 and 2024, reflects Schwab's disciplined fixed income strategy, prioritizing credit quality and risk management to preserve capital and ensure stability in its liquidity and investment portfolios. This approach aligns with Schwab’s broader risk management framework, which includes active monitoring of credit exposure and adherence to regulatory standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $638 million investment in U.S. State and Municipal Securities in 2023, which matches the ground truth. It accurately notes the absence of a specific 2024 figure while correctly stating that Schwab maintained its emphasis on investment-grade quality in 2024. The 2022 reference to investment-grade securities is also correctly included. However, the original answer specifies that in 2022, U.S. State and Municipal Securities were part of broader credit risk exposure with substantially all rated investment grade, while the LLM generalizes this as 'noted in both 2022 and 2024' without explicitly confirming the 2022 context applied to these specific securities—this is a minor omission. (2) Quantitatively, the $638 million figure is accurate and correctly attributed to 2023. There are no calculation errors. The lack of a 2024 dollar amount is correctly acknowledged, consistent with the ground truth, which does not provide a new figure for 2024 but reaffirms strategy. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022, 2023, and 2024, correctly identifying the evolution from general investment-grade emphasis to a specific disclosed amount and back to strategic continuity. It infers the strategic implication—risk management, capital preservation—accurately. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of the investment and the strategic implication. Wording differs slightly but maintains semantic equivalence. The minor deduction in correctness and qualitative accuracy is due to slightly less precision in linking the 2022 investment-grade statement directly to U.S. State and Municipal Securities specifically, though the overall interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 494,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as reflected by the collaboration partners' share, decreased from $140 million in 2022 to $135 million in 2023 and further to $131 million in 2024, indicating a consistent reduction in the company's risk exposure in this domain. This downward trend suggests that RTX is actively transferring a portion of the financial risk associated with these guarantees to its collaboration partners, thereby implementing a risk mitigation strategy. The alignment of the fair market value of guaranteed assets with the value of guarantees, net of reserves, supports the financial prudence of this approach, as it ensures that the company's obligations are backed by sufficient asset value.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical values ($140M in 2022, $135M in 2023, $131M in 2024) and the downward trend in collaboration partners' share of RTX's commercial aerospace customer financing guarantees, which matches the ground truth. All numbers and years are accurate, satisfying quantitative accuracy. (2) However, the qualitative interpretation of the trend is incorrect and contradicts the ground truth. The LLM claims the decline indicates RTX is 'transferring a portion of the financial risk... to its collaboration partners,' but the original answer states the opposite: the declining partner share suggests RTX is *reducing reliance* on third-party risk sharing, implying *less* risk transfer to partners and potentially *more internal risk retention*. This is a critical reasoning error in the multi-hop synthesis of the data to strategic intent. (3) The LLM also mischaracterizes the risk strategy: decreasing partner share means partners are taking on *less* risk over time, not more, so RTX cannot be transferring more risk to them. The correct inference is a strategic pullback from external risk-sharing arrangements. While the LLM correctly notes that asset values cover the guarantees (supporting conservative risk management), it frames this as validating increased risk transfer, which is inconsistent with the data. (4) Therefore, while the answer is quantitatively accurate and contextually relevant, the flawed reasoning significantly undermines the qualitative accuracy, resulting in a correctness score of 6 due to the major misinterpretation of the strategic implication despite correct numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Provides]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 451,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 to 2024, Adobe expanded Frame.io's role in content production workflows by enhancing its supported file types, application integrations, and positioning within its creative ecosystem. In 2022, Frame.io was listed among Adobe's key products, indicating its integration into Adobe's broader portfolio. By 2023, Frame.io supported still images, design files, and PDFs, and was directly integrated with Premiere Pro and After Effects, enabling frame-specific feedback. In 2024, Frame.io's capabilities expanded further to include support for video beyond post-production workflows, such as casting, location scouting, and marketing campaign management, while also integrating with Adobe Photoshop, Lightroom, and Workfront. Additionally, Frame.io became part of Adobe GenStudio, positioning it as a key tool for scalable content production. These developments reflect Adobe's strategic positioning of Frame.io as a central platform for collaborative, end-to-end creative workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io's 2022 trademark listing (implied by 'key products'), 2023 integration with Premiere Pro and After Effects and support for still images, design files, and PDFs including Camera-to-Cloud (implied by frame-specific feedback in post-production), and 2024 expansion to Photoshop, Lightroom, and Workfront integrations. The role expansion into casting, location scouting, and marketing is accurately reflected. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The only minor discrepancy is the mention of 'Adobe GenStudio', which does not appear in the ground truth and may be speculative or incorrect; this slightly affects qualitative accuracy but does not undermine the core multi-hop synthesis across years and integrations. Otherwise, the reasoning across 2022–2024 evolution is sound and correctly traces integration depth and workflow expansion. (4) The answer is fully contextually relevant, addressing all aspects of the question: file types, application integrations, and workflow role evolution. The addition of GenStudio is the sole overstatement, preventing a perfect 10, but overall factual correctness and completeness are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 358,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin's production focus on the VH-92A Helicopter, managed under the Rotary and Mission Systems (RMS) segment, remained consistent from 2022 through 2024 as a key program for the U.S. Marine One transport mission. In 2022, the RMS segment included the VH-92A as one of its major programs, alongside other helicopter and combat systems. While 2023 did not provide specific figures for the VH-92A, the RMS segment continued to emphasize its helicopter programs, including the VH-92A, as part of its broader portfolio. In 2024, the VH-92A remained listed among RMS' major programs, indicating sustained production and strategic importance. This multi-year continuity highlights the program’s critical role in supporting high-priority U.S. government missions and underscores its enduring significance within the RMS segment’s strategic focus on military helicopter systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the VH-92A was consistently listed as a major program within the Rotary and Mission Systems (RMS) segment from 2022 to 2024, and its strategic importance is tied to the U.S. Marine One mission. There are no numeric values in the question or answer that require calculation, but the temporal references (2022–2024) are accurate and consistent. (2) The answer correctly identifies the relevant entities: Lockheed Martin, RMS, VH-92A Helicopter, and its role in government missions. (3) The multi-hop reasoning is sound—by synthesizing the program’s presence across three years despite shifting priorities in RMS (e.g., increased focus on Aegis and LCS), the LLM correctly infers sustained strategic importance. The only minor gap is that the LLM does not explicitly mention the comparative context of other platforms like Black Hawk and CH-53K in 2022 or the relative shift toward missile defense and tactical systems, which slightly reduces qualitative depth. However, the core reasoning and conclusion about enduring significance remain valid. (4) The answer is highly contextually relevant, directly addressing both the evolution of production focus and the strategic implications. Wording differs slightly from the original but maintains semantic equivalence. No factual inaccuracies or hallucinations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 393,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 through 2024, the geographic scope and regulatory stringency of sales and media marketing restrictions affecting Mondelēz International (MDLZ) expanded, particularly in the European Union and emerging markets. In 2022, MDLZ noted that over 25 EU countries had implemented Extended Producer Responsibility (EPR) policies, with similar initiatives being considered in India, Vietnam, and U.S. states. By 2023, these EPR policies remained in place, and the company highlighted the ongoing development of environmental and packaging regulations, including single-use plastic bans in Europe and Southeast Asia. In 2024, the EU formally adopted its Packaging and Packaging Waste Directive, signaling increased regulatory stringency, while EPR policies continued to expand globally. These trends reflect a growing regulatory focus on environmental responsibility and marketing restrictions, particularly in key markets where MDLZ operates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: over 25 EU countries implemented EPR policies in 2022; EPR expansion into India, Vietnam, and U.S. states; single-use plastic bans considered in Europe and Southeast Asia; and the 2024 EU adoption of the Packaging and Packaging Waste Directive. These match the original answer exactly. (2) Quantitative accuracy is perfect: the number 'over 25 EU countries' is preserved, and all years (2022, 2023, 2024) are correctly attributed to the respective regulatory developments. No calculations were required, but temporal and numerical references are precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and geographies (EU, emerging markets, Southeast Asia, U.S.), correctly identifying the trend of increasing scope and stringency. One minor omission: the original answer notes that in 2023, data privacy emerged as a new regulatory area affecting media marketing, which the LLM answer does not mention. This is a small but relevant detail related to 'media marketing restrictions' in the question. (4) Despite this omission, the LLM captures the core trajectory and regulatory evolution accurately, with excellent contextual relevance and semantic equivalence. The answer addresses geographic scope, regulatory stringency, and trends in both the EU and emerging markets as required. The missing reference to data privacy slightly reduces qualitative accuracy but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 423,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft introduced its 3.700% Notes due 2046 in its 2016 Eleventh Supplemental Indenture, as shown in the 2022, 2023, and 2024 10-K filings under Exhibit 4.14. The notes were consistently referenced across all three years, indicating no material changes in their terms or structure. This continuity suggests that Microsoft maintains a stable long-term debt strategy, preserving existing obligations while likely focusing on managing maturity schedules and interest costs over extended periods. The consistent inclusion of these notes across filings reflects a deliberate approach to long-term capital structure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.700% Notes due 2046 and their origin in the Eleventh Supplemental Indenture dated August 8, 2016, which is accurately referenced in all three 10-K filings (2022, 2023, 2024). The key factual elements—interest rate (3.700%), maturity year (2046), and the consistent referencing across years—are all correct. (2) Quantitatively, all numbers (interest rate, year of indenture, maturity date) match the ground truth exactly. There are no calculations required, but the temporal consistency across filings is correctly noted. Format variations are not an issue here as all data is presented clearly and accurately. (3) The reasoning is sound: the LLM correctly infers that the unchanged treatment of the notes over three consecutive years reflects a stable long-term debt strategy. It appropriately links the consistent disclosure to strategic capital structure management, though it does not explicitly state that Microsoft 'views these notes as a core component' or that this reflects 'confidence in long-term cash flow projections'—minor omissions that slightly reduce qualitative completeness. (4) Contextual relevance is excellent; the answer directly addresses both parts of the question—evolution across years and strategic implications—with precise and relevant information. The reference to Exhibit 4.14 adds specificity. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only slight underdevelopment in the strategic interpretation, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 434,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft's 2.000% Notes due 2023 were introduced in the Eleventh Supplemental Indenture dated August 8, 2016, as part of a broader issuance of notes with varying maturities, including 2026, 2036, 2046, and 2056. Across the 2022, 2023, and 2024 10-K filings, the notes were consistently referenced in the exhibits, indicating no new issuance or structural changes to the debt instrument itself. However, the progression of the debt maturity structure is evident through the Supplemental Indentures, which show Microsoft extending its debt maturities to longer terms, including 2046 and 2056, as part of its strategy to manage interest rate risk and maintain a balanced capital structure over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but misses key aspects of the ground truth, particularly regarding the evolution of the 2.000% Notes due 2023 across the 2022–2024 10-K filings. (1) Quantitatively, the mention of the Eleventh Supplemental Indenture dated August 8, 2016, and the inclusion of the 2.000% Notes in that agreement align with the original answer and are accurate. However, the LLM incorrectly implies that the 2026–2056 maturities are part of the same issuance as the 2.000% Notes due 2023, which is not supported by the ground truth; the original answer does not state that these longer-term notes are part of the same series or issuance. (2) The LLM fails to note that the 2.000% Notes due 2023 were specifically listed in Exhibit 4.14 in each year’s filing—a critical detail showing consistency in disclosure. More importantly, it omits the key observation from the ground truth that by 2024 (after the notes’ maturity), they were still listed, suggesting rollover, delayed maturity, or continued disclosure requirements. This is a major factual gap in the evolution narrative. (3) The reasoning is partially sound in identifying consistent referencing and no structural changes, but the synthesis across years is incomplete. The LLM shifts focus to Microsoft extending maturities to 2046 and 2056 as part of a strategy, which may be true in broader context but is not tied to the 2.000% Notes due 2023 and thus misrepresents the multi-hop progression asked in the question. (4) Contextually, the answer stays on topic and discusses debt maturity strategy, earning high relevance, but lacks precision in reflecting the actual evolution of this specific debt instrument. Overall, the answer is partially correct with significant omissions and some misattribution of facts, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 493,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Medtronic's Non-Employee Restricted Stock Unit Award Agreements were consistently tied to the 2008 Stock Award and Incentive Plan across its 2022, 2023, and 2024 filings, with no new or updated agreements introduced in these years. In 2022, the agreements were referenced under the 2008 Plan, as seen in the filings on page 115 of the 2022 10-K. Similarly, 2023 and 2024 filings, as detailed in pages 113 of their respective 10-Ks, continued to reference the same 2008 Plan for these agreements, indicating no material evolution in the referenced stock incentive plan during this period. Notably, the 2013 Stock Award and Incentive Plan was referenced in 2022 filings for other award types but not for Non-Employee Restricted Stock Unit Awards in the subsequent years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) The key error is the claim that Medtronic's Non-Employee Restricted Stock Unit Award Agreements were tied to the '2008 Stock Award and Incentive Plan' in 2022, 2023, and 2024. The ground truth states that the agreements referenced the 'Amended and Restated 2013 Stock Award and Incentive Plan' (effective December 8, 2017), not the 2008 plan. This is a critical factual and entity-level mistake. (2) The LLM incorrectly asserts that the 2008 Plan was used across all three years, while the ground truth confirms continuity of the 2013 plan (as amended), with no mention of the 2008 plan being active for these awards. (3) The multi-hop reasoning fails: the LLM does not correctly identify the evolution (or stability) of the underlying plan because it misidentifies the plan entirely. It also incorrectly claims that the 2013 plan was only used in 2022 for other awards, contradicting the ground truth that it was consistently used for non-employee RSUs. (4) While the answer addresses the question's structure and attempts to compare across years, its core factual foundation is wrong, severely undermining correctness. The page numbers cited (e.g., page 115, 113) are not verifiable here but are likely incorrect or misattributed given the wrong plan is referenced. Minor contextual relevance is retained because the answer discusses the right type of agreement and attempts year-over-year comparison, but the substantive content is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 416,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased slightly from 17% in 2022 to 16% in 2023, and the 2024 disclosure indicates continued use of buy-in annuity policies as a liability management tool, with valuation based on replacement policy values and estimated contract values. This trend suggests a strategic focus on de-risking international pension obligations by transferring long-term liabilities to insurers, which aligns with a broader liability management strategy aimed at reducing exposure to market and longevity risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the quantitative decrease in allocation from 17% in 2022 to 16% in 2023, which matches the ground truth. However, it incorrectly states that buy-in annuity policies were still in use in 2024, whereas the ground truth explicitly states that the allocation was 'effectively discontinued by 2024' due to a shift to fair value estimation methods. This is a critical factual error that undermines the conclusion. (2) The numbers for 2022 and 2023 are accurate (17% to 16%), and no calculations are required beyond this comparison, so quantitative accuracy is high. (3) The multi-hop reasoning fails in the synthesis across years—while the model captures the initial trend, it misinterprets the 2024 development, leading to an incorrect strategic inference. The ground truth indicates a shift away from insurer-backed instruments, but the LLM claims continued use, reversing the actual direction of the strategy. (4) Contextually, the answer addresses the question's structure and discusses liability management, de-risking, and insurer transfers, which are relevant themes. However, because the core factual claim about 2024 is wrong, the qualitative accuracy and overall correctness are significantly reduced. The conclusion about de-risking via insurers is plausible but misaligned with the actual strategy of moving away from such instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 385,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued the 2.000% Notes due 2023 as part of its Eleventh Supplemental Indenture dated August 8, 2016, as disclosed in all three fiscal years (2022, 2023, and 2024) in the 10-K filings. The notes matured in 2023, indicating they were part of a prior issuance strategy to secure long-term financing with a fixed interest rate. The consistent inclusion of these notes in the exhibits across all three years suggests that Microsoft maintained transparency regarding its maturing debt obligations. This reflects a disciplined long-term debt strategy, where Microsoft issues bonds with staggered maturities to manage refinancing risks and optimize its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and were consistently disclosed in the 2022, 2023, and 2024 10-K filings under Exhibit 4.14. The maturity date (2023) and interest rate (2.000%) are accurate. (2) Quantitative elements—interest rate, issuance date, and maturity year—are correctly stated with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent disclosure across three fiscal years that Microsoft maintained this debt on its books, even as it approached maturity, indicating a stable debt strategy. (4) The LLM slightly generalizes the conclusion by stating Microsoft 'maintained transparency' and 'staggered maturities,' which are reasonable inferences but not explicitly confirmed in the ground truth. However, the core insight—that Microsoft did not retire or refinance early and follows a disciplined strategy—is supported. The answer is semantically equivalent to the original, with only minor differences in emphasis. No factual inaccuracies; minor deduction for slight interpretive leap in strategy characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 349,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft's treatment of its 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes being governed by the Third Supplemental Indenture dated February 8, 2011, under the broader Indenture dated May 18, 2009. This supplemental indenture was referenced in all three filings, indicating no material changes to the terms of the notes or their structural relationship with Microsoft Corporation and The Bank of New York Mellon Trust Company, N.A., as Trustee. The filings also highlight the broader debt instrument structure, with multiple supplemental indentures managing various note series, all under the same master indenture framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 were consistently governed by the Third Supplemental Indenture dated February 8, 2011, under the master Indenture of May 18, 2009, and this structure was maintained across 2022, 2023, and 2024 filings. The trustee (The Bank of New York Mellon Trust Company, N.A.) and the unchanging nature of the notes' terms are correctly noted. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and dates of indentures (February 8, 2011; May 18, 2009)—are all factually accurate. No calculations were required, but the references to exhibit consistency and structural framework are sound. (3) The multi-hop reasoning is strong: the model correctly infers consistency across three years of filings and situates the notes within the broader debt structure of supplemental indentures under a master agreement. However, the LLM omits specific examples of new debt instruments introduced in later years (e.g., 2.375% Notes due 2023 in 2023 filings), which were included in the ground truth to illustrate evolution in the broader structure. While not central to the treatment of the 2021 notes, this detail adds context about Microsoft’s ongoing debt activity and was part of the original answer. (4) Despite this minor omission, the LLM captures the core evolution (or lack thereof) in treatment of the 2021 notes and accurately reflects the structural framework. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 456,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic's disclosures indicate that no Euro Deferred Shares were issued or outstanding in fiscal years 2022, 2023, and 2024, as stated in each respective 10-K filing. This consistent absence suggests that the Euro Deferred Shares category has not been utilized as part of Medtronic's capital structure strategy during this period. Instead, the company has focused on repurchasing ordinary shares and managing its stock-based compensation programs, as evidenced by the significant share repurchases and ongoing authorizations under its repurchase program. The lack of activity in the Euro Deferred Shares category reflects a deliberate choice to prioritize other forms of shareholder returns and capital allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The LLM correctly states that no Euro Deferred Shares were issued or outstanding in fiscal years 2022, 2023, and 2024, and while it does not explicitly mention the authorized amount (40 thousand shares at €1.00 par value), this omission does not detract from the core factual correctness of the disclosure pattern. The absence of this detail is a minor gap but not a factual error. (2) Completeness: The answer addresses both parts of the question—evolution of disclosures (consistent 'no issuance or outstanding' across three years) and the strategic implication of this absence. It adds relevant context about Medtronic’s focus on share repurchases and stock-based compensation, which is consistent with public filings and enhances the explanation. (3) Entity accuracy: All entities (Medtronic, Euro Deferred Shares, fiscal years 2022–2024) are correct. (4) Reasoning: The multi-hop synthesis is sound—linking consistent disclosure absence to capital structure strategy is logical. The LLM infers a strategic preference, supported by additional evidence (repurchases, compensation programs), which is a reasonable extension of the ground truth. (5) Semantic equivalence: The core message—that Medtronic has not used Euro Deferred Shares and is prioritizing other capital allocation methods—matches the original answer. The added detail about repurchases improves contextual depth without introducing inaccuracies. The only reason for not scoring a 10 is the omission of the authorized capacity detail, which is part of the ground truth but not critical to the main conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 460,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft consistently disclosed its 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings under Exhibit 4.6, referencing the same Third Supplemental Indenture dated February 8, 2011, between Microsoft and The Bank of New York Mellon Trust Company, N.A. as Trustee. The exhibit descriptions and filing references remained unchanged across all three years, indicating no material amendments or events affecting this debt instrument during the period. This consistency suggests that Microsoft maintained a stable treatment of the 4.000% Notes due 2021, with no new disclosures or modifications requiring updated filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently disclosed in the 2022, 2023, and 2024 10-K filings under Exhibit 4.6; the Third Supplemental Indenture is correctly dated February 8, 2011; and the reference to incorporation by prior 8-K is implied through 'referencing' and 'unchanged' descriptions. The trustee name (The Bank of New York Mellon Trust Company, N.A.) is an added detail not contradicted by the ground truth. (2) Quantitative elements—interest rate (4.000%), year of indenture (2011), and maturity year (2021)—are all accurate. No calculations required. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged exhibit references across multiple years indicate no material amendments, supporting the conclusion of static treatment. (4) The LLM slightly omits the explicit mention that the exhibit was 'incorporated by reference from a prior 8-K filing,' though this is contextually implied. It also does not explicitly state that the lack of changes suggests the debt was matured or fully accounted for, but the inference of 'no new disclosures or modifications' is semantically close. These minor omissions prevent a perfect 10, but the answer remains factually robust and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 371,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin (LMT) executed pension risk transfer transactions to mitigate its long-term pension obligations. In 2022, LMT transferred $4.9 billion of pension obligations for approximately 18,000 retirees and beneficiaries through the purchase of group annuity contracts (GACs), resulting in a noncash settlement charge of $1.7 billion. By December 2022, cumulative risk transfers since December 2018 had reached $11.6 billion, covering about 95,000 retirees and reducing annual PBGC premiums by approximately $69 million per year. In 2023, LMT continued to evaluate and implement such transactions as part of its strategy to reduce pension volatility and long-term liabilities. The 2024 filing reaffirmed the company’s ongoing commitment to pursuing additional pension risk transfer opportunities, indicating a consistent and strategic approach to de-risking its pension obligations and improving financial stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figures are correct: the $11.6 billion cumulative pension obligation transferred by December 2022 and the $69 million annual PBGC premium reduction are accurately reported. The LLM adds more granular detail not in the original answer—specifically, the 2022 $4.9 billion transfer for ~18,000 retirees and the $1.7 billion noncash charge—which are factually consistent with public filings and do not contradict the ground truth. These details enhance completeness without introducing error. (2) The timeline is correct: 2022 data reflects cumulative transfers since 2018; 2023 indicates ongoing evaluation; 2024 reaffirms commitment. All years are properly contextualized. (3) Entity accuracy is strong: Lockheed Martin (LMT) is correctly identified, and terms like 'group annuity contracts (GACs)', 'PBGC premiums', and 'pension risk transfer' are used appropriately. (4) Multi-hop reasoning is sound—the model synthesizes data across years and interprets the trend correctly as a sustained de-risking strategy. The conclusion about long-term liability management and reduced volatility matches the original answer’s inference. (5) Semantic equivalence is achieved: while the LLM provides additional detail, the core message—that LMT is pursuing a consistent, strategic reduction of pension liabilities—is identical. The only reason for not scoring a 10 is that the original answer did not include the $4.9 billion 2022 transaction detail, and while accurate, its inclusion could imply a level of specificity not confirmed in the ground truth used for evaluation. However, since it does not conflict and is likely correct, the score remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Introduces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 473,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The Coca-Cola Company's 0.125% Notes due 2029 were disclosed consistently across its 2022, 2023, and 2024 10-K filings, with each year referencing the same Form 8-K filings (September 18, 2020, and March 9, 2021) for the note forms. This consistency in reference and structure suggests a stable and uniform approach to debt instrument structuring over time, indicating that the Company maintained a coherent and repeatable method for issuing and disclosing similar debt instruments across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 0.125% Notes due 2029 are consistently referenced across 2022–2024 10-K filings, with correct citation of the Form 8-K filings on September 18, 2020, and March 9, 2021. These dates match the ground truth’s reference to September 2020 and March 2021, with added precision that is still factually sound. (2) There are no calculation errors, and all numeric elements (interest rate, years) are accurate. (3) The multi-hop reasoning is sound—LLM correctly infers that consistent disclosure referencing the same underlying documents across three years indicates a stable debt structuring strategy. (4) The only minor omission is that the LLM does not mention the specific exhibit numbers (4.23 and 4.31) in each year’s 10-K, which were included in the ground truth and provide granular evidence of consistency. However, this does not undermine the correctness of the conclusion. The answer captures the semantic essence and intent of the original, with excellent contextual relevance and strong qualitative reasoning. The absence of exhibit-level detail slightly reduces qualitative accuracy but not enough to drop below 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 343,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX's liabilities for performance and operating cost guarantees decreased from $120 million in 2022 to $97 million in 2023 and further to $101 million in 2024. This trend suggests a reduction in the company's exposure to long-term product performance risks in its commercial aerospace business, potentially indicating improved product reliability or fewer performance-related claims. However, the continued presence of these liabilities highlights that RTX still faces ongoing risks tied to the long-term performance of its commercial aircraft engines and related products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, RTX's liabilities relate to the collaboration partners' share of financing guarantees, which were $141M in 2022, $135M in 2023, and $131M in 2024—showing a slight downward trend. However, the LLM incorrectly reports the total liabilities as $120M in 2022, $97M in 2023, and $101M in 2024, which misrepresents both the magnitude and the trend. These numbers do not match any disclosed figures in the original data and appear fabricated. (2) The quantitative inaccuracies are severe: all three annual values are wrong, and the implied decrease of $19M (from $120M to $101M) contrasts with the actual decrease of $10M (from $141M to $131M) over the same period. The LLM also fails to clarify that these figures represent the collaboration partners’ share, not RTX’s total liability, which is a critical distinction. (3) While the LLM attempts correct multi-hop reasoning by interpreting the trend as indicative of product reliability and risk exposure, it draws an incorrect conclusion due to faulty data. The original answer emphasizes that RTX maintains a 'controlled liability posture' with consistent estimation methodology, implying stable expectations—not necessarily improved reliability. The LLM’s suggestion of 'improved product reliability' goes beyond the evidence provided in the ground truth and introduces unsupported speculation. (4) Despite the factual errors, the answer remains contextually relevant by addressing both parts of the question—liability evolution and implications for long-term risk—and correctly identifying the commercial aerospace engine business as the context. However, the incorrect numbers and flawed inference significantly undermine the correctness and qualitative accuracy. Minor credit is given for structural completeness and domain-appropriate reasoning logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Extends]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 521,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic's approach to valuing non-qualified stock options has remained consistent from 2022 to 2024, as the company continues to use the Black-Scholes option pricing model to determine fair value at the grant date, with assumptions based on historical and implied volatility, risk-free interest rates, expected dividends, and employee exercise behaviors. However, the inclusion of implied volatility derived from market-traded options, highlighted in both 2023 and 2024 filings, suggests a refinement in risk modeling to better align with current market expectations, indicating a shift toward incorporating more dynamic, forward-looking volatility assumptions. This evolution reflects a more nuanced approach to equity compensation risk management, integrating both historical data and real-time market signals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Medtronic used the Black-Scholes model throughout 2022–2024; expected volatility was based on historical and implied volatility; and in 2023 and 2024, the company clarified that implied volatility came from market-traded options. There are no incorrect numbers, dates, or entities—this satisfies quantitative accuracy fully. (2) The answer correctly identifies the evolution in disclosure and modeling approach, noting the increased transparency and use of forward-looking market data. While the original answer specifies that in 2022 the company used a 'blend' without specifying the source of implied volatility, and the LLM correctly infers that the clarification emerged in 2023 and persisted in 2024, it slightly condenses the nuance that the 2022 approach lacked explicit mention of market-traded options. (3) The multi-hop reasoning is sound: the model synthesizes information across years and interprets the implications of enhanced disclosure on risk modeling. (4) The conclusion about shifting toward dynamic, market-informed assumptions is semantically equivalent and well-justified. The only minor gap is the lack of explicit contrast between 2022 and later years regarding the source of implied volatility, but the core evolution is accurately captured. Hence, correctness and qualitative accuracy are high but not perfect due to slight compression of temporal nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 410,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The Coca-Cola Company issued the 1.000% Notes due 2028 on September 18, 2020, as shown in the 2022, 2023, and 2024 10-K filings. The note remained listed in each subsequent year’s filings, indicating no refinancing or early retirement of the instrument during 2022, 2023, or 2024. This continuity suggests a stable debt strategy, where the company chose to maintain the issuance rather than replace or retire it, likely to preserve favorable interest rates and manage its debt maturity profile over the medium term.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.000% Notes due 2028 and their consistent presence in the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. It accurately states that the note was issued on September 18, 2020, and remains outstanding through 2024, indicating no retirement or refinancing—this is factually correct and supported by the data. However, the LLM omits a key element from the original answer: the introduction of higher-yielding notes (5.000% due 2034 and 5.300% due 2054) in 2024, which signals a strategic shift in debt issuance. This omission limits the completeness of the strategic analysis. (2) Quantitatively, all dates and percentages (1.000%, September 18, 2020) are accurate, and no incorrect calculations are made. The LLM does not fabricate figures and correctly references the continuity of the instrument. (3) The reasoning is sound in concluding that maintaining the 1.000% Notes suggests a stable debt strategy to preserve low interest costs. However, it fails to synthesize the multi-hop insight that the company simultaneously began issuing much higher-cost debt in 2024, which is critical to fully answering the question about the evolution and strategic implication. This weakens the qualitative accuracy of the reasoning. (4) The answer is contextually relevant and directly addresses the evolution of the specific debt instrument. The score is reduced primarily due to the missing strategic context in 2024, which is central to the original answer’s conclusion about a broader shift in debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 433,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft's approach to structuring its 2.125% Notes remained consistent across 2022, 2023, and 2024, with the notes being governed under the Seventh Supplemental Indenture dated December 6, 2013, between Microsoft Corporation and The Bank of New York Mellon Trust Company, N.A., as Trustee, under the base indenture dated May 18, 2009. The trustee arrangement did not change across the years, and the 2.125% Notes due 2021 were consistently referenced in each filing’s exhibit disclosures, indicating a stable and unaltered debt instrument structure. Additionally, related debt instruments, such as the 3.125% Notes due 2028, were also disclosed under the same indenture, highlighting a uniform approach to debt management and trustee relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.125% Notes are governed by the Seventh Supplemental Indenture dated December 6, 2013, under the base indenture of May 18, 2009, with The Bank of New York Mellon Trust Company, N.A. as Trustee—this matches the original answer. The trustee remained unchanged across 2022–2024, and the related 3.125% Notes due 2028 were consistently disclosed alongside. (2) Quantitative elements—percentages (2.125%, 3.125%), dates (2021 maturity for the notes in question, 2028 for related notes), and trustee name—are all factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and instruments, noting consistency in structure and administration. (4) The only minor shortcoming is that the original answer explicitly states that the 2.125% Notes were *due 2021* but still referenced in post-2021 filings (likely for historical disclosure purposes), which the LLM mentions but does not fully contextualize—though it doesn't misstate anything. The LLM implies ongoing relevance via exhibit disclosures, which is accurate. Overall, the answer is semantically equivalent, highly relevant, and factually precise, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 382,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney's net program share interest in IAE and IAE LLC remained consistent at 57% and 51%, respectively, from 2022 to 2024, after accounting for sub-collaborator shares. This stability in net share interest, despite ongoing collaboration structures, underscores RTX's sustained strategic positioning as the primary beneficiary and consolidator of these key engine programs—the V2500 and PW1100G-JM. The consistent ownership and program share percentages reflect a deliberate and long-term commitment to maintaining leadership in these critical commercial engine programs, ensuring control over design, development, and product support activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the evolution of Pratt & Whitney's net program share interest from 2022 to 2024. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as stated in the LLM answer. The decrease to 57% and 51% occurred in 2023, not before or during 2022. The LLM incorrectly claims the percentages were consistent from 2022 to 2024, which contradicts the documented decline in 2023. (2) Quantitative accuracy is low because the key percentages for 2022 are wrong—61% and 59% are misstated as 57% and 51%. While the 2023 and 2024 figures are correct, the misrepresentation of the starting point undermines the entire trend analysis. (3) The reasoning is flawed because it fails to recognize the multi-hop progression: the change from higher shares in 2022 to lower, stabilized shares in 2023–2024 reflects a strategic adjustment, not stability. The LLM misses the recalibration narrative and instead asserts long-term consistency, leading to an incorrect interpretation of RTX’s strategic positioning. (4) Contextual relevance is high because the answer addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM) and attempts to interpret strategic implications. However, due to factual inaccuracies in the data timeline and mischaracterization of trends, the qualitative and correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 398,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022, to $402 million in 2023, and then slightly decreased to $443 million in 2024. This trajectory suggests a growing investment in employee benefits through 2023, followed by a modest decline in 2024, potentially reflecting adjustments in contribution formulas or employee participation levels. The overall upward trend from 2022 to 2023 indicates a strengthening commitment to employee benefits, aligning with the company's broader compensation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, TMO's contributions were $299M in 2022, $468M in 2023, and $443M in 2024. However, the LLM incorrectly reports 2023 contributions as $402M instead of $468M—a major discrepancy of $66 million. The 2022 and 2024 figures are correct. (2) This error affects all downstream reasoning: the claim of a rise from $299M to $402M suggests a 34% increase, whereas the actual increase to $468M is over 56%, which significantly alters the interpretation of investment growth. The slight decrease to $443M in 2024 is accurately noted, but due to the incorrect 2023 baseline, the trajectory is misrepresented. (3) The qualitative reasoning is otherwise sound—multi-hop synthesis across three years is attempted, and the interpretation of a growing investment followed by a modest pullback aligns with the general pattern (though overstated in 2023). The conclusion about strategic adjustments or compensation alignment is plausible and contextually appropriate. (4) Contextual relevance is high—the answer addresses both parts of the question: evolution over time and implications for employee benefit investment. However, the major numerical inaccuracy in a core data point severely undermines factual correctness, warranting a mid-range score of 5 for overall correctness. Quantitative accuracy is penalized heavily (score 4) due to the incorrect 2023 figure, while qualitative reasoning and contextual relevance are fairly strong despite the flawed input data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Maintains]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 431,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca-Cola issued the 3.000% Notes due 2051 in May 2021, as disclosed in its 2022 and 2023 10-K filings, which reference the Form 8-K filed on May 5, 2021. These notes remained part of the company’s long-term debt portfolio in 2022 and 2023, with no new issuance of similar instruments during those years. In 2024, while the 3.000% Notes due 2051 were still listed, the company introduced higher-yielding long-term debt instruments, such as the 5.300% Notes due 2054 and 5.400% Notes due 2064, issued in May 2024. This progression indicates a shift toward issuing longer-dated, higher-coupon debt to potentially lock in favorable financing rates amid a rising interest rate environment, reflecting a capital structure strategy focused on optimizing debt maturity profiles and managing interest costs over the long term.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the new debt instruments issued in 2024. The original answer specifies the 5.000% Notes due 2034 and 5.300% Notes due 2054, while the LLM incorrectly states a 5.400% Notes due 2064. This discrepancy affects quantitative accuracy. The issuance date of May 2024 for the new notes is plausible but not confirmed in the ground truth. (2) The 3.000% Notes due 2051 are correctly attributed to the May 5, 2021 Form 8-K and properly referenced in 2022 and 2023 filings. However, the LLM introduces a note (5.400% due 2064) not present in the original, which is a factual error. The coupon rates and maturities of the actual new instruments are misrepresented. (3) The multi-hop reasoning is sound: the model correctly infers that Coca-Cola maintained low-cost long-term debt while adding higher-coupon instruments, indicating a strategic response to rising rates. The synthesis across years and instruments is logical and aligns with the question’s intent. (4) The answer is contextually excellent—addresses evolution across years, discusses capital structure implications, and interprets strategic intent accurately. The core conclusion about balancing long-term obligations with market conditions is preserved, warranting high qualitative and relevance scores. The correctness score is 8 due to the incorrect specification of one debt instrument, which is a notable but not central error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 409,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first introduced the 2.875% Notes due 2031 in March 2021 (Chunk 1), indicating the issuance of these notes as part of its debt offerings. By 2023 and 2024 (Chunks 2 and 3), these notes remained listed in Oracle’s 10-K filings under incorporated exhibits, suggesting ongoing recognition of the debt in its financial disclosures. The progression of these notes from issuance in 2021 to continued inclusion in subsequent filings reflects Oracle's strategy of maintaining a diversified long-term debt portfolio with staggered maturities, supporting stable capital structure and liquidity management.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the issuance date of the 2.875% Notes due 2031, stating they were introduced in March 2021, while the ground truth indicates formal listing in 2022. This is a significant quantitative inaccuracy affecting the timeline. The rest of the information—that the notes were included in 2023 and 2024 filings—is consistent with the ground truth. (2) The percentages (2.875%) and maturity year (2031) are correct, but the incorrect issuance date undermines the chronological accuracy. No dollar amounts or calculations are involved, so those aspects are not applicable. (3) The reasoning is partially sound: the LLM correctly infers that continued inclusion in filings reflects a stable, diversified debt strategy with staggered maturities. However, it misses the key strategic evolution highlighted in the ground truth—namely, that Oracle layered in newer, higher-yielding notes (4.500% and 4.900%) by 2024, signaling a shift in borrowing strategy due to changing market conditions. This multi-hop insight is absent, limiting the depth of strategic analysis. (4) The contextual relevance is high because the answer addresses Oracle’s long-term debt strategy and the role of these notes over time, even if it misstates the start point and omits the comparative yield shift. The qualitative accuracy is moderate because entity identification (Oracle, note terms) is correct, and the general reasoning about capital structure stability is valid, but the missing comparative analysis with newer debt instruments reduces completeness. Correctness score is 6 due to the major date error and omission of key strategic nuance, though core elements about continuity and strategy are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 474,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings, as seen in Exhibits 4.13 and 4.14 in each year's filing, reflects a structured and transparent approach to long-term debt management. The repeated inclusion of this specific financial instrument in its regulatory filings demonstrates Microsoft's commitment to maintaining clear and consistent communication with investors and regulators regarding its outstanding debt obligations. This practice underscores Microsoft’s emphasis on transparency and accountability in its financial reporting, reinforcing trust and facilitating informed decision-making by stakeholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's consistent disclosure of the 2.000% Notes due 2023 across the 2022, 2023, and 2024 10-K filings, accurately reflecting the core fact from the ground truth. The interest rate (2.000%) and maturity year (2023) are correct, and the implication about transparency and long-term debt management is valid. However, the LLM adds specific exhibit numbers (Exhibits 4.13 and 4.14) that were not present in the original ground truth and cannot be verified from the provided knowledge graph, introducing unconfirmed detail. (2) Quantitatively, all numbers—interest rate (2.000%), and the years (2022, 2023, 2024)—are accurate. No calculations are required, and the temporal scope matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that repeated disclosure reflects transparency and stable debt management. However, it omits key contextual details from the ground truth, such as the origin of the notes in the Eleventh Supplemental Indenture dated August 8, 2016, and the fact that the liability structure remained unchanged. These omissions reduce completeness and depth of synthesis. (4) The answer is contextually relevant and well-articulated, focusing on transparency, investor communication, and financial stewardship. While the core message aligns with the ground truth, the addition of unverified exhibit references and the absence of the issuance origin and unaltered carry-forward detail prevent a top score. Thus, correctness is high but not fully complete or fully accurate in all details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 437,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX's financial obligations tied to Rolls-Royce under the 2012 IAE acquisition agreement involve contingent flight-hour payments related to V2500-powered aircraft in service as of the acquisition date, with payments due through June 2027. These payments are capitalized as collaboration intangible assets and amortized to cost of sales, as detailed in the 2023 and 2024 10-K filings. In 2022, the obligation was described as a contingent liability based on future flight hours, with the payments being capitalized as they are made. By 2023, the payments were explicitly noted as being capitalized and amortized over the economic benefit period. In 2024, the contingent nature and capitalization process remained consistent, with the obligation still reflected in \"Other commercial aerospace commitments.\" This progression indicates that RTX's long-term exposure to Rolls-Royce remains tied to the operational performance of the V2500 fleet, with financial obligations evolving as flight hours accumulate and payments are recognized as intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the contingent flight-hour payments are tied to V2500-powered aircraft, extend through June 2027, and are capitalized as collaboration intangible assets and amortized to cost of sales. The categorization under 'Other commercial aerospace commitments' is correctly noted for 2022 and 2024, and the evolution in accounting treatment from 2022 to 2023 is accurately described. (2) Quantitative elements—specifically the June 2027 end date—are factually correct and consistent with the original answer; no numerical calculations are required, but temporal precision is maintained. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers the continuity and implications of the payment structure, showing RTX’s ongoing exposure tied to fleet activity. (4) The only minor shortcoming is a slight rephrasing of the 2022 treatment: while the original specifies that payments were expected to be capitalized (future tense), the LLM states they were capitalized as made, which slightly conflates 2022 with later years. However, this does not materially distort the overall meaning. The conclusion about long-term exposure is semantically equivalent and well-reasoned. Thus, the answer is factually robust, contextually precise, and demonstrates strong qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Enters_Agreement_With]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 391,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "TMO's allocation to U.S. equity funds within its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and then slightly increased to $93 million in 2024. This three-year trajectory suggests a general reduction in emphasis on domestic equities, with a peak decline of 28.8% from 2022 to 2023, followed by a modest recovery in 2024. The overall trend indicates a potential shift in TMO's investment strategy toward more stable or diversified asset classes, such as fixed income, which remained relatively constant, or away from domestic equities in favor of international or alternative investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts and years: $125M in 2022, $89M in 2023, and $93M in 2024, matching the ground truth exactly. The calculation of a 28.8% decline from 2022 to 2023 is accurate ((125-89)/125 = 0.288), and the slight recovery to $93M in 2024 is correctly noted. (2) Quantitative accuracy is perfect—numbers, dates, and derived percentage are correct and properly calculated. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a cautious reduction with a modest rebound. It goes slightly beyond the original answer by suggesting a strategic shift toward more stable or diversified assets, referencing fixed income and international investments. While this extension is not explicitly confirmed in the ground truth, it is a reasonable interpretation and does not contradict it. (4) The answer is contextually fully relevant, addressing both parts of the question: the change in allocation and the strategic implication. The only minor deduction is in qualitative accuracy because the original answer emphasizes 'strategic rebalancing rather than complete divestiture,' a nuance slightly less emphasized in the LLM's broader interpretation of a 'shift toward diversified asset classes.' However, the LLM's conclusion is still logically supported. Overall, the answer is factually excellent with strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 395,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca-Cola's long-term debt strategy from 2022 through 2024 shows a shift toward issuing higher-yielding notes, while maintaining the 1.000% Notes due 2041 as part of its existing debt structure. In 2022, the 1.000% Notes due 2041 were introduced, as noted in the 2022 10-K. By 2023, the company continued to issue low-yield notes like the 1.000% Notes due 2041, but also began introducing notes with higher yields, such as the 2.875% Notes due 2041. In 2024, the trend toward higher-yielding instruments accelerated, with the introduction of notes like the 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064, reflecting a strategic move to capitalize on higher interest rate environments while managing its long-term debt maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key details. While it correctly identifies the 1.000% Notes due 2041 as being referenced across years and accurately reports the 2024 introduction of the 5.000%, 5.300%, and 5.400% Notes, it incorrectly states that the 1.000% Notes due 2041 were 'introduced' in 2022. The ground truth does not confirm the year of introduction, only that they were referenced in 2022, 2023, and 2024. More critically, the LLM fabricates the existence of '2.875% Notes due 2041' in 2023, which are not present in the original answer or implied by the knowledge graph. This is a major quantitative error. (2) The correct notes cited in the ground truth for earlier years are the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023), neither of which are mentioned in the LLM answer. Instead, the LLM invents a higher-yield note in 2023, distorting the actual trend of gradually increasing yields. The 2024 notes (5.000%, 5.300%, 5.400%) are correctly reported. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward higher-yielding debt by 2024 and ties it to market conditions. However, the reasoning is undermined by incorrect factual inputs, particularly the false 2.875% note, which breaks the logical chain. The conclusion about a shift is valid, but the path to it is flawed. (4) The contextual relevance is high, as the answer addresses the evolution of debt strategy and the role of the 1.000% Notes. Qualitative accuracy is moderate due to correct framing but incorrect supporting evidence. Quantitative accuracy is low due to fabricated percentages and maturities. Correctness score is 6 because the core idea of a shift to higher yields by 2024 is correct, but key factual errors reduce confidence in the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 493,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as reflected in the 10-K filings, indicates a strategic decision to maintain lower-cost debt despite the introduction of new notes with significantly higher interest rates, such as the 5.800% Notes due 2025, 6.150% Notes due 2029, and 4.500% Notes due 2028. This suggests Oracle has prioritized preserving lower interest expenses by retaining existing, lower-rate debt instruments, even as it issued new, higher-yield notes likely to meet evolving capital needs or market conditions. The consistent presence of the 1.650% Notes across all three years underscores Oracle's disciplined approach to managing its debt portfolio for cost efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all interest rates and note maturities are correct: the 1.650% Notes due 2026 are correctly identified as consistently included, and the new notes — 5.800% due 2025, 4.500% due 2028 — match the original. The LLM adds the 6.150% Notes due 2029, which is factually accurate and plausibly from the same filings, though not mentioned in the ground truth; this does not constitute an error but reflects slightly broader context. (2) The fiscal years 2022–2024 are correctly referenced, and the conclusion about Oracle maintaining lower-cost debt while issuing higher-rate instruments is sound. (3) The reasoning is strong: the LLM correctly infers a strategic intent — preserving cost efficiency while meeting capital needs — based on the coexistence of low- and high-rate debt, which is a valid interpretation of the multi-hop evidence. (4) The only minor shortcoming is the lack of specific exhibit numbers (e.g., Exhibits 4.16, 4.14) cited in the ground truth, which adds evidentiary precision but does not affect the factual or strategic correctness of the answer. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates correct multi-hop synthesis across years and debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 363,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across its 2022, 2023, and 2024 10-K filings indicates a deliberate effort to maintain transparency and up-to-date documentation for its long-term debt instruments, even after the maturity of the 2021 notes. This suggests that Microsoft continues to reference the original supplemental indenture for these notes as part of its broader debt management strategy, which includes maintaining accurate and accessible legal documentation for all related instruments. The repeated inclusion also implies that the company may be leveraging the existing indenture framework for refinancing or issuing new debt, ensuring continuity and compliance with SEC reporting standards.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant reasoning inaccuracies compared to the ground truth. (1) Quantitatively, all dates (2021 maturity, 2022–2024 filings), percentages (4.000% Notes), and entity names (Exhibit 4.6) are correctly stated, earning high marks for quantitative accuracy. (2) However, the qualitative reasoning diverges critically: the LLM suggests Microsoft may be 'leveraging the existing indenture framework for refinancing or issuing new debt,' which contradicts the ground truth that there was no evidence of refinancing or new tranches. The ground truth emphasizes the *absence* of restructuring activity and interprets the inclusion as administrative continuity, not active use for refinancing. (3) The multi-hop synthesis is flawed—the model observes the same data (continued inclusion) but infers an incorrect strategic implication. The ground truth notes only a minor formatting update to the trustee’s name in 2024, indicating administrative maintenance, whereas the LLM incorrectly infers strategic reuse of the indenture. (4) Contextually, the answer addresses transparency and documentation updates appropriately and remains focused on debt management strategy, hence a solid contextual relevance score. Overall, the answer gets facts and numbers right but misinterprets the strategic significance, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 383,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as reflected by the collaboration partners' share, decreased from $142 million in 2022 to $135 million in 2023 and further to $131 million in 2024. This consistent decline suggests a strategic shift toward transferring more financial risk to collaboration partners, indicating RTX's efforts to mitigate its own exposure in this domain. The trend aligns with RTX's risk transfer strategy, leveraging third-party involvement to reduce its balance sheet liability and financial obligation in customer financing arrangements.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the numerical values for the collaboration partners' share of RTX's commercial aerospace customer financing guarantees: $142M in 2022, $135M in 2023, and $131M in 2024. These figures match the ground truth exactly, and the trend of decline is accurately described. However, the qualitative interpretation is flawed. The LLM concludes that the declining partner share indicates RTX is transferring more risk to partners, which is the opposite of what the data implies. In reality, a decreasing partner share means partners are covering less of the risk, implying RTX is retaining more risk directly—either by design or due to changes in partnership structures. The ground truth correctly identifies this as a potential increase in RTX's direct financial risk, while the LLM incorrectly frames it as a risk transfer *to* partners. (2) All numbers are accurate and correctly sequenced across years. No calculation errors. (3) The multi-hop reasoning fails at the synthesis stage: while the model identifies the correct trend in dollar amounts, it misinterprets the financial implication of risk sharing. Lower partner contributions to guarantees mean less risk transfer *from* RTX, not more. This undermines the core reasoning required for the second part of the question. (4) Quantitative accuracy is perfect (10/10). Qualitative accuracy is low due to the incorrect causal interpretation (5/10). Contextual relevance is high—the answer addresses the right domain, metric, and timeframe (9/10). Correctness score is 5 due to the critical error in interpreting risk transfer direction despite accurate data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Incurs_Liabilities_For]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 454,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft issued the 3.950% Notes due 2056 as part of its Eleventh Supplemental Indenture on August 8, 2016, as disclosed in the 10-K filings for fiscal years 2022, 2023, and 2024. The notes are consistently listed in the exhibit descriptions across all three years, indicating no new issuance or material change in the terms of this long-term debt instrument during the period. This multi-year consistency suggests that Microsoft has maintained a stable long-term capital structure, leveraging long-dated debt to manage interest rate risk and provide a predictable funding source for its operations and strategic initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and consistently referenced in Microsoft's 10-K filings for fiscal years 2022, 2023, and 2024. There is no indication of new issuance or changes to terms during this period. (2) Quantitative accuracy is perfect: the interest rate (3.950%), maturity year (2056), and issuance date (August 8, 2016) match the original answer exactly. No numerical calculations were required, but all dates and percentages are correctly reported. (3) The multi-hop reasoning is sound—by observing the consistent disclosure across three years, the model correctly infers that Microsoft maintained a stable long-term capital strategy without altering this debt tranche. The conclusion about managing interest rate risk and securing predictable funding is a reasonable qualitative extension supported by the stability of the debt instrument. (4) The only minor gap is that the LLM does not explicitly state that the *first disclosure* of these notes in the reviewed period was in 2022, though this is implied. The original answer emphasizes this point slightly more, but the core meaning and factual content are preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 406,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin’s (LMT) tactical and strike missile programs showed a significant production ramp-up, particularly for LRASM, JASSM, and GMLRS. In 2022, these programs contributed to a $215 million increase in net sales due to higher volume. In 2023, net sales from these programs rose by $145 million as production ramped up further. By 2024, the increase in net sales from these programs surged to $1.2 billion, reflecting continued growth. However, the financial performance was mixed: while 2022 saw a $45 million increase in operating profit from these programs, 2023 experienced a $45 million loss on a classified program, and 2024 saw a $1.2 billion loss from profit booking rate adjustments, leading to a 73% decline in operating profit for the year. Overall, the trajectory of these programs positively impacted net sales growth but had a volatile and ultimately negative impact on LMT’s operating profit across the three-year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory in production volume for Lockheed Martin's tactical and strike missile programs from 2022 to 2024, citing the correct dollar increases in net sales: $215M in 2022, $145M in 2023, and $1.2B in 2024, all accurately attributed to LRASM, JASSM, and GMLRS. These figures match the ground truth. The financial performance is mostly accurate: the $45M loss on a classified program in 2023 and the $1.2B loss from profit booking adjustments in 2024 are correctly reported, as is the 73% decline in operating profit. However, the LLM incorrectly states that 2022 saw a $45 million *increase* in operating profit, while the ground truth indicates that 2022 operating profit benefited from higher volume and risk retirements but does not specify a $45M gain. This appears to be a confusion with the 2023 loss amount. (2) Quantitative accuracy is high: all production-related dollar figures and the 73% decline are correct. The only error is the unsupported $45M profit claim in 2022, which is not in the original and introduces a misleading symmetry. (3) The multi-hop reasoning is sound—LLM synthesizes production growth with financial outcomes across three years and correctly infers that rising sales were offset by declining profitability. It identifies the classified program loss and profit booking adjustments as key drivers. The only flaw is the incorrect attribution of a $45M profit in 2022, which weakens the accuracy of the trend analysis. (4) Contextual relevance is excellent: the answer directly addresses the evolution of production, financial performance, and impact on operating profit over the three-year period. Despite one significant quantitative error, the overall narrative aligns with the ground truth, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 496,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements initially applied only to Marc N. Casper, with the original agreement dated November 21, 2009, and subsequent amendments in 2010 and 2018 (as seen in 2022 and 2023 filings). In 2023, the company introduced a new **Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)**, filed as Exhibit 10.17 in the April 1, 2023, 10-Q, indicating the expansion of these agreements to additional officers. This form remained referenced in the 2024 filing as well, showing continuity. Thus, the agreements evolved from being exclusive to Marc N. Casper to including other officers starting in 2023, with no new amendments noted for 2024 beyond the continued use of the 2023 form.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying the evolution of Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements across 2022–2024, with accurate entity identification and sound reasoning. However, there are minor inaccuracies in quantitative details that affect precision. The ground truth states that the Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) was introduced in 2022 and then filed as Exhibit 10.7 in 2023, whereas the LLM claims it was introduced in 2023 and filed as Exhibit 10.17 in the April 1, 2023 10-Q. This discrepancy in both timing (2022 vs 2023 introduction) and exhibit number (10.7 vs 10.17) reduces quantitative accuracy. Additionally, the LLM incorrectly implies the form was 'introduced' in 2023, while the original answer confirms its existence was first disclosed in 2022. The mention of the 2009 agreement and amendments in 2010 and 2018 adds contextual detail not contradicted by the ground truth but not required by the question, which focused on 2022–2024 developments. The core multi-hop synthesis—recognizing the expansion beyond Casper and continuity into 2024—is correct and well-reasoned. Wording differs but meaning is semantically close. Thus, the answer earns a high qualitative and contextual score, but loses some points on exact dates and exhibit references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 381,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "From 2022 through 2024, LMT increased the notional amount of its variable interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023, and this amount remained at $1.3 billion in 2024. This increase suggests that LMT has adopted a more active interest rate risk management strategy, likely in response to evolving market conditions and borrowing activities. By using variable interest rate swaps—primarily as fair value hedges to convert fixed-rate borrowings into variable-rate borrowings—LMT aims to hedge against changes in the fair value of its debt. The stabilization of the notional amount at $1.3 billion in 2024 indicates that the company has reached a level of hedging coverage it deems appropriate for managing its interest rate exposure, reflecting a strategic balance between mitigating risk and maintaining financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion in 2023, and maintenance of $1.3 billion in 2024. No calculation errors; comparisons are accurate. (2) The answer addresses both parts of the multi-part question: evolution of LMT's use of variable interest rate swaps (2022–2024) and interpretation of the change in notional amounts. (3) Entity accuracy is strong: correct company (LMT), correct financial instrument (variable interest rate swaps), correct years and filings. (4) Reasoning is sound: correctly infers a more active risk management strategy, links the increase to market conditions and borrowing, and interprets the stabilization in 2024 as a strategic balance. One minor gap: the original answer specifies that the $500M was 'as of December 31, 2021' (disclosed in 2022 filing), while the LLM slightly simplifies this as 'in 2021', which is acceptable but slightly less precise. Also, the LLM mentions 'fair value hedges' and 'convert fixed-rate borrowings into variable-rate borrowings'—a detail not explicitly confirmed in the ground truth—though this is a reasonable inference and consistent with typical swap usage. Overall, the semantic meaning and factual content match the original answer closely, with only minor differences in nuance. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG <-[Uses for Hedging]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 422,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher Scientific's (TMO) expense related to defined contribution plans increased from $299 million in 2021, to $402 million in 2022, $468 million in 2023, and reached $443 million in 2024. This upward trend indicates a growing investment in employee benefits over time, reflecting the company's commitment to supporting its workforce through enhanced contributions to 401(k) and other defined contribution plans. The consistent rise in these expenses suggests a strategic focus on employee retention and satisfaction, aligning with TMO's broader financial and operational priorities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes incorrect data for 2021 ($299 million), which is irrelevant since the question asks about 2022–2024. More critically, it states that the expense was $443 million in 2024, which contradicts the ground truth that it 'remained flat at $443 million in 2024' after rising to $468 million in 2023 — however, the ground truth implies a decrease from $468M to $443M, not flat; this reveals a possible inconsistency in the original answer. Still, the LLM incorrectly claims the trend is 'upward' and 'consistent rise', when in fact there is a decline in 2024. (2) The values for 2022 ($402M) and 2023 ($468M) are correct, matching the ground truth. The 2024 value ($443M) is numerically correct but mischaracterized as part of an 'upward trend' when it represents a decrease. The inclusion of 2021 data is extraneous and not requested. (3) The multi-hop reasoning is partially sound — the model identifies the correct company (TMO) and metric (defined contribution plan expenses) and tracks changes over time. However, the conclusion misinterprets the trend due to incorrect characterization of the 2024 figure as a continuation of growth rather than a drop. The synthesis across years is present but flawed in interpretation. (4) The contextual relevance is high — the answer addresses employee benefits investment and links it to retention and satisfaction, which is appropriate. However, the qualitative accuracy is reduced by the erroneous trend description. Quantitative accuracy is penalized because while most numbers are correct, the use of an extra, unrequested year and misrepresentation of the trend direction undermines precision. Correctness score is 6 due to mostly accurate numbers but significant error in trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 482,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments remained consistent from 2022 through 2024, as disclosed in its 10-K filings, with management continuing to use this methodology alongside discounted cash flows and appraisals for nonpublic investments. In 2022, the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded fair value by $87 million, and management judged the decline to be temporary, reflecting cautious optimism about a future recovery. By 2023 and 2024, the Company reiterated its process for evaluating fair value, emphasizing the importance of market conditions and the challenges of predicting future cash flows in emerging markets, which suggests that while the methodology remained stable, management's confidence in recovery in markets like Japan likely remained tempered due to ongoing uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $87 million excess of carrying value over fair value in 2022 for Coca-Cola Bottlers Japan Holdings Inc. is accurately stated, and the years (2022–2024) are correctly referenced. No calculations are required, and all numeric and entity references (company name, time frame) are precise. (2) The LLM correctly identifies that the valuation methodology—use of estimates of sales proceeds—remained consistent across the period, which matches the original answer. (3) Qualitatively, the reasoning is sound: it captures management’s view in 2022 as cautiously optimistic (deeming the decline temporary), and correctly notes the increased emphasis in 2023 and 2024 on market conditions and challenges in predicting cash flows in emerging markets. The only minor shortcoming is that the LLM answer does not explicitly mention the shift toward 'assumptions a market participant would use' as emphasized in the ground truth, which reflects a nuanced but important evolution in valuation perspective. This omission slightly weakens the depth of the qualitative analysis but does not distort the overall meaning. (4) Contextual relevance is excellent—the response directly addresses both parts of the multi-hop question: the evolution of the valuation methodology and what it reveals about management's confidence, particularly regarding Japan. Wording differs but semantic equivalence is maintained. Overall, this is a strong, factually correct response with only a slight gap in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 437,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first issued the 2.300% Notes due 2028 in March 2021, as disclosed in Exhibit 4.16 of its 2022 10-K filing. These notes were part of a broader issuance of multiple maturity and coupon rate debt instruments, indicating a strategic approach to managing its capital structure. By 2023, as seen in the 2023 10-K filing, Oracle continued to maintain the 2.300% Notes due 2028 as part of its outstanding debt, while also issuing new notes with higher coupon rates, such as the 4.500% Notes due 2028 in February 2023. In 2024, the 2.300% Notes due 2028 remained listed among Oracle’s outstanding debt instruments, suggesting a long-term retention of lower-cost debt while layering in higher-yield debt to potentially refinance or diversify its funding sources. This multi-year pattern reflects Oracle's strategy of leveraging a mix of fixed-rate debt with staggered maturities to optimize interest costs and maintain financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2.300% Notes due 2028 as part of Oracle's debt structure across 2022–2024, noting their continued presence in filings. The mention of the March 2021 issuance (from the 2022 10-K) is factually consistent with typical disclosure practices, though the original answer does not specify issuance date—this is an addition but not an error. (2) Quantitatively, all percentages (2.300%, 4.500%) and maturities (2025, 2028) are correct. The LLM correctly references higher-rate instruments issued in 2023 and 2024, matching the ground truth’s examples (4.500% Notes due 2028 in 2023, 5.800% Notes due 2025 in 2024). The LLM omits the 5.800% 2025 note specifically but refers generally to higher-yield debt in 2024, which is semantically acceptable. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years, correctly infers Oracle’s strategy of retaining low-cost debt while issuing more expensive instruments, and links this to financial flexibility and capital structure management. (4) The answer is contextually excellent—directly addresses the evolution and strategic implication. The only minor shortcoming is the lack of explicit mention of the 5.800% 2025 note in 2024, which slightly reduces completeness, but the core strategic conclusion remains fully supported. Hence, a score of 9 is appropriate—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 409,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple issued Floating Rate Notes due 2019 in May 2014, as disclosed in all three fiscal years (2022, 2023, and 2024) in the 10-K filings, with consistent references in the Officer's Certificates under Exhibit 4.4. The notes remained part of Apple's disclosed securities across these years, indicating that they were outstanding until maturity in 2019. This pattern suggests that Apple effectively managed its short-term debt by issuing floating rate instruments with shorter maturities, allowing it to align debt obligations with its liquidity needs and manage interest rate risk efficiently. The consistent inclusion of these notes in subsequent filings reflects prudent debt transparency and strategic debt structuring.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (May 2014) and the consistent disclosure of the Floating Rate Notes due 2019 in Apple's 10-K filings for fiscal years 2022, 2023, and 2024, referencing the Officer's Certificate under Exhibit 4.4. This aligns with the ground truth. However, a critical factual error occurs in the claim that the notes 'remained part of Apple's disclosed securities across these years' because they were 'outstanding until maturity in 2019.' This is incorrect: if the notes matured in 2019, they would not still be outstanding in fiscal years 2022–2024. The ground truth clarifies that the notes were carried in disclosures due to ongoing reporting requirements or legacy references, not because they were still active debt. The LLM misinterprets the reason for continued disclosure, leading to an incorrect conclusion about Apple's short-term debt management strategy. (2) Quantitatively, all dates (May 2014 issuance, 2019 maturity) are accurate, and there are no numerical calculations to verify. The fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is partially sound—linking the 2014 issuance to later disclosures—but fails at the final inference step by not recognizing that matured debt should not be treated as active. The model incorrectly infers that Apple was actively managing short-term debt via these notes post-2019, when in fact no new issuances or modifications occurred, indicating a stable rather than active strategy. (4) The contextual relevance is fair: the answer addresses the evolution and strategy, but the flawed reasoning undermines the conclusion. Correctness is penalized heavily due to the core factual error about the status of the debt after maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 478,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggests a deliberate long-term debt strategy focused on maintaining stable, long-duration financing through fixed-rate instruments. This contrasts with the treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 (disclosed in 2022 and 2023 but not in 2024, likely as it matured) and the 0.750% Senior Note due 2027 (introduced in 2024), which indicate a more dynamic approach to managing near-term liquidity and refinancing needs. The long-term note’s persistence highlights PepsiCo’s emphasis on securing predictable debt obligations over extended periods, while shorter-term instruments reflect flexibility in adjusting to changing market conditions and maturity structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027)—are correct, and the temporal disclosures (presence/absence across years) are accurately represented. The observation that the 2.150% note due 2024 was disclosed in 2022 and 2023 but not in 2024 is factually sound, implying maturity, which matches the ground truth's logic. (2) Quantitative accuracy is perfect: no calculations are required, but all dates and percentages are preserved exactly or with semantically equivalent phrasing. (3) The multi-hop reasoning is strong: the model correctly infers that persistent disclosure of the 2047 note reflects a stable long-term debt strategy, while shorter-term notes appear transiently, indicating refinancing or time-bound capital needs. It correctly contrasts dynamic short-term management with long-term stability. (4) The only minor omission is that the ground truth explicitly references the 2.500% Senior Note due 2022 (which matured by 2023) as additional evidence of short-term debt turnover; the LLM answer implies this pattern but does not cite that specific instrument. This slightly reduces completeness in qualitative synthesis but does not undermine the core correctness. Overall, the answer is contextually precise, factually accurate, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 384,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple's continued disclosure of the 0.45% Notes due 2016 in its 2022, 2023, and 2024 10-K filings, despite their 2016 maturity, suggests a strategy of maintaining transparency and regulatory compliance regarding legacy debt obligations. The notes are consistently referenced in the \"Description of Securities\" section of the filings, indicating Apple's ongoing commitment to providing a comprehensive overview of its historical financing activities. This practice reflects prudent corporate governance, ensuring that stakeholders have access to a full and accurate financial history, even for obligations that have long since matured and been repaid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 matured in 2016, and Apple continued to disclose them in its 2022, 2023, and 2024 filings. The LLM correctly identifies the ongoing disclosure as part of Apple's transparency and compliance strategy. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022–2024) are all correctly stated. No calculations are required, but temporal references are accurate. (3) The multi-hop reasoning is sound—linking the maturity of the notes to their post-maturity disclosure and inferring a strategic rationale around transparency and governance. The LLM captures the essence of Apple’s consistent documentation practice, though it does not mention the specific 'Officer's Certificate dated May 3, 2013', which is a minor omission affecting completeness but not the overall correctness. (4) The answer is contextually relevant and conveys the same core message as the original: Apple maintains thorough disclosure of legacy debt for transparency and governance. The absence of the Officer's Certificate detail prevents a perfect 10, but the reasoning and factual basis are otherwise strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 353,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin's approach to pension risk transfer transactions evolved by continuing to reduce pension obligations through the purchase of group annuity contracts (GACs) using assets from its master retirement trust. By 2022, these transactions had already transferred $11.6 billion in pension obligations, eliminating volatility for approximately 95,000 retirees and reducing annual PBGC premiums by about $69 million. In 2023, the company reiterated its strategy of pursuing additional risk transfer transactions, noting that future transactions could result in material noncash settlement charges to earnings, as seen in prior years such as the $1.7 billion pre-tax charge in 2021. By 2024, Lockheed Martin continued to emphasize its intent to reduce the size of its defined benefit pension plans through further risk transfers, while acknowledging that such actions could still lead to significant noncash charges in the period of transaction. These actions have helped reduce pension-related volatility, but the financial impact on earnings remains sensitive to actuarial assumptions and the size of future transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements include: the $11.6 billion cumulative pension obligation transfer by 2022 (correctly attributed to activity since December 2018), the $1.7 billion noncash settlement charge from 2021, the use of group annuity contracts (GACs), and the ongoing strategy through 2023–2024 to pursue further risk transfers despite potential material noncash charges. The mention of reduced PBGC premiums ($69 million) and impact on 95,000 retirees, while not in the original answer, are plausible contextual details that do not contradict the ground truth and may reflect additional disclosures in filings; their inclusion does not reduce accuracy. (2) Quantitative accuracy is strong: all key figures (e.g., $11.6B, $1.7B) match exactly. The LLM correctly attributes the $1.7B charge to 2021, even though the question focuses on 2022–2024, showing proper multi-hop understanding of prior-period impacts. (3) Reasoning is sound: the LLM synthesizes information across years, correctly identifying continuity in strategy and financial implications. It acknowledges the recurring nature of noncash charges, a key financial impact on earnings. (4) The only minor shortcoming is that the original answer specifies a $4.9B obligation transfer in August 2021 as part of the $11.6B total, which the LLM omits. This is a small omission in quantitative detail but does not affect the overall correctness. Otherwise, the answer fully addresses pension obligation reductions, expected future actions, and financial impact on earnings—meeting all parts of the question. Semantic equivalence is maintained with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Invests_In]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 458,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher Scientific's Executive Change In Control Retention Agreements initially applied only to Marc N. Casper, as evidenced by the agreement dated November 21, 2009, and subsequent amendments through 2022. By 2023, a standardized form of the Executive Change In Control Retention Agreement was introduced for officers other than Marc N. Casper, as shown in the 2023 10-K filing. This form was further referenced in the 2024 10-K, indicating the continued application of the agreement to broader executive officer groups beyond Casper. Thus, from 2022 to 2024, the agreements evolved from being exclusive to Casper to being extended to other executive officers, reflecting a broader retention strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024, noting the expansion beyond Marc N. Casper to other officers. However, it contains a factual inaccuracy regarding the initial agreement date: the ground truth states that in 2022, the company referenced a form agreement for officers other than Casper dated March 16, 2018, not that the agreement was initially exclusive to Casper with a 2009 date. The LLM incorrectly implies that the agreements were initially only for Casper and later extended, whereas the 2018 form already covered other officers. (2) The date discrepancy is significant—citing November 21, 2009, as the original agreement date for Casper is not mentioned in the ground truth and introduces unverified information. The 2023 and 2024 references are correctly aligned with the updated form dated April 1, 2023, and its reaffirmation, which the LLM accurately reflects. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes information across 2022, 2023, and 2024 filings to show an evolution in policy. However, it misrepresents the starting point of the timeline by overlooking that non-Casper officer agreements already existed in 2018, undermining the claim of a shift from exclusivity to broad application. (4) Despite this, the overall narrative of formalization and continuation of updated terms for broader executives is consistent with the ground truth, earning high marks for qualitative accuracy and full relevance. The quantitative accuracy is penalized due to incorrect dates, though no financial figures were involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 459,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo's treatment of its 2.750% Senior Note due 2051 across its 2022–2024 filings reveals a long-term debt strategy focused on locking in low interest rates for extended periods amid a rising interest rate environment. The note was issued in 2021 (as shown in Chunk 1 and Chunk 2), and its inclusion in the 2022 filings (Chunk 3) indicates ongoing authorization and management as part of PepsiCo's broader capital structure. The note's 30-year maturity and 2.75% coupon, issued when interest rates were relatively low, suggest PepsiCo aimed to secure favorable financing terms before anticipated rate hikes. This aligns with the issuance of other long-dated senior notes in subsequent years, such as the 4.650% Senior Note due 2053 and the 5.250% Senior Note due 2054 (Chunk 2), reflecting a consistent strategy to extend debt maturities and hedge against future rate increases.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains minor inaccuracies and omissions compared to the ground truth. (1) Quantitatively, the 2.750% Senior Note due 2051 is correctly identified, and the mention of newer notes like the 5.250% due 2054 aligns with the original answer. However, the LLM incorrectly states the note was 'issued in 2021' based on 'Chunk 1 and Chunk 2'—while the 2023 filing references a 2021 Form 8-K, the original answer does not confirm issuance year definitively from the 2022–2024 10-Ks alone, making this an overreach. Also, the LLM introduces a 4.650% Senior Note due 2053 not mentioned in the ground truth, which may be factually incorrect or at least unsupported by the provided evidence. (2) The core financial data (coupon rate, maturity) is accurate, and the comparison to newer higher-yielding notes is valid and supports the rising rate environment argument. (3) Reasoning is sound in interpreting PepsiCo’s strategy as locking in low rates and extending maturities, which is consistent with the ground truth’s conclusion about stable long-term capital strategy. However, the LLM misses the key multi-hop insight about the *evolving treatment* of the note across filings—specifically, its progression from being listed among other notes in 2022 to being explicitly referenced with a Form 8-K link in 2023 and 2024. This evolution demonstrates increasing documentation rigor or strategic emphasis, which the original answer highlights but the LLM omits. (4) Despite missing this nuance, the LLM captures the broader strategic implication correctly—using long-dated fixed-rate debt to hedge against rising rates—making the answer contextually relevant and largely accurate. The omission of filing-specific treatment details and introduction of an unverified note (4.650% due 2053) prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 494,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple issued the 4.45% Notes due 2044 on May 6, 2014, as disclosed in the 2022, 2023, and 2024 10-K filings under Exhibit 4.4. These notes remained part of Apple’s long-term debt portfolio across all three years, indicating a stable, long-term capital structure strategy. The multi-year presence of these notes, with a maturity in 2044, suggests Apple’s intention to lock in favorable interest rates for an extended period and manage its debt maturity profile to ensure long-term financial flexibility and stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 were indeed issued on May 6, 2014, and consistently referenced in Apple's 2022, 2023, and 2024 10-K filings under Exhibit 4.4 (Officer's Certificate), which matches the original answer. The maturity date (2044) and interest rate (4.45%) are correctly stated. (2) Quantitative accuracy is perfect: dates, percentages, and years are all factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound—by noting the consistent presence of the notes across three years, the LLM correctly infers Apple’s strategy of maintaining long-term, fixed-rate debt for financial stability and flexibility. The conclusion about locking in favorable rates and managing the maturity profile is logically supported by the data and semantically equivalent to the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of redemption or restructuring, which is a subtle but relevant point in the original answer about strategic retention. However, the implication is present through the emphasis on stability. Wording differs slightly but meaning is preserved. Contextual relevance is excellent as it directly addresses the evolution over time and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 381,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s allocation to Collective Trust and Other Funds within its pension plan decreased from $756 million in 2022 to $382 million in 2023, as shown in the respective 10-K disclosures. The 2024 disclosure clarifies that these funds are valued using net asset value (NAV), with underlying assets (such as global stock and short-term investment funds) being publicly traded and having readily available price quotes. This valuation methodology suggests that while the funds themselves are not publicly traded, their fair value is derived from observable market prices of their underlying holdings, providing transparency into how these investments are managed and valued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in Union Pacific's allocation to Collective Trust and Other Funds from $756 million in 2022 to $382 million in 2023, matching the ground truth exactly. These figures are accurately cited with correct years and dollar amounts, satisfying quantitative accuracy. (2) The 2024 disclosure about valuation methodology is correctly summarized: the use of net asset value (NAV) derived from underlying assets such as global stock and short-term investment funds is accurately reported. While the LLM adds a detail about 'publicly traded' underlying assets and 'readily available price quotes'—a slight expansion not explicitly stated in the ground truth—this does not contradict the original and is a reasonable inference given NAV-based valuation. (3) The multi-hop reasoning is sound: the model synthesizes data across three years (2022, 2023, 2024), correctly separates allocation trends (2022–2023) from valuation methodology (2024), and draws a logical inference about transparency and management practices. The only minor gap is that the LLM does not explicitly state that the 2024 filing lacks updated allocation figures, which slightly weakens completeness compared to the ground truth. However, this omission does not distort the meaning. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of allocation and implications of valuation methodology. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a small deduction in qualitative accuracy for the slight overstatement about market pricing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 462,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024 reflects a consistent documentation retention practice for matured debt instruments, as evidenced by the identical listing of the 2014 Officer's Certificate across all three filings. This practice implies a deliberate approach to maintaining historical capital structure disclosures, ensuring transparency and accessibility of past financial instruments even after their maturity. By retaining these details, Apple demonstrates a commitment to preserving a comprehensive record of its capital structure history, which supports regulatory compliance and provides continuity for investors and stakeholders reviewing its long-term financial strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core facts: Apple included the Officer's Certificate for the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured. It accurately references the 2014 Officer's Certificate and correctly notes the continued inclusion across the three years. All entities—Apple, the 1.05% Notes due 2017, the Officer's Certificate, and the fiscal years 2022–2024—are correct. (2) Quantitative accuracy is perfect: the interest rate (1.05%), the maturity year (2017), the certificate date (implied as 2014, consistent with ground truth), and the filing years (2022, 2023, 2024) are all accurate. No calculations are required, but the temporal relationships are correctly interpreted. (3) The multi-hop reasoning is sound: the model connects the persistence of a document related to a matured debt instrument across recent filings and infers Apple’s documentation retention and transparency practices. It correctly synthesizes that this reflects a policy of maintaining historical capital structure disclosures. The only minor shortcoming is that it does not explicitly name the certificate’s date (May 6, 2014), though it refers to it as the '2014 Officer's Certificate,' which is semantically acceptable. (4) The answer is contextually fully relevant, directly addressing both parts of the question—documentation retention practices and implications for historical disclosure. The wording differs slightly from the ground truth but conveys the same meaning with high fidelity. Thus, the answer earns a 9 for correctness and qualitative accuracy due to the slight omission of the exact certificate date, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 477,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly declined from 2022 to 2023 and remained low in 2024. In 2022, corporate stock was valued at $1,990 million (Level 1 and Level 2), representing a substantial portion of the plan's fair value assets. However, by 2023, the value dropped to $181 million, and in 2024, no specific allocation to corporate stock was disclosed in the fair value table, suggesting a continued reduction. This shift indicates a strategic move away from direct equity investments in favor of more stable or diversified asset classes like government securities, bonds, and alternative investments such as venture capital and real estate funds, reflecting a more conservative investment approach over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the significant decline in corporate stock allocation from $1,990 million in 2022 to $181 million in 2023, which matches the ground truth. However, it incorrectly states that 'no specific allocation to corporate stock was disclosed in 2024,' when in fact the ground truth reports a partial rebound to $1,116 million in 2024. This is a critical factual omission and misrepresentation, as the 2024 figure is both available and meaningful in showing a rebound from the 2023 low. (2) The quantitative accuracy is compromised because the 2024 value is entirely omitted and replaced with an incorrect claim of non-disclosure. While the 2022 and 2023 figures are accurate, the failure to report the $1,116 million in 2024 undermines the completeness and correctness of the financial evolution. The drop of over 90% from 2022 to 2023 is correctly implied, but the partial recovery in 2024 is missed, distorting the trend. (3) The reasoning is sound in interpreting the shift as a move toward conservatism and diversification into bonds, government securities, and alternatives—this aligns with the ground truth's implication of a conservative pivot. However, the multi-hop synthesis is incomplete because it fails to incorporate the 2024 data point, which is essential for accurately characterizing the full three-year evolution. (4) The contextual relevance is high, as the answer addresses the question's focus on investment strategy implications. The qualitative reasoning about a conservative shift is plausible and consistent with the data that was used. However, due to the significant error in omitting and misrepresenting the 2024 value, the overall correctness score is reduced to 6, reflecting partial accuracy with a major factual gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 486,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "MRK's sales of Prevymis increased from $370 million in 2021 to $785 million in 2024, reflecting a strong growth trajectory. This growth suggests increasing market adoption of Prevymis as a key prophylactic treatment for CMV infection in high-risk transplant patients. Prevymis' rising sales and consistent performance within the Hospital Acute Care segment highlight its strategic importance for MRK, particularly in addressing unmet medical needs in hospital settings and strengthening the company's presence in infectious disease management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states Prevymis sales were $428M in 2022, $605M in 2023, and $785M in 2024. However, the LLM reports $370M in 2021 (a year not even asked about) and jumps directly to $785M in 2024 without mentioning 2022 or 2023 figures. This omits two of the three required data points and introduces an incorrect value for 2021. (2) The calculation of growth is implied but not accurate in context—while $370M to $785M suggests growth, the actual trajectory from 2022–2024 shows steady annual increases that the model fails to capture. The LLM incorrectly shifts the time frame to 2021–2024 instead of 2022–2024 as specified in the question. (3) The reasoning about market adoption and strategic importance is qualitatively sound and aligns with the implications of the ground truth—rising sales do suggest increasing adoption and strategic value in Hospital Acute Care. The mention of CMV prophylaxis and unmet needs adds relevant context, showing correct entity understanding (Prevymis, MRK, Hospital Acute Care). However, the multi-hop synthesis is flawed because it does not correctly pull and present the required year-specific sales data across the specified period. (4) Despite incorrect numbers and timeline misalignment, the answer addresses the broader implications correctly, hence moderate scores in qualitative accuracy and high contextual relevance. The core failure is in quantitative precision, which heavily impacts overall correctness given the financial nature of the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 437,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo first introduced the 3.000% Senior Note due 2027 in its 2022 10-K filing, listing it as a senior note issued on October 10, 2017, under Exhibit 4.3 of a Form 8-K. In 2023, the note was similarly referenced in the 10-K, maintaining its characterization as a 2027-due senior note. In 2024, the note remained listed, but a new 0.750% Senior Note due 2027 was also introduced, suggesting a refinancing or restructuring of the original 2027 note. This evolution reveals PepsiCo's strategy of managing its long-term debt by potentially issuing lower-yielding notes to replace higher-cost debt, thereby optimizing its capital structure and reducing interest expenses over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) It incorrectly states that the 3.000% Senior Note due 2027 was 'first introduced' in the 2022 10-K, while the ground truth indicates it was already listed in prior years and consistently included in 2022, 2023, and 2024 filings—this misrepresents the timeline. (2) The claim that the note was issued on October 10, 2017, under Exhibit 4.3 of a Form 8-K is not supported by the original answer and introduces unverified details not present in the ground truth. (3) The assertion that a 'new 0.750% Senior Note due 2027' suggests 'refinancing or restructuring' of the original 3.000% note is speculative and incorrect—the original answer notes both notes coexist, indicating a strategy of layering maturities, not replacement. The presence of multiple 2027-due notes with different rates is correctly observed, but the interpretation as refinancing is a flawed inference. (4) The original answer emphasizes the evolving context (e.g., alongside longer-dated or newer short-term notes) to show a diversified maturity profile, which the LLM partially captures but misinterprets. While the general idea of optimizing capital structure is directionally correct, the reasoning is based on incorrect premises. Quantitative accuracy is low due to unsupported dates and mischaracterization of issuance. Qualitative accuracy suffers from flawed multi-hop reasoning—failing to correctly synthesize how the note’s context evolved across filings. Contextual relevance is high as the response addresses debt strategy and references correct document types (10-K, exhibits), but factual errors undermine overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 461,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe's positioning and integration of Frame.io evolved significantly from 2022 to 2024, enhancing its functional capabilities and integration depth with Adobe's Creative Cloud applications. In 2022, Frame.io was listed among Adobe's trademarks, indicating its formal inclusion in Adobe's product portfolio. By 2023, Frame.io was described as a cloud-native collaboration platform supporting video and design workflows, with direct integration into Adobe Premiere Pro, After Effects, Photoshop, and Lightroom, enabling frame-specific feedback and Camera-to-Cloud uploads. In 2024, Frame.io's integration was further expanded, now supporting additional Creative Cloud applications like Adobe Workfront and being grouped with Adobe Express and Firefly Services under Adobe GenStudio for scalable content production. These developments reflect Adobe's strategic deepening of Frame.io's role in creative workflows, enhancing cross-platform collaboration and automation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, functional evolution, and integration depth. (1) All dates (2022, 2023, 2024) are accurate, and the progression of Frame.io's integration is correctly outlined. (2) There are no numeric values requiring calculation, so quantitative accuracy is not compromised. (3) The LLM correctly identifies Frame.io's acquisition via trademark listing in 2022 and its role as a cloud-native collaboration platform by 2023. However, there is a minor discrepancy: the LLM states that Frame.io had integration with Photoshop and Lightroom in 2023, while the ground truth specifies those integrations were emphasized in 2024. This over-attribution to 2023 slightly distorts the timeline of integration depth. Additionally, the ground truth explicitly notes the expansion to still images, design files, and PDFs in 2023, which the LLM omits. In 2024, the LLM correctly identifies the grouping under Adobe GenStudio with Firefly and mentions Workfront integration, though it incorrectly includes Adobe Express as part of GenStudio—this is not mentioned in the ground truth, which emphasizes Firefly and Substance 3D instead. (4) Despite these minor inaccuracies in integration timing and component inclusion, the overall reasoning and synthesis across years are sound, and the answer remains contextually relevant and semantically close to the original. The core strategic narrative of deepening integration and expanded functionality is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 417,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple's 2.40% Notes due 2023 were consistently disclosed in its 10-K filings from 2022 through 2024, as evidenced by the repeated inclusion of the notes in the \"Officer's Certificate\" exhibits under the indenture agreements (Chunk 1, 2, and 3). The notes were issued in 2013 and remained part of Apple's debt portfolio as the maturity date approached. Notably, the notes were not replaced or refinanced with new debt instruments in these filings, suggesting that Apple likely repaid the 2.40% Notes at maturity in 2023. This reflects a disciplined debt maturity management strategy, where Apple proactively manages its debt obligations to avoid refinancing risk and maintain a stable capital structure as debt instruments reach their due dates.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.40% Notes due 2023 and their disclosure across 2022–2024, aligning with the ground truth that Apple maintained the notes until maturity. The key factual elements—interest rate, maturity year, and absence of refinancing—are accurate. However, the LLM incorrectly states that the notes were 'consistently disclosed in its 10-K filings from 2022 through 2024', specifically claiming inclusion in 2024. The ground truth states that by 2024, the notes were no longer listed, indicating they had been retired. This is a significant qualitative error in reasoning and completeness, as the disappearance in 2024 is a critical signal of repayment. (2) Quantitatively, all numbers (2.40%, 2023 maturity, 2013 issuance) are correct, and no calculations are required. The dates and percentages match the original answer. (3) The multi-hop reasoning is partially sound: the model correctly infers from continued disclosure in 2022 and 2023 that no early retirement occurred. However, it fails the final hop—interpreting the absence of the notes in 2024—as evidence of repayment, instead falsely claiming they were still disclosed in 2024. This undermines the synthesis across all years. (4) Contextual relevance is high, as the answer addresses debt maturity strategy and draws a reasonable conclusion about disciplined management. The core strategy interpretation aligns with the ground truth, but the factual error on 2024 disclosure prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 413,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "From 2022 to 2024, Union Pacific's Multiple Purpose Locomotive fleet decreased from 7,242 to 6,893 units, with owned locomotives declining from 6,204 to 5,973 and leased units dropping from 1,038 to 920. Concurrently, the average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023 and further to 25.2 years in 2024. This multi-year trend of a shrinking fleet and aging assets suggests a potential shift in asset management strategy, possibly indicating a move toward optimizing existing assets rather than expanding or renewing the fleet, which could reflect cost containment efforts or a strategic focus on operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative data from the ground truth: total Multiple Purpose Locomotives decreased from 7,242 in 2022 to 6,893 in 2024; owned units declined from 6,204 to 5,973; leased units dropped from 1,038 to 920; average age increased from 22.5 to 24.3 to 25.2 years across 2022–2024. All numbers match exactly and are presented accurately. (2) Calculations are not required beyond reporting values, and all figures align with the original answer. Format consistency is appropriate and clear. (3) The multi-hop reasoning is sound—information spans three years and combines fleet size (owned + leased) with age profile trends. The LLM correctly synthesizes the decline in units and aging of fleet to infer strategic implications. (4) The qualitative interpretation slightly differs in tone—'potential shift' and 'optimizing existing assets' suggest a strategic pivot, whereas the ground truth emphasizes 'lack of significant new investment' and 'conservative strategy.' However, the interpretation is semantically close and logically supported by the data. The LLM adds 'cost containment' and 'operational efficiency' as plausible drivers, which are reasonable inferences and do not contradict the original. Thus, while the wording is slightly more speculative, it remains within acceptable interpretive range. No factual or numerical errors; minor difference in emphasis does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 400,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "From 2022 through 2024, Merck’s HIV-1 treatment MK-8591A (doravirine+islatravir) progressed through key regulatory and clinical developments. In 2022, MK-8591A was listed in Phase 2 development for HIV-1 infection and was on FDA clinical hold (Footnote 4). By 2023, it remained in Phase 3 development, with no indication of the clinical hold being lifted. In 2024, the FDA lifted the clinical hold on December 4, 2024, and the program entered a Phase 2/3 study that commenced in August 2024. Additionally, a related compound, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, signaling Merck’s continued investment in islatravir-based HIV treatments. These developments reflect Merck’s evolving regulatory engagement and clinical strategy for its HIV-1 portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. First, it incorrectly states that MK-8591A was in Phase 2 in 2022, while the ground truth confirms it entered Phase 3 in February 2020 and remained in Phase 3 through 2022–2023. This misrepresentation of clinical phase progression undermines the core of the answer. Second, the LLM claims a Phase 2/3 study commenced in August 2024, which is not supported by the original answer—no such study is mentioned, only that MK-8591A remained in development. Third, the LLM states the FDA lifted the clinical hold on December 4, 2024, but the original answer only confirms the hold was lifted in 2024 without specifying a date; adding a precise date not in the source constitutes overprecision or fabrication. (2) Quantitative accuracy is low due to incorrect dates and phases: the Phase 3 entry date (Feb 2020) is ignored, the 2022 phase is wrong (Phase 2 vs actual Phase 3), and the December 4, 2024, FDA action is not in the original data. The October 2024 entry of MK-8591D into Phase 3 is correctly reported. (3) Multi-hop reasoning is partially sound—the model connects MK-8591A and MK-8591D and infers strategic continuity in Merck’s HIV program, which aligns with the original’s interpretation. However, the flawed clinical phase and regulatory timeline weaken the synthesis. (4) Contextual relevance is high because the answer addresses the full time span, discusses both clinical and regulatory aspects, and includes related compounds appropriately. Despite this, major factual errors in phase status and FDA actions reduce overall correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 457,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "From 2022 through 2024, Merck's development of MK-1308A, the coformulation of its investigational anti-CTLA-4 antibody quavonlimab with pembrolizumab, evolved from early-stage evaluation in multiple cancers to a focused immuno-oncology candidate specifically for renal cell carcinoma (RCC). In 2022, MK-1308A was listed as being evaluated in advanced solid tumors, including RCC, colorectal, hepatocellular, melanoma, and small-cell lung cancers. By 2023, Merck explicitly highlighted MK-1308A as being evaluated for the treatment of RCC, aligning it with its immuno-oncology pillar. In 2024, MK-1308A was formally positioned as a Phase 3 candidate for RCC, with Merck emphasizing its strategic focus on immuno-oncology and combination therapies. This progression indicates Merck’s increasing commitment to innovation in RCC treatment, leveraging its expertise in checkpoint inhibitors and combination immunotherapy to address unmet needs in this therapeutic area.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is a coformulation of quavonlimab and pembrolizumab; it was in development from 2022–2024 with a focus on RCC; it remained in Phase 3 through 2024; and Merck emphasized its role in immuno-oncology. The entry date (April 2021) is not mentioned in the LLM answer, but this is a minor omission and does not affect the overall correctness. (2) There are no numeric values, dates, or calculations in dispute—timeline references (2022, 2023, 2024) match exactly, and no financial figures are involved. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Merck’s evolving strategic focus across years, noting the shift from broad solid tumor evaluation to RCC-specific development and positioning within the immuno-oncology pillar. (4) The LLM slightly expands on the original by mentioning other cancers (colorectal, hepatocellular, etc.) in 2022, which is plausible context but not in the ground truth; however, this does not contradict it and adds reasonable background. The core progression and strategic implication—Merck’s sustained and growing focus on RCC innovation via combination immunotherapy—are accurately captured. Thus, the answer earns a 9 for correctness and qualitative accuracy due to excellent fidelity with minor contextual expansion, full quantitative accuracy, and perfect relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 394,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft's 2022, 2023, and 2024 10-K filings consistently reference the 4.000% Notes due 2021 under the Third Supplemental Indenture, indicating no material changes in the terms or structure of this debt instrument across the three years. The notes are consistently linked to the same indenture dated February 8, 2011, and incorporated by reference from the same 8-K filing. This consistency suggests that the 4.000% Notes due 2021 were refinanced or matured prior to 2022, and Microsoft has maintained a stable long-term debt structure by relying on existing indentures for other instruments rather than introducing new debt with similar maturities, reflecting a disciplined refinancing strategy focused on longer-term obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 4.000% Notes due 2021 across Microsoft's 2022, 2023, and 2024 10-K filings and correctly references the Third Supplemental Indenture. However, it incorrectly states the original indenture date as February 8, 2011, when the ground truth specifies May 18, 2009, with the 8-K filing on February 8, 2011, being a subsequent event (likely the issuance date of the notes). This is a critical factual error affecting the accuracy of the legal timeline. (2) The LLM claims the notes were 'refinanced or matured prior to 2022,' but the ground truth does not support this inference; instead, it emphasizes the consistency of disclosure as evidence of no restructuring. The original answer explicitly states no refinancing occurred, so the LLM's conclusion contradicts the ground truth. (3) The multi-hop reasoning is partially sound—linking consistent disclosure to stable debt structure is reasonable—but the incorrect date and erroneous conclusion about refinancing undermine the logical chain. The model fails to correctly synthesize that unchanged documentation implies no action, not that refinancing occurred. (4) The contextual relevance is high because the answer addresses the evolution of disclosure and draws implications about debt strategy. However, due to the incorrect date and flawed conclusion about refinancing, the qualitative and quantitative accuracy scores are reduced. The correctness score is 5 because while some core facts are right (consistent disclosure, same exhibit), key details and the final inference are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 444,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm's strategic positioning in the automotive sector, particularly through its Digital Cockpit offerings, evolved significantly from 2022 to 2024, reflecting a broader transformation in its automotive business. In 2022, Qualcomm emphasized the growing importance of 5G-enabled digital cockpits and the shift toward software-defined vehicles, projecting that 60% of vehicles in 2023 would feature 5G connectivity. By 2023, the company began reporting revenue contributions from automotive systems, including the Digital Cockpit, as a distinct category, highlighting its increasing focus on this segment. In 2024, Qualcomm's 10-K explicitly listed the Digital Cockpit as a key product offering under its QCT segment, underscoring its integration into the company's core semiconductor business. This progression indicates Qualcomm's strategic pivot toward becoming a key enabler of automotive digitalization, leveraging its mobile and connectivity expertise to capture growth in the evolving automotive ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall strategic evolution of Qualcomm's Digital Cockpit from 2022 to 2024 correctly, including its increasing integration into financial reporting and strategic focus. However, there is a significant factual error in the quantitative projection: the LLM states that Qualcomm projected '60% of vehicles in 2023 would feature 5G connectivity,' which is incorrect. The ground truth states that Qualcomm projected 60% of vehicles in 2028 (not 2023) would feature 5G. This is a major misstatement of both the percentage and the timeline. Additionally, the 2022 projection of 'over 70% of new vehicles in 2028 having embedded cellular connectivity' is omitted in the LLM answer. (2) The revenue categorization in 2023 and product line listing in 2024 under QCT are accurately described, and the general progression toward software-defined vehicles is correctly interpreted. (3) The multi-hop reasoning across years and strategic developments is sound—linking 2022 vision to 2023 reporting changes and 2024 operationalization—but the incorrect date undermines the quantitative foundation of the argument. (4) Despite this, the qualitative assessment of strategic transformation is strong and contextually relevant, with appropriate use of terms like 'software-defined vehicle' and 'automotive digitalization.' The answer aligns well with the intent of the question but loses accuracy due to the critical date/percentage error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 404,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "From 2022 through 2024, LMT's use of variable interest rate swaps remained relatively stable in terms of notional amounts. In 2022, the aggregate notional amount of outstanding interest rate swaps was $500 million at year-end. By 2023, this amount increased to $1.3 billion and remained unchanged at $1.3 billion in 2024. This consistency in notional amounts suggests that LMT has maintained a balanced and deliberate interest rate risk management strategy, using these swaps primarily as fair value hedges to convert fixed-rate borrowings to variable-rate borrowings and mitigate exposure to interest rate fluctuations. The stable notional amounts indicate a measured approach to managing interest rate risk, rather than aggressive or reactive adjustments, reflecting LMT's focus on hedging economic exposures without overexposure to market volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the notional amounts for 2022 ($500 million), 2023 ($1.3 billion), and 2024 ($1.3 billion), matching the ground truth exactly. All numeric values and time periods are accurate, satisfying quantitative accuracy. (2) However, the qualitative interpretation diverges from the ground truth. While the original answer identifies a 'fourfold increase' and a 'strategic shift' in 2023 followed by stabilization, the LLM characterizes the trend as 'relatively stable' and 'measured,' which downplays the significance of the 160% increase from 2022 to 2023. This misrepresents the evolution as stable rather than transformative, missing the strategic shift implied by the data. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the notional amounts across years and links them to interest rate risk management—but fails to accurately interpret the trend's implications. The conclusion that the strategy is 'balanced and deliberate' with 'consistency' contradicts the ground truth's emphasis on a significant strategic change. (4) Scores reflect full credit for numbers (10), high relevance to the question (9), but reduced qualitative accuracy due to flawed reasoning (6), leading to an overall correctness score of 7—core facts are right, but strategic interpretation is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses for Hedging]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 376,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft's treatment of the 3.950% Notes due 2056 in its 2022, 2023, and 2024 10-K filings reflects a consistent approach to long-term debt maturity management and refinancing strategy. The notes were issued in August 2016 under the Eleventh Supplemental Indenture, as disclosed in Exhibit 4.14 across all three filings, indicating no refinancing or restructuring activity during this period. The continued inclusion of the notes in each year’s 10-K suggests a long-term fixed-rate debt strategy, with Microsoft maintaining the issuance as part of its capital structure to manage interest costs and maturity schedules over an extended horizon. This consistency implies a deliberate decision to preserve long-term financing flexibility and avoid short-term refinancing risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and consistently disclosed in the 2022, 2023, and 2024 10-K filings. The LLM correctly notes the absence of refinancing or restructuring, which matches the original answer’s implication of strategic continuity. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), issue date (August 2016), and reference to the Eleventh Supplemental Indenture—are all factually accurate. The mention of Exhibit 4.14 adds specificity and is consistent with SEC filing practices, though not in the original answer; this is a minor enhancement rather than an error. (3) The reasoning is sound: the LLM correctly infers that maintaining this long-dated debt reflects a strategy to lock in fixed-rate financing and avoid refinancing risk, which is logically supported by the multi-year consistency in disclosure. It appropriately contrasts this with other maturing instruments (though less explicitly than the original answer, which names the 2.000% Notes due 2023 and 2.400% Notes due 2026). (4) The answer is contextually relevant and fully addresses the question about Microsoft’s long-term debt management and refinancing strategy. The only minor shortcoming is the lack of explicit comparison to other notes (e.g., shorter-term maturities being refinanced), which slightly weakens the multi-hop synthesis compared to the original. However, the core conclusion about strategic preservation of long-term debt is correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 447,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, in its 2022, 2023, and 2024 10-K filings underscores the importance of the 3.700% Notes due 2046 as a key component of its long-term debt structure. These filings consistently list the indenture under Exhibit 4.14, indicating Microsoft's ongoing obligation under the terms established in 2016. The repeated inclusion across three consecutive annual reports reflects the company’s commitment to maintaining transparency and consistency in its financial obligations, particularly for long-dated debt instruments like the 2046 Notes, which contribute to the stability and predictability of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016; it governs the 3.700% Notes due 2046; and its consistent mention in the 2022, 2023, and 2024 filings is accurately noted. The percentage (3.700%), maturity year (2046), and date of the indenture are all factually correct. (2) Quantitative accuracy is perfect—no calculations are required, but all dates, percentages, and references (e.g., Exhibit 4.14) match the expected data. (3) The reasoning is sound: the LLM correctly infers that the repeated reference indicates ongoing obligations and reflects stability in Microsoft’s long-term debt structure. It captures the significance of transparency and consistency, though it does not explicitly mention the base Indenture dated May 18, 2009, or the broader layered financing structure, which is a minor omission affecting completeness. (4) Contextual relevance is excellent—the response directly addresses the significance of the repeated reference and ties it to long-term debt management. The only reason for not scoring a 10 is the lack of mention of the base Indenture and the broader supplemental indenture framework, which slightly reduces qualitative depth compared to the original answer. Overall, the answer is factually correct, well-reasoned, and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 394,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft's 2.125% Notes due 2021 were disclosed in its 10-K filings for fiscal years 2022 through 2024 under the Seventh Supplemental Indenture dated December 6, 2013, consistently referenced as Exhibit 4.1 in each filing. The identical disclosure across all three years suggests that the notes were fully amortized or refinanced prior to their 2021 maturity, as no material changes in terms or status were reported. This continuity implies a stable debt management strategy, where Microsoft either settled the obligation before maturity or integrated it into a broader refinancing plan, reflecting disciplined capital structure management and proactive liquidity planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key factual elements: the 2.125% Notes due 2021, the Seventh Supplemental Indenture dated December 6, 2013, and their consistent inclusion as Exhibit 4.1 in Microsoft's 10-K filings for fiscal years 2022, 2023, and 2024. These details align with the ground truth, and all dates, percentages, and exhibit references are accurate. (2) Quantitative accuracy is perfect: the interest rate (2.125%), maturity year (2021), indenture date (December 6, 2013), and exhibit number (4.1) are all correctly reported with no calculation errors. (3) However, the reasoning and qualitative interpretation diverge significantly from the ground truth. The LLM concludes that the notes were 'fully amortized or refinanced prior to their 2021 maturity' and implies closure, whereas the original answer highlights uncertainty and raises questions about whether the notes were actually refinanced, extended, or simply not removed from disclosures. The ground truth emphasizes that the continued listing of a matured instrument is unusual and may reflect reporting lags or unresolved obligations, while the LLM presents a definitive and optimistic interpretation without acknowledging ambiguity. This reflects a failure in multi-hop reasoning to consider alternative explanations or the implications of persistent disclosure for a post-maturity instrument. (4) The contextual relevance is high because the answer addresses the evolution of disclosure and attempts to infer strategy, but the incorrect inference reduces overall correctness. The answer is factually solid on inputs but flawed in synthesis and conclusion, warranting a mid-range score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 463,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued its 2.000% Notes due 2023 as part of its Eleventh Supplemental Indenture, dated August 8, 2016, with U.S. Bank National Association as Trustee, as disclosed in all three fiscal years (2022, 2023, and 2024) of the 10-K filings. The consistent inclusion of these notes across the years indicates that the issuance was a one-time event in 2016, with the debt maturing in 2023. The multi-year pattern suggests a long-term, stable debt management strategy, where Microsoft strategically issued bonds to raise capital and maintain a diversified maturity profile, allowing for predictable debt servicing and financial planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.000% Notes due 2023, the Eleventh Supplemental Indenture dated August 8, 2016, and their consistent disclosure in Microsoft's 10-K filings across fiscal years 2022, 2023, and 2024. The core factual elements—issuance date, interest rate, maturity year, and indenture details—are all accurate and match the ground truth. (2) Quantitatively, all dates (2022, 2023, 2024, August 8, 2016), percentages (2.000%), and document names (Eleventh Supplemental Indenture) are correct. No calculations are required, but the temporal references are precise. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated disclosure that the debt was maintained through maturity without early retirement or refinancing, and links this to a stable, long-term debt strategy. It adds contextual insight—such as predictable debt servicing and diversified maturity profile—that aligns with and slightly extends the ground truth without introducing inaccuracies. (4) The only minor gap is that the original answer explicitly notes the absence of refinancing before maturity as implied by the continued disclosure, while the LLM implies it but does not state it as clearly. However, the semantic meaning and strategic interpretation are equivalent. Thus, the answer is factually complete and well-reasoned, warranting a high score with only slight room for more precise inference phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 400,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "From 2022 through 2024, Lockheed Martin (LMT) expanded its use of pension risk transfer transactions to reduce the scale of its pension obligations and mitigate financial volatility. By 2022, LMT had already transferred $4.9 billion in pension obligations in 2021, and since 2018, had collectively transferred approximately $11.6 billion in obligations, covering 95,000 retirees and beneficiaries, significantly reducing annual PBGC premiums by around $69 million per year. In 2023, the company reiterated its strategy of using pension risk transfer transactions to further reduce the size of its defined benefit pension plans, acknowledging that future transactions could result in material noncash settlement charges. By 2024, LMT continued this approach, emphasizing its intent to pursue additional transactions to manage pension liabilities, while also noting the potential for earnings volatility due to actuarial assumptions and the financial impact of such transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the $4.9 billion pension obligation transfer in 2021, the $11.6 billion total transferred since December 2018, the $69 million annual PBGC premium reduction, and the $1.7 billion noncash settlement charge from 2021 are all correctly referenced. The LLM correctly notes the continuation of the strategy in 2023 and 2024, including the potential for future noncash settlement charges and earnings volatility. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and derived impacts (e.g., PBGC savings) match the original. The addition of '95,000 retirees and beneficiaries' is not in the ground truth but does not contradict it and may reflect supplementary data; it doesn't detract from accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings, correctly tracing the evolution of strategy from past actions to future intent. (4) The only minor shortcoming is that the LLM omits explicit mention of the 2022 reference to the 2021 transaction and the $1.7 billion charge—though it references the $4.9B transfer, it doesn't explicitly tie the charge to that transaction, slightly weakening the completeness. However, the core financial impact (noncash charges) is acknowledged in future contexts. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 413,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The consistent reference to Floating Rate Notes due 2019 in Apple's 10-K filings from 2022 through 2024 suggests that the company has maintained visibility into its long-term debt structure, even after the maturity of these notes in 2019. This indicates a disciplined approach to debt management, where Apple likely refinanced these obligations prior to maturity, leveraging its strong credit profile to access favorable financing terms. The continued inclusion of these notes in subsequent filings reflects Apple’s transparency in disclosing historical debt instruments and its strategic alignment of debt maturities to ensure liquidity and minimize refinancing risk. The pattern also highlights the company’s proactive capital structure planning, as evidenced by the issuance of various debt instruments with staggered maturities across the years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the Floating Rate Notes due 2019 are accurately referenced, and their maturity in 2019 is correctly acknowledged. The continued disclosure in 2022–2024 filings is properly interpreted as a sign of transparency and disciplined debt management. (2) There are no numerical inaccuracies—dates (2019 maturity, 2022–2024 filings) are correct, and no erroneous calculations are made. (3) The multi-hop reasoning is sound: the model correctly infers that despite maturity, the notes’ continued mention suggests refinancing or rollover, which reflects strategic capital structure planning. It appropriately links Apple’s strong credit profile to favorable refinancing, a reasonable inference consistent with the ground truth’s emphasis on disciplined strategy. (4) The answer is contextually excellent, directly addressing Apple’s long-term debt management and refinancing strategy as asked. The only minor gap is that the original answer specifically mentions the possibility that the notes were 'part of a broader, ongoing debt structure or refinancing plan,' which the LLM implies but doesn’t state as explicitly. However, the core meaning—proactive rollover, transparency, and strategic planning—is fully captured. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 379,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings under the Third Supplemental Indenture (Exhibit 4.6), indicating the ongoing relevance of this debt instrument in its capital structure. The notes were issued in 2011 and remained part of the company’s disclosed debt instruments through at least 2024, even after their 2021 maturity date, likely due to amortization schedules or remaining principal balances. This continued inclusion suggests that the notes were either partially outstanding or required ongoing disclosure for regulatory or contractual obligations, reflecting their historical significance and continued relevance in Microsoft’s broader debt management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Microsoft, 4.000% Notes due 2021, 2022–2024 10-K filings, Exhibit 4.6 (Third Supplemental Indenture). The maturity date (2021) and continued disclosure through 2024 are correctly stated. (2) Quantitative accuracy is perfect: no numerical errors; dates and percentages match the ground truth. The mention of issuance in 2011, while not in the original answer, is plausible and does not contradict known facts. (3) Multi-hop reasoning is sound: the model correctly infers that post-maturity disclosure implies ongoing relevance, possibly due to remaining obligations, covenants, or disclosure requirements. It accurately synthesizes the idea that maturity does not necessarily mean immediate removal from disclosures. (4) The only minor gap is that the LLM attributes the continued relevance to 'amortization schedules or remaining principal balances,' whereas the ground truth emphasizes structural/legal continuity (e.g., indentures, covenants). This is a slight difference in emphasis, not a factual error. Overall, the answer captures the core insight—ongoing disclosure reflects ongoing relevance—and does so with excellent contextual and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 352,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS's treatment and disclosure of its $276 million 7.620% debentures remained consistent from 2022 through 2024 in terms of redemption terms and interest payment structure. The debentures, maturing in April 2030, are redeemable at UPS’s option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October, and the debentures are not subject to sinking fund requirements, as noted in both 2022 and 2024 filings. In 2023, the debentures were listed with a face value of $276 million and a carrying value of $280 million, indicating no material change in their debt positioning during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $276 million face value, 7.620% interest rate, April 2030 maturity, semi-annual interest payments (April/October), redemption terms (greater of principal plus accrued interest or present value using treasury yield + 5 bps), and absence of sinking fund requirements are all correctly stated and consistent across years. The 2023 carrying value of $280 million matches the original answer. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, dates, and financial terms are factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 filings, showing continuity in disclosure and treatment. However, the LLM slightly underrepresents the *evolution* in narrative focus described in the ground truth: while it notes consistency, it omits the shift from historical interest rate context (2022) to structural detail and global debt positioning (2024), particularly the comparative framing with Pound Sterling and Euro notes. This nuance is important for a full characterization of 'evolution' in disclosure. (4) Despite this minor omission in qualitative emphasis, the answer remains factually complete and contextually relevant, accurately summarizing the core treatment and positioning of the debentures over time. Hence, a score of 9 is warranted—excellent accuracy with only a slight gap in capturing the full depth of disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 423,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "From 2022 through 2024, ABBV's development and commercialization of Vraylar demonstrated significant growth and strategic importance within its neuroscience portfolio. In 2022, ABBV reported Vraylar U.S. sales of $2,037 million, with total global sales of $2,038 million, reflecting a 17.9% year-over-year increase. By 2023, U.S. sales rose to $2,755 million and total global sales reached $2,759 million, representing a 35.4% increase, indicating strong market acceptance and expansion. In 2024, while specific sales figures for Vraylar are not provided, its inclusion in the neuroscience portfolio alongside Botox Therapeutic and Duodopa underscores its role in addressing complex neurological conditions. Vraylar’s continued commercial success and its approval for multiple indications, including schizophrenia, bipolar disorder, and major depressive disorder, highlight its strategic value in ABBV’s neuroscience segment, contributing to sustained revenue growth and reinforcing its focus on difficult-to-treat neurological diseases.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key discrepancy in the 2022 sales figures. The ground truth does not provide 2022 revenue for Vraylar, but the LLM states $2,037 million (U.S.) and $2,038 million (global) in 2022 sales, which is not supported by the original answer. The 2023 revenue of $2,759 million is accurate and matches the ground truth. The 35.4% year-over-year increase is correctly cited. However, the LLM incorrectly implies that the 35.4% growth is from 2022 to 2023 using its own stated 2022 figure (~$2,038M), which would actually yield approximately a 35.4% increase to $2,759M—this calculation is numerically consistent but based on an unsupported 2022 figure. The original answer does not provide 2022 revenue, only trial results. (2) The LLM fabricates 2022 sales data not present in the ground truth, which is a significant quantitative inaccuracy. While the 2023 revenue and growth rate are correct, the inclusion of unsupported 2022 numbers reduces quantitative accuracy. (3) The qualitative reasoning is strong: the LLM correctly identifies Vraylar’s multi-indication approvals (schizophrenia, bipolar, MDD), its strategic role in the neuroscience portfolio, and its commercial growth trajectory. It appropriately infers strategic importance from clinical and commercial data, demonstrating sound multi-hop reasoning across development and financial performance. (4) Contextual relevance is excellent—the answer directly addresses the evolution from 2022 to 2024, covers development, commercialization, and financial performance, and draws a meaningful conclusion about strategic importance. The only major flaw is the unsupported 2022 revenue figures, which prevents a top score in correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 482,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The consistent inclusion of the 0.45% Notes due 2016 in Apple's 10-K filings across fiscal years 2022, 2023, and 2024 suggests that the company maintains a structured and transparent disclosure strategy for its long-term debt, including legacy instruments. Despite the maturity date of 2016, the repeated listing of these notes in the exhibits indicates that Apple continues to reference these instruments in its regulatory filings, likely for completeness and to reflect ongoing obligations or contractual terms. This practice underscores Apple’s commitment to comprehensive financial reporting and highlights the enduring relevance of historical debt instruments in its disclosure framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 0.45% Notes due 2016, and their inclusion in Apple's 10-K filings for fiscal years 2022, 2023, and 2024 are correctly stated, matching the ground truth. There are no numerical or date inaccuracies, so quantitative accuracy is perfect. The entity identification (Apple, the specific notes, and the time frame) is correct, and the answer addresses the core question about long-term debt structure and disclosure strategy. However, the LLM slightly mischaracterizes the reason for continued disclosure by suggesting 'ongoing obligations or contractual terms,' which implies current financial relevance. The ground truth clarifies that the inclusion is for transparency and historical record-keeping, not because there are active obligations. This subtle but important distinction affects the qualitative accuracy, as the reasoning slightly misrepresents the intent behind the disclosure. Despite this, the overall reasoning is sound, and the answer remains contextually relevant and well-aligned with the question. The multi-hop synthesis—linking repeated disclosure across years to a broader disclosure strategy—is logically supported. Thus, while not fully precise in interpretation, the answer is largely correct and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 363,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "From 2022 through 2024, UPS SurePost evolved from a residential ground service primarily reliant on the U.S. Postal Service (USPS) for final delivery to a more strategically integrated component of UPS’s U.S. Domestic Package business. In 2022 and 2023, it continued to serve non-urgent, lightweight residential shipments, leveraging the reliability of the UPS ground network with USPS handling last-mile delivery. By 2024, UPS announced the insourcing of final delivery for UPS SurePost, effective January 1, 2025, to enhance control and service quality, reflecting a strategic shift toward consolidating delivery operations under its own fleet. This evolution aligns with UPS’s broader goal of optimizing its domestic delivery network and improving service consistency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost served non-urgent, lightweight residential shipments in 2022 and 2023, used the UPS ground network with USPS for final delivery, and in 2024 announced a shift to insource final delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. (3) Multi-hop reasoning is sound—information is synthesized across three years and reflects the evolution in delivery methodology and strategic positioning within the U.S. Domestic Package business. (4) The answer fully addresses the question’s focus on operational structure and strategic role, capturing continuity from 2022–2023 and the strategic shift announced in 2024. Wording differs slightly but meaning is preserved, including the intent to enhance service quality and control. All entities (UPS, USPS, UPS SurePost, U.S. Domestic Package business) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 302,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple issued the 4.45% Notes due 2044 on May 6, 2014, as disclosed in the 2022, 2023, and 2024 10-K filings, indicating that the issuance was a one-time event and remained unchanged across these years. The continued inclusion of these notes in the exhibits across all three years suggests Apple maintains a long-term capital strategy focused on securing stable, low-cost financing through extended-maturity debt instruments. This multi-year consistency reflects Apple’s disciplined approach to capital structure management, leveraging long-term debt to support its financial flexibility and investment needs over the long horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 were indeed issued on May 6, 2014, and consistently referenced in Apple's 10-K filings from 2022 to 2024. The LLM correctly identifies this as a one-time issuance with no changes over the period, which matches the ground truth's assertion that there was no early redemption or restructuring. (2) Quantitative accuracy is perfect: the interest rate (4.45%), maturity year (2044), and issuance date (May 6, 2014) are all correctly stated. No calculations are required, but the temporal consistency across three years is accurately captured. (3) The multi-hop reasoning is sound—by synthesizing information across three years of filings, the LLM correctly infers that Apple maintained this debt instrument over time, indicating a strategic long-term capital approach. The conclusion about financial flexibility and stable financing mirrors the ground truth’s interpretation. (4) The only minor gap is that the LLM does not explicitly mention the 'Officer's Certificate' as the document vehicle carrying forward the note details each year, which is a small but relevant procedural detail in the original answer. However, this omission does not affect the overall correctness or interpretation. The answer remains semantically equivalent and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 386,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle's treatment of the 2.875% Notes due 2031 remained consistent across its 2022, 2023, and 2024 10-K filings, as evidenced by the notes being consistently listed as Exhibit 4.14 in each filing. This exhibit references the forms of the notes issued on March 24, 2021, under an Officers' Certificate, indicating no material changes in the terms or presentation of this debt instrument over the three years. The consistent positioning of the 2.875% Notes due 2031 as Exhibit 4.14 across these filings reflects Oracle's disciplined capital structure management and long-term debt strategy, emphasizing continuity and transparency in its debt disclosures. This consistency suggests that Oracle maintains a stable and well-organized approach to managing its debt portfolio, ensuring that key instruments like the 2031 notes are consistently documented and accessible to investors and regulators.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully aligned with the ground truth. (1) All factual elements are correct: the 2.875% Notes due 2031 are accurately described as being consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, with no changes to terms. The issuance date of March 24, 2021, under an Officers' Certificate is correctly cited. (2) Quantitative accuracy is perfect: percentages (2.875%), years (2031, 2021, 2022–2024), and exhibit number (4.14) match the original answer exactly. No calculations are required, but the temporal consistency across three years is correctly noted. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual filings and infers the strategic implication—stable capital structure management and consistent debt strategy—directly supported by the unchanged exhibit positioning. (4) The answer is semantically equivalent to the ground truth, using slightly different phrasing (e.g., 'disciplined capital structure management' vs. 'stable approach') but conveying the same meaning. All parts of the question are addressed: evolution over time (no change), exhibit consistency, and strategic implications. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 338,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters collective bargaining agreement introduced wage and benefit rate increases for employees in the UPS Pension Plan and the UPS/IBT Full-Time Employee Pension Plan, as disclosed in the 2023 10-K. These increases were recognized in the year-end measurement of the plans, directly impacting the pension obligations by raising future benefit liabilities. The UPS/IBT Full-Time Employee Pension Plan, which is sponsored by UPS and includes employees previously covered under the Central States Pension Fund, accrues benefits based on service credits earned prior to retirement, as outlined in both the 2022 and 2024 disclosures. The 2024 10-K reaffirms the structure of the plan and notes that the UPS Retirement Plan and UPS Excess Coordinating Benefit Plan ceased benefit accruals for non-union participants in 2023, shifting more long-term pension obligations to plans like the UPS/IBT Full-Time Employee Pension Plan, which remains active for collective bargaining unit members. This shift, combined with the 2023 agreement, signals an increase in UPS’s long-term pension obligations, as reflected in the ongoing maintenance and measurement of these plans in subsequent disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 Teamsters agreement included wage and benefit increases impacting pension accruals in the UPS/IBT Full-Time Employee Pension Plan, which was factored into year-end measurements. The plan covers employees previously in the Central States Pension Fund, and the 2024 disclosures confirm no structural changes, indicating the 2023 agreement was the latest update. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024), plan names, and benefit structures are correctly cited. While the LLM adds detail not in the original (e.g., mention of the UPS Retirement Plan and Excess Coordinating Benefit Plan ceasing accruals in 2023), this information is contextually consistent and enhances the analysis without contradicting the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and plans, linking the 2023 agreement to ongoing pension obligations and UPS's shifting liability landscape. (4) The only minor deviation is that the original answer does not mention the cessation of accruals in non-union plans, so this addition, while plausible and relevant, slightly extends beyond the provided ground truth. However, it strengthens the conclusion about increasing long-term obligations under collective bargaining without introducing error. Thus, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Maintain]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 416,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple's 2022, 2023, and 2024 10-K filings consistently reference the 1.05% Notes due 2017 under the Officer's Certificate dated May 6, 2014 (Exhibit 4.4 in each filing), indicating no material changes in disclosure regarding this instrument across the three years. This continuity suggests that Apple maintained a stable approach to managing short-term debt instruments issued under its 2014 Officer's Certificate, treating the 1.05% Notes due 2017 as a consistent component of its broader debt structure without requiring updated disclosures or amendments. The repeated inclusion of the same exhibit across all three filings reflects a structured and consistent regulatory reporting practice, reinforcing Apple's disciplined approach to managing debt instruments under its existing frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are consistently disclosed under the Officer's Certificate dated May 6, 2014, across the 2022, 2023, and 2024 10-K filings, with Exhibit 4.4 referenced. These details match the original answer. (2) Quantitative elements—interest rate (1.05%), maturity year (2017), and date of the Officer's Certificate (May 6, 2014)—are all accurate, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure across three years that Apple maintained a stable, passive management approach to this debt instrument under the 2014 framework. (4) The LLM slightly softens the conclusion by using terms like 'stable approach' and 'structured reporting practice' rather than explicitly stating 'passive management' or 'no refinancing,' which are present in the ground truth. However, the semantic meaning is equivalent, and the inference is logically supported. The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in disclosure and the implied strategy. Minor deduction in qualitative accuracy due to less precise characterization of Apple's strategy, but overall excellent performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 361,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple's 2.40% Notes due 2023 were disclosed consistently in its 10-K filings from 2022 through 2024, as shown in the Officer's Certificate dated May 3, 2013 (Exhibit 4.3), which was incorporated by reference in each year's filing. This continuity suggests that Apple maintained these notes as part of its long-term debt structure, with no indication of refinancing or early repayment during this period. The consistent inclusion of these notes across multiple years reflects a stable and deliberate approach to debt management, emphasizing long-term planning and disciplined capital structure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple disclosed the 2.40% Notes due 2023 in its 2022, 2023, and 2024 10-K filings, referencing the same Officer's Certificate dated May 3, 2013. This consistency across years is correctly noted. (2) Quantitative elements—interest rate (2.40%), maturity year (2023), and document date (May 3, 2013)—are all accurate. No calculations were required, but the dates and percentages match exactly. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated disclosure that there were no changes to the terms, repayments, or extensions, which implies a stable debt management strategy. (4) The LLM slightly softens the conclusion by saying 'no indication of refinancing or early repayment' rather than asserting outright that none occurred, which is a more cautious phrasing than the original answer but still reasonable given the source-based nature of the filings. The core message—that Apple maintained a consistent, stable approach to this debt instrument—is preserved. Minor deduction in qualitative accuracy due to slightly less definitive causal inference compared to the original, but overall excellent semantic equivalence and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 356,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "From 2022 through 2024, Vraylar's commercial trajectory demonstrated strong revenue growth and continued therapeutic positioning within AbbVie's neuroscience portfolio. In 2022, Vraylar generated $2,038 million in revenue, reflecting a 17.9% increase compared to 2021, with the U.S. contributing $2,037 million and international markets adding $1 million. By 2023, revenue grew significantly to $2,759 million, a 35.4% increase from 2022, driven by $2,755 million in U.S. sales and $4 million in international sales. In 2024, Vraylar remained a key component of AbbVie's neuroscience portfolio, with its therapeutic positioning as a dopamine D3-preferring D3/D2 receptor partial agonist supporting its use in schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder, as disclosed in AbbVie's 10-K filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects—clinical development, revenue growth, and therapeutic positioning of Vraylar from 2022 to 2024. It accurately reports U.S. sales of $2,037 million in 2022 and $2,755 million in 2023, and total revenues of $2,038 million (vs. $2,037M in ground truth—likely a rounding or reporting variation) in 2022 and $2,759 million in 2023, matching the ground truth exactly. The 35.4% growth rate cited (vs. 35.2% in original) is due to precise calculation: ($2,755M - $2,037M) / $2,037M ≈ 35.23%, which rounds to 35.2% or 35.4% depending on rounding method—this minor discrepancy is acceptable under format flexibility. (2) International sales are correctly implied as minimal ($1M in 2022, $4M in 2023), consistent with the dominance of U.S. sales. (3) The qualitative synthesis across years is sound: the LLM correctly identifies Vraylar’s clinical progress in 2022 (though it omits the detail about one successful and one numerically positive but non-significant Phase 3 trial), captures the revenue trajectory accurately, and correctly positions Vraylar in 2024 as a key neuroscience asset with indications for schizophrenia, bipolar I disorder, and adjunctive MDD treatment. (4) The omission of the specific clinical trial outcome details in 2022 slightly reduces completeness, but the core commercial trajectory—revenue and therapeutic positioning—is fully addressed with high fidelity. The reasoning is multi-hop, connecting revenue data across years and integrating therapeutic indications from clinical development. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness—excellent but not perfect due to minor omission in clinical trial detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 477,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM's emphasis on client relationships and trust as a competitive differentiator remained a consistent strategic pillar from 2022 to 2024, with a growing integration into its hybrid cloud and AI positioning. In 2022, IBM highlighted client relationships and trust as a core method of competition, emphasizing their role in delivering business outcomes and differentiating through deep expertise and secure, open hybrid cloud solutions. By 2023, the company expanded on this by linking client trust with strategic partnerships and a broader ecosystem, reinforcing its ability to deliver end-to-end solutions. In 2024, the focus evolved further to emphasize how trust and long-standing client relationships, combined with incumbency and innovation, position IBM to lead in hybrid cloud and AI while preparing for future opportunities like quantum computing. This multi-year progression underscores IBM's strategic positioning as a trusted, long-term partner in the complex and rapidly evolving hybrid cloud and AI markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: IBM consistently emphasized trust and client relationships from 2022 to 2024, with evolving strategic framing each year. In 2022, trust was tied to hybrid cloud, AI, and secure solutions; in 2023, it was linked to strategic partnerships and end-to-end solutions; in 2024, it became foundational in go-to-market strategy with ecosystem integration. The LLM correctly captures this progression. (2) There are no numeric values, dates, or financial metrics in dispute—dates (2022–2024) are accurate and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes IBM’s evolving emphasis across three years and connects it to strategic positioning in hybrid cloud and AI. The only minor gap is that the LLM mentions 'preparing for future opportunities like quantum computing' in 2024, which is not in the original answer and slightly extends beyond the ground truth. While not incorrect per se, it introduces an element not supported in the source, slightly reducing qualitative accuracy. (4) Despite this, the answer remains semantically equivalent in intent and core content, with excellent contextual relevance and a clear, logical progression that directly addresses the question. Thus, the correctness score is 9—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 382,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024 in terms of both disclosure practices and its role within the company's debt portfolio. In 2022, the notes were disclosed as part of IBM’s broader debt offerings, with the instrument incorporated by reference in filings such as Form 8-K from 2019. By 2023, the 1.250% Notes due 2027 were explicitly listed among other notes, including higher-yielding instruments like the 4.150% Notes due 2027, suggesting a more diversified debt structure. In 2024, the 1.250% Notes due 2027 were clearly identified in the debt listing under the ticker IBM27B, traded on the New York Stock Exchange, indicating a consistent and transparent disclosure approach. The notes appear to serve as a low-yield component in IBM’s broader fixed-income portfolio, which includes multiple maturities and coupon rates to manage interest costs and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were initially incorporated by reference in 2022 via a 2019 Form 8-K (Exhibit 4.3), consistent with the original answer. In 2023, the note was listed among a broader set of instruments, reflecting a more complex debt structure. By 2024, it was explicitly identified with ticker IBM27B, traded on the NYSE—this matches the ground truth's claim of formal recognition and active trading. (2) Quantitative elements—coupon rate (1.250%), maturity year (2027), and trading symbol (IBM27B)—are all correct. No calculations were required, but all dates and identifiers are accurate. (3) The multi-hop reasoning is sound: the model correctly infers increasing transparency and structural importance over time based on evolving disclosure practices across three years. It synthesizes information across filings and years appropriately. (4) The only minor gap is that the LLM mentions the 4.150% Notes due 2027 as a comparison point not present in the original answer, which, while plausible, isn't supported by the ground truth. However, this doesn't introduce inaccuracy but adds context. Overall, the answer captures the evolution in disclosure and role within the debt portfolio accurately and completely, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 375,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM's disclosures regarding the 6.50% Debentures due 2028 remained consistent from 2022 to 2024, as each year's 10-K filing referenced the same exhibit—Exhibit 2 to Form 8-K, filed on January 8, 1998. In 2022 (Chunk 1), the 6.50% Debentures due 2028 were listed among other debt instruments, with exhibit references varying by issuance date. By 2023 and 2024 (Chunks 2 and 3), the 6.50% Debentures due 2028 were specifically highlighted under the \"Instruments defining the rights of security holders\" section, alongside other long-term debt instruments, but retained the same exhibit reference. This consistency in exhibit reference reflects IBM's standardized approach to disclosing historical debt instruments across its filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed on January 8, 1998, across 2022–2024, and this exhibit reference remains unchanged. The years and exhibit details are factually accurate. (2) Quantitative elements—interest rate (6.50%), maturity year (2028), exhibit number (2), filing date (January 8, 1998)—are all correct with no calculation errors. (3) The reasoning is sound: the LLM correctly identifies consistency in exhibit referencing and notes the evolving context in disclosure focus, particularly the integration of legacy and newer debt instruments. It accurately reflects that in 2022, the debentures were listed among various debt instruments, and in 2023–2024, they were highlighted in the 'Instruments defining the rights of security holders' section. (4) The only minor omission is that the original answer adds context about newer instruments like the 6.22% Debentures due 2027 and 5.875% due 2032, and frames the consistency as supporting regulatory compliance and investor understanding—nuances not fully captured in the LLM response. However, the core multi-hop synthesis across years and disclosure practices is correct. The answer is semantically equivalent in key aspects and fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 380,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "From 2022 to 2024, the geographic reach of FedEx International Connect Plus expanded significantly, growing from nearly 50 origin countries to over 60 origin countries, and from over 130 destination countries to more than 190 destination countries. This expansion trajectory underscores FedEx’s strategic focus on strengthening its position in the e-commerce logistics market by enhancing its global coverage and delivery capabilities to meet the rising demand for cross-border e-commerce solutions. The growth aligns with broader initiatives like the DRIVE transformation program and the integration of TNT Express, which have bolstered FedEx’s international network and operational efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the quantitative evolution of FedEx International Connect Plus from 2022 to 2024: nearly 50 to nearly 60 origin countries, and over 130 to over 190 destination countries. These figures match the ground truth exactly, with acceptable phrasing variations (e.g., 'more than 190' = 'over 190'). The 2024 stabilization at nearly 60 and over 190 is implied by stating the endpoint of the expansion, though the LLM does not explicitly note that the reach remained stable in 2024, which is a minor omission. (2) All numbers and timeframes are accurate. No calculations are required, but the directional changes (increase in origin and destination countries) are correctly presented. (3) The reasoning is sound: the expansion is tied to FedEx’s strategic focus on e-commerce logistics, which aligns with the ground truth. The mention of the DRIVE transformation program and TNT Express integration adds contextual depth supported by broader knowledge of FedEx’s strategy, though these are not in the original answer. While insightful, their inclusion doesn’t detract from accuracy but slightly shifts focus. (4) The answer is semantically equivalent in conveying the expansion trajectory and strategic implication. The only minor gap is the lack of explicit mention that the geographic reach stabilized in 2024, suggesting maturity—this nuance is missing but doesn’t invalidate the core correctness. Hence, high scores across all dimensions with a 9 on correctness due to partial completeness on the 2024 status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 427,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "From fiscal 2022 through 2024, Qualcomm’s human capital advancement goals evolved to place a stronger emphasis on diversity, equity, and inclusion (DEI), particularly in leadership roles, while maintaining a direct linkage to executive compensation through a non-financial performance modifier. In fiscal 2022, Qualcomm set specific 2025 DEI goals, including increasing women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. For fiscal 2022, progress toward these goals served as a modifier for executive bonuses, allowing payouts to vary by a multiple of 0.9 to 1.1. By fiscal 2024, the company continued this linkage, with the HR and Compensation Committee using progress on human capital advancements as a non-financial performance modifier for fiscal 2024 bonuses, maintaining the same 0.9 to 1.1 adjustment range. This consistent mechanism underscores Qualcomm’s ongoing commitment to aligning executive incentives with DEI and human capital outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Qualcomm set 2025 diversity targets in 2022 to increase women in leadership by 15%, URM in leadership by 15%, and overall URM representation by 20%; these targets were maintained through 2024. The non-financial performance modifier for executive bonuses correctly ranges from 0.9 to 1.1 based on progress, and this mechanism remained consistent across fiscal years 2022–2024. (2) Quantitative accuracy is perfect: all percentages and the bonus adjustment range are correctly reported with no calculation errors. (3) The reasoning is sound and reflects proper multi-hop synthesis across fiscal years and compensation policies. The LLM correctly infers sustained incentive alignment over time. (4) The only minor omission is that the original answer notes increased emphasis on external initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025—a detail absent in the LLM response. While this doesn't affect core correctness, it slightly reduces completeness in describing the evolution of supporting strategies. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth with only minor qualitative nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 369,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024, as reflected in its 10-K filings, indicates a deliberate strategy to manage short-term interest rate risk by maintaining exposure to floating rates, which adjust with market conditions. This approach allows Apple to hedge against potential interest rate increases, ensuring more predictable interest expenses in a volatile rate environment. Additionally, by retaining these notes in its debt portfolio, Apple demonstrates a focus on liquidity planning, as floating rate instruments typically offer more flexibility in refinancing or restructuring debt obligations compared to fixed-rate instruments, supporting its broader financial stability and operational flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Apple included Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024, which reflects a consistent approach to managing short-term interest rate risk and liquidity planning. The dates (2019 maturity, disclosures in 2022–2024) are accurate and match the original answer. (2) There are no numerical values requiring calculation (e.g., dollar amounts or percentages), so quantitative accuracy is not compromised—only correct time periods and instrument types are referenced, which are accurate. (3) The multi-hop reasoning is sound: the model correctly infers that continued disclosure implies ongoing exposure and strategic use of floating rate instruments for interest rate risk management and liquidity flexibility. It logically connects floating rate exposure to adaptability in changing rate environments, consistent with the ground truth. (4) The only minor shortcoming is that the LLM slightly reframes the purpose as 'hedging against potential interest rate increases' and 'predictable interest expenses,' which is plausible but not explicitly supported—the original emphasizes alignment with market conditions and avoiding new issuances, rather than hedging per se. This subtle shift in rationale prevents a perfect 10 on qualitative accuracy, but the core reasoning and contextual relevance remain strong. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 418,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolved as part of its broader automotive business segmentation. In 2022, Qualcomm highlighted the growing demand for embedded cellular connectivity in vehicles, projecting that 70% of new vehicles in 2028 would include such features, with 60% utilizing 5G. The digitalization of the automotive cockpit was emphasized as a key driver, with Qualcomm leveraging its high-performance, low-power computing technologies to support advanced driver assistance and automated driving features. By 2023, Qualcomm included revenues from automotive products such as connectivity, digital cockpit, and ADAS/AD in its segment reporting, reflecting the increasing importance of the automotive market. In 2024, the company's QCT segment explicitly listed automotive systems for connectivity, digital cockpit, and ADAS/AD as core offerings, indicating a more defined and strategic focus on the automotive industry. This evolution aligns with the projected market demand for software-defined vehicles and Level 2+ autonomous features, as Qualcomm continues to integrate mobile technologies into automotive platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology from 2022 to 2024 accurately, with correct entity identification (Qualcomm, QCT segment, digital cockpit, ADAS/AD) and appropriate segmentation of developments by year. The overall trajectory—from market positioning in 2022, to revenue inclusion in 2023, to strategic integration in 2024—is correctly conveyed. (2) However, there is a quantitative discrepancy: the LLM states that 70% of new vehicles in 2028 would include embedded cellular connectivity, while the ground truth specifies 'over 60%' with 5G connectivity by 2028. The 70% figure is not present in the original answer and appears to be an overstatement or conflation. This affects the quantitative accuracy score. All other numbers (60% 5G penetration) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and business segments, noting the progression from R&D emphasis to commercial revenue to structural integration within QCT. It appropriately links mobile-derived technologies to automotive digitalization and recognizes the consolidation of automotive offerings. (4) Despite the minor numerical inaccuracy, the qualitative reasoning and contextual relevance are strong. The answer addresses all parts of the question, including strategic positioning, revenue focus, automotive segmentation, and market demand projections. Semantic equivalence is largely preserved, with only the overstated percentage detracting from full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 443,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott's unfunded commitments to private real estate funds decreased from $585 million in 2022 to $569 million in 2023, and further declined to $555 million in 2024. This slight but consistent decline suggests a measured approach to its long-term investment strategy in illiquid alternative assets, indicating that Abbott is either fulfilling its existing commitments or reducing its exposure to such investments while maintaining a presence in private real estate and other illiquid funds. The continued allocation to these funds, despite the reduction, reflects an ongoing commitment to diversify its portfolio with alternative assets that offer potentially higher returns, albeit with lower liquidity and longer investment horizons.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, Abbott's unfunded commitments were $569M in 2022, $555M in 2023, and $540M in 2024. However, the LLM incorrectly reports $585M in 2022, $569M in 2023, and $555M in 2024—shifting all values upward by $16M in 2022 and propagating this error forward. This results in an incorrect year-over-year decline of $16M and $14M instead of the correct $14M and $15M. These errors affect the quantitative foundation of the analysis. (2) Calculations are therefore inaccurate: the actual trend is a consistent $15M annual decrease, while the LLM implies a slightly less uniform decline. The direction (downward) is correct, but the magnitude and starting point are wrong. (3) The qualitative reasoning is partially sound—the interpretation that the decline suggests a measured or cautious strategy in illiquid alternatives aligns with the ground truth’s 'strategic de-risking' conclusion. The mention of continued exposure and long-term horizons matches the spirit of the original answer, though the LLM does not mention the 2025–2034 liquidation periods, missing a key supporting detail. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of commitments and strategic implication) and stays focused on Abbott’s investment behavior. However, due to the critical numerical inaccuracies in the core data, the correctness score is significantly reduced despite reasonable interpretation. Quantitative accuracy is low due to incorrect base figures; qualitative accuracy is moderate due to valid logic on strategy; contextual relevance remains strong as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 477,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple's 0.45% Notes due 2016 were issued as part of its broader long-term debt strategy, as evidenced by the consistent inclusion of these notes in the company's filings across fiscal years 2022, 2023, and 2024. Each year's 10-K filing (2022, 2023, and 2024) lists the 0.45% Notes due 2016 under the relevant exhibit sections (e.g., 4.3), indicating that the notes remained outstanding and were incorporated by reference in the company's ongoing securities descriptions. This continuity suggests that Apple maintained a structured approach to its long-term debt, retaining these low-yield instruments as part of its diversified debt portfolio to manage interest costs and maturity schedules over time. The pattern reflects Apple's strategy of issuing long-term debt with staggered maturities and varying interest rates to optimize its capital structure and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 0.45% Notes due 2016 were consistently disclosed in Apple's 2022, 2023, and 2024 10-K filings, and were originally issued under an Officer's Certificate dated May 3, 2013. While the LLM does not explicitly mention the 2013 issuance date, it correctly infers the notes were retained over time, which is the core of the multi-hop insight. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and fiscal years of disclosure (2022–2024)—are all accurate. No calculations are required, and all numbers match the original answer. (3) The reasoning is sound: the LLM correctly interprets the repeated disclosure as evidence of Apple maintaining the debt instrument in its capital structure, reflecting a stable, diversified long-term debt strategy with staggered maturities and interest rate management. This aligns with the ground truth’s conclusion about Apple preserving older, low-yield debt. (4) The only minor omission is the lack of explicit reference to the May 3, 2013 Officer's Certificate, which slightly reduces completeness but does not affect the overall correctness of the conclusion. The answer remains semantically equivalent in substance and effectively addresses both parts of the question: the evolution (consistent inclusion) and strategic implication (stable, diversified debt structuring).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 394,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM's emphasis on client relationships and trust has evolved from 2022 to 2024 as a core competitive differentiator, particularly in hybrid cloud and AI, by reinforcing its incumbency in mission-critical infrastructure and integrating deep industry expertise with a flexible, secure, and open hybrid cloud platform. In 2022, IBM highlighted its ability to combine trust and security with AI and cloud to deliver business outcomes, while in 2023, it expanded this by emphasizing strategic partnerships with hyperscalers and ecosystem alliances to enhance its go-to-market reach. By 2024, client relationships and trust were positioned as central to IBM’s strategy, underpinning its ability to solve complex business challenges and accelerate growth in hybrid cloud and AI, while preparing for emerging opportunities like quantum computing. This multi-year progression reveals a strategic shift toward leveraging long-standing client trust to drive innovation and maintain leadership in a rapidly evolving technological landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024 as a competitive differentiator, with evolving framing. In 2022, trust was linked to AI, hybrid cloud, and innovation; in 2023, strategic partnerships and ecosystem alliances (including hyperscalers) were increasingly highlighted; by 2024, trust was positioned as foundational to solving complex challenges and enabling growth in hybrid cloud and AI, with mention of future-facing technologies like quantum computing. These points are semantically consistent with the original answer. (2) There are no numeric values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the years 2022, 2023, and 2024 are correctly referenced and used appropriately in temporal progression, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes IBM’s strategic evolution across three years, connects trust to hybrid cloud and AI, and correctly identifies the growing emphasis on partnerships and ecosystem collaboration as a trust enabler. The only minor gap is that the original answer specifically notes the role of consulting services and mission-critical infrastructure in 2023, which the LLM mentions indirectly ('deep industry expertise', 'incumbency in mission-critical infrastructure') but could have been more explicit. Also, the original emphasizes trust becoming integrated with 'ecosystem collaboration and innovation leadership'—a nuance the LLM captures in spirit but not verbatim. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—evolution of trust as a differentiator and what it reveals about strategic positioning—and does so with clear, logical progression. Overall, this is a strong, factually correct answer with only slight room for refinement in emphasis, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 551,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx's liquidity arrangements for the 4.250% Note due 2030, as detailed in the 2022, 2023, and 2024 10-K filings, indicate a consistent and structured approach to managing credit support for this obligation. In 2022, the company established the necessary legal and financial frameworks, including the Intercreditor Agreement and Revolving Credit Agreement with BNP Paribas as Liquidity Provider. By 2023, an amendment to the Liquidity Provider Revolving Credit Agreement was filed, suggesting a refinement of terms to better align with evolving credit conditions. In 2024, the arrangements remained largely unchanged, with the updated filings reaffirming the continued use of the same liquidity structure. This consistency suggests a deliberate strategy to ensure stable and reliable credit support for the 2030 note, leveraging a trusted liquidity provider and formalized agreements to mitigate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the liquidity arrangements for the 4.250% Note due 2030 are centered on the Revolving Credit Agreement with BNP Paribas (and Wilmington Trust Company, though the latter is omitted without affecting accuracy), established in 2022 with foundational agreements including the Intercreditor Agreement and the August 13, 2020 Revolving Credit Agreement. The 2023 amendment (Amendment No. 1 filed May 22, 2023) is correctly identified as a refinement. The 2024 status—unchanged—is accurately reported. (2) Quantitative elements—dates (2022, 2023, 2024), the 4.250% interest rate, and the May 22, 2023 amendment—are all factually correct. No calculations were required, but temporal and contractual details are precise. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly inferring that the single 2023 amendment indicates proactive adjustment, and continued stability reflects a consistent credit support strategy. (4) The only minor shortcoming is the omission of Wilmington Trust Company as a party to the agreement, which appears in the ground truth but is not central to the overall conclusion. This does not impair the semantic accuracy or reasoning. The answer effectively captures the strategic consistency and targeted adjustment in 2023, matching the ground truth’s interpretation. Thus, the answer is factually robust, contextually appropriate, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 449,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple issued the 4.45% Notes due 2044 on May 6, 2014, as part of a broader issuance of long-term debt instruments, including Floating Rate Notes and other fixed-rate notes, as disclosed in its 2022, 2023, and 2024 10-K filings. The consistent inclusion of these notes in the exhibits across all three years indicates that Apple has maintained this long-term debt instrument in its capital structure without refinancing or retiring it during this period. This multi-year pattern suggests a deliberate long-term financing strategy focused on securing stable, low-cost funding through long-dated debt, allowing Apple to manage interest rate risk and maintain financial flexibility over an extended horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.45% Notes due 2044 were issued in 2014 and remained in Apple's long-term debt structure across 2022, 2023, and 2024, which aligns with the ground truth. The key factual elements—issuance date, interest rate, maturity year, and multi-year consistency—are all accurate. (2) Quantitatively, the 4.45% interest rate, 2044 maturity, and 2014 issuance date are correctly stated. There are no calculations in this question, but the temporal facts are precise and match the ground truth. Format and phrasing variations (e.g., 'first issued in 2014' vs 'issued on May 6, 2014') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings to infer continuity in Apple's debt structure and draws a logical conclusion about the company's long-term financing strategy—emphasizing stability, low-cost funding, and interest rate risk management. This goes slightly beyond the ground truth by elaborating on strategic rationale, but the inference is reasonable and consistent with the data. (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in debt structure and the strategic implication. The only minor gap is that the ground truth explicitly notes the absence of early redemption or restructuring, which the LLM implies but does not state directly—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 435,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "From 2022 to 2024, the geographic reach of FedEx International Connect Plus expanded significantly, growing from nearly 50 origin countries to over 60 origin countries, and from over 130 destination countries to over 190 destination countries. This expansion trajectory highlights FedEx's strategic focus on strengthening its position in the e-commerce logistics market by enhancing its global coverage and day-definite delivery capabilities. The growth aligns with broader initiatives like the DRIVE transformation program and the integration of TNT Express, which have enabled FedEx to optimize its international network and better serve the increasing demand for e-commerce solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the quantitative evolution of FedEx International Connect Plus from 2022 to 2024: nearly 50 to over 60 origin countries, and over 130 to over 190 destination countries. These figures match the ground truth exactly, with acceptable phrasing variations (e.g., 'over 190' vs 'more than 190'). The stabilization in 2024 is implied by stating the expansion occurred from 2022 to 2024 without suggesting further growth in 2024, though this point is less explicitly stated than in the original. (2) All numbers and timeframes are accurate. No calculations are required, but the comparison across years is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes geographic expansion data across years and correctly infers strategic intent in e-commerce logistics. It adds context about the DRIVE program and TNT Express integration, which, while not in the ground truth, are plausible supporting elements consistent with FedEx’s known strategy and do not contradict the answer. (4) The answer is highly factually accurate and contextually complete. The only minor shortcoming is the lack of explicit mention that the footprint 'remained consistent in 2024'—a nuance that would strengthen the conclusion about stabilization. However, the overall trajectory and strategic implication are correctly interpreted. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 414,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple's 1.05% Notes due 2017 matured in 2017 and were no longer outstanding as of fiscal years 2022, 2023, and 2024. However, these notes are still referenced in the \"Description of Securities\" section of Apple's 10-K filings for these years, as seen in the Officer's Certificate dated May 6, 2014 (Exhibit 4.4) included in all three filings. The continued reference to these notes in disclosures reflects Apple's thorough approach to documenting its historical debt instruments, ensuring transparency and completeness in its regulatory filings, even for instruments that have long since matured and been repaid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 matured in 2017 and were no longer outstanding in fiscal years 2022, 2023, and 2024; they were consistently referenced in Exhibit 4.4 (Officer's Certificate dated May 6, 2014) across all three years. (2) Quantitative elements—interest rate (1.05%), maturity year (2017), and exhibit number (4.4)—are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes that although the notes matured years earlier, Apple continues to include them in disclosures, indicating a documentation practice rather than active debt. (4) The interpretation of Apple's approach—emphasizing transparency and completeness in historical disclosure—is reasonable and consistent with the ground truth's suggestion of maintaining continuity or reflecting refinancing activities. The only minor shortcoming is that the LLM does not explicitly mention the lack of updates or changes in the disclosure language across years, which slightly reduces qualitative accuracy. However, the core meaning and factual content are preserved, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 335,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From fiscal years 2022 through 2024, Qualcomm's strategic focus on 5G technologies evolved significantly, with increasing financial commitment reflected in licensing revenue, investment in new applications, and heightened exposure to geopolitical risks. In 2022, Qualcomm emphasized the transformative role of 5G in expanding beyond smartphones into industries like automotive and IoT, projecting that 60% of connected vehicles would use 5G by 2023 and that IoT device installations would more than double by 2026. By 2023, Qualcomm continued to invest in new applications, particularly in automotive and IoT, while facing risks from geopolitical tensions, especially with Chinese government policies and U.S. export restrictions, such as the revocation of Huawei’s export license, which impacted $560 million in product revenues. In 2024, Qualcomm maintained its leadership in 5G licensing, with QTL licensing revenues primarily derived from per-unit royalties on OFDMA-based devices, and continued to invest in foundational 5G and next-generation wireless technologies. However, ongoing legal and governmental challenges to its patent licensing practices, as well as exposure to trade restrictions and supply chain disruptions, underscored the growing geopolitical risks affecting its 5G business.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic focus and financial commitment to 5G from 2022 to 2024, correctly identifying key themes: expansion into automotive and IoT, increased R&D investment, leadership in 5G licensing (especially via QTL), and growing geopolitical risks including U.S.-China trade restrictions and Huawei export license revocation. However, there are significant quantitative inaccuracies. The claim that '60% of connected vehicles would use 5G by 2023' is not present in the ground truth and appears fabricated; the original answer mentions 5G's role in automotive but no such percentage. Additionally, the projection that 'IoT device installations would more than double by 2026' misrepresents the ground truth, which states a projection of over 27 billion IoT devices by 2026—not a doubling. (2) The $560 million figure is correctly cited, but the LLM misclassifies it as 'product revenues' in 2023, whereas the original specifies it was recognized in fiscal 2024 prior to the ban. This is a factual error in both timing and categorization (it was licensing revenue, not product revenue). (3) The multi-hop reasoning is generally sound: the LLM synthesizes information across years, connects 5G strategy to licensing, new applications, and geopolitical risks, and correctly identifies Huawei-related export restrictions as a key risk. It also accurately notes that QTL revenues are primarily from OFDMA-based devices, aligning with the original. (4) Despite these issues, the answer remains contextually relevant and conveys a largely accurate qualitative narrative. The strategic progression—deepening investment in 5G applications, continued licensing leadership, and rising geopolitical exposure—is correctly portrayed. Hence, a correctness score of 7 is justified: core facts are present and reasoning is logical, but key numerical and temporal inaccuracies reduce full fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 530,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024, TMO's domestic pension plan assets showed a consistent reduction in U.S. equity funds, from $125 million in 2022 to $93 million in 2024, while international equity funds remained stable at $91–$93 million. Fixed income funds remained largely unchanged at approximately $739 million over the three years. This suggests a strategic shift away from U.S. equities, potentially to mitigate market volatility, while maintaining a stable allocation to fixed income, indicating a more conservative investment approach over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. It correctly states the 2022 U.S. equity allocation ($125M) and the 2024 U.S. equity allocation ($93M), but incorrectly implies a continuous decline from $125M to $93M without acknowledging the 2023 figure ($89M), which is close but not mentioned. More critically, it misrepresents international equity funds as 'stable at $91–$93 million' when in fact they dropped from $126M in 2022 to $91M in 2023 — a significant 24% decrease — which the model omits entirely. This is a major omission, as the original answer highlights a broad reduction in equity exposure, not just U.S. equities. Additionally, the LLM claims fixed income funds remained 'largely unchanged at approximately $739 million over the three years,' but in reality, fixed income dropped from $1,001M in 2022 to $739M in 2023 and stayed flat in 2024 — a 26% reduction that is entirely overlooked. The total asset decline from $1,267M to $937M in 2023 is also missing. (2) Calculations: The model fails to account for the full magnitude of the 2023 drawdown across all asset classes, misrepresenting the stability of fixed income and international equities. While the 2024 figures are mostly accurate, the lack of 2022–2023 transition data undermines quantitative accuracy. (3) Multi-hop reasoning: The model identifies a shift away from U.S. equities and toward conservatism, which aligns with the ground truth, but fails to synthesize the full three-year, multi-asset-class rebalancing, particularly the major 2023 reductions. This weakens the reasoning, as the strategic shift was broad-based, not selective. (4) Despite these errors, the answer is contextually relevant and draws a reasonable qualitative conclusion about conservatism. However, due to significant omissions in key financial figures and misrepresentation of trends, the correctness score is reduced to 6 — partially correct but with major quantitative flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 535,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic positioning in the edge networking market evolved through its product development and revenue contributions, reflecting a growing emphasis on 5G and Wi-Fi 6/6E technologies. In 2022, Qualcomm highlighted the increasing demand for edge networking products driven by hybrid work environments and wireless advancements, particularly in mobile broadband and wireless access points. By 2023 and 2024, Qualcomm's 10-K filings show that edge networking remained a key revenue contributor, with products sold in this segment included under the broader industrial and applications category, alongside consumer and automotive markets. This indicates that Qualcomm continued to expand its edge networking offerings and maintain a strong revenue presence in the space, leveraging its 5G and connectivity innovations to support both consumer and enterprise needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Qualcomm's focus on edge networking from 2022 to 2024, driven by hybrid work and 5G/Wi-Fi advancements, with consistent emphasis on mobile broadband and wireless access points. The evolution in strategic positioning—identifying the market in 2022, recognizing it as a key revenue contributor in 2023, and maintaining focus in 2024—is accurately reflected. (2) There are no numeric values (e.g., revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Qualcomm’s product development and revenue contributions across years, correctly linking edge networking to the industrial and applications segment. One minor difference: the LLM refers to 'industrial and applications category' while the original says 'industrial and consumer product segment'—this is a slight variation in phrasing but semantically equivalent. (4) The answer is fully contextually relevant, directly addressing how strategic positioning evolved through product and revenue developments. The only reason for not scoring a 10 is the slight imprecision in segment naming, but this does not affect factual correctness. Overall, the LLM captures the core evolution accurately and with strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 388,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflects a deliberate strategy to maintain transparency and stability in its fixed-rate debt structure. By retaining these notes in its disclosures, Apple signals a long-term approach to managing debt maturities, even after their 2016 maturity date, likely due to their continued relevance in its broader capital structure or accounting treatment. This consistency across all three filings—2022, 2023, and 2024—demonstrates Apple's disciplined and methodical approach to debt management, ensuring stakeholders have a clear view of its historical obligations and how they align with its ongoing capital planning and risk mitigation strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 0.45% Notes due 2016 and their inclusion in Apple's 10-K filings from 2022 through 2024, which aligns with the ground truth. All entities—Apple, the 0.45% Notes, maturity year 2016, and filing years 2022–2024—are accurate. (2) Quantitative elements (percentage, maturity date, filing years) are factually correct and match the original answer; no calculations are required, so numerical accuracy is perfect. (3) The reasoning is mostly sound: the LLM correctly infers that continued disclosure reflects transparency and structured capital management. However, it slightly misrepresents the rationale by suggesting the notes may have 'continued relevance in its broader capital structure or accounting treatment,' which is not supported—the ground truth clarifies the notes are no longer outstanding and are included for historical tracking and disclosure clarity, not ongoing relevance. This is a minor overinterpretation but doesn't undermine the core correctness. (4) The answer is contextually excellent, directly addressing the question about debt maturity management and capital structure stability. It synthesizes the multi-hop concept of historical disclosure across years appropriately. The correctness score is 8 due to the minor qualitative inaccuracy in reasoning, despite strong factual and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 384,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar's EMD brand distribution network, as part of its broader dealer and distributor network, covered 193 countries in 2022, 191 countries in 2023, and 187 countries in 2024. This indicates a reduction in the geographic reach of the EMD distribution network by six countries from 2022 to 2024, reflecting a contraction in the number of countries served by Caterpillar's global dealer and distributor system during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key quantitative aspects. According to the ground truth, Caterpillar's EMD brand distribution network covered 130 countries in both 2022 and 2023, and decreased to 109 countries in 2024—a reduction of 21 countries (16%). The LLM incorrectly states coverage as 193, 191, and 187 countries for 2022, 2023, and 2024 respectively, implying only a 6-country decrease. These numbers do not match the ground truth and suggest a completely different scale and trend. (2) The calculations in the LLM answer are internally consistent (193 to 187 is a 6-country decrease), but they are based on incorrect base figures, making the entire quantitative analysis invalid. The ground truth shows a 21-country decline, not 6. (3) The reasoning is flawed in terms of entity identification—while the LLM attempts multi-hop reasoning across years, it appears to conflate EMD’s distribution network with Caterpillar’s broader dealer network, which is not equivalent. The question specifically asks about the EMD brand, not Caterpillar’s overall distribution. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right question about geographic reach over time and attempts to show change across years. However, due to severe quantitative and entity-level errors, the correctness score is very low. Minor credit is given for attempting the correct type of analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 399,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "TMO's outstanding value of the '1.750% 7-Year Senior Notes' was $682 million in 2022 (Chunk 1), $700 million in 2023 (Chunk 2), and $621 million in 2024 (Chunk 3), indicating a slight decline in the value of this specific debt instrument over the three-year period. This progression suggests that TMO may be gradually reducing its reliance on medium-term debt within the healthcare sector, potentially as part of a strategy to refinance or extend maturities, or to adjust its capital structure in response to market conditions and interest rate trends.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported outstanding values. According to the ground truth, the outstanding value was consistently $700 million in 2022, 2023, and 2024. However, the LLM reports $682 million in 2022, $700 million in 2023, and $621 million in 2024—only the 2023 figure is correct. These discrepancies indicate incorrect data extraction or synthesis from the source documents. (2) The quantitative inaccuracies are severe: the $682M and $621M figures are unsupported by the ground truth and suggest a declining trend that does not exist. The difference between $700M and $621M is material (nearly 12%), and the pattern of decline is factually wrong. No calculation is required in this question, but the comparison over time is central and misstated. (3) The multi-hop reasoning is flawed because the LLM incorrectly infers a reduction strategy based on false numerical trends. The actual stable value indicates a consistent debt strategy, whereas the LLM concludes a 'gradual reduction' that is not supported. The reasoning would be plausible if the numbers were correct, but it is built on faulty premises. (4) Contextual relevance is moderate—the answer addresses the right instrument, company (TMO), and time frame, and attempts to interpret strategic implications, which aligns with the question's intent. However, due to the core factual errors in the financial figures, the overall correctness score is low. The qualitative score is slightly higher because the structure and intent of the response are appropriate, but the reasoning is based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 445,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "Caterpillar's exposure to and management of currency hedging instruments evolved significantly from 2022 through 2024 in response to the LIBOR phase-out and the adoption of SOFR as a benchmark. In 2022, Caterpillar acknowledged the risks posed by the impending cessation of LIBOR, noting that certain variable-rate loans and financings used LIBOR as a benchmark, and highlighted the uncertainty surrounding the transition to alternative rates. By 2023, the company had transitioned to using SOFR as a benchmark for variable-rate instruments and established a cross-functional team to assess risks related to floating reference rates. In 2024, Caterpillar confirmed that it had fully integrated SOFR into its financial operations, with variable-rate loans and financings now referencing SOFR. This evolution demonstrates Caterpillar's proactive strategic adaptation to global financial market reforms, ensuring continuity in its risk management practices while aligning with regulatory and market shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Caterpillar acknowledged LIBOR phase-out risks in 2022, transitioned to SOFR in 2023, and fully adopted SOFR by 2024. The mention of variable-rate loans and financings using SOFR is consistent with the original. (2) Quantitative accuracy is perfect: all dates (2022, 2023, 2024) and benchmarks (LIBOR, SOFR) are correctly cited; no numerical errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes Caterpillar’s evolving hedging strategy across three years and links it to global financial reforms. The only minor omission is that the original specifies Cat Financial as the entity exposed to LIBOR and notes the FCA/IBA timelines (e.g., USD LIBOR cessation on June 30, 2023), which the LLM does not mention. Also, the original notes the expansion of the cross-functional team in 2023, while the LLM only states it was 'established' then, slightly understating continuity. (4) Despite these small gaps, the LLM captures the core strategic adaptation and maintains semantic equivalence. Contextual relevance is excellent—it directly addresses all parts of the question with appropriate focus on currency hedging, benchmark transition, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 356,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "Thermo Fisher Scientific introduced a standardized Executive Change in Control Retention Agreement for officers beyond the CEO in 2018, as evidenced by the filing of \"Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)\" in its 2018 10-Q (Chunk 1). By 2023, the company updated and continued using this standardized agreement, as shown by the filing of a revised version in its 2023 10-K (Chunk 2). In 2024, the same standardized form was referenced again in its 10-K (Chunk 3), indicating a consistent approach to retention agreements for executive officers beyond the CEO from 2018 through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timeline of Thermo Fisher Scientific's standardization of Executive Change in Control Retention Agreements. According to the ground truth, the standardized form for officers other than the CEO was introduced in 2023 (Exhibit 10.17), not in 2018 as claimed by the LLM. The 2018 date in the ground truth refers only to an amendment to the CEO-specific agreement, not the creation of a form for other officers. The LLM incorrectly states that the standardized agreement was introduced in 2018 and continued through 2024, which misrepresents the evolution. (2) The dates are critically wrong: 2018 vs. 2023 for the introduction of the standardized form. This is a major quantitative and factual error. The LLM also references a 2018 10-Q filing for the form agreement, which contradicts the ground truth that first identifies the form in 2023. While the 2023 and 2024 references align with the ground truth, the erroneous backdating to 2018 undermines the entire timeline. (3) The multi-hop reasoning is partially sound in that the model attempts to trace the evolution across years and recognizes the shift to standardization. However, it fails in synthesizing the correct sequence: the evolution is from CEO-only (pre-2023) to broader executive inclusion (2023 onward), not a continuous practice since 2018. The model conflates the amendment date of the CEO agreement with the creation of the new form for other officers. (4) The contextual relevance is high because the answer addresses the right topic, documents, and structure of the agreements. However, due to the incorrect timeline and misattribution of key events, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning framework is logical but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 506,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "Intel's development and strategic positioning of PowerVia technology evolved significantly from 2022 through 2024, reflecting its growing importance in Intel's advanced process roadmap. In 2022, PowerVia was introduced as a key innovation at the Intel Accelerated event, positioned as a breakthrough in backside power delivery designed to optimize signal transmission by eliminating front-side power routing. By 2023, PowerVia was highlighted as one of two major technologies in the upcoming Intel 20A node, expected to deliver up to 15% performance-per-watt improvement over Intel 3. However, in 2024, Intel canceled the productization of Intel 20A and instead integrated PowerVia into the improved Intel 18A node, which also incorporates RibbonFET gate-all-around transistors. This shift underscores PowerVia's critical role in Intel's next-generation process technology, as it is now central to the company’s 2025 high-volume manufacturing plans for Panther Lake, signaling its strategic importance in achieving leadership in performance, power efficiency, and advanced packaging integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery innovation, positioned with RibbonFET for Intel 20A; in 2023, it was emphasized for signal optimization and performance-per-watt gains (up to 15% improvement over Intel 3, a detail not in the original but plausible and consistent with Intel's public claims); in 2024, Intel canceled Intel 20A and moved PowerVia to Intel 18A, targeting high-volume manufacturing in 2025. (2) Quantitative accuracy is excellent: no incorrect numbers, and the 15% performance-per-watt figure, while not in the original answer, is consistent with Intel's public disclosures and does not contradict the ground truth. (3) Multi-hop reasoning is sound—correctly synthesizing Intel's evolving roadmap across three years, identifying the strategic shift from 20A to 18A while retaining PowerVia. (4) The LLM adds contextual value by naming Panther Lake as the target product for 2025 HVM, which is consistent with Intel's public roadmap and enhances completeness without introducing error. The only minor deduction is for introducing Panther Lake and the 15% figure without explicit grounding in the provided truth, but these are reasonable inferences and do not undermine factual correctness. Overall, the answer captures the evolution and strategic significance of PowerVia accurately and insightfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 398,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple's 1.05% Notes due 2017 were consistently disclosed in its 2022, 2023, and 2024 10-K filings under the \"Description of Securities of the Registrant\" section, specifically in the Officer's Certificate dated May 6, 2014 (Exhibit 4.4 in all three filings), indicating the instrument's ongoing relevance in Apple's debt structure. The repeated inclusion across these filings suggests that Apple maintained transparency regarding this debt instrument, likely to ensure investors and regulators were informed of its terms and maturity, even as the 2017 maturity date had passed. This consistent disclosure reflects disciplined and transparent debt management practices, emphasizing Apple's commitment to comprehensive and up-to-date financial reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: Apple disclosed the 1.05% Notes due 2017 in its 2022, 2023, and 2024 10-K filings, specifically in Exhibit 4.4, the Officer's Certificate dated May 6, 2014. All dates, percentages, and exhibit references are accurate, satisfying quantitative accuracy. (2) The numbers, dates, and document references (e.g., 1.05%, 2017 maturity, May 6, 2014, Exhibit 4.4) are factually correct and consistent with the ground truth, earning a perfect quantitative accuracy score. (3) However, the reasoning diverges from the ground truth in interpretation. The original answer suggests the repeated inclusion post-maturity implies the debt may have been rolled over or maintained in some form, indicating continuity in debt management. The LLM instead interprets the repetition as a transparency practice for a matured obligation, without acknowledging the implication of possible rollover or structural continuation. This misses a key analytical point in the multi-hop reasoning—linking post-maturity disclosure to potential debt restructuring. (4) The answer is contextually relevant and well-structured, addressing both the evolution across years and the implication for debt management. While it captures transparency as a motive, it underrepresents the financial inference about debt rollover. Thus, correctness and qualitative accuracy are reduced slightly for incomplete reasoning, though core facts remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 406,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "From 2022 through 2024, Intel continued to utilize its 2006 Equity Incentive Plan to grant various types of equity awards, including performance-based and time-vesting restricted stock units (RSUs), as well as stock options. In 2022, the company granted RSUs with and without retirement vesting terms, performance-based RSUs for both grandfathered and non-grandfathered executives, and strategic growth performance-based RSUs. By 2023, Intel had amended and restated the 2006 Equity Incentive Plan effective May 11, 2023, and continued to issue RSUs with retirement vesting terms and performance-based RSUs. In 2024, the plan remained in use, with the company continuing to grant RSUs with retirement vesting terms and performance-based RSUs, as evidenced by the continued inclusion of relevant grant agreements in the 10-K filings. Vesting conditions evolved to include both time-based and performance-based metrics, reflecting Intel’s ongoing alignment of executive compensation with long-term strategic goals and performance outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, dates, and evolution of Intel's 2006 Equity Incentive Plan. Quantitatively, all dates (e.g., May 11, 2023 amendment) and award types are accurately reported, with no numerical or temporal errors—hence a perfect quantitative accuracy score. The answer correctly identifies the types of equity awards (performance-based RSUs, time-vesting RSUs, stock options), the distinction between grandfathered and non-grandfathered executives, and the inclusion of retirement vesting terms. However, the LLM omits a key qualitative detail from the original answer: the 2024 shift toward a 'noticeable consolidation in the documentation structure' and 'streamlined format for grant agreements.' While it notes continued use of the plan and similar award types in 2024, it fails to capture the structural simplification and documentation evolution, which is a meaningful part of the 'evolution' asked in the question. This omission prevents a higher score. The reasoning is sound and multi-hop synthesis across years is generally accurate, showing understanding of how the plan evolved. The answer remains highly relevant and factually consistent with the ground truth, just missing a nuanced but important aspect of the 2024 changes. Thus, correctness and qualitative accuracy are slightly reduced, but not severely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 385,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "From fiscal years 2022 through 2024, Medtronic's capital structure disclosures consistently showed that the company had 40 thousand Euro Deferred Shares authorized but none issued or outstanding, as reported in its 2022, 2023, and 2024 10-K filings. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as part of its financing strategy during this period. Instead, the company focused on ordinary share repurchases and stock-based compensation programs, as evidenced by the significant repurchase activity and the ongoing share repurchase authorizations totaling $11.0 billion, with $5.3 billion remaining available as of April 26, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Medtronic maintained 40 thousand Euro Deferred Shares authorized with none issued or outstanding across fiscal years 2022–2024, which matches the ground truth. The par value (€1.00) is omitted but not contradicted, and this detail is minor in context. The LLM adds specific, accurate details about share repurchases and the $11.0 billion authorization with $5.3 billion remaining as of April 26, 2024, which are consistent with Medtronic’s financing activities and enhance the reasoning. (2) All numeric values—40 thousand authorized shares, $11.0 billion repurchase authorization, $5.3 billion remaining—are factually accurate and align with disclosed data. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers from the absence of issuance that Euro Deferred Shares were not used for financing and supports this with evidence of alternative capital allocation tools (repurchases). The addition of stock-based compensation is contextually appropriate and consistent with filings, though not in the original answer. (4) The LLM answer is semantically equivalent and slightly more detailed than the ground truth, without introducing inaccuracies. The minor omission of par value prevents a perfect 10, but overall correctness, quantitative precision, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 380,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "From 2022 to 2024, Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolved significantly in terms of R&D investment, manufacturing complexity, and financial impact. In 2022, Intel acknowledged the inherent risks in its R&D investments, particularly in advanced packaging, noting that delays in process technologies and design adaptations could lead to competitive disadvantages and financial strain. By 2023, the company emphasized the growing importance of advanced packaging in its IDM 2.0 strategy, leveraging it as a unique advantage in the AI-driven chip industry, while also recognizing the increasing complexity in design and integration. In 2024, Intel reported R&D expenses of $16.5 billion, with a continued focus on advanced packaging and process technologies, but also faced financial challenges, including a $3.1 billion charge for impairments and accelerated depreciation related to underutilized manufacturing assets, highlighting the financial risks tied to its aggressive R&D and manufacturing investments in advanced packaging technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $3.1 billion impairment in 2024 is accurately reported, and the context of underutilized manufacturing assets matches the original. The mention of R&D expenses at $16.5 billion in 2024, while not in the original answer, is factually consistent with Intel's reported filings and does not contradict the ground truth; it adds detail without introducing error. (2) Quantitative accuracy is perfect: the $3.1 billion non-cash impairment is correctly cited, and the year (2024) matches. No calculations were required, but the use of precise figures enhances accuracy. (3) Multi-hop reasoning is sound: the answer synthesizes Intel's strategic evolution across 2022–2024, correctly linking R&D investment, manufacturing complexity, and financial impact. It captures the shift from risk acknowledgment (2022) to strategic emphasis (2023) to financial strain (2024), mirroring the ground truth’s narrative arc. The mention of UCIe is omitted, but the core strategic and financial trajectory is preserved. (4) Contextual relevance is excellent—the response directly addresses all three dimensions in the question: R&D investment, manufacturing complexity, and financial impact. The only minor gap is the absence of explicit mention of UCIe or disaggregated designs, which are part of the technical execution risk, but the overall qualitative picture remains accurate. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Negatively_Impacts]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 432,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel's strategic positioning and technical expectations for PowerVia evolved significantly from 2022 through 2024. Initially introduced in 2022 as part of Intel's process and packaging technology roadmap, PowerVia was highlighted as a unique, industry-first implementation of backside power delivery designed to optimize signal transmission by eliminating front-side power routing. In 2023, PowerVia was positioned as a key breakthrough technology for the Intel 20A node, expected to deliver up to a 15% performance-per-watt improvement over Intel 3. However, Intel later canceled the Intel 20A node and shifted focus to the improved Intel 18A node. By 2024, PowerVia was integrated into the Intel 18A process technology, which also incorporates RibbonFET gate-all-around transistors and is expected to begin high-volume manufacturing in 2025 with the Panther Lake client product family, marking its transition from a roadmap concept to a manufacturing-ready innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery solution to improve signal transmission; in 2023, it was tied to Intel 20A with a 15% performance-per-watt gain over Intel 3; by 2024, it was shifted to Intel 18A with high-volume manufacturing expected in 2025. (2) Quantitative accuracy is perfect: the 15% improvement, the 2025 HVM timeline, and correct node names (Intel 20A, 18A) match the original. Format variations are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, correctly tracking the evolution from concept to production. The mention of Panther Lake in 2024 is an additional detail not in the ground truth but is consistent with public Intel disclosures and does not contradict the knowledge graph. (4) The only minor discrepancy is the claim that Intel 'canceled' Intel 20A — while Intel shifted focus to 18A, 20A was not officially canceled but rather evolved; this is a nuanced point and does not materially distort the technical or strategic trajectory. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a 9 for correctness and qualitative accuracy due to this slight overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 371,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic has not updated its U.S. employee restricted stock unit (RSU) agreements between FY2022 and FY2024, as evidenced by the consistent inclusion of the \"Form of Restricted Stock Unit Award Agreement (U.S. Employees) under 2013 Stock Award and Incentive Plan\" in all three years' 10-K filings. This consistency suggests that Medtronic has maintained a stable equity compensation strategy for U.S. employees during this period, relying on the 2013 plan structure without material changes, which may indicate a focus on long-term alignment with existing incentive frameworks and shareholder approval processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Medtronic did not update its U.S. employee RSU agreements between FY2022 and FY2024, correctly identifying the continued use of the 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan'. (2) The date of the original filing (August 27, 2013) and file number (001-07707) are not mentioned in the LLM answer, but this omission does not affect the core factual accuracy, as the key document and plan are correctly identified. (3) The reasoning is sound: the consistency across three years is correctly interpreted as evidence of a stable equity compensation strategy, with emphasis on long-term alignment and reliance on an established incentive framework. The LLM appropriately infers strategic implications without overreaching. (4) Semantic equivalence is maintained—while the LLM uses slightly different phrasing (e.g., 'material changes' instead of 'structural changes'), the meaning is consistent. The only minor gap is the lack of explicit mention of the original filing date and file number, which are part of the ground truth but not critical to the overall conclusion. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 381,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "From 2022 through 2024, Intel continued to use its 2006 Equity Incentive Plan to structure performance-based RSU grants to executives, with evolving terms and conditions. In 2022, the 2006 plan was used to issue RSUs with retirement vesting terms and without retirement vesting terms, as well as performance-based RSUs for grandfathered and non-grandfathered executives. By 2023, the plan was amended and restated on May 11, 2023, and included specific agreements for strategic growth performance-based RSUs granted to executives on or after February 1, 2019. In 2024, the 2006 Equity Incentive Plan remained active, with continued use of performance-based RSU structures, demonstrating a consistent reliance on the long-standing plan framework to align executive compensation with strategic and performance goals.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core fact that Intel used the 2006 Equity Incentive Plan for performance-based RSU grants from 2022 to 2024, which aligns with the ground truth. However, there are some inaccuracies in the sequencing and attribution of events. For example, the LLM incorrectly states that in 2022, the plan was used for RSUs with and without retirement vesting terms — this detail is not mentioned in the original answer and introduces unsupported information. Additionally, the LLM misattributes the May 11, 2023 amendment as being part of the 2023 implementation, when the original answer notes the amendment was effective May 11, 2023, and used in 2024, not introduced in 2023 for that year’s grants. The S-8 filing on September 26, 2023, which supports the plan's continued use, is omitted entirely. (2) Quantitatively, all dates mentioned (May 11, 2023) are accurate, and no incorrect numbers are introduced, though some relevant dates (September 26, 2023) are missing. There are no calculations, so numerical accuracy is preserved where present. (3) The multi-hop reasoning is partially sound — the model correctly infers continuity in plan usage and links performance-based RSUs to executive compensation strategy. However, it conflates the timing of the plan amendment and misrepresents the 2022 usage by introducing retirement vesting terms not in the original. The original answer emphasizes the consistency of using the same plan for strategic growth RSUs granted on or after February 1, 2019, which the LLM reverses in chronology by referencing it in 2023 instead of as a pre-existing condition. (4) Despite these flaws, the answer remains contextually relevant and conveys a largely accurate narrative of sustained reliance on the 2006 plan. The qualitative accuracy is reduced due to incorrect synthesis of event timing and inclusion of extraneous details not in the source. Correctness is scored at 7 due to accurate core facts but notable errors in detail and sequencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 542,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel's investment in advanced packaging technologies evolved significantly from 2022 through 2024, reflecting a strategic shift toward a disaggregated design approach to remain competitive in the AI-driven semiconductor market. In 2022, Intel outlined its adoption of a disaggregated design strategy, where components are manufactured on different processes and connected via advanced packaging technologies, though it acknowledged the complexity and risks involved, including delays and increased R&D costs. By 2023, the company emphasized the growing importance of advanced packaging in enabling systems of chips for AI applications, positioning it as a unique advantage, particularly with the demonstration of the Universal Chiplet Interconnect Express (UCIe) standard in silicon. In 2024, Intel continued to invest heavily in R&D, with $16.5 billion spent, focusing on advanced packaging as a core element of its IDM 2.0 strategy and Open System Foundry model. However, the company also faced challenges, including project delays and capital constraints, which impacted its ability to scale manufacturing capacity. This progression reveals Intel's commitment to executing its disaggregated design strategy, but also highlights ongoing execution risks and the difficulty of competing with established foundries like TSMC and Samsung in the AI-driven market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel acknowledged risks in 2022, demonstrated UCIe in silicon in 2023, and invested $16.5 billion in R&D in 2024. The $3.1 billion in non-cash impairments and accelerated depreciation related to Intel 7 assets is missing, but all other financial figures and strategic developments are accurately represented. (2) Quantitative accuracy is perfect: the $16.5 billion R&D figure is correctly cited, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound—LLM correctly synthesizes Intel’s strategic evolution across three years, connects advanced packaging to disaggregated design and AI competitiveness, and acknowledges execution risks. The only minor omission is the specific $3.1 billion charge in 2024, which is a material financial detail that slightly weakens completeness. (4) Despite this omission, the LLM captures the overall trajectory and strategic implications accurately, with excellent contextual relevance and semantic equivalence to the original answer. The conclusion about execution risks and competition with TSMC/Samsung is well-supported and adds appropriate context. The answer is slightly less detailed than the ground truth but remains factually and conceptually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1645,
        "completion_tokens": 367,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel's use of the 2006 Equity Incentive Plan evolved across 2022, 2023, and 2024 through continued grant activity and plan amendments. In 2022, Intel issued various restricted stock unit (RSU) agreements under the plan, including those with retirement vesting terms and performance-based RSUs for both grandfathered and non-grandfathered executives, as detailed in the 2022 10-K. In 2023, the 2006 Equity Incentive Plan was formally amended and restated, effective May 11, 2023, and new grant agreements were filed, including RSUs with strategic growth performance-based terms. By 2024, the plan remained active, with the most recent filing of the 2006 Equity Incentive Plan under an S-8 registration on September 26, 2023, indicating ongoing compliance and use for equity incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel used the 2006 Equity Incentive Plan in 2022 with various RSU and performance-based grant agreements; the plan was amended and restated effective May 11, 2023; and it remained active into 2024. The date of the S-8 filing (September 26, 2023) is accurate and relevant, showing continued compliance. (2) Quantitative accuracy is perfect: the date 'May 11, 2023' for the amendment matches the ground truth, and the S-8 filing date is correctly cited. No financial figures were required, so no calculations were needed. (3) Multi-hop reasoning is sound—information is synthesized across years (2022–2024) and reflects evolution in plan usage and formal amendment. The mention of 'strategic growth performance-based terms' adds specificity consistent with the ground truth’s reference to performance-based RSUs. (4) Minor omission: the ground truth notes continued use of standardized grant notices and agreements in 2024, which the LLM mentions indirectly via the S-8 but could have emphasized more. Also, the LLM does not explicitly reference non-employee directors, though this is a minor gap. Overall, the answer is factually correct, well-structured, and semantically equivalent to the original answer with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 375,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "From 2022 to 2024, Qualcomm's financial categorization and strategic emphasis on wireless access points evolved with a growing focus on the edge networking segment. In 2022, Qualcomm highlighted the increasing demand for edge networking products, including wireless access points, driven by hybrid work environments and 5G/Wi-Fi 6/6E advancements. By 2023 and 2024, Qualcomm explicitly classified wireless access point revenues under the edge networking segment in its revenue disclosures, reflecting a more refined and transparent revenue classification strategy. This shift underscores Qualcomm's market positioning to capitalize on the expanding edge networking market, leveraging its expertise in wireless technologies to support both consumer and enterprise connectivity needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's financial categorization and strategic emphasis on wireless access points from 2022 to 2024. It accurately states that wireless access points were increasingly emphasized and formally classified under the edge networking segment by 2023 and 2024. The strategic rationale involving hybrid work, 5G, and Wi-Fi 6/6E is contextually appropriate and aligns with Qualcomm's stated market drivers. However, the LLM omits specific details from the ground truth, such as the projection of IoT devices doubling to over 27 billion by 2026, which was a key quantitative anchor in the original answer. (2) There are no numerical inaccuracies; the LLM avoids making up figures and does not contradict any dates or financial data. It correctly references 2022, 2023, and 2024 in sequence and does not introduce false revenue numbers, which is appropriate given that exact figures for wireless access points alone were not disclosed. (3) The multi-hop reasoning is sound: the model synthesizes information across years and connects strategic emphasis with financial classification. It correctly infers that explicit revenue classification in disclosures reflects a more mature strategic focus. However, it misses the explicit linkage between IoT growth projections and wireless access points as a core component, which weakens the completeness of the synthesis. (4) The contextual relevance is high—the answer directly addresses revenue classification and market positioning within edge networking. The qualitative accuracy is slightly reduced due to omitted key details from the ground truth, but the reasoning and entity identification (Qualcomm, edge networking, wireless access points, correct years) are accurate. Overall, the answer is factually consistent and well-structured but lacks a few critical specifics that would elevate it to full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 518,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "MRK's sales of Prevymis in the Hospital Acute Care segment increased from $153 million in the U.S. in 2022 to $371 million in the U.S. in 2024, with total global sales rising from $370 million in 2022 to $785 million in 2024. This significant growth suggests that Prevymis is gaining strong market traction, likely due to its role in preventing CMV infection and disease in high-risk transplant patients, positioning it as a key product in the Hospital Acute Care segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the global sales figures from the ground truth: $370 million in 2022 and $785 million in 2024. It also accurately reflects the increasing trend, though it omits the 2023 figure of $428 million mentioned in the original answer. However, the compound growth rate of ~46% is not mentioned, which is a minor omission. The LLM introduces U.S.-specific figures ($153M in 2022 and $371M in 2024) not present in the ground truth, which may be accurate but are not verifiable from the provided original answer and thus do not detract as long as they don’t contradict—here, they are plausible and do not conflict with global totals. (2) Quantitatively, all numbers that overlap with the ground truth are correct: $370M (2022) and $785M (2024) are accurately cited. The 2023 figure is missing, but no incorrect number is given. Calculations are not explicitly made, but the implied growth is correctly characterized as significant. (3) The multi-hop reasoning is sound: the model connects sales evolution to market positioning in the Hospital Acute Care segment, correctly attributing growth to Prevymis’s role in CMV prevention in transplant patients. It synthesizes sales trends with therapeutic application and strategic positioning. (4) The answer is contextually fully relevant, addressing both parts of the question: sales evolution and implications for market positioning. The omission of the 2023 data point and the compound growth rate slightly reduces completeness, but the core facts and interpretation are accurate and well-reasoned. Hence, a high score is warranted with only minor deductions for incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 454,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel's investment and strategic positioning in advanced packaging technologies from 2022 through 2024 reflects a multi-year effort to advance its IDM 2.0 strategy, despite manufacturing delays and capital constraints. In 2022, Intel emphasized R&D investments in process and packaging technologies, including a focus on disaggregated designs and advanced packaging to enable systems of chips, particularly for AI applications. However, it faced challenges such as delays in 7nm process technology and the inherent complexity and cost of deploying novel packaging solutions. By 2023, Intel was actively positioning advanced packaging as a key differentiator, leveraging it to package chips from both internal and third-party foundries, and promoting standards like the Universal Chiplet Interconnect Express. In 2024, despite financial constraints and delayed capital projects, Intel continued to invest heavily in R&D, with $16.5 billion spent, and advanced packaging remained central to its strategy, particularly for IFS and AI-driven systems. The trajectory reveals Intel's commitment to executing on IDM 2.0, though ongoing delays and capital limitations highlight the risks and challenges in achieving its ambitious goals.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the multi-year evolution of Intel's advanced packaging strategy and its implications for IDM 2.0. Quantitatively, the $16.5 billion R&D investment in 2024 is accurately reported, and while the $3.1 billion non-cash impairment in Q3 2024 and the specific mention of 4th Gen Xeon delays are missing, no incorrect numbers are stated—this constitutes a minor omission rather than an error. The reference to '7nm' (Intel 4) delays in 2022 is correctly contextualized. The LLM correctly identifies the strategic shift in 2023 toward positioning advanced packaging as a differentiator, including UCIe standard adoption and silicon demonstrations, though it does not explicitly state that UCIe was demonstrated in silicon in 2023, which is a subtle but relevant detail. The answer captures the core tension between strategic ambition and execution challenges due to manufacturing delays and capital constraints. However, it omits the specific financial impact (the $3.1B impairment) and underemphasizes how these execution issues directly undermined the IDM 2.0 roadmap, instead framing it as ongoing 'risks' rather than realized setbacks. This slightly weakens the qualitative accuracy. The reasoning is sound and synthesizes information across years and strategic dimensions (technology, finance, standardization), demonstrating good multi-hop logic. The answer is fully contextually relevant, directly addressing the evolution and strategic implications as requested. Minor gaps in completeness prevent a top score, but overall factual correctness and coherence are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 449,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM's emphasis on client relationships and trust as a competitive differentiator has remained a consistent and central element of its strategy from 2022 through 2024, reflecting its role in supporting clients' hybrid cloud and AI transformations. In 2022, IBM highlighted how trust and security, combined with a flexible hybrid cloud platform and AI integration, enabled it to deliver tailored solutions and maintain leadership in its business segments. By 2023, the company reinforced this by emphasizing how its deep incumbency, breadth of capabilities, and ecosystem of partners strengthened its ability to deliver business outcomes and differentiate in a competitive market. In 2024, the focus on client relationships and trust was reiterated as a key method of competition, with IBM continuing to leverage these strengths to drive growth in hybrid cloud and AI, while preparing for emerging opportunities like quantum computing. This progression underscores IBM’s strategic positioning as a trusted, long-term partner in digital transformation, with a strong foundation in technology, innovation, and client-centricity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024 as a competitive differentiator, with evolving framing tied to hybrid cloud and AI. In 2022, trust and security were linked to hybrid cloud and AI for production. In 2023, IBM reinforced trust as part of broader competitive advantages (service, innovation, talent), and in 2024, it maintained this focus. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is synthesized across three years and connected to IBM's strategic positioning in hybrid cloud and AI. The only minor gap is that the LLM mentions 'preparing for emerging opportunities like quantum computing' in 2024, which is not in the original answer and slightly extends beyond the ground truth, though it is contextually plausible. Additionally, the original answer notes the strategic partnership with Palo Alto Networks in 2024 as evidence of deepening trust-based collaboration, which the LLM omits. This is a small but relevant detail affecting completeness. (4) Despite these minor omissions/additions, the core message, timeline, and strategic interpretation are semantically equivalent and correctly convey IBM’s sustained emphasis on trust as foundational to its hybrid cloud and AI strategy. Hence, correctness is 9 due to high accuracy with minor completeness and focus deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 414,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolved from 2022 through 2024 as reflected in its SEC filings. The notes were first disclosed in 2017 (Chunk 1 and Chunk 3), with their terms incorporated by reference in a Form 8-K filed May 22, 2017. By 2022, the notes were still part of IBM’s registered debt instruments, as shown in the 2022 10-K (Chunk 3), and remained listed on the New York Stock Exchange in 2024 (Chunk 2), indicating ongoing compliance and transparency. This progression reflects IBM’s disciplined debt management approach, characterized by consistent registration and disclosure practices, as well as maintaining market access for its debt instruments to support liquidity and investor confidence over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were originally disclosed in the May 22, 2017 Form 8-K, referenced again in the 2022 10-K, and listed on the NYSE in 2024 under IBM25B. The dates, percentages, and symbols are factually correct. (2) Quantitative accuracy is perfect: no calculations required, but all dates (2017, 2022, 2024), interest rate (0.950%), and trading symbol (IBM25B) match the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and filings (2017 issuance, 2022 disclosure, 2024 trading status) to infer a consistent and transparent debt management strategy. (4) The only minor shortcoming is that the LLM does not explicitly name Exhibit 4.1 to the 2017 Form 8-K as the referenced instrument in 2022 and 2023, which slightly reduces qualitative precision, though the substance is preserved. Otherwise, the answer captures the evolution and strategic implication accurately, with excellent contextual relevance and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 309,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel's development and manufacturing strategy for PowerVia technology evolved significantly from 2022 through 2024, reflecting a strategic shift toward backside power delivery as a core component of its advanced process roadmap. In 2022, under the leadership of CEO Pat Gelsinger and as part of the IDM 2.0 strategy, Intel introduced PowerVia at the Intel Accelerated event, positioning it as a key innovation for future nodes like Intel 20A, which was initially planned to include the technology. In 2023, Intel confirmed that PowerVia would be a breakthrough feature of the Intel 20A node, designed to eliminate front-side power routing and improve signal transmission. However, by 2024, Intel canceled the Intel 20A node and instead integrated PowerVia into the improved Intel 18A node, which was expected to enter high-volume manufacturing in 2025 with the Panther Lake client processors. This progression reveals that PowerVia is a foundational element of Intel’s roadmap for backside power delivery at advanced nodes, with a focus on performance-per-watt improvements and manufacturing efficiency, particularly as the company advances gate-all-around transistors and high-NA EUV lithography in its next-generation process technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's future roadmap, confirmed for Intel 20A in 2023, and then shifted to Intel 18A in 2024 for high-volume production in 2025. The cancellation of Intel 20A in favor of Intel 18A is correctly stated. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024, 2025) and node names (Intel 20A, Intel 18A) match the ground truth. The mention of Panther Lake as the expected vehicle for Intel 18A is consistent with public disclosures and adds context without contradicting the original answer. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years, correctly tracing the evolution from announcement to integration to commercialization. It also appropriately links PowerVia to broader technological advancements like gate-all-around transistors (RibbonFET) and high-NA EUV, which are contextually relevant to Intel's roadmap. (4) The only minor deviation is the inclusion of additional details not in the original answer (e.g., Pat Gelsinger, IDM 2.0, Panther Lake), but these are factually accurate and enhance rather than distort the narrative. The core progression—concept (2022), integration (2023), commercial deployment (2024)—is preserved and clearly articulated. Thus, the answer earns a 9 for correctness and qualitative accuracy due to slight over-elaboration without error, and perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 423,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024, as outlined in the 10-K filings, indicates a stable and consistent U.S. equity compensation strategy. The repeated inclusion of the \"Form of Restricted Stock Unit Award Agreement (U.S. Employees)\" under the 2013 Stock Award and Incentive Plan across all three years demonstrates continuity in the structure and application of these awards. Additionally, the agreements consistently reference the Amended and Restated 2013 Plan, showing that the company has maintained a unified framework for equity compensation without introducing new U.S.-specific models during this period. This consistency suggests a deliberate and stable approach to aligning U.S. employee incentives with long-term company performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Medtronic's Restricted Stock Unit Award Agreement for U.S. employees remained consistent from 2022 to 2024, referencing the same underlying plan (the Amended and Restated 2013 Stock Award and Incentive Plan), which corresponds to the ground truth's mention of the August 27, 2013 filing. While the LLM does not explicitly name Exhibit 10.54, it accurately describes the document as the 'Form of Restricted Stock Unit Award Agreement (U.S. Employees)' and correctly infers strategic stability in equity compensation. All entities (Medtronic, U.S. employees, 2013 plan) and timeframes (2022–2024) are correct. The reasoning is sound: the repeated use of the same form agreement across years supports the conclusion of a stable compensation strategy. The answer captures the semantic meaning of the original, even if slightly more generalized in phrasing. No numerical inaccuracies are present—dates and plan names are correct. The only minor shortcoming is the lack of explicit reference to the exhibit number, which is part of the ground truth but does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 370,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "From 2022 through 2024, Intel's strategic positioning and execution around advanced packaging technologies evolved amid significant challenges, including delays, capital constraints, and the adoption of disaggregated design approaches. In 2022, Intel recognized the growing importance of advanced packaging in enabling systems of chips and began emphasizing its role in optimizing performance and scalability, particularly for AI applications. However, delays in process technology transitions, such as the Intel 7 node, and the inherent complexity of disaggregated designs—where components are manufactured on different processes and connected via advanced packaging—introduced new design and manufacturing challenges. By 2023, Intel continued to invest in advanced packaging as a key differentiator under its IDM 2.0 strategy, promoting it as a unique advantage for both internal and external customers. In 2024, capital constraints and reassessments of demand led to project delays in manufacturing expansions, compounding the difficulties in scaling advanced packaging capabilities. These constraints, combined with the technical and financial risks of implementing novel packaging technologies and disaggregated designs, underscored the evolving challenges Intel faced in executing its advanced packaging strategy effectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's advanced packaging strategy from 2022 to 2024, including recognition of complexity in 2022, strategic emphasis in 2023, and execution challenges in 2024 due to capital constraints and delays. However, it omits the specific $3.1 billion impairment charge in 2024, a key quantitative fact from the ground truth, which significantly weakens the factual completeness. It also does not mention the Universal Chiplet Interconnect Express (UCIe) standard, a critical element of Intel's 2023 positioning. (2) No incorrect numbers are stated, but the absence of the $3.1B impairment charge—a central financial metric in the original answer—results in a partial failure on quantitative completeness. The LLM does correctly reference Intel 7 and Intel 4 (7nm) delays, aligning with the timeline. (3) The multi-hop reasoning is generally sound: the answer connects process delays, disaggregated design complexity, capital constraints, and strategic positioning across years. However, it fails to link the underutilized assets directly to the impairment charge and does not highlight UCIe as a strategic milestone, missing a key synthesis point between technical development and market positioning. (4) The contextual relevance is strong—the response directly addresses all aspects of the question’s focus on strategic positioning, execution challenges, delays, capital, and disaggregated design. The qualitative accuracy is reduced due to missing key specifics (UCIe, $3.1B charge), but the overall narrative and reasoning trajectory align well with the ground truth. Minor omissions prevent a higher score, but core facts and flow are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 465,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture's target asset allocation strategy for its defined benefit pension plans from fiscal years 2022 to 2024 shows a consistent emphasis on achieving risk-adjusted returns through a diversified portfolio of fixed income and equities, with a focus on aligning asset allocation with long-term inflation-adjusted return objectives. In 2022, the company outlined its approach to maintaining flexibility around target allocations based on market conditions and investment committee decisions, with a balanced mix of fixed income and equities to manage volatility relative to liabilities. By 2023, the strategy remained aligned with this framework, emphasizing regular reviews of asset allocation and investment managers' guidelines to ensure alignment with the overall investment strategy. In 2024, the company reiterated its long-term capital appreciation goals through diversified equity investments and continued to prioritize matching the duration of debt securities to plan liabilities, reflecting a measured, risk-mitigated approach to asset allocation. This multi-year consistency suggests a strategic focus on balancing growth and stability to optimize risk-adjusted returns over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: Accenture maintained a balanced mix of fixed income and equities across fiscal years 2022–2024, with a consistent focus on risk-adjusted returns, duration matching of debt securities to liabilities, and long-term capital appreciation via equities. The evolution toward increased flexibility and ongoing review of allocations is accurately reflected. (2) There are no numeric values (percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies in dates or financial metrics. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Accenture’s strategy across three fiscal years, identifying continuity and subtle shifts in emphasis (e.g., flexibility, regular reviews, alignment with market conditions). The only minor shortcoming is that the LLM does not explicitly mention the introduction of the 'target allocation for fiscal 2025' in 2024, which is a small but relevant detail in the forward-looking aspect of the strategy. However, it does capture the intent behind it—ongoing adaptability within established ranges. (4) The answer is contextually excellent, directly addressing the evolution of the asset mix and what it implies about risk-adjusted return objectives. Wording differs slightly (e.g., 'inflation-adjusted return objectives' appears in LLM but not original), but this does not contradict known facts and may reflect permissible inference. Overall, the response demonstrates strong qualitative and contextual fidelity with no factual errors, meriting a 9 for correctness and qualitative accuracy, and a perfect score for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 492,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 10-K filings through 2023 and 2024 indicates a consistent and thorough approach to debt disclosure, ensuring transparency by maintaining records of historical debt instruments even after their maturity dates have passed. This reflects a practice of comprehensive and ongoing disclosure of all previously issued securities, regardless of their current status. In contrast, Apple's broader debt issuance strategy from 2022 to 2024 demonstrates a dynamic approach, with the company issuing a range of new debt instruments across varying maturities and interest rates, as evidenced by the numerous Officer's Certificates in each filing that detail new notes issued in subsequent years. This suggests a proactive strategy to manage capital structure and access capital markets efficiently while maintaining full disclosure of all prior debt offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are accurately referenced, and their continued disclosure in 2023 and 2024 filings is correctly interpreted as a sign of transparent, comprehensive reporting. The broader debt issuance strategy across 2022–2024 is accurately characterized as dynamic, with new instruments issued at varying maturities and rates. (2) Quantitative accuracy is perfect: the interest rate (1.05%), maturity year (2017), and reference years (2022–2024) are all correct. While the LLM does not list specific examples like the '3.45% Notes due 2024' mentioned in the ground truth, it correctly refers to 'a range of new debt instruments across varying maturities and interest rates' and cites Officer's Certificates as evidence—consistent with the data source. (3) Multi-hop reasoning is sound: the model synthesizes information across time (from 2017 to 2024), distinguishes between historical disclosure practices and current issuance behavior, and draws a valid contrast between transparency in reporting and active capital management. (4) The answer is semantically equivalent to the original, with slightly more emphasis on procedural aspects (e.g., Officer's Certificates) but no factual deviation. The only minor shortcoming is the lack of specific examples of new debt instruments, which slightly reduces qualitative precision but does not impair correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 415,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Accenture’s share repurchase activity and remaining authorization show a consistent and strategic approach to capital return. In fiscal 2022, the company had $3.13 billion in available authorization for share purchases and redemptions. By fiscal 2024, despite repurchasing 2.0 million Class A ordinary shares for $605 million in the fourth quarter alone, the remaining available authorization was $2.69 billion. On September 25, 2024, the Board approved an additional $4.0 billion in repurchase authority, raising the total outstanding authorization to $6.69 billion. This multi-year pattern, including the cumulative $50.1 billion in authorizations since 2001, reflects a long-term, disciplined capital return strategy focused on returning value to shareholders through sustained and flexible share repurchase programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually accurate in all key aspects. It correctly states the $3.13 billion available authorization in fiscal 2022 and the $2.69 billion remaining in fiscal 2024. It accurately reports the $4.0 billion new authorization approved on September 25, 2024 (specific date not in ground truth but plausible and not contradictory), resulting in a total outstanding authority of $6.69 billion, which is correct ($2.69B + $4.0B). The $605 million share repurchase in fiscal 2024 is correctly cited, and the LLM adds the detail of 2.0 million shares, which is not in the ground truth but does not contradict it and may be derived from supplementary data. The mention of $50.1 billion in cumulative authorizations since 2001 is additional context not in the original answer but is plausible and enhances the narrative without introducing error. (2) All numeric values match or are consistent with the ground truth. The calculation of total authorization after the new $4.0 billion approval is correct. The use of 'fourth quarter' for the $605 million repurchase is more specific than the ground truth (which says 'during fiscal 2024'), but this is a refinement rather than an error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of authorization over time, accounts for repurchases reducing available funds, and recognizes the renewal of authority as a sign of sustained strategy. It connects fiscal 2022, 2023, and 2024 data points into a coherent capital return narrative. (4) The answer is contextually excellent, directly addressing both the evolution of repurchase activity and what it suggests about strategy. The conclusion about a 'long-term, disciplined capital return strategy' aligns with and slightly expands upon the ground truth's 'sustained but measured' characterization. The only reason for not scoring 10 is the addition of the 2.0 million shares and $50.1 billion cumulative figure, which, while reasonable, are not verifiable from the provided ground truth and introduce unconfirmed details. However, they do not detract from correctness, hence a 9 is appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 573,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMY issued the 4.350% Senior Notes due 2047 in 2019, as indicated in the 2022 and 2023 filings, with no new issuance or restructuring noted in 2024. The consistent inclusion of these notes in the 2022, 2023, and 2024 10-K filings suggests that BMY maintains a long-term debt structure with extended maturities, aligning with a strategy to secure stable, long-term financing. This multi-year pattern reflects BMY's intent to manage interest rate risk and maintain financial flexibility by locking in favorable rates for extended periods, supporting its long-term capital needs and operational stability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMY issued the 4.350% Senior Notes due 2047 in 2019 and consistently referenced them in 2022, 2023, and 2024 filings, which aligns with the ground truth. The absence of restructuring or new issuance of these specific notes in 2024 is also accurately stated. However, the LLM omits key details about the broader debt structuring context in 2023 and 2024, such as the issuance of the $1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052, and $3.75B 4.250% Senior Notes due 2049, which are critical to fully capturing the multi-year pattern of diversified, staggered maturities. (2) Quantitatively, all dates (2019 issuance, 2047 maturity), interest rate (4.350%), and timeframes (2022–2024 references) are correct. No calculations were required, but the factual numbers are accurate. (3) The reasoning is partially sound: the LLM correctly infers a strategy of long-term financing and interest rate risk management. However, it misses the deeper synthesis that the persistence of the 4.350% notes alongside newer debt indicates a deliberate diversification of maturities and yields, rather than just 'locking in favorable rates.' The ground truth emphasizes the 4.350% notes as a 'stable, high-yield component' in a diversified portfolio, a nuance not captured. (4) The answer is contextually relevant and addresses the evolution and strategic implication, but lacks completeness in multi-hop synthesis across all three years’ debt activities, reducing qualitative accuracy. Overall, core facts are correct, but strategic interpretation is less precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 439,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple's disclosure approach for the 2.40% Notes due 2023 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes being referenced in the \"Description of Securities\" section under Exhibit 4.3, dated May 3, 2013. This exhibit, incorporated by reference in each year, included the forms of global notes representing the 2.40% Notes due 2023, indicating no material changes in the structure or disclosure method as the notes approached maturity in 2023. The continued inclusion of this exhibit in all three filings suggests a standardized and ongoing disclosure practice for these notes, reflecting their status as part of Apple’s broader long-term debt disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.40% Notes due 2023 were consistently disclosed in the 2022, 2023, and 2024 filings under Exhibit 4.3, with reference to the Officer's Certificate dated May 3, 2013. The LLM correctly notes the absence of material changes in disclosure despite the notes approaching and reaching maturity. (2) Quantitative elements—interest rate (2.40%), maturity year (2023), exhibit number (4.3), and date (May 3, 2013)—are all factually accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the unchanged inclusion of the exhibit indicates a stable disclosure approach. (4) The only minor shortcoming is that the LLM does not explicitly state that the disclosure approach was 'unchanged' or 'stable' in wording as directly as the original answer, though this is implied through phrases like 'remained consistent' and 'no material changes.' This slight omission in emphasis prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 345,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP increased from 127,000,000 in fiscal year 2022 (as reported in Chunk 1) to 141,000,000 in both fiscal years 2023 and 2024 (as noted in Chunks 2 and 3). This increase, combined with the consistent availability of approximately 27.3 million shares for future grants in 2022 and 2024, indicates a deliberate expansion of the company’s long-term share-based compensation capacity, likely to support ongoing employee retention and incentive programs while maintaining flexibility to reuse shares from terminated or cancelled awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of authorized shares for each fiscal year: 127,000,000 in 2022, increasing to 141,000,000 in 2023 and remaining at that level in 2024, which matches the ground truth exactly. All numeric values are accurate and properly attributed to the correct fiscal years. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of figures. The LLM correctly reports the increase of 14,000,000 shares from 2022 to 2023. However, the mention of 'approximately 27.3 million shares for future grants' is not part of the original answer and introduces extraneous data not present in the ground truth; while this may be factually correct from the source documents, it was not required and slightly distracts from the core progression asked. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years and draws a logical conclusion about the company’s long-term compensation strategy—namely, an expansion followed by stabilization. The interpretation aligns well with the ground truth, though the emphasis on 'reusing shares from terminated or cancelled awards' is an added detail not present in the original and slightly extends beyond the provided conclusion. (4) The answer is highly relevant and conveys nearly identical meaning to the ground truth, with only minor additions that do not detract significantly. The core facts, progression, and strategic implication are accurately captured, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 421,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel's development and strategic positioning of PowerVia technology evolved significantly from 2022 through 2024, reflecting its growing importance in Intel's advanced process roadmap. In 2022, PowerVia was introduced as part of Intel's broader process and packaging technology roadmap during the Intel Accelerated event, alongside future nodes like Intel 20A and innovations such as RibbonFET. By 2023, PowerVia was positioned as a key enabler of the Intel 20A node, designed to deliver up to 15% performance-per-watt improvement over Intel 3 by implementing backside power delivery. However, in 2024, Intel canceled the Intel 20A node and shifted focus to the improved Intel 18A node, where PowerVia was retained as a core technology, now paired with RibbonFET to enhance performance and density scaling. This progression underscores PowerVia's critical role in Intel's pursuit of leadership in advanced semiconductor manufacturing, particularly as it transitions to gate-all-around transistors and backside power delivery in its next-generation process nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel's roadmap alongside RibbonFET; by 2023 it was positioned as an 'industry-first' backside power delivery technology for Intel 20A; in 2024, Intel canceled Intel 20A in favor of Intel 18A, which retained PowerVia and targeted high-volume manufacturing in 2025 with Panther Lake. The LLM correctly notes the performance-per-watt improvement of up to 15% over Intel 3, which is consistent with Intel's public disclosures. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages. The 15% performance-per-watt figure is correctly attributed and within expected ranges from Intel's communications. (3) Multi-hop reasoning is sound: the answer synthesizes information across 2022–2024 developments, correctly tracing PowerVia’s evolution from concept to core enabler in Intel 18A. The cancellation of Intel 20A and pivot to Intel 18A is accurately reflected, though the LLM omits explicit mention of Panther Lake being the vehicle for 18A HVM—this is a minor omission but does not detract significantly from the overall correctness. (4) Semantic equivalence is strong: while the LLM does not quote 'backside power delivery' as an 'industry-first' verbatim, it accurately describes the technical and strategic significance. The conclusion about PowerVia’s foundational role in Intel’s roadmap is logically supported. One point deducted from qualitative accuracy for not explicitly naming Panther Lake as the 18A launch vehicle, which is part of the full progression. Otherwise, the answer is factually robust, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 467,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal years 2023 and 2024. This decline suggests a strategic shift or reallocation of capital away from equity-based investments, potentially reflecting a more conservative investment approach or a rebalancing of the company's portfolio toward fixed income or other asset classes. The consistent allocation in 2023 and 2024 indicates a stabilized position in equity investments, signaling a deliberate and measured stance in managing exposure to market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the allocation amounts for fiscal years 2022 ($239,293 million), 2023 ($196,226 million), and 2024 ($196,226 million), matching the ground truth exactly. The statement that the allocation decreased from 2022 to 2023 and remained unchanged in 2024 is factually accurate. (2) All numeric values are correct and properly formatted; no calculation errors are present. The decrease of $43,067 million is implied and accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and infers a strategic shift, which aligns with the ground truth's interpretation of 'strategic rebalancing.' The addition of 'potentially reflecting a more conservative investment approach' or 'rebalancing toward fixed income' is a reasonable qualitative extension supported by the trend, though slightly more interpretive than the original. (4) The answer is semantically equivalent to the ground truth, with only minor expansion in interpretation, not contradiction. The core facts, numbers, and trajectory analysis are correct, warranting a high score. The one-point deduction from 10 is due to the slight over-extension in speculation about fixed income without explicit evidence, though it remains plausible. Contextual relevance is perfect—directly addresses both the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 384,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "From 2022 to 2024, Merck’s financial and strategic treatment of Dificid evolved in terms of asset valuation, therapeutic positioning, and global revenue contribution. In 2022, Dificid was valued at $145 million as part of Merck’s acquired intangible assets, reflecting its role in the Hospital Acute Care portfolio for treating *C. difficile*-associated diarrhea. By 2023, Dificid contributed $274 million in U.S. revenue and $28 million internationally, indicating its continued therapeutic relevance in infectious disease management. In 2024, Dificid’s revenue rose slightly to $303 million in the U.S. and $37 million internationally, totaling $340 million, showing modest growth in its global contribution. While no impairment charges were reported for Dificid during this period, its valuation and revenue trends suggest Merck maintained a stable strategic position for the product, emphasizing its role in the acute care market without major shifts in asset value or therapeutic focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Dificid's $145 million valuation in 2022 as an intangible asset and its therapeutic positioning for C. difficile-associated diarrhea. It also accurately reports the 2024 global revenue of $340 million, with $303 million from the U.S. and $37 million internationally. However, it incorrectly states that in 2023, Dificid generated $274 million in U.S. revenue and $28 million internationally. The original answer (ground truth) does not provide any revenue figures for 2023—only that Dificid was strategically highlighted in the Pharmaceutical segment. Thus, the inclusion of specific 2023 revenue numbers is factually unsupported and incorrect. (2) Quantitative accuracy is compromised due to the fabricated 2023 revenue figures. While the 2022 valuation and 2024 revenues are correct, the erroneous 2023 numbers reduce confidence in financial trends. The sum of $274M + $28M = $302M in 2023 is also inconsistent with the $340M in 2024, making the 'modest growth' claim misleading. (3) The multi-hop reasoning is otherwise sound: the model correctly traces Dificid’s evolution across years in terms of valuation, therapeutic focus, and revenue contribution. It appropriately infers strategic continuity in the acute care market, aligning with the ground truth’s narrative of increasing recognition. However, the unsupported 2023 revenue data undermines the validity of the financial progression. (4) Correctness is scored at 7 because the core trajectory—increasing strategic and financial importance—is captured, and key 2022/2024 facts are accurate, but the inclusion of false 2023 revenue data constitutes a significant factual error. Quantitative accuracy is 6 due to this major error despite correct numbers in other years. Qualitative accuracy is 8 because reasoning and entity identification (Merck, Dificid, Hospital Acute Care, C. difficile) are strong. Contextual relevance is 10 as the answer directly addresses all aspects of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 545,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022 through 2024, Intel's strategic positioning around Advanced Packaging Technologies evolved as a core element of its IDM 2.0 strategy, aiming to leverage these technologies to enable systems of chips for AI and other high-growth applications. However, execution challenges persisted, including significant R&D investment delays and financial risk exposure. In 2022, Intel acknowledged delays in implementing advanced packaging technologies due to the complexity of disaggregated designs and the novel nature of these technologies, which increased costs and design timelines. By 2023, the company emphasized the importance of advanced packaging as a unique competitive advantage, particularly in the AI-driven market, and highlighted progress such as the demonstration of the Universal Chiplet Interconnect Express standard in silicon. In 2024, the company continued to invest heavily in R&D, with expenses reaching $16.5 billion, but faced ongoing implementation delays and financial risks, including a $3.1 billion charge for impairments and accelerated depreciation related to underutilized manufacturing assets. These challenges underscored the financial and operational risks associated with Intel's aggressive push into advanced packaging and foundry services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's strategic focus on Advanced Packaging as part of IDM 2.0, execution challenges due to complexity in disaggregated designs, progress on UCIe in 2023, and the $3.1 billion impairment charge in 2024. The R&D investment figure of $16.5 billion in 2024 is consistent with Intel's reported spending trends and does not contradict the ground truth, which does not specify an exact R&D dollar amount but confirms increased costs. (2) Quantitative accuracy is excellent: the $3.1 billion impairment charge is correctly cited, and while the original answer does not mention the $16.5B R&D figure, it is factually plausible and publicly reported in Intel’s 2024 10-K, so its inclusion enhances completeness without introducing error. (3) Multi-hop reasoning is sound—information is synthesized across 2022–2024, showing evolution in strategy, execution, and financial impact. The answer correctly traces the shift from strategic optimism to operational strain. (4) The only minor gap is that the original answer emphasizes the growing 'execution risks' contributing directly to product delays and higher costs in 2024, which the LLM implies but could state more explicitly. However, the core message about financial and operational risks is clearly conveyed. Wording differences are within acceptable semantic equivalence. All entities (Intel, UCIe, IDM 2.0, advanced packaging) and years are accurate. The answer fully addresses R&D investment, implementation delays, and financial risk exposure as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 443,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "From 2022 through 2024, Merck’s HIV-1 treatment MK-8591A (doravirine+islatravir) entered Phase 3 development in February 2020, as noted in the 2022 10-K. In 2023, the program remained in Phase 3, and the 2024 10-K revealed that by October 2024, Merck advanced a related compound, MK-8591D (islatravir+lenacapavir), into Phase 3, indicating a continued investment in islatravir-based regimens. Additionally, the 2024 10-K noted that the FDA lifted a clinical hold on December 4, 2024, suggesting regulatory progress. This progression reflects Merck’s long-term strategy to innovate in the HIV therapeutic area by developing novel, potentially long-acting regimens, as evidenced by the sequential development of MK-8591A and MK-8591D.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MK-8591A entered Phase 3 in February 2020 and remained in Phase 3 through 2022 and 2023, which aligns with the ground truth. It accurately notes the FDA lifted a clinical hold on December 4, 2024. However, it introduces MK-8591D (islatravir+lenacapavir) advancing into Phase 3 by October 2024, which is not mentioned in the original answer and is extraneous to the question about MK-8591A. While this may reflect real developments, it distracts from the core timeline of MK-8591A and could imply progress in the same compound when it's a different regimen. (2) Quantitatively, all dates (February 2020 entry, December 4, 2024 FDA action) are correct. The mention of October 2024 for MK-8591D advancement lacks corroboration in the ground truth and introduces uncertainty, though not a direct numerical error. (3) The multi-hop reasoning is partially sound—linking 2022–2024 10-K disclosures to track development status—but overreaches by incorporating MK-8591D as evidence of MK-8591A’s progression, which weakens the logical synthesis. The conclusion about Merck’s long-term strategy is reasonable and supported by both answers. (4) The answer is contextually relevant and well-structured, but the inclusion of MK-8591D reduces qualitative accuracy and completeness for the specific compound asked about. The core facts on MK-8591A are correct, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 400,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck's development strategy for MK-1308A has evolved from 2022 through 2024 with a focused clinical emphasis on renal cell carcinoma (RCC) as a combination therapy of quavonlimab (an anti-CTLA-4 antibody) and pembrolizumab (Keytruda). In 2022, MK-1308A was listed among Merck’s oncology pipeline candidates, highlighting its role in treating advanced solid tumors and specifically noted for RCC. By 2023, Merck explicitly outlined MK-1308A as a key immuno-oncology candidate in its strategic pillars, emphasizing its evaluation for RCC and its co-development with pembrolizumab. In 2024, the compound remained a core part of Merck’s immuno-oncology strategy, with continued focus on RCC and no new clinical or regulatory progress reported beyond its ongoing evaluation. This trajectory reflects a sustained, targeted approach to advancing MK-1308A in combination immunotherapy for RCC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is consistently linked to renal cell carcinoma (RCC), described as a combination of quavonlimab and pembrolizumab, and remains in Phase 3 development through 2024 with no regulatory approval yet. The evolution from being listed in the oncology pipeline in 2022 to a more explicitly defined coformulation in 2023 and sustained strategic focus in 2024 is accurately captured. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) and developmental phases (Phase 3) are correctly referenced. (3) The multi-hop reasoning across years and aspects—clinical focus, combination therapy, and regulatory progress—is sound. The LLM correctly synthesizes that the clinical focus on RCC has remained consistent while the formulation strategy became more clearly defined over time. (4) The only minor shortcoming is that the LLM does not explicitly state that MK-1308A is a 'coformulation' of quavonlimab and pembrolizumab until 2023, which the original answer highlights as a key evolution. While implied, this nuance is slightly underemphasized. Otherwise, the answer is semantically equivalent, contextually complete, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 356,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Accenture's share repurchase activity and remaining authorization demonstrate a consistent and substantial capital return strategy. In fiscal 2022, the company had $3,129,296 in available authorization for share purchases and redemptions. By fiscal 2024, despite repurchasing 2,000,308 Class A ordinary shares for $605 million in the fourth quarter alone, the remaining available authorization was $2,694 million as of August 31, 2024. On September 25, 2024, the Board further approved an additional $4,000 million in repurchase authority, raising the total outstanding authorization to $6,694 million. This multi-year pattern, supported by a cumulative $50.1 billion in authorizations since 2001, indicates a long-term commitment to returning capital to shareholders through disciplined and ongoing share repurchases, reflecting confidence in the company’s financial strength and strategic priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the $3,129,296 thousand (stated as $3,129,296, which is acceptable given context) available authorization in fiscal 2022, the $2,694 million remaining in fiscal 2024, the $605 million spent on repurchasing 2,000,308 shares in fiscal 2024, and the additional $4,000 million authorized in September 2024, leading to a total outstanding authority of $6,694 million. These figures match the ground truth exactly, with only minor formatting differences (e.g., missing 'thousand' label but number is correct in context). (2) Quantitative accuracy is high: all dollar amounts and share counts are correct. The LLM incorrectly states that the $605 million repurchase was in the 'fourth quarter alone,' while the ground truth specifies 'during fiscal 2024' without limiting it to Q4—this is a minor temporal overprecision but does not invalidate the overall correctness. The cumulative $50.1 billion since 2001 is not in the ground truth and appears to be an addition from external knowledge; while plausible, it is not verifiable from the provided data and thus introduces unverified information. However, it does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years, tracks the evolution of authorization, accounts for new approvals, and infers strategic intent. It captures the core pattern—sustained repurchases with replenishment of authority. (4) The answer is contextually excellent, directly addressing both the evolution of repurchase activity and what it indicates about capital strategy. The conclusion about 'long-term commitment' and 'disciplined' repurchases aligns with the ground truth's 'sustained but measured strategy.' The only minor issues are the unverified $50.1B figure and the Q4 specification, which prevent a perfect 10. Overall, the answer is highly accurate, well-reasoned, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 531,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 have been consistently included in its capital structure filings from 2022 through 2024, as evidenced by their appearance in the 10-K filings for each year. This persistence reflects the company's strategy of maintaining long-term fixed-rate debt obligations to manage interest rate risk and ensure stable financing over an extended period. By retaining this instrument in its capital structure, BMY demonstrates a disciplined approach to debt management, leveraging fixed-rate debt to lock in favorable terms and support long-term financial planning and operational flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750,000,000 2.350% Notes due 2040 are accurately described, and their consistent presence in capital structure filings from 2022 to 2024 is correctly noted. Dollar amounts, interest rate, and maturity year match the original answer exactly. (2) Quantitative accuracy is perfect: $750,000,000, 2.350%, and 2040 are all correctly reported with no calculation issues. (3) The reasoning is sound and captures the strategic intent behind retaining fixed-rate debt—managing interest rate risk, ensuring stable financing, and supporting long-term planning. While the LLM does not explicitly mention 'no refinancing or retirement despite market fluctuations' (a minor omission in 2024 context), it still correctly infers a deliberate strategy of retention. (4) The answer is fully contextually relevant, directly addressing how the persistence of the notes reflects BMY’s long-term debt management strategy. The only reason for not scoring a 10 is the slight lack of detail on the year-by-year reaffirmation and the explicit connection to not refinancing, which slightly reduces qualitative depth. However, the core message and factual correctness remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 353,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol-Myers Squibb's 4.350% Senior Notes due 2047 were first introduced in the 2019 filings (Chunk 3) and consistently referenced in subsequent filings in 2022 (Chunk 3), 2023 (Chunk 1), and 2024 (Chunk 2), indicating a stable and long-term commitment to this debt instrument. The consistent inclusion of these notes across multiple years, alongside the issuance of other senior notes with varying maturities and coupon rates, suggests a deliberate strategy to diversify its long-term debt portfolio and manage interest rate exposure over extended periods. This pattern reflects a disciplined approach to capital structure management, emphasizing long-term financing stability and flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.350% interest rate and the due date of 2047, and notes consistent disclosure across 2022, 2023, and 2024 filings, which aligns with the ground truth. However, it incorrectly references 'Chunk 3', 'Chunk 1', 'Chunk 2'—likely internal retrieval markers not present in original filings—and inaccurately states the notes were 'first introduced in 2019 filings (Chunk 3)', while the ground truth specifies the Form 8-K filing on November 22, 2019, as the source document, not a 2019 10-K. The LLM omits specific exhibit numbers (e.g., Exhibit 4bbb in 2022, Exhibit 4ff in 2023/2024) and supplemental indenture details (Twelfth and Fourteenth, with exact dates), which are key factual elements in the original answer. (2) Quantitatively, the 4.350% rate is correct, and the years 2019, 2022–2024 are accurately referenced in context, though the lack of precise dates (e.g., November 13, 2020/2023) and exhibit identifiers reduces precision. The claim about 2019 introduction is partially correct but lacks the specificity of the Form 8-K reference. (3) The multi-hop reasoning is sound in recognizing consistency over time and inferring a stable long-term debt strategy. However, the LLM generalizes about 'issuance of other senior notes' and 'diversify its long-term debt portfolio', which, while plausible, is not supported by the provided ground truth and introduces external inference. The original answer focuses on transparency and predictability, not diversification. (4) Despite missing specific legal document details and exhibit numbers, the LLM captures the core pattern of rate stability and links it to a coherent long-term financing strategy, maintaining high contextual relevance and qualitative accuracy, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 490,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Nike's reporting on FlyEase technology evolved from being listed among a range of innovative technologies in its R&D section to being more integrated into its global manufacturing operations. In 2022, FlyEase was mentioned as one of several technologies reflecting Nike's innovation, but no specific production details were provided. By 2024, the 10-K filing indicates that FlyEase had been scaled into Nike’s global supply chain, with quantitative evidence showing that 15 contract manufacturers across 11 countries, including major production hubs in Vietnam, Indonesia, and China, were involved in footwear manufacturing, and 68 contract manufacturers across 33 countries for apparel. This demonstrates FlyEase's integration into Nike’s broader production systems, supported by 169 strategic Tier 2 suppliers as of May 31, 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Nike's reporting on FlyEase from fiscal 2022 to 2024, noting its progression from an innovative technology to broader integration. However, it introduces incorrect quantitative details. The ground truth states that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% of total Nike Brand footwear (which includes FlyEase products), demonstrating geographic integration. In contrast, the LLM claims that '15 contract manufacturers across 11 countries' were involved in footwear manufacturing and '68 contract manufacturers across 33 countries' for apparel, which is not present in the original answer and not supported as specific evidence for FlyEase scale. These numbers appear to be hallucinated or misattributed from other parts of a 10-K filing. (2) The only correct quantitative element is the mention of Vietnam, Indonesia, and China as key production hubs, but the LLM fails to report the actual percentages (50%, 27%, 18%) that serve as the core evidence in the ground truth. Additionally, the reference to '169 strategic Tier 2 suppliers as of May 31, 2024' is contextually relevant to supply chain scale but does not specifically tie to FlyEase production and is not mentioned in the original answer as evidence for FlyEase integration. (3) The multi-hop reasoning is partially sound—linking increased mention of FlyEase to deeper integration over time—but the LLM substitutes general supply chain data for specific FlyEase-related production metrics. It fails to make the logical connection that the geographic distribution of footwear manufacturing (with exact percentages) serves as proxy evidence for FlyEase’s integration, since FlyEase is part of the broader Nike Brand footwear line. (4) The contextual relevance is high because the answer addresses both the evolution of reporting and attempts to provide quantitative supply chain evidence. However, due to significant inaccuracies in numbers and misalignment with the specific evidence in the ground truth, the correctness and quantitative accuracy scores are moderate. The qualitative reasoning is acceptable but not fully precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Expands]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 586,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This downward trend suggests that the effectiveness of Target's loyalty-driven payment strategy may have weakened over the period, as a lower share of purchases are being made using RedCards, which are designed to drive incremental sales and customer loyalty through discounts and rewards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (17.8%), matching the ground truth exactly. All numerical values and years are accurate. (2) There are no calculations required beyond reporting the trend, and the percentages are presented correctly with no formatting discrepancies. (3) The reasoning is sound: the downward trend is accurately interpreted as a potential sign of weakening effectiveness in Target's loyalty-driven payment strategy, consistent with the ground truth's conclusion. The LLM appropriately links the declining penetration to reduced customer engagement, aligning with the multi-hop inference required. (4) The answer is semantically equivalent to the original, capturing both the factual trend and its strategic implication. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 260,
        "total_tokens": 1491
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.82,
    "average_quantitative_accuracy": 8.49,
    "average_qualitative_accuracy": 8.06,
    "average_contextual_relevance": 9.49,
    "score_distribution": {
      "excellent": 444,
      "good": 194,
      "fair": 126,
      "poor": 36
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 17394.81,
    "timestamp": "2026-02-04T01:15:56.737855"
  }
}